00332c65-edad-a153-9c78-628931daa732_734_1.jpg £ N 8 /)=2/0%0-8.¢0 “Each fim-coated ablet contsing divalproex sodum, USP equivalet 10250 mg of valproic ok RIS ) o Once-Dally Dosing tsing achik-resistant closure: g Divalproex Sodium :TMZTWT £ i and all medication Extended-Release iy o mectonti Tablets, USP ‘Store at 20° to 25°C (68° to TT°F). e USP Contoled oom EXN () e Activity Usual Dosage: See accompanying Bk prescabing informaton PRARIACE Dispere e aconganying Meticaion Gt o cach patieat Mylan Pharmaceuticas Inc. o . ([MMylan MMylan® ) G5 Mylan.com
00332c65-edad-a153-9c78-628931daa732_734_2.jpg - R *Each film-coated tablet contains Dispense in a tight, light-resistant confainer & divalproex sodium, USP equivalent LT as defined in the USP using a chld-resistant = wz 10500 mg of valproic acid. Once-Daily Dosing _ closure. § o Divalproex Sodium Keep container tightly closed. £ W | — Extended-Release Keep this and all medication out of the °|°__ @ Tablets, USP reach of children. o @nkaa Store at 20° to 25°C (68° to 77°F). [See ﬂ_ 55 E 500 mg* € USP Controlled Room Temperature.] o é g g g Valproic Acid Activity Usual Dosage: See accompanying & paee PRARMACIST: Dispense the accompanying Wedication] _ rescribing information. J g 5 Guide to each patient. i : Mylan Pharmaceuticals Inc. - é @ Myl an® Merantown, WV 26505 USA g 311\ Tablets @]Mylan@\ Mylan.com o
00411010-9e39-4e7b-a82f-7b71383d1ba1_409_1.jpg Pashaged by Eryane Reanch Buabank. 04 91500 Glipizide ER 5mg 5™ Tablet oa B & Keepall drugs outof Compare To: reach of children [ — Sorm st morltamp F Par Pharmaceutical Inc. g 20-25 C (68-77F) #90 Exp: MMYY 5 NDC 7133503881 040711111245
00411010-9e39-4e7b-a82f-7b71383d1ba1_409_2.jpg Pachaged by Eopant Reech Bnbank. €4 91504 Glipizide ER 5™ ™woc:re 10mg Tablet 10 60021 Store at room temp of Compare To: 20°25°C (68°77°F) Glcotl XL 10mg Tabkt “Keop all drugs outof Par Pharmaceutical Inc. reach of children. #30 Exp: MMYY NDC 7133508511 031581120094 om
004de5a4-80f8-4040-a6ea-be5e99352a36_282_1.jpg NDC 47335-859-83 (Once Daily) Tramadol Hydrochloride Extended-Release Tablets @/ The tablets should be swallowed whole with liquid and not spl, chewed, dissolved or crushed. Rxonly PHARMACIST: Please dispen: o 30 Tablets Guide provided separately PULB1923B 1SS, 01/2017 GUIDRUGS/25/789 0Open for Full Labeling —
004de5a4-80f8-4040-a6ea-be5e99352a36_282_2.jpg Each extended-release coated tablet contains 200 mg of tramadol hydrochioride, USP. NDC 47335-860-83 (Once Daily) Tramadol Hydrochloride Extended-Release Tablets @/ Dispense in a tight, light-resistant container. m 'WARNING: Keep out of reach of children. The tablets should be swallowed whole ‘with liquid and not split, chewed, dissolved or crushed. PHARMACIST: Please dispense with Medication Guide provided separately 10 each patient. R only \ 30 Tablets Usual Dosage: Please see accompanying prescribing information. Store at 20°to 25°C (68° to 77°F); excursions permitted between 15°and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 3|| — — —_— — 47335 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India. GUJDRUGS/25/789 PJLB1927B ISS. 01/2017
004de5a4-80f8-4040-a6ea-be5e99352a36_282_3.jpg WO 47335-861-83 (0nce Daily) Tramadol Hydrochloride Extended-Release Tablels@/ The tablets should be swallowed whole with liquid and not spl, chewed, dissolved or crushed. PHARMACIST: Please dispense with Medication Guide provided separately to each patient. © Each extended-release coated tablet contains 300 mg of tramadol hydrochloride, USP Usual Dosage: Please see accompanying prescribing information. Dispense in atight, light-esistant container. WARNING: Keep out of reach of children. Store at 20° to 25°C (68° 0 77°F); excursions permited between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature). Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Rx only 30 Tablets ( 86 183 47335 N 3 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India. GUJDRUGS/25/789 PJLB1931B ISS. 01/2017
00570e0a-6cca-4513-8ab5-d3b5496cc151_155_1.jpg TS T CSHIS Tncarporiied G Tncorporaied _GSIS Tncorporared _GSMS Tncorporaed NDC 60429-121-30 VENLAFAXINE iHYDROCHLORIDE EXTENDED-RELEASE CAPSULES 37.5 mg* 30 capsules e paskags insart for dozags information. e B o oA e, Rx only
00570e0a-6cca-4513-8ab5-d3b5496cc151_155_2.jpg NDC 60429-122-30 VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 75 mg* 30 capsules Ses package nsertfor dosage nformation. oo o o e, Rx only
00570e0a-6cca-4513-8ab5-d3b5496cc151_155_3.jpg CSHS carparaied _GSNS crporared_GSMS Tncorporared Tneorporaied %1 Elz g% NDC 60429-123-30 VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 150 mg* 30 capsules - s £ i g & e package insertfor dosags informtion | e, | B oniy
01ad7942-99c3-40ee-9cfb-272fb6c44e2b_810_1.jpg NDC 67457-657-25 250 mL Esmolol Hydrochloride in Sodium Chloride Injection 2500 mg/250 mL LN (Single-Dose Plastic Bag) Iso-Osmotic No Preservative Added Single Intravenous Use Only ity s UG oy e U oy f e B o WY o R D DOROTINTRO00EADOTNES. as b Mttt o oo e DR 2016 S 125 () s it 15030 0015565 S R T L FROTECT RO FREEDNG Ao s ot l e
01ad7942-99c3-40ee-9cfb-272fb6c44e2b_810_2.jpg NDC 67457-658-10 100 mL. Esmolol Hydrochloride in Sodium Chiloride Injection 2000 mg/100 mL JEIREINN (Single-Dose Plastic Bag) 150-Osmotic No Preservative Added Single Intravenous Use Only et [WMylan® E2ch L contins 20 mg Esmool Hycochoride DO not remove unit rom overwrap. USP, 41 mg Sadium Chloride USP n Water fcr untl ready o use. nction US. Buffered with 28 mo Sotium AGEtate Do not use If verwrap has been Titytfrate USP and 0.546 mo Glacial Acetc AGId previously opened of damaged. USP. pH adjusted wilh sodium ydroxde andcr The overwiap s mosture barer. hydrochioriacid. pH5.0 (45105.5). The nner bag maintains the terlty Steie, nonpyrogenic ofthe product. Usual Dosage: See package insett. Gautions: After removing the overwrap, check for Manufactured for: leaks by squeezing container frmiy. I leaks are Mylan Institutional LLC found, discard as strlity may be impaired. Use only Rockord, IL 61103 .S A if solution i clear coloress to light yellow. DIscard o iy ndia unused portion. i DO NOT INTRODUGE ADDITIVES. ke Must not be used In series connections. ARG KIRGHIE RIS Store at 25°C (77°F). Excursions permitled to 1020637 16° 0 30°C (69° 1o 86°F). (See USP Controlled Room Temperature.) PROTECT FROM FREEZING. Avoid excessive heat. ! By \ 6745706581 TEARATNOTCH
0236cc2e-43ca-4ee4-8684-62e4c75053af_168_1.jpg NoC# Ti6100tE-16 Tizanidine, USP 4mg 6000 Tablets Tizanidine, USP 4mg 6000 Tablets
02806e6f-8746-4740-9327-ba58d320bff1_895_1.jpg NDC: 50436-0219-2 CEPHALEXIN 500 MG / 20 CAP Each capsule contans Cephalexin Mg by: Alkem Laboratories Ltd. Monoydrate equivalent to 500 mg Cephalexin. - Mumba - 400 013, India Dispense in a tight, iht-resstant container. Keep Tightly Closed, VUARNING: KEEP OUT OF REACH OF (CHILDREN, STORE AT 20.25°C (6877°F) ‘CONTROLLED ROOM TEMPERATURE. SEE PACKAGE INSERT FOR DOSAGE INFORMATION. MFG NDC: 67877-219-05 MFG LOT: Y00000X LOT: X000 EXP: XX/XX/XX Pkg by: Unit Dose Services, LLC e FL 33004 g onuy o S0436-0219:2 ORUG: CEPHALEXIN 500 MG /20 CAP LOTH000X BXP: XXX Noc: 5043602192 ORUG! CEPHALEXIN 50014/ 20 G2 LOT 0000 EXP: XXX NOC: 5043602192 ORUG: CEPHALEXIN 500 MG / 20 CAP LOT: 0000k X XXX NOC: 5043602192 ORUG: CEPHALEXINS00 MG/ 20 CAP frospiiongiop Lo b X
028cc371-6295-41c9-8d55-d3c1266ceb00_318_1.jpg nan
02c91fba-9c47-43ef-ac78-e82369798834_577_1.jpg nan
02e4f4fe-fa05-4162-a375-66c9a92018ed_946_1.jpg Packaged by Eryaut Ranch Burkank, Ot 91504 Phendimetrazine 5 BUEROMN03 S rescontsiue) Tart. 35mg (Clll) = 5 & | Store atroom temp of Compare To: 20-25 C (68-77F) Plegine 35mg(Clll) Tablet (Blue) Keep all drugs out of Mikart Inc: reach of children Aoy #30 Exp: MM/YY NDC 6362973191 073191111675
033a79c7-71dd-7b29-8dc5-21af1e4de8c5_522_1.jpg g N Bamee o L s Hydrochlorothiazide et imen orenaen Store at 20° 0 25°C (6810 77°F). Tablets, USP ) [See USP Controlled Room § Ll Tomeeeued ) - Protect rom excessive light mg/ ‘and humidity. Usual Aduit Dosage: e accom- P panging et mfomatn. Hylan Pharmaceuticas Inc. Homartown, /28505 USA [IMylan® ([MMylan® Rxonly 100 Tablets Mylan.com o &l A 3 1 o ! 1 o 0
033a79c7-71dd-7b29-8dc5-21af1e4de8c5_522_2.jpg g N Lisinopril, USP 20 mg Ll ] ‘container as defined in the USP Hytrochicothizide, USP 125 mg st kst doun, 5 Lisinopril and Konctainr Sy o, Hydrochlorothiazide | cersthssmechsrshiam: Tablets, USP B Coted oo Temperature.] He e and humidity. D S e e e s At s (i)Mylan® ([MMylan® Rxonly 100 Tablets Mylan.com 10=2102=82£0 6
033a79c7-71dd-7b29-8dc5-21af1e4de8c5_522_3.jpg wz ELE‘E:‘:»EE"“::W am N"C il 2 lﬁifn’ih‘%“dl‘«?ig““n'zifﬂ?p’"‘g o= 1 * Lisinopril and ot ks é — Lo Wi sl medaton — Hydrochlorothiazide et e oronaen: o E— Sl a2 2T @171, | — Tablets, USP » [See USP Controlled Room S 5945 0 i S 3528 pIE i w B E Usual Adult Dosage: See accom- 1= o0 25mg e el alenieis = i W Parmasmea . Comm fREE e— - ? Y (Mylan g Rxonly 100 Tablets Mylan.com
034fb7cd-e183-475e-8beb-64fd88facc8f_243_1.jpg U7 Cortratind Ao Tompertre] Oupmueina sght, bttt el kgt e (3 o). VEEP TS AND AL MEDICATIONS UT OF THE REACH OF CHLDREN. TEA PUBINGELTEAS US4 WG 3 0093-53¢6-01 & © = m s 88 - Se2= gge3 1 M.MMMM.MM sE2ii il B S 420" 0 25°C (8 1077°) (S0 e UsP s Rev A9 To932100852
034fb7cd-e183-475e-8beb-64fd88facc8f_243_2.jpg © = | 582 i g3ges i WMHWMMBMWNW s I Exch et s capnde contans eighendt ki, USP g Ul Donage: S packag et o i prscritg formtion S 420" 0 25°C (8 1077°) (S0 U7 Cortratind Ao Tompertre] Oupesenang s o 2 o U3, w3 Sttt cosn (e VEEP TS AND AL MEDICATIONS T OF THE REACH OF CreLREN. A PRNCETERS U5k B Norh W, A 18454 Rev A9 79932100889 % 0093-5347-01
034fb7cd-e183-475e-8beb-64fd88facc8f_243_3.jpg © £ m g 8= U §3323 I mmnmmmm.w,mm sEeRkiill s et e copd contins et ok nde, 5P W ol Dexage: So packag et o Wipresrion miomaon 25T 6810 77T (S o o Tomperstrs] KB THE AND ALL MEDIGATIONS UT OF THE REACH OF YL OREN TEA RARMCELTCAS USA WG Nort W, AT Ao A0S 7992100884 3 0093-5348-01 & L7
03d9ce02-0559-494c-a53d-de9b9a64b606_975_1.jpg .5 mg/250 mg PHARMACIS:PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET B only NDC 0093-7455-01 2 Usual Dosage: See package insert for prescribing information. Store a1 20"t 25°C (68”1 7°F) See USP. Controlled Room Temperaturel. Rev. 01272015 323K326730216 w 0093-7455-01
03d9ce02-0559-494c-a53d-de9b9a64b606_975_2.jpg ATTACHED PATIENT INFORMATION LEAFLET B only NDC 0093-7456-01 2.5 mg/500 mg FHARMACIST. PLEASE DISPENSE WITH Each fim-coated tabet contais 2.5 my ghpizde. USP and 500 mg metformin hydrochlonde, USP. : See package insert or full prescribing nformation. Store at 20" 0 25°C (68° 10 77°F) [See USP. Controlled Room Temperature]. Dispense in a tght, bgresistant container as Gefined inthe USP, with a chiesistant cosure (as requird). WARNING: KEEP THS AND ALL MEDICATIONS. ‘OUT OF THE REACH OF CHILDREN. Rev.0 1212015 Manutactured I frael By 323K326860216 n 0093-7456-01
03d9ce02-0559-494c-a53d-de9b9a64b606_975_3.jpg ] 5 g 3 o 42 3 3 g .m.n g Nmm £ &H] g 5mm>lxmﬁ Each fim-coated tablet contains § mg ghpinde. USP and 500 mg metformin hydrochloide, USP. Usual Dosage: See package Insert for full prescriting information. Store a1 20° 10 25°C (68"t 77°F) [Se0 USP Contrlled Room Temperaturel. Dispense na ight. bghresistant conainer as defined in he USP, wih a chtiesistant closure (s requied). WARNING: KEEP THIS AND ALL MEDICATIONS ‘OUT OF THE REACH OF CHILDREN. Manutactured b brae By & 323K227030216 n 0093-7457-01
03dd3301-e9ce-40af-84e1-7b70fc6557b0_727_1.jpg g z XY 10T L6=1162=8/2¢0 2 i costed et et s 5t gt Siaiern IRELOTI dee o b [ XECRCRRNRNNY NI sing a chid-resitantcosure. Capecitabine tesiemyoas Keep this and all medication Tablets, USP out o the reach of children. Store a1 20°1025°C (68° 0 77°F). 152 USP onirolld Room m Tempersture] Usual Dosage: See ccompanying Oncology Product prescibing infomaton, Mylan Pharmaceaticals . Nerganiown, W 8505 USA. [MMylan® [Mylan AM2511D1 a0 60 Tablets Mylan.com
03dd3301-e9ce-40af-84e1-7b70fc6557b0_727_2.jpg o in-costed it ot O Capeciabine, USP 500 mg & | — E —— I— == 3748 S= crc v 2 g3 ! “ S § Capecitabine Tablets, USP Oncology Product [MMylan® Dispenseina gt gt rsistant contaner 3 cetned nthe USP \aingachidrestant e Keep containr tighty cose. Keep this and all medication out ofthe reach of children. Store 2t 20° 10 25°C (68° 10 T7°F). [See USP Controlled Room Temperature] Usual Dosage: See accompanying prescrbing nformaton Mylan Pharmacouticals fn. Nrgastown, WY 26505 US A [MMylan® RM25120 Rx only 120 Tablets Mylan.com
03f6f6ae-66bc-6819-8ba9-7c9c3fbef90d_869_1.jpg Noc a2z CEPHALEXIN CAPSULES, USP Capees miOuy DAL ORUGS 0010 T A0 CHLDRE.
03f6f6ae-66bc-6819-8ba9-7c9c3fbef90d_869_2.jpg , US| CEPHALEXI | CAPSULES,
03f6f6ae-66bc-6819-8ba9-7c9c3fbef90d_998_1.jpg c_—_ (@m0 Ay S, USP RxOnly EPHALEXIN [ CAPSULE: 500 Capsules
03f6f6ae-66bc-6819-8ba9-7c9c3fbef90d_998_2.jpg (@sus0 muny ) 450 5] 41241 ) MR 01OV 110 100 o0 i e Ve s Sz 95 500 Y b N P , USI Rx Only NoC 42 EPHALEXI [ CAPSULES, 300 Capsuies
04895e7e-0faa-4c4a-a1c1-203743608a3f_485_1.jpg e OSSR — g EERSLER SRe e OSSR . t e R R epnmmem | 230 Mo ST b HOURS AS NEEDED. MK HE Se=- L TETRLETS et olRS, L T EEwn, A R :
04f1a804-00f1-48f5-acfa-0ed1a8544784_529_1.jpg 20 ExtENDED
0548a983-bb83-4713-9326-469dc483f7b1_458_1.jpg Pachaged by Eopant Reeck Znbank, €4 91504 Valacyclovir 5 Secmucsmdchuss S 500mg Tablet 189211 Keep in light resistant Compare To: container perUSP Valtrex 500mg Tablel Siore at room tempof | Cipb L . 2025C(68-T7F) #15 Exp: MMYY & NDC 7133500211 044681112681
0548a983-bb83-4713-9326-469dc483f7b1_458_2.jpg Pachaged by Eopant Reech Zbank. €4 90504 Valacyclovir Hel G Bscmuesueeceus: 1gm Tablet SYBETT Store at room temp of Compare To: 20-25 C (68-77F) Valtrex 1gm Tablet Keep in light resistant Ciph Limted container perUSP #30 Exp: MMYY NDC 7133501231 048371113845 om
05f08d62-9de9-4af9-931e-10b93c70e39e_526_1.jpg B “Eachcapulecrtain chone Dispence n ight gt eisant 2 enabra equvaert b 45 mg continer asdeied nhe USP lfenabric k. B v s chi-rsiar cure Keep contaier tighty closed Keep tis and all medication out of thereach of chidren, Store 2t 20° 10 25°C (88" to 77" [See USP Controlled Room Temperature] Protect from msture. Usual Dosage: Seo accompanying prescrbing nfrmation Swallow whole. Do notopen, rush, dissolve or chow capaules. Mylan Pharmaceuticals Inc. Worganiown, WA 28505 US A [MMylan® RM2589M) B XY 10T 5AXIOYIXT XY N5 COOORTRRNNNY AT [MMylan® e
05f08d62-9de9-4af9-931e-10b93c70e39e_526_2.jpg *Each capsule corfains choline Dispense in a tight, light-resistant 3 | Toctiteconmirt 155 my NARISICRPA VLR Coie e e n e U5 o 7o e i § £ N Keep this and all medication outof the each ofchlden. Store i 20° 0 25°C (8° W 77°F). [Se0 USP Gontrolld Room Temperature] Capsules Protect from moisture. Usual Dosage:See accompanying prscriting normaticn. Swallow whole. Do ot open, crush,disslve orchew capsules. Hylan Pharmaceutials fnc. Morgarionn, WV 26505 US A [@MMylan® [MMylan: P ‘ XY 10T ASIXIONAXT 4 /)=-0652-82£0 OO, XXX NI 7
060db20b-d889-48db-a034-83dc3811d723_777_1.jpg NDC 0517-0920-01 Each mlcontains: Busulfan 6 mg. =t O1 BusuLFAN Inactive ingredients: —_— Dimethylacetamide 33% (v/v) — INJECTION Pletiene Ghoo 400 673 /o) et O FOR INTRAVENOUS INFUSION ONLY- St & 60 Mg/10 ML (6 ME/ML) o0 nsor for spocalnstructions o & y under Preparation for Intravenous — ™ 10 mL Sterile Single Use Vial Administration. T Cytotoxic Agent Dosage and Administration: ~E===O . See package Inset for dosage and =z 01 Courtion: Mist b diiited sdministration Information. =c before use. istod b Soe gt bewean 2" = RxOnly REGENT,INC. 108°C(36° 1046°P), =5 SHIRLEY NY 11967 Rev. 0716 PC4930A
060db20b-d889-48db-a034-83dc3811d723_777_2.jpg @SN 910j0q PAINIP 9q ISNY :uopneY fiuoxy (Jw/3w 9)7w 0T /3w 09 NOILO3NI swinasnvomis Nv4InSng T oT X8 80°0260-L750 0N Each ml_ contains: Busuifan 6 mg Inactive ingredionts: Dimethytacetamide 33% (v/4) Polyethylene Giycol 400 67% (v/Y) Dosage and Administration: See package insert for dosage and administration information. Content: Eight sterile 10 mL single use vials Store reffigerated between 2°Cto 8°C (36°F to 46°F). 1wy NON COATING AREA 331 PCASAIA Rev 12/16 Distributed by: AMERICAN REGENT, INC. SHIRLEY, NY 11967 NDC 0517.0920.08 BUSULFAN INJECTION 60 mg/10 mL(6 mg/mL) Rx only Caution: Must be FOR INTRAVENOUS INFUSION ONLY-See insert for special instructions under Preparation for Intravenous Administration. CYTOTOXIC AGENT STERILE 8x10mL SINGLE USE VIALS luted before use. Distrbuted by: AMERICAN REGENT, INC. SHIRLEY, NY 11967
0617f38b-d150-48d9-a2f9-76e0505907eb_302_1.jpg Packaged and Distributed by 2“4&&{ edw pmté g 1‘_/@ 1-800-337-8603 Temperance, Ml 48182 Waming: Keep out of children’s reach. OXYCODONE & ACETAMINOPHEN 2eperee sty ot e 120 § MG { 325 MG TABLETS. Caution: Do not use with alcohol E Each tablet contains Oxycodone hydrochloride, USP 5 mg without consulting a physician equivalent to 4.4815 mg Oxycodone Lot: Acetaminophen, USP 325 mg 8% oRs #EZ% o RS2 2 EXpi WARNING: MAY BE HABIT FORMING R i: =g ‘*: =g * REV. Item # 55700065801P Sy 83 32 &8 3§ NDC: 55700-0658-01 86 or B85 o & Mfr- Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512 §$ ;§ §g ;§ § Consult with a physician or see insert for dosage. NORGE x6 ox ™ Consultar con el medico o consulte insertar para dosis. || == = white to off-white, round, uncoated tablets debossed w ."—; @3 with “5/325" on one side and “C"” on one side of scoreline Ez Eg
062a8e35-94e7-448c-8da6-9e1dd06c0ccb_170_1.jpg Venlafaxine HCI 37.5 mg Capsule, ER arv: 30 ID #: ZA;35;37;5;mg Expires: NDC #: 70518-0478-00 Shape: Capsule LOT #: Ref #: 68382-0034-10 MFG: ZyGenerics/Zydus Pharmaceuticals, Pennington, NJ 08534 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
06c529fc-272c-f889-f5e5-7f3e5ef2c59d_910_1.jpg omoverss s RO Dty T ssne VISONPABOGA WA E MSSONFARAA NP ST 5 Sk X o | e v A e o ey v s oy ol AR TR | %'"""H" I =
06c529fc-272c-f889-f5e5-7f3e5ef2c59d_910_2.jpg s gentte natevre Oyl buneod 5300 CihaNagHgm o Up 5'?*“300 \Li
06c529fc-272c-f889-f5e5-7f3e5ef2c59d_910_3.jpg citranatal.com Coating KO Confains Stool Softener CitraNetp{ 072 b o & rs " Gl Ths gt nature s its stren
06c529fc-272c-f889-f5e5-7f3e5ef2c59d_910_4.jpg S i S S g
06c529fc-272c-f889-f5e5-7f3e5ef2c59d_910_5.jpg aitanatal com " vow | CitraNatal ESSUEE CitraNatal ESSUGE RPrenaa Supemet bl Rebental Tblet and 300 mg DHA St el 300 mg DA CitraNatal ES CitraNatal ESEE Rx Prenatal Supplement Tablet Rx Prenatal Supplement Tablet ant 300 mg DFA Soft Ge and 300 mg DHA Soft Gel HAEN YOU WANT COMPLETE CAR ity st i citronotal.com S march /k:) of dimes’ amJ o
072e37e3-5a0d-469a-a34c-019c5513a172_260_1.jpg for Injection, USP b=y Single Dose Vial For IV Use Only SANDOZ “Each vial provides piperacilin and tazobactam cryodesiccated powders for inection equivalent to 2 piperaciin, 0,25 g tazobactam and 4,69 mEq (108 mg) of socsum, Contains no preservative. See package inser for reconstitution nstructions and Complete drections for use. Prior to Reconstitution: Store at 20° 10 25° C (68 10 77° P)[ses USP Controled Room Tomperature). 24 hours f stored at room temperature or Sepn e e, M e = e 90 I‘ S3es8-144- e
072e37e3-5a0d-469a-a34c-019c5513a172_260_2.jpg o] Tnzobo:ta: for Injection, USP Single Dose Via For IV Use Only SANDOZ “Each vial provides piperacilin and tazobactam cryodssiccated powders for injection tio 3 piperacilin, 0.375 g tazobactam and 7.04 mEQ (162 mg) of sodium. Contains o preservaive. See package insert for raconstitution instructions and Complete drections for use. Prior to Reconstitution: Storo at 20° 10.25° C {68° to 77° ) [see USP Controlled Room Temperature]. After Reconstitution: Discard any unused portion after 24 hours if stored at room temperature o it 4 hours # ofgeatod. 500 package mcer, S 45-90 I. D :
072e37e3-5a0d-469a-a34c-019c5513a172_260_3.jpg ﬁpemw rocillin and Tazobactam for Injection, USP ;i;o Dose Vial For IV Use Only SANDOZ *Each vial provides piperacilin and tazobactam cryodesiccated powders forinjection equivalent i 4 piperacilin, 0.5 § tazobactam and 9.39 MEQ {216 mg) of soduum. Contains no preservative. See package st fo feconstiution instructions and Complete directions for use. Prior to Reconstitution: Store at 20° t0 25° C {8810 7" fses USP Controded Foom Temperature] o After Reconstitution: Discard any unused portion after 24 hours f stored at room temperature or after 48 hours f refrigerated. See package insert Uondcard A by S Gt S e P RS T850 s NI o
07d01d5a-7243-4389-8548-01846df24cdb_346_1.jpg Each fm-coated ablet contins: Hydosyzne ydrochloride, USP £ N 10mg TN 10T A5AX10Y AT 10-9862-8/50 s TR T TS (ol y 8t TR HydrOXYzine contineras dfind i the USP. usinga chidesitantclosur. Keep conainer il cosed Keep this and all medication out of the reach of children. Store at 20° o 25°C (68° to 77°F). [See USP Controlled Room Temperature] | Usual Dosage: See acscmpanying preseribing information Nylan Pharmaceuticals In. Morgantorm, WY 265U S A [MMylan® Dispense na g, ightresistant g = Hydrochloride Tablets, USP Mylan® Rxonly 100 Tablets
07d01d5a-7243-4389-8548-01846df24cdb_346_2.jpg Each fim-caaed abet T Sty e I Dy i g st 5y M :nghm; »ﬁmﬂggne W cnnmnevha‘iddmn;d \:\ ﬁve Usp % e - I s B 2 HydrOXYzine prcscimminsigg . 3 is and all me tion N Hydrochloride [rtresterme —_— Store at 20° to 25°C (68° to T7°F). = Tablets, USP R ol Tve, 4 % (Bug) ) mm—m = .. o= e ~ (I)Mylan® [Mylan: Rxonly 100 Tablets Mylan.com g
07d01d5a-7243-4389-8548-01846df24cdb_346_3.jpg v £ N P o S 3 * T TEOY QG AN W (e i s oot Hydrochloride [rretermey Store at 20° to 25°C (68° to 77°F). Tablets, USP ol ve, ;e 9 i r Mylan Pharmaceuticals Inc. Ao SEUSA [MMylan® [MMylan® Rxonly 100 Tablets Mylan.com Each fim-caaed ablet [N TRy VR W Diserse in a g, gt resistant § £ = XY 10T ARAXIOYAXT |0-8862-8250 AT TR NI 6
0918c44e-54f6-47b9-b927-4f1b0b394152_303_1.jpg levsin® injection (yoscyamine sifate inecton, USP) NDC 0037-5001.05 levsin® injection (hyoscyamine sulfate injection, USP) 0.5 mg hyoscyamine sulfate, USP per mL in water for injection, 5 Ampules (' mLeach) ‘GTIN TN SN TOOOOOOY EXPADIYYYY LOT XX i Iy 037 9001-0 sy Srarss e vy R0 e b rokes of Chi o s i e 1377 a1 : T e levsin® injection i i 3T {yoscyamine sl fecson, USF) ! { s [ dosac ano AomINsTRATION: i ioigi = | SRvTTE i (I | STRCr o remintss ! ] .4 1= | Wawcarasn i i B i B | S e ! opa ! - - .. =1l | I 18 | =3z! ! | g ! =z ! b og™ BE | i L& = ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !
09bccfc6-71eb-420f-92d3-cd21789a0dbc_92_1.jpg NDC 68084-756-35 Niacin Extended-release Tablets USP 60 Tablets (10 x 6) IOIIIII [ IN0n 00368084 756 35 1 | oTocr ks R R Niacin Extended-release Tablets USP 60 Tablets (10 x 6) PRARMACIST. Disponse wilh {10 accompanying. "Medication Guids 10 each patient Exch Fim-Goated Extendsd-Releaze Tablet Gontains: N USP, Womg Usul Dosages Sospackag sert for ol poscrbing nformaton Store at 2010 25°C (58 to 77°F). sxcursions parmitec Batioan 1812 30°G (30° 1o 86F) (500 USP Conrolied Room Temparaturel Keop ths and alldrugs out o reach of hildran. FOR YOUR PROTEGTIONs Do not use # biste s forn orbrakon. Rx Only Tho drug productcontainad inhis package s from NDC 1 GE360-251. Lupm Phammaceiears, ine. Distrbuted by Smorican Hedih Packaging 075635 Columbue, O 43217 0275635/011605 - -3
09bccfc6-71eb-420f-92d3-cd21789a0dbc_92_2.jpg L oo U 500 mg Lo o000t e LOT: 000000 EXPIRY:00/00 Niacin Niacin Dienielesse Toes O 500 mg Lo 000000 EXRRY,00/00 Niacin Exnducrsense Tanel O 500 mg Gt o oo Gt o e g i i Cotenor, oW 3217 Coumsus o317 o, O 17 ol 5 5w 005 asn ol Toem U B gog toem oseorsspopuas Bu oog asnoeL oseapspopuaa dsn o 00/00 AUIE 000000 101 oseopspapuaix 000000 101 00/00 A3 000000101 00/00 AIa = T s oo soea 36955
09bccfc6-71eb-420f-92d3-cd21789a0dbc_92_3.jpg Niacin Extended-release Tablets USP (I 1 TR (O (01) 00368084 773 21 1 NDC 68084-773-21 Niacin Extended-release Tablets USP PRARMACIST: Disperse wih the accomparying Pationt inormation Leale o sach patent Each Film- Goated Extanded- Releasa Tablet Gontains Niacin USP. 1600 mg Usual Dosage: Ses package insert forfull prescibing information. Store at 20° 0 25°C (63" 0 77°F) excursions permitted Botiuasn 16" 13 30°G (59" 13 85°F) (cea USP Contollad Foom Temperature] Keep this.and all drugs out of reach of children, FOR YOUR PROTECTION: Do not use f lster i trn orbroken. RxOnly The crug product contained in tis packaga is from NG # 68160-223, Lupin pharmaceutials, Inc. Distributed by: American Hebith Packaging 077321 Columbus, Ohio 43217 0277321/011608 k.
09bccfc6-71eb-420f-92d3-cd21789a0dbc_92_4.jpg 0/ RS 000000107 | Buwi 000} s el osae S o0/ 000000 101 Buwi 0001 asn e osea papuaig "o o000 aME 000000 101 Buw 000} s el aseore papueia uen 0/ A 00000 101 B 000} asn ey o BN ovmsi Goaith 01 Buw 0oL asnionel oseaelpapusis ] o - e 1000 mg Lor. 00000 EXPIRY. 00100 Nocn Exondod sclase Tibie Use 1000 mg Lo 000000 EPRY. 00100 wain - SaoE 1000 mg Lo7: 000000 R Nadn Exended rolesse Tanel 08P 1000 mg L0 000000 R Nacn e 1000 mg § Lo 000000 EPRY. 00100
09dc7f6a-cc69-4de8-8e13-b837ce144b4a_587_1.jpg By LTV ETEPATITEN v e n . T QT T AT I ooty e o LT o i 1mg e 100Tablts Axonly
09dc7f6a-cc69-4de8-8e13-b837ce144b4a_587_2.jpg oD 2 © LTIV TTEFATITN oot s prcion et VT LTI I 3o ot o LTSI o e ot = 2mg o Sy 100 Tablts Rxonly & 8 3 3 T 2 2 3
09dc7f6a-cc69-4de8-8e13-b837ce144b4a_587_3.jpg QT {TTT TS CPATITY oe o e S oot cosee Hydrochloride ety RCTTETNIT I = ot s SR Gty i s 5mg e 100Tablts Axonly
09dc7f6a-cc69-4de8-8e13-b837ce144b4a_587_4.jpg Trifluoperazine Hydrochloride Tablets, USP 0832-0497-11 2 100 Tablts Rxonly
0a1d47b5-0215-4636-acac-191e51df8754_992_1.jpg Lot o Rt v Oxycodone Hydrochloride Tablets USP. RS RS IOII[II (UL 003 68084 048 01 2 T Lot ot ROt R v | Oxycodone Hydrochloride Tablets, USP. W s aecompanyng Vs e 1 sach patient. Exch Tabiet Gontarns: Gxycodons hycrocrioride USP. 10mg Usual Dosage: Sao pat Tor i prasrbing nformation. Store o 5 Prot Keap this and all drugs out o reach of children. DEA Order Form Roquired FOR YOUR PROTECTION: Do ot use i bistar i tornar broken, RxOnly 49 prosuct contsined i i packag S 00ss01 Colamibus, Ohio 43217 020280110678
0a1d47b5-0215-4636-acac-191e51df8754_992_2.jpg o O {0f) 003064 05 111 Oxycodone 5 Fikrocriongs (@ Tabiel USP 10 mg e | {01)0036300405 111 Oueodone Qe @ T3bet U390 mg L s o s 1 Ouycotone Btroctionge (@ ek USF 10 mg af i {01) 00363064 04 111 SRR 1 © i {0f) 00306408111 ooooes 101 e fade Lot o [ mmm e i Lot o Expiy. ot xxxxxxW1 e e Lot oeser Bxpiy ot xxxxxxW1 oo A Lot oo Expiry. e xxxxxxW1 oo A Lot oo Expiy: ux Oxycodane. Blionge @ P mg {01) 00330 08 111 Ooodone Btiockongs @ 56 8550 mg ol v 01) 00053005 08 11 Ogoodone Siiie @ e 1550 mo 4 I I oy s 1 Ocodene Dt @ T o mg 1 i i o1 0030848 1 1 oo Rt @ U2 90 mo {01) 053084 045 11
0a1d47b5-0215-4636-acac-191e51df8754_992_3.jpg [ Oxycodone Hydrochiorde Tabits, USP (1 ) EIIII I T 00368084 828218 NDC 68084-828-21 Oxycodone Hydrochloride Tablets, USP 30 Tablets (3 x 10) Each tablet contains: xycodone hydrochloride, USP............... 20 mg SUAL DOSAGE: See accompanying package Insert for full prescribing information. Store at 25°C (77°F); excursions permitted to 15° 1o 30°C (59° to 86°F). [See USP Controlled Room [Temperature]. Protect from moisture. op this and all drugs out of reach of hildren. x Only e diug product contained in this package is from IDC # 68382-796, Zydus Pharmaceuticals (USA) Inc 9| Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 082821 Rev. 08/2014
0a1d47b5-0215-4636-acac-191e51df8754_992_4.jpg o Ocadone oo i irochloride B o5 B o B @ 4 e PRl i LOT: soo000¢ T v £ e S & B i Oxycodone oo 8 Fooionda TR @ f AR HARTRR et o B o LoTome s B o B ' L - o I L e R @ 3 mewe e PoB R ore I Lo o 1 Loromn SR H [ B Oncadons el Briraionse TR @ 4 Tk U5 TRk = o o Ot 7 o - B4 Ik oncoine it Ei £7 rydrochiorice TETTR @ 4 5 e T hoog o O B lompmos f [} Lommme
0a645c0e-2660-4165-9761-48453dec51df_852_1.jpg i i i & i
0a645c0e-2660-4165-9761-48453dec51df_852_2.jpg AT SRR OXYGEN, REFRIGERATED LiQuiD usp UN1073 WARNING: For emergency use only when administered by properly trained personnel or oxygen deficiency and resuscitatin. For all other medical applications, R only. Uninterrupted use of high concentrations of oxygen over long duration, without monitoring s effect on oxygen content of artrial blood, may be harmiul. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment. Keep out of reach of chidren. Federallaw requires thatthis container b refiled with oxygen USP only by establishments registered as a drug manufacturerin accordance with the Federal Food, Drug, and Cosmetic Act Produced by Air Liquefaction. DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS REFRIGERATED GAS; MAY CAUSE CRYOGENIC BURNS OR INJURY. COMBUSTIBLES IN CONTACT WITH LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. Do not handie unti alsafety precautions have been read and understood. Keep and store away from clothing and other combustible materal. Keep valves and ftings free from grease and oi. Use and store only outdoors orin a well-ventiated place. Wear cold nsulating loves, face shied, and eye protection. In case offire: Stop leakif safe to do 5o. Use a back flow preventive device in the piping. Use only with equipment of compalible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. DO NOT change or force fit ‘connections. Avoid spills. Do not walk on or roll equipment over spills. Close valve after each use and when empty. Always keep container in upright postion. Read and follow the Safety Data Sheet (SOS) before use. FIRST AID: IF ON SKIN: Thaw frosted parts with lukewarm water. Do notrub afected area. Get immediate medical advicefattention. CAS: 7782447 DO NOT REMOVE THIS PRODUCT LABEL ALLIED GASES 945 E CURRY RD. « TEMPE AZ 85281 - 41533 (480) 894-6000 ©1n5)
0b1b40d2-e674-4cc9-b017-597bcd24fb2b_854_1.jpg | Vitamin i - B-Complex | . Sodium Hydrosde and/or used to adiust pH. 100 Injection e 100 Injection idoxine. HCI 2 mg, Dexpanthendl st oo B 2 lactogenesis to parenteral thiamine has been reported. Each mL contains: Thiamine HCl 100 mg, Riboflavin & 'STORE UNDER REFRIGERATION 2° TO 8°C (36° TO 46°F). o8 package nsert forful prescribing Irformaton. i § L 1 % a5 ; | 9 == | Forlntramuscularor ! s a3 : For Intramuscularor | £ & - | SlowIntravenous Use | g: % £ §§§ | SlowIntravenous Use | 2 g % § - i 25 SE2s o i 2228 8 = 4FLON 533 2358 | 4FLON | .ot = | L-albcfatoﬂes uc ; ggé 2358 : Lébofctores uc | BgEfizem: § ol & i | NDC: 7141422501 SN: 123456789 Exp.: 05/09/2021 Lot: ABG1231A % :Imu 22501
0bdd91e1-fd94-4ce8-9c99-1b0fa6fe8ae4_722_1.jpg Lunaan pesanny uatousg 0 Y g s IS i DS 0 2 Ser Dient fr g s g £ 5 = Injection, USP Dehydrated Alcohol
0bdd91e1-fd94-4ce8-9c99-1b0fa6fe8ae4_722_2.jpg Lunaan pesanny uatousg 0 Y g s IS i DS 0 2 Ser Dient fr g s g £ 5 = Injection, USP Dehydrated Alcohol
0bdd91e1-fd94-4ce8-9c99-1b0fa6fe8ae4_722_3.jpg ouvaisonoz NO COATING Y 8605101 101500 LY J NDC 70710-1525-9 Gl 0000 Carmustine for Injection, USP s s cumsios o Carmustine for Injection, USP g, 15 vith3 il he Woar loves aalimes ehen | o st et nanding containers. 7 o n e i 100 mg per vial By L T e o cameine o npoton, (5P T RETURMABLE. | 0ectinst Each carton contains: 1 vial carmusting fo njecton,USP 100mg, Al orsiicna <ot Each carton contais: 1 vial carmusting fr njecton, USP 100 mg, Vil Strile Diuent for carmustinfo njecton, USP 3L || e ke, I 1 vil Sterile Diluent for carmusting for injection, USP 3 mL. heson 25030107 S Pt s For intravenous infusion after reconstitution | i o rysfrrmton i For intravenous infusion after reconstitution Forigou i DEeH o sl e bseed, ey |y b edosoted by et sl o et i 'REFRIGERATE IMMEDIATELY | agitation.Protect fom fight. REFRIGERATE IMMEDIATELY | USUALDOSAGE: e encocd SingloDoso Vil - Discard Unused Poton | pckage nsetfor ndsatons, Singlo DoseVa - Discard Unusad Prton ocag,dctons o e and § s | prcautios, zydus Reony | Rxonly pidmacetioat i
0be2918e-55b3-4c66-aba0-09099a1c7770_499_1.jpg Raad prescribing Information for DDOSAGE AND ADMINISTRATION. 'WARNINE: Accidental overtiose of Iron-cantalning products is 2 leading ‘caus of faial polsoning In chldren under B. KEEP THIS PRODUCT OUT OF ‘THE REACH OF CHILDREN. In case of ‘accioental overdose, call & dockr of polson control certsr Immediately. Fomalat® 90 s a green, modfled rectangle shaped, fim-coated tablet, debossad with “F6” on one slde and bk on the other, Sior at 25T (7). MISSION PHARMACAL COMPANY San Antonio,TX 76230 1355 L00BRS0 CO1 Rev 011080 NDC 0178-0088-90 Rx Only Ferralet 9O 90 mg Dual-iron Deiive 90 Coated Tablets (3 Mission
0bfce004-ab2f-4bc1-a498-b1bf9683da33_423_1.jpg Paciaged by Eryant Rench Bunbank. 04 91500 = 5, YELLOW (Opaqe B, BROWN Doxycyeline &g eaiieiinions Monohydrate 100mg Cap. & & Keep in light resistant Compare To: container perUSP Monodox 100mg Capsule "Store at room temp of | [C—— 2025 C (68-77F) #30 Exp: MMYY NDC 7133504361 053611114263 om
0bfce004-ab2f-4bc1-a498-b1bf9683da33_659_1.jpg Paciaged by Eryant Rench Bunbank. 04 91500 = 5, YELLOW (Opaqe B, BROWN Doxycyeline &g eaiieiinions Monohydrate 100mg Cap. & & Keep in light resistant Compare To: container perUSP Monodox 100mg Capsule "Store at room temp of | [C—— 2025 C (68-77F) #30 Exp: MMYY NDC 7133504361 053611114263 om
0c2fb9a0-5586-4428-b705-5fa179a73e08_849_1.jpg | TNbc oes 026t s ougero | |ALCLOMETASONE ' DIPROPIONATE OINTMENT ‘usp 0.05% st Dosege: opy = e i cmert T e ey e e R el S e 2 and 3 (6" and 26, ‘Yowznm-unm:umws WEORTANT Dorut e e s |Beerpineted ol . R e sk FOR DERMATOLOGI USE ONLY OT FoR OPHTHALMIC USE | WARNNG: Keopouolsech | ek NET WT 15 grams } Each gram containg: Acomeiscne Sporfoai 00 < ormeny S S Gy v E:esmﬁv of s for CoNorkerans Expraion Do UG Arai | (i IILIII IIIIIIJU 0168-0264 o e
0c2fb9a0-5586-4428-b705-5fa179a73e08_849_2.jpg 3 0168-0264-158 NDC 0168-0264-15 Bony Alclometasone Dipropionate Ointment USP, 0.05% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE fougera® Usual Dosage: Apply a thin fim of olntment to the affected ki areas two or oo times daily. See package Insert for ullprescibing nformation ‘Store between 2° and 30°C (36 and 86°F), KEEP OUT OF THE REACH OF CHILDREN. E FOUGERA & CO. A duision of Fougera Pharmaceuticals Inc, Mol NowYork 11747 NDC 0168-0264-15 Blony Alclometasone Dipropionate Ointment USP, 0.05% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC USE ougera’ See crimp of tube for Lot Number and Exp. Date. NET WT 15 grams IMPORTANT: The opening o ths product is covered by a metal amper-rsistant sal. s sl hasbeen pncured or {snotvisble,donotuse and relum producttoplac of purchase O OPEHN: o puncture th sl reverso the cap and place the punciur-topont hetub. Puch dovn iy unt eal s open. 0 CLOSE: Serew the cap back oo the tube. Each gram contalns: Alclomelasane diproplonate. 0,05% in an olntment base of hexylene gycol, ‘white wax, propylene ghycol stearate and whits pelrolatum; NET WT 15 grams NDC 0168.0264-15 ws213c RIIN7 W70 Alclometasone Dipropionate USP, 0.05% fougera ® A
0c64bc71-2e7f-4b15-a8e1-acb8de04395f_149_1.jpg Each film-coated bi-layer tablet contains: Zolpidem tartrate, USP. 625mg Usual Adult Dosage: One tablet at bedsime as directed. See complete prescribing information. Store at 20°t0 25°C (6810 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant, child-resistant containers (USP). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Distrbuted by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-307-88 Zolpidem Tartrate Extended-Release Tablets, USP (3 PHARMACIST: Please dispense with Medication Guide provided separately to each patient. Rx only 100 Tablets Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T.0f D & NH), India. DNH/DRUGS/NH/138 PGLBO906 1SS. 04/2017
0c64bc71-2e7f-4b15-a8e1-acb8de04395f_149_2.jpg Each film-coated bi-laer tablet contains Zolpidem tartate, USP. 12.5mg Usual Adult Dosage: One tablet at bedsime as directed. See complete prescribing information. Store at 20°t0 25°C (6810 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Dispense n tigh, light-esistant,child-resistant containers (USP). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Distrbuted by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-308-88 Zolpidem Tartrate Extended-Release Tablets, USP (v, PHARMACIST: Please dispense with Medication Guide provided separately to each patient. cony O \ 100 Tablets S Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T.0f D & NH), India. DNH/DRUGS/NH/138 PGLBO908 1SS. 04/2017
0ccf7914-0920-4410-bad5-d639daf829e7_66_1.jpg Paciaged by Eryant Rench Bunbank. 04 91500 = 5, YELLOW (Opaqe B, BROWN Doxycyeline &g eaiieiinions Monohydrate 100mg Cap. & & Keep in light resistant Compare To: container perUSP Monodox 100mg Capsule "Store at room temp of | [C—— 2025 C (68-77F) #30 Exp: MMYY NDC 7133501681 053611114263 om
0d213a24-ebbf-41df-8f32-de44a572829e_181_1.jpg Paciaged by Eryant Rench Bunbank. 04 91500 = 5, YELLOW (Opaqe B, BROWN Doxycyeline &g eaiieiinions Monohydrate 100mg Cap. & & Keep in light resistant Compare To: container perUSP Monodox 100mg Capsule "Store at room temp of | [C—— 2025 C (68-77F) #30 Exp: MMYY NDC 7133501681 053611114263 om
0da965bf-3d38-403b-a572-a61e25977c3f_252_1.jpg Xylocaine Lidocaine HCI 2% 20 mg 1mL Injection, Solution arv: 10 ID#:. Expires: NDC #: 70518-0078-00 Shape: . LOT #: Ref #: 63323-0486-17 MFG: Fresenius Kabi, Lake Zurich, IL 60047 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_1.jpg nan
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_10.jpg (570 9pen th pack. Pushtabet through from athr sid. Continus taking one tablet sach day 35 your doctor prescribes. 000000 000000 280 tablet lmbm_xlc_a' mg per table Qo000 0 0o00000«0 Imbruvica- 280 mg per tablet (brutinibl ssies
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_11.jpg NDO 5706242028 Imbruvica* (ibrutinib) tablets et i 0 75 Wallet card cortains 28 tablets: Recriy - b > 10 open {/pharmacychcr Janssen }' oacopy —— (ibrutinib) tstes *Take IMBRUVICA® tablt by mouth, at about the sams time each day, with a glass of water 28 Tablets » Swallow e tablet whole. Do ot cut, crus, or chew the tablt « Do ot stop taking IMBRUVICA® without talking to yourdoctor « Rememberto refl your IMBRUVICA® prescription befors urving ot rouation i you miss a dose of IMBRUVICA, ake it as soon as you remember on the same day %harmacyclics‘ ]ansse07 button, pull card from sleeve at purple dot ! = Imbruvica® 420 mg Pty (orutind) s i gy R o oot = T—— | BT and 057 NDC 57062-420-28 ‘ For maes formation sbout IMBRUVICA®, cal 1-877-877-3636 or visit www IMBRUVICA.com GTIN 00357062420286 i = ! w:u.m. ‘ szmmescen. | e = osNtzozs | 53 o Lo N
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_12.jpg Timg e\ Dayl___ D2 Day3___ Day4___ DayS___ Dy6___ Dyl Dayls___ Dayl___ Dayl___ Day8___ Dayl9___ Day20_ | BayZo 0000000 1000000 Start dosing on Day 1. Take one tablet, once a day. Imbruvica’ 420 mg per tablet 0000000] {iB00O00000 Day8__ DayS_ Dayl0__ Dayl___ iy DayB__ DayM__ NI e e ey oy Sowor oem =)
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_13.jpg N ( ] N N U U Uy Imbruvica* 420 mg per tablet (brutinib skes (" = N
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_14.jpg NDG §7062-560-28 Imbruvica® (ibrutinib) tablets i Walet card sontins 28 ablets =2 Gph lics anssen J i rmacyclics* 0 open gpharmacy: ) o . (ibrtinib) ues #Take IMBRUVICA® tablt by mouth,at about the same tme ‘ach day with a glass of water 28 Tablets » Swallow the tablet whole. Do notcut, cush, o chew the tablet Do not stop taking IMBRUVICA® without taling to yourdocter «Remermbertorefl your IMBRUVICA® prescrpton befors mng oot P fyou s dose o IMBRUVICAS, ke i 5 s00n 88 you - Temamber o he ams day Qpharmacyclics: ey s Janssen )' STEP 2: While pressing button, pull card from sleeve at purple dot TO CLOSE: Fold card and push back into carton firmly until locked. 3 ST S =y I Dosegti B promehing i s | Keap outof the reach ofchidren. Imbruvica* 560 mg prAntlitaidas ot s San oS erbre b dosag ormaton. == - . | NDO 706266028 o oot R —— ‘ o e ot st INBRUVICA® o 1677-07-3638 vt PR | i ‘ Pnsstmaenen: | R : e 3 | - Samme e sls796205 602809 | 55 oAl Lo Fioeumidd
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_15.jpg ggooﬁoom
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_16.jpg nan
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_2.jpg NocoTsez0m 28 Imbruvica* (orutinib) capsdes Exchcapte ot b 70y Sl st ik it e 28 Gapsules new smmpmuny, P
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_3.jpg | sonsdeo quinia) | | «@21ANIqW| | \ | Dosage: A et by a phlin s | | Dot g | | noc ooz ra0ce | o | i i ‘Store betwaen 20°C-25°C [8°F-7TF: : : Imbruvica® | s¥Erimes™=""*| Imbruvica® | Imbruvica® (brufinib) Capsules | keepoutofraschotontdn | (briinib) capsules | (rutinib) capsules ST oo rommitincons | T 140 mg | bttt snd Wttt | £ | oy 10 ! | S G | | Exch oo cotir: s 40mg | | S B Slon copmioswhclo it e | | Horhan, PA 10018 Usa | © Phamacyeo 1. 207 | © Jaraan Bteoh . 2017 | werme | | | i i | | | | BT, 90 Capsules: | qgharmacyciics psen Y
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_4.jpg ‘sajnsden (quigniqy) LE21AnIquI| aonmes o | Dosage: o diecsd by gcian 50 T TRk kst s | | : ‘ S 270256 BET7RS A | ‘ K& Imbruvica® | SEERmms™=""" | Imbruvica® | Imbruvica® £Xq (ibrutinib) capsules Kesp Out of Reach of Children (ibrutinib) capsules. 1 (ibrutinib) capsules 1 .“‘ | | Aot et Modo nChina. | Db ant Mkt | Pramacylicolic. | Sty CA 04085 U (LT ‘ LT ‘ o2 000; XX = > XXX 5% X © danesn Hetac, . 2017 g S RR = %S & 3 S XX <2 120 Capsules | A ony 3570201 2 | jcs*
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_5.jpg NDO 57062-014-28 Imbruvica® (ibrutinib) tablets Exntaaconts bt 40 ‘Wallet card contains 28 tablets ! s @harmacyclics- Imbruvica* 140 mg R AL Gorutnt) ks « Take IBRUVICA tabet by mout,at about the same time each day,with a giass of water 28 Tablets + Swalowthe tabet hoe. Donot cut, crush, o chew the talet + D0 no stop taking IMBRUVICAS without flking toyour dctor +Remembar foeflyour IMBRUVICAS presrpton befors i ot Bronates 1 you miss dose of IMBRUVICAY, take 38 soon 3 you ; emamber cn the same day ggharmacyclics: < Janssen J STEP 2: While pressing button, pull card from sleeve at purple dot TO CLOSE: Fold card and push back into carton firmiy until locked. Imbruvica® 140 mg Dasage: Kop outof the resch of chidren. Achsngreclant made Chna. (rutit) s 5o cccomparying Horaur b desage nfomaton Scs botwean 201 v 25 (05 and 777 xcursons pamited botwean 15 and ST EFFendoshy NDG 5708201428 Formers nfomation st IMBRUVIGA’, cal 1-677-877.3536 or vt warw IMBRUVICA som ‘GTIN 0357082014267 B o o won o~ toedorazl 3 eoRAIR
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_6.jpg ooooooo ﬂooooooo S G e W Imboruvicar 140 mg per tabie OOOOOOO OOOOOOO DayB_ DayS_ Dayl0 Oyl Day2_ Days_ DayW Day22___Day2s__ Day24__Day%5__ Day2%___ Day2l__ Day2s__
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_7.jpg Fifp open the pack.Push tablet though from other side. ‘Continue aking one tablet ach day 25 your doctor prescribes. M) xS O S ok o Red el WA Yy WY Y o Y Xad Ad N et Nt Imbruvica’ 10 tablet (ibrutinib) s Rk O O 5 N O QOO Imbruvica® 140 mg per tablet (ibrtinib) s O O -~ A Y st sseRel
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_8.jpg NDG 5706228028 Imbruvica® (ibrutinib) tavlets ot coarstno 20 ‘Wallt card contains 28 tablets b - Liftto open harmacyclics* anssen L REpamayCles panssen J Imbruvica: 280 mg R L o ale +Toko IMBRUVIGAS abet by mouih, a about hesame tmo eachday,with a giass of water 28 Tablets « Swallow the tblet whoe. Do notcu, crush o chew th ablet + 00 ot st taking IMBRUVICA® without aking o your doctr ettt s WA oo ernong o RS +1tyou miss a dose of IMBRUVICA, take it as soon s you 5 Temermber n the same day Qpharmacyclics' ey g janssen ' STEP 2: While pressing ‘button, pull card from sieeve at purple dot 'O CLOSE: Fold card and push back Into carton firmly until locked. POt T e qgrarmeeyicr ) Dosage: Sesproscrbing information. Keop outof th reach of shdran. Acivo rgrdiontmads i Crina. S ceccmpanying st e dosage normation. Stors batwean 20 and 25 B8 and 7P excurscns prite batwsen 16 nd 30C: T a5 For morsnfrmetion abcut IMBRUVICAT,call 1-877-677-3538 vt wwoe MBRUVICA.com Imbruvica® 280 mg (ibrutini) ses NDG 57062.250-25 GTIN O0s570E2280286 e o = wor ».m'!%mm. i, o Roemzsoeet |
0dfd0279-ff17-4ea9-89be-9803c71bab44_672_9.jpg Doyl Dy2__ Day3__ Dw4__ DS Dws__ D7 D15 Day¥__ Dy Dayte___Dayis___oay20 AT 0000000 'gWOOOOOOO Start dosing on Day 1. Take one tablet, once a day. lmbﬂMca 280 mg per tablet 0000000 ([lOO0D00O0D Day8__ Dayo_ Daylo__ Dayll__ Day__ DayB__ DayM___ D3y2_ Day23_ Day24_ Day2s__ Dy DayZl_ DB
0e15feec-d27e-4861-8152-c5a8b8ccacd4_139_1.jpg Lovastatin Tablets USP NDC 0093-0926-06 10 mg Each tablet contains 10 mg lovastatin, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Lovastatin tablets must be protected from light. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Croatia By: PLIVA HRVATSKA d.o0.0. Zagreb, Croatia Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Y 0093-0926-06 s Rev. D 12/2015 70050781
0e15feec-d27e-4861-8152-c5a8b8ccacd4_139_2.jpg Lovastatin Tablets USP 20 mg NDC 0093-0576-06 Each tablet contains 20 mg lovastatin, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Lovastatin tablets must be protected from light. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Croatia By: PLIVA HRVATSKA d.o.0. Zagreb, Croatia Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Y 0093-0576-06 5 Rev. D 12/2015 B only 70050783
0e15feec-d27e-4861-8152-c5a8b8ccacd4_139_3.jpg Lovastatin Tablets USP 40 mg NDC 0093-0928-06 Each tablet contains 40 mg lovastatin, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Lovastatin tablets must be protected from light. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Croatia By: PLIVA HRVATSKA d.o.0. Zagreb, Croatia Manufactured For: TEVA PHARMAGEUTICALS USA, INC. North Wales, PA 19454 Y 0093-0928-06 » B only Rev. D 12/2015 70050785
0e198d28-4986-4b93-833f-17c7ed4ce13e_769_1.jpg camrese® camrese® - ” tradol
0e198d28-4986-4b93-833f-17c7ed4ce13e_769_2.jpg 2 omnsn camrese® vcergesel oty esva and et
0ee89f89-e90d-4706-9fa5-a61b5fde4470_793_1.jpg p— i e, w8 | e APPLY T0 AFFECTED 2 i o st AREA TWCE A DAY i o e o = [ omserer aneser : e ; 1 s
0f0fbf64-0423-4432-a948-4b1bbb97f391_206_1.jpg nan
0f2abab7-6dbe-4b18-b001-002b668eb370_205_1.jpg e LEVORA O SROIG TRESZEORY 2 o TAKE 1 TABLET DALY ASDRECTED, abhiEaS s
0f30f885-d0cd-4fa6-a8e0-142f08a56792_219_1.jpg Each fim-coated tablet contains nalrexone hydrochioride USP 50 mg. Usual Dosage: See accompanying prescribing informtion. Dispense n a tight container Store at 20°to 25°C (66° to 77°F); excursions. permited between 15° and 30°C (59° and 86°F) [see USP Controled Room Temperature]. NDC 47335-326-83 Naltrexone Hydrochloride Rxonly 30 Tablets Tablets, USP 50 mg o SUN Distributed by: Sun Pharmaceutical Industries, Inc. Granbury, NJ 08512 Manufactured by: Sun Pharmacetical Industries Limited Survey No. 25/15, Dada-396 191, (UT.of D & NH), India PGLBO218B PGLEO215E 155, 10/2014 DNH/DRUGS138 Bah No. B
0f8b1964-212e-43ab-aa4b-424d99bc4558_83_1.jpg Paclaged by Ergant Raxch Losartan Potassium/Hctz 100/12.5mg Tab Compare To: Hyzaar 100/12.5mg Tablet #30 NDC Chon Pharma LIC Exp: MMYY 7133509161 10° 618121 om Baban. 04 91506 WHITE OVAL F 74 Keep in light resistant container perUSP Store at room temp of 20°25°C (68°77°F) 048881121819
0f958942-1504-40a1-8ad8-43df2c3f717e_707_1.jpg Each film-coated tablet contains: Fenofibrate, USP 43mg Usual Dosage: See accompanying prescribing information. Keep this and all medication out of the reach of children, Store at 20° t0 25°C (68° to 77°F). [See USP Controlled Room Temperature] Protect from moisture. Manufactured for: Mylan Pharmaceuticals Inc. Morgartovm, W 26505 U.SA. Made n ndia [MMylan® | wi.con NDC 0378-3065-77 Fenofibrate Tablets, USP 90 Tablets, 11 3 0378=3065-77 Do not accept if seal over bottle opening s broken or missing. Dispense in a tight,lght-resistant container as defined in the USP sing a child-resistant cosure. Keep container tighty closed. Code No.: MHDRUGS/25NKD/B0 5 9 75063056
0f958942-1504-40a1-8ad8-43df2c3f717e_707_2.jpg ach fim-coated tabet conains: NDC 0378-3066-77 “I| N ey T IR 10 et e RN EAA Gy & osromoiemrn s Keep this and all medication out of Do not accept if seal over bottle opening s broken or missing, Tablets, USP i Stare at 20° t0 25°C (68° to 77°F). [See contaner as defined in the USP USP Gontrolled Room Temperature.] using a chikd-esistant cosure. Keep container tighly closed. Protect from moisture. o e ity cosst, Manufactured for: Mylan Phammaceuticals fnc. Morgantown, WY 26505 U5 Made in ndia 75063058 RMXZOGEMM2 ‘CTIN TOCOOROOOTOn
102358dc-2109-4829-b333-b99417334e39_865_1.jpg NDC 0703-5043-03 Rx only DOXO0rubicin Hydrochloride Injection USP 10 mg/5 mL @2 mg/ml) For Intravenous Use Only Sterile, Isotonic Solution Contains No Preservative 5 mL Single Dose Vial 10 Vials Each mL contains 2 mg doxorubicin hydrochloride, USP, sodium chloride 0.9%, water for injection g.s. pH adjusted with hydrochloric acid or sodium hydroxide. pH2.5t04.5. Usual Dosage: See package insert for full prescribing information. Store under refrigeration between 2° to 8°C (36° to 46°F). Protect from light and retain in carton until time of use. Discard unused solution. WARNING: Severe cellulitis, vesication and tissue necrosis will occur if doxorubicin hydrochloride is extravasated during administration. Teva Parenteral Medicines, Inc. Irvine, CA 92618 I 1 Iss. 9/2011 IWI Y10625
102358dc-2109-4829-b333-b99417334e39_865_2.jpg J (13w 7) i Gz/Bw og dS uonoaful 3pLIoJya0IpAY uIgnipxoa e— nexy [ WOE 70250060 Ry — muruhicin Hydrochloride Injection USP (2mg/ml) PHARMACIST: PLEASE DISPENSE WITH ATTACHED. PATIENTINFORMATION LEAFLET For Intravenous Use Only Sterile, Isotonic Solution Contains No Preservative 25 ml Single Dose Vial Usual Dosage: See package insert for ull rescriing informaton. Store under refrigeration Detween2° 0 8°C (36° to 45°FL. Protect from light and retain n carton until time. of use. Discard unused solution, WARNING: Severe celuits, vesication and tissue necrosis will occur if dororubicin hydrochloride s extravasated duting administration, See battom panel for lot number and expiation date, s, 912011 Jes arns odcies, e, e CA 2318 e o0ssa1 R — mﬂrubicin Hydrochloride Injection USP (2mg/ml) PHARMACIST: PLEASE DISPENSE WITH ATTACHED. PATIENT INFORMATION LEAFLET For Intravenous Use Only Sterile, Isotonic Solution Contains No Preservative 25 mL Single Dose Vial Each mL contains 2 mg doorubicin hydrochlonde, USP,sodium chlorice 0.9%, wale for ijection .5 pH adjusted with hydrochlorc acidor sodion hycoride, PH251045. 0703=5046=01
102358dc-2109-4829-b333-b99417334e39_865_3.jpg kR LTV A | dsn uonaaluj apLIoJya0IpAH urdiqn.oxod o e NOC 0703-5040-01 Rx orly Y DOXOrubicin Hydrochloride Injection USP 200 mg/100 mL (2 mg/mL) PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET For Intravenous Use Ony Sterile, kotonic Solution Contains No Preservative 100 mL Multiple Dose Vial Usual Dosage: See paciage insert for full prescribing nformation. Store under refrigeration between 2010 8°C (36° to 46°F). Protect from light and retain in carton until contents are used. WARNING: Severe celults, vesication and tissue necross will occur if doxorubicin hydrochlorice s extravasated during administration. See bottom panelfor ot number and expiration date. Iss.9/2011 Teva Parenteral Medicines, Inc. rvine, CA 52618 NDC 0703-5040-01 Rxonly Y S DOXOrubicin Hydrochloride Injection USP AL Ty (2 mg/mL) PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET ForIntravenous Use Only Steril,Isotonic Salution Contains No Preservative 100 mL Multiple Dose Vial X12-X10-L28 Ech mL contains 2 mg doorubicin hydrochloride, USP, sodium chloride 0.9% vater for inection .. pH aGjsted vith hydrochlric 2cidorsadium hydroside. pH 2510 45.
10db92f9-2300-4a80-836b-673e1ae91610_903_1.jpg 8 750458-577-60 0 oozisror wssarsiozo) w0 e 10300 dasy “{omeisdus] ooy pagonuc dsn 3] 50851 01 panpasad suofsimans iadiuia) W04 40 (4.22) 3,52 1¢ %03S 60 Tablets NDC 50458-577-60 wXi Tablets [p.J] Dispense the accompanying e hsertfor Medication Guide to each patient. Each tablet contains: haroten 25 mg See ll prescribing informaton, Rx only ey sz goc .im VSRS s oy oS s 0094585508800 NLS N N /)
10db92f9-2300-4a80-836b-673e1ae91610_903_2.jpg , IR 3 50458-580-90 7 Auewsan asmyan ovaouyes afeg 09580 N o0 ‘eamnaDeu g Uassuer 10} B Aueusian ‘Uasyana g9ELS DY Jakeg Aq By Aueua 0 DPOIY — 105 i@ £ ) o8 8 =" fe ged O, & ° o §s . 3. ;0S8 5, % IXER :in g 2 $58:07 g B z as 32852 000U oSSR 1020 R “uBIpR J0 43201 10 310 domy &' (4.98-.65) 2.08-.51,03 panyyuisad ‘Suoringe foinesaduy WO04 30 (4.42) 95T 4035 107 axa NS 20608585V0SE00 NILD
10db92f9-2300-4a80-836b-673e1ae91610_903_3.jpg @ £ g g g 5 varclio Tablets Dispense the accompanying 30 Tablets Medication Guide to each patient. Each tablet contains: Fraroban 15 mg Sec package nsetfor fiibrescbing informaton. " isee USP Controlled Room Temperaturel. Store a1 25°C (77 or room temperature; xcursions permitted to 15°30° (59' Keep out of reach of children. 10482400 £ N 0 0$-8.5-85%0S
10db92f9-2300-4a80-836b-673e1ae91610_903_4.jpg 3 50458-579-30 7 oot w076 “uBIPP 40 43e94 40 1o doay (4.98-65) 2.06-51 01 ponyused suoysinoxa ‘eameRdwe Woo: 10 (1.42) 3,52 Ve 24015 4 f L I : mm | 2 885 » i geie : B 2 mmmmwm,m oscto s o
10db92f9-2300-4a80-836b-673e1ae91610_903_5.jpg NDC 50458-584-51 yXarelto - (rivaroxaban) Tablets Starter Pack for treatment of deep vein thrombosis and treatment of pulmonary embolism Days 121 Days 22-30 @ 2ubies & o obies — First 30-day supply How do I take XARELTO"™? e S et First 21 days On Day 22 o T One 15mg tablet One 20myg tablet To® 1 20 el ¢ 0010 e end20mg o @2 & ‘mouth, with food # The starting dose is one 15mg 7 /7 tablet taken twice a day for TS the fist 21 days Then the dose changes to one 20mg tablet taken once day It's important to see your doctor before Day 22 of treatment 10 get your new XARELTO prescription, You should take XARELTO exactly as prescribed by your doctor. Do not change your dose or stop taking XARELTO unless your doctor tells you to. seieL (epoen) ORIOK vXarelto EDETD (veroxaban) Tablets | g 1. Use thumbrnai to push the utton gently. 2. wilehoking the utton down, pull ot the meslcation carc. 3. Refer to calendar on medication card o find correct day, press ot and take correct dose. . Shde medication car back o lock. Xarelo (ivaroraban) Tablets Starter Pack PLACE PHARMACY LABEL HERE Plas s ull rsciing Information,Induding BOXED WARNRIGS, and Medicton Glde s, Sae 21 25°C (7P o oo ampurire: i e o TS0 G¥) Xaaﬂorh_ s ﬁ:“ﬂ':;:“:?::’“ CarePatl et e B lbﬂll e o ko . e O, G, 8077 i o i st Tl G e sanssen J Lo // Exp suigz ‘ LEETH peasmms SB[0eL (Uege0e) QUMDY
11828685-dc27-42d8-a6ff-f110018207d1_427_1.jpg Pacbaged by Eryant Rench Banban. €4 91506 5 VHITE CAPSULE SHAPED 713 Ezetimibe 10mg S Tablet e 2 store at room temp of Compare To: 20°25°C (68°-77°F) Zetia 10mg Tablet Keep all drugs outof Waton Pharma Private Limited 5 reach of children. #30 Exp: MMYY 3 NDC 7133509331 074131122689
119e1752-8131-4a91-97d0-f7e6b91c555e_653_1.jpg Ondansetron 2mg/ 1mL Inj. for L.V./LM. Use ary: 2 ID#:. Expires: NDC #: 70518-1422-00 Shape: . LOT #: Ref #: 70860-0776-02 MFG: Athenex, Schaumburg, IL 60173 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
12ae85f0-023c-49ca-8c4a-0a6a7585290e_227_1.jpg NDC 60687-292-01 Donepezil Hydrochloride Tablets, USP 100 Tablets (10 x 10) RxOnly AT LT (01) 0 03 60687 292 01 4 PHARMACIST: Dispense wih the accomparying Patent Packags nsert o each patont. NDGC 60687-292-01 Donepezil Hydrochloride Tablets, USP 100 Tablets (10 x 10) Rx Only Each Film-Coatad Tablet Contain Gonepezi ygrochiorde USP... ... ) Usual Dosage: See package nser or full prescrising iformation. Store at 20° 1025°C (68° 1o 77°%); axcursions pormitied betuzen T51530°C (53¢ 1 8 [so6 USP Controlied Room Temperdursl Koop this and al drugs out of reach of children. FOR YOUR PROTEGTION: Do ot use bister & orn o broken. T e ko T pmatsiconnea o pecage'e Fecagaiond Tovmus 720201 aszsegiioate
12ae85f0-023c-49ca-8c4a-0a6a7585290e_227_2.jpg Donepezi RReBeEe Tk, usp Smg vk, 2 o0 s g 222113 o e Dopepei BEDRaN e Tabiet UsP £ 7 smg &g . 2 iz Chwmemrmits F Donepez DieENGnae Tabir, Us g I @ cossoser 232 113 5 Donepezi Birofiande Tabit, Use 5mg g Donepezi Biimatiiande Tebier, UsP smg o T Donepezil Fftnothiance Tetiat, USP £3 5o g2 i 8 Oustrosrzearis Donepezil § BS0RBTehde Tablel UsP 5mg TR, (o1 a3 soser w2 113 Expiry: mioc Donepezi, Btretionde Tablet, USP i%smg i 53 (o1 ooneosar 52113 § {07 cossosar 252115 é £ paenn @ aomeosar 252113
12ae85f0-023c-49ca-8c4a-0a6a7585290e_227_3.jpg NDC 60687-303-01 Donepezil Hydrochloride Tablets, USP 100 Tablets (10 x 10) Rx Only (01) 0 03 60687 303 01 7 PHARMAGIST: Dispense with he accompanying Paliant Package Insert 1o zach patint. NDC 60687-303-01 Donepezil Hydrochloride Tablets, USP 100 Tablets (10 x 10) Rx Only Each Film-Coated Tablet Contains: Donepezi hydrochloride USP. 10mg Usual Dosage: See package insert forful prescribing information. Store at 20° 10 25°C (68° 1o 77°F): excursions permitied betwesn 15° (0 30°C (58" to 86°F) see USP Controlled Room Temperature]. Keep this and all drugs out of reach of children. FOR YOUR PROTEGTION: Do not use i bister i torn or broken. The drug product contained n ths package is from NOC 31722-738, Camber Pharmaceuticals, Inc. Packaged and Distrlbuted by: American Health Packaging Columous, Ohio 43217 730301 0430301/0818
12ae85f0-023c-49ca-8c4a-0a6a7585290e_227_4.jpg Donepezil Denspeil B cp gy R e mg g o A L e £ ssl Plomarats RE 5% LA, v IR R 10 mg 3 ;Eﬂmg i i D miiheen momree, MY Smmenn . o bt B p g S g B g foma TR, Es ol WRTHA DR, e g g Lot xooor Expiry g I I 01)003 60687263116 o onse0e87 02 115 0000 107 e 03 carceat e 10 mg 8% 2fi0mg iy K £ ssl LU S R LU
12bb15b3-3bf6-4861-9a0a-58a4828c07a5_608_1.jpg Sulfatrim Sulfamethoxazole/Trimethoprim 800mg/160 mg Tablet, DS ary: 6 ID #: 1P;272 Expires: NDC #: 70518-1517-00 Shape: Oval LOT #: Ref #: 53746-0272-01 MFG: Amneal Pharma, Bridgewater, NJ 08807 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
12bb15b3-3bf6-4861-9a0a-58a4828c07a5_608_2.jpg Sulfatrim Sulfamethoxazole/Trimethoprim 800mg/160 mg Tablet, DS arv: 14 ID #: 1P;272 Expires: NDC #: 70518-1517-01 Shape: Oval LOT #: Ref #: 53746-0272-01 MFG: Amneal Pharma, Bridgewater, NJ 08807 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
130f4b5b-eefe-4ce6-8555-c872a8082c17_757_1.jpg Packaged by Begant Rancl Burkank, G 91504 T YELLOW, BROWN (LIGHT) CAPSULE 3408 S, (oymbat) 565 ymbol 260 GABAPENTIN - 300MG CAPSULE 5 % [ store atroom temp of Compare To: 20-25 C (68-77F) GABAPENTIN 300MG CAPSULE Keep all drugs out of WasonProm abatores . reachiofehildrén swox #30 Exp: MM/YY NDC 6362967921 067921102637
130f4b5b-eefe-4ce6-8555-c872a8082c17_757_2.jpg Packaged by Begant Ranel Bunkank, G 91504 5 LIGHT BROWNWHITE CAPSULE Gabapentin 100mMg S i) s - (symborsss (CV) Capsule May cause dizziness 80211 Store at room temp of Compare To: 20-25 C (68-77F) Neurontin 100mg (CV) Capsule urorie 100 (C) Do Keep all drugs out of Watson Pharma Private Limited reach of children #90 Exp: MM/YY NDC 6362973051 073051112708 fwoxy
130f4b5b-eefe-4ce6-8555-c872a8082c17_757_3.jpg Packaged by Brqant Ranch Burbank. G 91504 = ORANGEILIGHT BROWN CAPSULE Gabapentin 400mg S i) e smbolyer (CV) Capsule % May cause dizziness & | store atroom temp of Compare To: 20-25 C (68-77F) Neurontin 400mg (CV) Capsule Kespalldrugs outof Watson Pharma Private Limted reach of children #90 Exp: MM/YY ¢ NDC 6362973091 073091110988
134a09e1-8c73-2943-e054-00144ff88e88_46_1.jpg e leR et o R v MORPHINE SULFATE EXTENDED-RELEASE TABLETS 100 Tablets (10 x 10) (01) 0 03 68084 403 01 9 NDC 68084-403-01 MORPHINE SULFATE EXTENDED-RELEASE TABLETS 100 Tablets (10 x 10) PHARMAGIST: Disgarz Wi 176 2ccompanyng Medicaton Blide io sach patient Exch Tablet Gonains: 15mg i presciing nemmaton. e 1510300 59" 10 DEA Order Form Recuired Keep this and alldrugs out of aach of children. FxOnly Tre g produc conined n i package s from NOC 1§ G0951 652, Qualtos Pharmaceutons Packaged and Distrbuted . American 1eath Packsging 040301 Golomous, oo 45217 Rev. 0172015
134a09e1-8c73-2943-e054-00144ff88e88_46_2.jpg exencenreteast (3 o ExTENDEDRELEASE (T Soeze @ § e § I 5 (01)0% 8308 5 15 orPHIE suLpATE 1ORPHNE s STBon AL (@ 5 BEnptD e SrsREs 5y SEBEEE @ sl 1 i LRBNNIB e SR sorpumE susre uorpane asrave LERSRLE @ Tt 1 mg s @ 5T oz 23 Hg oI BT CHI o T ( vorme suisre yomne susare ERISMEE @ 5y SESSRIE @ SRR R £ WihiiG £ 5 D TSRS yorpting suPiTe wore sueire ETRENDE @ SISREE @ ST s mg e 15mg i i R 1 5 T
134a09e1-8c73-2943-e054-00144ff88e88_46_3.jpg NDC 68084-404-01 MORPHINE SULFATE EXTENDED-RELEASE TABLETS 30 mg R R} (U101 MR © 1) 0 03 68084 404 01 6 NDC 68084-404-01 MORPHINE SULFATE EXTENDED-RELEASE TABLETS 100 Tablets (10 x 10) PHARMAGIST: Disgarz Wi 176 2ccompanyng Medicaton Blide io sach patient Exon Tabiat Nocprine S s0mg packags nsert ol srseiong nformaion, [t s AR e o GE0TE
134a09e1-8c73-2943-e054-00144ff88e88_46_4.jpg MORPHINE SULFATE TARET 30 mg o100 egea 04 115 o o TARET 30 mg o1) 00 agea 0s 515 womeye surire LTRSHEE @ S I o) 003 6gea 04 115 o) 003 egea 0s 515 wonpn supire LERSUIE @ i AR I i msmasns BRSSREE @ S S o7 95 caoes 404 115 MoBHNE SuEATE EEs eese (1 Srmeemuic @ R | I {91 03 Sa0e4 404115 yorerne suraTe LREMCRUAE @ e o it | o7 o5 caeaana 115 — exenceoReErse (1) Smpemas I R | Tttt AR, (o1 003 o 04515
137038a6-12ed-47fd-a97c-01073c5141d1_416_1.jpg g N “Eachcapule conane apre .t hts Hcranon oy 57 A Attt A Vot e g cialent t T mo oo g achiessantcoare. 5 g ecrmnen e 5 NTtrOfUFANTOIN Ko mmmie it ot o o cqsvalen 1 28 mg b X — Capsules, USP = (Monohydrate/Macrocrystals) ~ Storeat20°to 25 (68° 1o 77°F). J‘ %Smﬂsfnll’}m]tmlbdﬁnun fempersure] N UL B oo vy 17 Rows i oot T — (Twice-a-day Dosage) st Ses scomuanyin prescrbng O_— Urinary Tract Antibacterial Mylan Pharmaceuticals Inc. o= M —_— © B ylan [MMylan® m Rx R My
13bb8267-1cab-43e5-acae-55a4d957630a_661_1.jpg NDC 0456-2006-01 2 Lexapre [, escitalopram “oxalate Equivalent to 5 mg escitalopram 100 Tablets Rx only Allergan Pharmacist: Must be dispensed with Medication Guide Usual dosage: See package insert for full prescribing information. Keep this and all drugs out of the reach of children. Each tablet contains 5mg escitalopram Dispense in tight container as described in the USP. Store at 26°C (77°F)— Excursions permitted to 15° 0 30°C (59° to 86°F) Licensed from H. Lundbeck A/S MPO1
13bb8267-1cab-43e5-acae-55a4d957630a_661_2.jpg NDC 0456-2010-01 o esci(a\op(amloxalate g. Tablets—10 mg Equivalent to 10 mg escitalopram 100 Tablets Rx only Allergan. Pharmacist: Must be dispensed with Medication Guide Usual dosage: Seg package insert for full prescribing information. Keep this and all drugs out of the reach of children. Each tablet contains 10mg escitalopram Dispense in tight container as described in the USP. Store at 25°C (77°F)— Excursions permitied to 15° 0 30°C (59° to 86°F) Licensed from H. Lundbeck A/S MPO1
13bb8267-1cab-43e5-acae-55a4d957630a_661_3.jpg 40841 wz (I NDC 0456-2020-01 escitalopram loxa\ate g. Tablets—20 mg Equivalent to 20 mg escitalopram 100 Tablets Rx only Allergan. Pharmacist: Must be dispensed with Medication Guide Usual dosage: Sea package insert for full prescribing information. Keep this and all drugs out of the reach of children Each tablet contains 20mg escitalopram Dispense in tight container as described in the USP. Store at 25°C (77°F)— Excursions permitted to 15° 10 30°C (59° to 86°F) Licensed from H. Lundbeck A/S MPO1
13bb8267-1cab-43e5-acae-55a4d957630a_661_4.jpg Keep this and all drugs out of the reach of children. Dispense in tight container as described in the USP. T ©! SC NDC 0456-2101-08. Lgxapro alopram “oxalate E Oral Solution - 5mg/5mL Equivalent to 1mg escitalopram/mL 8 fl 0z (240 mL) Ry only Allergan. Pharmacist: Must be dispensed with Medication Guide Store at 25° C (77° F)- Excursions permitted to 15°10 30° C (59° to 86° F) See package insert for full prescribing information. Distributed by: Allergan USA, Inc. Irvine, CA 92612 © 2016 Allergan. Al rights reserved. Licensed from H. Lundbeck A/S RMC 5372
13bb8267-1cab-43e5-acae-55a4d957630a_661_5.jpg “ 9]B|EX0g WRIAO[RYISE oidpbxa] Lep(apro ! escitalopram "oxalate o et 10 g o - 10510 o s S 2 7)o 0 ToE Ra) S g o i et S B Wt ol g Eorty “#3Allergan \ Lexapre ; Lexapro <g escitalopram “oxalate: . ./ e | 3 z|| \
13bb8267-1cab-43e5-acae-55a4d957630a_661_6.jpg “ 9]B|EX0g WRIAO[RYISE oidpbxa] Lep(apro ! escitalopram "oxalate o et 10 g o - 10510 o s S 2 7)o 0 ToE Ra) S g o i et S B Wt ol g Eorty “#3Allergan \ Lexapre ; Lexapro <g escitalopram “oxalate: . ./ e | 3 z|| \
13c89fbb-f8e7-1f70-ef5a-468b90efb933_964_1.jpg Clear, coloress gel provides. e L ety Testosterone ok Gel 1.62% @ Topeai st 30 Unit-dose Packets [y Contains 20.25 mg oftesfosterone /, ForTopial Use Ony s, st o nt ptonc o
13c89fbb-f8e7-1f70-ef5a-468b90efb933_964_2.jpg 30 Unit-dose Packets Clear, colorless gel provides TR L O e Contains 40.5 mg of testosterdfie 025 Grams of ge per unt ése Testosterone Gel 162% € P iy \ For Topial Use Only Topcaltestosterone products may have difershtdoses, stengths, or applcation nstructions that may result i diffent systemic expose. zydus \ Dispense th encosed Medion Guide o each patien. G 2 g cinie i
13c89fbb-f8e7-1f70-ef5a-468b90efb933_964_3.jpg NDC 68382-362-11 _~ Dispense the accompar Medication Guide to each paiet. Testosterone Gel 1.62% @ 20.25 mg of testosterone per pump actuation* “Each actuaion delivers 1.25.g of gel For Topical Use Only Topical testosterone products may have. ieren doses stengths,arapplcaton nstuctons that may resultin different systemic exposure. Testosterone G ihG Mult-dose pump capable of dispensing 60 metered pump actuations. 14 Zydus Rxonly
144379e1-93b7-41c1-bc3a-7bdec5afa309_122_1.jpg Packaged by Evgant Ranch Bunbank. CA 91504 Bupropion Hel G "tovrous! 75mg Tablet SI88TT | Store at room temp of Compare To: 20°-25°C (68°-T7°F) Wellutin 75mg Tabkt “Keop all drugs outof Heritage Pharmaceuticals Inc. reach of children. #30 Exp: MMYY NDC 7133507911 034491118815 om
14841608-dc8e-4278-9b2a-b664e51bf207_824_1.jpg Packaged by Bvyant Ranch Bebank. @A 91504 Isosorbide Mono. 5 ER 120mg Tablet Store at room temp of Compare To: 20-25 C (68-77F) csortide Nom, ER 120mg Tabket " Keep all drugs outof Qualitest Pharmaceutical, Inc. reach of children #30 Exp: MMYY NDC 6362974771 074771114600 om
14fd7c1c-778e-46d4-9024-89b319f15f39_936_1.jpg BusPIRone Hydrochloride Tablets, USP 100 Tablets 74 Zydus Rronly NS 6505.01.253.28%2 Each ablt comane BusPRone hydrochorde, USP. 5 mg Usual Dosage: See pacage nser forcompete prescrbmn nformaton Sore i 20" o 25°C (88 to TI°F) See USP Contolled Room Temperatur]. Dispense in a o ghtesistant conainer. KEEP THIS AND AL DRUGS OUT (OF THE REAGH OF CHILDREN. 2 Code No: GUIDRUG/ A6 gi Wanufactured by: 3 Cala Heathere Lt Abmedatad, rdia Distrbuted by: ydus Pharmaceuticals (USA) nc Pemington, N
14fd7c1c-778e-46d4-9024-89b319f15f39_936_2.jpg '-?i zydus e BusPIRone Hydrochloride Tablets, USP @ 1nn Tablets Rxonly NSN 6505.01.267-3149 Each ablt comane: BusPRone hydrochiorde, USP_10mg Usual Dosage: See pacage nser: forcomplet prescrbmng nformaton. Sore 20" 0 25°C (88 to T°F) See USP Contolled Roon Temperatur]. Dispense i a o ghtesistant container KEEP THS ANDALL DRUGS OUT OF THE REACH OF CHILOREN. 2 Code No- GUIDRUGI 486 i Manufstured by 5 Gl Heakhcare Lt Abmedatd, ndia Disrbuted by: ydus Pharmaceuicals (USA) nc. Pemingon, M
14fd7c1c-778e-46d4-9024-89b319f15f39_936_3.jpg L [ BusPIRone Hydrochloride Tablets, USP PRARMACST:Copors il Paten asiuchan st 100 Tablets bt S e up_tsmg ey e e . S e e l&!usvoa-rm oo Temperture]. Do na st . R AT o Ao cHen P oo g o Distributed by- Zydus Phamaceicals (USA) Raony o R g 2 e
14fd7c1c-778e-46d4-9024-89b319f15f39_936_4.jpg BusPIRone oo Hydrochloride Vet Do Seeresom et complee preserbing formaton. Tablets, USP S azromoErbTrn ez USP Corirlld Room Tengeraure], Dispense in a tgh gt resistant contane. oD KEEP TS AND ALL oGS out OF THE REAGH OF CHILDREN. o No: GUJDRUGI485 S P i e e ; oo : P oy A 2]
1553312b-ed76-421c-a055-2579bdcf366c_620_1.jpg ysiueA oN Each bt oo sz 000 USUAL DOSAGE:So rcingenying sk o o formaion Dspese conents 3 esstnt coraner = G o LS w3 - cotr, o P s vt HEEPTGHTY L0660, Stor a2 1 26 81077 o USP sl Room Tengaras, KEEP TS AKD ALL MEDICATION OUT OF THE REACH O ChLonen. Nanachsed by i rama, LG Lt W1 11413 Sancz . oo, 0 08540 Prodctal s e tooes Isoniazid Tablets, USP RBeonly 30 Tablets A SANDOZ 0185-4351-30
1553312b-ed76-421c-a055-2579bdcf366c_620_2.jpg arq6q ySILEA ON o 300 bt oo sanaza 300 g USUAL DOSAGE:So scamgoryig erahre o s et efoaion Dpense conets 1 g ket contner s Gt e U5 wiha ch- e ctre, & foaurs Prec ekt nd . HEEPTGHTY 056D, St sl 2010 280 681 77 e USP ool Rou Temparsr, EEP TS AND ALL MEDICATION OUT OF THE REACH Nantachsed by i Prarma, LG Ut Wy 11412 Sand . roceon 109540 Prodctol g e w08 Isoniazid Tablets, USP 300 RBeonly 30 Tablets A SANDOZ 0185-4350-30
1560b731-2379-4055-a63f-a7b92e6b7abc_694_1.jpg TraZODONE Hydrochloride 50 mg Tablet arv: 30 ID #: APO;T50 Expires: NDC #: 70518-1410-00 Shape: Round LOT #: Ref #: 60505-2653-01 MFG: Apotex Corp., Weston, FL 33326 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
15906fc2-67ce-4c7e-abc9-73bd1d9f5498_59_1.jpg B e G e Eie Sebpommof g ETE e By R e £ Eimman R i g THCEA DAY i S ] R, .o o | EEEL | — ;
15906fc2-67ce-4c7e-abc9-73bd1d9f5498_603_1.jpg B e G e Eie Sebpommof g ETE e By R e £ Eimman R i g THCEA DAY i S ] R, .o o | EEEL | — ;
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_1.jpg NDC 60687-387-01 Midodrine Hydrochloride Tablets, USP 100 Tablets (10 x 10) Rx Only (01) 0 03 60687 387 01 7 NDC 60687-387-01 Midodrine Hydrochloride Tablets, USP 100 Tablets (10 x 10) Rx Only Each Tablst Contains: Nidogine hycrochionde. 25mg Usual Dosage: Ses package insertfor il preserlbing nformation. Store at 20° 10.25°C (8" 10 T7°) excursions permited between TE%15.30°C (55 1 Bo°F) [soe USP Controlied Room Temparatrs]. Koop this and all drugs out of reach of childron. FOR YOUR PROTEGTION: Do nol use biser & orn orbroken. Tne chug product contained i s package I fom NBG'S 603051520, Apores Corp. Packaged and Distributod by Amarcan (aith Packaging Colimbus, Oneo 43517 738701 DLaBTON0 TS
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_2.jpg Midodrine Midodrine W v e g R o g 82 fp it e 52 £ gl onomsossrsgrie 5 03 onooososrsar i Vidostine Vidodiine Mo rav e £ 3 ¢ R e, e P 28 By a 53 ifzome S i: &5 Vidodiine Vidodiine S e o, use i S an,use 25 59 §i3%mg N B afasms 5 &l ig g3l widodrn widodme Mot ro v g R e e 25mg 8 £y i §r 5 MhlAR DL, 2% g GRDALAI, Vidodrin Midodine W v uop g R o o 82 fpio " 2 e [E {01) 00360587 387 116 ¢§ &3 o) oussosarser 15
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_3.jpg NDC 60687-398-01 Midodrine Hydrochloride Tablets, USP 100 Tablets (10 x 10) Rx Only (101NN 0 I (01) 0 03 60687 398 01 3 NDC 60687-398-01 Midodrine Hydrochloride Tablets, USP 100 Tablets (10 x 10) RxOnly 5mg o package insetfo ol presériong nformaton. Store at20° 1025 (88" 10 77°F) axcursions permited between T5°12.50°C (53 1o 86'F) 566 USP Contralea Room Temperatur) Kesp this and all drugs out of reach of children. FOR YOUR PROTECTION: Do not use f bister s fornor broken The drug procuct contained i this package s from NDC' 80503 1321, Apoiex Carp. Packaged and Distrbuted by Amencan gl Packang Colombus, Onio 43217 730801 043980110978
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_4.jpg Midodrine Hydrocnioice Tablet, USP g £E e g 52 @tz %% Midodrine Hydrochiona Tablet, USP 5mg Midodrine Hyerochibid Tablat, USP. g i Midodrine Byt Tasler, UsP smg ﬂﬁ%ﬁfﬁiﬁﬁ'ﬂ'\é o 005 oo 353112 Midodrine Hydochioed Tablat, USP s'mg e o000 101 § £ @)omamT sz Midodrine. 5 y Dochioride Tablet USP 3 g smg 3 i F5l 3 Ehovsesesrse 12 Midodrine HySrochibnde Tablet, USP. § smg sy g o 003 sose7 350 112 Midodrine Hyaracriendo Tablet, USP 0100350567 350 112 Midodrine % § Hyerehience Tanier, UsP 1 | &3 oyoosswersss 112 «, Midostne 3§smg Hydrochioride Tablet, USP. § e 0100350557 355 112
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_5.jpg NDG 60687-409-25 Midodrine Hydrochloride Tablets, USP 30 Tablets (5 x 6) Rx Only IJI LTI 1) 0 03 60687 409 25 2 NDC 60687-409-25 Midodrine Hydrochloride Tablets, USP 30 Tablets (5 x 6) Rx Only Each Tablet Contains: Widodrin hyrochioride. 10mg Usual Dosage: See package insert for full prescribing information. Store at 20" t0 25°C (68" to T7°F); excursions permitted betwesn 15° 0 30°C (58" to 86°F) [see USP Controlled Room Temperaiure]. Keep this and all drugs out of reach of children. FOR YOUR PROTECTION: Do not use I biister s torn or broken. The drug produst contained in this package is from NDC 60505-1325, Apotex Corp. Distributed by: American Health Packaging ‘Golumbus, Ghio 43217 740925 0440925/091808
159cb0cb-4b27-4a1c-8ad4-dc93604c79c7_94_6.jpg Bui o asn el SpUOIUROIDAH uLpop Bui o} asn el SpuOjUoOIPAH uLpopI Bu o} a5 el SPUGIUOOIDAH ulpopy i e 1 < S g 5 £ BoEs Midodrine Hydrochioride Tehiel, USP 10 mg y Midodrine Hydrochloride 52 e e B 10 mg Midodrine Nydrochorde 5 g 10 mg =
15fe05b6-de2e-4b95-876f-30226a9b60f1_988_1.jpg buPROPion HCI 150 mg Tablet, ER (XL) ary: 30 ID #: LO15 Expires: NDC #: 70518-0859-00 Shape: Round LOT #: Ref #: 68180-0319-02 MFG: Lupin Pharma, Baltimore, MD 21202 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
15fe05b6-de2e-4b95-876f-30226a9b60f1_988_2.jpg buPROPion HCI 150 mg Tablet, ER (XL) ary: 30 ID #: LO15 Expires: NDC #: 70518-0859-01 Shape: Round LOT #: Ref #: 68180-0319-02 MFG: Lupin Pharma, Baltimore, MD 21202 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
16238287-d4b0-4afa-8483-1f4ae250a625_156_1.jpg Indomethacin 25 mg Capsule arv: 30 ID #: G406;G Expires: NDC #: 70518-1458-00 Shape: Capsule LOT #: Ref #: 68462-0406-01 MFG: Glenmark, Goa, India 403513 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
167ecefd-4553-41b8-8160-81a48dbca076_441_1.jpg G E R 0000 1 IMENTAX" [MMylan' butenaflne HCI) Cream 159 NDC 0378-6151-46 IMENTAX"® bulenaflne HCI) Cream [MMyla [ e WERIRSICAE i IMENTAX" (i3 mm;cmv;& v ‘(buiena(xne HCI) Cream TMylan Fuup\'w[@ P A i) 4 e (4,98 PUP.11) Q0% PUE & Usomoq 0l | i UBIPIP JO PEAIBU10INO SUTIpOUIIopu A1) dow | ! o osn ewopo104! i B oy BUGLES K 10} 198 SBE3FEd MABAGOR 5 BeB0 eS| [ s amz1sg unpos pue i ouaU P SN 019 21ed 3640803(E7) v uiaiolod N | 198 SUBe15 51 LITVEGIRC 2 K 35 S BORISOUEL JURAB N IOYCOIE 03 S 1 UROAR BALCEDID,| 100D suepde G5 1 Py SEUOIDQIDAY U0 4 05U W o3| CRTIEE S 15—
174fadaa-f1ba-4316-bae4-40ab36c5b6d9_433_1.jpg Each fim-coated tablet contains: Donepezl hydrochioride, USP 23 mg Usual Dosage: Ses accompanying prescribing information. Keep this and all medication out of the reach of children. Store at 20° to 25°C (68° o 77°F). [See USP Controlled Room Temperature.] Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WY 28505 U.S A. Made in India RMX1025K2 | EXP MMYYYY \V@yyilan [ Myten:com Rx only R BPAMTY i Nl (PR Donepezil HCI Tablets, USP [MMylan® L, 0378-1025-93 Dispens Ina tight, light-resistant contalner as defined In the USP using a child-resistant closure. Keep container tighty closed. Cade No.: MKDRUGS/25/NKD/89 [ 3 SN XXX0000K 75062061 GTIN X0
17850520-f823-4d05-8f9b-5eadfa68bae2_670_1.jpg NDC 62559-730-01 Felbamate Tablets USP Medicatlon Gulde foeach patont. il Rx only 100 Tablets Each tablet contal Felbarate USP. 400mg Usual Dosage: Sao accormpanying prescribing informmation. Store at 20 to 25°C (68° t0 77°F) fsee. USP Controlled Room Terperature) Dispense n a tight container. KEEP THIS AND ALL MEDICATION ‘OUT OF THE REACH OF CHILDREN, Produstofndia Mansactod Bors Bramasiutial aborstoia . i, Tavan Dertuedy A Prarmatautst . Baudots, N 8625 LA-3000-01 05/2018 Rev.
17850520-f823-4d05-8f9b-5eadfa68bae2_670_2.jpg NDC 62550-731-01 Felbamate Tablets USP Medicaton Guids 1o each patont. . Rx only arm 100 Tablets Each tablet contains: Felbamats USP. 600 mg Usual Dosage: See accompanying prescibing information. Store at 20°to 25°C (68" t0 77°F)[see. USP Gontrolled Room Termperature). Dispensain a tight container. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Productof s Mandactaod vy Bors Pramaotute abortories Iiran, Towan Derturedby: A Prarmoteutist . Beudets NN 682 LA-3001-01 05/2018 Rev. | o
17e976c6-ee44-42c5-987f-5360ee6d7c1e_432_1.jpg Paclaged by Ergant Raech Binbank. 04 91500 Terbinafine o= 250mg tab. 9T61Z1 Store at room temp of Compare To: 20°25°C (68°77°F) Lamisil 250mg Tablet “Keep all drugs outof Leonsa reach of children. #30 Exp: MMYY NDC 7133509181 028071121916 om
17f85d17-ab71-4f5b-9fe3-0b8c822f69ff_711_1.jpg S/ NDC 50242-145-01 Perjeta® (Pertuzumab) Injection 420 mg/14 mL (30 mg/mL) Dilute Prior To Use For Intravenous Infusion Only Single-Dose Vial Discard Unused Portion No preservative. ﬁ Ronly 1vial Genentech 10195566
18495527-add4-42a5-bbf7-9f8dc2df06af_581_1.jpg e AL e E = 2 T T T T 2 VeI T I SAGEANd STORACE SELPACKAGEINSERTE 43063-633-30 43063-1132-90 43063 643 30 VENLATAXINE VENLAFAXINE VENLAFAXiiK usp Us# usp 75 MG 75 MG 75 MG 90 TABLETS 20 TABLETS 90 TABLETS ReOrder # 109056 ReOrder # 109056 ReOrder # 10S056 Lor 118Fa40 Lor 118F40 LOT J18F40 EXP 02/20 FXpP n2/20 EXP D2/2G CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: VENLAFAXINE HYDROCHLORIDE USP EQUIVALENT TOD 75 MG OF VENLAFAXINE DASE ORGANOLEPTIC MARKINGS: PEAC|I 335 SHIELD SHP SC NDC: 43063-633-S0 VENLAFAXINE Usp 75 MG 90 TABLETS {01)10343063633508 (21))18F40000002 {17)200228 (10)118F40 BDACEIETIETE 1 0BV 10O AHVONNH SONYT AVEYY 1HZ dWOD TWIIWIHD YAIOTYITY BBYGEOVILS
185627d7-710d-4956-8d20-50fed5b506ba_909_1.jpg Spironolactone 25mg 90 Tablets NOC# 43363023960 Spironolactone 25mg 90 Tablets Spironoiacione 25mg 90 Tabets 2 % won switens
1926eadd-d11f-44fa-971f-0041060f7589_969_1.jpg NDC 42192-136-06 Sodium Sulfacetamide 10% Sulfur 5% Cleanser Rx Only SHAKE WELL BEFORE USE 60z (1703 g) Acella PHARMACEUTICALS, LLC Indleations: For the topial conrol o acns wiges, e osace and sborfelc demas, Directons: Wash afeteases o rtic dally o3 dieced by 2 shysicla, v conlac wih eyes o muoous membrares, Wt s el gy 10 tea o b cloanse, massagegenty o ki for 10- 20 seconds,woring o e, rine thoroughly and ol . tying ocur, it may b cotole by insingf socr o Lang e ofln.Sespaage et o pscrting Informaton, Warnings: Fo exemal s ony. Woid colct i yes. KEEP OUT OF REACH OF CHILDREN. Koep bote gty et Acive Ingrodients: Sodium Sutacstanide, USP 10% an Sulfr 5% Other Ingredionts: it ytonlene, s, s EDTA isodum e M slsuiiae, gy saread PG 00 sl gnesum sminan s, mahypisie,proplparin,pred vt o e S ki i, S o Sy S, i e o e g Storeal conole oo emperaire 15 - 30° (59 -85°F). rlct o frosing ot Sulacearide 10% - Sul 5% Clarsr i sugpied 136z (1703 il (NDC 42152-136:06)For o number 40 expiaoncal, s b of bt Agrsciphon ssttors an ommendalors g ol b made Syt 0 S a et Sl 5 spolcable. NOTE: Ths s o an Orange Book prodact. No epresentalon is made as fo generc stalus or bioequivalency. Fiezs e pacage nser or more normaton. 3742192'13606" 5 Manutactured or: foslsPramacaicas, LLC Agharea, GA30008 1800 541480 Rew 08110
1935473b-2910-4828-b778-5f2fb5c23cc1_539_1.jpg Amitriptyline HCI 25 mg Tablet arv: 30 ID #:12 Expires: NDC #: 70518-1484-00 Shape: Round LOT #: Ref #: 16729-0172-17 MFG: Accord Healthcare, Inc., Durham, NC 27703 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
19678edf-934a-45f3-b5da-94d10e9b3248_464_1.jpg DO NOT ABRUPTLY STOP TAKING THIS MEDICATION WITHOUT HIRST CONSULTING YOUR PHYSICIAN, R ony 43063-821-90 WARNING KEEP THIS OUT OF THE REACH OF CHILDREN DOSAGE avd STORAGE SEE PACKAGE INSERT 43063 821-90 43063-821-90 METOPROLOL METOPROLOL METOPROLOL TARTRATE USP TARTRATE USP TARTRATE USP 50 MG 50 MG 50 MG 90 TABLETS 490 TABLETS 90 TABLETS ReOrder # 110448 ReOrder # 110448 ReOrder # 110448 LOT 118C75 LOT J18C75 LOT 118C75 EXP 10720 EXP 10/20 EXP 10/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains; 50 MG OF METOPROLOL TARTRATE USP ORGANOLEPTIC MARKINGS: 74 RND/BRKLINE NDC: 43063-821-90 PD-Rx PHARMACEUTICALS INCORPORATED®, Oklahoma City, 0K « 73127 METOPROLOL TARTRATE USP 50 MG 90 TABLETS Lasvk (01)10343063821909 (21)118C75000002 (17) 201031 (10)118C75 506128 90CPE VRV 0 VION| ‘OVUvHITAH L0E50029854 a1 VWNYHA 0aniaodny
196b4f19-c965-4c88-ab15-3705c2ccef74_974_1.jpg WO 0T 057 TAKE 1 TEASPOONFUL. THCE A DAY FOR 10 DAYSORAS DRECTED. somDson . e e ooner
196b4f19-c965-4c88-ab15-3705c2ccef74_974_2.jpg et RO oL MR ST —— O o 3 TAKE 1 TEASPOONFUL. STHESADAY. somDsonTa. ey e g ooner
198a4140-f4c0-4478-9157-ee1d68d0bb96_420_1.jpg s = | 0=0028=82£0 v Exch capsule cortains: Ketoprfen, USP RN NDC 0378-8200-01 Ketoprofen Extended-Release Capsules, USP EIED § [PARRACIT Disgene th accompanyng [MeicaonGide toeach patent. [MMylan® Rxonly 100 Capsules Dispense ina gt lightrsistart. containeras defined i the LGP gty Keep conaier tighty cosed. = Keep this and all medication out of the reach of chidren. Store at 20° o 25°C (89° o T7°F). [See USP Controlled Room Temperature.] Protect from direct light and excossive heat and humidity. Usual Dosage: See accompaning prescrbing iformaticn Mylan Pharmacoutcals fnc. Morgantown, WV 28505 US A [MMylan® Mylan.com
19a60d50-7319-44d9-9ade-72922cfcb39d_335_1.jpg MM *J72 NDC 55154-2064-0 FOLIC ACID TABLETS, USP 1mg 10 TABLETS Each Tablet Contains Folc Acid, USP 1 mg Usual Dosage: See product inseft fer full prescribing inormation, precautions and warnings. 'STORAGE: Store at 20° 0 25° G (8" to 77 F); excursions permitted between 15 to 33" C (59° to 86" F) [see USP Controlled Room Temperature]. PROTECT FROM LIGHT AND MOISTURE. RXONLY WARNING: This Unit Dose package is not child resistant and is Intended for Insttutional Uss Only. KEEP THIS AND ALL DRUGS OUT OF THE REACH ‘OF CHILDREN. If dispensed for outpatient use, a chid-resistant contairer should be utized. FOR YOUR PROTECTION: Do notuse if bister is torm or broken. “The drug product contained In this ackage s from NDC # 65162-361, Amneal Pharmazeuticals. Packaged and D strbuted by: American Health Packaging Columbus, Ohio 43217 An AmerisourceBergen Company ‘americanheaithpackaging.com AMERICAN HEALTH PACKAGING® Distributed by Cardinal Health Dublin, OH 43017 43305690816 LOT #: XXXXXXXXXX EXP.DATE: XX/XX/XX
19e79382-afc1-4a4d-8540-459e61e79baa_804_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT. MAT CAUSE DROWSINESS USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTNESS. CAUTION: FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG TO ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED. R WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN LR DOSAGE and STORAGE SEE PACKAGE INSERT 55289-487-06 55289-487-06 55289-487-06 LORazepam LORazepam LORazepam usp usp usp 1 MG 1MG 1 MG 6 TABLETS 6 TABLETS 6 TABLETS ReOrder # 100468 ReOrder # 100468 ReOrder # 100468 LoT J18A98 LOT J18A98 LOT 118A98 EXP 10/19 EXP 10/19 EXP 10/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800 FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: LORAZEPAM USP 1 MG ORGANOLEPTIC MARKINGS: WHITE 241 1 WATSON D ROUND SCCR (m)mzssz 17057 sooﬁnm m) 191031 (10)118A98 L90LBYSEZESE (R R T VIONI 'vOD JLLITTVS YNUIA Q17 3LVAINd VNEYH NOSLYM [UTH20T6S00
1a88218c-5b18-4220-8f56-526de1a276cd_862_1.jpg N 3 50458-585-01 8 v 20070 oy joyoea jo o dsay Ay woy o fomusduo wooy pooa e s e 24165 1 pomsund omme 11.1) . B sy g toaop ) sy 5 g g ot ry @ na contolle-release formulation. Please seo the Medication Guide provided by your phamacis. (methylphenidate HC1) Rx only Extended-release tablets Eachtablet contans 18 mg methyiphenidate hydrochloride G S0956-585.07 CONCERTA" s J 100 Tablets jeoziol oesa0 e U SeopneIRULB U 1) B 9955 v0'apweoen diog iy 1082008 ‘0quny jom Suunpegnuey S -vssuer ia oy 510858105200 NLLS N ¢
1a88218c-5b18-4220-8f56-526de1a276cd_862_2.jpg 4 750458-588-01 ¢ BSSE Z00Z.0 TBpIp o Ea1 o 00 daey “fgprumy woy papy “{amessdus) woay pogoquo) 451 355 (4.96-68 9.06-G1-0} PaRLEA SDB IO 13,.1) .52 1 9101S Wy aDteop o e aieoed aes jep aau) 20esop enen © o “. 2= 52 55 EBbE o 8 KE% 8 e WcE t2i5 2 gse £3538 C oo TR BIR 22 g E B SRR AN BVUEZIN 5528 & |s0418LOL 09580 N ‘apns | S0 Smnacnu uassuep o, B 88956 V0 ey oy eay 081100 0quiny| jo Buumpeyuey Boyg-vassior 49 o B 101 a3
1a88218c-5b18-4220-8f56-526de1a276cd_862_3.jpg 3 50458-586-01 5 “uapypo joovai jo mo doay Atpung o o {arywrsiue woog paaue) s 00 4.8665 0,085} ¥ papuiad sty 11,) 9571 a5 Ul 205 0} et EmoRd s Ap ) SERSEp ) © oy s =, .2 2 = £ 23 2 8 off 8B e = e85 85 = W: g 288 88 29z <[ s 8 2 iy 8~ N i %3 =3 § B < Eil i R H S B 2 B VE FKell 58z £228 § o w00 oese0ry ) ‘geaponueg vasuer ) O 101 o NS 54069595705800 NLO |
1a88218c-5b18-4220-8f56-526de1a276cd_862_4.jpg N ¥ 50458-587-01 2 WP Jo yowaijo o dooy tpung iy yomig-{ay e woog paaue) s o0 4,865 0,065} ¥ papuiod sty {1,.) 9571 a5 o205 0} v <Emond s AP ) 08T ) © e, (methylphenidate HCI) DC 50458-587-01 Extended-release tablets Please see the Medication Guide provided by your pharmacist. na conbole-roease formiatn. Rx only Each tablet contains 54 mg ‘methyipheridate hycrochioide 100 Tablets - janssen J jo2! = ~ 0 SoeraI0L & ST 002D | ogsE0rN ‘ansemL “u‘geainug vesuer ) Oy 69956 10" iweon) do iy o 8L100 i ‘oqeng 71 BT Bog-Essuny o B 101 xa NS 210/8595905500 NLO H\\
1aa44bff-9a62-48b4-a520-98d7d524e3a9_50_1.jpg (L Hydroxychloroquine fawwees™ 55 | EE Sulfate b e | 55 |52 Tablets, USP Smazrasc ey L fesinepe et S L 200mg e || s — Seneive s e b B o opt ot of Dok 1o i e acanganog s scer ez 100 TABLETS wanutactursary: G ydus Reonly ot oo my
1b0195d9-8cbd-7442-e054-00144ff8d46c_336_1.jpg nan
1b0195d9-8cbd-7442-e054-00144ff8d46c_336_2.jpg AVGER: MAY CAUSEGRNTENSIY FIRE: OOZER,CONTANS GAS UNOERPRESSURE: WAY XPLOGE ¥ HEATED. OXYGEN, COMPRESSED UsP UN1072 s T PROBUED DA URUTATON RO T 0] S ioon
1beaead9-bc14-432e-ae7a-5fd628ac3c11_154_1.jpg Rosuvastatin Calcium 10 mg Tablet arv: 12 ID #: H;R4 Expires: NDC #: 70518-1601-00 Shape: Round LOT #: Ref #: 31722-0883-90 MFG: Camber Pharma, Inc, Piscataway, NJ 08854 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
1bf70380-8272-4c0d-8841-d39ef2772351_538_1.jpg NDC 51407-011-09 SUMATRIPTAN TABLETS, USP 25 mg 9 tablets See package insert for dosage information. Store at 20° to 25°C (68° to 77°F) [Sse USP Controlled Room Temperaturs]. 5140701109 « Each film-coated tablet contains: sumatriptan succinate, USP equivalent to 25 mg of sumatriptan. « Dispense ina ﬂmz». light-resistant container as defined in the USP using a child-resistant closure. « Keep this and all medication out of the reach of children. « Keep container tightly closed. * Protect from light. * Swallow tablet whole with water. « Do not mw__» tablets. +« PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient. GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated Manufactured by Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Packaged by GSMS, Incorporated Camarillo, CA 93012 USA
1bf70380-8272-4c0d-8841-d39ef2772351_538_2.jpg NDC 51407-012-09 SUMATRIPTAN TABLETS, USP 50 mg 9 tablets See package insert for dosage information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. 5140701209 « Each film-coated tablet contains: sumatriptan succinate, USP equivalent to 50 mg of sumatriptan. « Dispenseina H_mn. light-resistant container as defined in the USP using a child-resistant closure. * Keep this and all medication out of the reach of children. « Keep container tightly closed. « Protect from light. « Swallow tablet whole with water. * Do not split tablets. * PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient. Manufactured by Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
1bf70380-8272-4c0d-8841-d39ef2772351_538_3.jpg NDC 51407-013-09 SUMATRIPTAN TABLETS, USP 100 mg 9 tablets See package insert for dosage information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. 5140701309 « Each film-coated tablet contains: sumatriptan succinate, USP equivalent to 100 mg of sumatriptan. ! . . « Dispense ina @WE. light-resistant container as defined in the USP using a child-resistant closure. « Keep this and all medication out of the reach of children. « Keep container tightly closed. » Protect from light. « Swallow tablet whole with water. » Do not mw_z tablet. « PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient. Manufactured by Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
1c2370fd-6b40-48dc-a42d-2488041d5b37_818_1.jpg Packiaged by Eogant Reasck Banbank. 04 91504 Phendimetrazine G */*™"°** Tart. 35mg (CIII) 10° TLSHTT Store at room temp of Compare To: 20-25 C (68-77F) Plegine 35mg(CII) Tablet (Blue) Keep all drugs outof KVKTECHING reach of children #30 Exp: MMYY NDC 7133500741 073191114571 om
1c2370fd-6b40-48dc-a42d-2488041d5b37_818_2.jpg Packaped by Erpact Ranck Zbank. €4 91504 Phendimetrazine g '*"""%™ Tart. 35mg (CliI) Tab. 662YTT | Store at room temp of Compare To: 20-25 C (68-77F) Plegine 35mg(CI) Tablet yelon) Keep all drugs out of KUK Techine reach of children #30 Exp: MMYY NDC 7133503241 072661114299 om
1d480bbc-9716-427e-a558-e6dd48a90edf_362_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. 55289-019-30 AMOXICILLIN usp 250 mg 30 CAPSULES ReOrder # 100019 LOT J18B55 EXP 02/20 AMOXICILLIN AMOXICILLIN - usp usp g 250 mg 250 mg = 30 CAPSULES 30 CAPSULES s ReOrder # 100019 ReOrder # 100019 E E LoT 11BB5S LoT 118855 &z EXP 02/20 EXP 02/20 QF CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE CAPSULE(S) TIMES A DAY. TOME CAPSULA(S) VECES AL DIA. Each CAPSULE Contains: CAR/BUFF 55289-019-30 55289-019-30 AMOXICILLIN TRIHYDRATE EQUIVALENT TO 250 MG AMOXICILLIN USP CAPSULE NDC: 55289-019-30 PHARMACEUTICALS Y|IINCORPORATED?® =) Oklahoma City, OK = 73127 AMOXICILLIN USP 250 mg 30 CAPSULES sk (01)10355289010305 1 " = {21)18B55000002 (17) 200228 (10)118855 SOE6T06BISSE IR RV 0 VOYNYI ‘OLNOYOL Q3LIWM YAVNYD VAL SCLOTEEG000
1e0f6733-7ec2-47ce-802a-6132a701e1b3_518_1.jpg Pachaged by Eopant Reech Bnbank, €4 91504 Metformin ER § ™ ovsussweia 750mg Tablet 10 g @ Keepall drugs outof Compare To: reach of children Chsepege XATONG T g o o mesiaseins |~ 3006'C @77F) #30 Exp: MMYY & NDC 7133501401 048101114573
1e102c44-232b-4aaf-b457-2a740c47193a_355_1.jpg NPC 0143-9300-01 Rxonly gammvﬁumhils Pantoprazole (i i st . . - sodium) Reconstitution needed. See Sodium for Injection ;ackags insar for dosags and admin- 5 2 Equivalontto. Istration. Store at 20°-25°C (68"-77°F); excarsions permitted f 15°-30°C (50° 40 mg 86°F) [Se USP Controlled Room pantoprazele per vial Temperature]. Protect from light. For Intravenous Infusion Only CLC ST HIKMA FARMACEUTICA (PORTUGAL), S A Distibutedby Y WEST-WARD Estontown, NJ 07724 USA (01)00301439300014 PLB137-NOV/1 Lot Exp:
1e102c44-232b-4aaf-b457-2a740c47193a_355_2.jpg PLB138-NOV/T NDC 0143-9300-10 :.R;x only Pantoprazol Sodium for Injection ‘Equivalent to 40 mg ] For Intravenous Infusion Only Sterile Single-dose vial-Discard » unused portion No filter required Contains 10 Vials PROTECT FROM LIGHT To open - Cut seal along dotted line. Each vial contains: Pantoprazo... 40mg (equivalent to 45.1 mg of pantoprazole sodium) Pantoprazole Sodium for Injection is intended for intravenous use only. Reconstitution needed. See package insert for dosage and administration. Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (50°-86°F) [See USP (Controlled Room Temperature]. Protect vials from light; use of vial carton is recommended. CONTENTS: Ten (10) Pantoprazole Sodium for Injection vials and 1 copy of the package insert. Mid. by: HIKMA FARMACEUTICA (PORTUGAL). SA. Distributed by 3 WEST-WARD Eatontown, NJ 07724 USA N# is a registered trademark of Vizient, Inc. (01)00301439300106
1e3abdf3-5810-42f3-ba5d-be5934c41f40_201_1.jpg e T i Chlorothiazide | Sodium for Injection, USP 500 mg*/vial FOR THE PREPARATION i OF INTRAVENOUS SOLUTIONS | For Intravenous Use Only (Mytan® 67457=26330 ¢ Mandecung Nfan fttutoal LLC Rockhd L6110 USA. Mate iS4 MasaicRz Sodium for Injection, USP 500 mg*/vial FOR THE PREPARATION OF INTRAVENOUS SOLUTIONS For Intravenous Use Only. Stere,Nonprogeric. | Lyophitzed “Each vial contains: Chicothiazie sodium equhlent 0500 mg chioothiazge and 250 mg mannitl Sodum yorcide may e boen added forp adjstment. Roconsttute with a mikmum of 18 L of stere vterfor injecion. (An sotonc sokdion obtaned 18 L s acked) For single-goss only, Use recorsiitted souton Immediatoly. iscad uwiosd porion. Ustal Adult Dosage: Soe accompanying prescibing informaton. Store yophilized powder at 20° 1025°C (68" o 77°F). [Se0 USP. Contrfled Room Temperature]
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_1.jpg Each film coated tablet contains: Amitriptyline Hydrochloride USP 10 mg Usual Dosage: See package insert. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured for: Accord Healthcare, Inc., Durham, NG 27703. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA. Mfg. Lic. No.: G/1339 NDG 16720-171-17 Amitriptyline Hydrochloride Tablets USP Rx Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. 1,000 Tablets I & CC ord INL092 101103 0 669155 sIls 7297 77 |s Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 50X 25 mm IHHH
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_2.jpg Each film coated tablet contains: Amitriptyline Hydrochloride USP 25 mg noc 1672017217 v Usual Dosage: See package insert. vl 3 3 Store at 20° to 25°C (68° to 77°F) [see Am Itrl ptyl I n e USP Controlled Room Temperature]. HVdI‘OGMOI‘idE Tablets USP 8 S ||1nzv 17217|| |z 0 Dispense in a tight, light-resistant = container. o - O 5 eep area blank & varnish free for KEEP THIS AND ALL DRUGS OUT OF m 2 overcoding Lot and EXP & Data matrix THE REACH OF CHILDREN. e 50X 30 mm Manufactured for: Rx Only 3 Accord Healthcare, Inc., PHARMACIST: Dispense the enclosed = Durham, NG 27703. Medication Guide to each patient. 0 Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA. 1,000 rabies m"Hl ‘" Mfg. Lic. No.: G/1339 I 2ccord i
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_3.jpg Each film coated tablet contains: Amitriptyline Hydrochloride USP 50 mg Usual Dosage: See package insert. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA. Mfg. Lic. No.: G/1339 NDC 16729-173-17 Amitriptyline Hydrochloride Tablets USP Rx Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. 1,000 Tablets L[l ord ll INL095 10 1108 0 669159 N s| 1 317| 9 16729| 7 Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 50 X 30 mm I
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_4.jpg Each film coated tablet contains: NDC 16729-174-17 Amitriptyline Hydrochloride USP 75 ay = - UstzglgDusage: See package Am Itrl ptVI I n e insert. = Storeat 20°t0 25°C (6810 Hydrochloride 77°F) [see USP Controlled Room Tab'ets USP Temperature] Dispense in a tight, light-resistant container. KEEP THIS AND ALL DRUGS QUT OF THE REACH OF CHILDREN. Rx Only MEimdr PHARMACIST: Dispense the Accord Healthcare, Inc., = : Durham, NG 27703, enclosed_ Medication Guide to each patient. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. 1 ,000 Tablets IoiA I accord B Ilwzvl\Julvl Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 50 X 30 mm o 3 6 5127060713805 INLOOG Mig. Lic. No: G/25/1883
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_5.jpg Each film coated tablet contains: Amitriptyline Hydrochloride USP 100 mg Usual Dosage: See package insert. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No.: G/25/1883 NOC 16720-179.17 Amitriptyline Hydrochloride Tablets USP Rx Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. 1 ,000 Tablets I 2 ccord l 7z 7 NI| | Sl s Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 50 x 30 mm 5127470713071 INLOS® 5725 Insw
1e6d2c80-fbc8-444e-bdd3-6a91fe1b95bd_269_6.jpg Each film coated tablet contains: Amitriptyline Hydrochloride USP 150 mg Usual Dosage: See package insert. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No.: G/25/1883 noc 16720-17617 Amitriptyline Hydrochloride Tablets USP Rx Only PHARMACIST: Dispense the enclosed Medication Guide to each patient. | ,lll]l] Tablets I occord l T Keep area blank & vaish free for overcoding Lot and EXP & Data matrix 50x 30 mm 5127430713970 INLO%6
1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a_557_1.jpg Ry ONLY. Each 1 mL contains 287 mg gadodiamide, 12 mg caldiamide sodium, in Water for Injection. The pH is adjusted between 5.5 and 7.0 with hydrochloric acid or sodium hydroxide. No preservative added. For intravenous use only. Each vial for one procedure only. Discard unused portion. Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP]. Protect from light. Do not freeze. For indications and dosage, see package insert. GE Healthcare 1192971 NDC 0407-0690-10 = w = (o /TS VIl £ = 2==8 it o SoS — o 8 [CLCCETUERNRTE Y S 05 53 mumm 2 s £580% mm o 2 e = 3 ISEET =S £ 287 mg/mL S2o0C g 2o38o =R 3 10 mL Single-Dose Vial ggé S o S Sterile Aqueous Injection 28SBF — g = = 25535 ==~ ) azZz Ea T Exp.: Lot:
1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a_557_2.jpg 60w eswoy p o0y = sovsootiosamung | 1WAw.e QITER OOy D50 SY2DID3HI) K1 ENDLINI st VSNZSLI0 W UNCITADH U A0NYOH BAGpamEs | U oo oPe S 1 9Zv|mmmvni 00100 o @ 2-1690-L070 JON EU LA 0l ooy oonao NDC 0407-0691-62 (CONTAIN: 1— Omniscan™ 15 mL fill in 20 mL Single Dose Prefilled Syringe 1—5mL 0.9% Sodium Chloride (0.9% NaCl) LV. Flush Syringe Shirrinis OMISCAN o iector - o L caros 251 g ot 219 (gadodiamide) Injection codmie s, et o necion e 41 st bevee 55 o 20w ‘hydrochloric acid or sodium hydraxide. No preservative added. For intravenous use only. Each syringe for one procedure only. Ok mseagorion 58S e e o Cch el g s sl ‘solution of 0.9% Sodium Chlaride 10.9% NaCll. Eoch mL contains 9 mg sodium chioride. 287 mg/mL The osmalary is 0308 mOsmolimL clc. Fresevatve ree Fr V. fush ony. GE Healthcare Prefill Plus™ needle-free system oot use folution s discoloed or ontains & precipate. Store ot 20%-25°C [68*-77°F| excursions permited 0 15-30°C 59°-86°)see UsP) Protectfom ight. Do not freeze For indicotions ond dosage, see package insert, Rk ONLY. 1192196 usa
1e9f779d-5859-4b11-9b7a-d3efcbe83693_555_1.jpg ‘NDC 0781537 1-01 Each tablet contins: Lorazepam, USP 0.5 mg. USUML DOSAGE: Se accompanying e, Lorazepam SO, s e R0 Tablets, USP i uic i st e as e LT @ ceonenemoorone Reony 01 Manucyodby Sandcic, Pocso, W 08500 MG, i i Pt sz iz i porad oy s e 100 Tablets ‘ = SANDOZ 0781-537 1
1e9f779d-5859-4b11-9b7a-d3efcbe83693_555_2.jpg NDC 0761-5377-01 Each tablet contsins: Lorazepam, USP 1 mg. LOrazZepam Sowezscirs ame it 150 30°C (59° 0 86°R. —— Tablets, USP e uic o et o o0 == 7 definedinthe USP. ~ (1mg| @ Femona erescnoromome & Rx Only Maruiachsed by Sande b, Piceton W 085D e L PHARMACIST: Dispsnos the Mdication Productof iy P ca01sdeiz24ss S 0 s s == 100 Tablets ‘ —_ZM SANDOZ
1e9f779d-5859-4b11-9b7a-d3efcbe83693_555_3.jpg NDC 0781.5379-01 Each tablet contains: Lorazepam, USP 2 mg. LOrazZepam fuwrcirs sevoesomits R Tablets, USP b nams st antine s G eavania R only Wanacrodty Sandeic, Pocson, W 06540 MG, i oo Pty sz zz) P ey o ok . 100 Tablets ‘ SANDOZ 0781-5379-01
1ef44915-8e59-40d7-a43a-c1ea33bfdf53_405_1.jpg T PR R ] Temperance, Mi 48182 Waming: Keep out of children's reach. OXYMORPHONE HCI ER 15 MG Dispense in this tight/light resistant container. Store at controlled temperature 59-86 degrees F. 30 EXTENDED-RELEASE TABLETS Caution; Do not use with alcohol Each extended-release tablet contains SRR S e Lot: 15 mg of oxymorphone hydrochloride Exp: WARNING: MAY BE HABIT FORMING pZmcsg FEFWCSY 4 £ QTR x0Tnls s REV. Item # 35356065530P §; ﬁ §§ ES 2 NDC: 35356-0655-30 R)D(nly g8 =2 g%’ g 3 - " B & S = B Wifr: Actavis Elizabeth LLC, Elizabeth, NJ 07207 af #2 =z fz © Consult with a physician or see insert for dosage. | | 4 B & n o Consultar con el medico o consulte insertar para dosis. 3 o2 EXTENDED-RELEASE, WHITE TO OFF-WHITE, ROUND TABLETS, B &3 DEBOSSED WITH “LOGO" ON ONE SIDE AND "262" ON THE OTHER SIDE @ @
1f93d72b-6595-4f5f-8ecc-664a612471e5_225_1.jpg Ammonia N 13 injection USP 3.75mCi-37.5 mCilmL at End of Synthesis (EOS) Diagnostic—For Intravenous Use Only Sterile, Non-pyrogenic Expires 30 minutes after EOS Batch # EOS Date EOS Time: Activity @ EOS: mCi Concentration mCifmL Volume: mL Exp. Date, Exp Time: NDC #24275-0385-1 [10 mL Multiple Dose Vial [Each mL contains 0.138 GBq to 1.39 GBq (3.76mCi to 375 ImCi) of no carrier added ammonia at EOS and 9.0 mg of Isodium chloride Store at 25°C (77°F) excursions permitted fto 15-37°C (59-86°F) [see USP controlled room ftemperature]. Store upright in shielded container. |Aseptically withdraw and handle doses. Do not use if |cloudy or contains particulate matter. Calculate correct |dosage from date and time of calibration Caution: Radioactive Material Rx ONLY Manufactured by UCSF Radiopharmaceutical Faciity San [Francisco,CA 94107 "*N Halflife = 9.96 Iminutes
205be197-5ad5-4849-bc78-5fda9927b531_959_1.jpg Each tablet contains: *Oxycodone Hydrochloride, USP Acetaminophen, USP .. 25mg .. 325mg #2.5 mg of oxycodone HCl is equivalent to 2.2409 mg of oxycodone. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Keep this and all medication out of the reach of c Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Usual Dosage: See accompanying prescribing information. DEA ORDER FORM REQUIRED Manufactured by: Mayne Pharma Greenville, NC 27834 61111 Rev. 08/2017 dren. NDC 68308-840-01 ( 1l Oxycodone and Acetaminophen Tablets, USP RN YN )4 PHARMACIST: Dispense the accompanylng Medication Gulde to each patient. Multiple strengths: Do not dispense unless e Rx Only 100 Tablets
205be197-5ad5-4849-bc78-5fda9927b531_959_2.jpg Each tablet contains: *Oxycodone Hydrochloride, USP Acetaminophen, USP .. 5 mg of oxycodone HCl is equivalent to 4.4815 mg of oxycodone. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Keep this and all medi Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Usual Dosage: See accompanying prescribing information. 'DEA ORDER FORM REQUIRED Manufactured by: Mayne Pharma Greenville, NC 27834 61112 Rev. 08/2017 NDC 68308-841-01 ( 1l Oxycodone and Acetaminophen Tablets, USP LR T YL 7 PHARMACIST: Dispense the accompanying Medication Gulde to each patient. Multiple strengths: Do not dispense unless pme S Rx Only 100 Tablets
205be197-5ad5-4849-bc78-5fda9927b531_959_3.jpg Each tablet contains: *Oxycodone Hydrochloride, USP Acetaminophen, USP .. 75mg . 325mg 7.5 mg of oxycodone HCl is equivalent to 6.7228 mg of oxycodone. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Keep this and all medication out of the reach of children. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Usual Dosage: See accompanying prescribing information. 'DEA ORDER FORM REQUIRED Manufactured by: Mayne Pharma Greenville, NC 27834 61113 Rev. 08/2017 NDC 68308-842-01 ( 1l Oxycodone and Acetaminophen Tablets, USP 7.5 mg*/325 mg PHARMACIST: Dispense the accompanying Medication Gulde to each patient. Multiple strengths: Do not dispense unless S Rx Only 100 Tablets
205be197-5ad5-4849-bc78-5fda9927b531_959_4.jpg Each tablet contains: *Oxycodone Hydrochloride, USP Acetaminophen, USP. 10mg 325mg *10 mg of oxycodone HCl is equivalent to 8.9637 mg of oxycodone. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Keep this and all medication out of the reach of c Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Usual Dosage: See accompanying prescribing information. 'DEA ORDER FORM REQUIRED Manufactured by: Mayne Pharma Greenville, NC 27834 61114 Rev. 08/2017 dren. NDC 68308-843-01 Oxycodone @ and Acetaminophen Tablets, USP 10 mg*/325 mg PHARMACIST: Dispense the accompanying Medication Gulde to each patient. Multiple strengths: Do not dispense unless strengh s stated Rx Only 100 Tablets &
205be197-5ad5-4849-bc78-5fda9927b531_959_5.jpg GTIN 00368308405478 68308| 40547 NDC 68308-405-47 Oxycodone and Acetaminophen Tablets USP e ) [ e cony B0 e s et Jelisbber Tl =, e o ot EEE oo e T oo S e oA e o 7 a5 o e e sy FERSERSE, i ot T e e RIS e ot (@ P T SRS o s
205be197-5ad5-4849-bc78-5fda9927b531_959_6.jpg GTIN 0368308475471 L NDC 68308-475-47 I Oxycodone and Acetaminophen Tablets, USP O Multiple strengths. Do not dispense [y RxOnly 100 (10x10) unit-dose tablets Each ablet contains: Gryeodone O, U5, 75 mgt Acetaminaphen, USP . s mg 575 mg cupeodone HEI & 6quiaiont o 67338 g of foass SR, e e acampanyog Medication Guide to each patient = e T o S e oA o o 7 e 5 o e T g pmohenies TR it R ons BINGIRN IS, e T e rsae St (@ O s T
205be197-5ad5-4849-bc78-5fda9927b531_959_7.jpg (GTIN 00368308480475 3 Wl58308"4804 7! NDC 68308-480-47 Oxycodone and Acetammuphen Tablets, USP unless the strength is state Eaony 100 (10x10) unitdose tablets Each tabet conine: Gycodone HCl Us?. e 10 Acataminopher, UsP g oy oo i G 1 8567 mgof [ARMACIST:Dispense the accompanying Medication Guide o each patint USUAL DOSAGE See package msert fo complte prescrioing nformtion, ETORAGE Store at 20t 25°C (68" 10 777 see UsP Conroled foom Temperature] Keep tabiets i box o protec rom ght. Protect from mosture. Thisproduct s potected wit sealed blstr s Dot use fatyareton o broken. This unkdose package s not chidesisant: I dispensed fof outpatentuse a chidesisant Conthiner showid b use, EA ORDER FORM REQUIRED. Manfacured by: Wayne Pharma Greeniie NC 27250 10071 ouzo17
20729216-a384-4629-a348-cb133bd2fef7_584_1.jpg nan
2105d1c1-54ef-4d1a-a63c-b1619e8b50db_462_1.jpg waia ey ssn e ow e od o o7 Wmwod bk 1119 uonoaluj spliojyy | wniseubepy | i \ CITT R / T LR (TR TR | cact L contais: Mecnssuan | Grord Hovanyorte 200mg. B oohel 1% 2. resareh, Magnesium | eiognss m ‘adjusted with Hydrochloric Acid Chloride el RN Total oomalaitysqualent o R Injection 2951 mosmmL Niyfan insttutional LLC Fotor, 1 6103 USA Mot by 200 mg/mL (20% whv) Nyian sututonat 2951 mOsm/mL MiseicR 2.951 mOsm/mL s g WARNING: DO NOT USE IF A For Intravenous Use For intravenous Use PRECIPITATE IS PRESENT. Ao Olidas After Dilution Store at 2 1025° 8" o TR {520 USP Cotrolled Room i | 1. Gonans 17 mEq ot gt 200 mg/mL | orperm. [P || USUAL ADULT DOSAGE: Sea | accompanying prescribing [ [ i i | WMy lar .II||| Imll‘ | i i i i i i e i i i i i i i 67457=134=50 5 | G
210774a9-aaab-4bd4-ac5a-481ed72e0c0c_914_1.jpg NDC 42192-147-08 Sodium Sulfacetamide 10% Sulfur 2% Cleanser Rx Only SHAKE WELL BEFORE USE 80z.(227 ) Acella PHARMACEUTICALS, LLC Active Ingredients: Soclum Sufacetamide 10% and Sulfur 2% Other Ingredients: BHT, Gety Alcahol, Disodium EDTA, Giyceryl Stearate, Lactic Acid, Magnesium Aluminum Siliate, Methyiparaben, PEG-100 Stearate, Petrolatum, Propylparaben, Purfied Water, Sodium G14-16 Olefin Sufonate, Sodium Thiosufate, Searyl Alcohol, Xarthan Gum, Indications: For the topcal contrl of acne ulgari, acne rosacea and seborhelc demattis Directions: Wash affected areas once or twice dally o as directed by a physican. Avold contact with eyes of mucous membranes. Wet skin and Hiberaly apply to areas t be cleansed, massage genty nto skin for 10-20 seoonds, wiorking Into a ful lather, inse thoroughly and pat ry. f crying occurs, It may be controled by Ainsing off sooner o using less ften. Sse package insertfo fullprescribing nformation. WARNINGS: FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. KEEP OUT OF REACH OF CHILDREN. Keep cortainer tifty closed. Store at 20°C to 26°C (BS°F o 77°F), sxcursions permited between 15°C and 30° (bstween 5S°F and 86°). [See USP, “Cantroled Room Temperature."] Praect from freezing and excessive hea. Al prescripton substtuions andor recommendations using this product shall be made subject o state and federal statutss as applcable. NOTE: This Is not an Orange Book product. No representation Is made as 1o generlc status or bioequivalency. Please ses package insert or more nformation Manufactured for: Acela Pharmaceutcals LLC Alpharetta, GA 30022 1-800-541-4802 - HlH \ “I |‘H 3 9
2131a038-f102-49c7-bab9-b74bd6d37eb9_167_1.jpg nan
213f1d2e-65a4-4cad-91e9-85c0fc65ac94_212_1.jpg R e B R e § S A : S R GRASOREITED. i R e e
213f1d2e-65a4-4cad-91e9-85c0fc65ac94_212_2.jpg Gmeta i CHRIEDOL S I TS o4 s % o R Gt Ry THKE TABLET e e THCEADAY R ORASDRECTED. R e e ooner
213f1d2e-65a4-4cad-91e9-85c0fc65ac94_212_3.jpg G CiRiEoLol AT o4 e o R T Gt R THKE TABLET Pt e THCEADAY RE ORASDRECTED. R e e s s e ooner
213f1d2e-65a4-4cad-91e9-85c0fc65ac94_212_4.jpg Bes CWelimemEms— gmew | el SO BE, R T et £ S, Tcehon - B % GRHsORETED { SRR e T
214cfc23-c637-43bd-8ce9-b859399c9028_351_1.jpg eSSVt e e e e e N e e e S i s Sales KAt e Migdlesex Welding 284505, . 1 Horth Bunsu
21628112-0c47-11df-95b3-498d55d89593_767_1.jpg TR TR §750458-639-65 0 *.52, D% O, Y0 PESS009p YA, pUno Paleod ‘aiof Weai) UGIDRYD J0 40ee Jo 00 dady “QUNSIOW WOY 138101 “ aumesadua) woos pajo3u0d 1 B10iS “ourey Iuyduechuooae ees ‘uopewwio Bugosaid oo pue abesop 103 28 5% £ 2,8 2 3 g 2w o gE3 & o = M.m § et fzis e 0% s5ils S =2 3EZEE 20298101 wssuer 900z o
21628112-0c47-11df-95b3-498d55d89593_767_2.jpg 1/ 3 50458-640-65 6 705, P ,NINO, POSSOCED ‘oKTE) PN pafecd paiofod MoRer-iry waIpgy? J0 4oea1Jo 10 doey “BINSIOW WO 102104 4,98 aimpadi) W00 pEOUCI 2 20IS “RUERCD sy onpoud Sueduioane 525 uogewoju; Buguasaid 14)0 pue aBesop 104 2 o 23 e £ &5 x ° £3 2 g = - 'S T L e= 2 gE8% 53 < § SES & m £ mmsu ' =S8 (eZ|O |28, sC S| EEEE Shm £ EE3s5 R S01606L wssier 900z o [N | 09550 ‘AL E U] ‘SfRaGnODeILIRY UOSSUeF 0} Ty 7 8LL00 Ud ‘oqeing T oy uassuer Ky T
21628112-0c47-11df-95b3-498d55d89593_767_3.jpg . ITRRG | 4 50458-641-65" 3 .04 PUE NI, PSSOG2P a1 PN aleod ‘paiojod 1Ogax UBIDRYO J0 49201 0300 dooy “OINSIOW WO 130101d (399 mesadiua) 00! pagOIU0D e BI0S “UIENCD 1R “aungeisyl onpoud | Buykueduosae sas ‘wopeuwioju Bugosad Jayio pue abesop 1o ® 60 tablets Rx only (topiramate) Tablets CCAUTION: Verify Prescription Before Dispensing Medication Guide to Each Patient ATTENTION PHARMACIST: Dispense Accompanying NDC 50458-641-65 } Top 128 uassuer 9002 o 09580 ‘s ‘seonsouDyg UsSSUep o B 811004 ‘oqeis) 1 OupIg uassuer :kq Gy
21628112-0c47-11df-95b3-498d55d89593_767_4.jpg . ITRRG | 4 50458-641-65" 3 .04 PUE NI, PSSOG2P a1 PN aleod ‘paiojod 1Ogax UBIDRYO J0 49201 0300 dooy “OINSIOW WO 130101d (399 mesadiua) 00! pagOIU0D e BI0S “UIENCD 1R “aungeisyl onpoud | Buykueduosae sas ‘wopeuwioju Bugosad Jayio pue abesop 1o ® 60 tablets Rx only (topiramate) Tablets CCAUTION: Verify Prescription Before Dispensing Medication Guide to Each Patient ATTENTION PHARMACIST: Dispense Accompanying NDC 50458-641-65 } Top 128 uassuer 9002 o 09580 ‘s ‘seonsouDyg UsSSUep o B 811004 ‘oqeis) 1 OupIg uassuer :kq Gy
21628112-0c47-11df-95b3-498d55d89593_767_5.jpg . ITRRG | 4 50458-641-65" 3 .04 PUE NI, PSSOG2P a1 PN aleod ‘paiojod 1Ogax UBIDRYO J0 49201 0300 dooy “OINSIOW WO 130101d (399 mesadiua) 00! pagOIU0D e BI0S “UIENCD 1R “aungeisyl onpoud | Buykueduosae sas ‘wopeuwioju Bugosad Jayio pue abesop 1o ® 60 tablets Rx only (topiramate) Tablets CCAUTION: Verify Prescription Before Dispensing Medication Guide to Each Patient ATTENTION PHARMACIST: Dispense Accompanying NDC 50458-641-65 } Top 128 uassuer 9002 o 09580 ‘s ‘seonsouDyg UsSSUep o B 811004 ‘oqeis) 1 OupIg uassuer :kq Gy
21628112-0c47-11df-95b3-498d55d89593_767_6.jpg ", IRy 3 50458-645-65 1 0L, S° powiew ‘0 Jeogo pue*, ui 7, 5% pax ey “Apo ajnsdea anibeco ey uy Sa194dS G40 C) N RS RIPRYD 10 432440 10 doay aysou woy 109104d *(oLL) 452 MOJRG 10 12 B10IS “aueIIC IR € | asuadsi( | “aimesay] Jonpoid| | Buruecucoa ss ‘wopenwoju Buguasasd sego pue afesop 1o 223 gss g8 8 SES S mm& @ 7 N z<s w €, 09 m@mm © a5 g2 Q 2@ Eigf § o o o O < 2 3 g 9 . | = > 3 - § [ X 3. O02a & S0 ] | oL s 000 “- 09580 I AL nl.m u'sfeapnaceLg uessuer 1o} By 8100k 0N | T oy uassuer < 0 |
2238c70f-b0b5-4755-896b-45b28777b217_638_1.jpg = L1/€0 808606 373344 LON 0Q “{einjeseduue) WooY PaJoXUOD dsn 80s] (4.2.01.89) 052 01 02 12 8I01S TFVHOLS 8IS0 UEISISSPID © Ul JBNIEI0 1B1 © i 95UedSIQ LSIOVINEYH ..m g mu.m.m_ 2 § <832 2 1 98d¢g Eog m MMMM@ T Amoo 2 See package insert for complete prescribing information. WARNING: Keep this and all drugs out of the reach of ety CLEBVER
2238c70f-b0b5-4755-896b-45b28777b217_638_2.jpg faryueduey wooy pepeato dsn 5] (4.01.01.30)0.5201 02 R 01 oo Buauosad 0 0 e 900N 305 “wpro 0881341010 SUOREORL U S G55 ONINUYM. 0 o 2 3 sk, f mAms 3 Sif sge i g £ s &9 m 0@ Dispense n tight containe a5 defned in the USR.
2238c70f-b0b5-4755-896b-45b28777b217_638_3.jpg .ar01.80) 94510170 SRS I PUE 514 6555 SONINHVM 1000 mg 30 Tablets AMICAR® Aminocaproic Acid Tablets Rx Only g § 3 g Dispense n tight container as deined i the USR,
227ee46a-2050-4e11-bfa9-6b1cc1634302_776_1.jpg G s i mﬁ‘imnm“‘s x!wwuﬁmnd"w*vﬁiﬂww i mmmwcummmm'“"’“mmm == S e i mm:"’m‘umms Miwnwwﬂmmmww i ww“w,ﬂmw“‘ mers S Wmmm&muwmwmwww’%w\ e e o w8 “’w.n%\\““"%ﬁmS c- o et 51 s
227ee46a-2050-4e11-bfa9-6b1cc1634302_776_2.jpg (615) 254-1457
23561142-45e0-46f5-b17f-d67760b4db27_339_1.jpg NDC 71205-123-30 & ProficientRx » RX only Hydroxyzine Pamoate 25mg #30 Capsules Each capsule contains: Hydroxyzine Pamoate, USP equivalent to 25mg Hydroxyzine Hydrochloride. Dark green opaque cap/light green opaque body filled with yellow powder. Imprinted in black "IX" on the capsule cap and "657" on the capsule body. Product ID: QH012330 Mfr. By: Patheon Phamaceutica's Inc. Cincinnati, OH 45237 USA Store below 30°C (86°F) Keep medication out of the reach of children Lot #:00000 Exp. 00/00/00 RX# MASTER Hydroxyzine Pamoate 25mg #0 Capsies i WASTER Lot #00000 Exp000000 NOC 7120512330 Hydroxyzine Pamoate 25mg #30 Capsules Ret MASTER Lot #0000 ExpOD0I00 NOC 7120512330 Hydroxyzine Pamoate 25mg #30 Capsules Rxk MASTER Lot #0000 Exp00000 NOC 7120512330 Packaged By: Proficent Rx LP ‘Thousand Oaks, CA 91320
24015d4f-8827-4f61-bd12-4a1f45dbe1d5_447_1.jpg Packaged by Bvyant Ranch Bibank. @A 91504 AMLODIPINE/BE G i ™ c#rsue NAZEPRIL 0 5/10MG 2 CAPSULE 2 Store at room temp of ComparsTa: 20°:25°C (68°-77°F) WOTRELIOBOASULELD oo TeaPramaatialid e reach ofchildren #30 Exp: MMYY 5 NDC 6362976441 076441120297
24015d4f-8827-4f61-bd12-4a1f45dbe1d5_447_2.jpg Pashaged by Eryane Reanch Babank. €4 91504 AMLODIPINE/BE 5 5L (e om carsuTeva NAZEPRIL 10/20MG CAPSULE Store at room temp of Compare To: 20°25°C (68°77°F) LOTREL 1020MGCAPSULELR et O 698611 Keep all drugs out of Teva Pharmaceuticals Ind Lt reach of children. #30 Exp: MMYY NDC 6362976451 076451119869 om
24015d4f-8827-4f61-bd12-4a1f45dbe1d5_447_3.jpg Paclaged by Ergant Raxch AMLODIPINE/BE NAZEPRIL 5/20MG CAPSULE Compare To: LOTREL 5/20MG CAPSULES-LIB Teva Pharmaceuteal Ind. Lid #30 NDC Exp: MMYY 6362977461 10 562021 om Bunbank. 04 91500 PINKIWHITE CAPSULETEVA 7272 Store at room temp of 20°25°C (68°77°F) Keep all drugs out of reach of children. 077461120295
2414058b-5d39-42f2-915f-03a5e1101ab5_760_1.jpg Po4g27 ‘S package et fo ol prescribing nformation. Follow the Patier Instructionsfo roper s of Budesonids Inaton Suspemon Orce th ol sl s cprad.us he v weth 2k, Uoe v By 3 rysean 10O NOT DISCARD THE FORL ENVELOPE UNTIL THE LAST VIALIS USED. Once 3 vl s opened,uss the contts mmediatel. Stors a1 20° 10 25°C (68" 0 T7°F) [Sae USP Cantroled Room Temperatare]. Do ot hresze. o smpesed vl i e ol nvloe placed wpigt s Protect from lght NDC 0033681573 Budesonide Inhalation Suspension 0.25 mg/2 mL Each unit dose i devers 2 o st suspersion contaning 0.25 g of mrongsd ducsscnide St bando Stario Unt Dose | Vials For Oral nkaltion Use Only NOT FOR INJECTION Forusm nly i 3t nebulzer. Do NOT s i an arasonic. et
2414058b-5d39-42f2-915f-03a5e1101ab5_760_2.jpg u 2/6ui z° uossuadsng Uone] eyuj apiuosapng sy [ — R e R e e e s Semmaesael == e e R S o v e ? - gy e g e e 4 - e X g et A e 5. [@ PR 5 s et me et e e I lIlI |I e T w513 1
2414058b-5d39-42f2-915f-03a5e1101ab5_760_3.jpg h-mi_-mnu—s)nm-: NOC 0093-6816-73. Ferpommimes | ahiolote - T nhalation Suspension Onoa 2 vl is opsnad, se the cortants imvoadly. ‘Stare 21 20° 0 25°C 68" 10 77°F) e USP Contolled Foom Temperatare]. Do nat reee. m vl inthe il envelope plced uprightia | Qe e ol B s ooy Prtect rom lght o
2414058b-5d39-42f2-915f-03a5e1101ab5_760_4.jpg (325 0m 00 o s sz bis mmd s /b g un—ﬂkl}swlﬁlwsfl: R S P e g et e 2 T AN RR N fet B
2423ae12-e70e-40db-bf9b-b7597a911413_637_1.jpg & 2 a i se3 mm i Pn 8. I jfch EM s EE5Sii8l 200 ool o Ecouprzensc 308 () sk e 485 5 cortvraeno s OWA) e e 735 Ul Dosage: See e et s 1 g mrmaton. o 271025 (8710 7T (S LS ool oo Tempeata), 0ot e P o e,
24259865-233b-4258-a01b-e895a873f2c4_259_1.jpg NDC 0703-7351-02 Rx only Sumatriptan Succinate Injection 6 mg* (Base)/ 0.5 mL For Subcutaneous Injection Only Discard Unused Portion 5x0.5 mL Single-Dose Vials Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperaturel. May be refrigerated. Protect from light. 'USUAL DOSAGE: See package insert for Dosage and Administration. *Each 0.5 mL of olution contains, 6 mgof sumatriptan (as the succinate salt) and 3.5 mg of sodium chloride, Sterile, nonpyrogenic. Retain in carton untiltime of use. TEVA PHARMACEUTICALS USA, INC. Nort Wles, PA 19454 I Rev A11/2015 ek
24b5613e-590a-42d1-87c0-5ffff1d58138_573_1.jpg nan
24b5613e-590a-42d1-87c0-5ffff1d58138_573_2.jpg GARBON DIOXIDE, REFRIGERATED LIQuID UsP u“21 87 é@ CAS: 124-38-9 LoT# NET CONTENTS Path G U CTwPLP %W 0 Rt REFRIGERATED LIQUID Only 'WARNING: Administration of Carbon ‘may be hazardous or contraindicated For use ‘only by or under the supervision of a licensed practitioner who is experienced in the use and ‘administration of Carbon Dioxide and is famillar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, ‘contraindications and side offects. and the precautions to be taken. Produced by Air Liquetaction. 'WARNING: CONTAINS REFRIGERATED GAS: MAY CAUSE CRYOGENIC BURNS OR INJURY. MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION. MAY INCREASE RESPIRATION AND HEART RATE. D0 not handle uni il safety pracautions have been read and undersiood. Use and stor only outdoors ot ina wellventated place. waxmmmﬂ.nmmmmnmmmm In e piping. DO NOT change or force it connectons. Close valv afe each use and when ompty. ‘Always keep container in upright position. Read and follow the Safey Data Sheet (SDS) before use. FIRST AID: IF INHALED: Remove person 1o fresh air and kvep comiortable for beathing 1F ON SKIN: Thaw rosted pars with lkewarm water. Do not rub afected area. Get immediate medica advicelatention. nexAir LLC » www.nexAircom v‘ g 1330 Concourse Ave., Suite 103 » Memphis, TN 38104 St | W 585.639.2474 DO NOT REMOVE THIS PRODUCT LABEL.
24b9880e-626b-14e7-23a6-4960f1008e97_73_1.jpg T f TeIA 350p-3[3UIS (Qu/3wz) uondafur (3ye(Asaq wnunoeses|d) XoquIN WARNING: Praing Age. 437824 || [Premenpronce as Causes Respiratory Arrest. NDC0074-4378-24 registered trademark of Facites s Tmedaely P iathers ocs, i o i L ead et teonse epiaton Nimbex® Nimbex® i o Ao st ronprogens sl _ % - 2 North Chicago, L 60064 USA for ivsncus iacton Canavs. | || (cisatracurium (cisatracurium Bl o ¥ g Sy el besylate) injection | || besylate) injection ||| e o * Each L contains S g st Yo (2mg/mL) (2mg/mL) sl sosoges enpockags oo ey o Wasi: Paraaing Agont. ||| WAsWING: Partyang Agent Storoat2 1080 360 467) inihe carton, 0 ot e P tomian. Upensenous o eigesion, “TTT Single-dose vial Single-dose vial uso vihn21 days oven | rerefigeraled. Nimboc s aregitered ecemarc Gancsrencos, T Rxonly ek o 150 by AV . €01) 00300744378244 Oscardby: . CA10036 Unvarnished copy free panel for variable data (1.375 x 1.313)
24b9880e-626b-14e7-23a6-4960f1008e97_73_2.jpg t i Tein a50p-a[dnnv (w/Bwz) uondaful (d1ehsaq wnpnoeses) XIqUIN VARG Paing Ao 43807 || [PrewreRpromet Causes gy NDC 0074438079 | || ni v :-:‘mmm:dﬂmw Premier Healthcare Aliance, 8 . & . ° L., used under cense. e, s ||| NIMbDEX Nimbex o Fo Ao, Sl nese (|| (cisatracurim | f|(cisatracurium || [FERCRR LR s ontenl o ||| besylate)injection || |besylate) injection | || czors sovone et conties eivoiont | | | E L0 T 1o cisairacurium bosyiato " ~ 2.8 g, vith 0.9% wi benzy! (2mg/mL) (2mg/mL) o WABNING: Paolyzing A ’ 2 U"F'u"m"’.’w Sepac rabing Agent | | | waRNING: Paraiyzing Agent 8 riomaton. 3 Somazegom ien EMuIUP\e-dose vial || Multiple-dose vial £ rotect from light. @ e i 0.9% benzyl alcohol | |]0.9% benzyl alcohol 2 e e (addedasa (addedasa s e oot preservative) preservative) - el Gancaniios, == i o use by Aooie e 2 Rxonly oiscaravy: [CA10037 PREMIERProRx? Unvarnished copy free panel for variable data (1.375x 1.313) } 1
24b9880e-626b-14e7-23a6-4960f1008e97_73_3.jpg [e1n350p-3[BuIg| (qw/3wQr) PR Lonaful (1e)sd wnndeses) NDC0074-4387-91) | PREMIERPioR> 5 | i Jegiicrea ademarkof | i O ™ | Nimbex” Nimbex® e (cisatracurium | | |(cisatracurium e e ] besylate) injection sylate) injection | zorsaien ! 200 mg/20 mL* e | ! 10 mg/mL) (10mg/mL) = | L naman: parsangAgers | | foamsinc:posvangngont | | | mm | Single-dosevial | | [Single-dose vial [ ForICU use onl ForiCUuseonly.]| | | =328 | - P il N PREMIERProRx® Copy Freo & Unvarrished Arca or Variablo Data
24cb9c83-a7e4-4bae-997c-c3a87426f78c_612_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MFNTAL ALERTNESS. o WARNINGEREEPTHISIDUTIORTHEIREACHIOFCHILOREN === ~ DOSAGE and STORAGE SEEPACKAGE INSERT 3063-518-30 43063-518-30 43063-518-30 hydrOXYzing hydrOxYzine hydrOXYzine & HCLUSP HCLUSP HCLUSP 8 25 MG 25 MG 25 MG = 30 TABLETS 30 TABLETS 30 TABLETS Z ReOrder # 103363 ReOrder # 103363 ReOrder # 103363 E LOT 18811 LOT 18811 LOT JjigB11 E EXP D1/20 EXP ni/20 EXP 01/20 g CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: HYDROXYZINE HCL USP 25 MG WHITE K 11 ROUND NDC: 43063-518-30 SPD-Rx \| PHARMACEUTICALS INCORPORATED?® Oklahoma City, 0K « 73127 ‘ hydrOXYzine HCL USP 25 MG 30 TABLETS i LT (01)10343063518304 1{: (21)118B11000001 Y {17)200131 (10}118B11 POEBISES0EYE NN TR INIHITLNAN 10TT00Z0L0T
2524b253-069e-4028-819c-361b888df110_386_1.jpg pav—l s T
2524b253-069e-4028-819c-361b888df110_386_2.jpg QUL e Tk ol L) P o (TR 8T rﬁmmﬁm THBLETS 1 mg/0.038 mg poe i B - (O g T 5d (norethindronefethiny] estradiol) Y Y i P =t U e T e e L e
25621933-804e-4181-8524-d60f72969e55_644_1.jpg 43063-866-30 43063-866-30 43063-866-30 PredniSONE PredniSONE PredniSONE usp usp usp 10 MG 10 MG 10 MG 30 TABLETS 30 TABLETS 30 TABLETS ReOrder # 110587 ReOrder # 110597 ReOrder # 110597 LOT 118A62 LOT Ji18A62 LoT J1BAB2 EXP 05/20 EXP 05/20 EXP D5/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY WITH FOOD. TOME TABLETA(S), VECES AL DIA CON COMIDA. Each TARLET Contains: PREDNISONE USP 10 MG ORGANOLEPTIC MARKINGS: WHITE TL173 ROUND SCORED NDC: 43063-866-30 PHARMACEUTICALS INCORPORATED® (Oklahoma City, OK = 73127 PredniSONE USP 10 MG 30 TABLETS (01)10 (21)118A62000002 (17)200531 (10)118A62 “INI ANV HA VLSIAYD LINYHBNI JTELTOIVLES
256910fe-91f2-48f6-b0b4-55edc52dacd4_600_1.jpg Cution: urthe |[SNIRLARY b 5 dilued before use. 5 e ;1 2 dnomtdun Fomepizolelnjection =21 2 tempermtur, 2025 i —_ ey LT —= & L = om0 o navenus nfusion only. = £ W S o s Py am| 45mm 150% Enlarge Caution : Must be ) 3 diluted before use. i L —_— 3 & Store etconroledoon FOmepizole Injection | = temperature, 20°-25°C _ — i = [8°77°F) [see USP] AR = 3 Distributed by : Zycus (1g/mL) St = Pharmaceuticals USA Inc A o e | e Penrington For intravenous infusion only. =ZFo ! B NJ08534 7 Zydus Singewsevel o | 2 QB 10270718R0 Rxonly =w ! 9 0 S
256910fe-91f2-48f6-b0b4-55edc52dacd4_600_2.jpg 45x35x75mm G18/F101£0£€00 NILD (DI TR BT ——————— NDC 70710-1478-1 e For Intravenous - infusion only. - Fomepizole | ... ocism Fomepizole - - (1g/mL} vial of - - Injection Fomepzoe jecion Injection s;c;;ﬂ::;ﬁﬂl: sim7o71001M4781 5 1.5g/1.5 mL 1.5g/1.5mL (1g/mL) Dosage and (1g/mL) Administration : See Code No KRDAUGSKTKL8290/07 Caution: Must be diluted P e o osags Cautlon: Must be diluted before use. Information. before use. :::yl.mravnnous Iinfusion T ::;'vllnhv-nous Infusion Dittutedby Store at controlied room Zydus Phamaceuficals USA I temperature, 20°-25°C (68°-77°F) [see USP]. Pennington NJ08534 ? zydus Single Use Vial ? zydus Single Use Vial R only Rx only 20270718A R0
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_1.jpg Dispenser: nclude *Information for the Patient” leaflet with each presaription dispensed. Store at 20-25°C (8-77°F); excursions permilted to T5-30°C (58.6°). [See USP Controlled Room Temperature] Dispense i tight (USP), child-resistant containers Each tablet contains 0.3 mg of conjugated estrogens, UsP. inthelr naturely aceurring conjugated form. Usual Dosage: See accompanying descriptive literature. Visit us at wnvvPREMARIN.com @ NDC 0046-1100-81 PREMARIN° (conjugated estrogens tablets, USP) 100 Tablets Rx only o 2 = & S o & N3 0046110081 4 & s 2 S 3 S
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_10.jpg g (omgadestones et (S} Rorty PREMARIN'0.625 s sepsuspinny bugz90. NRIVIWNR PREMARIN0.625 mg {omaedxtoges e 59 FREMAGIN oé2em Each tablet conain 0,625 g of conpgated estogens, USP. J st Dosage: e endose formatn. PREMARIN'0.625ng | " o g e U | ' \ | PREMARIN® {conjgated esrogens ablets, USP) 0.625 mg
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_11.jpg Dispenser: ncude “Information for the Patient” lealet with each prescription dispensed. Store al 20-25°C (68-7T°F); excursions permitted to 15-30°C (59-86°F). [See USP Cantrolled Room Temperature] Dispense in tight (USP) child-resistant containers Each tablet contains 0.9 mg of conjugated estrogens, USP, intheir naturally occurting conjugated form Usual Dosage: See accompanying descriptive literature. Visit us at v PREMARIN com NDC 0046-1103-81 @ PREMARIN® (conjugated estrogens tablets, USP) 100 Tablets Rx only 2 N3 0046110381 5 12111202 82 £ i B2s 3
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_12.jpg Dispenser: Inlude “Information for the Patient” leaflet with each prescripton dispensed. Store at 20-25°C (68-77°F); excursions emited o 1&-0° (SS-46%F) (See SP Controlled Room Temperature] Dispense infight (USP) child-resistant containers Each tablet contans 1.25 mg of conjugated estrogens, USP, in their naturally occurring conjugated form sl Dosage: Seesccompanying descriptive literature. Visit us at www.PREMARIN.com w NDC 0046-1104-81 PREMARIN® (conjugated estrogens tablets, USP) 100 Tablets Rx only FPO: UPC 80% x 5.5 mm N3 0046-1104-81 2 Distributed by Wyeth Pharmaceuticals nc Asubsidary of Pfize Inc Philadeiphia, PA 19101 MADE IN CANADA 12111400
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_13.jpg o @ PREMARIN® (conjugated estrogens tablets, USP) o e it 59 i it it o o e i 1,000 Tablets NDC 0046-1104-91 & PREMARIN® (conjugated estrogens tablets, USP) in tight (USP), o istant containers. This package not for household use. 1,000 Tablets Rx only Each talat contains .25 mg of conjugatad cstrogens, USP i thar naturaly occuring corjugated form. Usual Dosage: Soe accompanying descritie arature. Dispensar: Include “Information for th Patient” leafletwith sach prescription dispensad. Storo at 20-26°C (68.-T7°F) ‘xcursions pormitted to 15-30°C. (50-86°F). [Sao USP Controllod Room Temperature] Dispensaintight (USP), chid-resistant containars. Distibutad by: Wyeth Pharmacauticals inc Asubsidiry of fzst inc: Phiadaiphia, PA {6101 MADE IN GANADA ‘ $0046-1104-911 Visit us ot wwwPREMARIN com 13819401 GTIN: 0300461104911 IMPRINT AREA| (conjugated estrogens tablets, USP) PREMARIN® @ 1,000 Tablets @ tablets, USP) Note: This package not for household use. 1,000 Tablets PREMARIN® (conjugated estrogens Dispense i tight (USP), child-resistant containers.
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_14.jpg PROFESSIONAL SAMPLE. NOT FOR SALE, PREMARIN"1.25 mg [conjgated estrogens tebets USP) A semmmewey i Lo yeuspen es e 2520 0 o> eade . N SRR lomerduny wooypaloaw) ¢sn vs| (10265 X061 01 poRd SIOK T (4 159 DT OL R BIAS B ID J01pER) S 11000 P [ s doey SIS D 10 0EEq BHON ogew 13 upesop 0 oas DU U0 DB SN K15 1210 DU E 31 PUE UOTERUEP DIPOL Y USRI e IATE DU 4L 5023 Y00 IR E 10K LOLAD 10K S 0 B Y 15 afew 28 000 ADS2 451 S0 800 3 D) I 10k 1y o 11 uoyeIpay P pUig DA A1NSPIOL MK 80 Sbosse eiEn U U 71, BN P E MRk 03
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_15.jpg FIN SEAL v3s an3 Iv3san3 NDC 0046110451 {ongeeestogers Bonly Visit us at 1 blister card Tv3s N3 PROFESSIONAL SAMPLE- NOT FOR SALE 1.25mg | Tv3san3 [rs—
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_16.jpg mssiepin) NRIVWTId mezL R /
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_2.jpg (conjugated estrogens tablets, USP) > i@@ i & NDC 004611001 g o | x only PREMARIN® oo PREMARIN® ! tablets, USP) (conjugated estrogens } (conjugated estrogens tablets, USP) | tablets, USP) | s, cenunaty: penittiyg Prisdops A 1101 Note: Dispense In tight USP), chikd-resstant containers. | "% This package not for household use. b bl el i Note: Dispense in tight (USP), child-resistant containers. | T package ot or e s, | | | | i | | | | | | | | | | i | \]‘ 1,000 Tablets
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_3.jpg NDC0086-110051 PREMARIN' 0.3 mg [conjugaed estogens tabets, USP) Blistercardcontans five 0.3 mg tabets SESNDRLLEL (30 Y USRS 3508 29U P XRIEEdE [2esdust wooy peijoaue) 4 s 1499652065103 paBwSd LA (4,11 0) 24T L B 2108 | aR230 peal a1 10 VOB P € R 31 Geaf ey P> VU opes Mon | o pxcpueEs i p U T 20:26e500 s || s poanrugsp eamey pue Vope3ymepl pupudiaiy it UsaIb R SI6E O £0 X1 \ “51p 211D soeueis nof wosa6 ok 3 ap e | s s papy uon s s S s B S paTGERIH) o N 17K 20 1k UM N loreXipa J0 pIE 103 AU3PI0L HOH £ 45 a5 poEnkp s £0 S 130 U35 pE3 \> X SR - SBLTIRR JUIAM N N
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_4.jpg VASanN3 IV3aSAaNg | Rk LIS NYDISAHS / / (a1t VA 101 nsitais paceibsaty el PROFESSIONAL SAM; g 2 2 v3s NI
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_5.jpg Dispenser: Include “nformation for the Patient” leaflet with each prescription dispensad. Store at 20-25°C (68-77°F); excursions permilted to 15-30°C (59-86°F). [See USP Controlled Room Temperature] Dispense in tight (USP), child-resistant containers Each tablet contains 0.45 mg of conjugated estrogens Use.n et natualy accitring conjugated form. Usual Dosage: See accompanying descriptive literature. Visit us at Wi PREMARIN.com @ NDC 0046-1101-81 PREMARIN* (conjugated estrogens tablets, USP) 100 Tablets Rx only %) 2 g N3 0046110181 1 Phiadeiphia, PA 19101 MADE N CANADA Wyeth Pharmaceiticas nc Asubsidiay of Piter Inc £
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_6.jpg Dispenser Include “Information forthe Patient” leaflet wth each prescription dispensed. Store at 20-25°C (68-77°F); excursions permitted to 16-30°C (59-86°F). [See USP Controlled Room Temperature] Dispense in tight (USP) child-resistant containers Each tablet contains 0.625 mg of conjugated estrogens, USP, in their naturally occuting conjugated form. Usual Dosage: See accompanying descriptive literature. Visit us at wunw PREMARIN.com @ NDC 0046-1102-81 PREMARIN® (conjugated estrogens tablets, USP) 100 Tablets Rx only 2 ° N3 0046110281 8 & S 2 3 & Distibuted by MADE IN CANADA
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_7.jpg Dispenser Include “Information forthe Patient” leaflet wth each prescription dispensed. Store at 20-25°C (68-77°F); excursions permitted to 16-30°C (59-86°F). [See USP Controlled Room Temperature] Dispense in tight (USP) child-resistant containers Each tablet contains 0.625 mg of conjugated estrogens, USP, in their naturally occuting conjugated form. Usual Dosage: See accompanying descriptive literature. Visit us at wunw PREMARIN.com @ NDC 0046-1102-81 PREMARIN® (conjugated estrogens tablets, USP) 100 Tablets Rx only 2 ° N3 0046110281 8 & S 2 3 & Distibuted by MADE IN CANADA
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_8.jpg PREMARIN'0.625 mg [conjugted estrogens tabets, USP) istrcard oo s 0625 m aits \ \\ u SPHATHIRR JIAM ‘SEXNDBIEL] P 0 Y EWAPEN E I SIFAE 291 J0 DUEIEadde Y [2umesdwa) uiooy paij03u0) 45 Bs| 4.98-65) 2.06-51 0} P3RS SUASIONS 4. 1/ -89) DSTOT ¥ 310K U240 1PERI 30 1170 LOBD 3L |2 PUR 51 4334 WeISS3 BIY) KU ey ey 210N UiEID 1 P35 0pUa 335§ U 1343 2up:afesod s ‘0L 210 ADUDSP ALY PUE“UIDIRIBP DIpOX] AU M 132 B2 RS b IV AL | “Sap 23 o0 sEeUR Y ol wospab ok S apag | a5 afeuw papy ucadisaH (4571 ‘9310 SRBUS3P2NEDNAI) QU WES 410K 312y ok U ‘UoneIpBIN J0 pUBIg ANOA ATU3PI 0} MOH . 450S1eto s et B 619 DSBS Ui TS S S ST R N
258e1602-a3cf-4ccc-ca80-73dbbfb812ff_133_9.jpg v3s an3 Iv3SANIT & ZZZLT 215808 /| uBNaLS NS A LALTLS / 7 fu'xats 7, yesion Lo NDC 0046-1102-51 V3S N4 Iv3Isan3d Tv3s N3 ‘
25f400d9-1d6e-4d38-8f0d-98d471eba73b_479_1.jpg NDC 27808-086-01 | Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension C (equivalent to 10 mg hydrocodone hitartrate and 8 mg chlorpheniramine maleate per 5 mL) 12-hour Dosing Contraindicated in children under 6 years of age PHARMACIST: Dispense the accompanying Medication Guide to each patient. Rx only 41l oz. (115 mL) SHAKE WELL Nonalcoholic DESCRIPTION: Each § mL contains hydrocodone polstrex equivalent to 10 mg hyckocodone biarrate, and chiorpheniramine polistrex equivalent o mg chlorpheniramine maleate. INDICATIONS: See package insert. DOSAGE: Adults and children 12 years and older: 5 mL every 12 hours; do not exceed 10mL in 24 hours. Chikdren 6o 11 years of age: 25 mL eve 12 hours: do ot Sceed 5 L n 24 hours. 'WARNINGS: Contins sodium metabisulite, asulfte that may cause allergic-type reactions, Keep this and all medications out of the reach of children. Dispense entire bottle as one unit. Store at 20° 1o 25°C (68° fo 77°F); excursions pemitd o 5°1o 0°C 60 85 ee P Cortroled Room Temperature]. Manufactured by: Tris Pharma, inc. Monmouth Jinction, NJ 08852 ‘wevew rispharma.com 3 278087086 01 zo LB8536 Rev.00 0772018 00 07/2018 GTIN 00327808086013 Rev. LB8536
25f400d9-1d6e-4d38-8f0d-98d471eba73b_479_2.jpg uojsuadsng aseajay-papuapg D xamsyod sunuesuaydiojyg pue Xains||od auopodcIpAy VY T3 ONL¥0D som0anaz o ¢ - 'NOC 27808-086-01 NDC 27808-086-01 SHAKE WELL Nonacoholic %o o Hydrocodone Polistirex Hydrocodone Polistirex ?HF':':“":LRZLE% %z and Chiorpheniramine and Chlorpheniramine ﬁﬁgﬁﬁm:‘em Polistirex POSHIEX (| s cumessupu . Extended-Release Extended-Release \~ | cpuor uusmser e Suspension Suspension S T : i (equivalent to 10 mg arx (equivalent to 10 mg & s hydrocodone bitartrate PHARMACY hydrocodone bitartrate | X e and 8 mg chlorpheniramine Lot and 8 mg chiorpheniramine | o oo maleate per 5 mL) maleate per 5 mL) R ey e 12-hour Dosing 12-hour Dosing s and ll medcations ot Gontraindicated in children Contraindicated in children | """ under 6 years of age under 6 years of age Diperse e bl as e it oo nan s ot Swonr LT, conig ot i T8 Lo i om0 suspensin, e oS cup. suspesin. e o cup P packaas mor snd medeaton e packag o and medcaton o Disponsaenira carton s one anit Dispons onircaron asoneuntt | My PHAGHUCIST:Dipnse e ccompsing PHARMAGIS: D hescmoansng | Ve ok 502 l Hedcation uld o each paen. Medicalion Gide 1o gech palent. e reghamacam |« Rxonly 4l oz (115mL) Rxonly 4fl. oz (115mL) @Tris @Tris = o $27s0s0a601 (COKTING FREE AREA o CONTING FREE AREA
25f400d9-1d6e-4d38-8f0d-98d471eba73b_479_3.jpg NDC 27808-086-02 SHAKE WELL Nonalcoholic T Hydrocodone Polistirex oescmI s s s codone polsirex equivalent and Chlorpheniramine o mgioocoion b, w0t ¥ chlorpheniramine polistirex equivalent to Polistirex T 8mg chlorpheniramine maleate. DOSAGE: Aduits and chidren 12 years ® m and older: 5 mL every 12 hours; do not 8o Extended-Release = £ 2nt = exceed 10 mL in 24 hours =88 Suspension et ol ——8 o8 (e 0T every 12 hours; o not exceed 5 mL in S g 20nt 2Uhours. £ hydrocodone bitartrate and e i &8 8 mg chlorpheniramine maleate alergic ype reacions 5E 2k Keep this and all medications out of ge per 5 mL) the reach of children. S hE: 12-hour Dosing Dispense in a well-closed container - Contraindicated in children Store at 20° o 25°C (68 to 77°F); excursions under 6 years of age permitted from 15° to 30°C (59° to 86°F) PHARMAGIST:Dispense the accompanying [see USP Controlled Room Temperature]. 160m Medcaton Gulde each paten. Manufactured by. Rx only 161, 0z. (473 m) Wanacturedby Tt 1‘|—is Monmouth Junction, NJ 08852 APPRDMATE YOLINE e P R W rispharma.com Lbss37 e 00 0772018 S RO .
27178b07-42bd-496d-aebb-d9428664ee72_134_1.jpg NDC 0378-6550-53 L Levonorgestrel and Ethinyl Estradiol Tablets, USP [/ [XElmg ey e ek e gt v o e i ot e Ty R [—— ([l Mylan A s oo e culE/o« ETET dSN 'siegeL [01pelisy JAuiy13 pue ja53sabiouona |opens3 Aupg pue ja3596.10U0AST [ oo oo [Mylan
2738feae-316e-426f-971c-5f142ac01b60_283_1.jpg Contains: NDC s2856-750-40 {TraradamalSysame (Ons package of 4 Dispesa Units 0 Buprenorphine Transdermal System [Aamos @ == Systemic delivery of § meg per hour of buprenorphine for seven days. | upandspensing. Because serious o life-threatening breathing problems could resuft, DO NOT USE BUPRENORPHINE TRANSDERMAL SYSTEM for: « pain that can be treated with immedate-release opioids or non-opioid analgesics. « intermittent (on an as-needed basis) pain Ry Only Buprenorphine Transdermal System e o e A NQUHD J0HOVE 40100 EIH {4m 59005 Bewsa pawipd aaroe 12u) o eaas o100 simodorms st use <o U Dous,vain oAy Vo Boged s olema e a5 wogos; oo w0 oty ~a 03 Apeal [3un tamod 10} pauadoun Ui susisks UieRY “ouydiousidng Jo Buig SURMOD UISAS [eUlAPSURI 4TI D WwaysAg [puispsunJ] suiydiousidng os-0s-8525 2N
2738feae-316e-426f-971c-5f142ac01b60_283_2.jpg B e e e Ty — e —— Contains: NDC 42856-353-40 TransdamalSysisms. Ons package of & Dspesa Unts ¥ | i i i i i i i 7.5 mcg/hour @ it ‘Systemic delivery of 7.5 meg per hour of buprenorphine for seven days. Because serious or ife-threatening breathing problems could resul, DO NOT USE BUPRENORPHINE TRANSDERMAL SYSTEM for: = pain that can be reated with immediate-release opioids or non-opioid analgesics « intermittnt (on an as-needed basis) pain Ry Only ! i | | | 1 i Buprenorphine Transdermal System [Zmamon i i | | i i i i | Bupilr';r;;;ilri;::l';;ﬁsdermul Sys;ém | | | | 7.5 meg/hour @ ! i [yl S04 e e i s o i e A NHATHD JOHOVE 0100 &N {4 59005 .5 Bewa paiIRd Aar00 1) 02 12 305 1oion stmoduo s sosn Duse orod ek ot v BBy Vo B s oo ma e a5 ey ooy 0 oty ~a 03 Apear [3un orod 10} pavadoun Ui sueiSks uERl “sunydiousidng jo Bus 577 SuRMUOD UmSAS [euNEpSURD YO8 D WwaysAg [puispsunJ) suiydiousidng os-e-852r AN
2738feae-316e-426f-971c-5f142ac01b60_283_3.jpg B e e e Ty — e —— Contains: NDC 42856-353-40 TransdamalSysisms. Ons package of & Dspesa Unts ¥ | i i i i i i i 7.5 mcg/hour @ it ‘Systemic delivery of 7.5 meg per hour of buprenorphine for seven days. Because serious or ife-threatening breathing problems could resul, DO NOT USE BUPRENORPHINE TRANSDERMAL SYSTEM for: = pain that can be reated with immediate-release opioids or non-opioid analgesics « intermittnt (on an as-needed basis) pain Ry Only ! i | | | 1 i Buprenorphine Transdermal System [Zmamon i i | | i i i i | Bupilr';r;;;ilri;::l';;ﬁsdermul Sys;ém | | | | 7.5 meg/hour @ ! i [yl S04 e e i s o i e A NHATHD JOHOVE 0100 &N {4 59005 .5 Bewa paiIRd Aar00 1) 02 12 305 1oion stmoduo s sosn Duse orod ek ot v BBy Vo B s oo ma e a5 ey ooy 0 oty ~a 03 Apear [3un orod 10} pavadoun Ui sueiSks uERl “sunydiousidng jo Bus 577 SuRMUOD UmSAS [euNEpSURD YO8 D WwaysAg [puispsunJ) suiydiousidng os-e-852r AN
2738feae-316e-426f-971c-5f142ac01b60_283_4.jpg Contains: NDC s2856-56-40 TransdamalSystams: ‘One package of 4 Dispesa Unis Buprenorphine Transdermal System 15 meg/hour @ Systemic delivery of 15 meg per hour of buprenorphine for seven days. Because serious o life-threatening breathing problems could resut, DO NOT USE BUPRENORPHINE TRANSDERMAL SYSTEM for: = pain that can be treated with immediate-release opioids or non-opioid analgesics. « intermittnt (on an as-needed basis) pain Ry Only 4 | i i i i i i i Buprenorp 15 mcg/hour ;f:é%“f 2 PRI et haigpr e st S i sokow 10400 2T 149 590085 8ewa paIRd Lqaros L2) 0% 12 3as 151on Simodo s sesn e <orod o oo0s, el o ULy Vo S oged s olema e a5 ey oo g Pty 2 03 Apeal [3un Yomod 10} pauadoun Ul suajSks uiEll Suydiouaidng jo Bus S}, SURIUOD UBISAS [PUlapSURA YouT ED anoy/Bowi G| WwaysAg [punispsunJ] suiydiousidng or-om-s5s AN
2738feae-316e-426f-971c-5f142ac01b60_283_5.jpg Contains: NDC s2856-830-40 3 Tranedormal Systams ‘On package of 4 Disposa Unts —— == 20 meg/hour U |2 = Systemic delivry of 20 meg per hour of buprenorphine for seven days. | tpes apenting. Because serious or life-threatening breathing problems could resut, DO NOT USE BUPRENORPHINE TRANSDERMAL SYSTEM for: « pain that can be treated with immediate-release opicids or Ron-opioid analgesics intermittent (on an as-needed basis) pain I i | | | i i Buprenorphine Transdermal System [Zmmor i i | | i i i i Ry Only a NIUTUHO 0 HOVAH 30100 4N L4500, 51 sma Al womroxa 3y 032 20 “espiasiimodio o o ason ymal Uy ks o AaELLIAY ok step i o2 semeaienn sy perounyamg sy o o} Apeo. jun (oned [0} pausdotn u susisks uERY ~auydiasaidng Jo Bul 07 SuIEIuo0 Wolsks e BpsuE (P D o Bruige. wiaysAg [puuspsundy suiydiouasdng oreeassEm o
27586e4f-66f1-4583-981c-e0bccb8b02e0_517_1.jpg NDC 59579-102-01 Noxivent nitric oxide j{oJ@iEIE1T 800 PPM Rx only CAUTION: HIGH PRESSURE GAS. CAN CAUSE RAPID SUFFOCATION WITHOUT WARNING, Use equipment rated for cylnder pressure, Store and use with adequate ventiation, Secure cylinder in use and storage, Close valve: after each use and when empty. USE IN ACCORDANCE WITH APPROPRIATE SDS. WARNING: Administration of this gas mixiure may be hazardous or contraindicated. For use only by or under the supervision of alicensed pracitioner who is experienced in the use and administration of gas mixtures, and is familiar wih the indications, effects, dosages, methods, and frequency and duration of administraton, and with the hazards, contreindications, and side effects and precautions o be taken. FIRST AID: IF INHALED, remove person to fresh air If not breathing, give artficial respiration,If breathing is diffcult, ‘give oxygen, Get medical help, RETURN WITH 25 PSIG. TO BE REFILLED ONLY BY A LICENSED FACILITY AUTHORIZED BY PRAXAIR DISTRIBUTION, INC. DO NOT REMOVE THIS PRODUCT LABEL, Store at 25°C (77'F) with excursions permitted between 15-30C (59-86'F). Volume: 2082 Liters PRAXAIR DISTRIBUTION, INC, 145 Shimersville Road Bothlehem, PA 18015 UN1956 COMPRESSED GAS, N.0S. (NITRIC OXIDE, NITROGEN) 22 Net Weight: 2.5 kg ZZAPRAXAIR I vedipure MMG-500-AQ (09/2018) MedcalGuses
27586e4f-66f1-4583-981c-e0bccb8b02e0_517_2.jpg NDC 59579-102-02 Noxivent’ nitric oxide j{oJ@ILEIELO 800 PPM Rx only CAUTION: HIGH PRESSURE GAS, CAN CAUSE RAPID SUFFOCATION WITHOUT WARNING. Use equipment rated for cylinder pressure, Stors and use with adequate ventlation, Secure cylinder in use and storage, Close valve after each use and when emply. USE IN ACCORDANCE WITH APPROPRIATE SDS. WARNING: Administration of this gas mixture may be hazardous or contraindicated. For use only by or under the supenvision of a Icensed practitoner who is experienced in the use and adminisiraion of gas mixtures, and i fa with the indications, effects, dosages, methods, and frequency and duration of adminisiration, and with the hazards, contraindications, and side effects and precaulions o be taken. FIRST AID: IF INHALED, remove person t frosh air I not breathing, give artificial respiration. I breathing s dificul, give oxygen, Get medical help, RETURN WITH 25 PSIG, TO BE REFILLED ONLY BY A LICENSED FACILITY AAUTHORIZED BY PRAXAIR DISTRIBUTION, INC. DO NOT REMOVE THIS PRODUCT LABEL. Store at 25°C (77'F) vith excursions permitted between 15-30°C (59-86'F). Volume: 323 Liters. PRAXAIR DISTRIBUTION, INC, 145 Shimersville Road Bothlehem, PA 18015 UN1956 COMPRESSED GAS, N.0O.S. (NITRIC OXIDE, NITROGEN) 22 Net Weight: 0.5 kg ZAPRAXAIR Medipure MMG-800-AD (09/2018) Medical Gases
28ddc9e0-05c5-482f-9371-60bbee451b33_178_1.jpg Paroxetine 10 mg Tablet arv: 30 ID #: 710;HH Expires: NDC #: 70518-1406-00 Shape: Capsule LOT #: Ref #: 43547-0347-03 MFG: Solco, Cranbury, NJ 08512 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
28e6becd-a65a-4245-b282-5766127567a2_635_1.jpg e S, o AN SR TSR R EATIT g ELE e et By £ ] pme e LSHOURS ORASDRECTED. P i, S i i HEEE e e b s F
291a45f6-ed27-4dcc-8364-358d08623797_641_1.jpg NDC 50111-333-01 Metronidazole Tablets USP 250 mg B only Each tablet contains 250 mg metronidazole, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperatur PROTECT FROM LIGHT Dispense in a tight, light-resistant container as defined in the USP, with achild-resistant closure (as -mn:_ﬁm& S KEEP THIS AND ALL _,\_mc_oa_ozm < OUT OF THE REACH OF CHILDREN. Manufactured In Gzech Republic By: & TEVA CZECH INDUSTRIES 5.r.0. Opava-Komarov, Czech Republic Manufactured For. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 4456501 N 3 50111-333-01 7
291a45f6-ed27-4dcc-8364-358d08623797_641_2.jpg Metronidazole Tablets USP 500 mg NDC 50111-334-01 B only Each tablet contains 500 mg metronidazole, USP. Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperatur PROTECT FROM LIGHT Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as -gsa& 5 KEEP THIS AND ALL _,\_mo_an_ozm = OUT OF THE REACH OF CHILDREN. Manufactured In Gzech Republ TEVA CZECH INDUSTRIES Opava-Komarov, Gzech Rep! Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. A 4456801 ¥ 50111-334-01 4
29a0d87e-6afb-4766-9045-1963c5b0d183_713_1.jpg NDC 71205-122-30 ProficientRx » e RX Only Amlodipine Besylate 5mg/ Benazepril 20mg #30 Capsules Each capsule contains: Amlodipine besylate USP equivalent to amlodipine 5mg and benazepril hydrochloride USP 20mg White to pale yellow colored powdr filed in empty hard gelatin capsule shels, size “0" of pink cap_and pink body imprinted with " on pink cap and 98" on pink body with black edible ink. Product ID: QA012230 Dist. By: Citron Pharma LLC Suite-1101 2 Tower Center Bivd East Brunswick, NJ 08816 Made in India Store at 20°-25°C (68°-77°F) Keep medication out of the reach of children Lot #:00000 Exp. 00/00/00 RX# MASTER Amiodipine Besylate Smg/ Benazepril 20mg #30 Capsules RetMASTER Lot 00000 Exp000000 NDC 7120512230 ‘Amlodipine Besylate Smg/ Benazepri 20mg #30 Capsules Ret MASTER Lot 00000 ExpODON00 NOC 7120512230 Amlodipine Besylate Smg/ Benazepri 20mg #30 Capsules RxtMASTER Lot#00000 Exp000000 NOC 71205-122:30 Packaged By: Proficient Rx LP. Thousand Oaks, CA 91320
29d98cf3-a0f2-3f89-e054-00144ff88e88_875_1.jpg ALCOHOL OR ALCOHOLIC BEVERAGES SHOULD NOT BE CONSUMED WHILE TAKING THIS MEDICATION. 43063-650-20 NAPROXEN Usp 375 mg 20 TABLETS ReOrder # 109093 LoT ii8cas EXP 10/20 43063 650-20 NAPROXEN Usp 375 mg 20 TABLETS ReOrder # 109093 LOT 118c49 EXP 10/20 W L e = T R L e “DOSAGE and STORAGE: SEE PACKAGEINSERT 43063-650-20 NAPROXEN Usp 375 mg 20 TABLETS ReOrder # 109093 LOT ii8cas EXP 10/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TOME TABLETA(S)___ Each TABLET Contains: NAPROXEN USP 375 MG _____TIMES A DAY WITH FOOD. VECES AL DIA CON COMIDA. ORGANOLEPTIC MARKINGS: WHITE IP 189 375 OBLONG NDC: 43063 650- 20 NAPROXEN USP 20 TABLETS o RERE (01)10343063650202 < (21)118C49000001 T (17)201031 (10)11849 C0Z0S3€90EVE AN T VIGN| ‘GVavaInHy QLT LAd "WHYHD TYINNY DI68T0ZITSS
2a2a7fcc-dfe7-5d64-e054-00144ff8d46c_469_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT. MAY CAUSE DROWSINESS. USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTNESS, CAUTION: FEDERAL LAW PROHIBITS THE TRARSFER OF THIS DRUG TO ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED, R 1v VARNING: KEEP THIS OUT OF THE REACH OF CHILDREN et DOSAGE and STORAGE: SEE PACKAGE INSERT 43063-653-10 43063-653-10 43063-653-10 oxyCODONE & oxyCODONE & oxyCODONE & ACETAMINOPHEN ACETAMINOPHEN ACETAMINOPHEN SMG*/325MG SMG*/325MG 5MG*/325MG 10 TABLETS 10 TABLETS 10 TABLETS REORDER #109180 REORDER #109180 REORDER #109180 LOT [18A41 LOT [18A41 LOT 118A41 EXP 01/20 EXP 01/20 EXP 01/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 TAKE __ TABLETISIEVERY __HOURS AS NEEDED FOR PAI, TOME __ TABLETA[S|CADA__HORA COMO KECESARIO POR DOLOR, ORGANOLEPTIC MARKINGS: WHITE ROUND/BISECT 5 325 R P i ~ATTACH LABEL HERE----vorsrr e EXP: [ l LOT: 11844 I T (Il PD-RX NE NDC 43063-653-10 HPD-Rx I)‘(I PHARMACEUTICALS - M INCORPORATED® Ll Oklahoma City, 0K « 73127 otyCODOJE & ACETAMINOPHEN ol ol 10 TABLETS Each Tablet Contains: OXYCODONE HCL, USP 5 MG ACETAMINOPHEN, USP 325 MG +5 Q}G OXYCODONE HCL IS EQUL- VALENT TO 4.4815 MG OF OXYCODONE *(WARNING:MAY BE HABIT FORMING) = S — &= S i — o — E= B — >— = o NI —_— — —_— —_— = — o B =R oo T 2= S N OV e O o
2a2a7fcc-dfe7-5d64-e054-00144ff8d46c_836_1.jpg AVOID ALCOHGL WHILF TARING THIS PRODUCT. MAY CAUSE DROWSINESS. USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTNESS. CAUTION: FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG TO ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED. R i WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN DOSAGE and STORAGE: SEE PACKAGE INSERT 43063-653-12 43063-653-12 43063-653-12 okyCODONE & oxyCODONE & oxyCODONE & ACETAMINOPHEN ACETAMINOPHEN ACETAMINOPHEN 5MG*/325MG SMG*/325MG 5MG*/325MG 12 TABLETS 12 TABLETS 12 TABLETS ReOrder # 109182 ReOrder # 109182 ReOrder # 109182 Lot 118824 LoT 118B24 LoT 118824 EXP 06/20 EXP 06/20 EXP 06/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE___TABLET(S)EVERY. HOURS AS NEEDED FOR PAIN. TOME TABLETA(S)CADA___HORA COMO NECESARIO POR DOLOR. Each TABLET Contains: OXYCODONE HCL USP 5 MG, ACETAMINOPHEN USP 325 MG * 5 MG OXYCODONE HCL 1S EGUIVALENT TO 4.4815 MG OF OXYCODONE *(WARNING: MAY BE HABIT FORMING) ORGANOLEPTIC MARKINGS: WHITE 5325R P RND/BISECTER ox¥CODONE & ACETAMINOPHEN 5MG*/325MG 12 TABLETS i (01)10343063653128 (21)118B24000002 (17) 200630 (10)J18824 8TTESYEIOEDE o ~ o w = S - o = @ o - = = g [= m o x > a2 2 > E 2
2a69f986-38c4-4dcd-81bc-21fe39b5f7aa_572_1.jpg NDC 4219215206 RKONY LT Sulfide 2.25% Shampoo 6 fluid oz. (180 mL) FOR TOPICAL USE ONLY NOT FOR OPHTHALMIC USE HAcella ngrdions: Exch il ofSeerim Slide 2.25% Shampon o 725 gk s, i s st oKk i, a4, comitepp bade et e e FOACyelon’, st vl 360 s, miin e, it dicdim, g, oo ety gt ks i, meprsten, aerl, 5.2 konet| s pgjne i, pepashen, ot FOSC R 1) s, gl st i i, e e prre. Dosage and Admiistaton: SHAKE WELLBEFORE USING Fo b dematis s donrt Gl 2 splcis e ek i Zweds il ot srpons Subequety, o o e g s ety ek iy 2wk, vy 3 0 vk 5 i by i Shul ot ol e ety h sy o, Fortines vrsicolor, Vs and py o st s Msage gy tosinwotin s Alowpodct o e o s o 10 i, e e g Repeat e e oy for s o o 5 ety 3 i A st sistutons andor rommadatrs g e o b e et 20 el s s gl NOTE-Ths s ot an Orange ook produc N epresenation made s 1 gnerc st o biequialency P s pdage st o e fmtin Seelmser for fl rescibiog nfomation. T — DO NOT USE GN BROKEN SKH O NFLAMED AREA. sl eacionccrs, o s A s wih s, e st Snd ittt s i S ot rse Sy e KGEPTHIS AND ALLMEDICATIONS OUT OF THE REACH OF GHLOREN. Storage:Sor st 20°C1 25 C B8 Fra T, s pmicedbewan 15°Cand 0 (b 5 Fand 35 e fom i, Acellg Mendacusdtor s Pamacasics LC A, GA 0022 it 3 lllv
2a69f986-38c4-4dcd-81bc-21fe39b5f7aa_572_2.jpg Rx Only SELENIUM SULFIDE 2.25% SHAMPOO DESCRIPTION: A liquid antiseborheic, antifungal preparation for topical application. Each mL of Selenium Sulfide 2.25% Shampoo contains 22.5 mg selenium suifide, ammonium lauryl suifate, caprylic/capric trighyceride, citic acid, cocamidopropyl betaine, chromium oxide green, FDRC yellow 8, distearyl phthalic acid amide, diazolidinyl urea, edetate disodium, fragrance, hydroxypropyl methyicellulose, magnesium aluminum siicate, methylparaben, panthenol, PPG-2 hydroxyethy! cocolisostearamide, propylene glycol, propylparaben, purified water, FD&C Red 40, sodium citrate, tocopherol acetate, titanium dioxide, urea, and zinc pyrithione. CLINICAL PHARMACOLOGY: Selenium sulfide appears to have a cytostatic efect on cell ofthe epidermis and follcular epitheium, reducing comeocyte producton. PHARMACOKINETICS: The mechanism of action of topicaly applied selenium sulfce s not yet known. INDICATIONS & USAGE: A liquid antiseborrheic, antifungal preparation for the treatment of seborrheic dermatits of the scalp, danruffand tinea versicolor. Urea hydrates and s usefulfor conditions such as dry scalp. 'CONTRAINDICATIONS: Contraindicated in persons with known or suspected hypersensitiy to any o the lsted ingredients. WARNINGS: For exteral use only. Not for ophthalmic use. DO NOT USE ON BROKEN SKIN OR INFLAMED AREAS. If allergic reaction occurs, discontinue use. Avoid contact with eyes, genital areas and skin folds, as irritation and burning may resul. If accidental contact occurs rinse thoroughly with water. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. PRECAUTIONS: This medication is to be used as directed by a physican. Not to be used when inflammation or ‘exudation is present as increased absorption may occur. (CARCINOGENESIS: Dermal application of 25% and 50% solutons of 2.5% selenium sulfce foton on mice over an 88-week period indicated no carcinogenic effcts. USE IN PREGNANCY: CATEGORY C Animal reproduction studies have not been conducted with this medication. It s also not known whether this product can cause fetl harm when applied o the body surfaces of a pregnant woman or can affectreproducton capaciy. Under ordinary ircumstances, seenium sulfde 2.25% shampoo should not be used by pregnant women. NURSING MOTHERS: It is not known whether of not this drugis secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when this product is administered to a nursing woman.
2aa312d6-4618-45ad-9a43-b3abd130f8dc_590_1.jpg o o | soewe venssss eI e Nouosazsmn 0tvosa Sk fompidun st s dSes (1214 915 32 a2 ot ey oy v et e i ‘5500 Ay wnipos e poe OCHOIPAY PSS &7 A2U K+ Q $E 5 WNTOS sy p HA b Lol o) K, 5 9501 034 918k Bl 2 oS (1 SPAOIID. A SUZBIEIDA FSUEWID Tl 423 BN EIS a3 onmnomig NDC 67457-291-01 hydrALAZINE Hydrochloride Injection, USP For Intramuscular or Intravenous Use Mylan-, PSR IR Rx only z g 5 3 1 nocer4s7-291.01 o B hydrALAZINE Hydrochloride Injection, USP ForIntramuscular or Intravenous Use [Mylan | 8 =7 53 D i Hes i Hes e £z HIS> ¢ ci RS [ > g 2 &N £ v - m spuo o g i - g 3 = ¢ g ‘ 5 L0=162=25%.9 2 z 8 g 8 i B
2bc91eeb-5d8d-4058-b16a-532ba114fcd5_379_1.jpg ] ey pee g L T R e Ry L] dsn ‘uonoslu| Jo uljjivjeN L R NOISN3NI L9380 404 LON - 39V)OVd YN8 ADYIAYH LINN v SV G3SN3dSIA 36 OL LON CEC R e T ) iogy et L e TR R T Lo s D P s ] ekt il 1 NOLLAIO ¥3HLHNS NOLLNLLLSNOIIY HILAY “JunLONNd T e VAL T o) T e T I E e ) T e ey T e ) El e s e e T e LTy T T e L e o oy ey Ly .17 18 0 opmupsu3ey 0 i P PR e Y L] Fryr T o) Ery 4 e DT e g sy por o] T L e T T IS £ | 2 TUCIEL RN T TR for Injection, USP 1 Ogums NOT FOR DIRECT INFUSION WL =Rl | NOT TO BE DISPENSED AS A UNIT PHARMACY BULK PACKAGE -| Nafcillin Loy V) 1666409802£00(40) [
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_1.jpg 5 et T i e o U], NDC 68025-075-30 ‘SEE PACKAGE IISERT FOR DOSAGE NFORMATIO. ™ 8 szmase™ Osmolex"ER = St ot 2°C25°C (6°F-77°) exousions . 2 [ N B S (amantadine) g = & /ERTICAL Extended-release Tablets g = = e A g Brdgevate NJ 03807 200125 Rev 032018 30 Tablets Rx Only - 3
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_10.jpg swige aseoja-gapuapy (suipejuEWwE) Y3.xe|owsQ JVSIH HOd LON TS SR y1-910-52089 OON 14Tl 2047 4Tl 2067 NDC 68025-076-14 Uk Dose Bastor Packs. | NDC 68025-076-14 ot tos bt Fke. SAMPLE Osmolex”"ER NOT FOR RESALE (amantadine) Extended-release Tablots f 'Osmolex™ER (193ma] (amantadine) Extended-relgase Tablsts Eh et cntos 146 g cncrtagn {eqent 0 240 mg et oo USP, i Dosage: oo posrbing nosion Soro 26 25° TR excusare ol 0 15690 (0 ) 1550 USP Conoied FcmTorpae, T s kg s ol st KEEPOUT OF REACEHOF CHLDREL, sige sseqa- el (SUIPEIUBLUE) 1y 5y XD|OWUSO P01200 Nutra Med Osmolex 193 mg 14ct Prog# 0768187C 04/03/18 SeIEL oseole-popuard Black Pantone Pantone ~ (suipejuBWE) oz 3 . Xs|owsQ 3vS3d Ho4 LON FdWYS Osmolex™ER (amantadine) exendsd.eiase asets Sfoed Jeysig 850 Hun (1x1) 2 'swigeL v}
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_2.jpg Each tablet contains 129 mg NDC 68025-075-90 amantadine (equivalent to 160 mg amantadine hydrochloride USP). ™ SEE PACKAGE INSERT FOR I e E R DOSAGE INFORMATION. o s m O x Swallow whole: Do not spit, crush, or chew. (amantad in e) Keep out of reach of children. Store at 20°C-25°C (68°F-77°F); Extended-release Tablets excursions permitted to 15°C-30°C (59°F-86°F) [See USP Controlled Room Temperature]. Distributed by: Vertcal Pharmaceuticals, LLG Bridgewater, NJ 08807 <& 200127 Rev. 03/2018 Y ERLIGAL GTIN 00368025075909 90 Tablets Rx Only
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_3.jpg exch aie contas 103 mg amentadine (equivalent o 240 mg avatadine ycrechiride USP, SEE PACKAGE INSERT FOR DOSAGE INFORMATIN. Salow whoe: Do totspt crsh,or chew, Keep outof each o chidren. Streat20°0.25° (BYF-TT excursions pomted o 5°C.20° (8°F-86°F) 5ee UsP Contled Room Terperature) ERTICAL ettty e Bttt 1o jrelictine g S b NDC 68025-076-30 Osmolex"ER (amantadine) Extended-release Tablets 30 Tablets Rx Only ~ GTIN 003|TO|25076302 68025 076 3
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_4.jpg Each tablet contains 193 amantacine oquivalent 1240 mg NDC 68025-076-90 ‘amantadine hydrochloride USP). SEE PACKAGE INSERT FOR ™ DOSAGE INFORMATION. s m o ex Swllow whole: Do not spit,crush,or chew. Keep out of reach of children. (am antad | n e) ‘Store at 20°C-25°C (68°F-77°F); excursions permitted to 15°C-30°C Extended-release Tablets (59°F-86°F) [See USP Controlled Room Temperature]. \/ERTICAL Distributed by: Vertical Ph: uticals, LLC Bridgeviater NJ 08807 90 Tablets Rx Only 200129 Rev. 03/2018 GTIN 00368025076906
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_5.jpg 9 eschtatetcontains 258 mg amartadine NDC 68025-077-30 {equivalent to 320 mg amantadine hydrochioride USP). 2 ) ‘SEE PACKAGE INSERT FOR DOSAGE INFORMATION. ™ ‘Swallow whole: Do not spit, crush, or chew. = EoEgs Osmolex"ER = Sl i 3 = Emme e (amantadine) = V/ERTICA Extended-release Tablets g = (ERTICAL S==° i = = Pl = 200150 Ao 0312018 30 Tablets Rx Only =
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_6.jpg Each tablet contains 258 mg ‘amantadine (equivalent to 320 mg NDC 68025-077-90 amantadine hycrochiorde USP). SEE PACKAGE INSERT FOR ™ @ DOSAGE INFORMATION, s m o ex S Swallow whole: S Do not spit crush, or chew. . S Keep out of reach of children. (amantad"]e) o Store at 20°C-25°C (68°F-77°F); S excursions permitted to 15°C-30°C Extended-release Tablets 2 (59°F-86°F) [See USP Controlled S Room Temperature]. 8 S = RTICAL = ek ie 5 Distrbuted by: Vertical Pharmaceuticals, LLC Bridgewater, NJ 08807 90 Tablets Rx Only 200131 Rev. 03/2018
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_7.jpg 707 Tabets Un oss BistrPck NOG 68025-075-07 LOT X00000¢ EXPX0000K: SAMPLE | NOTFOR RESALE Osmolex"ER (amantadine) Exndet s Bt Rx Only Each tablet contains 129 mg amantocine. (oquivalnt 1o 160mg amantadine hydrochioride USP). V&mw e 707 Tabkts U Dose Bister Pack DG 68025-075-07 LOT XXX EXPXXP00X. “SAMPLE NOT FOR RESALE Osmolex”ER (amantadine) e s Tots Rx Only _ Each tablet contairs 129 mg amantadine (equivalent 10 160 mg ‘amantadine hydrochloride USP). 200222 Fow.03/2018 7907 Tabkets Ui Do Bt Pack NOC 58025-075-07 LOTX0000X EXP XX00K SAMPLE NOT FOR RESALE Osmolex"ER (amantadine) Exodes s ol Rx Only Each tabletconteifs 129 mg amantadine (oquivalent 10160 g amantadine hydrochiorkde USP). VERTIGAL 200222 Row 03/2018 7147 Tathets Ut Dose Blster Pack NOC 68025-075-07 LOT XX000X EXR XXX SAMPLE NOT FOR RESALE Osmolex”"ER (amantadine) /| s oss s Rx Only. Each tablet contains 120 my ‘amantacine equisent t0 160 g ‘amantadine hydrochloride USP). Vuncu B
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_8.jpg swige aseojargapuapy (euipejuEWwE) Y3.xe|owsQ JVSIH HOd LON TS SR 161052089 OON 14Tl 27 4Tl 2067 NDC 68025-075-14 Uk Dose Bastor Packs. © NDC 68025-075-14 U Dose Bister Packs. SAMPLE - Osmolex"ER HOT FOR RESALE (amantadine) Extended-release Tablots - f 'Osmolex”ER Hom (amantadine) Extendsd-rolase Tablets Eh et o 129 mgcncetad: {eqent 0160 mg et oo USP, 120 mg i Dosage: oo posrbing nosion Soro 26 25° TR excusare ol 0 15690 (0 ) 1550 USP Conoied FcmTorpae, T s kg s ol st KEEPOUT OF REACEHOF CHLDREL, w21 . 21 Detruted by Vil Pamacsics LG B, 10 0207 ot siaeL sseqa-puaid (SUIPBIUBLUE) 1y 5y XD|OWUSO ! — ) P01201 Nutra Med Osmolex 129 mg 14ct Progi# 0768187C 04/03/18 Bw 621 Sjo|qe aseafal-papuard Black Pantone Pantone (suipejuBWE) oo 3 . Xs|owsQ 3vS3d Ho4 LON FdWYS Osmolex™ER (amantadine) exendsd.eiase asets Sfoed Jeysig 850 Hun (1x1) 2 'swigeL v}
2bced627-51e3-4e5c-a23c-30deb86ff37b_500_9.jpg 7 {1x7)Tabets UniDose Biser Pack DG 68025.076.07 LOT Y0000 EXPX0KX0X- SAMPLE NOTFOR RESALE Osmolex”"ER (amantadine) . et s i Rx Only Each tablet contains 183 mg amantaine (equivalent 10 240 mg amantadine hydrochlonide USP). VERTICAL 200223 BrSeome 710 aets Uit Dose BstrPack DG 68025.076.07. LOT XH0000KX EXP X000 SAMPLE NOT FOR RESALE (amantadine) e Tvts Rx Only. Each tablet cortains 193 mg amanadine (equivalent 10 240mg. ‘amantadine hydrochloride USP). VETcAL 200223 Rev.03/20%8 7 (97 Tabkts Uit Dose Bister Pack DG 6025-076.07 LOT 00000 EXP. XOX/X00K “SAMPLE NOT FOR RESALE Osmolex"ER (amantadine) Extnces s s RxOnly Each tablet contars 193 mg, amantadine (oquivalont 10240 mg ‘amantadine hydrochioride USP). 20023 Row 0372018 7 (17 Tathets Ut Dose Blste Pack NDC 68025.076-07 LOT X00000X EXP XXX - ‘SAMPLE NOT FOR RESALE Osmolex”"ER (amantadine) Exondes s it Rx Only Each tablet contaips 193 mg. ‘amantacine foquialent 10240 mg ‘amantadine hydrochioride USP).
2bd1ee6d-dffe-4647-ae27-986e534b3991_666_1.jpg NDC 71205-102-90 & ProficientRx > RX Only Losartan Potassium 100mg #90 Tablets Each tablet contains: 100 mg of losartan potassium, USP. White to off-white colored, oval shaped, biconvex, film coated tablets debossed with 100" on one side and *115" on the other side. Product ID: QL010290 Mir. By: TORRENT PHARMACEUTICALS LTD. Bharuch-382130, INDIA. Store at 20°-25°C (68°77°F) Keep medication out of the reach of children Lot #:00000 Exp. 00/00/00 RX# MASTER Losartan Potassium 100mg #90 Tablets R MASTER Lot #00000 Exp000000 NDC 71205-10290 Losartan Potassium 100mg f0 Taes | Rawren o 00000 Exp 000000 NDC 71205-102-90 ¥ Losartan Potassium 100mg #90 Tablets Rut MASTER Lot £00000 Exp000000 NOC 7120510290 Pacaged By: Proficent Rx LP Thousand Oaks, CA 81320
2c0d0f9f-2df5-41f6-891f-454c8012ef26_265_1.jpg B — Goionin CPROFLONGND3{OPRTHSOLT — | Memawe, Sowe e L L e B o g i e o T AFFECTED EVE(S) EVERY i1 o PR e B SR awwcses T s 1 ot : '
2c42171e-1b44-4d34-b6ca-5b6a94f0e694_961_1.jpg Packaged by Beyant Ranch Burllank, Gt 91504 =, OPAQUE GRAY CAPSULE TL 383 Terazosin HCI o773 1mg Capsule - s d ~ | Store at room temp of Compare To: 20-25 C (68-77F) Hytrin 1mg Capsule Keep in light resistant S Cessaramaseessine container perUSP swox #150 Exp: MM/YY NDC 6362945251 045251107312
2c562d11-805e-42b0-a7df-032e5c2161d1_64_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT.MAY CAUSE DROWSINESS. NDC 43063-887-21 USE CAUTION WHILE PERFORMING TASKS REOUIRING MENTAL ALERTNESS. CAUTION: FEDERAL LAW FRUHIBITS THE TRANSFER OF THIS DRUG TO ANY PERSON OTHER THAN TN WHOM IT WAS PRESCRIRED E R WARNING KEEP THIS OUT OF THE REACH OF CHILDREN —— " 3-— SO DOSAGE and STORAGE SEE PACKAGE INSERT 3==s S = ' =0 Z o 43063-887-21 43063-887-21 43063-887-21 A==23 T — m[zjgr;m dia[zjesl;AM dinzePAM ] ' E _— - — d PAN = 5m 5 mg i ES—‘—E";. laze ﬁé— 21 TABLETS 21 TABLETS 21 TABLETS S op " 23 — REORDER #110648 REORDER #110648 REORDER #110648 §g =° T g :E s LOT [18E45 LOT I118E45 LOT I18E45 5SS =6 | BE = EXP 04/19 EXP 04/19 EXP 04/19 i AW 8 = T ' el CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. B == . o YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 l B 21 : ) 8 = = Pach Tablet Contains: / ! Z o TKE__TABLETS) _TIMES A DAY, E=r DAEPANUSFSHG. | SRimm ) e TOME__ TABLETA(S) _VECES AL DIA. ~ § = ORGANOLEPTIC MARKINGS: YELLOW ROUND/SCORED DAN 5619 5 a=
2c562d11-805e-42b0-a7df-032e5c2161d1_912_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT. MAY CAUSE DROWSINESS. USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTNESS. CAUTION: FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG TO ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED. 43063-887-06 43063-887-06 R WARNING IKEEP THIS QUT OF THE REACH OF CHILDREN R DOSAGE and STORAGE: SEE PACKAGE |NSERT 43063-887-06 diazePAM diazePAM diazePAM usp use usp 5MG 5 MG 5 MG 6 TABLETS 6 TABLETS 6 TABLETS ReOrder # 110660 ReOrder 8 110660 ReOrder # 110660 LOT jisciz LOT 118C17 LoT J1scaz EXP 10/19 EXP 10/19 EXP 10/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: DIAZEPAM USP 5 MG YELLOW ORGANOLEPTIC MARKINGS: DAN 3618 5 ROUND SCORED NDC: 43063-887-06 J= (01)10343065887066 SRHI8C17000001 (17) 181031 {10)118c17 990LBBEIOEVE I A 0 TDES00ZIBTS YIGN! 'VOD JLLIDTYS YNHIA QL7 ILVAING VINEYHD NOSLYM
2c76b8f9-5385-4c98-aebb-bdca8613d24b_665_1.jpg %S 0 uonnjos anweywdo aujweyjawolg 9e|010}3) 066 12-SEELY JON ~FOR USE IN THE EYES ONLY Each mL contins: Active: keoroac omethamine USP 0.5% Prossnativ: berzakonium chorde soution (50%) NF0.02% Inactves:eceta dsofium USP 0.1% octanynol 43 wateforinjecon USP, ‘Sodm chorde USP; and hydrochiorc aci N andlor sodum hgodde N o adjst e 1074 Usual Dosage: e drop fous mes aday. Reerto package insert. Note:Slore a1 20° 0 25°C (66710 77 excursions permitted between 15" and 30°C (69" and 86°) 52 USP Contoled Room Temperatre]. Prtectfrmlight. Botte led 1o sproimately Vecapacy. This packageds not chid resistant. KEEP OUT OF REACH OF CHILDREN Ditbued by: Sun Phamacesica ndustrie, . Canbury, N 08512 Manufachred by Sun Phamaceutical Industries 1. Hall Baroda Highway, Hall:359 350, Gufarat, Inia. NODC 47335-219-90 Ketorolac Tromethamine Ophthalmic Solution PJSBOB4SA 18S. 04/2017 GUJ/DRUGS/28/396 NDC 47335-219-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% FOR USE IN THE EYES ONLY Rx only 3mL NDC 47335-219-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% FOR USE IN THE EYES ONLY Rx only 3mL O SUN PHARMA
2c76b8f9-5385-4c98-aebb-bdca8613d24b_665_2.jpg FOR USE IN THE EYES ONLY NDC 47335-220-90 —" Distributed by: ) Sun Pharmaceutical Industries, Inc. Each mL contains: Active: —_— ketorolac tromethamine USP 0.5%. Ke‘“""a‘? =2 &ranb;]ry, N dogs,u Preservative: benzalkonium Tromethamine = s;ﬂﬁ?r%gceuyfinal {nd. Lt India GUJDRUGS/28/396 chloride solution (50%) NF 0.02%. Ophthalmic SO|I.Iﬁ0ll Usual Dosage: One drop four times a day. Refer to package insert. 0.5% Protect from light. Rx only 5mL PJLB2344 18. 11/2014 § ||I|1. 733 5"2
2c76b8f9-5385-4c98-aebb-bdca8613d24b_665_3.jpg %S"0 uonnjog anwjeyiydg aujwey)awo.| 9e[0J0jay 06-022-SEELY JAN FOR USE IN THE EYES ONLY Each mL contains: Active: ketorolec romethamine USP 0.5%. Preservative: benzalkonium chioride solution (50%) NF 0.02%. Inactives: edetate disodium USP 0.1%; octoxynol 40; water for injection USP; sodium chioride USP; and hydrochioric acid NF and/or sodium hydroxide NF to adjustthe pH1o 7.4 Usual Dosage: One drop four imes aday Refer o package insert Note: Store at 20°t0 25°C (68°to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Protect from light. This package is not child resistant. KEEP OUT OF REACH OF CHILDREN Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujara, Inda NDC 47335-220-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% 3473350220 ||2 PJSB0846A 1SS. 04/2017 GUJ/DRUGS/28/396 NDC 47335-220-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% FOR USE IN THE EYES ONLY Rx only S5mL NDC 47335-220-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% FOR USE IN THE EYES ONLY Rx only 5mL o SUN PHARMA
2c76b8f9-5385-4c98-aebb-bdca8613d24b_665_4.jpg FOR USE IN THE EYES ONLY NDC 47335-221-90 gism:);ﬂe" by, R Exichi il conlaliies Active: 5 un Pharmaceutical Industries, Inc. ketorolac romethamine Usp 05, Ketorolac Tromethamine Cranbury, NJ 08512 Preservative: benzalkonium i i Manufactured by: chioride solution (50%) NF 0.02%. Opmhalmlc somllon Sun Pharmaceutical Ind. Ltd, India. Usual Dosage: One drop four o 5% GUJ/DRUGS/28/396 times a day. Refer to package i insert. Batch No.: Protect from light. Rxonly 10 mL PJLB2345 188. 11/2014 By
2c76b8f9-5385-4c98-aebb-bdca8613d24b_665_5.jpg %S 0 uoynjos alweywdg aujweyjawolg 9e]010}3) 06°1.22-S€ELY JON "FOR USE IN THE EYES ONLY Each mi_conais: Actve: kelorolac tometramine USP 05% Prossnativ: berzakcrium chorde soltion (50% NF0.02%. Inactives: et dsofium USP 0.1% octaynol 47 wateforinoton USP; ‘Sodum chor USP; and hydrochiorc: a6 F andlor sodum e NF o adistbe p10 7.4 Usual Dosage: e drop four mes aday Relerto package nsrt Not: Store a1 2010 25 66710 77 xcursions permitted betwean 15°and 30°C (69" and 86°) see USP Contoled Room Temperatre. Prtectfrm ligh. This packageis not chid resistant. KEEP OUT OF REACH OF CHDREN Ditbud by: Sun PhamaceuticalIndusres, Inc. Canbury, N 08512 Mandachied by: Sun Phamacedtical Indusiries 1o, HalolBaroda Highway, Hall:389 350, Gufara, Inia. NDC 47335-221-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% |I2219C|l N 3 M47335 PJSBOBATA 1SS. 04/2017 GUJ/DRUGS/28/396 NDC 47335-221-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% FOR USE IN THE EYES ONLY Rx only 10mL NDC 47335-221-90 Ketorolac Tromethamine Ophthalmic Solution 0.5% FOR USE IN THE EYES ONLY Rxonly 10mL o SUN PHARNA
2cf16c47-4c68-423e-a596-d0b1d3c5e067_846_1.jpg C ) dx3 101 2865901L66LS¢ £8YEE 14 'UOjeY eX0g Ul ‘|ednnadeuweyy abpuuaydaig :Aq panquisig oBpLitis3s.gE S ‘paIn|ip 3q 3snw asoq uondafu] 312311q 403 30N ‘[aanjesadwia) wooy P3]|013u0D dSN 33S] (do/L 01 089) DoST 01 00T 1€ 310}S ‘uoneusioul 1osad ||ny 995 :abesoq ‘suonn|os uoisnjul Bujuieluod winp[ed Yiim xiw 10U oq Rev.07/17 065-98 NDC51991 bu c 2> S £® 5 59 95 volals¥32 8% 28 SgE 28 EE|E|ERE 2 8 Sowi5fy 255 = © TE D EC3 5% so Ele8c e O .S cgco & NG ¥ =5> &2 < o8 £E \ £ 5w £ 2
2cf16c47-4c68-423e-a596-d0b1d3c5e067_846_2.jpg Distributed by: Breckenridge Pharmaceutical Inc. Boca Raton, FL 33487 Manufactured by: Pharmaceutics International, inc Hunt Valley, MD 21031 arenueuo) sjuss. Ajuo x A 5500 Sjbuls 1 30 uoxy Uoisnyu| snouanesu) oy 1e11U2dU0) £lug esn snousnenu] 04 (Tw/Bw g°0) Jw g/bui uopoaluj PpIoy dluoipajoz 86-GOQ-L6615 daN See package insert for DOSAGE and ADMINISTRATION and Preparation of Solution. Each vialdelivers zoledronic acid monohydrate 4.264 mg (equivalent to 4 mg zoledronic acid on an anhydrous basis); mannitol, USP, 220 mg; water for injection and sodium citrate to adjust pH. The pH of the concentrate is 5.7 -6.7. Zoledronic Acid diluted with infusion media, may be stored under refrigeration at 2°C - 8°C (36°F Total time between dilution with infusion media and end of administra- tion must not exceed 24 hours. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] 6°F). Rev.07/17 NDC51991-065-98 NDC51991-065-98 Zoledronic Acid Zoledronic Acid Injection Injection 4mg/5 mL e ana el 1 (0.8 mg/mL) g mL I For Intravenous Use O (0.8 mg/mL) e o For Intravenous Use Only Intravenous Infusion Concentrate for Sterile Concentrate Intravenous Infusion e Sterile Concent Not for direct injection. Dose must be diluted. Discard unused portion. See package insert for Preparation of Solution. Do not mix with calcium - containing infusion solutions. One s mL Single Dose Vial One 5 mL Single Dose Vial Rx Only RxOnly GTIN: 00351991065982 sN: 000000001582 EXp: 05/2020 LOT: 5536.000A
2d0eca5d-fe5f-410b-991e-5e365c173703_906_1.jpg 2 Each tablet contains: Onycodone Hydrochioride, USP 5 mg* 5 mg oxycodone HCI is equivaent to 45 mg of axycodone. See package insert or complete prescribing nformation. Store a1 25°C (77°F) excarsions are permitied 10 15°-30°C (§9°-86°F). [See USP Controlied Room Temperature.] PROTECT FROM MOISTURE. Dispense in a well-closed container s defined in the USP/NF, with a chiesistant closure NDC 65507-501-10 100 Tablets RoxyBond™ @ (oxycodone hydrochloride) Tablets o, €D Manutactured for: Daiichi Sankyo, Inc Basking Ridge, M/ 07920 Daiichi-Sankyo TABLETS IDENTIFIED I0T/05 sum ) e (8) DONOT USE UNLESS TABLETS CARRY THIS DENTFICATION P1709964 —
2d0eca5d-fe5f-410b-991e-5e365c173703_906_2.jpg 50210|m 65597 Each tablet contains: Oxyoodone Hydmhloride, USP 15 mg* “15 g mycodone HC! is equivalent o 13.4mg of oxycodone. See package insertfor complete prescriing information. Store at 25°C (77°F) excursions are: permitied 1o 15°-30°C (59°-86°F), [See USP Contrlled Room Temperature PROTECT FROM MOISTURE. Dispense in a wellclosed container a5 defied in the USP/NF, with a chil-resistant closure. NDC 65597-502-10 100 Tablets RoxyBond™ @ (oxycodone hydrochloride) Tablets Rx Only @ Manufactured for: Daichi Sankyo, nc Basking Ridge, N 07920 o Daichi-Sankyo TABLETS IDENTIFIED IDT/0 15 (Side one) © 00 NOT USE UNLESS TABLETS CARRY THS IDENTIFICATION P1709965 —
2d0eca5d-fe5f-410b-991e-5e365c173703_906_3.jpg 5597 6 - Each tablet contains: Oxycodone Hydrochioride, USP 30 mg* *30 mg arycodone HCI i equivalent 269 mg of aycodone. ‘See package insertfor complete prescribing information. Store at 25°C (77°F) excursions are permitted to 15°-30°C (59°-86°F), [See USP Caontrlled Room Temperature ] PROTECT FROM MOISTURE. Dispense in a wel-closed container as defned in the USP/NF, with a chikd-resistant cosure. NDC 65597-503-10 100 Tablets RoxyBond™ @ (oxycodone hydrochloride) Tablets wowy €T Manufactured for: u Daichi Sankyo, . Basking Ridge, \J 07920 Daiichi-Sarkyo TABLETS IDENTIFED 107/0 30 O \Sutwn) D0 NOT USE UNLESS TABLETS CARRY THS IDENTIFICATION P1709966 ==
2d125ea4-5430-5b4e-e054-00144ff88e88_681_1.jpg (= R?“!Y DOSAGE and STORAGE=SEE PACIKAGEANSERT = 43063-661-90 43063-661-90 43063-661-90 FSCITALOPRAM ESCITALOPRAM ESCITALOPRAM usp usp usp 20 MG 20 MG 20 MG 90 TABLETS 80 TABLETS 90 TABLETS ReOrder # 109139 ReOrder # 109139 ReOrder # 109139 LoT Jji8ca3 LOT J118C23 LOT ji8ca3 EXP p2/20 (2424 02/20 EXP 02/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: ESCITALOPRAM OXALATE USP EQUIVALENT TO ESCITALOPRAM 20 MG e T TR O a8 T2 2 P A R T 1 ORGANOLEPTIC MARKINGS: WHITE ROUND/BREAKLINE NDC: 43063-661-90 1PHARMACEUTICALS {INCORPORATED?, B Oklahoma City, DK » 73127 ESCITALOPRAM USP 20 MG 90 TABLETS Ly (01)10343063661301 {21)118C23000001 (17) 200228 (10)118¢23 TOGT59ES0EVE R 0 YIONI ‘600 OBE A¥EVAIINHY QILIWIT SIVILNIIYINYYHA SYLNI T10DL106ZL9T
2d125ea4-5431-5b4e-e054-00144ff88e88_325_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALERTNESS. R TR G ST W IO T T “\DOSAGE and STORAGE: SEE PACKAGE INSERT: '43063-662-30 43063-662-30 43063-662-30 MECLIZINE MECLIZINE MECLIZINE HCLUSP HCL USP HCL USP 25 MG 25 MG 25 MG 30 TABLETS 30 TABLETS 30 TABLETS ReOrder # 109132 ReOrder # 109132 ReOrder # 109132 Lot F18E6GS5 LoT F18E65 LOT F18E65 EXP 01/20 EXP 01/20 EXP 01/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Cantains: MECLIZINE HYDROCHLORIDE USP 25 MG ORGANOLEPTIC MARKINGS: WHITE M MCZ 25 ROUND NDC: 43063-662-30 LA I . |PHARMACEUTICALS 4 Oklahoma City, OK = 73127 MECLIZINE HCL USP 25 MG 30 TABLETS i {01)10343063662304 (21)F18E65000002 (17) 200131 (10)F18E65 POEZIIEIOEVE R “INIWHYHY NYIAN LL9BYSBLEOD
2d167219-e6d1-653c-e054-00144ff88e88_774_1.jpg DO NOT ABRUPTLY STOP TAKING THIS MEDICATION WITHOUT FIRST CONSULTING YOUR DOCTOR. DO NOT CRUSH OR CHEW. ] WARNING KEEP THIS DUT OF THE REACH OF CHILDREN Ll DOSAGE and STORAGE SEE PACKAGE INSERT 43063-663-30 43063-663-30 43063-663-30 METOPROLOL METOPROLOL METOPROLOL SUCCINATE ER SUCCINATE ER SUCCINATE ER 50 MG 50 MG 50 MG 30 TABLETS 30 TABLETS 30 TABLETS ReOrder # 109145 ReOrder # 109145 ReOrder # 109145 LoT 118€33 Lot 118c3a3 LoT J18c33 EXP 03/20 EXP 03/20 EXP 03/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Eachi TABLET Contains: EXTENDED-RELEASE 47.5 MG METOPROLOL SUCCINATE EQUIVALENT TO 50 MG METOPROLOL TADTOATE LICR PR A Lo ORGANOLEPTIC MARKINGS: WHITE 831 ROUND 5CORED NDC: 43063-663-30 F[PD-Rx PHARMACEUTICALS - Okishoma City, 0K + 73127 METOPROLOL SUCCINATE ER 50 MG 30 TABLETS "'I'g:E (01)10343063663301 (21)118€33000002 (17)200331 (10)11833 TOEE99ESOEVE IR 1 O “INI 14 'SBYT SIAV.OY TOTEBOLEDZS
2d77412a-e084-4406-ac33-d882aece9354_308_1.jpg *Each film coated tablet contains: Quetiapine Fumarate, USP equivalent to Quetiapine 25 mg USUAL DOSAGE: See accompanying Prescribing Information. WARNING: As with all medications, keep out of the reach of children. Store at 25°C (77°F); excursions permitted 10 1510 30°C (59 to 86°F) [see USP]. Medication guide available at www.accordhealthcare.us/products. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No. : G/25/1883 NDC 16729-145-10 Quetiapine Tablets, USP Rx Only Attention Pharmacist: Dispense the enclosed Medication Guide to each patient. 30 Tablets INLO88 510897 1713908 N| 316729114510 7 Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 45X 22 mm (NI
2d77412a-e084-4406-ac33-d882aece9354_308_2.jpg “Each film coated tablet contains: Quetiapine Fumarate, USP equivalent to Quetiapine 50 mg USUAL DOSAGE: See accompanying Prescribing Information. WARNING: As with all medications, keep out of the reach of children. Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP]. Medication guide available at www.accordhealthcare.us/products Manufactured for: Accord Healthcare, Inc., Durham, NG 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No. : G/25/1883 NDC 16729-146-10 Quetiapine Tablets, USP Rx Only Attention Pharmacist: Dispense the enclosed Medication Guide to each patient. 30 Tablets N accord INL088 510898 1713915 N| 3lmM16729114610 4 Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 45X 22 mm M
2d77412a-e084-4406-ac33-d882aece9354_308_3.jpg “Each film coated tablet contains: Quetiapine Fumarate, USP equivalent to Quetiapine 100 mg USUAL DOSAGE: See accompanying Prescribing Information. WARNING: As with all medications, keep out of the reach of children. Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP]. Medication guide available at www.accordhealthcare.us/products Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No.: G/25/1883 NDC 16729-147-10 Quetiapine Tablets, USP Rx Only Attention Pharmacist: Dispense the enclosed Medication Guide to each patient. 30 Tablets I accord INLO88 510899 1713916 N 3167294710l Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 45X 22 mm
2d77412a-e084-4406-ac33-d882aece9354_308_4.jpg “Each film coated tablet contains: Quetiapine Fumarate, USP equivalent to Quetiapine 200 mg USUAL DOSAGE: See accompanying Prescribing Information. WARNING: As with all medications, keep out of the reach of children. Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP]. Medication guide available at www.accordhealthcare.us/products Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA Mfg. Lic. No.: G/25/1883 NDC 16729-148-10 Quetiapine Tablets, USP Rx Only Attention Pharmacist: Dispense the enclosed Medication Guide to each patient. 30 Tablets N accord INL088 510900 1713917 N| 3167291481018 Keep area blank & varnish free for overcoding Lot and EXP & Data matrix 45X 22 mm I
2d77412a-e084-4406-ac33-d882aece9354_308_5.jpg “Each film coated tablet contains NDC 16729-149-10 Quetiapine Fumarate, USP equivalent to Quetiapine 300 mg N USUAL DOSAGE: See accompanying Quetiapine e o Prescribing Information. 8 WARNING: As with all medications, Tahlets, USP = keep out of the reach of children. Store at 25°C (77°F); excursions - permitted to 15 to 30°C (59 to 86°F) [see USP]. E ov':fffd?rr‘egagl[ag‘rl‘( d& E‘Q,;’yg;:e"::{rix Medication guide available at €9 45X 22 mm www.accordhealthcare.us/products Rx Only ~ Manufactured for Attention Pharmacist: Dispense = Accord Healthcare, Inc., the enclosed Medication Guide & Durham, NG 27703. to each patient. = o Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213.INDIA 30 Takipts Mfg. Lic. No.: G/25/1883 I a rd Il
2d77412a-e084-4406-ac33-d882aece9354_308_6.jpg “Each film coated tablet contains: NDC 16729-1 50_1 0 Quetiapine Fumarate, USP equivalent to N Quetiapine 400 mg . = USUAL DOSAGE: See accompanying Quetlaplne 3 SRTe resT50To TN Prescribing Information. S WARNING: As with all medications, Tahlels, USP = keep out of the reach of children. - Store at 25°C (77°F); excursions = X permitted to 15 to 30°C (59 to 86°F) [see USP]. 400 'l > ov';fce(fd?rr‘zagta;':‘f‘&;'zsgaf::emf:‘rrix Medication guide available at 0 45X 22 mm www.accordhealthcare.us/products Rx Only ~ Manufactured for: Attention Pharmacist: Dispense the o Accord Healthcare, Inc., enclosed Medication Guide to each & Durham, NC 27703. patient. ,c_’ Manufactured by: e Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA 30 Tablets Mfg. Lic. No.: G/25/1883 o rd Il
2df937ad-a458-4030-bb7b-4468baa3685e_855_1.jpg (ww p x ww gg) +dx3 78 "107 Y10} Ay paysiuieAun 8y 18991 12101/ G/10-0Wd 10-810¢-01 1oy /0880 N ‘“ajemebpug 977 S80uBIISOIg [eauLY q paingLasiq 9/4/940Z/SUNIN/ZE ON"ONTBUN—"WIONI Ut epeN uaby 9ixoj01hg 319YNUNLIY LON 'suonnesaid PUB ‘8SN 10} SUON2AIIP ‘9fiesop ‘SUoRIIPUI 0} Jasul abexjoed pasojoua pesy :abiesoq [ensn Buw ot dSN ‘aunsNULIEY :SUIRUOI [BIA YoBT JuBl| wouj 1081014 “uoijeyBe Ly ainjesadwal WOOI O} [BIA Y} BuiuLiem Aq panjossipal aq Aew Ay} ‘paniasqo ale s[eishio | “asn o} Joud uonewoy [eishio 10} PAUILUEX8 8 PINOUS S[BIA PAIN}ASU0IEY (9% 01 69€) 008 0} o UONRIBBYE 18pun $1n0Y 7 10} 8|QEIS SI 43 ‘Uoa8ful Jof 8UISNULEO ‘PBPUSILIOIAI Se LoNNISU08] Jajy (3,9 01 .9¢) 9,8 01,2 1 HOLYHIDIYAIY Y/ NI FHOLS *SIauIRIU0 fupuey uaym sauny jje 1e SaA0j6 Jeap € N Carmustine for Injection, USP 100 mg/vial For Intravenous Infusion after Reconstitution L TN AT NDC 70121-1668-1 Single-dose Vial Discard Unused Portion.
2df937ad-a458-4030-bb7b-4468baa3685e_855_2.jpg (ww g} x ww zz) *dx3 3 1107 “10} a1y paysiuieAun 12l0L 1910-0Nd 00-8102-60 Ned /0880 N ‘1eyemelplig J71 saduaidsolg |eauwny “Aq panguisiq YIONI * L0£60G euebueja] P11 "nd Abojoouq jeauwy :Aq paimoejnue| 9/4/9102/SLNIN/ZE "ON 91 ‘BYIA "(4o9 01,9€) 9,8 0} ,Z 10 401v43914434 V NI FHOLS "LHISNI J9Y)IVd G3S0TINI avad Rx only - Sterile Diluent for Carmustine usP for Injection, Injection, USP NDC 70121 3639 Dehydrated Alcohol
2df937ad-a458-4030-bb7b-4468baa3685e_855_3.jpg Y 0N S B (3 10T NILD thia Buoje apoaleq gz 10j ealy paysiweaun I NDC 70121-1482-2 Carmustine for Injection, USP 00 mg/ vial Each carton contains: 1 vial Carmustine for Injection USP, 100 mg and 1 vial Sterle Diluent for Carmustine for Injection, USP, 3 mL. For intravenous infusion after reconstitution REFRIGERATE IMMEDIATELY Discard Unused Portion Cytotoxic Agent Wear gloves at all times when handiing containers. STORE IN A REFRIGERATOR at 2° to 8°C (36° to 46°F). First, dissolve carmustine for injection, USP with 3 mL of the sl diluent supplied. Second, asepticall add 27 mL Sterile Water for Injection, USP. Each mL of resulting solution contains 3.3 mg of carmustine, USP in 10% ethanol. After reconstitution as recommended, camustine for njection, USP is stable for 24 hours under refrigeration 2°10 8°C (36° to 46°F) Reconsttuted vials shotid be examined for crystalformation prior o use. I crystals are observed, they may be redissolved by warming the vial to room temperature with agtation. Protect from light. Single-dose Vial Rx only NDC 70121-1482-2 Carmustine for Injection, USP 00 mg/vial Each carton contains: 1 vial Carmustine for Injection USP, 100 mg and 1 vial Sterle Diluent for Carmustine for Injection, USP, 3 mL. For intravenous infusion after reconstitution REFRIGERATE IMMEDIATE! Discard Unused Portion Cytotoxic Agent Single-dose Vial Rx only Usuial Dosage: Read enclosed package Insert for indications, dosage, directions for use, and precautions, NOT RETURNABLE Mfg. Lic. No. 32/MN/TS/2016/F/G Manufactured by: Amneal Oncology P Ltd. Telangana 500301, INDIA Distributed by: Amneal Biosciences LLC Bridgewater, NJ 08807 Rev. 09-2018-00 PM0-0158 |7 14822 7u12| 5
2e0570e7-d28f-4936-cba8-81ee0c4c3547_705_1.jpg _'gncfm‘ NDC 0409-1843-14 mL Levophed” nompinepmine bitartrate ISy 4 mg/4 mL (1 mg/mL) L [Each mL contains norepinephrine bitartrate equal to 1 mg norepinephrine base. [FOR INTRAVENOUS INFUSION JONLY. DILUTE BEFORE USE. PROTECT FROM LIGHT. Hospira, Inc. Lake Forest, IL 60045 USA
2e0570e7-d28f-4936-cba8-81ee0c4c3547_705_2.jpg socicorocat o) on 330 o b M on by i gpgoniny 45019551 tt 11912, Q07 a0 Jhaydona] 7 v s 10X 4 mLAmpuls STERILE INJECTION NDC 0408-1443.04 Levophed™ - norepinephrine bitartrate injection, USP 4 mg/4 mL (1 mg/mL) == Waring: Thiis s ot drup.Desage houd b consalle b Fraqunt dtaminsion o o Do Pt et g SmSsion. Avd S osehon FesdpeCHS FOR INTRAVENOUS WFUSION ONLY. DILUTE GEFORE USE, DISCARD UNUSED PORTION. D0 ot s e slton i clri ik rdrrtan sty ysloneor o R o ¢ et i oract i s, ks of G gt Levophed™ et ocon, 57 ” Wmg/ mL (1 mg/mL) Hoba
2ecea1ab-66c8-4eb0-8503-6d6b41b51328_997_1.jpg Single dose bottle - For oral use only For use in single contrast radiographic studies of the esophagus, stomach and small bowel in adult and pediatric patients. See prescribing information for complete dosage and administration information. Store at USP controlled room temperature, 20 to 25°C (68 to 77°F). Protect from freezing. SHAKE WELL PRIOR TO USE, THIS PRODUCT MUST BE FULLY SUSPENDED. DO NOT USE IF INNER SEAL 1S BROKEN OR MISSING rev.11/17 cinepo2 | | sracco | Bracco Diagnostics | 355 ml NDC 32909-186-02 Liquid E-Z-PAQUE’ (BARIUM SULFATE) ORAL SUSPENSION (60% w/v) YT L3201 Manufactured by ey Monroe Twp, Njogs31 Each 100 mL contains 60 g barium sulfate and the following inactive ingredients: Carboxymethyl cellulose sodium, itric acid, natural and artficial strawberry lemon cream flavor, polysorbate 80, potassium sorbate, purified water, saccharin sodium, simethicone emulsion, sodium benzoate, sodium citrate, sorbitol solution, xanthan gum. = - =: q =: - == n =: @ — A =: < = = =
2ecea1ab-66c8-4eb0-8503-6d6b41b51328_997_2.jpg NDC 32909-186-02 24 x 355 mL s-(nc\do Bracco Diagnostics Liquid E-Z-PAQUE" = (BARIUM SULFATE) ORAL SUSPENSION, (60% w/v) Single dose bottle For oral use onl For use in single contrast radiographic examinations of the esophagus, stomach and small bowel in adult and pediatric patients. Usual dosage: See prescribing information Each 100 mL contains 60 g barium sulfate and the following Ty citric acid, natural and artificial strawberry lemon cream flavo sorbate 80, potassium sorbate, purified saccharin sodium, simethicone emulsion, sodium benzoate, ate, sorbitol solution, xanthan gu Store at USP controlled room temperature, 2010 25°C (68 to 77°F) Protect from freezing Rx only Manufactured by E-Z-EM Canada Inc, EXP. Anjou, Quebec H112Z4, Canada for Bracco Diagnosiics Inc. Monroe Twp., NJ 08831 RO AR i CEDCCO2 % (01)30332909186020 rev. 06/18
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_1.jpg NDC 49884-054-01 Imipramine Hydrochloride Tablets, USP 10 mg PHARMACIST. PLEASE DISPENSE [WITH MEDICATION GIIDE. Rxonly 100 Tablets PAR Each tablet contains: Irmipranine HCI, USP ....... 10 mg USUAL DOSAGE: Read Accornpanying Literature KEEP THIS AND ALL DRUGS ‘OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15° to 25°C {59°to 77°F). LADB4-01-1-12 RO1/16 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 ) — — — L — < ——— o < @ — O =32 i~ = s
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_2.jpg NDC 49834-054-10 Imipramine Hydrochloride Tablets, USP 10 mg PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE. Rx anly 1000 Tablets IPAR Each tablet contains: Imipramine HCI, USP 10 my USUAL DOSAGE: Read Accompanying Literature. KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15° to 25°C {59° to 77°F). LAOB4-10-1-13 RO1/16 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 9884-054-105s i
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_3.jpg NDC 49884-055-01 Imipramine Hydrochloride Tablets, USP 25 mg PHARMACIST. PLEASE DISPENSE [WITH MEDICATION GUIDE. Rxonly 100 Tablets IPAR Each tablet contains: Irnipramine HCI, USP...... 25 mg USUAL DOSAGE: Read Accomnpanying Literature KEEP THIS AND ALL DRUGS ‘OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15° to 25°C {59°to 77°F). LAOBB-01-1-17 RO1/16 i B T 2 2 8 5 = g = ~ = _5 g< B s 8= g 3 Ex Sic <4 £3 Tz 5 &g 2 5 -055-011 2 3 49884 N
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_4.jpg NDC 49834-055-10 Imipramine Hydrochloride Tablets, USP 25mg PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE. Rx anly 1000 Tablets IPAR Each tablet contains: Imipramine HCI, USP 25 mg USUAL DOSAGE: Read Accompanying Literature. KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15° to 25°C {59° to 77°F). LAOBE-10-1-12 RO1/16 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 i © O i s} 0 O < D0 D0 [} <t © z &
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_5.jpg NDC 49884-056-01 Imipramine Hydrochloride Tablets, USP 50 mg PHARMACIST. PLEASE DISPENSE [WITH MEDICATION GUIDE. Rxonly 100 Tablets Each tablet contains: Imipramine HCI, USP" .. 50 mg USUAL DOSAGE: Read Accompanying Literature KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15° to 25°C (59°to 77°F). LADB6-01-1-15 R01/16 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 9884-056-01s8
2f7d5e7f-79aa-4f3a-b9a6-758d9f3ce74d_589_6.jpg NDC_49884-05(_5-10 Imipramine Hydrochloride Tablets, USP 50 mg PHARMACIST: PLEASE DISPENSE 'WITH MEDICATION GUIDE Rx only 1000 Tablets IPAR Each tablet contains: Imipramine HCI, USP 50 mg USUAL DOSAGE: Read Accompanying Literature KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN. Dispense in a tight, light-resistant container as defined in the USP. Store between 15 to 25°C {59° to 77°F). LAOB6-10-1-13 RO1/16 Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977 3 49884-056-100
2faca72c-be66-4d90-9cef-3ef79927723b_719_1.jpg GTIN: 00 Lot 000k Exp.: MMMYY 1 SR. No - 0000000000 Over Coding Template No Vamished Area (Do Not Prinf) (1841 mm) 000000000000 NDC 70710-1537-3 P Duloxetine Delayed-release Capsules, USP 30 Capsules Rx only Each delayed-release capsule contains 224 mg of duloxefine hydrochloride, USP equivalent to dulovefine .20 mg Usual Dosage: See package insert for complete prescribing information Store at 20°to 25°C (68° to 77°F) [See USP Controled Room Temperature] Dispense in a ight container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadia Healthcare Ltd. Ahmedabad, India Distributed by: 2Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 S0 MY
2faca72c-be66-4d90-9cef-3ef79927723b_719_2.jpg Exp: MMMYY SR. No - 00000000000000000000 Over Coding Template No Vamished Area (Do Not Print) (1841 mm) A S Du |°xeti he Each delayed-release capsule contains 337 mg of duloxefine hydrochloride, USP eqivalent to dulovetine .30 g Delayed-release usvose: sepocae neet for complete prescribing information Capsules’ USP Store at20° b 25° (8 1 77°F) [See USP Controlled Room Temperature] Dispense in a ight container. KEEP THIS AND ALL DRUGS OUT 30 mg - OF THE REACH OF CHILDREN. Manufactured by: 2 Cadia Healthcare Ltd. g provided separately to each patient. i : 30 Capsules Distributedby: dus Ph: uticals (USA) Inc. 4 2ydus Ruonly s Plammoniic UeA s
2faca72c-be66-4d90-9cef-3ef79927723b_719_3.jpg GT1N : 0000000000000 Lot xo000x Exp: MMMIYY 00000000000000000 Over Coding Template No Vamished Area (Do Not Print) (1841 mm) LRSSy Du loxeti he Each delayed-release capsule contains 67.3 mg of duloxetine hydrochioride, USP eqivalent o duloxetine _.._60 mg Delayed-release UsialDosge:So acage et for complete presciibing information. Cap5u|es’ USP Store at 20°t 25° (58°to 77°F) [See USP Controlled Room Temperature] Dispense in a fight container. * ) KEEP THIS AND ALL DRUGS OUT (O THE REACH OF CHILDREN. Manufactured by: PHARMACIST Caia Healthcare Ltd Provided sepakely bo oaoh Ahmedabad, India Distributed by: 30.Capsules ey Phamoculcls (USA) Ine. 773 zydus Rxonly Pomingion N 06634 [60mg g0 ey
2fb017fd-e55e-43ef-9024-07f2d412b37b_109_1.jpg ONE-VIAL FORMULATION Each L contains: 10 mg dcetaelantyirous SP, 260 mg plsortae 80, 4 mg anhydous citic aig, 25% i aloool USP equialert 0 2208% vy absout sl 5 ‘i pletyere gheol 00 Ready o addtonfusion solution. Usual Dosage: See package et fordosage nfomaton, diectons fo v and hending, Retainn oiginal package to protect from lght Store beween 20° 0 25°C (88° to 7). [See USP Controlled Room Temperature] Aftr first use, Docetaxel ljecton, USP mul-dose vials are stabl for P 1028 days when stored belween2* and 5% (3 and 46°7) and protected fomlight. Warning: Keep out ofreach of chidren. [ T gjSwQ9L ] B CITR LIS ET NDC 67457-533-16 Docetaxel [T T 160 mg/16 mL NDC 67457-533-1 Docetaxel ect;on LI5S For Intravenous oo/ Infusion Only Infusion Only. READY TO ADD TO 'READY TO ADD TO & INFUSION SOLUTION INFUSIONSOLUTION | % Caution: Cytotoxic Agent Caution: Cytotoxic Agent | ™~ Check concentration Mylan Institutional LLC Check concentration prior to preparation. Rockiord, L6103 USA See insert Compisie Hetructons. Mane e o ot o KRDRUGSKT 23812008 [MMylan®, [MMylan* (R e NO VARNISH ZONE iy o e sy Lo exe: TIN: OO0 /OO0 @ D e ooy n i
2fd1831a-248d-4adc-8375-a08969d181e2_224_1.jpg ONE-VIAL FORMULATION Each L contains: 10 mg dcetaelantyirous SP, 260 mg plsortae 80, 4 mg anhydous citic aig, 25% i aloool USP equialert 0 2208% vy absout sl 5 ‘i pletyere gheol 00 Ready o addtonfusion solution. Usual Dosage: See package et fordosage nfomaton, diectons fo v and hending, Retainn oiginal package to protect from lght Store beween 20° 0 25°C (88° to 7). [See USP Controlled Room Temperature] Aftr first use, Docetaxel ljecton, USP mul-dose vials are stabl for P 1028 days when stored belween2* and 5% (3 and 46°7) and protected fomlight. Warning: Keep out ofreach of chidren. [ T gjSwQ9L ] B CITR LIS ET NDC 67457-533-16 Docetaxel [T T 160 mg/16 mL NDC 67457-533-1 Docetaxel ect;on LI5S For Intravenous oo/ Infusion Only Infusion Only. READY TO ADD TO 'READY TO ADD TO & INFUSION SOLUTION INFUSIONSOLUTION | % Caution: Cytotoxic Agent Caution: Cytotoxic Agent | ™~ Check concentration Mylan Institutional LLC Check concentration prior to preparation. Rockiord, L6103 USA See insert Compisie Hetructons. Mane e o ot o KRDRUGSKT 23812008 [MMylan®, [MMylan* (R e NO VARNISH ZONE iy o e sy Lo exe: TIN: OO0 /OO0 @ D e ooy n i
30a602e9-495e-43ae-a4ea-acb564540b25_69_1.jpg Each tablet contains 7.265 mg of rizatriptan benzoate, USP equivalent to 5 mg of rizatriptan. Usual Dosage: See accompanying prescribing information. Keep this and all medication out of [See USP Controlled Room Temperature.] Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.SA. Made in India @Mylanﬁ | Myl Ganms RMX1403€S1 Rx only NDC 0378-1403-96 [Mylan® the reach of children. : Store at 20° to 25°C (68° to 77°F). Tablets, USP RPAELE G 3 0378-1403-96 2 Dispense in a tight,light-resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Code No.: MH/DRUGS/25/NKD/89 GTIN COOOOOOOY OO EXPMTYYY LOT Xronn 75059579
30a602e9-495e-43ae-a4ea-acb564540b25_69_2.jpg Each tblt on DL nOC 0073-1404-96 ||||H| ‘" ‘ ‘equivalent to 10 mg of rizatriptan. R = = ol Dosage izatriptan o Pt o el P Y aTe400m56 ' Keep this and all medication out of Be NZO at e Dispense in a tight, fight-resistant 75059580 the reach of children. container as defned inthe USP soe a2 w2sc e, 1ablets, USP 6842 ot e [See USP Controlled Room Keep container tightly closed. Temperature] m Coce Mo MHDRUGS 25NKD/8 Wanufacturd fo 5 Myan Pharmacautcalslne. 3 Morgantoun, WV 26505 USA. £ Made in india g [MMylan g SN Tononone MMylar® | v PP
30bdf2ea-008b-4cbb-81e4-c3474f2ad286_363_1.jpg [ N 1A 32d sypu) [euOpETITT 000°0T e T e e T e ] “ | SZeumg | lwayjuesAiyo eumig eseuibesedse | | | SO6VTL6LS DN, mAs | SV NDCSTS24505 | Dyersd dmto: e |5 Vit NDC 57902:249.05 asparaginase Erwinia chrysanthemi s reocien et asparaginase Erwinia chrysanthemi | (Sumdem o050 mg. Erwinaze® Erwinaze® [ ——— L e e R m ﬂﬂmlulml L e e e g e e 10,000 International Units per Vial 3 » 10,000 International Units per Vial ReOnly Single Use Vil Discard used porton Nt RxOnly Single Use Vial Discard umsd poron [ Qs | oo
30e8eeef-12ee-4389-b285-03ea81e1b163_982_1.jpg Pashaged by Eryane Reanch Babank. €4 91504 Ondansetron § " Rouoszs 4mg (ODT) 10 996811 Store at room temp of Compare To: 20°25°C (68°77°F) Zofan dmg ODT Bister Pck “Keop all drugs outof Pt reach of children. #30 Exp: MMYY NDC 7133508311 075131118966 om
3101d4c6-109c-4720-96bd-988357d7de66_49_1.jpg OXYGEN, COMPRESSED USP UN 1072 DANGER: MAY CAUSE OR INTENSIFY FIRE, OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED, 0 nothandie e sfety prcautions hve b e andundersiood. Keepsndsoe away fom cohngsnd thercombustiemters Keep s s it 1 fom € nd s and s oy oors o el ventoted pace In o of . 1o e st to 6o Us a ck owprsertie device 1 h ppng,Usc oy with squmet of compatle it of construcion nd atd forder s s oy it cauprent ceaned o cygen service.Open e ol Close Ve afer o i s nen mpty Pt fom s e st Exceds 52°C(125°F)Resdand olow th Sty OnaSht 4 P CASNO: T782-447 DONOT REMOVE T PRODUCT LABEL Contenis | _size Tialters | O M4 WARNING.or cmegencyus nly when e e o by proery e pesonnefor ygendeiency sndsciaton. for sl ther el sppicston, Re o, | 255 Liters | 0 C Uninegted e of ghconcenusvonsofgencws a5 Urers | 3 D Ao i b oo e e et witost oy e bt St aptto | 880 Uters | 1 E e s e g i et = el sadomtin ool U B ety Representative Labeling pursuant to 21 CFR 207.3 (10) Company name and contact information are printed in this box
310ce005-5a24-489a-b23c-d42ab6a3bfed_216_1.jpg NDC 68382-204-01 P Gabapentin e —— Tablets, USP oo compets presrbing momatan, Storest 20 025° (58 0 7). Eamee y @D v o T i Ere s [PHARMACIST: Dispense the Medicaton Gude| Y SUARI: PR e CasiaFeathoar L Ahmsdakad, i 100 TABLETS Dubuaty 73 zydus Rxonly Fongm o poey [
310ce005-5a24-489a-b23c-d42ab6a3bfed_216_2.jpg NDC 68382-205-01 pe— Gabapentin .. . Tablets, USP mion .. O — = kg sl o i e = Szt @) = e 1 71 ‘Dispense in a ight container. S ] 800 m |0 csesenasn = Keee s D AL oo 0T = ErenoF e, [PRARVACIST, Daperc e Nedton Gt Code N GLIDRUG45S Providd Sepotdly s exchPater. Manutsctusd by: CadisFeathoart L Anmsdsbad, i 100 TABLETS Jirbutsdty 7 2ydus Rxonly Fewngm o nosey e
314b1dab-8f4f-49ae-a105-f974842818b8_241_1.jpg NDC 54288-105-01 g L105L-01 R-1806 VLUV S _o Dehydrated Alcohol BERSRZR: = Injection, USP % %‘/% Sy o gm Imlof=9%by SR SEE . =% volume ethylalcohol i“fg %’ 85 = For Cardiac Septal Branch s = ?g & =w Intra-Arterial Use. G %‘ﬁ cEgs 5 =, Single Dose Ampule E 3 E\f—og = ROy Disardunusedporion = &£ 3= 68400 01
314b1dab-8f4f-49ae-a105-f974842818b8_241_2.jpg L105L-02 R-1806 D[Rzl R (VR Ablysinol Dehydrated Alcohol 1L T 5mLof>99%byvolume ethylalcohol For Cardiac Septal Branch Intra-Arterial Use. s I & f=1 &= 8 BJ < e L S S | g 3 X 2 o 3 S B m (==} = T = 5 £ = = = & £ 8 ar = 8 = e 5 = = = = = é g & 2 3 2 =, o = S 2 S £ s = WARNING: Donotuseifdiscolored or = =B = S S = s Single Dose Ampule Discard unused portion ROy EXP Lot 68401 01
314b1dab-8f4f-49ae-a105-f974842818b8_241_3.jpg seomoopay TTEVNNYTS ATHOIH sandwe asop-ajbuis ‘“Jw g ua) suleuo) sy pamoEan dsn ‘uonoafuj joyody paiespAyeqg I Ablysinol Dehydrated Alcohol Injection, USP For Cardiac Septal Branch Usual Dose: See prescribing information. Intra-Arterial Use. Store away from any heat source I Each mL contains: L105C-15 NDC 54288-105-15 >99% by volume ethyl alcohol (a sterile, preservative free solution) WARNING: Do not use if discolored or ipitated. E Contains ten 5 mL, single-dose ampules Lot i HIGHLY FLAMMABLE Rets06 EXP E __________________ £ Contains ten 5 mL, single-dose ampules gg’,’]';‘b;fr“’g;‘é“ C 102G e 0Tk Sl s %
31aeab13-8f71-49f1-b101-8b0abb21b0dc_924_1.jpg Pachaged by Eopant Reech Bnbank, €4 9050 Spironolactone G " fouo aiss 100mg Tablet 10 z8ever Follow Doctors Compare To: Instructions Adacbne 100mg Tabket "Store atroom tempof | rent PP 20°25°C (68°T1°F) #100 Exp: MMYY NDC 7133509661 040941124282 om
31c80f84-0169-4659-b9cf-8f897ed319eb_692_1.jpg ‘uolewloyul Buiquosaid 1IN} 10} pasino abexoed eeg « o @ Z .3 g 3 N: " or 0 g O o o — [ © £ g s 5 5 = o 3 o0 S > : Lo g g e & =z Each tablet contains: Fenofibric acid .. ...35mg Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature] DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER. Manufactured for: Aralez Pharmaceuticals US Inc., Princeton, NJ 08540 Tablet debossed: AR 787 Revised 12/2017
31c80f84-0169-4659-b9cf-8f897ed319eb_692_2.jpg r____ommor /% €0 /s | ‘uoleuuojul buiquosaid 1INy 4oy pesino abesjoed sag 30 TABLETS FIBRICOR"® (fenofibric acid) Tablets IDC 70347-105-30 L only NI Each tablet contains: Fenofibric acid ... 105 mg Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature] DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER. Manufactured for: Aralez Pharmaceuticals US Inc., Princeton, NJ 08540 Tablet debossed: AR 788 Revised 12/2017 )
32388e18-08de-455c-aad4-9c2264435f0f_867_1.jpg NDC68220-112-10 Levsin’tblets (hyoscyamine sulfate tablets USP) 0.125mg Rxonly ALNEN 100ubies For medicalinquiries call1-888-317-0001 TV XXy SN X000 EXPADIYYYY LOT XXonny Each tablet contains 0125 ma hyoscyamine sulfate US. USUAL DOSAGE See paclage et frfull prescrbing nformition Dispense i ight ightresistant containers 3 deinedin USPAI wht chld s tant costre Store at cotrolled oom temperatre 20 25°C 68" 7Ry e xcrions permied & 15+ 30°C (55 86 Flesa et 0 curentUSF Mg for: Aven PhamacautiaLc ety Neers, Ry IS npracon 40064407 Revo42017
326c83fc-afed-45ad-9c87-f47968fa1d2a_943_1.jpg Distributed By: Larken Laboratories, Inc. Canton, MS 39046 400744-08 Rev. 10/2017 NDC 68047-721-01 Rx only LARKEA 100 tablets Each tablet contal Butalbital, USP* .,50mg Acetaminophen, USP 325mg “WARNING: May be hebit-forming. USUAL DOSAGE: ORAL: Ori o two tablets every four hours as needed . Do not excesd 6 tablets per day. Ses package insert for full prescribing information. 'WARNING: Kesp this and all drugs out of the reach of children. Pharmacist: Dispense In a tiht, light-resistant container with achid-resistant closure. ‘Storage: Protect from light and moisturs. Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°). Dispenss ina tight container as defined in the USP.
326c83fc-afed-45ad-9c87-f47968fa1d2a_943_2.jpg Distributed By: Larken Laboratories, Inc. Canton, MS 39046 400745-04 Rev. 10/2017 NDC 68047-722-01 100 tablets Butalbital and Acetaminophen Tablets 25mg/325mg Rx only LABORXTORIES Each tablet contains: Butabbital, USP* 25mg Acetaminophen, USP 325mg "WARNING: Ma)y be habit-forming. USUAL DOSAGE: ORAL: Two tablets every four hours. Total Dally dosage should not exceed 12 tablets. See package insert for ful prescribing information. oop this and all drugs out of the reach of children. : Dispense in a tight,light-resistant container with ‘achid-resistant closure. Storage: Protect from light and moisturs. Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F). Dispense In a tight container as defined in the USP.
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_1.jpg dx3 1071 2062211 = _ “Bujudo JoYe UOW | UM SWeCD esn WG WOl 1981014 “(H:9 01 o9€) 3.8 0} o2 1e Pajesabiijel 8105 — Rxonly NDC 0008-1030-04 E . S8 o £ B £ =g i: 2 Y - 3 = m = mmm 2 = £ £ ze2 tT EoEPpN. & S SE=allze st : SESER:i| T S—t4d — B e S5iis _m © = eSSt 5§83 2 2 @ _.m,m‘.mmpm — 60mL _uam»mm AND USE: See accompanying prescribing Information. Keep out of reach of children. Distributed by |Wyeth Pharmaceuticals Inc MADE IN CANADA| A subsldiary of Pfizer Inc _ Philadelphia, PA 19101 \ €01)00300081030041 _/
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_10.jpg DOSAGE AND USE: See accompanying prescribing Informaon Store at room temperature, 2°C1025°C (8°Fto T7°F). [See USP Controlled Room Temperature.] Dispense In tight (USP), ight-resistant (USP), and child-resistant containers. Distrbuted by Wyeth Pharmaceuticals Inc Asubsidiary of Pizer Inc Philadelphia, PA 19101 MADE IN JAPAN FPO UPC 80% x 5.5 mm 0008-1042-05 1 ALWAYS DISPENSE WITH MEDICATION GUIDE NDC 0008-1042-05 Rapamune® (sirolimus) Tablets For oral use only. 100 Tablets Rx only GTIN: 00300081042051 LOT:/EXP: PAAD63671
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_2.jpg vy o INIHdNI 10 @ Ao oo | DOSAGE AND USE: @ s Ses accompanying prescrbing nformation. © © © Rapamune Rapamune Rapamune eop ataf rach of i, (slrohmus_) (slrollmus_) (slrohmus_) Shors o a2 5 Oral Solution Oral Solution Oral Solution B6° 0 46°F). Ty PROTECT ROMLIAT. Use contents of bottle within { month afte opening. For oral use only. Eah mLof MPAMLNE conis 1 mg siolimus 15%25% ethmol Ao contans a st of eyl bl andphsphatcychoine derved ram sy et nd ot componensand poyrtats 20 Disibutd by Viyeh Pramicaica ho A subsitiay of Pzernc Phiadelphia, P 19101 a0 tote amLbate Roonly | S0nLbotie MADEIN CaNADA 13123003 il
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_3.jpg ©) 30 amber oral syringes and 30 caps for daly dosing (sirolimus) ) 1 carying case . Also contains: Package Insert and Medication Guide Oral Solution You il isoneed: * glass or plastic cup ALWAYS DISPENSE WITH MEDICATION GUIDE 60 mL Patnt Kt 4 Each Rapamune Oral Solution carton contalns: w DG 0008-1030-06 @) A2.0z. (80 mL 1) amber glass botl of sirolimus Rapamune® (concentration of 1 mo/mL) P Rapamune® b) 1 oral syringe adapte or fitng ntothe neckofthe (sirolimus) atll Oral Solution ? | ! ! ! | ! ! | ! ! ! | 1 1) 1) L 60z of water or orange juice only | store rerigerated at | 2087 6" to 46, i i | i i i i i i i i i i PROTECT FROM LIGHT Use contents of botte \ A within 1 month after For oral use only. = opening. Each mLof RAPAMUNE contins 1 mg sirlimus e 1.5%-25% dthancl 210l Aiso contains a miursof propyens ayool and [ 1 phosphticyichaline derved from soy lecitn (and ot Tl componerts)and poysorbate 0. 60 mL Patient Kit Rxonly 4 0o0s-1030-06" 5 oy A 2 VIHY LNIHAE Hnios |81 (smuyous) JLsunwedey e Instructions for Use for RAPAMUNE® (sirolimus) Oral Solution 1 2 Ottt s oy tp Thfitine s ol sl Ui aran g anba ek Wik b anbt o g By G WG S R ot v e s Fgumus DSt a0 S, oyl gk pagctne T T R PALk ek s ) Do e o smns oo o bl Tk 904 3 U 0 o b Do o s e T, ) R ORI S A i sk cn RS btk e, s e i ke rmi sy gy o ke iyt 5 st 5 7 8 i ezt R, e e SRR bl = S o e T BRI, IR B S e il o e e e 1 0 eitn s s rd S T s st b iy et Distbued by ey s Wyeth rarmaceuticals e A suhsidary of Pz I Phiadeiphia PA 10101 WADE I CANADA 2005804 60 mL Patiert Kit (sirolimus) Oral Solution DOSAGE AND U See accompanying prescrting nformation. Refer 0 back of bax for Inetructons for Use for RAPAMUNE (sroimus) oral Sohution Keep out of reach of chidren.
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_4.jpg DOSAGE AND USE: See accompanying prescribing nformaton Store at room temperature, 2°C1025°C (8°Fto T7°F), [See USP Controlled Room Temperature.] Dispense In ight (USP), ight-resistant (USP), and child-resistant containers. Distrbuted by Wyeth Pharmaceuticals Inc Asubsidiary of Pizer Inc Philadelphia, PA 19101 MADE IN JAPAN £ E 0 s = s 8 © g S ° a o 0008-1040-05 7 ALWAYS DISPENSE WITH MEDICATION GUIDE NDC 0008-1040-05 Rapamune® (sirolimus) Tablets For oral use only. 100 Tablets Rx only ~ o S =3 3 o S S S = o S = = o PAAD63672
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_5.jpg 5 BLLELOWd L0161 Vd ‘Bl 5= g‘ o 1402 10 qnS b ek S0 018! 1oy0eL (Snuorss) NDC 0008-1040-10. Rapamune (sirolimus) Tabfet 0.5 mg Wyeth Sub of Pfizer | Phila, PA19101\2 2 PAAO73118 - BLLELOWd 10161 Vd Bllud 1162 J0 an§ b yakm . JoydeL (Snuors) 5 2= S0 8HLELOWd 10161 Vd Ellud 11102 J0 Qg UeAm S0 (10) 81LEL0Wd 10161 Vd ‘Blud 16244 0 Gng uekm. bw g0 10181 (Snuionts) aunwedey —01-0v01-8000 9N SHLEOWd 10161 Vd Bl ul 102 10 Qg ek bw g0 JoigeL Snuors) wedey <= @ 0L -8000 9N PAAO73118 N | NDC 0008-1040-10 Rapargq?me/@’ § (sirolimus) Tablet 0.5 mg Sub of Pfizer Ir Wyeth Phila, PA 19101 PAAO73118 NDC 0008-1040-10. Rapamune (sirolimus) T -0 Mg Wyeth S ofPrizer Phila, PA19101\25 & PAAO73118 g 0.5 S Sub of Pfizer I Phila, PA19101 PAA073118 NDC 0008-1040-10 Rapamune® (sirolimus) Tablet 0.5 mg Wyeth Sub of Pfizer | Phila, PA19101\ = A 0 «
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_6.jpg Lotorois000Emn 1 ALWAYS DISPENSE WITH MEDICATION GUIDE @ oo | Rapamune® | Rapamune® (sirolimus) Tablets | (sirolimus) Tablets For oral use only. Unit Dose - 100 Tablete Unit Dose - 100 Tablets (10 Bister Gards of 10 Talets Each) Rxonly | (10 Biser Cards of 10 Tablets Each) (w3 oL om0 e 01) o 004 - meq i sje|qe] (snwijoais) Lunwedey @ DOSAGE D USE: See aompamyig presnbng nfomaton. i oS T e e @ e s Tt die pckageis ot il st 1 ispansd foroutatert use, a chi-resisrt ortiner bttt i Rapamune® sttty (sirolimus) Tablets Wyeth ramacoutcas e Aubsitiny d Pizeroc iladepi,PA 16101 MADE W Pl . ”I“ ‘” ||‘|Iu|’ Unit Doss - 100 Tablets $70008-1040-10 1 (10 Blister Cards of 10 Tablets Each) PRADOGRO0
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_7.jpg DOSAGE AND USE: See accompanying prescribing nformaon Store at room temperature, 2°C1025°C (8°FtoT7°F). [See USP Controlled Room Temperature.] Dispense In ight (USP), ight-resistant (USP), and child-resistant containers. Distrbuted by Wyeth Pharmaceuticals Inc Asubsidiary of Pizer Inc Philadelphia, PA 19101 MADE IN JAPAN £ £ © I = s 8 © 2 5 o a o ALWAYS DISPENSE WITH MEDICATION GUIDE @ NDC 0008-1041-05 Rapamune® (sirolimus) Tablets For oral use only. 100 Tablets Rx only < o = 3 o S S S = o S = e o a > - S S PAAD63670
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_8.jpg ekm. B 1oiGeL (snwiors) eoUhwedey 01-1¥04-8000 0N 180980Wd 10161 Vd ‘Blilud 1024410 ang \ wekm. Bw | 19yeL (Snuwijolts) sunwedey 701-8000 OON = 180980Wd L0161 Vd ‘Bllud 5 = > “ujiezyd jo ng ekm. 21 (snwijons) sounwedey 01-1¥04-8000 OAN g 180980Wd 2 2\ 10161 vd Bl 1402l 10 qnS eAm . Bw | 1. (snwions) < 180980Wd 5\_\;{);5;\@ “eld 1162y Jo an§ wekm. b w | 1. (snwors) 4 i ™\ 180980Wd | NDC 0008-104 < 2 3\10161 vd ‘Blud 1167 J0 an§ Rapamune® (s\mhmus” t Wyath Sub of Pfizer In Phila, PA19101 3% ; PAA0B6081 = NDC 0008-1041-10 Rapamune (sirolimus) Tablet Wyeth Sub of Pfizer | Phila, PA19101 N2 2 PAAOBE0BT g NDC 0008-1041- 10 Rapam (s\mhmus}T e( Wyelh Sub of Pfizer | Phila, PA 19101 PAAOBG0BT = = x NDC 0008-1041-10. Rapamune® & (sirolimus) Tablet 1 m Wyeth 9 Sub of Pfizer | Phila, PA19101 N2 2 PAA0BG0BT g NDC 0008-1041-10. Rapamune® = (sirolimus) Tablet 105 Wyeth Sub of Pfizer | Phila, PA 1910135 PAA0BG0BT = > = g S 5==c
3275b824-3f82-4151-2ab2-0036a9ba0acc_130_9.jpg ALWAYS DISPENSE WITH MEDICATION GUIDE @ NDC 0008-1041-10 @ Rapamune® | Rapamune® (sirolimus) Tablets | (sirolimus) Tablets For oral use only. Unit Dose - 100 Tablete Unit Dose - 100 Tablets (10 Bister Gards of 10 Talets Each) Rxonly | (10 Biser Cards of 10 Tablets Each) \ / o =] M/ A e (oL 0 o) s 01) v 004 - weq s19|qeL (snwijous) gaumuedg_-: /ﬁ\ DOSAGE D USE: See azompamying pesrbig nfmaton. Stre roam temperatre, 207 1025° 69 o TFF). @ 5 USP Cnloled oom Temperature] Prolct bom ight it doe pckageis ot chil st i e Rapamune® ety (sirolimus) Tablets o i o Aubsitiny d Pizeroc ildepia,PA 19101 ADE I P " ”l |” |||I Unit Dose - 100 Tablets $70008-1041-10 5 (10 Blster Cards of 10Tablets Each) o | -
32d83d93-85e3-4e9e-b60c-732aa78959c7_778_1.jpg £ N Each tablet contains: Dispense in a tight, light-resist ) Bt 5o AU Cotooe, & ot 6 3 Hydrochlorthizide USP 12 mg using a chid-esistant closure, Enalapril Maleate keopconsiver sty oot RMO712 o 2 and L e N Hydrochlorothiazide femgzt ez -0 2 5383 Tablets, USP it SO Usual Adult Dosage: See. N—§ g g g 5mg/125mg ey v o== fifr Mylan Pharmaceuticas . | -agg [Mylan- Morgantor, w;snsm : - ([Mylan®
32d83d93-85e3-4e9e-b60c-732aa78959c7_778_2.jpg it i s in g, gt wz Bt a9 10nn AU SP AN (ot £ o 2 et SR Englapril Maleate | o0 raer = ; and e B @ Hydrochlorothiazide fesgtezcseem 548 Tablets, USP | By TS el 27 [MMylan: SR é Y/ [)Mylan: 4 Rxonly 100 Tablets Mylan.com
3310a3c2-389a-4b27-a478-67c905789854_706_1.jpg R ! WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN b DOSAGE and STORAGE: SEE PACKAGE INSERT 55289-315-12 LOPERAMIDE HCL USP 2mg 12 CAPSULES ReOrder # 101830 LOT Ji8c83 EXP 11/19 55289-315-12 LOPERAMIDE HCLUSP 2mg 12 CAPSULES ReOrder # 101830 Lot J18C83 EXP 11/19 55289-315-12 LOPERAMIDE HCLUSP 2mg 12 CAPSULES ReOrder # 101830 LOT 118C83 EXP 11/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE CAPSULE(S) TIMES A DAY. TOME Each CAPSULE Contains: CAPSULA(S) VECES AL DIA. 2 MG LOPERAMIDE HCL USP ORGANOLEPTIC MARKINGS: BROWN TEVA 0311 LE CAPSU: NDC: 55289-315-12 MY = PD-Rx ) PHARMACEUTICALS dMINCORPORATED® 28 Oklahoma City, OK = 73127 LOPERAMIDE HCL USP 12 CAPSULES (21)518C83000003 (17)191130 (10)118C83 (01)10355289315124 PeTISTEGBTESE JBETCT O 0T TOTTECEGOOD JNENd3Y HI3ZD AOYVINON-YAVLO “O°Y'S SIMLSNANI HI3ZD VAL
3361dd6c-4b03-4c42-9b95-4ecd43c34294_927_1.jpg 950 Wean) (UDeXouazD) .1d3; X! fwoxy Bog. = NDCTUR63-01130 “Xepi- (ozenoxacin) Cream, 1% [ P [ T ] et e e 20 NDC/0363.011.30 (ozenoxacin) Cream, 1% Usual Dose: At aershoul be ppi o afced area i e 05 s [ gl St e Gyl s Room Tempesanel. Pt For Topical Use Only ot orOphtali, 0l Inasal, orntavgial Use 7 ecusicns i ForTopical Use Only HotorOphtalmic, Ol Ianasal, orlnavgil Use ot e .,..F.F.u‘...‘...cl 1tk b et
33f3b99b-fa82-42e0-26bf-f49891ae3d22_17_1.jpg 5 E g L] =& 2 535 Rxony 7 No. 3843 =5s 25 ge3 L, - =gE 55,8°8 & INVANZ® Esgegzizecss (erapenem sodium) v GBEosacgast (erapenem sodum) v S 855 EEEES mctuengrdents: 175 mysodum bcatorate an syttt o S SokBag iu b e astpiiors Soutom ange fom okres o pae ylow. Vaaions - £ =22 =728 2 of colorwithin s range do not affect the potency of the product, =25 EEBZ5S2 FOR INTRAVENOUS OR INTRAMUSCULAR USE I . Merck ¢ X Corp. ¢ MERCK & CO, INC, Whitehouse Station, NJ 08889, USA By: Laboratoires Merck Sharp & Dohme-Chibret Clermont Ferrand Cedex 9, 63963, France SlEn] PR 3843 Exp. Date Batch
33f3b99b-fa82-42e0-26bf-f49891ae3d22_17_2.jpg Single dose ADD-Vantage®* vial £ g 2 B 2 DILUTION, USUAL DOSAGE, and NSTAUCTIONS FOR USE: Ses accompanying diular. rom cobrkessto peleyelow do notafect product potency powderabove 25° (77°). FOR INSTRUCTIONS ON RECONSTITUTIONAND *Registered trademark of Hospira Laboratories, nc. Solution color variations € MERCK &CO, INC, Wiitehouse Station, NJ 08889, USA By: Laboratoires Merck Sharp & Dohme-Chibret Clermont Ferrand Cedex 9, 63963, France ey B 190112-1 3845
350eb39e-6072-4467-8f57-ed6edcdbccd8_733_1.jpg NDC 0115-0671-51 Zolmitriptan Tablets 2.5mg Rx only ~ six Tabiets Impas)
350eb39e-6072-4467-8f57-ed6edcdbccd8_733_2.jpg NDC 0115-0672:50 Zolmitriptan Tablets 5mg Rx only THREE Tablets Impas)
350eb39e-6072-4467-8f57-ed6edcdbccd8_733_3.jpg NDC 0115-0691-51 Zolmitriptan Orally Disintegrating Tablets 2.5mg Rx only SIX orally disintegrating tablets. Impax,
350eb39e-6072-4467-8f57-ed6edcdbccd8_733_4.jpg NDC 0115-0692-50 Zolmitriptan Orally Disintegrating Tablets 5mg Rx only THREE oraly disinegrating tablets Impax)
3571038f-055e-462c-bed3-9d04ba1b5da0_528_1.jpg i W o e e ioge 635 T w“w e S, 2z e > R T e C (o e maon el ot 8 i rrra oo VTS TR
3571038f-055e-462c-bed3-9d04ba1b5da0_528_2.jpg nan
3573e3c9-ca05-413f-909f-93607a2ccb79_945_1.jpg £ Each i coated tblet contan: Oispese in foht, gt esistat = Dot 2w MUASCRIYY) ot e 0 7 el L - @ Exemestane o : e & Tablets Store 1 20°1025°C (68 77°F). [See USP Controlled Room % Temperature.] &= . prescribing nfrmaton. Mylan Pharmaceuticals In. Horgantown, W 26505 US A [MMylan® [MMylan: Rxonly 30 Tablets Wyian.com ) £6=1005=-8260 N 10T ARAR IOYXT s OO S OO NI &
359299b0-b94c-4791-b241-a6da686164fc_273_1.jpg Lo ™ o 160 TABLETS
35c16fbe-90d3-440e-a6bc-86b4a1d61c58_535_1.jpg [ D A oA K 502 e s Y S et ey s L gyt i s iy aaperg gy owrs i) e e pesoo o iy st s o 5195 12 ooy Ssgopuoa oy s e psasns ovporompuag s 5ot e e s sy s o i e s S s e g s s DS 5109050 A LR Lo T 52 R A o0y B o o BN 35ts Ya ) A s e oS S S oo oo o0 e 5 2 £ 3. £ 2 i : § § i SUrorme acac ACCDENTAL GIERDOSE, X ROTESUONAL ASSTANCE R COTAC R OB CONTROL e OATE FROTECT FROM LGHTIAOR FREEING StoRe A conTROED OO T S I SEE U CONROLLD ReStreRoR oonoraermGERATE LwoAn £102/%0 9¥0 NDC 49836.011-17 RX-Only P-Care D40 Kit Contains: 1 Depo-Medrol® Sngle Dose Vial (40 ma/ml) (1 ml) 1 Sterile Povidone-lodine Swabsticks 3 Swabs) 1 Sterile Pair Nitrle Powder Free Gloves (Sze 7.5) 1 Sterile Towel Drape 1 Sterle Fenestrated Towel Drape 2 Sterle Adhesive Bandage 2 Sterie Achesive Spot Bandage 3 Sterle Packs of dxd Gauze (6 Gavzes) 5 Sterle Isopropyl Alcohol 70% Prep Pad Needies and Syringes Not Included osmaTEoer aCTURD B P-Care D40 harma SCHMIGS wmwr:%q-(a HAuPAGE v 11788 NDC 4983601117 Questions/Comments 1-844.6327898
35c16fbe-90d3-440e-a6bc-86b4a1d61c58_535_2.jpg 0 |&= For M, intrasynovialand NDC 0008-3075.01 > |o softissue njeciononly. 1 mi. Single-Dose Vial 5] NOT for V use. I |2 vosace Ap use: see Depo-1V accompanyingprescribing (methyIPREDN|Solone 0 |S) inormation. Shakewell ~ gociate i oy o immediately before using. inj o) 5 [ gy " " suspension, ) harmaca & pfo Co 10 n 1 N [ 4 T New York, NY 10017 Rxonly
35c16fbe-90d3-440e-a6bc-86b4a1d61c58_535_3.jpg NDC 52380-3101-5 NPN 02076101 a Tearbere Hod Upight Tear Heee D THREE POVIDONE-IODINE SWABSTICKS ANTISEPTIC STERILE Solution Applicator is STERILE if Package is Intact Three 4-inch Saturated Swabsticks RU RO Reorder No. $-3101 8 Drug Facts (continued) Warnings Donotusem falegicodne m inteeyes For exemal use only Aska docorbefore use Tnjres are. 1 deeg o e WOuTdS B SertiS b Sopuseandaskadoclor u fefes, riaion sl wioeses o infecton ooours Aidpoolng beeah Keep ot feach of children. I cse o accdent ingesion,seek professinel asssance scrstapsn rinegalely. Avolecesse es. e Difections sgy ey s reeed Other information u {5 e odre m ke o ospll o professonl e oy Inactive ingredients civczcd. dsodum o, 000, s b, et Forgstors, ses s 3 800-760-3236 Monday ey §30 22500 p EST APLCARE, IC. NERDEN, CT 06450 US A BRAUPTON, N LY V3 CANADA et I orlorept
35c16fbe-90d3-440e-a6bc-86b4a1d61c58_535_4.jpg Sterile Alcohol Prep Pad tents: P St Aol Contents: One Prep Pad saturated with 70% isopropyl alcohol. Prep Pad Forriaa s 0 See box for complete drug facts tcaa st sl 2@k St Sotaion S [H & Manufactured for: totmdowtn st amitor, o o-\gehum|m S xcom " ey oA oo e Medium [OSETTE)
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_1.jpg NDC 70954-019-10 Prazosin Hydrochloride Capsules, USP Rx only =% novitium pharma 100 Capsules *Each capsule contains prazosin hydrochloride, USP equivalent to 1 mg of prazosin. Usual Dosage: See accompanying package insert for complete prescribing information. Store at 20° t0 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from moisture and light. Dispense in a tight, light-resistant container as defined in the USP. Keep container tightly closed. This package is child-resistant. Keep this and all medications out of the reach of children. Manufactured by: Novitium Pharma LLG 70 Lake Drive, East Windsor New Jersey 08520 Revised: 08/18 LB4040-01 Il 70954-019-10 7 3, 1V = NO VARNISH
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_2.jpg NOC 70954-019-20 Prazosin Hydrochloride Gapsules, USP Rxonly “‘)V},U}},,‘}l 1000 Capsules “Each capsule contains prazosin hydrochloride, USP equivalentto 1 mg of prazosin. Usual Dosage: See accompanying package insert for complete prescribing informaton Store at 20° to 25°C (68° 10 77°F). [See USP Controlled Room Temperature ] Protect from maisture and light. Dispense in a tight,light-resistant container as defined inthe USP. Keep container tightly closed. This package is child-resistant. Keep this and all mecications out of the reach of children. Manufactured by: Novitium Pharma LLG 70 Lake Drive, East Windsor New Jorsey 08520 Revised: 08/18 LB4041-01 70954-019-20 n 3 NO VARNISH
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_3.jpg NDC 70954-020-10 Prazosin Hydrochloride Capsules, USP Rx only v novitium pharma 100 Capsules “Each capsule contains prazosin hysrochioride, US? equivlent o2 mg of prazusn Usual Dosage: See accompanying package sert for complete prescrbing information. Store at 20° o 25°C (68°fo 77°F). See USP Contoled Room Temperature] Protect from maisture and liht. Dispense ina gh, laht-esistant conaine as defined in the USP. Keep conainer ighty cioses. “Tnis package i chid-esistant, Keep tis and all medications outof the reach of chiren. Nanutactred by: Novitium Pharma LLC 70 Lake Drie, East Windsor New Jersey 08520 Rovised: /18 70954-020-10 3 s NO VARNISH
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_4.jpg NDC 70954-020-20 Prazosin Hydrochloride Capsules, USP Rxonly e NOVILUM 1909 capsules *Each capsule contains prazosin hydrochlorde, USP equivalent o 2 mg of prazosin Usual Dosage: See accompanying package insert for ‘complete prescribing information. Store at 20° 0 25°G (66° to 77°F). [See USP Controlled Room Temperature] Protect from moisture and light. Dispense in a tight, ight-resistant container as defined inthe USP. Keep container tightly closed. This package is child-resistant. Keep this and all medications out of the reach of children, Manufactured by: Novitium Pharma LLC 70 Lake Driv, East Windsor Neww Jersey 08520 Revised: 08/18 LB4043-01 2 \ ° o 3 NO VARNISH
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_5.jpg *Each ile contair hydrochloride, USP NDC 70954-021-10 candensngoipraosn Usual Dosage: See accompanying package insert for Pra zosi n ‘complete prescribing information. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Hydrochloride [ e Protect from moisture and light. ca psu I es’ USP 5‘.'7%’:'&‘5’9.'" atight, light-resistant container as defined Keep container tighty closed. “This package is child-resistant. Keep this and all medications out of the reach of children, Manufactured by: Novitium Pharma LLG 70 Lake Drive, East Windsor novitium New Jersey 08520 pharma 100 Capsules peseq:oe/ie LB4044-01 10 o 70954 021 3 NO VARNISH
35c7aa71-6171-4ba5-916c-384c28e5f5c1_516_6.jpg L L NDC 70954-021-20 oo opene optlsprosi ol U5 PI’aZOSin m\"gzﬁ;ﬁmmmwu package insert for complete - H d hl .d ?mmméﬂ“;n?ﬁ“ﬁ (68° 10 77°F). [See USP Controlled Room o (% emporabre = ydrochloride T vesmion =" = Capsules, USP pemsenassuimimsimomnsosnaione == § % e conainer bty cose i < m This package s hi-sstnt. =3 = Keep this and all medications out of the reach of children. g Rx only Mot rarsa 16 v o 70 Lake Drive, East Windsor zm Z G New Jorsoy 08520 TOVILUM 250 Capsules v 0018 Wnison
35f99f76-f2ef-4a81-91ff-285419664be3_426_1.jpg NDG 65862-290-05 Rx only Ribavirin Capsules USP PHARMACIST: Dispense the accompanying Medication Gulde o each patient. /52 AUROBINDO 500 Capsules Each capsule contains: Ribavirin USP 200 mo. Usual Dosage: See product information. Read accompanying directions carefully. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86%) [see USP Controlled Room Temperature]. [AVOID PREGNANCY WHILE ITAKING THIS MEDICATION. READ THE MEDICATION GUIDE For combination use with INTRONCA (Interferon alfa-2b, recombinant) Injection* FOR IMPORTANT INFORMATION. * INTRON® A is a registered trademark of Schering Corporation Distributed by Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/19/1993 1422244 ~Over printing Zone oG @53 20mm) Doted nec ot o be prrted
36058589-b93b-4fd1-acce-1aa9fe70fbcb_842_1.jpg TraZODONE Hydrochloride 50 mg Tablet arv: 30 ID #: PLIVA;433 Expires: NDC #: 24236-0128-02 Shape: Round LOT #: Ref #: 50111-0433-03 MFG: Teva Pharma, Sellersville, PA 18960 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
360de855-b8be-409f-9ca6-d0a0368af174_395_1.jpg Packaged by Evgant Ranch Biabanb. @A 950G Propranolol HCL G PWerouev:ste 20mg Tablet .~~~ £ sause dizziness or drow 5 Store at room temp of Compare To: 2025 C (68-77F) Inderal 20 mg Tablet “Keep ail drugs outof ParPhamaceutal . reachofchildren #20 Exp: MMYY 3 NDC 7133500821 025701110315
360de855-b8be-409f-9ca6-d0a0368af174_395_2.jpg Pachaged by Eryant Ranch Propranolol HCL 40mg Tablet Compare To: Inderal 40mg Tablet Wation Pharma Prva Linited #30 NDC Exp: MMYY 7133504721 10 SEOETT om Binbank. 04 91500 GREENROUND DAN 5558 : DAN. Store at room temp of 20-25 C (68-77F) Keep all drugs out of reach of children 046101113035
360de855-b8be-409f-9ca6-d0a0368af174_395_3.jpg Pachaged by Eryant Ranch Bibank. @A 9504 Propranolol HCL g = foumv:sie 10mg Tablet 10 sause dizziness or drows Store at room temp of Compare To: 20-25 C (68-77F) Inderal 10mg Tablet Keep all drugs outof ParPhamaceutial reach of children #30 Exp: MMYY NDC 7133505541 014231112781 18211 om
360de855-b8be-409f-9ca6-d0a0368af174_395_4.jpg Pacbaged by Eryant Rench Buabank. 04 91500 Propranolol HCL ~ § ™\0% Fouwoktsssro g 80mg Tablet " 8 = Keepall drugs outof Compare To: reach of children. Inderal 80mg Tablel “Siore at room temp of ParPhamacential 20°25°C (68°-77°F) #30 Exp: MMYY NDC 7133509551 035871123214 om
3653a602-4551-4e6c-84a7-31861f5dc482_609_1.jpg Each mL contains testosterone - & cypionate, USP 100 mg. Also contains NDC 62756-017-40 s 0 - Tostosterone Cypionate cottonseed oil, 736 mg. o USUAL DOSAGE: See accompanying |ﬂ]ect|0ﬂ, USP @ prescribing information. ‘;’:Lﬂ':ﬁ,’::fﬁf,ﬂ?}ﬂ;m% 1’000 mg/10 mL PULBISGSC 1SS, 11/2016 i teoene: STV - GUJ/DRUGS/28/396 Store at 20° to 25°C (68 to 77°F). [See USP Controlled Room FOR INTRAMUSCULAR USE ONLY Temperature]. Rx only Protect from light. Retain in carton & 10 mL Multiple-Dose Vial until time of use. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
3653a602-4551-4e6c-84a7-31861f5dc482_609_2.jpg QUGN TNy 0 &0 ‘womaly ajeuoidAg auosasojsay 0v-L10-95229 ION PJSBOB12C Each mL contains testosterone. cypionate, USP 100 mg. Also cortans benzy! benzoat, 0.1 mL benzyl alcobol added as presenvatve, 945 mg; in cotonseed ol 736 mg. USUAL DOSAGE: See accompanying prescrbing informaton. Warming and shaking the vial should redissolve any crysals thalmay have formed during storage a temperatures Iower than recommended. Storeat 20°10 25° (6810 TT°F). {See USP Contrlled Room Temperatre]. Store product n this carton to protect contents from liht. Distributed by: Sun Pharmaceutical Industries, Inc. Granbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat India. NDC 62756-017-40 Testosterong Cypionate Injecion, U5~ 1,000 mg/10 mL (100 mg/mL) FOR INTRAMUSCULAR USE ONLY JHA 3 62756101740 GUIDRUGS/28/3%5 PUSBOBI2C 1SS 11/2016 5 NDC 62756-017-40 Testosterone Cypionate Ineeton, USP (5 1,000 mg/10 mL (100 mg/mL) FOR INTRAMUSCULAR USE ONLY Rx only @ One 10 mL Multiple-Dose Vial ~ SUN ‘ BAARIA NDC 62756-017-40 Testosterone Cypionate Injection, USP G RN Al (100 mg/mL)
3653a602-4551-4e6c-84a7-31861f5dc482_609_3.jpg Warming and shaking the vial should redissolve any crystals that may have formed during storage at temperatures lower than recommended. Store at 20°to 25°C (68°to T7°F). [See USP Controlled Room Temperature]. Protect rom light, NDC 62756-015-40 Testosterone Cypionate Ijection, USP (5 200 mg/mL FOR INTRAMUSCULAR USE ONLY Rx only K Single-dose vial — Distributed by: E Sun Pharma Ind. Inc, NJ 08512 &5 == Manufactured by: = =" SunPharmaInd. Ltd, ndia. = Il 0 GUJ/DRUGS/28/396 ISS. 08/2017 Il 6 — — 5 il 3
3653a602-4551-4e6c-84a7-31861f5dc482_609_4.jpg o) 450 wogely ajeuoidhy auosajsojsa] 0v-GL0-95£29 90N PisasD Each mL conins testosrone. cypionate, USP 200 mg. Also conans berayl benzee, 0.2 mL;beruy acohol added as preservatve .45 my; in Cattonseed ol, 560 m. USUAL DOSAGE: Seeaccompanying prescribing nomation. Warming and shaking the vial should redissolve any crystas that may have formed during storage at temperatures lover than recommended. Store at 20°to 25°C (68° 0 77). [See USP Controlled Room Temperature]. NDC 62756-015-40 Testosterone Cypionate Inction, USP FOR INTRAMUSCULAR NDC 62756-015-40 Testosterone Cypionate Injction, USP FOR INTRAMUSCULAR ‘Store product in this carton to USE ONLY USE ONLY protect contents from light. il e i SUN i xony SN i s s one EIET Single-dose vial e \ ettt #isw6a0 5 0017 NDC 62756-015-40 Testosterone Cypionate Injection, USP @
3653a602-4551-4e6c-84a7-31861f5dc482_609_5.jpg Each mL contains testosterone NDC 62756-016-40 cypionate, USP 200 mg. Also contains bt 2t o TasHsterong Cypionate cottonseed oil, 560 mg. 5 u USUAL DOSAGE: See accompanying |ﬂ|ect|0ﬂ, USP @ prescribing information. Warming and shaking the vial should ettt PALLUUET I BB it i it R PLUETR) ; GUJ/DRUGS/28/396 Store at 20° to 25°C (68° 10 77°F). [See USP Controlled Room FOR INTRAMUSCULAR USE ONLY Temperature]. Protect from light. Retain in carton until time of use. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
3653a602-4551-4e6c-84a7-31861f5dc482_609_6.jpg QI iFA) RO ) 450 Logealy ajeunidfy auosajsojsa 07-910-95L29 ION PJSBOS1AC Each mL contains testosterone. cypionate, USP 200 mg. Also contains berzyl benzoate, 0.2 L benzyl alcohol added s presenvative, 945 mg; n cotonseed of, 560 mg. USUAL DOSAGE: Sée accompanying prescibing informaton. Warming and shaking the val should edissove any crystal that may have formed during storage a temperatures lower than recommended. Store a1 20°t0 25° (6810 T7°). {See USP Contrlled Room Temperatire]. Store product in this carton to protect contents from lght. Distibuted by: Sun Phammaceutical Indusiries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat India. NDC 62756-016-40 Testosterone Cypionate Inecton, USP~ (05 2,000 mg/10 mL (200 mg/mL) FOR INTRAMUSCULAR USE ONLY 3 | I 627561101640 GUJDRUGS28395 PUSBOBIAC 1SS 11/2016 NDC 62756-016-40 Testosterone Cypionate Ineeton, USP (5 (200 mg/mL) FOR INTRAMUSCULAR USE ONLY Rx only L 10 mL | 9 \ Muttiple-Dose Vial ﬁk}x NDC 62756-016-40 Testosterone Cypionate Injection, USP G 2,000 mg/10 mL (200 mg/mL)
37078166-25f3-49a2-abe9-fb5b590ade44_686_1.jpg Loperamide HCI 2 mg Capsule arv: 16 ID #: TEVA;0311 Expires: NDC #: 70518-0052-00 Shape: Capsule LOT #: Ref #: 00093-0311-01 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
37078166-25f3-49a2-abe9-fb5b590ade44_686_2.jpg Loperamide HCI 2 mg Capsule arv: 6 ID #: TEVA;0311 Expires: NDC #: 70518-0052-01 Shape: Capsule LOT #: Ref #: 00093-0311-01 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
37078166-25f3-49a2-abe9-fb5b590ade44_686_3.jpg Loperamide HCI 2 mg Capsule arv: 8 ID #: TEVA;0311 Expires: NDC #: 70518-0052-02 Shape: Capsule LOT #: Ref #: 00093-0311-01 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
37078166-25f3-49a2-abe9-fb5b590ade44_686_4.jpg Loperamide HCI 2 mg Capsule arv: 100 ID #: TEVA;0311 Expires: NDC #: 70518-0052-03 Shape: Capsule LOT #: Ref #: 00093-0311-01 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
37241e87-4af4-4dc3-a1aa-ea6f20d8dc40_736_1.jpg NDC 0004-0259-43 CellCept® (mycophenolate mofetil capsules) Each capsule contains 250 mg mycophenolate mofetil. Ronly Attention Pharmacist: Dispense the accompanying Medication Guide to each patient. For additional Medication Guides call 1-800-617-8191 or visit www.gene.com/gene/ products/information/cellcept. 500 capsules Genentech
37241e87-4af4-4dc3-a1aa-ea6f20d8dc40_736_2.jpg NDC 0004-0260-43 CellCept® (mycophenolate mofetil tablets) Each tablet contains 500 mg mycophenolate mofetil. R only Attention Pharmacist: Dispense the accompanying Medication Guide to each patient. For additional Medication Guides call 1-800-617-8191 or visit www.gene.com/gene/ products/information/cellcept. 500 tablets (D Genentech
37241e87-4af4-4dc3-a1aa-ea6f20d8dc40_736_3.jpg NDC 0004-0298-09 CellCept® Intravenous (mycophenolate mofetil hydrochloride for injection) ﬁ 4 Vials Genentech ¢
37241e87-4af4-4dc3-a1aa-ea6f20d8dc40_736_4.jpg NDC 0004-0261-29 CellCept® Oral Suspension (mycophenolate mofetil for oral suspension) Each mL contains 200 mg mycophenolate mofetil after constitution. Attention Pharmacist: Dispense the accompanying Medication Guide to each patient. For additional Medication Guides, call 1-800-617-8191 or visit www.gene.com/gene/products/information/cellcept. R only E Genentech
377eafda-737c-4ba2-9ec5-61209b8814ed_60_1.jpg CIED34A-04 - 40 x 35 X 165 mm l:j Keyline I novemish Each gram contains 0,05 mg o calipotriene n a cream base of ceteary alcohol, ceteth=20, diazoldinyl rea, dichlorobenzyl alconl, disasic sodium phosphate, edetate disodium, dl-alpha tocopherol, lycerin, mineral ol petrolatum, and water: G S6983-877-61 Manufactured by: LEO Laboratoris L1c, Dublin 12, Ireland Manufactured fo: Prasco Laboratories, Mason, OH 45040 USA i I55.07/18 i i i FOR TOPICAL DERMATOLOGIC USE ONLY. Not for Ophthaliic, Oral or Intravaginal Use. Usual Dosage: Apply twice dail, o as directed by physician. SeeInsert for complete information. WARNING: Keep Out of Reach of Children. ig APRASCO N . - (alcipotriene (ream 0.005% Store at controlled room temperature 15°C-25°C (S9°F=77°F). Donotfreeze, 3 66993187761 7 owrEan 91X 68X 0 “4‘4‘4‘4‘4‘4‘4 Reonly NetwLs0g 05001 988
377eafda-737c-4ba2-9ec5-61209b8814ed_60_2.jpg CIE017B-03 - 50 x 38 x 210 mm Keyline 4 I vovamish 8 Each gram contains 0.05 mg of calcipotriene in a cream base of cetearyl alcohol, ceteth-20, diazoldinyl urea, ichiorobenzyt alcohol, = g dibasic sodium phosphate, edetate disodium, d-alpha tocopherol, glycerin, mineral of, petrolatum, and water. = S Manufactured by: LEO Laboratories Ltd., Dubli 12, keland s = o Manufactured for: Prasco Laboratories, Mason, OH 45040 USA = = 2 ¢ = & 155.07/18 ¢ £ = * i £ 8 i =z Q=S 3 FOR TOPICAL DERMATOLOGIC USE ONLY. Not for Ophthalmic, Oral or Intravaginal Use, Usual Dosage: Apply twice daily, or as directed by physician. See Insert for complete information. WARNING: Keep Out of Reach of Children. A PRASCO NDC 66993-877-78 (alcipotriene (ream 0.005% Store at controlled room temperature 15°C-25°C (39°F-77°F). Do not freeze, Eoasioan o1z xge X 05 36699387778 s
379d97d5-071e-73ea-e054-00144ff8d46c_617_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT, MAY CAUSE DROWSINESS. USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTNESS. § ‘5 CAUTION: FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG 2 TO ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED. § R - WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN 2 — L DOSAGE and STORAGE: SEE PACKAGE INSERT ~ 43063-686-60 43063-686-60 43063-686-60 * == HYDROcodone* & HYDROcodone* & HYDROcodone* & - d & — ACETAMINOPHEN ACETAMINOPHEN ACETAMINOPHEN Q HYDROCO One _ S5MG/325MG 5MG/325MG SMG/325MG = 0 o 60 TABLETS 60 TABLETS 60 TABLETS g : ACETAMIN " PHEN = ReOrder # 105924 ReOrder # 109924 ReOrder # 109924 "‘f‘ 9 —1 LoT 118814 Lot 18Bs14 Lot 118814 5T 5 M G/325 M G & EXP 0a/20 EXP na/z0 EXP 04/20 o= & << = g ] CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. = 60 TAB LETS E YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S)EVERY__ HOURS AS NEEDED FOR PAIN. “INIWHYHA OTVH Q TOME___TABLETA(S)CADA___HORA COMO NECESARIO POR DOLOR 5 (01)10343063686607 2 {21)118814000002 Each TABLET Contains: HYDROCODONE BITARTRATE L3P 5 MG = 1713 ACETAMINOPHEN USP 325 M§ g (17) 200430 *(WARNING: MAY BE HABIT FORMING| 2 (10)118814
37db393b-79a4-408d-ac72-51a7559a6d44_159_1.jpg Methocarbamol 750 mg Tablet arv: 30 ID #: 115;H Expires: NDC #: 70518-1554-00 Shape: Oval LOT #: Ref #: 31722-0534-05 MFG: Camber Pharma, Inc, Piscataway, NJ 08854 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
37e91a33-f4d6-4617-b107-9fefc4852862_615_1.jpg AMITRIPTYLINE HOL AMITHIPTYLINE HCL AMITRIPTYLINE HOL AMITRIPTYLINE HCL TABLETS,USP TABLETS,USP TABLETS,USP TABLETS, USP NDC 6076021450 AMITRIPTYLINE HCL TABLETS, USP @ S0mg 50mg 50mg 50mg 50mg & Horv o arviao arv: s arv- ary: 3 B [NDC 60760-214-30 NDC 60760-214-30 NDC 60760-214-30 NDC 60760.214-30 wwwricrureaer Jlge P LC TAKE AS DIRECTED Fxonly STORE AT CONTROLLED ROOM TEMPERATURE 15° 30° C (59°-86°F)
381b44e7-a5a1-42ad-bcea-1ab4c82ff5d4_6_1.jpg NDC 63187-636-03 RX Cnly Ondansetron 4mg #03 Tablets Each film-coated tablet contains: Ondansetron hydrochloride USP (dihydrate) equivalent to 4 mg of ondansetron. White to off-white, oval shaped, fim-coated tabiets debossed with ' on one side and ‘91" on the ofher side. Product ID: PO063603 Mfr. By: Aurcbindo Pharma Limited Hyderabad-500 072, India Store at 20°-25°C (68°-77°F) Keep medication out of the reach of children Lot #:00000 Exp. 00/00/00 RX# MASTER Ondansetron 4mg #03 Tablets R MASTER Lot #00000 ExpO0000 NOC 63187-636.03 Ondansetron 4mg #03 Tadlets Rt MASTER Lol #0000 Exp00000 NDC 63187-636.03 Ondansetron 4mg #03 Tablels R MASTER Lot £00000 ExpODON0 NDC 63187-635.03 Packaged By: Proficent Rx LP ‘Thousand Oaks, CA 91320
3832d3d3-15ce-4d41-8431-11e9bd04cf4d_334_1.jpg (/B 57) ajeouedaq asuizeuaydn|4 T o ] o Each ml contains: Fluphenazine Decancate, USP 25 mg in sesame ail; benzyl akonol 12mgasa preservative, Usual Dosage: See packzge insert. Store at 20° t0 25°C (68° to T7°F). [See USP Controlled Room Temperature.] NDC 67457-359-59 LN AR Fluphenazine Decanoate Injection, USP (25 mg/ml) Fluphenazine Decanoate [P (25 mg/mL) e e sl For Intramuscular or st For Intramuscular or Sxcosstvs heat. Subcutaneous Use fanbstttona 1S Subcutaneous Use PROTECT FROM LIGHT. Sterile o m]: Lk Sterile ot o KRGS 2200 (lMylan® Mylan: Wytancom G
388fd4bc-f12f-4e55-a1e7-72aa585519fa_218_1.jpg VLINDC 0615-8237.39 Divalproex Sodium DR Caps USP ==——= (Sprinkle) 125 mg ==: o1 8237 exp 12947-39 Qry 30 Mfg By Dr. Reddy's (NDC 55111-532-05) GLASGOW, kv 42141 30 29 28 27 26 25 24 Rx Only. 23 22 21 20 19 18 17 (Dr. Reddy's NDC 55111-532-05) Divalproex Sodium DR Caps USP (Sprinkle) 125 mg 16 15 14 13 12 11 10 9 Omnicare The overall configuration of this package is a trademark of Omnicare, Inc. Received: 2, 1. s n 5 . 7 W Reamn: Wsmunn Tomerse: P 2, . = w20 s S 2. w____ n —_— 2, 1, 10 2, . . . Start Date Start Time. Pig oy Vg, Gasgow, Y 421 Divalprosx Sodium DR Cap. USP (Sprinkle) 125 mg Lotz Divalproex Sodium DR Cap. USP (Sprinke) 125 mg T Pig by Vangr, Gasgow, Y a2t Divalprosx Sodium DR Cap. USP (Sprinkle) 125 mg Lotz Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg T Pig by Vangr, Gsgow, Y a2t Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg toTea37 Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg i m Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg e g P by Vanrd, Gasgom, K 4241 Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg i m P oy Vagar, Gasgom, K 42141 Divalproex Sodium DR Cap. USP (Sprinke) 125 mg Loraasy L Divalprosx Sodium DR Cap. USP (Sprnkle) 125 mg Ty Divalprosx Sodium DR Cap. USP (Sprinke) 125 mg Lor8237 TN T Divalprosx Sodium DR Cap. USP (Sprinkle) 125 mg T P b Vangard, Glsgow, K 42141 Divalproex Sodium DR Cap. USF (sprinke) 125 mg Lor8z37 Divalproex Sodium DR Cap. USF (sprinke) 125 mg iy Divalproex Sodium DR Cap. UsP (Sprinkle) 125 mg Lor8237 Divalprosx Sodium DR Cap. USP (sprinke) 125 mg i m STORE AT 20°- 25°C (68°- 77° F) (SEE USP CONTROLLED ROOM TEMPERATURE) Dispense in a tight, light-resistant container. Each cap contalns: Divalproex sodium USP equivalent to valproic acid 125 mg See Package Insert Binder for Dosage Information FOR INSTITUTIONAL USE ONLY Pig o Vangars, Gimgow, KY2181 Divalproes Sodium DR Cap. 1294680y 00 USP (Sprinkie) 125 mg gtz o U Divalproes Sodium DR Cap. USP (Sprinkle) 125 mg T m Pig by Vangur, Glagow, kY2141 Divalproex Sodium DR Cap. Dhalproex Sodium DR Cap USP (Sprinkle) 125 mg UsP (Sprinkle) 125 mg tor8az torsz37 TN T TN Dhalproex Sodium DR Cap UsP (Sprinkle) 125 mg i m Divalpros Sodium DR Cap. USP (Sprinkle) 125 mg “Hi Pig by Vangu, Glagow, KYa21A1 Divalproex Sodium DR Cap. Dhalproex Sodium DR Cap. USP (Sprinkle) 125 mg USP (Sprinkle) 125 mg. Lorsz37 torsz37 TN T TN Divalproex Sodium DR Cap. USP Sprinkle) 125 mg Lorszs7 I Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg i Pig by Vangurd, Glagow, kY214 Divalproes Sodium DR Cap. Dialproex Sodium DR Cap. USP (Sprinkle) 125 mg UsP (Sprinkle) 125 mg. Lorasy torezsy [ i Dwalproex Sodium DR Cap. USP (Sprinkle) 125 mg Lorszs7 w0 P by Vangrt, Gimgom, KY2141 Divalpross Sodium DR Cap. USP (Sprinkle) 125 mg “iiiym Divalproex Sodium DR Cap. USP (Sprinkle) 125 mg i m
388fd4bc-f12f-4e55-a1e7-72aa585519fa_218_2.jpg Phg By Vangrd, Glasgon, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg oT837- B AR 5511153205 gy Vangard, Glasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP AR T 5511153205 g By Vangard, Glasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg LOT8237- EXP TR 5511153205 gy Vangar, Gragow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg LOT8237- EXP AR 5511153205 Bivalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP AR T € 5511153205 Bivalproex Sodium DR Cap USP (Sprinkle) 125mg oT837- B AR 5511153205 By Vangard lasgow, K 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg LOT8237- EXP AR T 5511153205 Py Vangard Glasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP TR T 5511153205 Phg By Vangard, Giasgow, K 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP LT 5511153205 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg LOT8237- EXP AL 5 5511153205 L0T8237- LT 5511153205 L0T8237- AR T 5511153205 LOT8237- TARILLmOLI T 5511153205 LOT8237- AL 5511153205 LOT8237- gy Vangar lasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg EXP Py Vangard lasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg EXP Py Vangard lasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg EXP Phg By Vangars, Glasgow, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg EXP Phg By Vangard, Glasgow, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg EXP TR 4 5511153205 P By Vangar,Glasgons, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg 07837 EXP NRRIQEL I 5511153205 g By Vangard,Glasgon, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg L0T8237- EXP HORR LA 5511153205 g By Vangard, Glasgon, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg LOT8237- EXP TR DI 5511153205 g By Vangar, Glasgon K 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP TRRIEQLEL I T T 5511153205 Divalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP NRRIEQEL I 3 5511153205 8237-AA-UD2-v00 VLI NDC 0615-8237-30 Divalproex Sodium DR Capsules ary 30 (SEE USP CONTROLLED RODVI TEHPERATURE) Dispense in a tight, light-resistant container Lor: EXP, USP (Sprinkle) 125 mg Each cap contains: Divalproex sodium USP equivalent to valproic acid 125 g Rx Only STCRE AT 20°-25°C (68°-77°F) VLI NDC 0615-6237-30 Divalproex Sodium DR Capsues USP (Sprinde) 126 mg FOR INSTITUTIONAL USE ONLY Qry Lot 0 Exp nutscesy Dr. Reddy's o Insert or Laba! irformation 551115320530 Py By Vangard,Glasgon, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg LOT8237- EXP NRRIQEL I 5511153205 P8y Vangard,Glasgon, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg 10T 8237- EXP HARH LI 5511153205 g By Vangard,Glasgon, kY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg L0T8237- EXP HORER DI 5511153205 g By Vangar, G Divalproex Sodium DR Cap USP (Sprinkle) 125 mg L0T8237- EXP NRRIEQEL I T 5511153205 Divalproex Sodium DR Cap USP (Sprinkle) 125mg L0T8237- EXP HRREDLLLI b T 2 5511153205 Pl By Vangard, Glasgow, KY 42141 I Divalproex Sodium DR Cap USP (Sprinkle) 125mg L0783 EXP AR 5511153205 g By Vangard, Glasgow, KY 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125mg L0T8237- EXP TR e 5511153205 g By Vangard, Glasgow, Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg L0T8237- EXP NARH LR T 5511153205 kg By Vangard, Grasgow Y 42141 Divalproex Sodium DR Cap USP (Sprinkle) 125 mg L0T8237- EXP AR 5511153205 Peg By Vangar,Glasgow, kY 2161 Divalproex Sodium DR Cap USP (Sprinkle) 125mg L0T8237- EXP TR T 1 5511153205
39631f1f-5d19-43c1-b504-bf56d991ed97_704_1.jpg NDC 0187-0140-30 L Each tablet contains: 2.5 mg Enalapri Maleate: UsualDosages Ses package et for dosage infomtin, v o WARNING: Keep out ofreach of chiien. asotec o s Sh:-e nlﬁ'ﬁﬂm:-.tcmm permitted o (Enalapril Maleate) R Tl Kooy crt vy s, Profect from maistre, Botle conaine desiccant. Manufactured fr:Vlant Pharmaceutcale Nort Ameica LC, Bidgewater NJ 08807 USA By Valeant Pharmaceticas Intematonal, . Stinbach, B G 127 Canai Prchptof Canada ©VaeantPhamacausicals North Anerca LLC VASOTEC® i trademark of Vs Pramaceuticdls Intemationa, . or s aftes. 30Tabkets WVALEANT 56500 200016%
39631f1f-5d19-43c1-b504-bf56d991ed97_704_2.jpg gII | NDC 0187-0141-30 Rx only Vasotec’ (Enalapril Maleate) 0Tablets WVALEANT Each tablet contans: § mg Enlapi Heleate Usua Dosages S package ner forcksage infomation, WARMING: Kesp out of reach of ilden. Pharmacist:Dpens in gt conaier s por USP. Storeat 25°C (77°F) excursions perittd to 1610 30°C (8 10 86°F) soe USP Controlled Room Temperatur]. Keep container tightyclosed. Protet from moisture. Botle conains desiccant. Manufactured for: Vel Phamaceutcals NorthAerica L, Bridgewat, J 08807 USA By:Valeant Pharmaceicas ntmational, . Stinbach, B RSG 127, Caraca Prductof Ganada CVleantPharmacauicas Nrth America LLC VESOTEC® i trademark of Vlsan Phamaceutidls Intemationa, . or s aflats. 9556700 2001637
39631f1f-5d19-43c1-b504-bf56d991ed97_704_3.jpg NDC 0187-0142-30 Vasotec: (Enalapril Maleate) 30Tablets WVALEANT Each tablet contans: 10 mg Evlaprl Maleate Usual Dosages S package nsert forcisage infomation, WARMNG: Kesp out of reach of cilden. Pharmacist:Dpenss i it conainer s por USP. Storeat 25°C (77°F) excursions peritted to 1610 30°C (88 1o 86°F) soe USP Controlled Room Temperature]. Keep container tightyclosed. Profet from moisure. Botle conains desiccant. Manudactued for:Vloant Phamaceutals North America L, Bridgewate, J 08807 USA By:Valeant Pharmaceuicas ntmational, . Stibach,MB RSC.127, Caac Prductof Ganada CVaeantPhamacauicas Nrth Amrica LLC VESOTEC® i trademark of Vlsan Phamaceutidls Infmationa, . or 5 affats. 9557000 20001638
39631f1f-5d19-43c1-b504-bf56d991ed97_704_4.jpg £ i = S W; [ o NDC 0187-0143-30 Vasotec’ (Enalapril Maleate) 30Tablets WVALEANT O] Each tabletcontans: 20 mg Evbprl Haleate Usua Dosages See package nsert for cosage infomation, WARMNG: Kesp out of reach of ilden. Pharmacist:Dipen in it contaier s per USP. Storeat 25°C (77°F) excursions peited to 1610 30°C (8 10 86°F) swe USP Controlled Room Temperature]. Keep container tightyclosed. Protet from moisture. Bote confains desiccant. Manufactued for:Valant hamaceutiale NorthAnerica L, Bridgewater, M 08807 USA By:Valeant Pharmaceuicas nmationl, . Stibach, VB RSC 127, Caac Prduct of Ganada CVaeantPharmacauicas Nrth Amrica LG VESOTEC® i rademark of Vlsan Phamaceutidls Infmationa, . or 5 affatzs. 9567300 20001630 |
39c4a680-b3ac-478b-8cf9-d0428d3638ad_721_1.jpg nan
39c710ba-ac05-4195-8673-59c746ed07e7_91_1.jpg Pioglitazone 15 mg Tablet arv: 90 ID #: P;15 Expires: NDC #: 70518-1548-00 Shape: Round LOT #: Ref #: 16729-0020-16 MFG: Accord Healthcare, Inc., Durham, NC 27703 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
39e3fa5d-ea48-4b02-80f6-44591f5e013f_730_1.jpg Prazosin HCI 5 mg Capsule arv: 30 ID #: MYLAN;3205 Expires: NDC #: 70518-1443-00 Shape: Capsule LOT #: Ref #: 00378-3205-01 MFG: Mylan, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
39e3fa5d-ea48-4b02-80f6-44591f5e013f_730_2.jpg Prazosin HCI 5 mg Capsule arv: 30 ID #: MYLAN;3205 Expires: NDC #: 70518-1443-01 Shape: Capsule LOT #: Ref #: 00378-3205-01 MFG: Mylan, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
3a7418a2-bd6e-4082-b0fe-a5498e7b944a_2_1.jpg CLINICAL solutions WHOLESALE Buprenorphine SL 2mg Tablets NDC: 58118-0176-8 aty: 30 Mg NOC: 00054-0176-13 T G oossertaon7ees Mig Lot - SAPLE123 Bl #: SMPLESS Mfg. By: West-Ward Pharmaceuticals Corp. Exp.: 0ct 2019 Eatontown, NJ, USA, 07724 SN:- T
3a7418a2-bd6e-4082-b0fe-a5498e7b944a_2_2.jpg CLINICAL solutions WHOLESALE Buprenorphine SL 8mg Tablets NDC: 58118-0177-8 Qty:30 Mg NOC: 0005401771 o o oossertens Mg Lot - SMPLE123 it #: SUPLESS Mfg. By: West-Ward Pharmaceuticals Corp. Exp.: 0ct 2019 Eatontown, NJ, USA, 07724 SN: - Repacted st Dt by i Sctons Wi LLC
3aada4c2-0c2a-4afb-8df1-bdac68972111_300_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. MAY DISCOLOR URIRE. 55280.186.28 55289.186-28 55269-186-28 KITROFURANTON NITROFURANTOIN NITROFURANTO MACROCRYSTALS MACROCRYSTALS ~ MACROCRYSTALS 50 mg 50 mg 50 mg 28 CAPSULES 28 CAPSULES 28 CAPSULES REORDER §101300 REORDER 4101300 REORDER #101300 10T GISC46 LOT GISCA6 LOT G15C: EXP 05/16 EXP 05/16 B W CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. ‘YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 TAKE_ CAPSULE}S) _TIMES A DAY WITH FOOD. ‘OME__CAPSULA{S)_ VECES AL DIA CON COMIDA, ORGANOLEPTIC MARKINGS: BROWN CAPSULE MYLAN 1650 ATTACH LAETL FERE————— 00 LOTY NDC 55289-186-28 & PD-Rx PHARMACEUTICALS INCORPORATED?, &) Oklahoma City, OK « 73127 NITROFURANTOIN MACROCRYSTALS 28 CAPSULES Each Capsule Ao e {MACROCRYSTALS) 50 MG S0S97 A# ‘'NMOLNVDYON 10089782800
3acbc324-9a11-4e48-b5ad-b4cc3b38dd48_353_1.jpg Take This Medication Until All Gone Unless Otherwise : NDC 55289-217-28 Advised By Your Doctor, i | & PD-Rx - | == | PHARMACEUTICALS | = ) RAGE; SEE : (NSEF I R=¢g Z|INCORPORATED" H— A— . HE=8 2 |5] Oklahoma City, 0K+ 73127 = 55289-2117-28 55289-217-28 5528921728 B N=—Q ERY-TAB ERY-TAB ERY-TAB SEE=® = DELAYED-RELEASE DELAYED-RELEAS ~ LELAYED-RELEASE 3Q=—o # o= mg mg mg == = 28 TABLETS 28 TABLETS 28 TABLETS Ea== DELAYED-RELEASE — REORDER #101233 REORDER #101233 REORDER #101233 £ O B LOT Z17201 10T 717201 10T Z17201 $s=H e EXP 01/19 EXP 01/19 EXP 01/19 = 500 i g | === £ CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. | B=—R8 , — =y YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 ! C=x 28 TABLETS 2 TAKE TABLETSS| TIMES ADAY [ BR—u Each Tablet Contains: 8 Al Tt '_ ' o1 ERYTHROMYCIN, UBP 500 MG ® b AS THE FREE BASE = TOME _ TABLETA(S) _ VECES ALDIA & ENTRIC-COATED & w ORGANOLEPTIC MARKINGS: WHITE OVAL aED
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_1.jpg 5mlL NDC0409-4713-75 Preservative-Free Rxonl Lidocaine HCI (/A | , USP 50 mg/5 mL (10 mg/ml) Hospira, Inc. RL-4821 Lake Forest, IL 60045 USA
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_10.jpg 20 mL Single-dose Rxonly NDC 0409-4776-10 Preservative-Free FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. Each mL contains idocaine hydrochloride Lidocaine B ‘mg; sodium chloride 6.5 mg. May contaln sodium hydroxide and/or 1 0 | (o TSIV 1 crochiorc aci for pH adjustment. p W /0 6.5 (5.0 t0 7.0). Sterlle, nonpyrogenic. ELLLLETRUR TN (o osage: See insert. Store at 20 to (15 mg/mL) 25°C (68 to 77°F). [See USP Controlled Room Temperature] Hospira, Inc, Lake Forest, IL 60045 USA RL-4791 Hospira
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_11.jpg 20 mL 25 single-dose Ampuls NDC 0409-4776-01 Preservative-Free Rxonly Lidocaine HCl 1 5 jection, USP . 0 300 mg/20 mL (15 mg/mL) FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. Each miL contains idocaine hydrochloride 15 mg; sodium chloride 6.5 mg. May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH 6.5 (5.0 to 7.0). Usual dosage: See insert. Sterile, nonpyrogenic. Discard unused portion. Store at 20 to 25°C (6810 77°F). [See USP Controlled Room Temperature.] Hospira, Inc, Lake Forest, 160045 USA ri-4792 Hospira
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_12.jpg 20 mL Sterile Pack Single-Dose Ampul Preservative-Free Lidocaine HCI 1.5% " Injection, USP 300 mg/20 mL (15 mg/ml) FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. Ay R Note: Inspect ampul. Discard If hipped, cracked or underflled. Each mL contains: idocaine hydrochloride 15 mg; sodium chloride 6.5 mg. May contaln sodlum hydroxide and/or hydrochlori acid for PH adjustment. 0333 mosmol/mL (calc) PH65 (5010 7.0) Y0377 Hospia, Inc. Lok oot 1L 6045 Usk Hospira Rxonly NDC 0409-4056-11 Store at 200 25°C (68 to 77°F). [see USP Controlled Room Temperature,] Contents sterlle In Intact unit package. Medication sterlle and nonpyrogenc. Usual dosage: See Insert,
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_13.jpg NDCos034056-01 20mL serterade 53 20 ML sterepsdk ssmgamiog NOC os0m4056.01 FORINFILTRATION XD 1 50/ R [TETT Y [o PSR neRve sLock iNCLUDING ORI TP NETNGEERTIY oo w0 g 20 mL sterle Pack NDC 0409-4056-01 5 Single-dose Ampuk Rxonly Presenvative Frea Lidocaine HCl injection, use 1.5% B (15 mg/mL) FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. EschmL contans Idocaine hytrochioide 15 mg; sodium chorde .5 mg. May cotainsodum yohoxideanfos byrochiorc ac o pH adustment. 0333 mOsmol/nL () H 65 (501071 Storeat 2010 25°C (5810 77, [5ee USP Contrlled Room Temperatre] Contts sefle mintac un. package.Mediaton seleand nonpyrogenic Usualdosages See nsert. Not: Inspectampul. Dicard i hipped, acked o undertie Hospira, Inc, Lake Foret L 60045 USA Hospira 09°L AT (/b sL) Tul 6g/6ul 00€ sumanoant EUREET BT ETTLET QwhaIvATN D DH d 1095 ¥e0s0 20N wommatas o TATTG0F <E oy VS0 59009 1 9104 2401 201" enson osaEvo FORINFILTRATIONAND 'NERVEBLOCKINCLUDING EPIDURAL AND GAUDAL. Patpun 0pspeD pa> 2 B 5 s e M ot e R W12 U39 F SR [N eidua | WOOY PAOIIC) S BS] 14.LL 0 §9), ST OZ1E IS 5 {90305 59 Hd (It ] 1U41OWSO W E5ED LRWSPEHA.B PIE HOPOIpA 10/pue HKaPAY =5 wnipos uie e Aey*Bul £9 3PHOILP WINP oS Bl €1 39 40 01 Y 2UIE 0P| SUIE D Ui e B venvanvmnaiasnanuiorasmmany o vos 4 S 2| REVETE) 8 . s i Juopwooe o KR ER RUEREIT] = (BT ECELT N = & corgomo msera o | Auoxy sndusy 350p216u s § — 10-950+-60¥0I0N Rdopns WO
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_14.jpg NDC 0409-4282-11 2mLSingle-dose Rxonly Preservative-Free ALY ] (AL 0 20mg2mL 20 mo/m) Hospi, Inc. RL-4795 Lake Forest L e00ss USA itk
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_15.jpg 2Zmt s Single-dose Ampuls NDC 0409-4282-25 Preservative-Free Rx only p LT 40 mg/2 mL (20 mg/mL) MAY BE USED FOR INFILTRATION, PERIPHERAL OR SYMPATHETIC NERVE BLOCKS, EPIDURAL AND CAUDAL BLOCKS. Not for spinal use. Each mL contains lidocaine hydrochloride, anhydrous 20 mg; sodium chloride 6 mg. May contain HCl and/or NaOH for pH adjustment. pH 6.5 (5.0 to 7.0). Usual dosage: ﬂ See insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Hosplra Hospira, Inc. Lake Forest, IL 60045 USA RI:-5339 o o ~ o M o — ~ i o ~
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_16.jpg 10 mL Single-dose NDC 0409-4282-12 Preservauve Free Rx only Each mL contains lidocaine HCl, [0 (Y- 1170 s (@ W 2nhyd. 20 mg; NaCi6 mo. May contain HCl and/or NaOF for pH 200 V[ fo T PN I ciusten. i 65 5010 7.0 Sterile, nonpyrogenic. Usual pL LR T TR LN I ciosage: See insert. Discard unused portion. Store at 20 to 25°C (68 to (20 mg/mL) 77°F). [See USP Controlled FOR INFILTRATION AND NERVE BLOCK "o0™ Temperature] INCLUDING EPIDURAL AND CAUDAL. RL-4797 Hospira Hospira, Inc, Lake Forest, IL 60045 USA "l Il ||I "II| "I | ”II Il
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_17.jpg e EPIDURAL AND CAUDAL. Hospira | EPIDURAL AND CAUDAL. | 10mL 25 Single-dose Ampuls. NDC 0409-4282-02 | 10 mL 25 Single-dose Ampuls. NDC 0409-4282-02 | Preservative-Free X | preservative-Free Bronh) | | 3 Lidocaine HCl § ALY T (o] | Injection, USP ! Injection, USP | 200 mg/10 mL i 200 mg/10 mL | (20 mg/mL) | (20 mg/mL) i FOR INFILTRATION AND NERVE BLOCKS INCLUDING % i FORINFILTRATION AND NERVE BLOCKS INCLUDING | | | | | | | VAN aNY 1VNaIda ONIGNTINI SHD018 IAYIN ANV NOILVHLTIANI HO4 (Jw/bw 07) RN T4 dsn ‘uondafuj PTEIUCELTTY 2214-3An0MI3591d fuo xy 202824600 YN sinduwy 3sop-2(Buis 5z W Q| j i 10 mL 25 Single-dose Ampuls NDC 0409-4282-02 | Each mL contains lidocaine hydrochloride, anhydrous 20 mg;sodium ! Rxonly | chloride 6 mg. May contain hydrochloric acid andor sodium hydroxide for pH adjustment. pH 6.5 (5.0 to 7.0). Serile, nonpyrogenic. Usual dosage: Seeinsert. Discard unused portion. Store at 20 t0 25°C (68 to 77°F). [See USP Controlled Room Temperature] Preservative-Free Lidocaine HCI 2% Injection, USP 200 mg/10 mL (20 mg/mL) RINFILTRATION AND NERVE BLOCKS INCLUDING EPIDURAL AND CAUDAL. 3 Hospira, Inc, Lake Forest, IL 60045 USA
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_18.jpg Reony NDC 0409-4277-16 20 ml T FORINFILTRATION AND NERVEBLOCK. [RLLT ] TN Lol | 2% Injection, USP 20 mg;sodm cride 6 mg; mefpataben't o adoed a5 presentive. May contain HCl andior NaOH for pH b oS a0 e oo tog e 400 mglzo L ‘dosage: See insert. Store at 20 to 25°C (68 to 77°F). [See USP (20 mg/mL) Cantrolled Room Temperature] Hospira, Inc, Lake Forest,IL 60045 USA RL-4678
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_19.jpg [20 ML 25 Multiple-dose Fiiptop Vials Reonly NDC 0409-4277-01 FORINFILTRATION AND NERVEBLOCK. Lidocaine HCI S PRI g oL (20 mg/ml) Hospr Store 2 20 10 25°C (68 077°F). [see USP Controlled foom| Temperature.] oy poIpA et Aeangenasaid OLLpOpAY: VSN 570091 353103 afE7 Ul Bk ue 3p huga <3 g2 52 pabeuwiepun pue 11 Ajuo 350 vasu aas rabesop ey [USE ASEPTIC TECHNIQUE aspi Remove cover from phastic vialand cleanse stopperwith | eudson LTV R o LRl ] A)z 5 P amiumope e o | [JH 2U1EI0PI] loutmodm won omm gt seadents =opaRmMN S T 07|
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_2.jpg RL-4825 5mL NDC 0409-4713-75 Preservative-Free Lidocaine HCI Injection, USP 50 mg/5 mL (10 mg/mL) Rx only Hospira, Inc. Lake Forest, IL 60045 USA Hospira
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_20.jpg 5 Reonly NDC 0409-4276-16 PR Multiple-dose FOR INFILTRATION AND NERVE BLOCK. e e ) Lidocaine HC| | MGG jecti et el njection, USP | se s onetvite st i 65 (50 0 20, Sene onpyrgenc. sl dome: e 200mg/20 mL | s wanto s otor7F) < [See USP Controlled Room Temperature ] (0mg/ml) | rees camin aLaczs. Hodnka
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_21.jpg Each mL contains idocaine hydrochhbide, anhydrous 10m;sodium chbide 7 mg; methylparaben 1 mg added as presenative. My contain hydroch bric cic anclor sdium hydronice for pH acjustment. pH 6.5 (50 ©7.0) Sterle, nonpyrogentc Hospira Inc. Lake Forest, IL 60045 USA TsoTdomge:See Wt Use oy T larand sl e andundamaged NDC 0409427601 FORINFILTRATION AND NERVE BLOCK. Rxonly 200 mg/20 mL. (10 mg/ml) S X @ i s S o = S Injection, USP 120 mL 25 Muttiple-dose Fiiptop Vials 1e20pI] S1A doxilg =0paPANN ST W 07| dsn ‘uonalfu IDH 3u (Tu/Bwot) Tw 0Z/Bwi 007 ) " on A s : oy losizranoson [aimeaduay oay aanUO) dS 935 14, 2 01 §9) 15201 0 1e 10 oudasue, W sadd s asuep puejen sed waisano> aroway 3NDINHAL DU1d3sY 35
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_22.jpg N Rx only NDC 0409-4275-16 50 mL XTSRS FOR INFILTRATION AND NERVE BLOCK. . . Not for epidural and caudal o 5% Lidocaine HC| [ty . | njection U SP Each mL contains lidocaine hydrochloride, anhydrous 5 mg; y sodium chloride 8 mg; methylparaben 1 mg added as preservative. May contain HCland/or NaOH for pH adjustment, 250 mg/50 mL PH65 (5010 7.0). terlle, nonpyrogenc. Usual dosage: See Insert. Store at 20 to 25°C (68 to 77°F). (5 mg/mL) [See USP Controled Room Temperature.] Hospira, Inc., Lake Forest, IL 60045 USA RL-4672 Hospira
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_23.jpg 50 mL 25 Multiple-dose Fliptop Vials. Reonly NDC0409-4275-01 \ 0.5% Lidocaine HCI [RGERGA \ J70 Injection, USP [ — Contains preserv: 250 mg/50 mL (5 mg/mL) Hospira Susbokduouap Vi1 %003 71 a103 37T z g 7 g i : g z : i g g Poppe bur | uaqedjAyiaw ‘bur § apuojyo iy Bu g snopAue ‘3pLolpOIRA DO LD Y Store at 2010 25°C (@10 77°F). ¢ USP ConiroledRoom Temperature | pobew epun PUe e 1 e3s pue a1 Ao 367 Uasu a3 :abesop [ensp) Remove cover from plasticvia and cleanse stepper with g s < Bt Mg eudsoy E Y (Jw/bw ) e Lo OS/BW 9z D078 INEIN ANV NOLVALTINIH04 LOSZr60/0 XN Amoxy IDH duredopi %S0 st dowdiy ssopidiim T Ju 0.
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_3.jpg i i | Sl | i SsEis | | SR . ! 235 g ! ! 2353 | & i i g3z 4 2 I g o & 2 mL 10 ingle-dose Ampuls N "”9";;1:;3 | = | g 3 Preservative-Free - ——— 2 i = ! ! g 2 Lidocaine HCl Injection, UsP P2 : 5 =2 20mg/2mL |2 | g (10 mg/mL) ! ; £ & | FORINAILTRATION AND NERVE BLOCK INCLUDING EFIDURAL AND CAUDAL ; ; g 2 : ! g 3 ! ! LA, | | 8 Hospira | i eudsoy VSN 5700971 ‘153104 €] U] ‘eaIdsOH [omeiadua] Wooy payonu0) dsil 32s] ol £0189) 2,520} 0T 18 21015 "UdsU| 395 :26esop [ensf) *(3]e2) Tu/OWSOW L €0 “(0'2 030°5) 59 Hd Jusuasn(pe Hd 10} pi%e JHORPOIPAY 10/pue SPIXQIPAY WNIPCS URIUD3 Aeyy 6 £ pYOILD Wnjpos 1B 0L SNQIPAYUR ‘9P HOYDQIPAL BUIRDOPI] SUIRUOD i Lpe3 VANV IONY TVANGIE SNKIDNIND 018 IAEN ONY NOLLWALTLNI %04 (u/Bw o) T z/bw 0z oy STEL L6010 20N dsn‘uopaful [JH auredopr] 2a14-ane DS I sinduyesop=1Bus0L W 7 [2'ML 10 Single-dose Ampus Preservative Lidocaine HCl mjection,Us? 20mg/2mL (10mg/mL) NDC 0409471325 Hospira FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_4.jpg 50 mL single-dose Preservative-Free Rxonly NDC 0409-4278-16 i H FOR INFILTRATION TECHNIQUE INCLUDING 0 5% ||'"d°'ca"b§ PHC PERCUTANEOLS IIECTIONAND njection, INTRAVENOUS REGIONAL ANESTHESIA. Each . J ‘mL contains idocaine hydrochloride, anhydrous 5 mg; Nacl 8 mg. May contain HCl and/or 250 mg/50 ML N0k for p adjustment. pH 65 (5010 7.0) Sterlle, nonpyrogenic. Usual dosage: See insett. Bmg/mL) kg sorea 20 t0 25°C (68 to 77°F). [See USP. Hospira, Inc, Lake Forest, L60045USA RL-4680 Controlled Room Temperature] - HoSpira
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_5.jpg 0 ML 25 Single-dose Teartop Vials NDC 0409-4278-01 o 5% Lidocaine HC| Presativesree meon . Injection, USP INCLUDING PERCUTANEOUS o 250 mg/50 mL 'REGIONAL ANESTHESIA. (5 mg/mL) Holha o i g : F ; £ s . E * 7 E = : i e e E € worvod s e o 105 pabatn Stesop ersn) 1. Remove ab. Cleanse sopper with antsepic 2 Wibdraw desied amountof sohtion, 3 Dicard urwsed porton eadsoy (Tw/Bui 5) issusaw oD Twog/bwosT NV NN NI dsn ‘onafuj (), 9 OMIDINOIYALTiN 303 e fuons saennenesag [JH BUIRIOPIT /OS o 108216070 XA sleindoyea1 350p-3uISSZ W O
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_6.jpg 30 mL Single-dose Rx only NDC 0409-4279-16 ive-| FOR INFILTRATION AND NERVE BLOCK Preservative:hree INCLUDING EPIDURAL AND CAUDAL. id . || e comans ascane v, s Lidocaine HC 10 mg; NaCl 7 mg. May confaln HCl R andfor NaOH for pH adjustment. pH 65 = Injection, USP (50 to 7.0). Sterlle, nonpyrogenic. Usual = dosage: See Insert. Discard unused portion, Store at 20 to 25°C (68 to 77°F). 300 mg/30 mL [See USP Controlled Room (0mg/ml) | e Hospira, Inc, Lake Forest, IL 60045 USA RL-4789 Hospira
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_7.jpg i and seal & [sch L contains idbcaie hydrochbrde, anfydous 10 g, Usual dsge: See nsert Use oy 1 act o s 7 mg. Ve Crtan ydracione 3¢ ander and.undamases. Coans o bacteosat e prompe o e st H 65 5,01 7.0, Gsordunisatporion E— s, Lok s L6003 U5 38 £ &y scl3d 5 wegl|e & : =8328| & ; $3g2 i e w3 g Bl 58 g0 3% £ - 2 323 g i 8 gfd £85 252 885 EEH B ) .- 5 gsf 3 B g 3 g g 2 25 2> g2 = .= § EH U E amng . = SF 3 |3 RE ile 25 s |EZ 2E § |®B2Es i lgss2 : | 8g {g|BER 45\ 0= it o B EJ 2 & vaudpomin e famyenduny bda ooy P10 s 991 (4L 01 ) 152 0107 0 9IS By Ao pue SRILG Jo [eAcu oy KiSo30 wouad psnun s ¢ o og womnes pssonanwis o1 bt ¢ P nepn 2 saddo1s pue Jeasiano ‘qe) anoway | pdagiue yum saddorsasu &) qel iy 1 Aprewsayy INDINHIL IUIISYISN|
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_8.jpg One/No. 0409-4270-11 Lidocaine HCI Injection, USP 300 mg/30 mL (10 mg/mL) 30 mL sineLe-pos viaL
3b2dd84e-cee8-4e58-d494-395a65a353a0_872_9.jpg 733, o Sterile Pack One/No. 0409-4270-11 Preservative-Free Rxonly Lidocaine HCI Injection, USP 300 mg/30 mL (10 mg/mL) 30 ML SINGLE-DOSE TEARTOP VIAL FOR INFILTRATION AND NERVE BLOCK INCLUDING EPIDURAL AND CAUDAL. Each mL contains lidocaine hydrochloride, anhydrous 10 m; sodium chloride 7 mg. May contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 6.5 (5.0 to 7.0). Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Contents sterile inintact unit package. Medication sterile and nonpyrogenic. Usal dosage: See insert, Discard unused portion. TY-0375 Hospira, Inc., Lake Forest, IL 60045 USA Hospira
3b631aa1-2d46-40bc-a614-d698301ea4f9_636_1.jpg 5| O | Store at or bolow 86°F (30°C). 2| Z | Dosaceanuse 1 | S | Sesaccompanying presibig NDC 0069-3150-84 Rx only 5 (3 . = .. ® ° Costitute to 100 mg/mL* with = g : A,BmLnfSterHeWagtevFm\mewnn — Zl_thromax__ } on || Must bo urher diuted botore use, = (@2ithromycin for injection) S | For appropriate dilvents and storage. = ) e recommendations, refer to = ) M( prescribing information. 1 g == For LV. infusion only *Each miL contains azithromycin dihydrate equivalent to 100 mg of azifhromycin, 76.9 mg of ciric acid, and sodium hydroxide for pH adjustment. MADE IN IRELAND 7 DISTRIBUTED BY PFIZER LABS Injectables DIVISION OF PFIZER ING, NY, WY 10017 STERILE equivalent to 500 mg of azithromycin NoLatex No Preservative
3b631aa1-2d46-40bc-a614-d698301ea4f9_636_2.jpg 5| O | Store at or bolow 86°F (30°C). 2| Z | Dosaceanuse 1 | S | Sesaccompanying presibig NDC 0069-3150-84 Rx only 5 (3 . = .. ® ° Costitute to 100 mg/mL* with = g : A,BmLnfSterHeWagtevFm\mewnn — Zl_thromax__ } on || Must bo urher diuted botore use, = (@2ithromycin for injection) S | For appropriate dilvents and storage. = ) e recommendations, refer to = ) M( prescribing information. 1 g == For LV. infusion only *Each miL contains azithromycin dihydrate equivalent to 100 mg of azifhromycin, 76.9 mg of ciric acid, and sodium hydroxide for pH adjustment. MADE IN IRELAND 7 DISTRIBUTED BY PFIZER LABS Injectables DIVISION OF PFIZER ING, NY, WY 10017 STERILE equivalent to 500 mg of azithromycin NoLatex No Preservative
3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f_779_1.jpg 2008052635 100 m 55566-0302- ACTHREL® NDC 55666-0302-1 Ilwwl (corticorelin ovine triflutate for injection) Contains 100 mag corticorelin ovine (as the trifluoroaceate), 10 mg lactose, 0.88 mg ascorbic acid, and 26 mg cysteine hydrochloride monohydrate. Sterile. For intravenous se only. Reconsttute with sodium chloride injection immediately prior 10 use. Protect from light. Rx only. Dosage: See package inserl. Store at reffigerator temperature 2° to 8°C (36° to 46°F). Manufactured for: Rt Ferring Pharmaceuticals Inc. 601008 o % Parsippany, NJ 07054 Made in Germany —aw
3c996da2-c606-4043-9992-5bfb7f9b97a7_995_1.jpg CansoNATE RELEASE TABLETS
3cacd754-73f4-496e-a529-9ca39fa6692d_918_1.jpg noC 65862-070-01 Rxonly Amoxicillin for Oral Suspension, USP 200 mg/5 m 100 mL when reconstituted /2 AUROBINDO Diecions o miing: Tap oo unl al powder flows freely. Add approximately 1/3 total amount of waler o econstuton (TR RRshake vigorously o et powder. A emaINNG vatr aain shae vgorousy Each 5 mL (1 teaspoontu) willconain amoxicillin trihydrate equivalent to 200 mg anhydrous amoxicillin. Dosage: Admirister every 12 hours. See accompanying prescribing information. Keep tightly closed. ‘Shake well before using. Retrigeration preferable but not required. Discard suspension after 14 days. Netcontents: Equivalent t 4 grams anhycrous amoxiciln Store dry powder at 20°to 25°C 68° to 77°F): excursions pemitted to 15° to 30°C (9° to 86°F) [sez USP Controled Room Temperature], Distriouted by: ‘Aurobindo Pharma USA, In. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/57/2003 v Printng Zone Dt e ot e vt
3cacd754-73f4-496e-a529-9ca39fa6692d_918_2.jpg Dirctonsfor mixing: Tap bttt all powder Disrbuted by: fows fesy. Addapproimatly 31t zmount Aurobindo Pharma USA,Inc. NoC 65852-07 101 e o[ TR 57 it sopstonn s VIGOOUSly o et powder. A remainng vatr, — East Windsor, J 08520 again shake vigorously. Made in India Each 5 mL (1 teaspoontul) will contain amoxicillin trinydrate equivalentto 400 mg Code: TS/DRUGS/57/2003, — anhydrous amoxiclin. Dosage: Administer every 12 hours. See accompanying prescribing information. Amoxicillin o ‘Shake well before using. for Oral Suspension, USP ersgerston peteapiebut not requiea. 4("] mg/5 mL Discard suspension after 14 days. Netcontents: Equivalent t 8 grams anhycious 100 mL when reconstituted amoviilin. ‘Store dry powder at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to /59 AUROBINDO 86°F) [see USP Cortrolled Room Temperature]. Rxonly Goting ke (5220 mm) Dot ne et o e pret
3cb843fd-c312-46b0-8023-6f06f2c34c1e_137_1.jpg Dosage: See package insert { MedStart‘“ Sample - Not for sale L Sertraline HCI Take _tab(s) Tablets USP, 50mg —.o"" % 30 Tablets for___days. STORE AT CONTROLLED ROOM TEMPERATURE NDC: 42708-068-30 Lot: XXXXXXXXXX Exp. Date: MM/YY Dist. By: QPharma, Inc. Keep container tightly closed Cedar Knolls, NJ 07927 Keep out of reach of children Rx Only E
3d46d6e6-9b06-45f8-a983-526005d75e69_144_1.jpg Pactoped by Eopast Reeck Bbank. @4 9504 NABUMETONE "M ovaLamt 750 MG TABLET 10 gL | 5| Store at room temp of Compare To: 20°25°C (68°77°F) RELAFEN T50MG TABLET-13 Keep all drugs outof Watson Pharma Private Limited 5 reach of children. #30 Exp: MMYY & NDC 6362976091 076991122318
3d485c1d-2d77-49fb-9358-b18dd9e7d050_370_1.jpg AVOID SUNLIGHT. TAKE WITH A FULL GLASS OF WATER. DO NOT TAKE WITH ANTACIDS OR MINERALS, FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. 8 —_— 43063-891-04 43063-891-04 43063-891-04 | B8 DOXYCYCLINE DOXYCYCLINE DOXYCYCLINE =3 HYCLATE USP HYCLATE USP HYCLATE USP éo = 100 MG 100 MG 100 MG == 4 TABLETS 4 TABLETS 4 TABLETS EE =3 REORDER #110632 REORDER #110632 REORDER £110632 = S=—i LOT HI8G50 LOT H18GS0 LOT HI8G50 ga=H EXP 08/20 EXP 08/20 EXP 08/20 EIE= | = CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. | E=2 YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 ; == TAKE__TABLET(S) TIMES A DAY WITH FOOD. 12=8 TN T = PD-RX NET TOME__TABLETA(S)__ VECES AL DIA CON COMIDA. ORGANOLEPTIC MARKINGS: ORANGE ROUND 3626 NDC 43063 891-04 DOXYCYCLINE HYCLATE USP 4 TABLETS Each Tablet Contains: DOXYCYCLINE HYCLATE EQUIVALENT TO 100 MG DOXYCYCLINE “OT1 "WHVHd TTIMLIVHO SS0SS0S0VL9
3e12ed30-a093-4eb2-84bb-75a5929e36d9_550_1.jpg 43063-894-30 43063-894-30 43063-894-30 PIOGLITAZONE PIOGLITAZONE PIOGLITAZONE USP USP USP 15 MG 15 MG 15 MG 30 TABLETS 30 FABLETS 30 TABLETS REORDER #110639 REORDER #110639 REORDER #110639 LOT 118B98 LOT [18B98 LOT I18B98 EXP 09/20 EXP 09/20 EXP 09/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 TAKE__TABLET(S) TIMES A DAY, TOME__TABLETA(S) _VECES AL DIA. ORGANOLEPTIC MARKINGS: WHITE ROUND P 15 i iﬁ_i > éo:o .-1__.\ = oy m— §3=° O —.. §3= £ m—r E?&= — o == —_— E—|=H ﬂ—[: ZES a a NDC 43063-894-30 PD-Rx = PHARMACEUTICALS E = I IINCORPORATED®, 1 DOklahoma City, OK = 73127 E m—— PIOGLITAIONE = USP S5 BS gt S = S mm = . 30 TABLETS = Each Tablet Contains: Q== PIOGLITAZONE HYDROCHLORIDE USP EQUIVALENT TO § — PIOGLITAZONE 15 MG D — SEm OV
3e354b4d-70e1-5089-e054-00144ff88e88_915_1.jpg @ NuCare Pharmaceuticals, NDC .66267-102-90 —xp. Date:00-00 GIyBURIDE 25mg #90 Tablets ach tapiet comans 2.5 Glybunde USP Capsule Shaped Pink Scored Tabiet De-bossed: I 36' on the un-scored Lot # 000000 —eWe) Aq pade: “Raone Bue. au ‘sieannéSSEESR Siwony *Aup & sowy 000000.000000.06.06201049299 sinoy ‘8801-YQ-008"} 18 V04 9} PO102090 Product " x Only Inc. GlyBURIDE 2.5mg e Exp Date: 00-00 NDC 66267.0102-90 AWP: $184.92 Hfg NDC 23155-057-01 Lot #: 000000 R # 23138215 GlyBURIDE 2.5mg 45 Tablets . ExpDate:00-00 NDC 66267.0102.90 AWP: $184.92 Mfg NDC 23155-057-01 Lovs: 000000 ox# 23138215 GlyBURIDE 2.5mg #50 Tablets Exp Date: 00-00 NDC 66267.0102-90 AWP: $184.92 Mfg NDC 23155-657-01 Lot #: 000000 R #23138215 GlyBURIDE 2.5mg 990 Tablets | ExpDate:00-00 NDC c6267-0102-90 g NDC 23155 05701 o2 S G00000 ) RX# 23138215 Rx# 23138215 WARNING: KEEP OUT OF REACH OF CHILDREN. - STORE AT CONTROLLED TEMPERATURE 63-77°F.
3e8149e1-ada2-4f3d-996b-466759cbb344_310_1.jpg Bl imniRE R e S | pewnamET - . Ruay ‘TAKE 1 TABLET DALY o s soneen -
3ec62ecc-677d-4f61-88a3-1bd9d9108fd5_412_1.jpg CLINICAL solutions WHOLESALE Lithium Carbonate 300mg Capsules NDC: 58118-0545-8 aty: 30 Mig. NOC: 31722-0545-01 GTIN: 00358118054584 Mig_Lot #: SAMPLE123 Balch #: SAMPLEASE Mig.By: Camber Pharmaceutcals Exp- 0ct 2019 Piscataway, N, USA, 08854 SH: YMMDDOOD000 ey iy P e e S P IWSRETU
3efa5604-96c3-42a0-8e99-b3de4a66aa92_764_1.jpg NDC 68083-113-01 P | BT T R LR ONDANSETRON INJECTION USP 4 mg Ondansetron/2 mL (2 mg/mL) & only Manufactured by: 5 Gland Pharma Limited Sterile o @ D.P. Pally, Dundigal Post, For LV. or I.M. Injection Hyderabad-500 043, INDIA. o = Ll o o O o < o M.L.No. : 103/AP/RR/97/F/R
3eff42c0-0c14-4ccb-a3d4-8261f4bfab2b_514_1.jpg NDC 64376-648-01 c Hydrocodone Bitartrate and Acetaminophen Tablets, USP Tspersorie sccomguny et G ek gt Rxonly 100 Tablets PAR Descripion: Each tablgtcontains: Hyrocodons Biar Smg “WARNING: May bo habi forming Acstaminophen 0mg a 'USUAL ADULT DOSAGE: Se0 packgs nser ol prscrona KEEP THIS AND ALL DRUGS OUT (OF THE REAGH OF CHILDREN, Pharmacis: ispense i ot Lot asistant contane with & chidosisant osuro GTIN 00364376648014 64376-648-01 Storage: Store at20°to 25°C 66 t077°) 500 USP Controled Room Temperaturel. N 3
3eff42c0-0c14-4ccb-a3d4-8261f4bfab2b_514_2.jpg NDC 64376-649-01 @ Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5 mg/300 mg T o Madiion Gude s eahprten. Rxonly 100 Tablets PRAR Description: Each tablgtcontains: Fybocedons Brariate’ . 15 ma “WARNING: May bo habi forming Acstaminophen 0mg 'USUAL ADULT DOSAGE: Se0 packgs nser ol prscrona KEEP THIS AND ALL DRUGS OUT (OF THE REAGH OF CHILDREN, Pharmacis: ispense i ot Lot asistant contane with & chidosisant osuro Storage: Store at20°to 25°C 66 t077°) 500 USP Controled Room Temperaturel. oy 1216 R0 Disrbuted by Por Prasmacautial Chetion Ridge WY 10877 64376-649-01 1 N 3
3eff42c0-0c14-4ccb-a3d4-8261f4bfab2b_514_3.jpg NDC 64376-643-01 G Hydrocodone Bitartrate and Acetaminophen Tablets, USP Rxonly 100 Tablets PRAR Descripion: Each tablgtcontains: Hyrocodons Biare oma “WARNING: May bo habi forming Acstaminophen 0mg 'USUAL ADULT DOSAGE: Se0 packgs nser ol prscrona KEEP THIS AND ALL DRUGS OUT (OF THE REAGH OF CHILDREN, Pharmacis: ispense i ot Lot asistant contane with & chidosisant osuro Storage: Store at20°to 25°C 66 t077°) 500 USP Controled Room Temperaturel. Disrbuted by oy 1276 B0 Por Prasmacautial Chetion Ridge WY 10877 GTIN 0036437643019 64376-643-01 9 N 3
3ffb8392-963f-4b3a-b0eb-8791ea6309ff_141_1.jpg nan
405074f3-9c1a-46cd-889e-76ec8966a556_904_1.jpg m—. e ST S RS SREEEERUS . PEEE et . R e g P R o ATHESADAY § i i " S ORASDRECTD. Do e oz = Py EEEL e l i :
413b6f65-101e-e2cf-0802-711d080b851b_288_1.jpg Packaged by Eryant Ranch Burbank, O 91504 S RED CAPSULE SHAPED (Torrent Zolpidem <, fogo) 56 Tartrate 5mg (CIV)Tablet S troom temp of 20-25C ¢ 5 = | Keep all drugs out of Compare To: reach of children Ambien Smg (CIV) Tablet T Lek Pharmaceuticals d.d machinery swox #30 Exp: MM/YY NDC 6362935491 035491107176
413b6f65-101e-e2cf-0802-711d080b851b_288_2.jpg Packaged by Bopact Rach Bnbank. @4 9508 ZOLPIDEM 10MG 5 Sy cosu swe (CIV) TABLET Lzzen Store at room temp of Compare To: 20°25°C (68°77°F) ANBIEN 1OMG V) TABLET-LB o — #30 Exp: MMYY NDC 6362977951 077951122727 Keep all drugs out of reach of children. om
41470a8c-e101-4246-917e-be80cc846da3_11_1.jpg 1uady ol U0E) 4N vonaalug 0} aeydsoud auiqesepn|4 —— —— Wen e o ue Fludarabine Phosphate for Inecton USP Single Dose Vial Lyophilzed For IV Use Only Castion: Cytotasic Agent sl Dosage: e package nsertfor ol prescribing Fludarabine retigerated TRFTOE 0. When ecostitted with 2 mL sterk watrfor nctin, USP, e resling sltion wil contain: 25 my/mL fhcarabios phosphate, USP, Single Dose Vial Lyophilzed For IV Use Only Caution:Cytotoic Agent s witi 8 hours of Contain no prsaratve. 50mgof maitl, US? and sadum troide o st pHia 2.7 Toe g range o the il paduct 5,210 82, Sen botom panelfor bt umbes ad exiationdate. for Inecton USP X12-X10-926
41f83de2-1aef-47a1-a65c-99cebee9b1b5_292_1.jpg Over Coding Template No Vamished Area (Do Not Prin) (18x41 mm) NDC 70774-1344-3 P Duloxetine P ity Delayed-re'ease USP equivalent to duloxetine. ... 20 mg. Usual Dosage: See package insert Capsules, USP gl e o Store at 20°to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a ight container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. 50 ey 30 Capsules © ,?Pf-y-i": Rxonly Ahmedabad, india
41f83de2-1aef-47a1-a65c-99cebee9b1b5_292_2.jpg b_ver Coding Template No Vamished Area (Do Not Print) (1841 mm) NDC 70771-1345-3 | Duloxetine SR G e Delayed'release USP equivalent to duloxetine 30 mg Usual Dosage: See package insert Capsules, USP forcomplt prescriang ieraton. Store at 20°to 25°C (66°to 77°F) [See: B - USP Controled Room Temperature] g Dispense in a ight container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. 0oy 30 Capsules ~ Manufactured by: Rx only
41f83de2-1aef-47a1-a65c-99cebee9b1b5_292_3.jpg GTIN 0000000000000 ¥ Lot %000 | Exp. MMMIYY ! 1 SR No 0000000000000 i Over Coding Template No Vamished Area (Do Not Print) (1841 mm) Duloxetine Delayed-release Capsules, USP 30 Capsules Rx only NDC 70771-1346-3 A Each delayed-release capsule contains 67.3 mg of duloxetine hydrochioride, USP eqivalent to duloxetine .60 mg Usual Dosage: See package insert for complte presciibing information. Store at 20°to 25° (68° to 77°F) [See. USP Controled Room Temperature] Dispense in a ight container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadia Healthcare Ltd. Ahmedabad, India EEEY
4226222a-7729-42aa-8dff-887491a5dab7_450_1.jpg s filn-costd et cortaine Disponseina fight, it esistant ot s, U5 st ARSI P ot e i 09 80 mg offavasatin, using acilresistat o, Y Keep conaier tighty coce. Keep this and all medication out of thereach of chikdren. Store 3t 20°1025°C (69" o 77°F). [See USP Controlled Room Temperature.] Protectfrom lght. Usual Dosage: See accompanying prscrbing nformaton. Mylan Pharmaceuticals Inc. Worgantoun, Wi 26505 US A lMylan® [MMylan® T Mylan.com € N RMS121H1 ASAXIONAXT X 10T : : 2 g Z g g g g g g 0 £6=1215=8/£0 '
4241d01a-8144-4e73-8cac-a5052f85be39_211_1.jpg vawe OAKORN ;:;;:um:@ [T23:Y 0.05% i 1 | £ FORTONCAL USE Y NOTFOR DAL OVTVALME, 08 NTRAAGHNAL USE K s k8 msion ot ench e fry oy e et e [ S O0SAG gy o i e e ot TR S 2 25T 2 ottt gt OAKORN Noc e174n 20740 n:soxmnnsone@ use I FORTORCAL St LT NOT FOR AL OPVIMALMK 08 NTRAAGHAL USE s s st f e e f e o 09 e S e e g e, e SISIDITIIIIN ==
424d18bd-bf3b-4556-b50a-71afe597d7e8_160_1.jpg £rSTCATE ORYE LMo GTLLE LN T AT
424d18bd-bf3b-4556-b50a-71afe597d7e8_160_2.jpg OXYGEN, REFRIGERATED LIQUID USP UN1073 WARNING For amargancy useanywhenaiministre b proer el prsonne foroygendfslncy and ressctaton,Foral oftr mcia aplcators, B ony. Unirterptad oo ighcnsrraons of g o 7o contnt of arril bood, may 5 harmfl. Do ot atempt 0 o on patats who e sopped beain unlss s I conunton vt susctalv gt eep ot ofreach o cilien, Fodaalaw requles tha s comtar b 252 0ng manfectrr nacortancewih the PRODUCED BY AIR LIOUEFACTION DANGER « MAY GAUSE OR INTENSIFY FIRE; OXIDZER, - CONTAINS REFRIGERATED GAS:AY CAUSE CRYOGEIC BURNS OR INUAY P, Drg and Cosme At ~ COUBUSTIBLES IN CONTACT WIT LIGUID OXYGEN HAY EXPLODE O GNITION OR INPACT. Do ot handle unlllsafly precauios hve been 1 and undortoad away from lthn and othr combustlemateias. lorgduration, it montrig s st i xy0¢ USP only by etblmets elstored Use only ithsquipment of conpathi materialsof Consructon and ratedfor clinder presure. Use only with squipment lesnad for orygenservice, DONOT change orforcs i conactons, Avod spls. Do ot walk o o ol eauprentavr o, Glse valv e ech e and when ety Alvs ke Contaner It upightposton Read and ol te Safty Dat Shet (SDS) efore se F ON SN Traw fostedparts withukavarm wte. Do ot ru affcted ar, Gt Inmadte medial dvcsattan- d fitings frae from greass and oil. oo @ tore ol dors £ v e — e el cok st o ILMO ooz tinos ssso Use # back fow preventve device inthe ipig. SECURE ALL CYLINDERS WHILE IN STORAGE AND IN USE. e company 2172452183 DO NOT REMOVE THIS PRODUCT LABEL.
4260d746-bb58-4e10-9ffe-fc414f22b591_226_1.jpg Gemfibrozil 600 mg Tablet arv: 45 ID #: 225;I1G Expires: NDC #: 70518-1563-00 Shape: Oval LOT #: Ref #: 69097-0821-12 MFG: Cipla USA, Inc., Miami, FL 33156 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4290e001-c03c-4bde-a132-5203cc57afb4_475_1.jpg NDC 45802-929-49 Mesalamine | Rectal Suspension, USP Enema 4g/60 mL Unit-Dose For Rectal Use Only ‘SHAKE WELL BEFORE USING Made nsael Manacured e Yeruhom, | Nk‘ly Disibuted 8y NDC45802-929-49 Mesalamine | Rectal Suspension, USP Enema For Rectal Use Only SHAKE WELL BEFORE USING 4(7x60 mL UNIT-DOSE BOTTLES) KITS Perrigo® Each o the 4 isIncudes 7 complmentary cleansng wipes. ispense nexstng packagingas ono un, 6o not repackage. oot g e EaEmeaey R R o e o D e S ey NOTE s o e g o S 25257 77 5 e o e B e ateed e e e
42c49deb-713b-427a-9670-08af08adcffb_611_1.jpg NDC 50242-130-01 Alecensa® (alectinib) capsules Each capsule contains 150 mg of alectinib (equivalent to 161.33 mg alectinib HC). Ronly 240 capsules Genentech §
4304955f-8ac5-4c18-9998-a8d747709a8d_716_1.jpg Allopurinol 300 mg Tablet arv: 30 ID #: DAN;DAN;5544 Expires: NDC #: 70518-1573-00 Shape: Round LOT #: Ref #: 00591-5544-05 MFG: Actavis, Parsippany, NJ 07054 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
43785b49-5d1e-4ae9-b2ff-26be910bde7f_161_1.jpg : only LU EEE G G R UF T}{E REACHIOF CHILDREN! 43063-683-90 43063-683- 90 43063-683-90 CITALOPRAM CITALOPRAM CITALOPRAM Usp usp use 20 MG 20 MG 20 MG 90 TABLETS 90 TABLETS 90 TABLETS ReOrder # 110036 ReOrder # 110036 ReOrder # 110036 LoT H18F95 LOT H1RF35 LOT H18F95 EXP 08/20 EXP 08/20 EXP a8/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) ___ TIMES A DAY. TOME___TABLETA(S) VECES AL DIA. Each TABLET Contains: CITALOPRAM HYDROBROMIDE USP EQUIVALENT TO 20 MG CITALOPRAM ORGANOLEPTIC MARKINGS: TAN 1010 20 OVAL/BRKLINE NDC: 43063-683-90 CITALOPRAM USP 20 MG 90 TABLETS (01)10343063683903 (21)H1RF95000001 (17) 200831 (10)H18F95 E06EBIEIVEYE TR 0 VIONI HINYvHE “aL1 WHYHd LINJHYOL T00TOOB9SET
43d1f68d-874b-4cbc-94ff-fd498cc9f2c1_217_1.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED LIquID UN1073 WARNNG: o ey ey et s b g o st e e i 1 4 e A e o e ot s s o g Mt o oo T 9 e e s o s e s i i i el i, K . oo o b i i S8 - s g . S etk o, A oA Fresd oy Ar . OANGER: WA/ GASE O TS DBOER COTAIS EFSERATED kG CYCEAG LA 04 P CNSISTLES e W LA GG W BOLES O BTN A wacr Onet b s s e e iy o e el G s o e g o o s L 1 ot i vt W g, x5 4 o ow it Sep a0 U ik o s s 1 i, U oty AR e o it o G e s oy ot ca o oy Sk 00 Nl o e s s, ool o 0k i st s Wy s b et om0 o S0 ot FARSTAD: FONSE: ottt v e sl s s os 00/UOT REMOVE TS PRODUCT UBEL DALE OXYGEN, INC. 145 HORNER ST + JOHNSTOWN, PA 15302 . arss 8145353594 P
43d1f68d-874b-4cbc-94ff-fd498cc9f2c1_217_2.jpg monkorg s st on ek usad ing ures used inconkncten 0 containe b refled with D Food, Drug and Cosmetic Act EXPLODE IF HEATED. Do not coting and thercr orina wel-veniated psc. 11 28 piing. Use only with squpmett fpmes ceaned 01 P meLnet: W 814-535-3594
44bcc8df-a803-010f-e054-00144ff88e88_244_1.jpg ileZ1EH NDC 66267-665-90 Lot#: 000000 Exp. Date:00-00 Allopurinol 100mg #90 Tablets =—— Each tablet comtains: Allopurinol USP 100mg. ound White/Off-White Scored Taviet.. inscption” *AW” on the un-scored BONN ‘aBuei0 X paBexoY ‘9pis yoda: Asu nos 10} 10130p 0ok (8D 8 VO Lietg e. 2 000000.000000.06,06§990£9299 E 2 8801°Y04-008 Product #: P06 Rx Ol WARNING: KEEP OUT OF REACH OF CHILDREN. [[g[e Hopurinol 100mg A #90 _Tablets Exp Date: 00-00 NDC 66267-0665-90 AWP: $35.50 i NDC 16726-134-16 Lot #: 000000 Rx # 23140591 Aliopurinol 100mg #90 _ Tablets Exp Date: 00-00 NDC 66267-0665-90 AWP: $35.50 Mfg NDC 16720-134-16 Lot #: 000000 Rx # 23140591 Aliopurinol 100mg 50 Tabiets Exp Date: 00-00 NDC 66267-0665-90 AWP: $35.50 hg NDC 16726-134-16 g N oto00 | Rx # 23140591 Aliopurinol 100mg oo Tabless | Exp Date:00-00 NDC 66267-0665-90 Mfg NDC 16720-134-16 ot #: 000000 Rox # 23140501 Rx# 23140591 STORE AT CONTROLLED TEMPERATURE 68-77°F.
4532f5fd-0396-481e-b827-fbf12e025231_578_1.jpg Pashaged by Eryane Reanch Bunbank. ¢4 91500 5 VHITE OVAL Ei2 Gemfibrozil g 600mg Tablet 5o R store at room temp of Compare To: 20°25°C (68°-77°F) Lopid 600mg Tablet Keep all drugs out of Citon Plarma LC reach of children. om #60 Exp: MMYY NDC 7133508991 013901121262
454054f1-0730-41b3-844a-c7b65f1b47c5_921_1.jpg UsSP 3.125 mg 100 tablets See package insert for dosage information. F) TABLETS, to 30°C (59°-86° [See USP Controlled Room Temperature]. NDC 51407-039-01 CARVEDILOL Store at 25°C (77°F); Excursions permitted to 15° 5140703901 « Each tablet contains: 3.125 mg of carvedilol, USP * Dispense in a tight, light resistant container as defined in the USP, with a child-resistant closure (as required) « Keep this and all medication out of the reach of children ™ X 3 S & S & S A B ~ ,Vp N S £ S = S A O ~N ” X S & 8 & S A 8 Manufactured by BEXIMCO PHARMACEUTICALS LTD., Kathaldia, Tongi, Gazipur, 1711, Bangladesh Packaged by GSMS, Incorporated Camarillo, CA 93012 USA
454054f1-0730-41b3-844a-c7b65f1b47c5_921_2.jpg USP Excursions 100 tablets See package insert for dosage information. F); NDC 51407-040-01 CARVEDILOL TABLETS permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Store at 25°C (77° 5140704001 « Each tablet contains: 6.25 mg of carvedilol, USP « Dispense in a tight, light resistant container as defined in the USP, with a child-resistant closure (as required) * Keep this and all medication out of the reach of children B .Vv m S B 3 5 S % O = S m S & S & S A O N ” 3 S & S RS m A © Manufactured by BEXIMCO PHARMACEUTICALS LTD. Kathaldia, Tongi, Gazipur, 1711, Bangladesh Packaged by GSMS, Incorporated Camarillo, CA 93012 USA
454054f1-0730-41b3-844a-c7b65f1b47c5_921_3.jpg NDC 51407-041-01 CARVEDILOL TABLETS, USP 100 tablets See package insert for dosage information. permitted to 15°-30°C (59°-86°F) Store at 25°C (77°F); Excursions [See USP Controlled Room Temperature]. 5140704101 « Each tablet contains: 12.5 mg of carvedilol, USP « Dispense in a tight, light resistant container as defined in the USP, with a child-resistant closure (as required) * Keep this and all medication out of the reach of children = .W-v 3 S & 3 15 3 A O = 8 m S IN S s S A O = 8 m S IN 2 g m A O Manufactured by BEXIMCO PHARMACEUTICALS LTD. Kathaldia, Tongi, Gazipur, 1711, Bangladesh Packaged by GSMS, Incorporated Camarillo, CA 93012 USA
454054f1-0730-41b3-844a-c7b65f1b47c5_921_4.jpg 25 mg 100 tablets See package insert for dosage information. °C (59°-86°F) TABLETS, USP -30 NDC 51407-042-01 CARVEDILOL permitted to 15° [See USP Controlled Room Temperature]. 5140704201 « Each tablet contains: 25 mg of carvedilol, USP « Dispense in a tight, light resistant container as defined in the USP, with a child resistant closure (as required) » Keep this and all medication out of the reach of children = ” 3 S & 2 i s > O ~ X B S IS 3 W s A O = ‘Vv 3 S & 3 i S A O Manufactured by BEXIMCO PHARMACEUTICALS LTD. Kathaldia, Tongi, Gazipur, 1711, Bangladesh Packaged by GSMS, Incorporated Camarillo, CA 93012 USA
45af3eda-caaa-4478-9372-95aa65adc9b3_135_1.jpg £ z Non-Varnish and 1 0-5%02-8260 ‘Serialization Area 2z e Each capse conains: Tacrolimus, USP osmy IV LR Tacrolimus Capsules, USP Rxonly 100 Capsules Dispense ina figh, ightresstant contineras defincd in the USP. using a chid-esistant closure. Keep container gl close. Keep this and all medication out of the reach of chikren. Store at 20° 0 25°C (65° o 77°F). [See USP Controlled Room Temperature] Ustal Dosage: Ses accompanying presenbing information. Mylan Pharmaceuticals Inc. Morgantown, W 26505 US A [MMylan® Mylan.com RM2045A4
45af3eda-caaa-4478-9372-95aa65adc9b3_135_2.jpg | 0-9%02-8/250 v e 2 z 2 2 £ z g 3 Exchcapul contan: _ Disgense in ight, gt reisnt w= Toerinus, 0P tmy AL al contaner 3 defined i the USP Tacrolimus Capsules, USP Rxonly 100 Capsules using a chid-esistant closure. Keep container gl close. Keep this and all medication out of the reach of chikren. Store at 20° 0 25°C (65° o 77°F). [See USP Controlled Room Temperature] Ustal Dosage: Ses accompanying presenbing information. Mylan Pharmaceuticals Inc. Morgantown, W 26505 US A [MMylan® Mylan.com RM2016A4
45af3eda-caaa-4478-9372-95aa65adc9b3_135_3.jpg € N o] o A ool i N o i ~: 1 S L e Each capse conains: Tacrolimus, USP 2 z 2 2 g 2 5 5 3 N NDC 037: LIE] Tacrolimus Capsules, USP [ 100 Capsules Dispense ina figh, ightresstant contineras defincd in the USP. using a chid-esistant closure. Keep container gl close. Keep this and all medication out of the reach of chikren. Store at 20° 0 25°C (65° o 77°F). [See USP Controlled Room Temperature] Ustal Dosage: Ses accompanying presenbing information. Mylan Pharmaceuticals Inc. Morgantown, W 26505 US A [MMylan® Mylan.com RM2047A4
45e6dce4-92e2-4ad1-bf11-bbcefb753636_858_1.jpg ¢ £ g Sior0nsi0Ee0 READY T0 ADD TO INFUSION SOLUTION For Intravenous Infusion Only Contains 1 mL Rx ONLY SANOFIJ By oy pa0id “UaLL58) 2,572 Uoamig 21015 wiplp o Upeas 01010 6333 W38 0100 ONINAVM “Sugpuey pue asn 1o} suorasp onewsojuy afesop 1oy asu aSeyped 335 uopEnspY pue a3esoq “Hreudoidde sya1uo> pasnun piesiq e 350 s “uopnfo uojnyut o ppe o Apeay 104Oo|e parespAyIp {08 oo s () 505 1 0 B F o0 s pes w0z Sreaueu0) vomsfu (2010p) 4PHR0XEL Contains 1 mL ] §
45e6dce4-92e2-4ad1-bf11-bbcefb753636_858_2.jpg B ooon Injecti (20 mg/mL) Contains 4 mL 80 L 0 mg/mL) READY T0 ADD TO INFUSION SOLUTION For Intravenous Infusion Only Contains 4 mL Rx ONLY SANOFING etaxel) Concentrs (20 mg/mL) Contains 4 mL 00,8200 o iy | Il e W8y wosy PAoI .L2-98).57-7 sawisn siors woipp jo el J0 100 daay JuaTe IN0I0IK) “ONINEVM “Sugpun pue 51 oy suopoup oo SBesop oy os obeyped 2% ONERSINAPY pue sFesoq Aavedoidde sunuon posnun prexi e 350 o oIS (U P e A e e 3 BT Ty ) Eoa “uofnjos uojsnyuy o1 ppe o Apesy “Toyafe paiesphyap 108 91eGU054]00 01124 (V) 05/05 U1 |9XEID0D Bl G SURNI0) 1 P (1w/Bw 07) 1w p/Aw 0g (20 mg/ml) Contains 4 mL. |
45f59e6f-1794-40a4-8f8b-3a9415924468_509_1.jpg 3 50458-659-60 3 “[imyesadwial ooy PalIoAU0Y ds 995] (.98 0} papiuLad SUOISINOX® '(4,//~89) D520t oUEI0D 16 & Ul “9DIS PRIODS AL UO 65 90, PUE OIS WNVHLIN, Pajuudul 18gE) pajeod ‘padeys-ajnsded ‘alum| “yasur abeyoed Buikueduioooe 225 :abesog e g 3 8 © 2 s S = g s ®G“m = o mHDB e W alw.m 2 o 5 I’} ° = ° ."a 3 > B SN = € e 5 W g =2 $: B POLBLLOL 09580 PN ‘NS o] ‘sfzogneceLR USSSUEr 10) By 81400 4d ‘ocEIno)| OT1 ‘o Usssuer :Aq ByA| PUEPOZINS 10 12NPOld) = 101 el ﬁ NS i £096598570S€00 NILD
463cb005-7ba6-4f8c-835d-ba8f1714a6e1_790_1.jpg Ubt CAUTION WHILE DRIVING OR PFRFORMING 'ASKS REQUIRING mAENTAL ALERTNESS. AlLCOHOL OR ALCOHOLIC REVERAGES SHOULD NOT BC CONSHMED WHILE TAKING THIS MEDICATION. ™ R only WARNING:KEEP-THIS OUT{OETHE REACH OF CHILDREN] DOSAGEand STORAGE:SEE PACKAGEINSERT 55289-328-10 55289 328-10 5289 328-10 KETOROLAC KETOROLAC KE{ORQLAC TROMETHAMINF TRUMETHAMINE TROMETHAMINE 10 MG 10 MG 10 MG 10 TABLETS I0 TABLETS 10 TAGLETS ReOrder i 100322 ReOrder # 100422 ReOrder # 100422 LoT 118063 LGT J18D63 LoT J18D63 EXP 10/20 EXr 10/20 EXP 10/z0 CALL YOUR DOCTOR FOR MERICAL ADVICE ABOUT SIDE EFFECTS YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TABLETA(S) VECES AL DIA. TOME UL Each TABLET Contains: KETOROLAC TROMETHAMINE USF 10 MG ORGANOLEPTIC MARKINGS: 2 TF M 134 ROUND NDC: 55289-328-10 KETOROLAC TROMETHAMINE (01)103552893281C0 (21)J18DA 3000002 {17) 201031 {10)118D63 e DL I N TOVETTHLEOD ININYEYHAE NYIAN
465c1343-b123-47ca-b3d2-f8c046c69ab1_125_1.jpg Nam fwoxy BT 10-282:08189 9GN 2508 NDC 68180-282-01 NDC 68180-282-01 NDC 68180-282-01 Each 5 mL (1 teaspoonful) contains 750 mg of Atovaquone USP SHAKE GENTLY BEFORE USING. Rx only LUPIN 210 mL 750 mg/5 mL Usual Dosage: See accompanying prescribing information Storage: Sore at 5% (77°F); excursions permitted to 16° to 30° (59° to 86°). [See USP Contraled Room Temperature] DO NOT FREEZE. Dispense in a fight container as defined in USP 750 mg/5 mL Each 5 mL (1 teaspoonful) contains 750 mg of Atovaquone USP SHAKE GENTLY BEFORE USING. Rx only LUPIN 210 mL N | 6 3 180028201 Manufactured for: Lupin Pharmaceuicals, Inc. Baltmore, Maryland 21202 Uniteg States 8 8 3 Wanufactured oy: Lupin Limited Aurangabad 431 210 INDIA Code No.: MH/DRUGS/633
465c1343-b123-47ca-b3d2-f8c046c69ab1_125_2.jpg NDC 68180-282-01 Each 5 mL (1 teaspoonful) contains 750 mg of Atovaquone USP SHAKE GENTLY BEFORE USING. Rx only LUPIN 210mL Usual Dosage: See accompanying prescribing information. Storage: Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. DO NOT FREEZE. Dispense in a tight container as defined in USP. Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States. Manufactured by: Lupin Limited Aurangabad - 431 210 INDIA Code No.: MH/DRUGS/633
46732a10-1f0d-4022-9689-256c44683e96_983_1.jpg Each capsule contains: Hraconazole, USP 100 mg. Dosage: See accompanying product lterature. NDC 16714-743-02 ‘Store at 20° t0 25°C (68° to 77°F) [see USP Unvarnished area Omited i o] Itraconazole Capsules A0 e 1) Protect fom light and moisture. Keep outof reach of children. Dispenseina tight,lightesistant container as 100 mg Gefined in the USP using a chic-resistant closure. Voo bt LS N, st 30 Capsules 1Lt om0 m M w PP | Mumbai -400013, NDIA. oo il 1062017 16714174302 P NORTHSTAR, €200 NorthSa HeshcareHoldings UC.
46732a10-1f0d-4022-9689-256c44683e96_983_2.jpg Manufactured for: Northstar R LLC Memphis, TN 38141. Manufactured by: Akem Laboratores Lt Mumbi- 40 013, INDIA Product of India ¥ 3 Iuk |||‘ ML No-DDZD NS oS . 063017 NDC 16714-743-01 Itraconazole Capsules 28 Capsules (7 x 4) NDC 16714-743-01 ‘NORTHSTAIkm Each capsule contains: traconazole, USP 100 mg. Dosage: See accompanying product terature. Store at 20° t0 25°C (68° to 77°F) [see USP Controlled Room Temperature] Protect from light and moisture. Keep out of reach of chikdren. NDC 16714-743-01 Itraconazole Capsules 28 Capsules (7x 4) ‘NGRTHSTAI&W e o o o L o L o ] DO Itraconazole Capsules 100 mg 28 Capsules (7 x 4) (LIS, Y
46ac55cf-d85e-4c34-bb33-f49e078c4a03_601_1.jpg NOC 0781:210201 Note: Tacrobmus capsues are no filed 1o maxmum capsuie | Tacrolimus Siecteslommm Capsules, USP Store at 20° 10 25°C (68" 10 77°F). Rx Only 100 Capsules A SANDOZ ' |
46ac55cf-d85e-4c34-bb33-f49e078c4a03_601_2.jpg NDC 0781-2103-01 Note: Tacrolmus capsules are ot fled Code No.: MHDRUGSKD-548 1o maximum capsule capacty. B i Tacrolimus Unon Dosage Soepackge e ettty Capsules, USP [rtiersam tem b m Manactured n ndia by Sandoz Private Lid. {or Sandos nc..Prioceon, N 08540 Rx Only 100 Capsules A SANDOZ Rev.102016 | 46188668
46ac55cf-d85e-4c34-bb33-f49e078c4a03_601_3.jpg NDC 0781-2104-01 Tacrolimus Capsules, USP E__ Rx Only 100 Capsules A SANDOZ i e 5 e e wa = e en e 5= et a1 8 = for Sandoz Inc., Princeton, NJ 08540 !» — PEARABI e wommi = =i = 2 C. = — = — N 3 I
4724dbb4-3613-4e6a-948f-a43d34f97f06_917_1.jpg Each filn-coated tablet contains: Distributed by: | 7 5 mg of simvastatin USP. Aurobindo Pharma USA, Inc. nDc 65862-050-30 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert $0£05029859EN for Dosage and Administration. Made in India Rxonly Code: TS/DRUGS/22/2009 . . Store at 20° to 25°C (68° to 77°F); excursions Simvastatin Tablets, USP pemited to 15° o 30°c (59° to 86°F) [see P1421547 * m USP Controlled Room Terperature] Pharmacist: Dispense ina tight, lightresistant | N container as defined inthe USP, vitha : /2 AUROBINDO 30 Tablets child-resistant closure (as requied). i “Over Printing Zone Coding Area (@5 15 mm) Dotted lines ot to be printed
4724dbb4-3613-4e6a-948f-a43d34f97f06_917_2.jpg Each filn-coated tablet contains: Distributed by: ol g 10 mg of simvastatin USP. Aurobindo Pharma USA, Inc. NDC 65862 051 30 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert L0E1S029859¢N for Dosage and Administration. Made in India ] Rx only Code: TS/DRUGS/22/2009 . . Store at 20° to 25°C (68° to 77°F); excursions Simvastatin Tablets, USP permited o 15° to 30° (50° o 86°) [s2e P1421555 USP Controlled Room Temperature] 10 mg container as defined in the USP, with a /5 AUROBINDO 30 Tablets child-resistant closure (as required). Pharmacist: Dispense n atight,light-resistant | “Over Printing Zone Caiing ks (@5 15 mm) Dotted lines ot to be printed
4724dbb4-3613-4e6a-948f-a43d34f97f06_917_3.jpg Each film-coated tablet contains: Distributed by: - NDG 65862-052.30 20 ma of simastatin USP: Aurobindo Pharma USA, Inc. = 279 Princeton-Hightstown Road — East Windsor, N 08520 Usual Adult Dosage: See package insert 80£26029869&N for Dosage and Administration. Made in India Rx only Code: TS/DRUGS/22/2009 . . ‘Store at 20° to 25°C (68° to 77°F); excursions Simvastatin Tablets, USP pemited o 15° to 30° (50° o 86° fs2e 1421562 m USP Controlled Room Temperature]. Pharmacist: Dispense n atght,light-resistant | container as defined in the USP, with a /9 AUROBINDO 30 Tablets child-resistant closure (as required). *Over Printing Zone Sadinghia (@5 15 mm) Dotted lines ot to be printed
4724dbb4-3613-4e6a-948f-a43d34f97f06_917_4.jpg Rx only Each film-coated tablet contains: NDC 6586205330 40 mg of simastatn USP: Usual Adult Dosage: See package insert for Dosage and Administration. ‘Store at 20° to 25°C (68° to 7°F); excursions Simvastatin Tablets, USP pemited to 15° to 30° (52° o 86°F) [see £ AUROBINDO USP Controlled Room Temperature]. Pharmacist: Dispense in a tight,light-resistant container as defined in the USP, with a 30 Tablets child-resistant closure (as required). Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/22/2009 *Over Printing Zone S0EE60298G9EN Coding Area (#5 15 mm) Dotted fines not o be printed
4724dbb4-3613-4e6a-948f-a43d34f97f06_917_5.jpg Each film-coated tablet contains: Distributed by: X ki 80 mg of simvastatin USP. Aurobindo Pharma USA, Inc. NDC 65862 054 30 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert for Dosage and Administration. Rx only Code: TS/DRUGS/22/2009 - - ‘Store at 20° to 25°C (68° to 7°F); excursions Simvastatin Tablets, USP pemited to 15° to 30° (50° o 86°F) [see USP Controlled Room Temperature] G i Pharmacist: Dispense in a tight, light-resistant | container as defined in the USP, with a | Made in India 20£960298G69 &N /9 AUROBINDO 30 Tablets child-resistant closure (as fequired). “Over Printing Zone Coding Area (#5x 15 mm) Dotted fines not to be printed
472bd78e-be17-4b9d-90f4-9482c3aec9ff_463_1.jpg C V1001982965800° LD Yondelis (rabectedin] for Injection Y For Intravenous Infusion Only NDC 59676-610-01 Sidedose DS any unused prtion Yondelis (trabectedin) for Injection Y Reconstitute before further dilution For Intravenous Infusion Only vt g of b S o por Storeunapened vils n a refgertor st CEE R o Kt R only janssen f Yondelis (trabectedin) for Injection Y For Intravenous Infusion Only IIG ot 1 gl oD aryursed parn ot rsra o a1 g a3 sk Woonlzedponies, o g e 212 ma poasum drogen it shosore 64 St o fo s ihstrert o3bam Gt s, Reconstute each vl w20 Sl W for Fiecton, S Resuking sl erars .08 g e a4 b ot ot 855 e Gl or 3 S Fiecton, U5 eares frer dsionprar s s, The ecrsitted oion ol e i anded et USUAL DOSAGE e pcage e for Prcbiogomaior. Soreunopred s eigentor a2 °C an, podiesn N e St P Gamany N o sy Foram Rxonly © 2015 nsen ramaceotc Companies Janssen f B
473d8757-9135-453f-bbe2-e3c7ed7f3106_52_1.jpg T ——— T == 0 _N_X;q 2%20G g€ 8L02-90/1A LL-h6¥| PUBJIAZIMG Ul 3Peyy 8079-6£92€ T4 ‘0puBLIQ 077 ‘S[eauinaoeuLIByd SNUsBU| +10} painjaejnueyy *Dasn aie Sjuajuod [jun UOKE3 uj 210j§ *JBI| wos) 138)04d *(4,9p 01 4,9€)! 08 010, 1¢ J01esablujas uj a0 :afieinlg “(SININYVM 88S) “pasu abeyoed 9ag :afiesoq [ensn| “anIeAIasald ou SUEI0) *(6°8 01 6'9) (8 03 Juswisnipe Hd 1o} apixoIpAY LINIpOS pu Jui/Bul €8 8PLIOYD WINIPOS “Ju Jad uonoanajone| Bui g} 0} JuajeAnba WNi3[ed UL0A0INS|0AS| SUIIUOI [eIA 3[LI3]S YB3 1!'!} JLITS NDC 50742-494-17 evoleucovorin Injection present as levoleucovorin calcium For Intravenous Use 17,5 mL Single-Dose Vial Discard unused portion R Only —l L000-280% Levoleucovorin should be dosed at half that of racemic leucovorin G
473d8757-9135-453f-bbe2-e3c7ed7f3106_52_2.jpg w375-0801 P | NOC 50742-494-17 Levoleucovorin Injection presentas levoleucovorin calcium For Intravenous Use 1X17.5 mL Single-Dose Vial Discard unused portion R Only Sch st VAl corars vl ucoma Jacium egunalnt o 10 g levolacorcrinper L, sodium clorids 183 moirl. and sodtum hytoxide or i adjustment 0 &0 (5 1083 [Conain no reseratv, [usual osage: ee pctage nser WARNINGS), g Soreo iuaor 2010 Protet romlgh Strs i carton il conentsare used. |Levoleucavorin should be dosed Jat halt that of racemic leucavarin| NDC 50742-494-17 Levoleucovorin Injection presentas levoleucovorin calcium For Intravenous Use 1x17.5 mL Single-Dose Vial Discard unused portion R only Wanifacured or: Ingenus Prarmacaticals, LG Ortando, 7L 328356408 ade in Swizsang age.17 62018 |u 9417
473d8757-9135-453f-bbe2-e3c7ed7f3106_52_3.jpg NN e NN NN S e _.m_m_@ = NN == N S~ [4 __mmmm¢ 2%2068 8102-90/1 G¢-96% | PURJIZIMG Ul BPe)y 8079-6£82€ T4 ‘0puBlIQ 077 ‘S[eaunaoeuLIByd Snuabu| 10} painjaejnueyy *Dasn aie Sjuajuod jun UOKEA uj 210j§ “JB1] wo) 193101 (4,9 01 4.9€) 048 010, 1€ Joresablugas uj a0 :afiesnlg “(SININYYM 89S) “pasul abeyoed aag :afiesoq [ensn| “anIeAIBsaId U SUEI0D) *(6°8 01 6'9) (8 03 Juswisnipe Hd 1o} apixoIpAY, LINpOS pue Jui/Bul €8 8PLIOYD WINIPOS “Ju Jad uonoanajone| bui g} 0} JuajeAnba WNI9[eI ULI0AOIN3|OAS| SUIBIUOD [BIA 3|1I3]S YIBT| > NDC 50742-495-25 Levoleucovori Injection present as levoleucovorin calcium Levoleucovorin should be dosed at half that of racemic leucovorin For Intravenous Use 25 mL Single-Dose Vial Discard unused portion K Only rE S
473d8757-9135-453f-bbe2-e3c7ed7f3106_52_4.jpg 376-080 NDC 50742-495-25 Levoleucovorin Injection prasentas evoleucovorin calcium For Intravenous Use 1x25 ml Single-Dose Vial Discard unused portion R Only Sch ol VAl corars Tvalucom lscium equalnt o 10 g levolacoorin per L, sodium chlorids 183 moiml and sodum e for o adjustment 2 20 (.5 1083 [Conains no reservatve, See package nser WARNIAGS), ge: Stoe i efigerator st2°C o F 0 46°F) e rom ligh, Stor n carton il conentsare used. |Levoleucovorin should be dosed Jat half that o racemic leucavorin| NDC 50742-495-25 Levoleucovorin Injection presentas levoleucovorin calcium For Intravenous Use 1x25 mL Single-Dose Vial Discard unused portion R only anifacured or: Ingenus Prarmacautials. LLC Ortando, L 328356408 age in Swizedang 49505 vime-2018 315 0742 wszs||2
477691f5-0591-4544-840a-ac590e1f25a1_537_1.jpg Pacliaged by Eryant Ranch Binbank. 04 91500 7 ORANGEILIGHT BROWN CAPSULE Gabapentin G grujeer:ymioiee 400mg (CV) . Capsule 5 | May cause diziness & Store at room temp of Compare To: 20°25°C (68°77°F) Neorin400mg CY e oo o o ‘Amneal Pharmaceuticals Pvt Lid reach of children. #90 Exp: MMYY NDC 7133508201 073091117095 om
47924917-bbd5-45de-96cb-c7ff9754da97_236_1.jpg *Each film-coated tablet contains: Distributed by: NDC 65862-293-30 Rosuastati calcium equivalentto Aurobindo Pharma USA, Inc. fosuvastatin 5 o, 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Dosage: See accompanying Rx only Prescibing Informtion Made in Indiz 0 i 'WARNING: As with all medications, Rosuvastatin Calcium keep out ofthe reach of children. Tablets Store at 20° to 25°C (66° to 77°F); - excursions permited t0 15°10 30°C | (59° 10 85°F)[see USP Controlled | Code: TS/DAUGS/191993 Room Temperature]. Potect from /5 AUROBINDO 30 Tablets moisture. Over Printing Zone Coding Area (é5x 15 mm) Dotted fines notto be printed
47924917-bbd5-45de-96cb-c7ff9754da97_236_2.jpg 1911 (sB10%) g oy uem 1203 S BISIE 01) 03 Jbug sia|qel wniajeg ujejseAnsoy Ao xy OaNIHONNY ¢ 90-662-29859 0N “Each film-coated tablet contains: Rosuvastatin calcium equivalent to fosuvastatin 5 o, Usual Dosage: See accompanying Prescribing Information. WARNING: As with all medications, keen out of the reach of children. e package i chi || |I|| Issz.szlzazuall ‘Store at 20° to 25°C (68° to 77"F] excursions permitted to 15° to 30°C (59° to 86°F) NDC 65862-293-06 [see USP Controlled Room Temperature] Protect from moisture. Z E Rx only g8 Rosuvastatin Calcium g3 Tablets = /D AUROBINDO 50 (10 bistercarts each containing § tablts) Tablets Distributed by Aurobindo Pharma USA, Inc. 279 Princeton- ightstowin Road East Windsor, NJ 08520 Made in India Code: TSDRUGS19/1993 Rosuvastatin Calcium Tablets 0,10 it caras achconatnn it Tl (Dotted lines not to be printed) UNVARNISH ZONE *Over printing Zone PloaIsta
47924917-bbd5-45de-96cb-c7ff9754da97_236_3.jpg *Each film-coated tablet contains: Distributed by: NDC 65862-294-30 Rosuvastatin calcium equivalent to Aurobindo Pharma USA, Inc. rosuvastatin 10 mo, 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Dosage: See zccompanying Rx only Presoribing Information. Made in India i i WARNING: As with ll medications, Rosuvastatin Caleium 0% 50 reiens - P1521602 = Tablets Store at 20° 0 25°C (66° to 77°F); m excursions permitted t0 15°10 30°C | (5810 86°F) [see USP Controlled | Code: TS/DAUGS/191993 Room Temperature]. Potect from OBINDO 30 Tablets moisture. “ver Printing Zone . Coding Area (45 15 mm) Dotted nes notfo be printed
47924917-bbd5-45de-96cb-c7ff9754da97_236_4.jpg 2 (s s s si9|qel wnia|eg ujjejseAnsoy fuo xy oaNEONY & N6 IN “Each il <satd ablet cotan: Rosuvastatn cakim squialint o osistain 10mg Usaal Dosag: 0 accompanying Prascringfomaton WARNING A vithal mcicaions, ke outof th rch ofcidr. This untdosa pacage s hldresistan. Ill 10257 68 b 77 xcursons NDC 65862-294-06 e USP Contlle R et o oAl (3 g Prtctrom mastue. R only Rosuvastatin Calcium Tablets 6010 it cars exh comaining bl Tt e 7 AUROBINDO Disbutad by: Aurobindo Pharma USA, ine. 270 PrncstonHigisiown Road East Windsor, W 08520 Matain ngia Cote: TSDRUGS 101023 Rosuvastatin Calcium Tablets 000 e e s b (Dotiad inss ntto bs printad) UNVARNISH ZONE “Over printing Zone Pons
47924917-bbd5-45de-96cb-c7ff9754da97_236_5.jpg *Each film-coated tablet contains: Distributed by: NDC 65862-295-30 Rosuvastatin calcium equivalent to Aurobindo Pharma USA, Inc. rosuvastatin 20 mo. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Dosage: See accompanying Rx only Presoribing Information. Made in India, B s Code: TS/DRUGS/191993 WARNING: As with all medications, Rosuvastatin Calcium keep out ofthe reach of chidren. Tablets Store at 20° o 25°C (68° to 77°F); m excursions permitted to 15° 0 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from 9 AUROBINDO 30 Tablets moisture *Over Printing Zone Coding Area (@515 mm) Dotted ines not to be printed
47924917-bbd5-45de-96cb-c7ff9754da97_236_6.jpg am splqeL wnp(e) unelseAnsoy (Dot ines nct o e prinied) UNVARNISH ZONE “Over printing Zone 203 (3o fmama OANIOH &) sia|qeL wnia|eg ujjejseAnsoy Ao xy A-GHZ-2989 AN “Each il <gatd ablet cotain: Rsuvastat ki equivalint o osiastain 20mg sl Dasag: oa accompanying Prscibin infomation. WARNING: A witha mcicaions, ksp ot of thrach of i, This untdoss package s ehilresistan. S a2 075 779 s || pamited o 151030 (30 0 85%) NDC 65862-295-06 {5 USP Controld oo Temparatr] Protctfrom malstre. Rxonly Rosuvastatin Calcium Tablets /8D AUROBINDO 60 (10 bistercads sachcotasing ables) Tablets Disbutsdby: Rosuvastatin Calcium Tablets am [ ————— Auobindo Phama USA, nc. 270 Prnctonigisiown Rosd East Windsor, W 08520 Matainngia Cotl: TSDRUGS 191003
47924917-bbd5-45de-96cb-c7ff9754da97_236_7.jpg *Each film-coated tablet contains: Distributed by: NDC 65862-296-30 Rosuvastatin calcium equivalent to Aurobindo Pharma USA, Inc. rosuvastatin 40 mg 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Dosage: See accompanying Rx only Prescibing Information Made in Indiz 5 < Code: TS/DRUGS/191993 WARNING: As with all medications, Rosuvastatin Calcium keep out ofthe reach of children. - P1421614 5 Tablets Store at 20°t0 25° (68° 1o 77°F); m excursions permited to 15°10 30°C (59°to B6°F)[see USP Gontrolled Room Temperature]. Protect from /2 AUROBINDO 30 Tablets moisture. *Over Printing Zone Coding Area (#5x15mm) Doted ines not o be printed
47924917-bbd5-45de-96cb-c7ff9754da97_236_8.jpg (oed ins no o be priec) UNVARNISH ZONE “Over printing Zone ¥ ‘S91qeL (s1]qe 0} bupureina yoea spiea saisiig 0F) 00} oaNigouNy ¢ S]9]qe] WNI9[B] URISEANSOY 01-96Z-2989 9aN Ao “Each film-coated tablet contains: Rosuvastatin calcium equivalentto rosuvastatin 40 mo. Usual Dasage: See accompanying Prescribing Information. WARNING: A5 with all medications, keep ot of the reach of children “This unit-dose package is child-resistant. Store at 20° to 25°C (68° to 77°F): excursions permitted fo 15° to 30°C (59°to 86°F) [see USP Gontrolled Room Temperature]. Protect from moisture. Rx only NDC 65862-296-10 Rosuvastatin Calcium Tablets /D AUROBINDO 100 (10 blister cards each containing 10 tablets) Tablets Rosuvastatin Calcium Rirobindo Pratm USA, i 279 Princeton-Hightstown Road Tablets East Windsor, NJ 08520 e s 100 (10 bister cards eachcontining 10 tablets) Tablets Code: TSIDRUGS/19/1993
47a8928f-708d-418a-829b-36eded96bac0_773_1.jpg NOC S0320-23661 23881 CEFAZOLIN FOR INJECTION, USP 10 grams er PharmacyBuk Pckage ronsusust T To B DRFESED s AT AR AT B ERED G
47a8928f-708d-418a-829b-36eded96bac0_773_2.jpg NDC 63323-238-51 23881 CEFAZOLIN FOR INJECTION, USP 10 grams per Pharmmacy Bulk Package FOR INTRAVENOUS USE NOTTO BE DISPENSED AS A UNT FURTHER DILUTION 5 REQUIRED 10.x10 g Pharmacy Bulk Packages
47a8928f-708d-418a-829b-36eded96bac0_773_3.jpg NOG S0R24461 M CEFAZOLIN FOR INJECTION, USP FomTRAVOROUS USE WOT T0BE DSPENSED A5 A 0T FURTHER LLUTION IS REGURED Reonly
47a8928f-708d-418a-829b-36eded96bac0_773_4.jpg NDG 6352344951 2581 CEFAZOLIN FOR INJECTION, USP FOR INTRAVENOUS USE NOTTO BE DISPENSED AS A UNIT FURTHER DILUTION S REQUIRED 1020 g Pharmacy Bulk Packages.
484c132f-3d3d-4218-b22f-82e9b56cc2f4_131_1.jpg Pacbaged by Eryant Rench Bnbank. €4 91506 5 ORANGE ROUND 124 CIPLA Topiramate 9 100mg Tablet 3 Store at room temp of Compare To: 2025 C (68-77F) Topamax 100mg Tablet Koo il drugs out of Cph L reach of children om #60 Exp: MMYY NDC 7133503251 032941113676
484c132f-3d3d-4218-b22f-82e9b56cc2f4_131_2.jpg Pacbaged by Eryant Rench Bnban. @4 91504 5, LIGHT ORANGE ROUND 123 € Topiramate 50mg S Tablet oa £ % Store at room temp of | Compare To: 2025 C (68-77F) Topamax 50mg Tab. Follow Doctors Cila g i Instructions #30 Exp: MMYY 3 NDC 7133504871 039951114613
484c132f-3d3d-4218-b22f-82e9b56cc2f4_131_3.jpg Pacbaged by Eryant Rench Bunbank. 0491500 5, VHITE ROUND 1220 Topiramate 25mg 9 Tab. oa g 5 Keep inlight resistant Compare To: container perUSP Topamax 25mg Tab. Store at room temp of Cigl Linied | 2025 C(68-T7F) #30 Exp: MMYY 3 NDC 7133505481 039941114217
484c132f-3d3d-4218-b22f-82e9b56cc2f4_131_4.jpg Pashaged by Eryane Reanch Buabank. 04 91500 5 BROWN ROUNDS 12 Topiramate 9 200mg Tablet 8 @ Store at room temp of Compare To: 20°25°C (68°-77°F) Topamax 200mg Tablet "Keepin light resistant Sttt container perUSP om #30 Exp: MMYY NDC 7133509251 049471122278
49289133-6071-406e-8b18-73a6e4db8782_48_1.jpg 4 r to 77 caning 125 3 = premne o DR ID R 5o Tempeakin] Dextroamphetamine @ 125 o ey roriy Saccharate, Amphetamine = 13t saveee i i 1o ls\sEanate, l‘)\extwamphelamine e, ulfate and Amphetamine sl A4 Dispense ina tight,light-resistant cortainer as Sulfate Tablets ‘*’24 e 0 oy o e mmlxmsﬂnmaslngle ° o Entity Amphetamine Product) ke s and s meatn o PHARMACIST: Dispense the accompanying |yl Phamaceutis e Medication Guide to each patient. Mg, W 25505 USA R ' Vier | s | 0=1¥5Y=-8/60 I 10T ASAXIONANT RM4541A 2z T S IO NI
49289133-6071-406e-8b18-73a6e4db8782_48_2.jpg vz Sgeremser oy, [RRSRIWTTTRCRRR e empiratre] Dextroamphetamine @ s Saccharate, Amphetamine = S i o Aspartate, Dextroamphetamine oiiens it USP. (47 g of tal amghetrine bse i Sulfate and Amphetamine e s V= ;g E Sulfate Tablets bt —- Mixed Salts of a Singl Kep ottt ced. = E et i R . 3 idge the reach of hidren. 3 < — g PRAFMAGIST: Dispenie o 3ccomparsing | mmempnsio g : e oo i —— 2 g £
49289133-6071-406e-8b18-73a6e4db8782_48_3.jpg Store at 20° 10 25°C (68° 10 77°F). [N o eRey (B LV K Il Exch bt cortains 25 mgof 5 £ - emperatre] Dextroamphetamine @ e e e a : Saccharate, Amphetamine = 1 Z;ﬁﬂ%ﬁ%’l‘w{“fs’mﬁ" % =B Aepartae, Doxiroamphetamine S SE= 5549 Sulfate and Amphetamine S e o g Sulfate Tablets sk e s w gz (Mixed Salts of a Singl i g ggg XD L itnitone it 3 g g e enpriened| | Dy, £ o g = { Rx only TRy [Mylan® | i com
49289133-6071-406e-8b18-73a6e4db8782_48_4.jpg = I 2 = wz [See USP Controlled Room ] ‘destroamphetamine saccharate, 2925 mg of Tams /s Dextroamphetamine @ b bty bt r me me mphetamine == Saccharate, Amphetamine .u"&f’ﬁ‘g“’.sd;ﬁziﬁ’:"nﬁhhmem e|a=_ Aspartate, Dextroamphetaming o) o R Sulfate and Amphetamine _ Tl el ] §?§E Sulfate Tablets e e = 72 (Mixed Salts of a Single Keepcrtivr ity et = D Mt M=t 3 ——F Ay Amphetamine PIOCY 0 et sien 3 < : o AT P i Medication Guide to each patient. e e z B Ry (Mylan® | wincon
49289133-6071-406e-8b18-73a6e4db8782_48_5.jpg {50 U5 Controled foam Pl Tanpeaire) Dextroamphetamine @ e e i Saccharate, Amphetammin = 37 res e a5 svne Aspartate, Dextroamphetamine yie wecs oo Sulfate and Amphetamine et Medication Guide to each pat Moo, WY 25505 USA T e | coug g Digene gt st i 3 g g 3 Sulfate Tablets e tn 6P g il e ot B Kot oty el g2 (Mixed Salts of a Single . ga g [ 15m | Entity Amphetamine Product) £ s andal medaton u of g g PHARMACIST: Dispense the accompanying | yian Phamcsutcl e, 3 z
49289133-6071-406e-8b18-73a6e4db8782_48_6.jpg femprare] Dextroamphetamin S i = oamph o (] e seed Saccharate, Amphetamine gt s, 5P (253 f il Aspartate, Dextroamphetamming sy o moogsmcctin Sulfate and Amphetamine Tousios Dipense i g gt et ctier as Sulfate Tablets definedinthe SPucing achilf-rsistn chure, Yo gty e (Mixed Salts of a Singie " - m Entity Amphetamino Product) Kt s andalmedcsion ol PHARMACIST: Dispense the accompanying Phormaceutcs . g Medication Guide o cach paient. M B U5 z Ve |
49289133-6071-406e-8b18-73a6e4db8782_48_7.jpg storeat20°1025° 601077, [ R G YA Each it onians 75 o f See USP Contolec Room et ot 1oyl Lt + | s ntaniv: s cqiet 75 Tamaeinl € anphetarie st oncha, 1 5m3 of deanphanine e, SPond 5 gt gt U5 (83t v et b i) [ ———— et pense it it st ot o delne nih ISPusing it chure Mixed Satsofa Single Kospcorter ity ced. " Entity Amphetamine Product) Kees s adall medcaton out of PHARMACIST, ispense the accompanyind| s mscsiss . Medication Quide o sach patient. Mo 5% A 4 L) PRy Mylane | win com RM4547A
493a5946-e750-4500-afd1-8f3fdc1d420e_920_1.jpg Pacbaged by Eryant Ranch. Bunbank. CA 91504 7 5 BUUEREENCAPSULE G Fluoxetine 20mg S 4 Capsule o § May Cause Drowsiness & Store at room temp of Compare To: 20°25°C (68°-77°F) Prozac 20mg Capsule Keep all drugs outof Tew CaechInstiessro | reach of children. #30 Exp: MMYY 3 NDC 7133509241 016101122159
494b2aa1-020b-432c-977e-a5d74e31e342_929_1.jpg (2 pue speiep jeg CAR-009224-00 m For Intravenous Infusion. This package contains one single- dose vialof sterle Daplomycin for Injecton and one package nsert Note: Parenteral drug products should be inspected visually for pariculate matter pror to admini- sraton. NDC 70594-034-01 See enosed package insert for RKOf econsiution nstructions and com- y plete information on dosage and For Intravenous Infusion. | administraion Daptomycin for Injecion contains 500mgvialof daptomycin. Reconstitute with 10 mL 0,9% Sodium Chloride Injection to obtain a final concentration of 50 mgimL_. NDC 70594-034-01 @ Rx Only For Intravenous Infusion. Daptomycin TR DTTES T T] Daptomycin LA TS 500 mg/vial 500 mglvial Manufactured for: Xellia Pharmaceuticals USA, LLC Raleigh, NC 27616 010 54 store at: 2°C to 8°C (36°F to46°F). | N W Contains no preservatives. v Made | lndia Code No: APIDRUGS/103197 Use 0.9% Sodium Chloride Injection for reconstitution only. One Single-Dose Vil |||| | | Discard Unused Portion (0110037059 =ellia PHARMACEUTICALS 40 PHARMACEUTICALS 40x40x75mm
4999bbd9-44ed-4749-9730-be2337bdf490_319_1.jpg ~ *Each tablet contains: Doxycycline monohydrate equivalent NDC 0527-1335-01 1o 50 mg of doxycycline. USUAL DOSAGE: See package insert for Doxycycl i ne complete prescribing information. Dispense in a tight, light-resistant Ta b I ets, USP container as defined in the USP with a child-resistant closure. Store at 20° to 25°C (68° to 77°F) [See UL ) USP Controlled Room Temperature]. Protect from light. KEEP THIS AND ALL MEDICATION I OUT OF THE REACH OF CHILDREN. B onty This bottle has been sealed 100 TABLETS A for your protection. P - Distributed by: Lannett Company, Inc. Made in the USA Philadelphia, PA 19136
4999bbd9-44ed-4749-9730-be2337bdf490_319_2.jpg *Each tablet contains: Doxycycline menohydrate equivalent NDC 0527-1535-01 to 75 mg of doxycycline. USUAL DOSAGE: See package insert for Doxycycl i ne complate prescribing information. Dispense In a tight, light-reslstant Tablets, USP container as defined in the USP with a child-resistant closure. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protact from light. KEEP THIS AND ALL MEDICATION 1S3 OUT OF THE REACH OF CHILDREN. F;(O’“Y This bottle has been sealsd 100 TABLETS for your protection. Distributed by: Lannett Company, Inc. Made In the USA Philadelphia, PA 19136 Rev. 05/16 CIB70518B 6 0527-1535-01
4999bbd9-44ed-4749-9730-be2337bdf490_319_3.jpg 1 *Each tablet contains: Doxycycline monohydrate equivalent to NDC 0527-133 100 mg of doxycycline. USUAL DOSAGE: See package insert for D oxycycl Ine complete prescribing information. Di in a tight, light-resi mmaigesen . Tablets, USP a child-resistant closure. hr]‘ ] Store at 20° to 25°C (68° to 77°F) [See 'ﬂ“‘[ 'r USP Controlled Room Temperature]. Protact from light. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. B oniy This bottle has been sealed for 50 TABLETS g your protection. e qm«iﬁﬂ Rev. 05/16 CIB70516B . : § Lannett Company, Inc. Philadelphia, PA 19136 Made in the USA 0527-1338-50
4999bbd9-44ed-4749-9730-be2337bdf490_319_4.jpg 0 *Each tablet contains: Doxycycling monohydrate equivalent NDC 0527-1537-30 1o 150 mg of doxycycline. fII'FUAL DtllstMiE Segbpaclga?e ins:lrt Dﬂxycycl ine r complete prescribing information. Dispense in a tight, light-resistant Ta b Iets, USP container as defined in the USP with a child-resistant closure. E Y w Store at 20° to 25°C (68" to 77°F) [See USP Controlled Room Temperature]. Protact from light. KEEP THIS AND ALL MEDICATION ] 5 3 7 OUT OF THE REACH OF CHILDREN. B(Only This bottle has been sealed 30 TABLETS for your protection. 2 Distributed by: & 23 £ = @ o & = o © M o 1 & ~ E —m g2 = £ - s _— 5 —— & — N — N o g 5 g £ 3 £ g 3 Rav. 05/16 CIB705198
499ab990-2b21-474f-aaba-d86388965f40_237_1.jpg NDC 71558-590.28 Rx Only LftHere AN ARIKAYCE' For veewith the Lamira™ Nebuier Handset ard Lamica™ Rerosol Heads provided insmed® st oy ey ey unges L TR e e oty RS ADAW 1YY 1-833-ARIKARE (1-833-274-5273) Contains 28 sterile unit-dose vials Each vial contains amikacin 590 mg/8.4 mL (equivalent to amikacin sulfate 623 mg/8.4 mL) Ag For oral inhalation only ARIKAYCE’ Limited Population’ e T msmed® =xorontecto e el EEEEOVTIV TR LR PR PIE0) ARIKAYCE.COM R R 2 8 S 2 ] 3 K P 5 KEEP THIS AND ALL MEDICATIONS OUT S st fo full presabiog infrmatio i e S fyetiy vy Tl P
499d5530-5cd2-45b5-9e72-f29777312003_384_1.jpg S By sackaeen v s1u HERD B S PROPRANOLOL HYDROGHLORIDE see mwursenuses s gt + neom. INJECTION, UsP FRBSERUEVRLC RPRRAETEN° in sineue vose viee temperature 68F to 77F. FOR IV USE ONLY. PROTECY FROM FREEZING AND EXGESSIVE HEAT. REYAIN IN BAG UNTIL TIME OF USE. BETA ~ ADRENERGIC BLOCKER. TARCFACTURER TFORKAT ION s » me Ticas i |0 O ITEME 2486714 “II| RX ONLY
49d5a0eb-14ac-412e-a9d8-ed92488c643f_654_1.jpg mmummn«nﬂvﬂ”’“mm P Pt e e 22 o R e S S 0 s oo ot A satey e Comsi , o e S e e o ¥ e e S & s e s S o 2 e e TR e e o i Y e e o, e T S b e e S o = D03 oyt Tk PRODUCY LABCL
49d5a0eb-14ac-412e-a9d8-ed92488c643f_654_2.jpg nan
49f500af-0ee8-4384-91d9-8822cffac976_194_1.jpg Packaged by Ecyant Ranch. Bubank, G 91504 = ORANGEROUNDK & Cyclobenzaprine < HCI 5mg Tablet g May Cause Drowsiness 2| Store at room temp of Compare To: 20-25 C (68-77F) Flexeril 5mg Tablet Keep all drugs out of KVK-TECH Inc. reach of children o #30 Exp: MM/YY NDC 6362936401 036401107591
4a4de4ca-6e4a-4b62-b2b4-26cef6dafb2f_847_1.jpg o1 Cosing Tempiate NoVamished Area (00 Not Prin) (1Bx41mm) L L Zonisamide ZEED Capsules [ —— complte ekt oo, S 220 025°C 8 0T 525 USF Conoled Soom Temperaee] 2y pace an poeced o gh ATTENTION PHARMACIST KEEP THS AND ALL THE DRUGS Dispense theaccompanying ‘OUT OF THE REAGH OF GHILDREN. Medicaion Guide fo each patent 100 Capsules Manuaciudy A et oz Reonly mearet e ovnuay
4a4de4ca-6e4a-4b62-b2b4-26cef6dafb2f_847_2.jpg NoVamishes Area (0o Not i) (1841 mm) R Zonisamide — =EtEn Capsules i kg compis prserong mimin S 220" 025°C 68 7). 5o USP Conrote oo Temprsss] B TENTON PHARIACST Keep s A0 AL HE D Dipere e esompanny o Tt Rench oF Lo etiaton G o exch paent = z 100 Capstles Hmiendo: 2 > et z 73 zydus Reonly Sncsoios s =
4a4de4ca-6e4a-4b62-b2b4-26cef6dafb2f_847_3.jpg No Varnsned Avea (Do Not i) (815 mm) G L Each capsue cotais: Zonisamide " Capsules umomesmome 1 | | ! ! ! ! ! ! ! ! ! ! Store 207 0 257 68" 0 7°F) | See USP Contolied Room Temperature] ! i dypace and protcid o gt ! ! ! ! ! ! ! ! | ! ! ATTENTION PRARMAGIST KEEP THIS AND ALL THE DRUGS Dispense the accompanying OUT OF THE REACH OF CHILOREN Medicaton Guidefo e3ch paent Manufactured by: 100 Capsules 2L L a Geaplar Rionly Anmedata, nda
4a5a2686-5160-49fa-8ad6-47fb9e4b55c1_204_1.jpg Acetaminophen/Codeine Phosphate C-li 300mg/60 mg Tablet arv: 30 ID #: 4;93;350 Expires: NDC #: 70518-1592-00 Shape: Round LOT #: Ref #: 00093-0350-10 MFG: Teva Pharma, North Wales, PA 19454 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4a82cef5-693e-46e9-90c4-bff753cdce37_114_1.jpg Venlafaxine 37.5 mg Tablet arv: 30 ID #:1;19 Expires: NDC #: 70518-1385-00 Shape: Round LOT #: Ref #: 57237-0173-01 MFG: Citron/Rising, Saddlebrook, NJ 07663 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4a82cef5-693e-46e9-90c4-bff753cdce37_114_2.jpg Venlafaxine 37.5 mg Tablet arv: 90 ID #:1;19 Expires: NDC #: 70518-1385-01 Shape: Round LOT #: Ref #: 57237-0173-01 MFG: Citron/Rising, Saddlebrook, NJ 07663 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4a959c89-b34d-42e5-8c85-86b7a6eb8e91_994_1.jpg [ P = ) e 2 i g i - 2 :5; : £ i 3! I i} | i Eptifibatide Eptifibatide ===~ Injection Injection SR Errs oros-tes-or 1
4b72ea7a-a0b0-4980-84ad-84f64e2e6368_128_1.jpg Exch scoredabot comains 25 mgof matniine, USP. Senpedapuon s Dosge Store s 20° 10 25°C (6t 77 e USP ‘Canroled Rom Tempeature] n s dry lace. Dipense 8. lt-essantcortanr 22 Ganas « na DSE. ‘CAUTION: Vory rosuc Dipenses. Jsocarce NDC 29300-111-01 Lamotrigine Tablets, USP rroumon AT Eun ol e ra s B ecess G oy 100 s 5 — Manfsctured by UNCHEH LABORATORIES LTD. 5 Pleme nd_Esae Pleme, Brdez Goa 403511, nda =} Manufactured for:UNICHEM PHARMACEUTICALS (USA),INC. 3 Hostrouck eigts, W 0760¢.
4b72ea7a-a0b0-4980-84ad-84f64e2e6368_128_2.jpg Each scored tablet contains. 100 mg of lamotrigine, USP. See package outsertfor Dosage, and Admiristraton. Store at 20" to 25°C (68° to 77°F) [see USP Controlied Room Temperature] in a dry place. Dispense in a it ight rosistant container as dafined in the USP. CAUTION: Very Product Dispensed. SIlZSS O0NTTZ 0 Ne sav0a71s 06R0E2017 NDC 29300-112 Lamotrigine Tablets, USP ATTENTION PHARMACIST: Each gatient s roques 0 rceive the accompanying Medication Guide R Only 100 Tablets [ Manufacured y: UNICHEM LABORATORIES LT Pllme Ind. Estte, Plerne, Bardez, Goa 403 511, Inda Manfactured fo: UNICHEN PHARMACEUTICALS (USA), I, Hasbrouck Heigis, NJ 07604
4b72ea7a-a0b0-4980-84ad-84f64e2e6368_128_3.jpg Each scored tablet contains 150 mg of lamotrigine, USP. See package outsert or Dosage and Administration. Store at 20° to 25°C (68" to 77°F) [see USP Controlled Room Tomperature] in a dry place. Dispens in a igh, lght resistant container as dafingd n the USP. cAUTIO! i N silZe 300071516 ety Product Dispensed. Lamotrigine Tablets, USP ATTENTION PHARMACIST: Each patent s required 0 tecevethe ‘accompanying Medicaton Guide R Only 60 Tablets wLz Mafactred by, UNICHEM LABORATORIES LTD. Pilomo Ind. Estato, Pllrno, Barde, Goa 403 511, ndia Manufctured for:UNICHEM PHARMACEUTICALS (USH), INC. Hastrouck Higts, NJ 07606
4b72ea7a-a0b0-4980-84ad-84f64e2e6368_128_4.jpg Each scored tablet contains 200 mg of lamotrigine, USP. Soa package outsert for Dosage and Administraton, Store at 20° to 25°C (68" to 77°F) [see USP Controlled Room Tomperature] in a dry place. Disponso n a tign, ignt osistant container az daiined n the USP. CAUTION: Verify Product Dispensod. N I‘ 3 29300111516 NDC 29300-114-16 Lamotrigine Tablets, USP ATTENTION PHARMACIST: Each patent s required o recev e accompanying Medcaton Gude R Only 60 Tablets &) Manufacurd by UNICHEM LABORATORIES LTD. Plorne Ind. Estate, Plerne, Bardez, Goa 403 511, Il anufectured or UNICHEN PHARMACEUTICALS (USA), INC. Hastrouek Hoigts NJ 07604
4be76756-4114-4d50-a36c-fd410f6c773d_911_1.jpg £ E 22| o E i =.2 =1 s £t =2 22 T 2 o C i & o S &2 IS = 22 B2 £ HES =2 H << ==|f calcium, USP eqivalentto 10 mg of atovasttin sage: See acoompanying en, Store at 20° to 25°C.(68° to 77°F) Mylan Pharmaceuticals inc. Morgantown, WY 26505 USA Maeininda [MMylane |, RMX4510H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_10.jpg 12L9505L 9 £6m6lSymBiE0 £ OO 10T ARAXIOVIOT IO AR A G8/0ANSZISOHT/HN “N ) “pascto ApuBy Jeuuco deay ainsofn Wesisepyp © Busn .zz;gsu uRlsEUB 40 U suedsig 2 -8 s o 23 e EC) R ©.2 @ 25| =0 g »'© =2 (RS P B HE =T [=12 S5G N2 FlT o= )22 SEg E[EH - i ES]EEH B << <0~ bl 52 *Each fim-coated taletcontains amicdipine besyiate, USP equivalentto amlodipine and atorvst calsium, USP equivalentto 40 mg of atonastatin Usual Dosage: See ascampanying Keop i and the reach of children. Store at20° 10 25°C (68°to 77°F). [See USP Controlled Room Temperature] Manufactured fo Hylan Pharmaceuticals Inc. Morgantown, WY 26505 U SA ade in india [Mylan® |wyiancon RMX4519H1 |
4be76756-4114-4d50-a36c-fd410f6c773d_911_11.jpg *Each film-coated tablet contains amlodipine besylate, USP equivalent to 10 mg NDC 0378-4520.93 of amlodipine and atorvastatin calcium, USP i i s o Amlodipine Besylate and = I 78-4520-93 2 Wi Usual Dosage: S i 0 o bempesemommnin - Atorvastatin Caloium | eyt mesatcnse Keep this and all medication out of the. Tablets as defined in the USP using a child-resistant reach of children. closure. Storo at 20° to 25°C (68° to 77°F). [See. — A0 41 Kespoontainertightly cosed. USP Contolled Room Temperature.] L) — 0 Code o MHDRUGS/25/NKD/B Manufactured for: = [PHARMAGIST. Dispense the accompanying Mylan Pharmaceuticals Inc. Patient Information Leaflet to each patient. Morgantown, WV 26505 US.A 2 Made in Ind i ® ‘GTIN XXOOIEROONNY lade in ndia m My|an EE RS EXP MMYYYY 30 Tablets [Mylan® | wyin.com LOT XXXTNY p
4be76756-4114-4d50-a36c-fd410f6c773d_911_2.jpg 80£9505L 0 g6mllSy=8iS0 € T 10T AZAXION10T AN S OO AT GBIDINSZSONHU/HN “N ) ‘asofo Ayt souyuco deey aunsopy s pyp © Buisn S0 84} U1 auep S Joureioa Juesiser 1B 46 e suedsig R Patient Information Leaflet to each patient PHARMACIST: Dispense the accompanying nDC 0378-4511-03 stain, Dosage: See acampanying [See USP Controlled Room Temperature] icals . Margantown, Wy 26505 U.S A ade n ndia ,r@_s_\_ma e RMX4S11H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_3.jpg AZSXIOVIO" VO OO TS & £t oE £ ©.2 Bz o B Bl o= [ |52 DEEES {25 o]z S SR SRS sl Hl<<—0lES Sioro 91207 10 25° (68 to [See USP Conrolled Room 0°F), T EE RMX4512H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_4.jpg 01295052 9 g6mgiSy=gu£0 & TN 10T AZAXIONIOT EYTYTIY s CBIOIN/SZISENIHN N 2 P Kb Jaueiwos deay n EE mlodipine Besylate and torvastatin Calcium c0a78-4513-93 PHARMACIST: Dispense the accompanying Patient Information Leaflet o each patient T *Each film-coate teblet contains ambodipine besylte, USP equiralent o5 mg of amiodipine and atorvastatin calium, USP equivalentto 10 mg of Store at 20°to 25°C (66° 1o 77°F). [See USP Gontrolled Room Temperatur Manufactured for Mylan Pharmaceuticals Inc. Morgantown, WY 26505 USA ade ninda [Mylan® | con RMX4513H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_5.jpg 21295052 | L se-iso-guso g BO/DINSUSINHTHN N 9 posalo Kby Jaueiuod dasy ‘ainsop wmsisa: 2 -H 5 g3 o E 25| ®.3 i N T EEl 2 2= Ho O gmiit e Wk 2% ot 52 (1T o2 BN g2 o c 2 =- R K E S2 Z:|H HESSH 22 b <C <C == |14 | *Each flm-coated tabet contains amlodipine besylte, USP equivaknt 195 mg of ambdpine and atorvestetin cabim, USP equivalentto 20 mg of | Soreat 20° 02890 (8 to ) [See USP Contralled Room Temperature.] RMXA514H1 o [Mylane |y« %
4be76756-4114-4d50-a36c-fd410f6c773d_911_6.jpg P1£9505L £6-516y-8450 & OO 10T 5RXIUEIOT \__z_g_sj Tablets npc 0378-4515.03 Amlodipine Besylate and Atorvastatin Calcium [ PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient. Myian Pharmaceuticals Inc. Mosgantown, WY 26505 S A Mate ininda [MMylan® | . R === U RMXAS15H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_7.jpg [ e, ST i = of il s o, 4 ini bty o 50 o of st Amlodipine Besylate and 78=4516=93 5 = Lo 4 il il = et Atorvastatin Calcium gy st s croner B Keep tis and all medicatimnoutor e Tablets a5 dfid e USP using a chiresstant 5 —— e o = Store ot 20° 1 25°C (68° 1o 77, fSee Keep cotanr ity . = USP Controled Room Temperature.] 5 mg/80 mg Gode No: MH/DRUGS/25/NKD/BS Manufactured for PHARWACIST: Dispense the accompanyi Mylan Pharmaceuticals nc. Patient Information Leaflet to each pat Morgantown, WV 26505 U.S.A. = @ Mylan® ‘GTIN TXXTOTRY y! % SN TooooToO [MMylan | o S LOT X000 o RS 16H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_8.jpg LVL9505L 7 £6milSymBIS0 £ IO 10T ARAXIONIOT O S IO NI BH/DINSSINHA “N ) “pasofa Ky seupauos doay z 3 2 & C\EEH o E 55 .2 |58 =2 82 g2 83 25 qo - Ballss ~EESEN E e = s [=4)22 4.m.”51 .m 45 55 25| i < ol 2 SJEEECIO | ¢ << <T - b |EE *Each filn-coated tablet contains amlodipine besyiate, USP equivalentto 10 mg of ambdpine and atorvast calsium, USP equivalent o 10 mg the reach of Store at 20° [5ee USP Controlled Room Temperature] Manufactured for Mylan Pharmaceuticals Inc. Morgantown, WY 26505 U SA Made it nda [MMylan® |wyn.con i RMXA517H1
4be76756-4114-4d50-a36c-fd410f6c773d_911_9.jpg 6149505L 6 £6m3icyegic0 € OO 10T ARAXIOVIOT OO S IO TS BHOINS/SOMHIHA: ON 200 ‘eSO B euieuco daay ainsop wasisei-pyup @ T pense the accompan) Leaflt to each pa inc 0378-4518.-03 Tablets ) o 5 & *Each fim-coated abletcentains anlodipine besylate, USP equialent , USP equivalent to 20 mg of aterastatin [5ee USP Gontralled Room Temperature] ,fgz_v._m.._s i
4bea68c7-3974-44d4-9916-0ed72d657206_112_1.jpg Glipizide/Metformin HCI 5mg/500 mg Tablet arv: 90 ID #: M;G33 Expires: NDC #: 70518-0116-00 Shape: Oval LOT #: Ref #: 00378-3133-01 MFG: Mylan, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4bea68c7-3974-44d4-9916-0ed72d657206_112_2.jpg Glipizide/Metformin Hydrochloride 5mg/500 mg Tablet arv: 180 ID #: M;G33 Expires: NDC #: 70518-0116-01 Shape: Oval LOT #: Ref #: 00378-3133-01 MFG: Mylan, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4c262b76-fd47-42f6-97bb-bb1b6f978a29_792_1.jpg Pravastatin Sodium Tablets, 40mg Generic for Pravachol Each tablet contains 40mg of Pravastatin Sodium Pkg Size: Exp Date Lot#. Batch# Ins Mfg: Accord Healthcare, Inc., Durham, NC Prod# TR s 11 SRRSO Imprimed FReheres Directions English Take —~ = T 8 = 8 > T E Instrucciones Espanol. Cada Tableta(s) vece(s) al dia (CAUTION: Federal law PROHIBITS transfer of this drug to any person other than the patient for whom it was prescribed. Pravastatin Sodium Tablets. 40mg Qu Ins Lot# Bas Prod# (NDC) Pravastatin Sodium Tablets. 40mg Qu " ns Lot# Ba Prod# (NDC) Pravastatin Sodium Tablets, 40mg Quy Insurance NDC: Lot# Bat¥ Pravastatin Sodium Tablets. 40mg Q- Ins: Lot# Baté, Prod# (NDC), Billing Chart Log Patient
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_1.jpg 1 Geftriaxone Injection, USP (i Dextrose) S Snl - CUIE = Toosmite o'l e R
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_2.jpg o S e I s L ot e e O et Y s i P e s 5 o i e e v s Boxter Ceftrlaxone Injection, USP (in Dextrose) TSR Rronly. Boxer. Cattriazone Injection, USP (inbexrose) ENTERIRTANT Roonly. 19 st 19 st
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_3.jpg NDC 0338-500241 Code 263504 oS w1 Code 263504 O ST AR O o By s, U S5 1 SOt D e e i S W SR e e et G o s e T R R R GALAXYcanamr s orpregn: 0t . omone S, UsP sk |3 e i g 81U e ST CesCAh p n oa rt st a0 g S g oo Aot 1 Ui e B, st s s et O et ey et T e U e b e 2 e 2 s, e ey = pe D v b oo ey
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_4.jpg Baxter 2 Ceftriaxone u Injection, USP (n Dextrose) e sonl e e Koomotic seacic: e i ma ot Pt ac e = ..n.m.-._“.m'.:m Ere - Ban copE POSIION ONLY| ansasooatrs
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_5.jpg I 41 Y RO DA T e 8 5 21 e i 8 o o e, Dt e e e e s o Pt e 5 £ 5 e e s o s o Il e 57t (07, 00w R e 1 T v 0 7 RO BB . T e e 213 ey 8 e e bt e o e s o A g 5 Bt oy g s 4 S o Baxaer Ceftriaxons Injection, USP g estse) AR Boxter Cefiriaxone Injoction, USP g Dexbose) TR 24 24 s
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1_187_6.jpg NDC 0336.500-41 Code 263505 o o msomt Code 263505 RNOT ‘GALAXY contrr ‘e Mangygen: AT, L5 a0 1 AL Ty Y s e e AU W S e et s g 0155 g S e ol vt 1Ly 51 B, At b s et Ot Sty el Sk T s O QUm0 P e . 1 e e s, HERTI Bty 2 e, D oo R St 7 GALAXYcanar s orpregn: o U5 e 1 S Tyt s e e AU W S e Wi s 1055, g G e . ol vt 1) S5 sy, At s et Ot eyt B AU e iy e 2 i 5 s, e e e ol et 9
4c7a151b-bbf9-4383-aa19-ab6672777e39_702_1.jpg Pasting flap shall be un-vamished. HINTTHTETET ™ 8p00 EwIEYq TR P Olopatadine HCI Ophthalmic Solution, USP For Use in the Eyes Only [MMylan® Sterile Each mL contains: Active: Olopatadine hycrochioride USP 1.11 mg, equivalentto dlopatadine 1 mg. Preservative: benzalkonium chioride 0.01% Inactives: dibasic sodium phosphate anhydrous, sodium chloride, hydrochlorc acid andlor sodium hydroside (o adjust pH) and water for njection. Usual Dosage: Ses accompanying prescribing information. Storeat&° 10 25°C R, Keep this and all medication outof the reach of children. This package is not chid resistant R PR Olopatadine HCI Ophthalmic Solution, USP 0.1% For Use in the Eyes Only [MMylan SmL L IR P S Olopatadine HCI Ophthalmic Solution, USP Warning: Do not touch dropper tp to any surface, as this may contaminate the solution. Manufactre o ‘Mylan Phamaceuticals inc. Morgartoun, WY 26505 US A Made inndia MCRBZ3ICR2 [Mmylan® ‘Myian.com ML No: KIK29357/2006 NII | 3 0378-8023-35 4
4d04ef9f-fae1-45e9-a65f-f8df997efdba_306_1.jpg Baclofen 10 mg Tablet arv: 30 ID #: 4096;TV Expires: NDC #: 70518-1515-00 Shape: Round LOT #: Ref #: 00172-4096-80 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4d04ef9f-fae1-45e9-a65f-f8df997efdba_440_1.jpg Baclofen 10 mg Tablet arv: 30 ID #: 4096;TV Expires: NDC #: 70518-1515-00 Shape: Round LOT #: Ref #: 00172-4096-80 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4d04ef9f-fae1-45e9-a65f-f8df997efdba_440_2.jpg Baclofen 10 mg Tablet arv: 90 ID #: 4096;TV Expires: NDC #: 70518-1515-01 Shape: Round LOT #: Ref #: 00172-4096-80 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4d2d4378-b729-4aa6-8dcd-c8019f289652_856_1.jpg = e LT e L 2 £ usinga chid-esitantclosur. L 8 Clonidine fmosmsue, ~; g ' out ve reach of children. v R Hydrochloride ¥Saise ! [5e2 USP Confrolled Room 2 55 E Tablets, USP :unnen;mve.ll . =— e o gER: Usual Adult Dosage; 5o acso- BoE sanying prescibing informaion. = S Sl = t gg Morgantonn, Wy 26505 USA. [MMylan: MMylan: Rxonly 100 Tablets Mylan.com
4d2d4378-b729-4aa6-8dcd-c8019f289652_856_2.jpg £ = | 0-9810-8/50 6 Each tblet ootain 0.2 mg of conidne hydrochloride, USP iR £ gE & AT S OO AT LRI U e o usinga chid-esistantclosure. Clonidine Keepconiner ity closed F e [ Hydrochloride S s 77 Tablets, USP o Protect fromlight. Usual Adult Dosage: See accom- panying pesering infomation. Nylan Pharmacouticas In. Morgantoun, W 2656 U S A (Mylan: [@Mylan Rxonly 100 Tablets Mylan.com RMO185A
4d2d4378-b729-4aa6-8dcd-c8019f289652_856_3.jpg £ usinga chid-esitantclosure. = Svinimnar IR O e e 2 g S Clonidine ; = : ’ . ] @ Hydrochloride e, = 5843 Tablets, USP :unvm'm:-'.llr ; o S= iy el Mok oo = 552 =B AT ——- Noganaun i 25 USA 0 (Mylan® [MMylan i Rxonly 100 Tablets Mylan.com
4d3ac73f-4970-4b7d-abfc-96844198525b_442_1.jpg IgENCY U5t osly when a4 Foralaher meica g, R oo el mmmgmmmmmm”mwm g i e a o B S 5 GAS UNDER [l ENSIFY FRE, OXIDIZER NW:M ot Yo 3
4d3ac73f-4970-4b7d-abfc-96844198525b_442_2.jpg 009-8L1-L18 5 61192 X1 'HLHOM LHO QYW SH3IANNYS 0005 KiddnNs| = EasSvO “134V1 1INA0YHd SIHL JACIN3H LON 00 L-vp-28LL *SWD “UONUSHE/2IADE [POIPALI AEIPaLILIL 195 BAJE PAIOBYE NI 10U 0 “JaTeM WRMAYN] Yl SHEd PaiSol} MeUL NINS NO 41 “asn 21048q (SQS) 199US E1EQ AIBJES 3L MO]j0} PUE PEAY “UONISOU 1Budn u} Jourewoo deay SAem)y “Kiduwa UBLM PUE 38N 40BS Jaye 10S JaA0 JUBWGINDA (103 JO U H[eMm 10U 0 ° PIOAY "SUGR93UUOA 11 2310} 0 BUBYD LON 0Q “BOINI3S U 10} pauea[o JuaWdinba yym AIUO 951) ‘0INSSald JapUIIAD Joj Pajel pUe UORINLISUOD 10 S{eUalew 9lqNedwoo 1o Juawdinba i Auo asn “Buidid auy anguanasd Mol YOEq 35 05 0p 03 ajes J yea| doIS oy 10 958D U) “Uondel0d aka puE ‘Pja1LS 28} ‘S2A0]0 BUNEINSUI PI0 1eap “30(d PareInUa /9% © U] JO SI00pIN0 AU B10IS PUE 35N 10 PUE 3SeaI0 w1} 831 SBUR); PUE Sanfen deay “S[eLaEU AIqSNI0D 194 pUE BuIIOD WO Aeme 210}s puE deay “POCISIPUR Pue peas Uaq aAey SUONEDRId Aj2}eS e [AUN 3jpUBY 10U og "LOVdII HO NOLLINSI NO 3007TdXa AVIN N39AXO QINOIT HLIM LOVINOD NI STTBLSNEN0D " AHNMNI HO SNENG OIN390AHD ISV AV SVD G3LYHIDIH3Y SNIVINOD "Y3ZI01X0 ‘3413 AJISNILNI HO ISNVI AV “HIONVQ “uogogjanbry a1y Aq paanposg uawdinba GATEISNSal uoRauNuoo uj pasn ssajun Buiyleasq paddos eney o siuaied i 40 SN 0} 0WaRe 10U 0Q ‘(MUY 2 AL ‘POO[q [ELIBLIE 10 102103 UBB/XO UO 199449 S1f BULIOYUOL INOLYA OTEINp BuO] & 1A0 UBBAXO J0 SUORLAUZ0U0D YOI JO SN PaidnIIBIIUN “Ajuo xy ‘suoneoldde feaipewy JoUTo e i 103 “UORENISNS) PUE AOUBIDAP UABAXD o} [BUOSIAG PAUIE fiado1d Aq pasaisiuipe uaym Auo osn Aouaiows 103 dSn ONINHYM Him————————————————— o =i ‘SININOD | "SNOLLIINNOJ L1 39404 HO JINVHI LON 00 1 1 "NOLLISOd LHOIHAN NI HINIVINOD d33N SAVMTV §| | €L0LNN : dsn : anor 031vH3DIHIY ‘NIDAXO ainoi1 a31v43odid43d
4d5c8c68-2755-4d7c-b689-6c5e50ff1b26_298_1.jpg NDC 0781-2081-02 Product Code: 6402-3 Calcium Acetate Gelcaps R.only 200 Gelcaps A SANDOZ
4d5c8c68-2755-4d7c-b689-6c5e50ff1b26_298_2.jpg | NDC 0781-2672-02 Product Code: 6402-3 Calcium Acetate Gelcaps R.only 200 Gelcaps A SANDOZ
4db5304f-fec8-40c2-90c6-e531cd0f4e1b_101_1.jpg WHEN PREGNANCY IS DETECTED DISCONTINUE R WARNING: KEEP THIS OUT GF THE REACH OF CHILDREN anly DOSAGE and STORAGE: SEE PACKAGE INSERT 43063-873-30 43063-873-30 43063-873-30 LOSARTAN K/ LOSARTAN K/ LOSARTAN K/ HCTZ USP HCTZ USP HCTZ USP 50MG/12.5MG 50MG/12.5MG 50MG/12.5MG 30 TABLETS 30 TABLETS 30 TABLETS ReOrder # 110600 ReOrder # 110600 ReOrder # 110600 LOoT j18ca2 LoT Jji18c22 LOT J18c22 EXP D7/20 EXP 07/20 EXP n7/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Cantains: | OSARTAN POTASSIUM USP 50 MG HYDROCHLOROTHIAZIDE USP 12.5 MG YELLOW ORGANQLEPTIC MARKINGS: E48 OVAL - NDC: 43063-873-30 PD-Rx I )‘( ” " PHARMACEUTICALS e |21 Oklahoma City, OK » 73127 LOSARTAN K/ HCTZ USP 50MG/12.5MG 30 TABLETS R (01)10343063873304 (21)118C22000004 (17)200731 (10)118C22 “J{INCORPORATED® POEELBEIOEVE OB A VIONI NI 3aVIN DELOTOLETLS 277 VWHYHL NOULID
4e5c06f1-f279-4f2f-b10d-0f70005a27e6_685_1.jpg PHARMACIST: Dispense the Medication Guide provided separately to each patient. B only NDC 0093-0711-01 Flurbiprofen Tablets USP 100 mg Each film=coated tablet contains 100 mg flurbiprofen, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Code No.: MP/DRUGS/25/10/92 Manufactured In India By: PIRAMAL ENTERPRISES LIMITED Pithampur, Madhya Pradesh, India Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Y 0093-0711-01 (! EM 15306 Rev. F 3/2015 20686554
4e6f1b18-b58f-4aeb-b165-060344bdcf86_343_1.jpg Furosemide 40 mg Tablet arv: 30 ID #: MYLAN;216;40 Expires: NDC #: 70518-0120-00 Shape: Round LOT #: Ref #: 00378-0216-10 MFG: Mylan Pharma Inc, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4e6f1b18-b58f-4aeb-b165-060344bdcf86_343_2.jpg Furosemide 40 mg Tablet arv: 100 ID #: MYLAN;216;40 Expires: NDC #: 70518-0120-01 Shape: Round LOT #: Ref #: 00378-0216-10 MFG: Mylan Pharma Inc, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
4eb02752-1cdc-4b70-90f1-d2a901709e1a_57_1.jpg Ry, NOC 68084-635-21 Fenofibrate Tablets USP 0Tablets (3% Rxony o LN TV N (01003 68084 63521 2. NDG 68084-635-21 Fenofibrate Tablets USP 30 Tablets (3x 10) RxOnly Each Film-Coated Tablet Gontains: Fenofbrate USP - 48mg Ususl Dosage: Ses package insertfor ol prescrising information Storo 212010 25°C 63 to 776 scursionsparmied boteen 15710 30C 65188 ) s USF Contvoled Room Tamparairl Toteot from mofsur. Keep this and all drugs out of each of children. FOR YOUR PROTECTION: Do notuse i bister i orn ar broken. The 81 product containgd n tis package s from NG 8750-960, Lupin Prarmacautcar, 0. Packaged and Distributed by Aimarcan fsain Zacaging Columbus, O 43517 aasse1 028352110978 .
4eb02752-1cdc-4b70-90f1-d2a901709e1a_57_2.jpg iy o s mgat e 15 01)03 60084635113 i o sos s s3s 115 T o sosssveasss 115 (@) o oegas 33 113 ooo00t-107 ogex 3 sooncoc 107 oo A 4 ] P oo sogee s i Expiy. st Lot oo Expiy: Lot ooeme Expiy 000x Lot ooceee Lot oo Expiy: i Lot o0 Expiy 00 Fenofibrate e USP 48mg I 01) 00260004 635 113 Fenofibrate TEel 05 48 mg o1 o3 saoes 35 13 Fenofibrate TEeOs 48 mg o1 0036904 635113 Fenofibrate TEneUSP 48mg I {o1) 003084 63513 Fenofibrate TaHlel DS 48 mg oo esveasss 113
4eb02752-1cdc-4b70-90f1-d2a901709e1a_57_3.jpg NDC 68084-636-25 Fenofibrate Tablets USP 30 Tablets (5 x 6) Rx Only [T 1 T i (01) 0 03 68084 636 25 7 NDC 68084-636-25 Fenofibrate Tablets USP 30 Tablets (5 x 6) RxOnly Each Film.Goatod Tablet Contains: Fanafirats USP 4smg Usual Dosage: See packags inser ol pescriong information. Store i 20" 19 26°C 68t 71 xcursions pormited betwon 35710 30°C 68°% 6o P saa USk Contrled Room Tamparatare Frotse am mosire. Keep this and alldrugs outof reach of chidren. FOR YOUR PROTEGTION: Dot usa bisar & frn or braken. The arug productcontaned n i package < fom BT G50-561, Lupin Prarmaceutcas, i Peckaged and sy American fieaih Pac aging oiimbus, O 4317 osas25 0z53625/0918
4eb02752-1cdc-4b70-90f1-d2a901709e1a_57_4.jpg At e P Fenofibrate Tablet USP 145 mg LOT: o000 EXPIRY.ixx 2 Fenofibrate £ Tablet USP £ 145 mg 8 LOT. oooocc S EXPIRY. 00 0 oo e o A et Pty §§ LOT: o000 Fenofibrate Tablet USP 145 mg 5 Fenofibrate 3 Tablet USP 145 mg EXPIRY. v i g A iond s rny %E R e 2 Fenofibrate 2 Tablet USP $145 mg £ i 2 % e A
4ec69e07-65ad-4547-98ca-cf83cf9f423f_7_1.jpg THRODT GRTBETS — o TR 5 TAKE 1 TABLET DALY ASDRECTED.
4edae668-9606-475e-9e99-455491999065_294_1.jpg o7 2 feome. o0 TABLETS
5017a927-2a24-4f27-89f9-27c805bf7d59_401_1.jpg | Lovenox® {enoxaparinsodiuminection) L oy Each LOVENOX® Syringe contains 30mg | enowaparin sodium injection derived from porcine intestinal mucosa in | Water for Injection. Dosage and Administration: For sub- NOCO7E 02430 | cutaneous injection. See package insert for dosage information and directions LOVENOX | Wk e o of s o (enaxaparin sodlum injecton) | diden. Store_at 25°C (77 permitted to 15-30°C (59-86°F) [see I 30¢0.3m. | UsP controlled Room Temperature] | RXONLY | SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | | FOR SUBCUTANEOUS INJECTION || |||| —— | Ten03mSyringes L bridgewater, ) 06807 | S ASANOR COMPANY ©2013 L Origin Singapore excursions SANOFI g | s SaBuuAS TWwE D uaL \ R NOLLD3INTSQOINYLNDENS %04 ~ DING AN AVROLNY Hib sasﬂms 3500 T1NIS . AINOXY g gigE (omal winypos wipdonous) XON3IAO01 Lovenax® | encxaparin sodium injection) Directions for Use of Lovenox || Sinle Bose Syrnge with AutomaticSafety Device: & R S — b e | N om e v one e ¥ g S e iy i ‘ e doe s e the pimvntn | LOV S e Pl T o oo | e i ol sy | O | Eeen® (oo /ﬂmﬂ/e’mﬂw | s ot e | R dsimin 2 jea_using_standrd dhniue, poshing the Phnger 0 the botom of - ety doe o | e Singe b e rearest S ariane: ! | rcomer | 3 Rerne e singe | SINGLE DOSE SYRINGES WITH o o ey AUTOMATIC SAFETY DEVICE | o L FOR SUBCUTANEOUS INJECTION | L * e et canory e s nce e e Thesfe e kot st e + hctton o may cave il - | ot ey st st s o st o by e e | T€n 03l Sytinges adng o el o ks il orening . et v fom yoursol 310 Do ot ephcethe e siel fericion aber. Area reserved for Serialization GTIN: SN Lot: Exp: Datamatrix code
5017a927-2a24-4f27-89f9-27c805bf7d59_401_2.jpg Lovenox® enovaparinsodium ijection) | Romy Each LOVENOX® Syringe contains 40mg | enovaparin sodiun injection derived from porcineintestinal mucosa in | Water for Injection. Dosage and Administration: For sub- [ L cwlancous necton. See pacge insert for dosage information and direcions LOVENOX® | W e o of s o | ( (enoxaparin sodtim inection) dhildren. ( & ) s Store at 25°C (77°F); excursions ‘ permitted to 15-30°C (59-86°F) [see 40mg/0.4m\ | UsP Controlled Room Temperature]. | T | RXONLY | SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | FOR SUBCUTANEOUS INJECTION | 1 iy |l"|”|| |||l|‘ r— Bridgewater, N) 08807 ASANOFI COMPANY ©2013 \ 3 0075-0620-40 5 | origin Singapore SANOFIG | e R v vaL NOLDAIRTSQ0IVNB1S 01 7 D0 A3 SIYWOLAY Hilhh SIONRLS 3500 T1ONIS ~_ AINO XY “”VO’}“’QV (it npes oo ) > XON3AO1 Lovenox® enovaparinsodium ijection) Directions for Use of Lovenox Single Dose Syringe with Automatic Safety Device: B e ek o1 a% et 2 S i e e St it b > °$'.;i£:é o sy e ko R i | T ol | / 21t ving_sonsas 18 i s e | e - e | R b d T | BN SRS | £ ReONLY | ‘// 1| e i o | SINGLE DOSE SYRINGES WITH | GBI | EESN 'AUTOMIATIC SAFETY DEVICE | | = | FOR SUBCUTANEOUS INJECTION [ | | ey oo b i e v e Ty i e s o i o sty et e | ol i st st b dore s s o by inne e | 7o O.ATL Syrines | g ek e ot S ok g vt e o vl s ot s sl e e ecion S Area reserved for Serialization GTIN: SN Lot Exp: Datamatrix code
5017a927-2a24-4f27-89f9-27c805bf7d59_401_3.jpg OO0 LOVENOX /frmpaﬂmd/mwamy GOmgIOonL Rx ONLY SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION I|||| Ten 0.6mL Syringes “ |l| 075=0621=6! 3 S SANOFI % | Lovenox® (enoxaparin sodium injection) BONLY Each LOVENOX® Syringe contains 60mg enoxaparin sodium injection derived from porcine _intestinal mucosa in Wate for Injection. Dosage and Administration: For sub- cutaneaus injection. See package insert for dosage information and directions for use. Each 0,025l graduation equals 25mg enoaparin sodium injection. WARNING: Keep out of reach of hldren. Store at 25°C (77°F); excursions permitted 10 15-30°C (59-86°F) [see USP Controlled Room Temperature]. sanofi-aventis US. LLC T eridgewater, N ce607 ASANOFI COMPANY ©2013 | origin Singapore o 50124702 saBuLS g0 uayL NOIDAITSQO VLB 01 ~ D30 AN VROLNY Rl SN 3500 TINIS < AINO XY 90709 (logpalus nypes updbnoug) X | {enoxaparin sodium injection) Directions for Use of Lovenox Single Dose Syringe with Automatic Safety Device: ON3AO01 000000 1 Remove the el ek oy pllng 1t svigh it he'syinge. I adsing the doe s recuie, the o sstmen: s bo tore prior onecting he precived doe o' the 4. Ornsig the nedl vy from o and ahess, st e sy e by iy gushing the phanger od The pro- fecive e wil ate. il e he e S e vl (enoxapanin sodlum injecton) e e o Gonfim e sewaton. | 60:0.61: s Ve LN (6|5 i, i i (| s aiates unger © the ot of S bty e o | | vt o te s s st b cons oy e st o i omovingre ol o he ' kin Do ot epce el sild e jecion aters GTIN. SN: Lot: Exp: Datamatrix code Area reserved for Serialization = S e S | e | T oF i > | reonty | s oo e s o T SINGLE DOSE SYRINGES WITH N e S AUTOMATIC SAFETY DEVICE | \ - o T FOR SUBCUTANEOUS INJECTION nore | * The sty e canan e st nc e e The ety shokd e e sl s * At of he sty st iy cae il i s ot ey | Tem 0.6mL Syringes hie ening it downwards awy o yourell snd
5017a927-2a24-4f27-89f9-27c805bf7d59_401_4.jpg | Lovenox® encxaparin sodim njection) T Romy fach LOVENOX® Syringe contains 80rig enoaparin sodium injection derived from porcine_intestinal mucosa in Water for Injection, Dosage and Administration: For sub- NoCooTs 062280 | cutaneous injction. See package insert for dosage information and directions LOVENOX® | Crak® . e enaxaparin sodfum /ryemory j en WARNING: Keep out of reach of children 80.:0.8. | e s B e | UsP Controlled Room Temperature]. RX ONLY | SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION I‘ | Ten 0.8mL Syringes T snofiavents Us. LiC Bridgewater, NJ 08807 3 0075=0622=8| ASANOFI COMPANY ©2013 | origin Singapore SANOFING | o < NOID!‘NTSDU!NVJH)EHS!OJ ~ DINIG AL UVAOLNY HLIN SIORMAS 3500 TINIS T AINOXY 1g:gP8 ﬂIMMI/WﬂMWMWJ/ XON3AO01 [ SaBUIAS g0 AL | Penad e injection) Directions for Use of Lovenox | Singe Dose Syrnge with Automatic Safety Device: . R the el sk by puling 1 sigt ot the'syinge. 1 sdlsing ine doe's reue, e o sfusment s be e P e e Pt e e e e | en. B head o tonfim N § T echmaue, pusning the [ LOVENOX® | (enoxaparin sodlum injection) | 4 Ornting e et way rom you and other, acvae he ey Ssons fimiy gt e | hinger "o The' o eciv seeve Wl st Jurern sehtma |5y Ny el dopoe o | | ‘ ik | R | ‘ ‘ Rx ONLY ‘ I\ 3. m‘;mmw'\: ‘ iINGLE DOSE SYRINGES WITH ‘ o g the pung UTOMATIC SAFETY DEVICE T FOR SUBCUTANEOUS INJECTION | o | e sty i oy e s e e g he sy oot s | P ki o e e o il |« Achrion ofthe sy s st b e oy s sgbterf . o otinal wiey cte e e | Ten 0.8 Syringes | emoringhe el o e ptnt's . ke reating 1 doumwards sy o yousell and * Do ot eplce he nede s e jecion. aen, Area reserved for Serialization GTIN' SN: Lot Exp: Datamatrix code
5017a927-2a24-4f27-89f9-27c805bf7d59_401_5.jpg Lovenax® {enoxaparin sodiurm injection) R ONLY Each LOVENOX® Syringe ~contains 100mg enoxaparin sodium injection derived from porcine intestinal mucosa in Water for Injection Dosage and Administration: For sub- NoCa75062340 | cutaneous inection. See package insert for dosage information and directions \ LOVENOX® T for e ach 0025l graduation equals 25mg enoxaparinsodium i sodium injection) injecton, | WM”-”—) | WARNING: Keep out of reach of ‘ T children, Store at 25°C (77°F); excursions | 100mg/1 mL permitted to 15-30°C (59-86°F) [see | USP Controlled Room Temperature]. | RaoNw SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | | FORSUBCUTANEOUS INJECTION T | Ten 1mL Syringes sanofiaventis U, LLC | ridgewater, N 08607 ASANOFI COMPANY ©2013 | rigin Singapore SANOFI\G | sem 75-0623-00 o X NOIINTSQ0IMINDANS 301 # DIAIA ALTIVS JLYIWOLNY HLIM STINTIAS 3500 T1ONIS S AINow uLAigoL (ww/u/wnmuwmw XON3A01 ovesvsisa N saBulAS TwL UdL enoxaparin sodiam injection) | Birectionsfor s of ovenax ingle Dose Syringe with Automatic Safety Device: | o ettt [ e B iy 4. Oening e noteawey | from youand o, pnirer JLOVENOX: | NoCOS02I0 the dos s rexuie, the e sstment mus bo phager ol The oo o oy e e i . enaxgparin sodum iection) | el st dose o' the ’ il aver e rele = 2 S an il e wil B heard o confim e 100mg Tm | st b be [ | g & L bt of Iy dipmse of | B : s ek % s conainer. | | B y | rxonwy = SINGLE DOSE SYRINGES WITH | | 7| e e, 1" AUTOMATIC SAFETY DEVICE 3 Vot nge n e g | o g | FORSUBCUTANEOUSINJECTION | o | | * Th sy e oy e st nc the g The sl sk o st o et * Acivaion o te e sstem may s il | At f e s s s b v e tr o . o ey S s Ten 1mLSyringes | e the sl o e ents i e osenting | dwwats o om ol 10 - Dot e e e e e, e Atea reserved for Serialization GTIN: SN: Lot Exp Datamatrix code
5017a927-2a24-4f27-89f9-27c805bf7d59_401_6.jpg E06LES<IVIN> (1wL/Bwoor) gl ooy wgrug0g ,x"ﬁﬁannv 2600290500500 NILO_| Lovenox® (enoxaparin sodium injection) B ONLY Each 0.1mL of LOVENOX® Injection contains 10mg enoxaparin sodium derived from porcine intestinal mucosa in Water for Injection and 1.5mg benzyl alcohol. Dosage and Administr: r subcutaneous or jection. See package dosage information and directions for use. WARNING: Keep out of reach of children. Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) see USP Controlled Room Tempera- ture]. Do not store the multiple dose vials for more than 28 days after the first use. sanofi-aventis U.S. LLC NDC 0075-0626-03 Bridgewater, NJ 08807 ASANOFI COMPANY ©2013 - 50124924 300me3m (100mg/1mL) R ONLY For Subcutaneous or Intravenous Injection Maultiple Dose Vial One 3ml Vial SANOFI NDC 0075-0626-03 LOVENOX® (enoxqpani Sodum injection) 300053 (100mg/imt) RONLY For Subcutaneous or Intravenous Injection Multiple Dose Vial One 3mL Vial <MAT>537903
5017a927-2a24-4f27-89f9-27c805bf7d59_401_7.jpg | Lovenox® (enoxaparin sodium injection) | Rowny fach LOVENOX® Syringe ~ contains | 120mg enoxaparin sodium injection derived from porcine infestinal mucosa L inWaterfor Inecton. Dosage and Administration: For sub- | cutaneous injection. Se package insert for dosage information and directons ~ /LOVENOX | e \ (enoxaparin sodlum injection) | ARG, o ut of reach of e e | Store_at 25°C (77°F;_excursions 120:50.8n | St -t Soacmins | RONLY | SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | FORSUBCUTANEOUS INJECTION I||I| | Ten08mLSyringes sanofi-avents US. LLC ‘ 3 0075=2912=0" | Bridgewater, N} 08807 ASANOFI COMPANY ©2013 | origin Singapore SANOFING | sonm (_ stuks g uaL NOUDINTSQOIVLIDANS 301 7 DINIO ALIVS VWLV HLIW SIBNRAS 3500 TTONIS . AINo Xy g0i0zL (ww://wm o) XON3AO01 Lozisz S0 | (enaxaparin sodium injection) Directions for Use of Lovenox | Single Dose Syringe with Awtomatic Safety Device: 1. B e el skl [~ 4. Orening e st iy by puling A svigt ot rom youand over, e yinge 1 adusting acvae e ey Ssons ine doe s e, 1 b iy g e | s sdusment s be Aunger rod T’ g Gone pror o et he focive docwe wil au HUSEERE | Be heand 1o conm e 120mg0.8m S sy dome o | | ot LOVENOX® /zwwpﬂﬂﬂmdmmlmﬂm} | ot | I I weomy | L SINGLE DOSE SYRINGES WITH | AUTOMATIC SAFETY DEVICE | | FORSUBCUTANEOUS INJECTION | i | | The ey e cn rly be st one the e+ The sty souk o e sl asbenempid Acvatan cf he sty e may case rininal . | S e ey Sy ST sl B e | Temoinghe nede o the ants sk il orening 1t dowtwards vy rom yousell and Dot epce the el ikt fctn. oter. Area reserved for Serialization GTIN: SN: Lot: Exp: Datamatrix code
5017a927-2a24-4f27-89f9-27c805bf7d59_401_8.jpg NoCO075291501 LOVENOX® (enoxaparin sodlum injection) 1 50mg/1 mL - 4 Lovenox® (enaxaparin sodium injection) oty Fach LOVENOX® Syringe ~ contains 150mg.enoxaparin sodium injection derived from porcine intestinal mucosa in Water for Injecton. Dosage and Administration: For sub- cutaneous injection. See package insert for dosage information and directions for use. Each 0.02mL graduation equals 3mg enoxaparin sodium injection. WARNING: Keep out of reach of children. Store_at 25°C (77" permitted to 15-30°C (59-86°F) [see UsP Controlled Room Temperature]. Rx ONLY SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE | FOR SUBCUTANEOUS INJECTION Ten 1mL Syringes DI AL SIVAOLNY HLIM SI9RMLS 3500 1ONIS AINO X4 Lovenox® | e i irections for Use of Lovenox || Singie Doe Syrnge vith Automatic sfey Device: T | SANOFIG 5 0075-2915-01 1 L saBupks TwL waL sanofi-aventis U.S. LLC Bridgewater, N} 06807 ASANOF] COMPANY ©2013 Origin Singapore 50124710 ~ NOLDIINTSQOINVLNENS 404 — (il anpes oo XON3AO1 wLRDGL Losiszsnoo . koo e et ety byl 1 sl of e 1 Shosing e de s e e e s st b Sone 0 gt e doe o the fecve e il et 2 usig_sandard ngue, pishing the phnge 5 0 bokom of Thesinge 3. Remore the singe fom he o s lzeoog vourngeron the phnger | o * The st sysem can ol he e anc h singe: o e |+ et of e ey e st e done ny e removing e necle o e pents hin oot epcethe e sie ferjcion. GTIN: SN: Lot: Exp: Datamatrix code Skt vt S coianer Thesenysysemshoukd ot he sz, * Aciation of the saey stem may e mininal Skt of . For opiml ety sctvae re ssem 4. Ornting the el uay from you andcibos, St e ety s by iy g e | Plnger ad The e fri o o | E S Immedialy dipase of e g i he et NoCa075291501 LOVENOX' erouparin sodum nictin) 1 50mg/1 mL ai < | mxomy | SINGLE DOSE SYRINGES Wik AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Ten 1mL Syringes il oenting i dovwars s om yourl snd e Area reserved for Serialization
503b1b25-a2c4-4388-b8d2-5f03efc40c76_668_1.jpg Spironolactone Tablets USP SOmg Generic for: Al Each tablet contains. Spironolactonc. USP. Somg Pkg Size: Exp Date Lot# Batch# Ins Mfg Amneal Pharm of New York, LLC Prod# Warning 7T SSe P Contolled S e 5101 Tablet Directions English time(s) a day Take CAUTION: Federal law PROHIBITS transfer of this drug to any person other than the patient for whom it was prescribed. Tableta(s) vece(s) al dia Instrucciones Espanol Cada Spironolactone Tablets USP S0mg Qy Ins Lotd. B Prod# (NDC) Spironolactone Tablets USP S0mg QuIns Lot# Bat# Prod# (NDC) Spironolactone Tablets USP S0myg Qe Insurance NDC Lot Bat# Spironolactone Tablets USP S0mg Qv Ins Lot# Baik Prod# (NDC): Chart Loy Billing Patient
506bf880-9564-404c-951a-703797ffdad8_970_1.jpg Packaged by Enyant Ranch. Bukbank, O 91504 = YELLOW (uff Buff CAPSULE [P 102 Gabapentin 300mg S ), (CV) Capsule & E May cause dizziness 2| store atroom temp of Compare To: 20-25 C (68-77F) Neurontin 300mg (CV) Capsule Keep all drugs out of Amneal Pharmaceuticals Pt Lid reach of children fwoxy #90 Exp: MM/YY NDC 6362973061 073061110487
50a58159-9572-4445-9859-b392632597da_127_1.jpg xonly Quinapril and Hydrochlorothiazide =~ e wehracrin Tablets, USP 10 mg/12. > oo NDC 65862-161-00. o vt s e Deribas by Vst Aubins Parma USK o o0 5ol 273 P Ao o b U5 Ex Wi N 0620 e TSRS 10 sl Dosage: s ks s o Do g ot U5 sweazroaT O | o 55051 olSp ot | 90 Tablets Foom onpeci. P fon gt | Coting Area et Dot s boprnd ‘l"““
50a58159-9572-4445-9859-b392632597da_127_2.jpg Each im-coated ablt contins: Distruted by NDG 6586216290 Gy mrcnions USPcquiert Aurobido Parma USA, e 1020 mg quinaprland 125 mgof 210 PrncelonHighistonn Road ar o U5 £ vingen NS850 QuinapriVail. . - ASssEsE—— Hydrochlorothiazide Tablets, USP Dispenseintigt ot (1571 St at20°1025° i LR oursins prmited o 5 507108 [s2 UP i oom 2 auronnoo 90 Tablets Temperaue, Pt ht Coding Area @sx15mm) Dotednes ot o be prnted
50a58159-9572-4445-9859-b392632597da_127_3.jpg Each il coated able contins: Distrbutzdy NDG 65862-163-90 oo USP et urobino P USA, . o2 ptand 5ot 210 P gtsown Fosd - oo U5 £ Vi 06520 Quingpriland imiimmpewie L Hydrochlorothiazide Tablets, USP Dipese gt o (057) Storeat20° 0 25° (6810 excursionspermied 0 1 o s U ot oo | 2 AUROENDO 90 Tablets Temperature], Prtectfom gt “Over Priting Zone. Coding Area (513 mm) Dotied ines not o be prirk
50df93bf-fe72-48f6-a02e-ea9a313d47c2_860_1.jpg AW ~m39 DiphenhydrAMINE HYDROCHLORIDE INJECTION, USP 50 MG/ML HIGH POTENCY 5 x 1 ML IN A 2 ML SINGLE DOSE VIALS For M or IV Use Sterle, Pyrogen-Free Each mL contains: Diphenhydramine hydrachloride, 50 mg and Water o Injection, q.5. Sodium hycoxide andjor hydrochioric acid added, f needed, for pH adjustment. USUAL DOSAGE; 10 to 50 mg intravenous or inframuscular See product insert for fll prescribing informaton, precautions and wamings. STORAGE: Store at 20° to 25° C (68" to 77" F) [see USP Controlied Room Temperature]. Frotect from freezing and light. Vial stoppers do not contain natural rubber latex. RX ONLY WARNING: This Unit Dose package is not child resistant andis Intended for Insttutional Use Only. Keep this and all drugs out of the reach of chidren APP Pharmaceutcals, LLC Schaumburg, IL 60173 Distributed by Cardinal Health Dudlin, OH 43017 135116230218 LOT #: XXXXXXXXXX ~ EXP.DATE: XX/XX/XX
51764347-8e0d-2fbb-e054-00144ff8d46c_759_1.jpg > NuCare Pharmaceuticals, Inc gegzris NDC 68071-3229- BusPRone HC smg 355: £ Lot# 000000 Exp. D33te:(g)0:-300 o o0 ssna m " 558852 o8 000000 ot 23126330 fioseil BusPRong HCImg soociiosen ™ 183 #30 Tablets eranTi I A Lot#: 000000 Rx # 23124330 Each tabiet contains Buspirone Hydrochlonde USP 5mg BusPiRone HCl 5mg 55 & iy #30 Tablets - Exp Date: 00-00 gf 5 =2 u . NDC 68071372903 AW: g2 8 i voxd Reciangular Shape Wide N NDC 1672570003 =z & ig Lot #: 000000 Rox # 23124330 5 g8 BusPiRone HCI 5mg g P #30 Tablets Exp Date:00-00 NDC 68071-3220-03 Mig NDC 16729-200-01 Product # P0305030 Lot #: 000000 Rx #23124330 - Rx Onl Re¥ 23124330 WARNING: KEEP OUT OF REACH OF CHILDREN. ~ STORE AT CONTROLLED TEMPERATURE 59-86°F. SIPUI 0} Z8C-PUGEROLIY PSIIU SISINNODNLISY S|
519b443e-19ce-4dd6-aa7e-92a5733240aa_697_1.jpg NDC: 50436-0726-1 Rev.1 FLUOXETINE HYDROCHLORIDE 20 MG / 30 CAP Exch capsle contons: Fuptie hdroconde, MIg by USP st 1020 3 o e ScieGen Pharmaceuticl, Inc. Diperse i, lhtestotcontaner it Huppauige, NY 11783 e o es G MFG NDC: 42543-726-10 N s s oo™ MFG LOT: X3000X WARNING: KEEP OUT OF REACH OF LOT: Y00 EXP: XK/XK/XX (CHILOREN, STORE AT 2025 °C (68.77°F ) it Dose Sevics LLC Dai, 2025 CXSSTIEED gy U oseSrvics, L Dai, 33008 TIGHTLY CLOSED, SEE PACKAGE INSERT FOR DOSAGE INFORMATION. RX ONLY. 0 06072561 0w /000 ORUG FLOOKETINE o oo B: 0000 joc sovsoms ondSRERe e 000 "loT o0 60% 10 NoC: 5083607261 oG G| oM/ 0e eRoCHLOR oo ov: o NOC: SOI60mEL 20MG /O SR HUOETE DROCHLORIDE . sonoiX
5200ae31-8a79-45f9-84fc-98f8448483a7_486_1.jpg NDC 65862-535-02 Rx only Amoxicillin and Clavulanate Potassium for Oral Suspension, USP 600 mg/42.9 mg* per 5 m 200 mL when reconstituted /59 AUROBINDO *Each 5 mL of recanstituted suspension contains: 600 mg amoxicilin USP as the trihydrate and 42.9 mg clavulanic acid as the clavulanate potassiurm The potassium content per 5 mL is 0.21 mEq. Directions for mixing: 1. Tap bottle untilall powder flows freely. ADD LI OF WATER IN TWO PARTS. 2. Add approximately 2/3 of the water for reconstitution. Shake vigorously 3. Add remaining water, shake vigorously. Usual Dosage: Administer every 12 hours. See accompanying prescribing information. Phenylketonurics: Contains phenylalanine 7.02mg per5 mL. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Keep tightly closed. Shake well before using. Must be refrigerated. Discard after 10 days. Use only if inner seal is intact. Net contents: Equivalent to 24 g amoxicilln and 1.716 g clavulanic acid. Store dry powder at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/57/2003 ,,,,,,,,,,,,,,,,,, PI4239% ... * *Over Printing Zone Coding Area (45%20 mm) Dotted line notto be printed
520b05ef-420e-47d5-9491-63a7ba9e5423_403_1.jpg 52959-011-21 AMOXICILLIN 250mg CAPSULE Lot #: AM200S Mfg: SANDOZ Exp: 11/10 Mfg India Loc.: RX Only: 1000000 Compare to: Amoxicillin Mfg. NDC: 65862-016-05 Pill ID: Blue and pink capsules Take as directed by your Doctor or See outsert for usual dosage information #XXX BT T e A 0 Bl e o L e ORIGLLIN 250 CAPSULE 52950-011-21 Qy T Lot AR moxiiin saBn2076:05 #21 [AMOXICILLIN 250ma CAPSULE 5205001121 ay #21 11110 Lot AM200S [Amoxicilin 65862-016-05 [AMOXICILLIN 250ma CAPSULE 5205001121 ay #21 11110 Lot AM200S [Amoxicilin 65862-016-05 |AMOXICILLIN 260mq CAPSULE 5205001121 ay #21 1110 AM200S Amoricilin 65862-016-05 Rapae T Tt o - o R 05ttt Diart i o, s g 125t contospor USP Lot
520b05ef-420e-47d5-9491-63a7ba9e5423_403_2.jpg 52959-020-21 AMOXICILLIN 500mg CAPSULE Lot #: AM502S Mfg: SANDOZ Exp: 03/11 Mfg India Loc.: RX Only: 1000000 Compare to: Amoxicillin Mfg. NDC: 65862-017-05 Pill ID: Blue and pink capsules #XXX Take as directed by your Doctor or See outsert for usual dosage information BT T e A 0 Bl o L e OXIGLLIN 500 CAPSULE ay #21 Lot Ao o205 ay #21 Lot AM502S 65862017-05 [AMOXICILLIN 500ma CAPSULE ay #21 Lot AMS02S 6586201705 |AMOXICILLIN 500mq CAPSULE 52059-020-21 ay #21 0311 AM5025 Amoricilin 65862-017-05 Rapae T Tt o - o R 05ttt Diart i o, s g 125t contospor USP Lot
525138cd-832a-41d0-84b0-83921b12bd2a_848_1.jpg I Each tablet contains 0.5 mg of u m e a n I e Bumetanide, USP. Usual Dosage: See package insert for Ta b I ets U S P complete prescribing information. 3 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a tight, light-resistant container (USP). KEEP TIGHTLY CLOSED. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadila Healthcare Ltd,, Baddi, India 100 Tablets Distributed by: zyd Zydus Phamaceuticals (USA) Inc. 4 &...._.'Ls Rx only Pennington, NJ 08534 21401 ey
525138cd-832a-41d0-84b0-83921b12bd2a_848_2.jpg Bumetanide Tablets, USP 100 Tablets ?&f-‘vy—'—’f Rx only Each tablet contains 1 mg of Bumetanide, USP. Usual Dosage: See package insert for complete prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a tight, light-resistant container (USP). KEEP TIGHTLY CLOSED. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadila Healthcare Ltd,, Baddi, India Distributed by: Zydus Phamaceuticals (USA) Inc. Pennington, NJ 08534 W0} hey
525138cd-832a-41d0-84b0-83921b12bd2a_848_3.jpg NDC 68382-527-01 " B u m eta n Id e Each tablet contains 2 mg of Bumetanide, USP. Usual Dosage: See package insert for Ta b I ets y U S P complete prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in atight, light-resistant container (USP). KEEP TIGHTLY CLOSED. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. L0226)128¢89 Manufactured by: Cadila Healthcare Ltd., Baddi, India 100 Tablets Distributed by: Zydus Pharmaceuticals (USA) Inc. '3 zydus Rxonly Phmingion NJ 08534 2W0) hey
52572bfb-43f0-4b55-b1fd-231a05c8b83e_530_1.jpg NDC 43063-825-14 o= D s — Q= = R ""I—demczﬁnp‘ms"nﬁn’rme’nﬁnﬁiur‘cmwﬁﬁu’ =3 5 Sttt A [V FT V6 B L5 Y 2 0 LV s LE=8 5 2 43063-825-14 43063-825-14 43063-825-14 | =2 O CELECOXIB CELECOXIB CELECOXIB n=° CELECOXIB — 800 —o 53 B ] 200 MG 200 MG 200 MG g2 = D e 14 CAPSULES 14 CAPSULES 14 CAPSULES e E—2 S === REORDER #110457 REORDER #110457 ~ REORDER #110457 =3$=: g = LOT I[18E67 LOT [18E67 Lor 118867 ga=x . — EXP 05/20 EXP 05/20 EXP 05/20 =y = == = CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. (B=% = YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 s O TAKE__CAPSULES)__ TIHESADAY 2 D a2 n E i | p==8 200 MG OF CELECOXIB 52 . 2 e o OO s TOME__ CAPSULA(S) _ VECES AL DIA. S — ORGANOLEPTIC MARKINGS: WHITE CAPSULE APO C 200
52572bfb-43f0-4b55-b1fd-231a05c8b83e_715_1.jpg 43063-825- CELECOXIB 200 MG 200 MG 200 MG 30 CAPSULES 30 CAPSULES 30 CAPSULFS ReOrder # 110454 ReOrder # 110454 ReOrder # 110454 1LOT 118D37 LoT 118D37 LOT Ji8D37 EXP 07/20 EXP 07/20 EXP 07/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE CAPSULE(S) TIMES A DAY. TOME CAPSULA(S) VECES AL DIA. Each CAPSULE Contains: 200 MG QF CELFCOXIB WHITE 'JRGANOLEPTIC MARKINGS: APQ C200 CAPSULE NDC: 43063-825-30 PD-Rx PHARMACEUTICALS ; F=|INCORPORATED?® - =% Oklahoma City, OK = 73127 CELECOXIB 200 MG 30 CAPSULES ). 13063825303 (21)118D370000u2 17) 200731 (10)118D37 EQESZBEJOEDE IR v VNVI OIMVLNO'OLNOYOL “INI X310dV TOGYBESOSIY
53240ab5-98e7-4050-b640-e09c1271899a_851_1.jpg NDC 52246-400-30 *Each delayed-release capsule contains 49.3 mg esomeprazole ESOMEPRAZOLE {ontim, caunalentto 30 mg STRONTIUM esomeprazole. DELAYED-RELEASE Keep continer ighty closed Keep out of reach of children. CAPSULES Store at 20" o 25°C (68 to 77°F); excursions pemnited fo 15' to 30°C (59' o 86'F) [See USP Conrlled Room Temperature] PHARMACIST: Dispense with medication quide provided separately USUAL ADULT DOSAGE RxOnly * 30 Capsules gorn 101 O ParaPRO Manufactured for ParaPRO LLC; Carmel, IN 46032 ES0-140-000 78009765 Dispense in a fight container.
53240ab5-98e7-4050-b640-e09c1271899a_851_2.jpg Imprint Area | 0.7500" NDC 52246-200-30 'Eac': delza Zg-release caps’:zlz ntains 24.65 mg esomeprazole ESOMEPRAZOLE Sioniim, squvantio 20 mg STRONTIUM osomeprEzDie. DELAYED-RELEASE Keep contaner gty cosed. Keep out of reach of children. CAPSULES Store at 20" to 25°C (68" 1o 77'F); excursions pemited to 15' to 30°C (59" to 86 F) [See USP Controlled Room Temperature]. PHARMACIST: Dispense with medication pispenge i a ight container. guide provided separately ; USUAL ADULT DOSAGE: RxOnly * 30 Capsules §0.0LI001 008 ParaPRO Menufactured for: ParaPRO LLC; Carmel, N 46032 ———, ESOA20000 780.09762 00 52246 ! 20030 3.1250" R0.1250"
535dd1ea-b567-49f7-9a84-8ea91e78c466_735_1.jpg Siatoed 2500 210UIS 08 swesy 0L Wi\ uonnios fe10 103 (@soimoe) NDG 66220719 Kristalose® Kristalose® Kristalose® o) Kristalose® flacuoss) (lactulose) (lactulose ) 10 Grams i For Oral Solution 0 Single Dose Packets For Oral Solution 10 Grams 30 Single Dose Packets 10 Grams 30 Single Dose Packets ‘s CUMBERLAND' 7!~ cuMBERLAND" (TR '~ CUMBERLAND" < 2
535dd1ea-b567-49f7-9a84-8ea91e78c466_735_2.jpg NDC 66220-719-01 Kristalose® (lactulose) For Oral Solution PHARMACEUTICALS 10 Grams B Single Dose Packet only CONTENTS: Each packet contains 10 grams lactulose (and less than 0.3 g galactose and lactose as a total sum). This unit dose packet is not child resistant. INDICATIONS: For the treatment of constipation. See accompanying package insert. USUAL ADULT DOSAGE: 10 to 20 grams daily. See accompanying package insert. Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24-48 hours may be required to produce a normal bowel movement. DIRECTIONS FOR PREPARATION: Dissolve contents of packet in half a glass (4 ounces) of water. Store at room temperature, 15°-30°C (59*-86°F). Manufactured for: Cumberland Pharmaceuticals Inc. Nashville, TN, USA, 37203 6622001719017 3 { CUMBERLAND®
535dd1ea-b567-49f7-9a84-8ea91e78c466_735_3.jpg sipeg 2500 8015 0F swesg 0z wonnos 10 04 (esoimoe)) osojeisuy| woszmen 1, | wosonsn 1, . Kristalose' Kristalose’ (lactulose) (lactulose) . & ForOra Soluton . % ForOraSoluton Kristalose Kristalose (lactulose) (lactulose) 20Grams For Oral Solution For Oral Solution 30 Single Dose Packets 20 Grams 20 Grams 30 Single Dose Packets 30 Single Dose Packets s cumeeriano: $rumesniane = cumBERLAND
535dd1ea-b567-49f7-9a84-8ea91e78c466_735_4.jpg ne 04 DU ot Kristalose® (lactulose) For Oral Solution PHARMACEUTICALS AMEUMBERLAND‘E e 20 Grams R Single Dose Packet ~[only CONTENTS: Each packet contains 20 grams lactulose (and less than 0.6 g galactose and lactose as a total sum). This unit dose packet is not child resistant. INDICATIONS: For the treatment of constipation. See accompanying package insert. USUAL ADULT DOSAGE: 10 to 20 grams daily. See accompanying package insert. Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24-48 hours may be required to produce a normal bowel movement. DIRECTIONS FOR PREPARATION: Dissolve contents of packet in half a glass (4 ounces) of water. Store at room temperature, 15°-30°C (59°-86°F). Manufactured for: Cumberland Pharmaceuticals Inc. Nashville, TN, USA, 37203 O — O\ e—— S —— W Z
5362ea50-38a4-48b4-a85b-d634c3d8b91a_873_1.jpg Each capsule contains: Phenytoin Distributed by: NDC 65862-692-01 sodium USP 100 mg. Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road Usual Dosage: Rxonly K2 it presaiiing East Windsor, NJ 08520 x information. EnendEd Pheny‘ﬂln NOTE TO PHARMACISTS - Do not i | Sodium Capsules USP ispense capsules which are Code: T/DRUGS22/2000 discolored. Store at 20° to 25°C (68° to 77°F) [see = USP Controlled Room Temperature]. » PHARMACIST: Dispenss the Medication oo CAO e P00t e Guide provided separately to each patient. Dispense in tight, light-resistant A9 AUROBINDO 100 Capsules continers (USP “Over printing Zone
5362ea50-38a4-48b4-a85b-d634c3d8b91a_873_2.jpg oavaou & eI 0 RO DDNIG DTS WP 8 SRRSO ISVWENH dsn sajnsdey wnipog ulolkuayd papuaixy oy ‘saisdeqasop 1 (01 X04) 001 82829859 500 s capstacotan: Py so0um USP 100mg. vt ousage S8 SmAryngprosstog fomato. NOTETO PHARMACISTS -0 ot sspnse capul i re dsclore. Sore f 210 25° (6 0 77°F) sk USP Conolle Foom ORGPt Tom gt ana o Disgonsan g, gt asstan cotanars (U5P). T 00 paiag 1 o g it sponses o a2 3l RS oo shot B 10 z [—— 2 oy o8 . = iz Extended Phenytoin Sodium 2 §§ Capsules USP : g2 i Se £ 2 PN D i Mecston Gt o gy b st : 5 2 aumaso 1001010 Ut e opies Extended Phenytoin Sodium Capsules USP Dy Auoings Prarma Ui, . 279t s s st wmsor, sz o g | oot TSRUGS 22008 Extended Phenytoin Sodium Capsules USP.
53918705-d2fe-4c6b-9501-a619a8ad3991_942_1.jpg Metronidazole 500 mg Tablet arv: 14 ID #: PLIVA;334 Expires: NDC #: 70518-1241-00 Shape: Oval LOT #: Ref #: 50111-0334-01 MFG: Teva Pharma, North Wales, PA 19454 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
53918705-d2fe-4c6b-9501-a619a8ad3991_942_2.jpg Metronidazole 500 mg Tablet arv: 4 ID #: PLIVA;334 Expires: NDC #: 70518-1241-01 Shape: Oval LOT #: Ref #: 50111-0334-01 MFG: Teva Pharma, North Wales, PA 19454 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
53decc36-622b-429b-8316-f144b8079b57_576_1.jpg Amoxicillin 875 mg Tablet arv: 20 ID #: A;6;7 Expires: NDC #: 70518-1438-00 Shape: Oval LOT #: Ref #: 57237-0029-20 MFG: Rising Pharma, Inc., Allendale, NJ 07401 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
5451596e-823d-4aaf-96f6-470f034b5f94_414_1.jpg CLINICAL solutions WHOLESALE Hydrochlorothiazide 25mg Tablets ND 118-0123-8 Qty: 30 Mg, NOC: 29300-0128-01 GTI: 0035118012386 Wi Lot i SAVPLE123 Batch SAMPLEAS6 Mig_By: Unichem Pharmaceuticals (USA), .00t 2019 Hasbrouck Heighs, N USA, 07604 SH: WMMDDOOD000 Ty ity P e, i 5. P TN 3708 U5
5462a012-049d-4399-bc6c-3ba144643a74_811_1.jpg 340B § WHITE OBLONG PLIVA 334 METRONIDAZOL _ E TAB 500MG & i | Keep all drugs out of Compare To: reach of children [ETRONIDAZOLE 500M' [ tore at room temp of TewCzeshndustriossro o | 20-25 C (68-TTF) #24 Exp: MM/YY o 'NDC 6362963791 063791105152
5462a012-049d-4399-bc6c-3ba144643a74_811_2.jpg Packaged by Evgant Ranch Berbank. @A 91504 METRONIDAZOL & "™ fourvss E 250MG TAB 10° 2 I = Store at room temp of Compare To: 20°25°C (68°-77°F) FLAGYL250MG TABLET-LIB Reepall drgsatof Teva Czech Indusiries s.ro . reachofchildren. #28 Exp: MMYY ¢ NDC 6362977541 077541120418
54fcdcb9-fb0e-4164-9e51-f2a5feae3217_833_1.jpg o s m ey s R, e e dund 1ad suainsase) 3w sToL ‘PO |edidoL 3U0]R]S0)S3Y wrsaE s seon sS40 ecsmsean sS4 Testosterone | Testosterone |Testosterone | Testosterone Topical Gel, | Topical Gel, Topical Gel, Topical Gel, @ 0] @ @ 2025 2025 mg of testosterone _ 20.25 mg of testosterone 2025 Per pump actuation” A e ‘per pump actuation® of testosterone *Each actuation defhers per pump actuation* i per pump actuation* 125g0fgel 125gofgel N “Exch acuaion delvers Each actuson defvers ool ss 45 Begae Aenlea vy ey Acohol 684% /v Akohol 684% /v [ T Tt 18 et e e e, ForTopcal Us Ory s s ATENTONPHARMACIST | | S v i . e D te oo e g, | | PP | | e vt e patene e e e Wik o pump copatle e n»_.,.m...n-:;-. A ek e Nesiacis | pump scustons P il = oy o Nortatsedey e lanzeed Terater Perrigor et Renen i B Perrigo CODE AREA
5501438d-5247-4f2a-8e15-085276d01725_531_1.jpg RNING: KEEP THIS OUT OF THE CH OF CHi DOSAGE and STORAGE SEE PACKAGE INSERT 43063-745-60 43063-745-60 43063-745-60 GEMFIBROZIL GEMFIBROZIL GEMFIBROZIL usep usP Usp 600 mg 600 mg 600 mg 60 TABLETS 60 TABLETS 60 TABLETS ReOrder # 110185 ReOrder # 110195 ReOrder # 110195 LoT H1BEG1 LOT H18E61 LoT H18EG1 EXP 05/20 EXP 05/20 EXP 05/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: 00 MG OF GEMFIBROZIL ORGANOLEPTIC MARKINGS: AHITE 1G 225 OBLONG NDC: 43063-745-60 EIPD-Rx " |PHARMACEUTICALS INCORPORATED® Oklahoma City, OK » 73127 GEMFIBROZIL USP 600 mg 60 TABLETS {01)10343063745601 (21)H18E61000002 (17) 200531 (10)H18E61 T095VLEIDEDE (LT ITTZ80LE069 “INI INHYHD N3SYANI
55136184-33b7-4230-b1bd-291a86168eca_629_1.jpg S £ N NDC 0093-0733-01 METOPROLOL TARTRATE Tablets USP 50 mg €££.0-£600 2 g = 2 2 0 S10270034IN05 Rev. G 3/2013 R only . =
55136184-33b7-4230-b1bd-291a86168eca_629_2.jpg = NDC 0093-0734-01 g METOPROLOL i TARTRATE a Tablets USP E : 100 mg i B only | f0TABLETS [T o K
553285e2-d0e9-8b7b-4766-a0a6b9496f87_648_1.jpg NDC 32909-125-22 12 x230 mL N i Diagnostics VARIBAR® PUDDING e e ingredients: artficial vanilla flavor, carboxymethylcelllose 80, potassium sorbate, purifed water, saccharin sodium, Store at USP controlled room temperature, 2010 25°C (6810 77°F). Protect from freezing, Lot Ruonly Lotand expiry encoding area Manufactured for X2 Bracco Diagnostis Inc, Monroe Twp., N) 08831 EXP. by E-Z-EM Canada Inc, Anjou, Quebec H1J224, Canada (01)30332909125227 rev. 0718 CE87FO3 ﬁ
553285e2-d0e9-8b7b-4766-a0a6b9496f87_648_2.jpg Multiple-dose container - For oral use only See prescribing information for complete dosage and administration information. Each mL contains 0.40 g barium sulfate and the following inactive ingredients: artificial vanilla flavor, carboxymethyl- cellulose sodium, citric acid, ethyl vanillin, glycerin, maltodexin, polysorbate 80, potassium sorbate, purified water, saccharin sodium, simethicone emulsion, sodium benzoate, xanthan gur, xylitol For use in modified barium swallow examinations o evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older Store at USP controlled room temperature, 2010 25°C (68 to 77°F). Protect from freezing, Once opened, may be used for up to 21 days when'siored at USP controlled room temperature, 20-25°C (68-77°F). Record discard date in the space provided below: Discard After /. /7 (01)10332909125223 rev.11/16 TX1808 CT88004 oo raceo Diagnostics ~/ 230 mL NDC 32909-125-22 VARIBAR’ PUDDING (BARIUM SULFATE) ORAL PASTE, 40% w/v For Oral Use Only Rx only Manufactured for Bracco Diagnostics Inc. Monroe Twp., NJ 08831 by E-Z-EM Canada Inc. Anjou, Quebec H1j224, Canada BACK FRONT
553285e2-d0e9-8b7b-4766-a0a6b9496f87_648_3.jpg Multiple-dose container - For oral use only See prescribing information for complete dosage and administration information. Each mL contains 0.40 g barium sulfate and the following inactive ingredients: artificial vanilla flavor, carboxymethyl- cellulose sodium, citric acid, ethyl vanillin, glycerin, maltodexin, polysorbate 80, potassium sorbate, purified water, saccharin sodium, simethicone emulsion, sodium benzoate, xanthan gur, xylitol For use in modified barium swallow examinations o evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older Store at USP controlled room temperature, 2010 25°C (68 to 77°F). Protect from freezing, Once opened, may be used for up to 21 days when'siored at USP controlled room temperature, 20-25°C (68-77°F). Record discard date in the space provided below: Discard After /. /7 (01)10332909125223 rev.11/16 TX1808 CT88004 oo raceo Diagnostics ~/ 230 mL NDC 32909-125-22 VARIBAR’ PUDDING (BARIUM SULFATE) ORAL PASTE, 40% w/v For Oral Use Only Rx only Manufactured for Bracco Diagnostics Inc. Monroe Twp., NJ 08831 by E-Z-EM Canada Inc. Anjou, Quebec H1j224, Canada BACK FRONT
5584d077-a14d-4fef-87ae-99cf3eef6f86_808_1.jpg nan
55c30f08-c42d-4d07-a66e-5c5c977e7fae_701_1.jpg Mycophenolale Mofetil Gapsules, USP IIIII[ I) IIIIIIIIII III ) 0 03 68084 795 01 5 Mycophenolate Mofetil Gapsules, USP GAUTION: Special Handling and Disposal Instructions see Insert, PHARMACIST: Dispense with the accompanying| Medication Guide to each pati “Each capsule contains: Mycophenolate Mofeti 250 mg Usual Dosage: See package insert Storeai 2 025°C (66" o 77°F)seo uSP Controlied Room Temperature. Protect from moisture, Keep this and all drugs out of reach of children. RxOnly ‘The drug product contained in this package is from NDC # 0781-2067, Sandoz Inc. Packaged and Distriouted by: American Health Packaging 09501 Columbus, Ohio 43217 Rev. 073014
55c30f08-c42d-4d07-a66e-5c5c977e7fae_701_2.jpg WSS Mycophenolate Nl Copoteuse 250 mg LOT: xoocx EXPIRY xxx Mycophenolate Mofetl Careue,Use 250 mg LOT.ooooex EXPIRY. o0 Mycophenolate Mofet Copmaeuse 250 mg LOT: oo EXPIRY: xox Mycophenolate Wofetl Caoate s 250 mg LOT: ooooox EXPIRY. mx Mycophenolate Nofet! Cogae use 250 mg LOT: xoo0x EXPIRY. x 5 Mycopnenolate 2 Mofetl 23 ot use 1250 mg OT: xooox 3 EXPIRY: Mycophenolate Moot 1250 mg 3 ! LOT: oooonc EXPIRY: wox 5 Mycopnenalate o4 Mofeti Cooateuse 250 mg LOT: xoooox EXPIRY. ox A & Uycophenolate woteti Copsieuse 250 mg LOT: o000 EXPIRY. oox 4 & Mycophenolate Notell o use 250 mg LOT: xooox EXPIRY. oicx i i § s
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_1.jpg m 0 L0-28%v-899€1L h 20N SB91H DU N VS LIIHHOL 0] pamae ey g0 s o s o 40 4 puEOUEN o | E & uorewiopn buqusoxt buecunooe og atesog fersn i 00 s I angsava pur e oo YU S 265 1,96 0 66) 6.1 51 il N9 1 0 691 0,5201 € 122515 BN Jo 388l )0 10 SEAD e pue S iy BUAG0U 615 ) WIS S LD augo oou 0103 insdea 19E3 Rx only NDC 13668-482-01 line , USP Hydrochloride Patient Information Sheet to each patient. PHARMACIST: Dispense the accompanying Minocyc Capsules 100 Capsules (
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_10.jpg Unvarnished area O VIONI ‘081 26E-Uonieyg QL1ST¥IILNIDVINHYHA LNIHHOL K panesey 8067227 SN PlOYASNOY 10} PapUBIU] J0U S| JBUIBIU0D SIY | “uopeuwoju Buquosaid Buifuedwoage sag :afiesog ensf NSO JUBISISAI-PIIYO UM Jaurejuoo juelsisal-1ybi ‘b e ul esuadsig ‘JBay 8AISSaOXa pue aimsiow ‘Wb wouj 198304 [ainesadwa] wooy PaJj0JIu0) dSN 885] (4,98 01065) Do0E 01 oS | 01 papuLIad SUOISINOXa {40/ 01 o89) 9s5Z 01 c0Z 12 21015 “UBIPIYP 40 4Ll 3} 10 SBNIP 12 pue siyy daey “gujoRoouiu B g}, 0} JusleAInba dSN ‘apuojyo0ipAy aujjakooulpy :surejuoa ajnsde yoe3, 8 = B 3 S &= < > g8 & b T s= S g8 3 = =l @® s = — 2e © = e a 28 = = 3 = — 0 eEs - ) §5 r..uh - 28 8 Q o = % E 2 8= @ (=] = N M.m F EB = £= = S & g =ExXo £5 o oo .
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_2.jpg 026 ) saamieg wonewsoj Bugusaid Lsts {aimesadua) wooy o panyusad 11 pue st dosy ol 6 0 0} WileAmb SN GPLIOIUO0IDAY BURAIOUI SUrEIOD afnsded yoe3 1 v9 g R g 2 2% 2 @B F £ g & S C s 88 5 —_—= b 2 = m £2 — = S5 o= & = V-he 25 2 o= &2 1 o3 5E 2 @ &= @& 5g S ET = g= c=>® ZE EE=EXT o £ N _ 3 13668-482-01 o
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_3.jpg Unvarnished area 10-¢8v-899 sty NI VIUYHA LNFIOL S0} paime e VION ‘051 58 pneUg Q0 SIYLLNIVYHI IN3HOL o panaeuey —juaiio} oL Bulguos9 1 DUk oot 905 esog fensn 151009 1 i asuadsig Jeay anjssaoka puR BnJSI0W 161 WO 08I0 saorzzs 0102529 0N 1 O WS- UO) PaU0) dS 93] (498 01 65) 9408 0} I 0} papuIad Suoisinoxa 01 05 0} WapAIba S0 ‘9 aujofoouy SujeNco afnsdea pe3, 5 £ B o £5 1) = E% e e 52 2 8% 8 g8 S.28 i 2 e.= 2z Ses= 25 s=S smmis E8=w = s 2o = GE 2 0= Sg e @ = SESER s = 2 S=ETO £E |
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_4.jpg B0 a9 DS <N VS LIIHHOL 301 prmaeuey fampsaduiay wooy o pauad NDC 13668-483-01 100 Capsules dsn'en Minocyc Hydrochlor W _jUsiiot R o yoea a0 o aujatoou Lol DA s oou sujEoa Rx only de UsP PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. Capsules
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_5.jpg Unvarnished area ~ i Z 10-€8v-899¢€1 ¢ saarzzs 0102529 ON 1 O _juaiiop uoeILIOjU Bujq0sA K BulALEduIoo0e sag WIS H0Y WO Ul asuadsig a1 anssaona S10U U] W04} 19910 Pa|jo-4u0D dS 335] (498 0 465) 408 01 GF 0} pauad Suojsinaxa (a2 01 489) a5 01 402 18 31015 api jo 0 snp e pue sty daay auafaou 6w G/ 0} WapAIba S ‘HPLOLPOIPAY aujokooupy Sulepiod ansded e3, v al B = = et Bl 0 o 2% 3 e E= 2 2z 8 2= 2 e.= 22 S sE= ] s=S smmis t828g; ! 2083 s 280 28 S0 @ = SEEsR SEE O EE
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_6.jpg £ 500 Capsules NDC 13668-484-05 Minocycline Hydrochloride Capsules, USP 100mg* " PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. ibing information. 58 2 t intended for \e ' s = 8 g 3 ¥ = g 2 /< sule contains: Minocydline hydrochloride, USP PHARMA North Brunswick, NJ 08902 torrent™ wanutactured by: ohm Laboratoris Inc 13668-484-05 Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920 * Each N 3
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_7.jpg N/I /‘ - BAJE SiUseA UoU o T = / 2 13668-484-50 zo 010N SO DNV INHED L0 B owSun o Aapomponwen oo | oo Ouguosaid buyueducooe 2o :afesog jensn anestrg u el aNSSEOXa PUPAINSIOW npesadusa wooy pi asn 5] 4098 0 o SIS0 (oL AUI0UIK Suleluoa apnsdes e . = = S > = NDC 13668-484-50 Minocycline Hydrochloride Capsules, USP PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. 50 Capsules
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_8.jpg ] 02620 PN ‘3091 DupSeg 0N VWAYHd LNFUHOL 0) Bamaeinuei EDRED L HOTNO SIED SN ‘2PUIONO0IPAY SUOAIOUIN :SulEIuo3 a|nsided Y3 . 8 > 2. = s :E 2 e S8 8 @®8 F £= g g5 2 e.us g8 = g8 mnr £2 i -_— - 82 o= 8 25 22 : DOS = = o2 5E N [— =] S¢g S EBT = £< = > (C zs E=TO £s 3 13668-484-05 2
55df55fb-18ec-4e00-9ed0-10bba0da513b_9_9.jpg Unvarnished area sz juaio} uosard buluedu 000k sag. whesoq fens P Yy Jueico U asuadsg ansop WEISE wesisa 168y anssaona PUB aINISIOW WO W0 9810k PRI 000 d ST S] (4,98 0} o6S) 406 018 0} payuad sUojs Nxa (4L 04289) 052 0} 02 18 31018 B 00} 0} WafeAnbe dsf) ‘spHOLOpAY auloAoou :suleiuoa ajnsdea yoe3, Rx only 50 Capsules NDC 13668-484-50 Minocycline PHARMACIST: Dispense the accompanying Patient Information Sheet to each patient. Hydrochloride Capsules, USP 7 e
565966b5-9ef3-4142-e054-00144ff8d46c_796_1.jpg wp ¥ sowy Kione —oNuL 000000,000000,0F.£04991 4 2098 sanoy 76 nGaRULIB Y 080NN £q paBex; : KEEP OUT OF REACH OF cHILDREN Lot # 000000 Exp. Date (O AR E Mt e S NDC.68071-1557-3 GIipiZIDE 2amy E-R Tablets Rx Only 00-00 Product# R1523030 GEpIZIDE 2.5mg #30 ERTablets ExpDate:00-00 NDC 68071.1557-03 AWP: Mg NDC_0551-0900-30 Lor 7 000000 . Rx # 23145407 GHpIZIDE 25mg #30 E-RTablers ExpDate:00-00 NDC 68071-1557-03 AWP: Mfg NDC_0591-0900-30 Lot #: 000000 Rx # 23145407 GBpIZIDE 2.5mg #30 E-RTablets Exp Dote:00-00 NDC 68071-1557-03 AWP: Mig NDC_0591-0900-30 Lot #: 000000 Rx # 23149407 GEpIZIDE 2.5mg 230 ERTablets NDC 68071155703 Tt NDC_ 0593.0900-30 Yot 47500000 " Rox # 2314407 Rx# 23149407 Exp Date: 00-00 'STORE AT CONTROLLED TEMPERATURE 6577 °F.
5664d350-2ab2-4e50-9c57-fd42f987c5dd_174_1.jpg NDC 70529-021-01 Nacellate Solution 0.9% - 100mL Injection System Contents: 1~ 100mL Sodium Chioride Injection 0.9% Storage: Store in a cool 25¢ 776 diy place at 25°C (77°F) e Excursions permilted fo P 15-30°C (59-86°F). See USP. . Couton, conaut Single ocompanng oot Controlled Room ueonly Goclmens ' lmiuctons emorare Temperature. 1L~ 2 2 ® > Lot : 111617 . 8 Exp: 8-1-18 ‘Assembled and Disributed by I13 Medical, LLC 190 E Stacy Road: STE 306-298 Allen, TX 75002-8734 For quesfions or comments: info@IT3-Medical com, www.T3-Medical com ©2017 113 Medical LLC. Assembled in the USA
56ad5b97-8e5f-48a5-b2ba-a5484b43d018_527_1.jpg e g L0 R | H H H‘ e B et s 9l Pantoprazole Sodium — INIAMIRIL NI~ rescribing information. =] o ;AR[[;S gnﬁ“st lll7‘] ‘BE SPLIT, CHEWED, Delayed Release Dispense in a tight, light-resistant 8 ORCRUSHED BEFORE AommisRation. Tablets, USP contaner as defined inthe USP @ Ko b d all mdtion o e Vonas ook et oo, bl 20 mg-| MPS Koo cortaer gy s, Somsi 20 0BT @ 0777 [ T ez Mesikachin i i g [PHARMACIST: Dispense the accompanying | | Mylan Pharmaceuticals Inc. g Medication Guide to each patient. Worgantown, WV 26505 US A E (40 x 15 mm) Made in India = @ My|an» Varnish Free area for Variabie Data Coding L [MMylan R <« )
56ad5b97-8e5f-48a5-b2ba-a5484b43d018_527_2.jpg W mom o [P I‘ |HH| HlH it M : s U39 Dasopton e Pantoprazole Sodium I TAMINKIL NIV o Yok Bore Sy ~6689- g et 1 Delayed-Release i 3 pomee Mt Tablets, USP TS N e i ; oot s CMPY | epcrane by e Storeat 20° 4o 200G [ e 7 LR ] Code No. MHDRUGS/25NKD/9 USP Controlled Room Temperature.] Mundachrod i " g [PHARMACIST: Dispense the accompanying| o Bhamacpicisne, 5 [ eoton G o ac et Morgantann, WY 26505 USA g Mvi (40 x 15 mm) Made nndia g @ ylan® Vamish Free area for Variable Data Coding Myla T TR = = g 2 3
5704eea9-a01d-6651-b953-da2a2128b464_708_1.jpg uonnjos jesidoy apiuoupon|4 w0z = NDC 47781-60249. Fluocinonide Topical Solution For Topical Use Only Not for ophthalmic use sl Dose: A sll mounshouks be aopbd o e fecied aea wo o our NDC 47781-60249 Fluocinonide Topical Solution For Topical Use Only. Not for ophthalmic use.
5753679a-506c-4ac4-b8b2-b27c664d1d40_887_1.jpg IV 0 90-£292-2600 & andey] yoez) Aoseucy-aaidQ “07°S SIIMISNANI HIEZ) VAIL g pandey PeXTIRNITY “NIHTTIHD 40 HOVEN 3HL40 N0 SNOLLYDIGIN TIV ONY SIHL 43 *3307 ALHILL T “(paifnbe se} NS0 WAL L 4S124) Ul PIUSED B8 SUELC) WSSl W] WA B U esuedsi “larmeisdue) Luooy peyanuog d ees] Utz 01.99) 0,52 0102 B IS Rev. B 10/2014 Non Vamish/Coding Arsa 1101702-02 SUBIUGD IO} PRTFOR-UIL BT (0806226800800 NLLD NDC 0093-7478-08 GAPECITABINE Tablets USP PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT 150 mg INFORMATION LEARLET B oy | 0TABLETS Cytotoxic Agent
5753679a-506c-4ac4-b8b2-b27c664d1d40_887_2.jpg 0 68-9.%2-£600 m YSVBL Vd ‘SO UION “ONI VSN STYOLNINVIRIVHA VAdL 210 PRINSENUERY ayqndey yaez) ‘Anewoy-eedQ 06 SIAMLSNANI HOTZD VAL g 99qndey) 4oez? U] PAINKEIWEY "NIYQTIHI 40 HOVIY 3H140 110 SNOILYOIGIN TV ONY SIHL 31 {422 01.,89) 9,62 01 .02 [€ ©0IS “uofpEuuioy] Buiquoseud jy Joy ‘pesu) efiped eog :aleson [Ras) g ‘suigeades Bu g SUEU0A J9IQE} PATEO-WIY 3 08892v28600800 NILD mw == ge w SE o = =1 - E uE Ex? g mm ¥ E=2_<=E S 082 Es gwo E 5o g <88 £ & 2 OO OF Rev. B 10/2014 1101901-02 B only Non Vamish/Coding Area
586c2dfc-6852-44a0-b886-6300c1abb276_505_1.jpg Depakote Divalproex Sodium 250 mg Tablet, DR arv: 30 ID #: a;NR Expires: NDC #: 70518-1454-00 Shape: Oval LOT #: Ref #: 00074-6214-13 MFG: AbbVie Inc., North Chicago, IL 60064 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
58a9975c-c442-4839-9809-93343e9a9e87_341_1.jpg NDC 55154-5224-0 V3 0 GlipiZIDE TABLETS, USP 5 mg 10 TABLETS Each tablet contains. Gipizide, USP 5 mg Usual Dosage: See product inset for prescribing information, precavtions and warnings. STORAGE: Store at 20° to 25° C (68° to 77° F), [See USP Controlled Room Terrperature | RX ONLY WARNING: This Unit Dose package is not chid resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the rezch of children Manufactured by. Mylan Pharmaceutizals Inc. Morgantown, WV 26505 U.S.A Distributed by. Mytan Institutional Inc. Rockford, IL 61103 U.S.A, Myian com Mylan® Distributed by Cardinal Health Dublin, OH 43017 128794920318 LOT #: XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
58a9975c-c442-4839-9809-93343e9a9e87_341_2.jpg I 734 NDC 55154-5588-0 GlipiZIDE TABLETS, USP 10 mg 10 TABLETS Each tablet contains: Glipizide, USP 10 mg Usual Dosage: See product insert for prescribing information, precautions and warnings, 'STORAGE: Store at 20 to 26 C (680 77 F) [See USP Controlled Room Temperature ] RXONLY WARNING: This Unit Dose package Is not chid resistant and s Intended for Insttutional Use Only. Keep this and al drugs out of the reach of children. Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U S.A Distributed by. Wylan Institutonal nc. Rockford, IL 61103 U.S A Mylan.com Mylan is a trademark owned by ts respective owner. Repackaged by Cardinal Health Zanesville, OH 43701 128795260517 orw o [N exe.onre: vzse [N
58ba729f-cca1-4e08-a131-dbe91258d99d_640_1.jpg nan
58c51c6a-5d8c-4205-a71e-e16da049332a_41_1.jpg 15" 0.875” HSIN"YVA ON NDC 55801-145-01 Chlorthalidone Tablets, USP L 25mg A0 100 Tablets Each tablet contains: Chlorthalidone, USP 25 mg Dispense in a fight, light-resistant container as defined in the USP wsing a dhild-resistant dosure. Keep container fighily dlosed. Keep this and all medication out of the reach of children. Store af 20° fo 25°C (68° 1o 77°F ). [See USP Controlled Room Temperature.] Protect from light Usual Adult Dosage: See accompanying prescribing information. Manufactured by: Appeo Phuma LLC Piscataway, NJ 08854 U.SA. Rev. 01/2018
58c51c6a-5d8c-4205-a71e-e16da049332a_41_2.jpg 0.875” HSINHVA ON NDC 55801-145-02 Chlorthalidone Tablets, USP Rx only 1000 Tablets Each tablet contains: Chlorthalidone, USP 25 mg Dispense in a fight, light-resistant container as defined in the USP using a child-resistant dosure. Keep container tightly closed. Keep this and all medication out of the reach of children. Store at 20° to 25°C (68° to 77°F ). [See USP Controlled Room Temperature.] Protect from light Usval Adult Dosage: See accompanying prescribing information. Manufactured by: Appco Pharma LLC Piscataway, NJ 08854 USA. Rev. 01/2018
58c51c6a-5d8c-4205-a71e-e16da049332a_41_3.jpg 1.5” 0.875” HSINHYA ON NDC 55801-146-01 Chlorthalidone Tablets, USP Each fablet contains: Chlorthalidone, USP 50 mg Dispense in a fight, light-resistant container os defined in the USP using o child-resistant dlosure. Keep container tightly closed. Keep this and all me¢ n out of the reach of children. Store at 20° o 25°C (68° to 77°F ). [See USP Controlled Room Temperature.] Protect from light Usual Adult Dosage: See accompanying prescrbing information. Manufactured by: Agpeo Pharm (1C Piscotaway, NJ 08854 USA Rev. 01/2018
58c51c6a-5d8c-4205-a71e-e16da049332a_41_4.jpg 0.875” HSINYVA ON NDC 55801-146-02 Chlorthalidone Tablets, USP i Rx only o 1000 Tablets Each tablet contains: Chlorthalidone, USP 50 mg Dispense in o tight, light-resistant container as defined in the USP using o child-resistant dlosure. Keep container tightly closed. Keep this and all medication out of the reach of children. Store at 20° to 25°C (68° to 77°F ). [See USP Controlled Room Temperature.] Protect from light Usual Adult Dosage: See accompanying prescribing information. Manufactured by: Appco Pharma LLC Piscataway, NJ 08854 USA. Rev. 01/2018
58fa9328-b1c7-407c-b215-9887db90cb94_786_1.jpg Haloperidol 5 mg Tablet arv: 30 ID #: ZC Q7 Expires: NDC #: 70518-1269-00 Shape: Oval LOT #: Ref #: 68382-0079-10 MFG: ZyGenerics/Zydus Pharmaceuticals, Pennington, NJ 08534 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
595ab888-6b55-4642-a32f-e8521821ed81_317_1.jpg s 4 penpB U NoC 63304-827-90 Atorvastatin Calcium Tablets Rxonly g Tablets OMM° NON VARNISH AREA e /
595ab888-6b55-4642-a32f-e8521821ed81_317_2.jpg NoC 63304-828.90 Atorvastatin . & (Calcium Tablets t au) ‘ssnpu Rxonly P N Tablets ONIM° 1o S e NON VARNISH AREA N oy o
595ab888-6b55-4642-a32f-e8521821ed81_317_3.jpg NoC 63304-829.90 Atorvastatin Galcium Tablets Rxonly gTablets ONM° o NON VARNISH AREA o \
595ab888-6b55-4642-a32f-e8521821ed81_317_4.jpg Noc 63304-830-90 Atorvastatin Galcium Tablets Rxonly = gTablets ONIM° 252 00000000 ot NON VARNISH AREA \
595bd7fb-640b-4d20-8059-40dbe10fbe1f_150_1.jpg ST VL0/ESNALLOD ‘xauauy 81020 BIUBWOY Ul 3pejy (vSn) £2409 71 ‘Binquineyog Xausuy 10} ‘PN [dsn #8g] (4,22 0} ,89) D52 0} 402 18 Japmod Aip i0jg ‘suopnesaid pue “aesop ‘suoliealpul pajielap 1o} LYISNI ONIANYAIWODIV aV3Y "Ugb W B 00g 0} 0GZ - SINpY :eBesoq ensn “IN0Y |, UJLYIM UORN|OS 8S() idwe B gz sulejuod (uesu 8_?&588 ForIntravenousor =5 Intramuscular Use & thenex
595bd7fb-640b-4d20-8059-40dbe10fbe1f_150_2.jpg R 00 V10/€SNAZL0d “XouaUpy 81020 BIUBWOY U 3pep (¥sn) £2109 11 ‘Binquineyog Xauayjy 1o} PN [dsn #9s] “(do2L 0} ,89) 0,52 0 02 1& 4apmod Aip ai0]S ‘suopnesaid pue ‘.wmmwou 'SuoIjealpul pa|iejep 10} 1¥ISNI ONIANVJINODIY aV3Y 4gb Wi B 00g 0} 0GZ - SINpY :eBesoq jensn “INOY |, UILYIM UORN|OS 8S) duwe B 0GZ surejuod uopnjos Buginsey “(pesul Peai) usnip 1u g'} ppe ‘as i Jod For Intravenous or Intramuscular Use 500 mg* per vial NDC 70860-113-41 Athenex 817€110980££00(10)
595bd7fb-640b-4d20-8059-40dbe10fbe1f_150_3.jpg o YI0/€SNAELOd “Xauslpy 81020 BIUBLIOY Ul 3pEly (¥Sn) £2409 71 ‘Binquineyog Xeusyy 10} ‘PN [dsn #98] ‘(do42 0} ,89) 052 0} ;02 1e 43pmod Aip aioig ‘suopnesald pue “afesop ‘suofjealpul pajiejap 1o} LYISNI ONIANVANOOIY QV3¥ "ugb Wi Buw 00g 0} 0GZ - SINPY :aBesoq |ensn “IN0Y | UILIM UORN|OS BS() w Jad we Bw (G sulejuco uopnjos Bupinsey *(uesul buiAueduioooe P W G'€ ppe ‘asn NI 04 ‘uoidwe welb | oy jusieanbs wnipos uljioidue :Sujejuoo [eIA siy 1, & For Intravenous or Intramuscular Use per vial NDC 70860-114-41 * 1 gram Allienex SLyb110980££00(10)
595bd7fb-640b-4d20-8059-40dbe10fbe1f_150_4.jpg . VI0/£SNAYLOd “Xausly 81020 BIUBWIOY Ul 8peyy (¥SN) €109 11 ‘Banquineyog Xauauyly 1o} ‘PIN [dsn #8s] “(d.22 0} ,89) 052 0} .02 1e 43pmod Aip aioig ‘suopnesald pue “afesop ‘suofjealpul pajiejap 1o} LYISNI ONIANVAWO DY aV3Y Ugb Al 6w 00g 0} 0GZ - SInpY :aBesoq |ensn “pasul Buikuedwoooe s8g :uoisnjul Al noy | ulym uopnjos asy) :uofosful Al ‘dSn ‘uonoalu| o} ejepm cEEw W g'y, ppe ‘8sn Al1081q 104 dwe sweb z 0} jusjeainba wnipos uljioidue :sufejuoa [eIA siy 1, = * per vial NDC 70860-115-41 AleneX Eor ntravenous Use g 2 grams
59678f8f-ea9f-4d22-9767-b475e07a4a6c_26_1.jpg BIONPHARMA Noc sass2 11420 Clobazam Tablets @ DISPENSE THE ENCLOSED MEDICATION ‘GUIDE WITH EACH PRESCRIPTION. Rxonly 100 Tablets Each tablet contains: clobazam. 10mg Usual Dosage: See package nsert or fullprescibing information. Store a 20°to 25°C (08° 10 77°) [See USP Controlled Room Temperature] Dispense n 2 USP tigh container Distibuted by: Bionpharma Inc 800 Alexander Road, Princeton, M 08540
59678f8f-ea9f-4d22-9767-b475e07a4a6c_26_2.jpg BIONPHARMA Noc 6ot 115.20 Clobazam Tablets @ DISPENSE THE ENCLOSED MEDICATION ‘GUIDE WITH EACH PRESCRIPTION. Rxonly 100 Tablets Each tablet contains: clobazam. 20mg Usual Dosage: See package nsert or fullprescibing nformation. Store a1 20°to 25°C (08° 10 77°) [See USP Controlled Room Temperature] Dispense n a USP tight container Distibuted by: Bionpharma Inc. 800 Alexander Road, Princeton, M 08540
5999f3c3-3225-4d24-82cd-0b8d7a309587_301_1.jpg DG QERATRAD 100 Tatlets 10X 10 Ut cioss) Oxycodone and @ Acetaminophen Tablets, USP F N NDG 4265010240 100 Tablats (10 10 urt o] Oxycodone and @ Acetaminophen Tablets, USP NDG 42656-102:10 Oxycodone and @ Acetaminophen Tablets, USP et P, oo PO [ - @ Unvarnished Area for Lot & exp. il NG 225010210 ™ Oxycodone and @ ™ Acetaminophen ~ Tablets, USP e R k! % \\\ Ry only EAGH TABLET CONTANS: Goyodonm idlanda P, s Aostnophen 39 g 51 Cryrodons 1 i et 44815 of yndors, NoG 25810210 ‘USURL DOSAGE: So pchage ot o cenpstepescions il i, S 17 o Ot OXYCOdOI'le and @ PROTECT FREMMOSTURE P Acetaminophen U s 3 It cortar o it WARNING:Keep 1 v a1 o o e rch f Tablets, USP e Terpa-Ewiat Dot uos (e it U s e ko e paed GO ISE NS TRLETS Gy G DA S 8 s b ¥ I ||I|||I|II|||||||| 100 Tablets (10 x 10 unit dosej Rkodes a2m68-10210 0 anesar-on / oo
5999f3c3-3225-4d24-82cd-0b8d7a309587_301_2.jpg NDG ES2A0RI0 100 Tatlets (10 10 it coss) Oxycodone and @ Acetaminophen e ol Ll o o o NDG 425210840 100 Tablats 102 10 unt cose) Oxycodone and @ Acetaminophen Tablets, USP &% Tablets, USP NDG 42855-108-10 Oxycodone and @ Acetaminophen Tablets, USP o - e e L, v S W e P P, St 1251 / NG 4265210810 Oxycodone and @ Acetaminophen Tablets, USP Ryonly EAGH TABLET CONTANS: Gercodos yiaciada UsP. T5m Aosnnophen USe wsmg 5 g O SUAL DOSAGE: e infmaim, Stom at20" 125G 65/ 1017 500 USP Gomtrl oo Temperatus). PROTECT FROMMOSTURE DEROFDERFORMFECLIFED, el et dspenes for- e ot oo 3. oepinc 4n 1 madcton ot s eschof il 1 728 05 f o, ige st forcamplas rescrong TG-St Dot cose (e it U s o o e opuron 0 W07 USE NS THBLETS CAFRY TAS DBMTFATN 75 32500 e 302 and B o e s o 42810310 7 02908 [ Oxycodone and 100 Tablets (10 x 10 unit dose) [ttt | Acetaminophen Tablets, USP @ @bodes
5999f3c3-3225-4d24-82cd-0b8d7a309587_301_3.jpg NDG 265210410 100 Tetiets (10 10 1t = Oxycodone and @ Acetaminophen Tablets, USP NDG 4265510440 100 Tablate (10 10 un coss) Oxycodone and @ Acetaminophen Tablets, USP NDG 4285610410 Oxycodone and @ Acetaminophen Tablets, USP o e s 1, ot Pl St 1 [ e o | s Oxycodone and @ g Acetaminophen g Tablots, USP e ~ o e g Oxycodone and @ Acetaminophen Tablets, USP glll!sl!!‘lnll'" 4 S 100 Tablets (10 x 10 unit dose) @ooden e | J
59a7cda8-34b4-4c02-b100-91f274918eef_115_1.jpg ach it it otain Diencein gt Izt 52 wz Suprion ot 19 150 ARSI L e e 5 g £ e e e sy, & Morgantown, WV 26505 USA. Keep container tightly closed. s D_ i : bty g o z 9 o Store at 20° to 25°C (68° to T7°F). 3 B o = R n 5529 2 Prot om fght S gk43 B koo e = s ‘bt dily oras directed by 0= Z2 g VRRHINE o o e combmation wil]| physician. See accompanying 1= H2 Zyban® o any olher medicinesthatcon- | prescrbing information ~—== & é é i proponhyrchride I= 54 r = £ [MMylan ~ g g Rxonly 90 Tablets [aiTi il
59a7cda8-34b4-4c02-b100-91f274918eef_115_2.jpg Each fim-coated tablet contains: y Dispernse n a tight,lght-resistant container as de- Bupropio hycochire, USP 300 mg. Mkt L fined i the USP using a chid-resistant closure wz Mylan Pharmaceuticals Inc. ONCE-DAILY Keep container tightly closed. - Morgantown, WV 26505 US.A. bu PROPion HCI :(::ghl:;sn:“graelrll.m“ica“n" out of the St t 20° to 25°C (68° to 77°F). [Se (STl Lo B IR T U Gonirolied Raom Jompornturen @ Tablets, USP (X L) Protect from light. RM200988 Usual Adult Dosage: Take one tablet daily or - as directed by physician. See accompanying 5353 Y (oo e gEd: PHARMACIST: e g WARNING: Do not use In combination with Zyban®" or any R e L R e R e ﬁ ) B ‘other medicines that contaln buproplon hydrochloride. e “This container is not intended for dispensing HE @ Mylan: [ fousenolduse. ~ g YIAN® 7o s registored trademark of Gasosmitiine. Medication Guides may be obtained at Rx only DOVR T Mylan.com/MedCenter or call 1-888-839-8993.
59e610dc-883e-4f07-9ec6-a5841b0bf9fb_471_1.jpg NN g pronky Todaies et 1006250670 TICAL EET] $ERTIC g B 8 3 2 Toyoes impde Rk VERTICAL DI]IIHI]I st opl | oy ot %10, (PO S1a1Q [° s - b g o st e el st o s 05
59e610dc-883e-4f07-9ec6-a5841b0bf9fb_471_2.jpg | sopns 0 s 05 g e Rxony VERTICAL A5 oy oo s a1y oS0 Fe, | s s o sl st o s e At e A0 o S e 5 o s e o s et s [ ————— A o Ay e DMgel' - estadil ) 01% Ry
59e610dc-883e-4f07-9ec6-a5841b0bf9fb_471_3.jpg o g Reoy D2Sq o025 g i NDC 12506530 [ sopms 028 125 g et Ranly T ICAL: S llMllﬂMI i i I 5 H £ I i ) sareie EED oo OOIAI i 1981ai0 oS00 g o b e . i it s s e g A s W e U o strsossn l\/ige Ry
5a95677e-61cd-45c4-8794-c1607e763750_15_1.jpg NDC 16714-737-01 Fenofibrate Tablets USP 90 Tablets Each film coated tablet contains: Fenofibrate USP 48 mg. Usual Dosage: See package Insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Do not accept if seal over hottle opening s broken or missing. Dispense in a USP tight container. M.LNo.: 22/MN/AP/2009/F/R Product of India Issued: 06/2017 Manufactured for: Northstar RX LLC Memphis, TN 38141. ©2005 NoriStar Healthcare Holdings UC. Manufactured by: Aurobindo Pharma Limited UNt-VII (SEZ) Mahabubnagar (D1)-509302, India. P1417516 0LE29L29LEN
5a95677e-61cd-45c4-8794-c1607e763750_15_2.jpg NDC 16714-738-01 Fenofibrate Tablets USP 90 Tablets ‘Nonrusrm;z Each film coated tablet contains: Fenofibrate USP 145 mg. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Do not accept if seal over hottle opening is broken or missing. Dispense in a USP tight container. M.L.No.: 22/MN/AP/2009/F/R Issued: 06/2017 Manufactured for: Northstar Rx LLC Memphis, TN 38141. Manufactured by: Aurobindo Pharma Limited Unit-VII (SEZ) Mahabubnagar (Dt)-509302 India. Product of India P1417517 a0 SOUPION SIeaESH FISYION 5002 @ 2108E2%L29LEN
5accc7a5-8209-4680-b0ae-2a6963500419_973_1.jpg Mustbe efigerated Picato® (ingenol mebutate) gel 0.05% 2Urit Dosa Tubes somm poyund fe= punisume oz st unpos SpREEL (el W s S i Al 1o e S50 168 S j0sbu) Lo 10 a0 90 dsoy 9 b Joye e el ey oo s e poori Gl _ 0571555 .50 3.0 05 - 4.2 voanian pai SRS (0.8-0.2) 190 4.8 16 DIERGHOIE Uit NetWe. 047 gin each tube 0. 3 Soauaas o yna o 1o 0ak 1umoa 10 1 Ap s 5 U AR S00S0p TR 0g 23 w071 nocsz a0 Rconly Picato® (ingenol mebutate) gel OUTSIDE passmpismi |
5accc7a5-8209-4680-b0ae-2a6963500419_973_2.jpg nan
5accc7a5-8209-4680-b0ae-2a6963500419_973_3.jpg nan
5accc7a5-8209-4680-b0ae-2a6963500419_973_4.jpg LR INSIDE
5accc7a5-8209-4680-b0ae-2a6963500419_973_5.jpg nan
5accc7a5-8209-4680-b0ae-2a6963500419_973_6.jpg nan
5accc7a5-8209-4680-b0ae-2a6963500419_973_7.jpg Picato" Al umrat Picato® inganol mebutate) gel 0.05% o g e
5accc7a5-8209-4680-b0ae-2a6963500419_973_8.jpg nan
5bbce8c0-a9c9-45b9-8457-1542bd3d9449_3_1.jpg G NDC 51525-0115-1 Exch tablt cortns 0375 mg yoscyamine sufte, ISP USUAL DOSAGE:Aduls and peditic ptnts 12 s 100 sblets ofageand dder: 102 ales evry 1 hurs. Secpackage et for ol pescting infomtion. 5 Dispense g, ot reitant containers as Hyoscyamine Sulfate deitedin S wihchid-rsisunt dosr. Extended-Release & 00T 0FREACH OF CHLDREN. Sors atsnold o tortr 200250 5 Tablets ocrsons pamited o 50500 (£60-86%) Pese o uren 5. 0.375 Mg it by: lhos Phrmaostcs Somaset, W BET2 4120 U5 For meficl s call 00510634 G0 U Plamacetss . LB-41510303 REV 32015 §251S o w waAarLLAcE
5c098a1b-cca0-4c27-8e0e-3a27cb2fc003_182_1.jpg Eac i ot ot i Dipersin g, gttt vz e oy, IARELCRCI O (ot LRl 2 g s Indapamide Eeemsmmae £ P Koo s i e Tablets, USP Store st 20° 10 25°C (68 0 TT°F). 560 USP Conrolled oom Temperature] Avoid excessive heat. Usual Dosage: See accompanying T Myla Mylan Pharmacouticals fnc. Rxonly 100 Tablets Morgntoum, WY 2655 U SA.
5c098a1b-cca0-4c27-8e0e-3a27cb2fc003_182_2.jpg s LS R e T I nda am Ide Keep container ight closed e Tablets, USP Store at 20° o 5°C (68° to' See USP Gontrolled Roam R Temperture] f Avoid excessive heat. /' Usual Dosage: See scxompanying prescrbing ormaton Mylan Pharmacouticas fnc. Morgantoun, ¥ 26505 S A [Mylan® MMylan Rx only 90 Tablets Mylan.com £ N MM AMO030! //=-0800-8/¢0 s
5c0a2d5f-8c34-4c04-8425-7543965cedd4_606_1.jpg ( This sterile single-dose vial contains: azacitdine 100 mg and mannitol 100 mg See prescribing information for dosing and administration Single-dose val. Discard unused porton Keep out of reach of chidren. VIAL LABEL NDC 72485-201-01 Azacitidine for Injection 100 mgivial FOR SUBCUTANEOUS AND INTRAVENOUS USE ONLY Store a1 25°C (77°F); excursions i . permitied to 15°C - 30°C (59°- 86°F). Reanly SitidteDose Vial {See USP Contoled Room Temperature] Armas CARTON LABEL o ssocsbus [e1n/Bui g} uonoaluj Joy suipnioezy wonesgz o Aoy Code: TSDRUGSI 12013 Manufactured by: Shipa Medicare Linited Jadcherla-508301, INDIA o Distributed by: ‘Amas Pharmaceuticals, Inc. Manalzpan, NJ 07726 (USA) 4500261 Rev: 0812018 NDC 72485-zxcxx | This sterie singl-dose vil contains: azacitdine 100 mg and manniol 100 mg Azacitidine for Injection D FOR SUBCUTANEOUS AND INTRAVENOUS USE ONLY See prescibing information for dosing and administration. ‘Single-dose vl Discard unused porion Keep out of reach of ehidren. Single-Dose Vil Store at 25°C (T7°F), excursions peritted 10 15°C.30°C (59°86F). [See USP Controlled Room Temperature.] Azacitidine for Injection 100 mglvial FOR SUBCUTANEOUS AND INTRAVENOUS USE ONLY. Single-Dose Vil NOC 72485 s Manusourea by Shipa Medicare Limited It s06301 INDiA % Dsrmeaty: S Pramisioss . Mansapan, N 07728 (US4)
5c0eb8b2-3fe4-4df4-b21a-09b18a652860_189_1.jpg alsartan Tablets mg/160 mg PHARMACIST. PLEASE DISPENSE WITH ATTACHED ATIENT TNFORMATION LEAFLET 1 only = = s ® L @ 8 = g 3 =] g 2 g8 E 2 61N 0030093769056 A Vi 5 Dispense i tght cona defined i tho USP,wih 2 Rev. A 1172014 323K553040217 30 TABLETS Coding Area
5c0eb8b2-3fe4-4df4-b21a-09b18a652860_189_2.jpg NOC 0082-7691-56 Amlodipine and Valsarian Tablets 10 mg/160 mg SO ML FRARMACET FLEASE ISPERSE I ATTACHED PATENT WEORMATION LERLET 23553050217 Resatinone B only Coding Area
5c0eb8b2-3fe4-4df4-b21a-09b18a652860_189_3.jpg 95-2692-5600 & (RPN 2 5 g 2 SISI0027 Rt Coing Area o NDC 0093769256 Amlodipine and Valsartan Tablets 5 mg/320 mg DOSZBALER00000 ML PHARNACIST PLEASE DSPENSE VT ATTACHED PATENT DECRUNTION LEAFLET R only 30 TABLETS
5c0eb8b2-3fe4-4df4-b21a-09b18a652860_189_4.jpg NDC 0083-7693-56 Amlodiging and Valsartan Tablets 10 my/320 mg oo e e W ATTACHED ATENT WEORNATION LET SO MY S23ESIN0217 e s R only Coding Area
5c8ffae3-3b3e-197e-e053-2a91aa0a59e3_901_1.jpg e et A g NDC 68071-4132-3 Someescrsnaiior NDC 68071-4132-03 AWP: xp. Date: 00-00 tanoe ososo775.07 3 Lot #: 000000 Rx # 23119628 e - - x ® Be308d d 8I8ONN Aq pa! s ul.lvua Ciniaan e vemea - e * o o S 8 ‘m #30 Tablets ‘Exp Date: 00-00 #30 Tablets | EEESERT 8% “au] 'S|@I[IN8IR Lot #: 000000 Fox # 23119628 f | aedroxyPROGESTERone Acctae 1o Acetate. USP | o0 rabiets . Exp Date: 00-00 i NoC 68071413203 AWP: “Kep ® sow| quion aul ‘ven BIdY 080010d - i . | mynpc 0555077902 ound White Scored Tablet Debossed o 200000 Rox # 23119628 555770 on the scored side " MeckoxyPROGESTERone Acctal. oy “b* 0 the other side 4 #30 Tablets Exp Date: 00-00 ) NpC 580714132-03 Product # P0140030 S N a0 o » 23119628 i RxOnly Rx# 23119628 WARNING: KEEP OUT OF REACH OF CHILDREN, . STORE AT CONTROLLED TEMPERATURE 68-77°F. s wo1APY sanoy~ Aieae $501-¥Q: 008"} 19 YT4 O} Seiie spie in Vove vd
5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58_830_1.jpg nan
5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58_830_2.jpg nan
5ca7a3ef-947d-4cd4-89ed-ab4d5a46ba58_830_3.jpg v = HYOROCHLORO-
5cb2674c-a70d-4022-9188-3f711cccff5e_504_1.jpg NDC 30698-335-01 R‘ Only FEE ® M. for and Dis by = 2 Demerol® @ MR 3 %2 (meperidine hydrochloride, Fo s 106 9 A0 Qip M g=3 6003801 £ T pin USP) Tablets §:0! S5s < £¢°) §E3 s EORRR] o, 1 SUOSAR i tesisant contan m h‘l?l} ftsunton Hg 100 Tablets Weticalon Guide o eachpaenl. validus NS alidus
5cb2674c-a70d-4022-9188-3f711cccff5e_504_2.jpg NDC 30698-337-01 R Only M. for and Dis by: ® Demerol® @ L (meperidine hydrochloride, S USP) Tablets Usuzl 11ablel. Rea i pajollio) s 235] 0],65 0| popused 4,100 R0l Odd i w S > © @ & o T & RS o SepESN; Goiny]
5cb9d285-1803-4a99-946a-d0b239b32df6_932_1.jpg Distributed and Marketed NDC 59148-070: Otsuka America Pharmaceutcal,Inc 2440 Research BIvd, Rackville, MD 20850 Manufactured by: Baxter Oncology GbH 33790 Halle, Westfalen Germany 51697048 Caution: Must be diluted before use, CYTOTOXIC AGENT Sterile sfei esnrelBuls (Twi/Bui g) Tw oL I3 uoyosful (UoNSNA) S 16-0,0-8¥16S OGN NDC 59148-070-91 FOR INTRAVENOUS INFUSION ONLY Dosage and Administration: See package insert for dosage and ‘administration information. Contains: Eight 10 mL Vials (6 mg/mL), Caution: Must be diluted before use. | i | | i (busulfon) |nj ecti IVBUSULFEX’ (busulfan) Injection. ! ! | CYTOTOXIC AGENT | ‘ |“ i | i i Store refrigerated between Eight 10 mL (6 mg/mL) Single-Use 2°C-8°C (36°F-46°F). 59148-070-91 °
5ce082e9-13eb-4e63-a9e2-657d3ef0e9f8_14_1.jpg Distributed and Marketed NDC 59148-070: Otsuka America Pharmaceutcal,Inc 2440 Research BIvd, Rackville, MD 20850 Manufactured by: Baxter Oncology GbH 33790 Halle, Westfalen Germany 51697048 Caution: Must be diluted before use, CYTOTOXIC AGENT Sterile sfei esnrelBuls (Twi/Bui g) Tw oL I3 uoyosful (UoNSNA) S 16-0,0-8¥16S OGN NDC 59148-070-91 FOR INTRAVENOUS INFUSION ONLY Dosage and Administration: See package insert for dosage and ‘administration information. Contains: Eight 10 mL Vials (6 mg/mL), Caution: Must be diluted before use. | i | | i (busulfon) |nj ecti IVBUSULFEX’ (busulfan) Injection. ! ! | CYTOTOXIC AGENT | ‘ |“ i | i i Store refrigerated between Eight 10 mL (6 mg/mL) Single-Use 2°C-8°C (36°F-46°F). 59148-070-91 °
5d035ba4-7d6d-4842-b34f-691c26749b33_723_1.jpg FROVETH N STRIP——— LT —— 5 T e e B | pmes e R HouRs S D Lo T RRCOUHORASOREETD, = | s ST e S P F o ot 1 I ] i
5d05df4a-463e-4e66-9387-f3a842e20cd0_143_1.jpg NDC# 60055-334-30 Fludeoxyglucose F 18 Injection Multple-Dose Vial caution 20 mCilmL to 300 mCilmL @ EOS* Activity @ EOS*: Total ___ Volume __ mL Concentration: —__ mCifmL RADIOACTIVE Sterile, Non-pyrogenic Diagnostic - For Intravenous Use Only MATERIAL Caibration (EOS*) Time ___ Exp. Date/Time: Calibration Date Batch # _ Contains: 0.74 GBq 1o 1.1 GBg (Expires 12 hours after EOS") (20 mGifmL. to 300 mCi/mL) Store al 25°C (77°F) (see insert) Store uprightin a shiekded container. of no-carrier added Fludeoxyglucose F 18 Aseptically withdraw and handle doses. [18F] Half-Life = 109.7 minutes Stal with 0.0 t0 0.5% wiw ethanal. Calculate correct dosage from date and time of calibration. Do not use if cloudy or if it contains particulate matter. | Manufactured by: Triad lsotopes *EQS = End of Synthesis Orlando, FL 32811 Rx ONLY
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_1.jpg r | TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0105-5. TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ »izos o ) Manufactured for 1BSA Pharma Inc by: 18SA Inss Bochimiaus SA, 915 Pambio-Noranca, Swizerknd Distibuted by: 18SA Pharma b, Persippany, NJ 67050 Tl 800.567.3513 sejndue g x sayanod 9 10S - eLNISONIL uoIN|OS [BIO (WNIPOS JUIXOIAYIOAS]) Dscription: Each 1 mlampull containg 13 meg levethyroxing sad . storage: Stors 31 25 (77°F); sxcursions pormitted to 1 (55:86°F) Storo ampules in the pouch uncl rea Once the poch s opsned, use ampules within 1 Usaal Dosage: See packags nsert fo dossge information Direction for Use: For Ol Use Only—NOT for[ahelation, yection or Ophthalmic Use. See pockage nser for complete nformaton. Tomper-Evident: For your protection, do not use if pouch incompletely sealed. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN.
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_10.jpg TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0150-5 TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use <> Rx Only 6 pouches x 5 ampules Manufactured for 18SA Pharma Inc by: 185A It Bochimiaus SA, 915 Pambio-Noranco, Switerkind Distibuted by 18SA Pharma b, Persippany, NJ 07054 Tl 800587.3513 sejndue g x sayanod 9 UoIN|OS [BIO (WNIPOS JUIXOIAYIOAS]) 710S - o LNISOYIL Description: Each 1 mlampulo containg 150 meg levothyroxine sodium, storage: Store 3t 25°C (77°F); excursions permitted 1o 15°-30°C. (59-86°F). Storo ampules in the pouch unil ready <o use. Once the pouch ' opened, use ampules within 15 days. Usual Dosage: See packag nser fr dossge information For Oral Use Only ~NOT for Inhalation,Injection or Ophithalmic Use. Ses package insertfor complete nformation Temper-Evident: For your protecton, do notuse f pouches are tom, opened or incompletely sealed. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH oF chILDREN. T | | | | | Direction for Use: | | | | | | | P |
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_11.jpg | TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0155-5 TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ Manufactured for 18SA Pharma Inc by: 18SA It Bochimiaus SA, 6915 Parmbio-Noranca, Swierknd Distibuted by: 18SA Pharma b, Parsippany, NJ 07050 Tl 8005873513 sejnduwe g x sayanod 9 710S - eLNISONIL uoIIN|OS [BIO (WNIPOS SUIXOIAYIOAD]) Descripion: Each 1 mlampull containg 175 meg levothyroxine sodium. storage: Stors 31 25°C (77°F cursions permitted to 1°30°C (55:86°F) Store ampules i the pouch uncl readly o se. Once the pouch s opaned, use ampules within 15 days. Usaal Dosage: Seo package insert for dosage informaton. Direction for Use: For Oral Use Only—NOT for[ahelaton, yection or Ophthelmic See pockage nsert for complete nformation. Tomper-Evident: For your protectin, do not use f pouches are torn, opned or incompletely sealed. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN. T | | | | | | Use. | | | | | | e o
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_12.jpg o TIROSINT® - SOL (levothyroxine sodium) Oral Solution —__ 6 pouches x 5 ampules NDC 71858-0160-5. o TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ 1 Manufactured o IBSA Pharma Inc by: 185A Inss Bochimiaus SA, 6915 Pambio-Noranca, Swizerkind Distibuted by: 18SA Pharma b, Parsippany, NJ 07050 Tl 800567.3513 Dscription: Each 1 mi ampull containg 200 meg levothyroxine sodium. Storage: Stors 31 25 (77°F); sxcursions permitted to 15°:30°C. (55186°F) Store ampules i the pouch uncl readly o use. Once the pouch s opaned, use ampules within 15 days Usaal Dosage: Seo package insert for dossge informaton. seyndue g x sayanod 9 Direction for Use: For Oral Use Only ~NOT for Inhe U, See package nsert for complete nformation, fon, Inection or Ophtholmic Tamper-Evident: For your protection, do notuse if pouches are torm, opened or incompletely secled. 10S - eLNISOYIL KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN. UoNIN|OS [BIQ (WNIPOS JUIXOIAYIONS])
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_2.jpg »izons TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0110-5. TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ Manufactursd fo IBSA Pharma Inc by: 185A It Bochimaus Sh, 915 Pambio-Noranca, Swizerkind Distibuted by: 18SA Pharma b, Persippany, NJ 07054 el 800.587.3513 sejnduw g x sayanod 9 <> 10S - eLNISOYIL uoIIN|OS [BIQ (WNIPOS JUIXOIAYIOAS]) Doscripion: Each 1 mlampull contains 25 meg levothyroxing sod . storage: Store a1 25°C (77°F); excursions permitted ta 15°-30°C (55:86°F) Store ampules i the pouch uncl ready 1o use. Once the pouch s opened, use ampules within 15 days Usual Dosage: Sea packag inser fr dosage information. Direction for Use: For Ol Use Only—NOT for Iahalation,Injection or Ophthalmic Use. See package nsert for complote nformator. Tampar-Evident; For your protection, do not use if pouches are torm, apaned or incompletely secled. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN.
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_3.jpg TIROSINT® - SOL (levothyroxine sodium) Oral Solution 50 microgram/mL 6 pouches x 5 ampules NDC 71858:0115:5 TIROSINT® - SOL (levothyroxine sodium) Oral Solution 50 microgram/mL For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use <> R« Only 6 pouches x 5 ampules Manufactursd for 18SA Pharm nc by: 8SA Inst Bochimiaus SA, 6915 Pambio-Noranca, Swizerkind Distibuted by: Pharma b, arsippany; NJ 07054 Tel. 8005873513 3 zd g 23 <0 2 s 3 - i | F g5 : ge 3 own g =0 s s @ : g Description: Each 1 mlampulo containg 50 meg levethyroxing sod . Storage: Stors at 26°C (77°F) excursions permitted to 15°-30°C. (59-36°F). tore smpales n the pouch unil ready <o use. Once the pouch s Gpenad, use ampules it 15 days. Usual Dosage: See package insert for dosage information. For Ol Use Only—NOT forInhelation, yjection or Ophthelmic Use, Se package insetfor complets information. Tomper-Evident: For your protection, do notuse f pouches are tor, opened or incompletely seoled. KEEP THIS AND ALL DRUGS. OUT OF THE REACH o7 chILOREN. T | | | | | Direction for Use: | | | | | | |
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_4.jpg TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0120-5. TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ R o Manufacturad for IBSA Pharma nc by: 18SA It Bochimiaus S, 6915 Pambio-Noranca, Swizerknd Distibuted by: 18SA Pharma b, Persippany, NJ 07050 Tl 800.567.3513 sejndue g x sayanod g |0S [B10 (WNIPOS JUIXOIAYIOAS]) / 10S - eLNISOYIL Dscription: Each 1 mlampulo containg 75 meg levethyroxing sodum, storage: Store a1 25°C (77°F); xcarsions permittad to 15°-30°C (59-86°F}. Storo ampules in the pouch unil ready <o use. ‘Once the pouch s opaned, se ampules within 15 days. Ususl Dosage: Sea package nsert fr dossge informton. Direction for Use: For Oral Use Only ~NOT for I Use. See pockage nsert for completa nformaton. tion,Injection or Ophthelmic Tomper-Evident: For your protection, do notuse f pouches re torm, opened or incompletely saled. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN. s oo \
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_5.jpg — e | | TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0125-5 TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ Manufactured for 18SA Pharma Inc by: 8SA Inss Sochimiaus SA, 6915 Pambio-Noranca, Swierkind Distibuted by: 18SA Pharma b, Persippany, NJ 67050 Tl 800587.3513 sejndue g x sayanod g 10S - eLNISOYIL UoIIN|OS [RIQ (WNIPOS JUIXOIAYIOAS]) Dscription: Each 1 ml ampulo contains 88 meg levethyrosing sod . Storage: Stors 3t 25°C (77°F); excursions permitted to 15°-30°C {59-36°F). Store smpules n the pouch uni ready <o use. Once the pouch ' opened, use ampules within 15 days. Usual Dosage: See package insrt for dosage information. Direction for Us For Ol Use Only—NOT for [ahelation, Inection or Ophthelmic Use See pockage nsert for completa nformation. Tamper-Evident; For your protection, do notuse f pouches are tom, opened or incompletely seoled. KEEP THIS AND AL DRUGS. |OUT OF THE REACH |OF CHILDREN.
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_6.jpg sejnduwe g x sayanod g TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858:0130-5 TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use R« Only & poliches b ampriles @ Manufactured fo IBSA Pharma Inc by 185A Inss Bochimiaus SA, 6915 Pambio-Norancs, Swizerkind Distibuted by: 1BSA Pharma b, Persippany, NJ 07050 Tl 800567.3513 70S - oLNISOYIL uo1IN|OS [RIQ (WNIPOS JUIXOIAYIOAS]) Description: Each 1 ml ampulo containg 100 meg levothyroxine socium, storage: Stors 3t 26°C (77°F) excursions permitted to 15°-30°C. (59-36°F). tore ampules n tha pouch uni ready <o use. Once the pouch s opened, use ampules within 15 days Usual Dosage: See package insart for dosage information. For Oral Use Only ~NOT for Inhalation,Injection or Ophthelmic Use, Ses package insstfor complete nformation. Tomper-Evident: For your protection, do notuse f pouches are tom, opened or incompletely seoled. KEEP THIS AND ALL DRUGS. 0UT OF THE REACH oF chILDREN. T | | | | | Direction for Use: | | | | | | |
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_7.jpg TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0135-5. + TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only 6 pouches x 5 ampules @ 1 Manufactured for IBSA Pharma Inc by: 18SA It Bochimiaus SA, 6915 Pambio-Noranca, Swizerkind Distibuted by: 18SA Pharma b, Persippany, NJ 07050 Tl 8005573513 Dscription: Each T mlampule containg 112 meg levothyroxine sodium. storage: Ususl Dosage: Sea packag insert fo dossge informton sejnduwe g x sayanod g For Oral Use Only—NOT for Iahelation, nection or Ophthelmic Use. See package nser for complata information. Tamper-Evident; For your protection, do not use i pouches are torm, apaned or incompletely seoled. 10S - eLNISOYIL KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN. uoIN|OS [BIO (WNIPOS JUIXOIAYIOAS]) T | | | | | Direction for Use: | | | | | | |
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_8.jpg TIROSINT® - SOL (levothyroxine sodium) Oral Solution & pouches x 5 ampules NDC 71858-0140-5 TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only — NOT for Inhalation, Injection or Ophthalmic Use <> R Only 6 pouches x 5 ampules Manufactored for IBSA Pharma Ic by: 1BSA It Siochimiaus SA. 915 Pambio-Norancs, Switzerknd sejndue x sayanod 9 uonN|OS [RIQ (WNIPOS JUIXOIAYI0AS]) 10S - o LNISONIL Doscription: Each 1 miampul containg 125 meg levothyroxine sodium, Storage: Store at 25°C (77°F); excursions permitad to 15°30°C (89-26°F). Store ampules in the pouch uncl ready o use. ‘Once the pouch s openad, use ampules withn 15 days. Usust Dosage: See package insert for dosage information Diraction for Use: For OralUse Only - NOT for Inhalaton, Injection or Ophihalmic Use. See package nsert for complete information. Tomper-Evident: For your protaction, do not use f pouches are tor, opened or incomgletely seoled [KEEP THS AND ALL DRUGS| 0UT OF THE REACH o chiLoREN. T
5d378add-f13d-40f2-99dc-0f2340ab44b7_766_9.jpg L o ol TIROSINT® - SOL (levothyroxine sodium) Oral Solution 6 pouches x 5 ampules NDC 71858-0145-5. TIROSINT® - SOL (levothyroxine sodium) Oral Solution For Oral Use Only —NOT for Inhalation, Injection or Ophthalmic Use Rx Only & pouches x 5 ampules @ Manufactured for 18SA Pharma Inc by: 18SA It Bochimicus SA, 915 Pambio-Norsnco, Swizerkind Distibuted by: 18SA Pharma b, Persippany, NJ 07050 Tl 800587.3513 sejndue g x sayanod 9 10S - eLNISOYIL UoIN|OS [RIQ (WNIPOS JUIXOIAYIOAS]) Description: Each 1 mlampul containg 137 meg levothyroxine sodium. storage: Store 3t 25°C (77°F) excursions permitted to 15°-30°C. (59-36°F). Store smpules n the pouch unil ready <o use. Once the pouch s opaned, se ampules withn 15 days. Ususl Dosage: Seca packags nser for dossge information. Direction for Use: For Oral Use Only —NOT for[ahelation,Injection or Ophthalmic Use. See package nsert for completa nformaton. Tamper-Evident; For your protection, do notuse f pouche are tom, apaned or incompletely secled. KEEP THIS AND ALL DRUGS. |OUT OF THE REACH |OF CHILDREN.
5d5872e9-2e06-445c-98f8-75a636f3b8e9_554_1.jpg pup pngoig 9v880 10 s sspon T A w0 “IHOTIHO 40 HOVZY 3HL40 100SINYA TIV OHY SIRL &30 RO U0 E 1SRRI ameiaduse woay pap3w0) SN seg] 42 01 89) 0.2.01 2 B oS oL Buguosald oo 10} Bupage| paugBpe 35S ceiesoq fensn B oo s ‘apungey NDC 64720-255-10 ‘gD 1eNe] TR PHARMACIST: Dispense the Medication Guide provided separataly to each patient G Gonepana Felbamate Tablets, USP 400 mg Rx only 100 Tablets
5d5872e9-2e06-445c-98f8-75a636f3b8e9_554_2.jpg pup pngoig 9v880 10 s sspon T A w0 “IHOTIHO 40 HOVZY 3HL40 100SINYA TIV OHY SIRL &30 RO U0 E 1SRRI ameiaduse woay pap3w0) SN seg] 42 01 89) 0.2.01 2 B oS oL Buguosald oo 10} Bupage| paugBpe 35S ceiesoq fensn B oo s ‘apungey NDC 64720-255-10 ‘gD 1eNe] TR PHARMACIST: Dispense the Medication Guide provided separataly to each patient G Gonepana Felbamate Tablets, USP 400 mg Rx only 100 Tablets
5de62aee-f3cc-4aaa-8588-2aed2bdeced9_624_1.jpg Packaged by Begant Rancl Burkank, G 91504 3408 5 ORANGEROUND H3 S HYDROCHLORO THZD TB50MG & HERGN1 [ Keep all drugs out of Compare To: reach of children HYDROCHLOROTHIAZIDE 50MG SERARUTATIBRITOR itas Prarmaceticas Linted 20-25 C (68-77F) #30 Exp: MM/YY g NDC 6362964691 06469190855
5de62aee-f3cc-4aaa-8588-2aed2bdeced9_624_2.jpg Packbaged by Eryant Ranch Binbank. @A 9504 Hydrochloroth 5, HYOROCHLOROTHAZIE 125 gt g de 12.5mg Tablet Store at room temp of Compare To: 20°25°C (68°77°F) Hydodur 125mg Tabket “Keop all drugs outof Intas Pharmaceuticaks Limited reach of children. #30 Exp: MMYY NDC 6362977821 0778210000 om
5e4f5f02-e92d-4c14-93a6-51764b4abc74_51_1.jpg NDC 68645-493-54 Each tablet contains: Atenolol, USP .... 50 mg White to off-white, round uncoated tablets debossed with'Z" '66' and bisect on one side ATENOLOL F Setidi Store at 20° to 25°C (66° to 77" Tablets, USP {See USP AR Tem?e«anxe]. Usual Dosage: One tablet daily or as directed 50 m g by physician. See package inseft. DISPENSE IN A TIGHT, LIGHT-RESISTANT CONTAINER. Rx Only Distbuted by: ‘The Kroger Co. Manufactured for: 30 Tablets 1014 Vine Street Zydus Pharmaceuticals USA Inc. Cincinnati, OH 45202 Pennington, NJ 08534 Take charge of your health by taking Packaged by: your medication properly. Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 o 2 P g = ) < n M o = n < o o © M o =z = © g
5e9ef92f-d7ed-4d49-8503-b02ef132fd9f_121_1.jpg Packaged by Bcyant Ranch. Burlank, Grt 91504 NOrtripty"ne {5 ORANGE CAPSULE TEVA75mg0813 9 75mg Capsule - s 2 & | Store atroom temp of Compare To: 20-25 C (68-77F) Pamelor 75mg Capsule Keep all drugs out of Teva Czech Industries 1.0 5 reach of children #30 Exp: MM/YY g NDC 6362950651 050651106636
5efabae7-ea15-4cb0-e053-2a91aa0a1bf6_434_1.jpg HDE60760-138:0 Allopurinol Allopurinol Allopurinol Aliopurinol Allopurinol Tablets USP Tablets USP Tablets USP Tablets USP TEH&(S USP g 300mg 300mg 300mg 300mg g QTyY: %0 Qry: 90 Qry: 90 QrY:90 300mg = RX# 000000000000 RX# 000000000000 RX#000000000000 RX# 000000000000 90 P NDC 60760-139-90 NDC 60760-138-90 NDC 60760-139-90 NDC 60760-139-90 O e B LOT# 7722777 LOT#272277? LoT# 2777772 LOT#22727? Exp 7277 EXP 77-72 EXP 7 EXP 77-2? ExP RX#000000000000 MANUFACTURED BY: Intas Pharmaceuticals Limited Ahmedabad-382 210, INDIA (01) 0036076039908 USE AS DIRECTED it (10) 222727277 PACKAGED BY: S; e, St. Mary's . lary’s 1oggMAVNEE DR, ~== 7 OROVALLEY, e MANAGED PHARMACY PROGRAMS Rxonly STORE AT CONTROLLED ROOM TEMPERATURE 15°-30° C (59°-86°F) -
5f1893a6-34d7-428a-b921-6b33e05f42ad_832_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. 43063-796-05 levoFLOXacin usp 750 MG 5 TABLETS ReOrder # 110386 LoT J1BE67 EXP 10/20 43063-796-05 levoFLOXacin usp 750 MG 5 TABLETS ReOrder # 110386 LoT J1BE67 EXP 10/20 43063-796-05 levoFLOXacin usp 750 MG 5 TABLETS ReOrder # 110386 LaT J1BEG7 EXP 10/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME Each TABLET Contains: TABLETA(S) VECES AL DIA. 750 MG OF LEVOFLOXACIN USP ORGANOLEPTIC MARKINGS: WHITE ML &4 OELONG NDC: 43063-796-05 | PHARMACEUTICALS INCORPORATED®, | Oklahoma City, 0K = 73127 |evoFLOXacin USP 750 MG 5 TABLETS (17)201031 {10}i18E67 (01)10343063796054 (21)18E67000002 PE0I6LEIOEDE R OO ZEEZOOIPEEE VIONI'HS3aVYEd TYHIVINIH “ALTVWHYHY SO031IVIN
5fb626c1-faab-4ac9-bd90-16ea09091459_525_1.jpg Quetiapine 100 mg Tablet arv: 30 ID #: 100;Q Expires: NDC #: 70518-1569-00 Shape: Round LOT #: Ref #: 16729-0147-17 MFG: Accord Healthcare, Inc., Durham, NC 27703 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
5fd60635-4b68-15e3-e053-2991aa0ab23a_4_1.jpg 70034.045.06 Lo %0 oty Ciprofloxacin Tablets, USP 500mg 6 Tablets ooy, RN o A e oo o Cmotorson e, U5 Sy o Tmssn o K L o Ea o ot e, 157ty e e o o ot e R B ot e, 19ty gl Sy
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_1.jpg Starter Pack for - Crohn’s Disease, - Ulcerative Colitis, or - Hidradenitis Suppurativa 7 HUMIRA'PEN adallmumab 3 Single-Use Prefilled Pens FOR SUBCUTANEOUS USE ONLY 80 mg/0.8 mL Each Sterile Single-Use. Prefilled Pen Contains: Adalimumab... Mannitol.. Polysorbate 80. Water for injection Sodium hydroxide added as necessary to adjust pH. Contains no preservatives. No U.S. standard of potency. DQ Mooz Gauge Needle a « Medication Guide for patient enclosed. Needle Cover for syringe is not made with natural rubber latex. Carton contains 3 dose trays (each containing 1 single-use prefiled pen with 29 gauge 1/2 inch length fixed neede), 4 alcohol preps, 1 Package Insert, 1 Medication Guide and 1 Instructions for Use. The entire carton is to be dispensed as a uni Do not accept if seal s broken or missing, Return to pharmacy if dose tray seal is broken or missing. www.HUMIRA.com Rx only. W To Open obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_10.jpg 2 Single-Use Prefilled Syringes HUMIRA adval’imvur‘nab FOR SUBCUTANEOUS ljSE.ONLV ATTENTION PHYSICIAN: Each patient is required to receive the enclosed Medication Guide. Needle Cover for Syringe May Contain Dry Natural Rubber. The entire cartonis to be dispensed as a unit. Return to physician if dose tray seal is broken or missing. www.HUMIRA.com W To Open NDC 0074-9374-71 NOT FOR SALE This carton contains: * 2 dose trays (each containing 1 single-use prefiled syringe with 1/2 inch length fixed needle) * 2 alcohol preps * 1 Medication Guide 1 package insert Rx only 1 Instructions for Use " abbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_11.jpg 2 SINGLE-USE PREFILLED PENS NDC 0074-4339-02 HUMIRRA’ PEN adalimumab 40 mg / 0.8 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required This carton contains: to receive the enclosed Medication Guide. « 2 dose trays (each containing 1 single-use prefiled pen . i with 1/2 inch length fixed needle) e T EL LA LT it The entire carton s to be dispensed as a unit. « 1 Medication Guide Return to pharmacy if dose tray seal is broken or missing. e LR RS TR T UEY [0 A\ Arleet www.HUMIRA.com obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_12.jpg Starter Package for - Crohn’s Disease, - Ulcerative Colitis, or - Hidradenitis Suppurativa HUMIRA’ PEN (adalimumab) 40 mg/0.8 mL FOR SUBCUTANEOUS USE ONLY 6 Single-Use Prefilled Pens | EI R T IERUEEY Prefilled Pen Contains: PR P Sodium chloride .. 4.93mg Monobasic sodium phosphate diydrate [T R L ARrL] BT (P2 Gitric acid monohydrate. AL Mannitol............ LG Polysorbate 80 S 0BG LRy Sodium hydroxide added as necessary to adjust pH. SO S LSRR e e Medication Guide for patient enclosed. Needle Cover for Syringe May Contain Dry Natural Rubber. Carton contains 6 dose trays (each containing 1 single-use prefilled pen with 1/2 inch length fixed needle), 6 alcohol preps, 1 Package Insert, 1 Medication Guide and Instructions. (A The entire carton s to be dispensed as a unit. Do not accept if seal is broken or missing. Return to pharmacy if dose tray seal is broken S www.HUMIRA.com
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_13.jpg Psoriasis/Uveitis/Adolescent e reeasg Hidradenitis Suppurativa Starter Package 4 Single-Use Prefilled Pens HUMRA® PEN adalimumab 40 mg/0.8 mL i FOR SUBCUTANEOUS USE ONLY i | Each Sterile Single-Use Prefilled Pen Contains: Medication Guide for patient enclosed. Adaimumab 40mg Needle Cover for Syringe May Contain Dry i Sodumchonde | 4oem Natural Rubber. i Monobasic sodum Carton Contans! i phosphate dhydrate...... 0.6 mg o onhs Dibasic sodlum « 4 dose trays (each containing Eloadosadin 1 singe-use prefiled pen with i phosphate dinydrate. ... 1.22 mg 1/2 inch length fixed nesdia) 1 Sodum citrate. 0.24mg 5 doldis i Citrc acid monohydrate.. 104 mg i bt Mannitol 9.6 mg * 1 Medication Guide Polysorbate 80 08mg « Instrucions for Use Vet el The entire carton is to be dispensed as a unit Sodium hydroxide added as Do not accept if seal is broken or missing. necessary o adjust pH i i Return to pharmacy if dose tray seal Contains no preservatives. is broken or missing. No U.S. standard of potency. SRR gon Rxony abbvie Rl = o o s o e e o s s oh s s e s o e o
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_14.jpg 2 SINGLE-USE PREFILLED PENS NDC 0074-4339-71 HUMIRA PEN adalimumab 40 mg / 0.8 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHYSICIAN: Each patient is required QSRR to receive the enclosed Medication Guide. « 2 dose trays (each containing 1 single-use prefiled pen Needle Cover for Syringe May Contain Dry Natural Rubber. _ i 1/2 inch length fixed needle) LTl ol(=o Y The entire carton is to be dispensed as a unit. PRy Return to physician if dose tray seal is broken or missing. s « 1 Instructions for Use T W ToOpen www.HUMIRA.com obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_15.jpg NDG 0074-4339-73 NOT FOR SALE Starter Package for - Crohn’s Disease, - Ulcerative Colitis, or - Hidradenitis Suppurativa HUMIRA’ PEN (adalimumab) 40 mg /0.8 mL FOR SUBCUTANEOUS USE ONLY 6 Single-Use Prefilled Pens S P TS Prefilled Pen Contains: R P PSRN pE Monobasic sodium [N TIET YT ISR TR P [T 024 mg Citric acid monohydrate.. e e LLLr] IR T L EEE U] Sodium hydroxide added as necessary. to adjust pH. Contains no preservatives. No U.S. standard of potency. e Medication Guide for patient enclosed. Needle Cover for Syringe May Contain Dry Natural Rubber. Carton contains 6 dose trays (each containing 1 single-use prefilled pen with 1/2 inch length fixed needle), 6 alcohol preps, 1 Package Insert, VS D e T A U The entire carton is to be dispensed as a unit Do not accept if seal is broken or missing. Retum to physician if dose tray seal is broken L www.HUMIRA.com obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_16.jpg Donotacceptif sealontop of cartonis broken or missing. One40mg Vial NDC 0074-3797-01 Humira® Adalimumab 40 mg/0.8 mL | | | | | | For Subcutaneous Use Only | Single-Use Vial i | | | | | | | | i | | | | | | \ Discard Unused Portion | | i | | l For Institutional Use Only ATTENTION PHYSICIAN: Each patient is required to receive the enclosed Medication Guide Rxonly
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_17.jpg NDC 0074-6347-02 2 Single-Use Prefilled Syringes H UMIRA® This carton contains: Medication Guide for patient enclosed. . a d a I I m u m a b Needle Covers for Syringe May Contain Dry Natural Rubber. Carton contains 2 dose trays, 2 alcohol preps, 1 package insert, 1 Medication Guide and Instructions for Use. 1 0 m gl 0.2mL Each dose tray contains 1 single-use prefilled syringe with FOR SUBCUTANEOUS USE ONLY 1/2 inch length fixed needle. The entire carton is to be dispensed as a unit. ‘T‘ ‘T‘ Return to pharmacy if dose tray seal is broken or missing, www.HUMIRA.com Rx only Please see package insert for full prescribing information. W To Open abbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_18.jpg 2 Single-Use Prefilled Syringes NDC 0074-0243-02 S 29 7 HUMIRA® adallm umab 0] mg/0.4 mL syringe FOR SUBCUTANEOUS USE ONLY
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_19.jpg 1 Single-Use Prefilled Pen NDC 0074-0554-01 29 7 HUMIRA’PEN - 2 adalimumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required This carton contains: to receive the enclosed Medication Guide. « 1 dose tray (containing 1 single-use prefiled pen with 29 gauge /2 inch length fixed needle) The entire carton is to be dispensed as a unit. * 2 alcohol preps. Return to pharmacy if dose tray seal is broken or missing. s 7 Modication Guido. 1 package insert » 1 Instructions for Use: Rx only www.HUMIRA.com obbvie W ToOpen
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_2.jpg NOC 0074012473 NOT FOR SALE 29 Gauge Needle Starter Pack for - Crohn’s Disease, = Ulcerative Colitis, or - Hidradenitis Suppurativa 7HUMIRA'PEN adallmumab 3 Single-Use Prefilled Pens FOR SUBCUTANEOUS USE ONLY 80 mg/0.8 mL Each Sterile Single-Use Prefilled Pen Contains: .80 mg 336 mg 08mg Water for injection Sodium hydroxide added as necessary to adjust pH. Contains no preservatives. No U.S. standard of potency. Medication Guide for patient enclosed. Needle Cover for syringe is not made with natural rubber late Carton contains 3 dose trays (each containing 1 single-use prefilled pen with 29 gauge 1/2inch length fixed neede), 4 alcohol preps, 1 Package Insert, 1 Medication Guide and 1 Instructions for Use. The entire carton is to be dispensed as a unit. Do not accept i seal is broken or missing. Return to physician if dose tray seal is broken or missing. www.HUMIRA.com Rx only 'V To Open obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_20.jpg 2 Single-Use Prefilled Pens NDC 0074-0554-02 7HUMIRA’PEN e 4 adallmumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMAGCIST: Each patient is required This carton contains: to receive the enclosed Medication Guide. * 2 dose trays (each containing 1 single-use prefiled pen The entire carton is to be dispensed as a unt. vl 29ca gelii2inctiegihifednesde) + 2 alconol preps Retum to pharmacy if dose tray seal is broken or missing. * 1 Medication Guide « 1 package insert www.HUMIRA.com * 1 Instructions for Use. Rx only. W ToOpen obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_21.jpg Psoriasis/Uveitis/Adolescent NDC 0074-0554-04 Hidradenitis Suppurativa Starter Package 4 Single-Use Prefiled Pens 7HUMIRA'PEN adalimumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY Each Sterile Single-Use Prefilled Pen Contains: Adaimumad 40mg Mannitol 16.8mg Polysorbate 80 04mg Water for njection. Contains no preservatives. No U.S. standard of potency. Medication Guide for patient enclosed. Carton Contains: « 4 dose trays (each containing 1 single-use prefiled pen with 29 gauge 1/2 inch length fixed nee * 4 aicohol preps o 1 package insert « 1 Medication Guide « Instructions for Use ‘The entire carton s to be dispensed as a unit Do not accept if seal is broken or missing. Return to phamacy if dose tray seal is broken or missing. vwvHUMIRA com Rxonly obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_22.jpg Starter Package for - Crohn’s Disease, - Ulcerative Colitis, or - Hidradenitis Suppurativa 7 HUMIRA"PEN adalimumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY 6 Single-Use Prefilled Pens Each Sterile Single-Use Prefilled Pen Contain: Adalimumab ...... — ) RO LRI . (XL (R (ST (R E P e e [ Medication Guide for patient enclosed. Carton contains 6 dose trays (each containing 1 single-use prefilled pen with 29 gauge 1/2 inch length fixed needle), 6 alcohol preps, 1 Package Insert, 1 Medication Guide and Instructions for Use. LU TR R G SRR Do not accept if seal is broken or missing. Return to pharmacy if dose tray seal is PR ‘www.HUMIRA.com elelaV/I=]
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_23.jpg 1 Single-Use Prefilled Pen 7HUMIRA'PEN adallmumab 40 mg/0.4 mL FOR SUBCUTANEOUS USE ONLY ATTENTION PHYSICIAN: Each patient is required to receive the enclosed Medication Guide. The entire carton is to be dispensed as a unit. Return to physician if dose tray seal is broken or missing www.HUMIRA.com ‘W ToOpen NDC 0074-0554-74 NOT FOR SALE Gauge Needle 4 This carton contains: 1 dose tray (containing 1 single-use prefilled pen with 29 gauge /2 inch length fixed needle) « 2 alcohol preps « 1 Medication Guide « 1 package insert 1 Instructions for Use Rx only obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_24.jpg 1 Single-Use Prefilled Syringe 7 HUMIRA® adalimumab 80 mg/0.8 mL FOR SUBCUTANEOUS USE ONLY 29 Gauge Needle NDC 0074-2640-01 This carton contains: * 1 dose tray (containing 1 single-use prefiled syringe with 29 gauge 1/2 inch length fixed needle) * 2 alcohol preps. * 1 package insert * 1 Instructions for Use * 1 Medication Guide ATTENTION PHARMACIST: Each patient is required to receive the enclosed Medication Guide. Needle cover for syringe is not made with natural rubber latex. The entire carton s to be dispensed as a unit. Return to pharmacy if dose tray seal is broken or missing. www.HUMIRA.com Rx only abbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_25.jpg Pediatric Crohn’s Disease Starter Pack (LB > FOR PEDIATRIC PATIENTS 240 kg 7HUMIRA® adallmumab 3 single-Use Prefilled Syringes FOR SUBCUTANEOUS USE ONLY Each 80 mg/0.8 mL Sterile Medication Guide for patient enclosed. iSingle;Use EreflledyingsiCopieRsy Needle cover for syringe is not made with natural rubber latex. ‘“""ﬂ“;’“"““ T l;:ﬁ Carton Contain feea e 3 dosa vays (aach containng 1 shge-Use prafed syrnge Poysoroata 80, -08mg with 29 gaugo 172 nch longth fxod noock) Wate forncton. * 4 alcohol preps. * 1 package insert Contains no preservatives * 1 Medcation Guide 1 nstructons fo Use “The enie carton s to bo ispensed as a uni Do not aceoptf sl is broken or missi Www.HUMIRA.com Roturn o pharmacyif doso tray seal s broken or missing. Rxonly obbvie E ¥ ToOpen
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_26.jpg Pediatric Crohn’s Disease Starter Pack » FOR PEDIATRIC PATIENTS < 40 kg 7HUMIRA’ adalimumab 2 Single-Use Prefilled Syringes FOR SUBCUTANEOUS USE ONLY One 80 mg/0.8 mL One 40 mg/0.4 mL NDC 0074-0067-02 29 Gauge Needle Medication Guide for patient enclosed. Each 80 mg/0.8 mL Sterile Single-Use Prefilled Syringe Contains: Adalimumab. Mannitol.. Polysorbate 80.. Water for injection. Each 40 mg/0.4 mL Sterile Single-Use Prefilled Syringe Contains: 80mg 0.8mg The Adalimumat 40mg Mannitol. . 16.8 mg Polysorbate 80.. 04 mg Water for injection. www.HUMIRA.com V1o Open Contains no preservatives. No U.S. standard of potency. Needle cover for syringe is not made with natural rubber latex. Carton Contains: 2 dose trays (each containing 1 single-use prefilled syringe with 29 gauge 1/2 inch length fixed needie) 2 alcohol preps 1 package insert 1 Medication Guide 1 Instructions for Use '@ entire carton is to be dispensed as a unit Do not accept if seal is broken or missing. Return to pharmacy if dose tray seal is broken or missing. Rx only aobbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_3.jpg NDC 0074-1539-03 Psoriasis/Uveitis/Adolescent Hidradenitis Suppurativa Starter Package FHUMIRA'PEN 2 adallmumab il 3 Single-Use Prefilled Pens T FOR SUBCUTANEOUS USE ONLY One 80 mg/0.8 mL Two 40 mg/0.4 mL Each 80 mg/0.3 mL Sterile. Single-Use Prefilled Pen Contains: Adalimumab. 20mg Mzt &mg 08mg Water fox injection Each 40 mg/0.4 mL Sterile Single-Use Prefilled Pen Contains: Adalimumab. 40ma Mamitol 168mg rbate 80, 04mg for njecticn Contains no preservatives. No U.S. standard of potency. Medication Guide for patient enclosed. Needle cover for syringe is not made with natural rubber latex. Carton Contains: + 3 dose trays (ear preflled pen wit edneede) taifing 1 single-use The entire carton fs to be dispensed as a unit Do not accept i seal is broken or missing. Store in carton until time of administration. Return to pharmacy if dose tray seal is broken or missing. wiw HUMIRA.com Rx only obbvie W ToOpen
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_4.jpg NDC 0074-0817-02 FHUMIRA® £ adalimumab 2 Single-Use Prefilled Syringes FOR SUBCUTANEOUS USE ONLY Gauge Needle 10mg/0.1 mL Please see package insert for full prescribing information. This carton contains: Medication Guide for patient enclosed. Needlle cover for syringe is not made with natural rubber latex. Carton contains 2 dose trays, 2 alcohol preps, 1 package insert, 1 Medication Guide and 1 Instructions for Use. Each dose tray contains 1 single-use prefilled syringe with 29 gauge 1/2 inch length fixed needle The entire carton is to be dispensed as a unit. Return to pharmacy if dose tray seal is broken or missing. www.HUMIRA.com Rx only W ToOpen obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_5.jpg H U M I RA® 2? NDC 0074-0616-02. adallmumab oo 2 Single-Use Prefilled Syringes FOR SUBCUTANEQUS USE ONLY ATTENTION PHARMACIST: Each patient is required This carton contains: ta:receive the enclosed Medication Guide: * 2 dose trays (each containing 1 single-use prefilled Needle cover for syringe is not made with natural rubber latex. syringe with 29 gauge 1/2 inch length fixed needle) The entire carton is to be dispensed as a unit * 2 alcohol preps Retum to pharmacy if dose tray seal is broken or missing. ~ * 1 Meilcation G;‘de « 1 package inse Rx only 1 Instructions for Use . www.HUMIRA.com W To Open obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_6.jpg 2 Single-Use Prefilled Syringes NDC 0074-3799-02 HUMIRA adalimumab 40 mg/0.8 mL Syringe FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required This carton contains: IS Ll Medlcahon [t L dose trays (& [eonlETOR B SRICA ] =] Needle COVerforsyrInge L= COniam Dry syringe with 1/2 inch length fixed needle) Natural Rubber. PRSI The entire carton is to be dispensed as a unit. * 1 Medication Guide Return to pharmacy if dose tray seal is broken or missing. ~ * AN E RN LN h CRNIS T S gV g www.HUMIRA.com W ToOpen obb
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_7.jpg Pediatric Crohn’s Disease Starter Pack — » FOR PEDIATRIC PATIENTS <40 kg HUMIRA adalimumab 3 SINGLE-USE PREFILLED SYRINGES FOR SUBCUTANEOUS USE ONLY 40 mg/0.8 mL Each Sterile Single-Use Prefilled Syringe Contains: Medication Guide for patient enclosed. Adalimumab. 40mg Needle Cover for Syringe May Contain Dry Natural Rubber. Sodium chioride. 4.93mg Carton Contains: Monobasic sodium * 3 dose trays (each containing 1 single-use prefiled Syringe phosphate dinydrate........... 069 mg with 1/2 inch length fixed needie) Dibasic sodium * 4 .alcohol preps phosphate dihydrate.... .122mg « 1 Package Insert Sodium citrate... 024mg * 1 Medication Guide Citic acid monohydrate. 1.04 mg * 1 Instructions for Use Mannitol.. 9.6mg The entire carton is to be dispensed as a unit. Polysorbate 80.. 0.8mg Do not accept if seal is broken or mis: 9. Water for injection. Return to pharmacy if dose tray seal is broken or missing. ‘Sodium hydroxide added as nece to adjust pH. . ! www.HUMIRA.com Contains no preservatives. No U.S. standard of potency. Rx only abbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_8.jpg 2 Single-Use Prefilled Syringes HUMIRA adalimumab 40 mg/0.8 mL Syringe FOR SUBCUTANEOUS USE ONLY ATTENTION PHYSICIAN: Each =10 ] to receive the enclosed [T € 3 Needle Cover for Syringe May Con'laln Dry Natural Rubber. The entire carton is to be dispensed as a unit. Retum to physician if dose tray seal is broken or missing. www.HUMIRA.com W To Open LT 2By IR NOT FOR SALE QLY RIS * 2 dose trays (each containing 1 single-use prefilled BV R RV e e R eyt 5] PRl e * 1 Medication Guide * 1 package insert T * 1 Instructions for Use = P obbvie
608d4f0d-b19f-46d3-749a-7159aa5f933d_515_9.jpg 2 Single-Use Prefilled Syringes HUMIRA® adalimumab FOR SUBCUTANEOUS USE ONLY ATTENTION PHARMACIST: Each patient is required to receive the enclosed Medication Guide. Needle Cover for Syringe May Contain Dry Natural Rubber. The entire carton is to be dispensed as a unit. Return to pharmacy if dose tray seal is broken or missing. www.HUMIRA.com W ToOpen NDC 0074-9374-02 This carton contains: * 2 dose tra%s (each containing 1 single-use prefilled syringe with 1/2 inch length fixed needle) * 2 alcohol preps * 1 Medication Guide * 1 package insert Rx only * 1 Instructions for Use . abbvie
608e9b5a-d296-4c66-8b1d-2f30ead87758_558_1.jpg = ” T e mnwmmw;m"" BT, o o e ! ot A O e . wEw BEproRD WELDNG SO0 MRS By 02051 R TR/
60aba812-59eb-4d40-9b6b-d135dca9d36b_628_1.jpg u e U0 1SIDOHIXOIPIN MedroxyPROGESTERone Acetate St ModroxyPROGESTERono. Acatats, e TN, B I S 1 L Bover, MedroxyPROGESTERone Acetate ngcate
60aba812-59eb-4d40-9b6b-d135dca9d36b_628_2.jpg e = R aunasBOB N
60aba812-59eb-4d40-9b6b-d135dca9d36b_628_3.jpg 2 & DOSAGE AND USE: See accompanying NDC 67457-887-00 Rx only - receribing information, Shake vigorously MedroxyPROGESTERone immediately before each use. Store upright. Acetate Manufactured in India for: Mylan Institutional LLC Injectable Suspension, USP Rockford, IL 61103 U. Code No.: m GUJ-DRUGS/ LOT: B Contraceptive Injection @}Mylan® 6/28/1297 For Intramuscular EXI Use Only Single-Dose Vial [RUUECUY 50088257 £9£00(10)
60dd4f4b-7132-385e-e053-2a91aa0ad5d6_937_1.jpg GOMPRESSED GAS, N.O.S. (OXYGEN, HELIUM) UN1956 20% OXYGEN USP 80% HELIUM USP MIXTURE CAS: (7782-44-7) (7440-59-7) ROnly 'WARNING: Adrministation o tis gas mixture may be hazardous or coniraindi- cated, For use only by or under the supervison of icensed practitioner who s experenced in the use and administraton of gas mixtures, and is familar with the indications, effects, dosages, methods, and frequency and duraton of admiristration, and with the hazards, contraindications and ide efects, and the precautions to b taken. WARNING: CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. D0 not handle until all afety precautions have been read and understood. Avoid breathing gas. Use and store only outdoors or in a wel-ventiated place. Use a back flow preventive device n the piping. Use only with equipment rated for cylinder pressure. Close valve afer each use and when empty. Protect from ‘sunlght when ambient temperature exceeds 52 C (125 ). Read and fllow the Safety Data Sheet FIRST AID: IF ACCIDENTALLY INHALED: Remove person to fresh air and keep. comfortabe for breathing. Get medical advce/atention. NET CONTENTS Liters. Cylinder Size Cubic Feet (Gaseous) K 2004 5675 E 220 625 D-puritan 135 382 DO NOT REMOVE THIS PRODUCT LABEL. Dissbuedty B S NeX i sl LG skl 1385 Corporate Ave. + Memphis, TN 38132 888.639-2474
60dd4f4b-7132-385e-e053-2a91aa0ad5d6_937_2.jpg GOMPRESSED GAS, OXIDIZING, N.0.S. (HELIUM, OXYGEN) = NON-FLAMMABLE % OXYGEN USP o HELIUMUSP MIXTURE CAS: (1782-44-7) (1440-58-7) ROnly WARNING: Administration of this gas mixture may be hazardous or contraindi- cated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of gas mixtures, and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, contraindications and side effects, and the precautions to be taken. DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. Do not handle until all safety precautions have been read and understaod. Keep and store away from clothing and other combustible materials. Keep valves and fitings free from grease and oi. Use and store only outdoors or in well-vent- lated place. Use a back flow preventive device in the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. Open valve slowly. Close valve after each use and when empty. Protect from sunlight when ambient temperature exceeds 52 ‘C (125 *F). Read and follow the Safety Data Sheet (SDS) before use. DO NOT REMOVE THIS PRODUCT LABEL Net Contents Cubic Feet: Liters: nex~As: Distributed by nexAir, LLC + www.nexAir.com 1385 Corporate Ave. » Memphis, TN 38132 » 888-639-2474
60e9397e-83b9-489e-9683-6f87e458bbaa_430_1.jpg o o o i~ N '~ < N 3 Each uncoated tablet contains: Glimepiride USP 1 mg Dosage and Adminisiration: See package insert for dosage information 'WARNING: Kezp out of reach o chilcren. Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20°-25°C (66°-77°F) se2 USP Contralled Room Temperature] Vamish free area for batch details A NDC 42571-100-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for Pharma code Manufactured by: Micro Labs Limited 60a-403 722, INDIA M. L.:651 Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 Artworkcode
60e9397e-83b9-489e-9683-6f87e458bbaa_430_2.jpg Each uncoated tablet contains: Glimepiride USP 2 mg NDC 42571-101-01 s alais oo bt GLIMEPIRIDE Area for Pharma code '~ WARNING: Kezp out of reach o chilcren S Pramacis:Depers i el TABLETS, USP = closed contaner wih chid-resistant closure = Store at 20°-25°C (68°77°F) m i [see USP Controlled Room Temperature] Manufactured by: - Micro Labs Limited i~ ONCE A DAY © Goa-403722, INDIA. § N Varnisk Rx Only g N arnish free area M. L.:651 T ' for batch details 100 Tablets R~ Z lanufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 3
60e9397e-83b9-489e-9683-6f87e458bbaa_430_3.jpg o o o 42571 N > Each uncoated tablet contains: Glimepiride USP 3 mg Dosage and Administration: See package insert for dosage information. WARNING: Keep out of reach o chilcren. Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature] Vamish free arca for batch details NDC 42571-102-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for i Pharma code Manufactured by: Micro Labs Limited * Goa-403 722, INDIA. M. L.:651 Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 Artworkcode
60e9397e-83b9-489e-9683-6f87e458bbaa_430_4.jpg Area for Each uncoated tablet contains: Glimepiride USP 4 mg NDC 42571-103-01 | Pharma code | Soe o it doe omaton GLIMEPIRIDE Farmadt gl TABLETS, USP 1) 2 closed container with child-resistant closure. ' Store at 20°-25°C (68°-77°F) m " [see USP Controlled Room Temperature] Manufactured by: — Micro Labs Limited 2 ONCE MDA G0a-403722, INDIA. € i e RxOnly 2 o Varnish free area 6 ok tads M. L:651 3 for batch details £ Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 N 3
60e9397e-83b9-489e-9683-6f87e458bbaa_430_5.jpg Each uncoated tablet contains: Glimepiride USP 6 mg Dosage and Administration: See package insert for dosage information. WARNING: Keep out of reach of chidren Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature] Varmnish free area for batch details NDC 42571-104-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for Pharma code | Manufactured by: Micro Labs Limited < Goa-403 722, INDIA M.L.:651 Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 Artworkcode
60e9397e-83b9-489e-9683-6f87e458bbaa_430_6.jpg o N o ~ N '~ ~ N 3 Each uncoated tablet contains: Glimepiride USP 8 mg Dosage and Administration: See package insertfor dosage information WARNING: Keep out of reach of chidren Pharmacist: Dispense in well closed container with child-resistant closure Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature] Varnish free arca for batch details NDC 42571-105-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for Pharma code Manufactured by: Micro Labs Limited 60a-403 722, INDIA M.L:651 Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 Artworkcode
60e9397e-83b9-489e-9683-6f87e458bbaa_430_7.jpg o o o i~ N '~ < 3 Each uncoated tablet contains: Glimepiride USP 1 mg Dosage and Adminisiration: See package insert for dosage information 'WARNING: Kezp out of reach of chilcren. Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20°-25°C (68°-77°F) se2 USP Controlled Room Temperature] Vanish free arca for batch details I NDC 42571-100-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for Pharma code Manufactured by: RA CHEM PHARMA LIMITED Hyderabad - 500 076, INDIA. M. L. No.: 23/RRIAP/2007F/R Artworkcode Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920
60e9397e-83b9-489e-9683-6f87e458bbaa_430_8.jpg o o Each uncoated tablet contains: Glimepiride USP 2 mg Dosage and Administration: See package insert for dosage information. 'WARNING: Kezp out of reach o chilcren. Pharmacist: Dispense in well closed container with child-resistant closure. Store at 20°25°C (68°-77°F) se2 USP Controlled Room Temperature] Varnish free area for batch details NDC 42571-101-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for i Pharma code Manufactured by: RA CHEM PHARMA LIMITED Hyderabad - 500 076, INDIA. M. L. No: 23/RR/APR007/F/R Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920
60e9397e-83b9-489e-9683-6f87e458bbaa_430_9.jpg 42571 10301|| Each uncoated tablet contains: Glimepiride USP 4 mg Dosage and Administration: See package insertfor dosage information WARNING: Keep out of reach of children Pharmacist: Dispense in well closed container with child-resistant closure Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature] Vamish free area for batch details NDC 42571-103-01 GLIMEPIRIDE TABLETS, USP ONCE A DAY Rx Only 100 Tablets Area for i Pharma code | Manufactured by: RA CHEM PHARMA LIMITED Hyderabad - 500 076, INDIA. M. L. No: 23/RRIAPR007/F/R Artworkcod Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920
60fcfb61-f594-4e7e-89a6-155965a143a9_398_1.jpg traMADOL HCI C-lv 50 mg Tablet arv: 100 ID #: AN;627 Expires: NDC #: 70518-0118-00 Shape: Round LOT #: Ref #: 65162-0627-11 MFG: Amneal Pharma, Hauppauge, NY 11738 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
60fcfb61-f594-4e7e-89a6-155965a143a9_398_2.jpg traMADOL HCI C-lv 50 mg Tablet arv: 30 ID #: AN;627 Expires: NDC #: 70518-0118-01 Shape: Round LOT #: Ref #: 65162-0627-11 MFG: Amneal Pharma, Hauppauge, NY 11738 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
60fcfb61-f594-4e7e-89a6-155965a143a9_398_3.jpg traMADOL HCI C-lv 50 mg Tablet arv: 120 ID #: AN;627 Expires: NDC #: 70518-0118-02 Shape: Round LOT #: Ref #: 65162-0627-11 MFG: Amneal Pharma, Hauppauge, NY 11738 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
60fcfb61-f594-4e7e-89a6-155965a143a9_398_4.jpg traMADOL HCI C-lv 50 mg Tablet arv: 30 ID #: AN;627 Expires: NDC #: 70518-0118-03 Shape: Round LOT #: Ref #: 65162-0627-11 MFG: Amneal Pharma, Hauppauge, NY 11738 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
60fcfb61-f594-4e7e-89a6-155965a143a9_398_5.jpg traMADOL HCI C-lv 50 mg Tablet arv: 90 ID #: AN;627 Expires: NDC #: 70518-0118-04 Shape: Round LOT #: Ref #: 65162-0627-11 MFG: Amneal Pharma, Hauppauge, NY 11738 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
61229829-55a0-4d6f-a423-4b48a2b4d8e5_369_1.jpg e Denavir . (penciclovir cream) 1% RILAL) Denav (penciclovir oream\ I3 ForTopical Use Only 59 (NetWt) Manufactured i Canada for: ‘Comments o Questons? Call 1-877-446-3670 (1-677-4 INF0-RY) Mylan Pharmaceutical Inc. Morgartown, W 26805 USA CONOT2SECA! m MMylan® | wercom 4§ 70378-9720-55 ¢ s epURL N 107 L R Pt P R | R LR e e T e e A S kSl e TP e gy ey B T e TR R S T T St e
61229829-55a0-4d6f-a423-4b48a2b4d8e5_677_1.jpg D e ocen 97205 L (penciclovir cream) 1% , SQ!I{ejWL) i Denavir S— (penciclovir cream) 1% MM YVYY [ ET 5g (NetWt) GTIN XX000000000K SN X000 E LOT XXy Manufacture i Ganada for: Mylan Pharmaceutical Inc. Morgariown, W 26505 USA CORT2DSEC! Commnts o st Cal .67 45 3670 (-07-4 WFO-) ﬂMylan' | mytncom Y 0378-9720-55 5 L IO LT TR B e P et e R T [ S e VTR P L oy ey ey R R et B e T L e I P QA P Py R g Y ey e e R AT SR M T TR T (R Pt [ e L
612a2688-2001-469d-92a4-e14e981309fe_120_1.jpg = S ® £ S @ = @ o e ? 4 £ = o > 0o » Q.5 P5 @ < _*0O¢ OO o=c ™ g g o © o [0)] @ n L - o L - 7)) < - = (@] permitted from 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. o ? e o X o AN 4 o O O Q Z Store at 20° to 25°C (68° to 77°F); excursions 6042993530 » Each capsule contains: 0.5 mg of dutasteride. » Keep this and all medication out of the reach of children. « Dispense in tight container [see USP]. = Capsules should be swallowed whole and not chewed or opened. * PHARMACIST: Dispense the accompanying Patient Information Leaflet to each patient. * WARNING: Dutasteride Capsules should not be used by women and children. Women who are or may %o»o:mm__,‘ be pregnant should not use or handle Dutasteride Capsules (see ﬂ..cmo;!:n information). If contact is made with leaking capsule, wash immediately with soap and water. = 8 ¥ S & 3 & m ] O N ] 3 S & 3 & m A B = X S S & S = m el O B X 3 S & 3 = = A B = X 2 S & m B m A O Manufactured by Catalent Ontario Limited Windsor, Ontario Canada N9C 3R5 Packaged by GSMS, Incorporated Camarillo, CA 93012 USA
612c3958-bb10-4fc9-8506-6533798fc8cb_710_1.jpg et T VST = 5 | e R s s20r0rsimo g et AFFECTED EVELS) 4 TWES. § § g e ey PP e e < l ! ;
615dfd5c-125a-40e2-a6da-afacde305282_562_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALERTNESS. § TIZANIDINE TABLETS ARE NOT INTERCHANGEABLE i WITH TIZANIDINE CAPSULES. B Rﬁ WARNING: KEERTHISIOUT:OFTHEREACHIDFCHILOREN i DOSAGESnd STORAGESEE PACKAGEINSERT == 43063-868-30 43063-868-30 43063-868-30 tiZANidine LiZANidine tiZANidine o usp usp usp g 2 MG 2 MG 2 MG = 30 TABLETS 30 TABLETS 30 TABLETS = ReOrder # 110544 ReOrder # 110544 ReOrder # 110544 g 2 LOT J18D46 LoT 118D4a6 LOT ji8Dae6 &= EXP 10/19 EXP 10/19 EXP 10/19 g CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: 2 288 MG TIZANIDINE HYDROCHLORIDE USP EQUIVALENT T0 2 MG TIZANIDINE BASE ROUND SCORED NDC: 43063-868-30 tiZANidine UsP 2 MG 30 TABLETS W (01)10343063868300 o (21)118D46000001 (17)191031 {10)118D46 0OZBIBEICEPE JNRON ATV YIANI VOD ‘Z304vE ST89TO00ESE Q41 SAYOLYHOEYT INFHDINM
620d348d-75e6-3d1a-e053-2991aa0a855f_510_1.jpg 1 only. WARNING: Aominstat contrangcatons and sde ‘OXDIZER, CONTAINS 6 rom cothng g oD beloe sse. CAS: QXYGEN 77244 FILLED & INSPECTED BY ‘supenvision of fcensed practcner Y00 S on et th o, fcs, dusage, mebods 00 g en D AS UNDER PRESSURE, WAY © s e W HEART RATE. Do no and et o st only utdoors of 2 ek devce in he pipeg. Use ooy pressare. Use 0y Wi e ampty. Prfectfom sunight hen EypL00% X comsthe it jment cleanedfor S st et o 7 CARBON DIDADE GENERAL AIR SERVICE & SUPPLY 1105 ZUNI ST » DENVER, CO 80204 * 308927003
62441488-fc97-4535-a249-4485fb075022_956_1.jpg | NDC 0409-2585.11 Each ADD-Vartage* vl contais, | ¥ celazolinsadum equivalent o 1 gram of || |/SesBomANe Mstinve cotazoin. The sodm contnt per gram | cefazolmfor umm-ummm 1 | iIniactk Tontana s sao g | Injection, USP &5 eier domanes 11 Room Temperature| Afer reconsthor: - B8 | | EEEYICRT fsbeds o et e, S 11 hours. oos rotaflect = | | o st ol USUALADLLY DOSAGE: 250 mg = cofazcin ram every 8 hours. See nsert. il Wm""'&"., g~ B E | e Foruseonty i ADD Vartage® gy WAKRAST o £ £ Pexble Ditent ",,,,,,, T 45N oS 0} OZEE) o o
628d1ff3-94bc-44bf-9de9-d3d535e199dc_678_1.jpg ""C"‘” WS e— ol corars el o1 00mg M henolate Mofetil =& 2 st s ompmcacs saf), 25 mg polysor and 5 mg atic ycophenolate Moteti Usual Dosage: See package insert for complete. for Injection, USP prescibing information. Store powder at 20° to 25°C (68° to 77°F) [See. USP Controlled Room Temperature; excursions L[] mg per Vial pemnied o 15° 0 30°C (69° o 86°F). 1 KEEP THIS AND ALL DRUGS OUT OF THE FOR INTRAVENOUS INFUSION ONLY o oriOF CHIDREN. “This container closure is not made with natural 1 1 1 : | [ PHARMACIST: Dispense the Medication Tubber latex. Exp. 1 | | Guide provided separately fo each patient. Code No.: GUJDRUGI1081 1 Manufactured by: bowo e o ~p2 zydus SINGLEDOSEVIAL Cyis eaiticare Ltd § Rev: 09/17 QL frntcat Rxonly Ahmedabad, india Lip80LL2L02€00(L0
628d1ff3-94bc-44bf-9de9-d3d535e199dc_678_2.jpg fuo xy et B Sy snphz 4 TVIA 3500 3TONIS KTNO NOISN4NI SNONAVYINI 404 1eIA Jad Bw gog dsn ‘uoposlu Jop 132J0[N @3ejousydoaky e [Ty Mycophenolate Mofetil for Injection, USP 00 mg per Vial G o sepaely o e e FOR INTRAVENOUS INFUSION ONLY SINGLE DOSE VIAL 4Vials ya w f-!_dff Rx only E3ch vl corains the equvaknt of 500 mg mycophenote o5, USP (as e ysohion s, 25 mg polysotate 80, a0 5o i acd. Mycoprennise mofelforiecson USP, 500 mg vils st be 1eoncinded Wih 14 L. 5% Destree jecon USP. Furre uonof th crtent of e econsied ks with 54 Dexcce iecion USP s requre 0 proce he fuson souon a e el corostaton of & mainL Refer 1 packege meet for conpltedrecios. OTHER INFUSION SOLUTIONS ARE NOT RECOMMENDED. FORDILUTION. Ustal Dosage: S package net o conplte prescrting lomaton ‘Sorepowser and econsttednsion solitons 2 20° 0 5°C (68" 7°7) [Se= P Conrolle Room Temperatrs,. ‘cursons pemited o 15" 1o 30°C (59 0 85°F), KEEP THIS AND ALL DRUGS OUT OF THE REACH OF GHLDREN. ‘COMMENGEMENT OF TREATMENT TO OCCUR WITHN ‘4HOURS FROM RECONSTITUTION AND DILUTION. “This contaiercloure s ok made it e e aex. [ Mycophenolate Mofetil for Injection, USP 500 mg per Vial PHARMACIST: Disperce e Nesiczion Gt providd separaey 1 3 ptert. Rev. 0317 Code No: GUIDRUGI10B1 Manufactured by: Catla Healthcare Lt FOR INTRAVENOUS INFUSION ONLY SINGLE DOSE VIAL 4Vials R only 74‘2 zydus A
62bdcf22-51f3-4c81-9bd4-a2dc48bec580_324_1.jpg OQAKORN QAKORN | g o susssstote ACYCLOVIR ORAL ACYCLOVIR ORAL SUSPRSIN, Us? 20 mysL SUSPENSION, USP [t 200 mg/5 mL ‘Each teaspoonful (5 mL) contains: Roon Sooma g Metyaraben 01% % o X (Added as prosarvaives) 5 USUAL DOSAGE:See package inset for 5 ot A e o gt 13 1 corane 3t e s Sorv o 701025 6810 779 s 557 s moi i Pt ot ooy ey p—— H 16 fl 0z (473 mL) #0303 810-10 2 HITECH PHARMACAL GO, G I ‘Amityile, NY 11701
62c2d8d7-1d90-4ae7-a6ff-6fc28f13e594_176_1.jpg Potassium Chloride 10mEq K(750mg) . Capsule, ER arv: 100 ID #: 357;G Expires: NDC #: 70518-1203-00 Shape: Capsule LOT #: Ref #: 68462-0357-01 MFG: Glenmark, Mahwah, NJ 07430 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
62c2d8d7-1d90-4ae7-a6ff-6fc28f13e594_176_2.jpg Potassium Chloride 10mEq K(750mg) . Capsule, ER arv: 90 ID #: 357;G Expires: NDC #: 70518-1203-01 Shape: Capsule LOT #: Ref #: 68462-0357-01 MFG: Glenmark, Mahwah, NJ 07430 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
638e4f36-1a27-4220-8ec9-3fa9d9b36c11_835_1.jpg o e 3T SO . 200y Reginen WERA (Noretinrone and hinEstadiol Talets, USP) 05mgl00mg e, wan | st WU | s meiuse | st o 13700 BaEa g | EWOS B agioss | SRS Gt ot : T T WS i WERA WERA: R Uy it Tl 5 (Noreigione (Noretindrone and T 51 and Ethinyl Estradiol i Qsmp0sng TR bt Etiny EstadiolTaiets, USP) i | onen I, = iy Rx Only
63d494c0-f1b5-4ec7-a118-f8e073ed2fbf_438_1.jpg Pacliaged by Eryant Ranch Bunbank. 04 91500 CYCLOBENZAPR G ™.0! @seisoctinouno INE 10 MG TABLET 2e9z21 | Store at room temp of Compare To: 20°-25°C (68°-T7°F) FLEXERLL 10MG TABLET-LIB Keep alldrugs outof ‘Amneal Pharmaceuticals LLC reach of children. #10 Exp: MMYY NDC 6362976531 076531122632 om
63df5af3-b8ac-4e76-9830-2dbb340af922_482_1.jpg NDC 4970222613 Rx Only Sor ¥ ol peage oot excursions permitted t0 1510 30°C - Tivicau® &= (dolutegravir) St Tablets VV " - ViV Ncallhmre P o Each film-coated tablet contains RTFN(27709 - < dolutegravir sodium equivalent 572QRcom 1010 mg of dolutegravir @ Giaxosmithiine 30 Tablets qrpycarm00 -13 i 2 702-226 = - — A146193
63df5af3-b8ac-4e76-9830-2dbb340af922_482_2.jpg 3 NDC 49702-227-13 Rx Only " . ® Tivicay (dolutegravir) Tablets Each film-coated tablet contains dolutegravir sodium equivalent t0 25 mg of dolutegravir. 30 Tablets Store at controlled room temperature of 25°C (77°F); excursions permitted 1015 t030°C (59° to 86°F) (see USP) See prescribing information for dosage information. Mmula(mredlm . Viv - ExE ik mes B 572QRcom @amwmxm Research Triangle Park, NC 27709 Madein Japan Rev. 417
63df5af3-b8ac-4e76-9830-2dbb340af922_482_3.jpg 9 49702-228-13 N 3 NDC49702-228-13 Rx Only 3 . ® Tivicay (dolutegravir) Tablets Each film-coated tablet contains dolutegravir sodium equivalent to 50 mg of dolutegravir. 30 Tablets Store at controlled room temperature of 25°C (77°F); excursions permitted to 15°t0 30°C (59° to 86°F) (see USP). See prescribing information for dosage information. Manu!actuved for VV [=]%3E] Healthcare ViV Healthcare = RTP, NC 27709 = 572QR.com @ClaxoSmxmKhne Research Triangle Park, NC 27709 — Made in Japan Rev. 6/16‘ < 41767
6422d983-a063-41ae-aa96-7ae2284cb123_207_1.jpg INDOMETHACIN Capsules USP PHARMACIST: Dispense the Medication Guide provided separately to each patient. 1 only NDC 0093-4029-01 25 mg Each capsule contains 25 mg indomethacin, USP, Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a welk-closed container as defined in the USP, wi child-resistant closure (as requ KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Mg, Lic. No.: PD/149 Manufactured In India By: EMCURE PHARMACEUTICALS LTD. Hinjwadi, Pune, India Manufactured For. TEVA PHARMACEUTICALS USA Sellersvile, PA 18960 Rev. C 5/20 510270015IN04 Y 0093-4029-01 7 i
6422d983-a063-41ae-aa96-7ae2284cb123_207_2.jpg INDOMETHACIN Capsules USP PHARMACIST: Dispense the Medication Guide provided separately to each patient. B only NDC 0093-4030-01 50 mg Each capsule contains 50 mg indomethacin, USP, Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a well-closed container as_defined in the USP, wi closure (as fequ KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Mg Lic, No.: PD/149 Manufactured In India By EMCURE PHARMACEUTICALS LTD. Hinjwiadi, Pune, India Manufactured For TEVA PHARMACEUTICALS USA PA 18960 Rev. C 5/201 510270017IN04.
6432d1aa-1e73-469e-835b-43d518963f71_563_1.jpg HydrOXYzine Pamoate 25 mg Capsule arv: 30 ID #: E613 Expires: NDC #: 70518-1504-00 Shape: Capsule LOT #: Ref #: 00185-0674-05 MFG: Sandoz Inc., Princeton, NJ 08540 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
6498c72c-51cf-4f7d-9a87-2f3c2a3bc95b_232_1.jpg (7 781.5036-3 Each tablet contains: o veLENIG Candesartan clxeti, USP 4 mg Candesartan e nossge see package et Cilexetil o copttoom I|l“||| Tablets, USP Temperaure] Disense matint. light-resistant container = KEEP THIS AND ALL DRUGS OUT OF THE REACH OF GHILDREK. Rx Only S i 30 Tablets (.0 AN e [ Hydrabod 500 13 i for 4 SANDOZ Sando o Princaion, N 03540 I
6498c72c-51cf-4f7d-9a87-2f3c2a3bc95b_232_2.jpg Each tablet contains: NDC 0781-5937-31 ars chenst, USP 8 . W Candesartan e boge see pacage ineet. | ‘Store at 20° to 25°C (68° to 7’ E oxetil ez || |"| | : Tablots, USP Jmesani oot VR, = KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. e © i 30 Tablets iy o A SANDOZ ‘vz ., Princton, Ml 08540
6498c72c-51cf-4f7d-9a87-2f3c2a3bc95b_232_3.jpg NDc 0781-5038-31 Each tablet cortains: Candesartan cllexstil, USP 16 mg. Candesartan yei bosge: See package inset L il H ‘Store at 20° to 25°C (8° to 7 el Cilexetil g T B Tublets, USP Temperature]. Dispense in a tight, B light-resista container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Cod Mo MHDRUGSZSAKD. P, 1072016 5938-31 sores & 30 Tablets A SANDOZ
6498c72c-51cf-4f7d-9a87-2f3c2a3bc95b_232_4.jpg NDc 0781-5038-31 Each tablet cortains: Candesartan cllexstil, USP 16 mg. Candesartan yei bosge: See package inset L il H ‘Store at 20° to 25°C (8° to 7 el Cilexetil g T B Tublets, USP Temperature]. Dispense in a tight, B light-resista container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Cod Mo MHDRUGSZSAKD. P, 1072016 5938-31 sores & 30 Tablets A SANDOZ
650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3_878_1.jpg Pacbaged by Eryant Rench Biabank. 04 91500 5 YELLOW ROUND AD Spironolactone S 25 mg Tablet £ & store at room temp of Compare To: 2025 C (68-77F) Aldactone 25mg Tablet Keqp all drugs out of Intas Pharmaceuticaks Limited 5 reach of children #30 Exp: MMYY 3 NDC 7133500531 018301114035
650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3_878_2.jpg Pacbaged by Eryant Rench Bunbank. 04 91500 Spironolactone § gt et 100mg Tablet 0£9TTT Follow Doctors Compare To: Instructions AHazbne 100 Tabket "Store atroom tempof | Intas Phamaceutcaks Limted 20-25 C (68-77F) #100 Exp: MMYY NDC 7133503041 040941111630 om
650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3_878_3.jpg Pashaged by Eryane Reanch Buabank. @4 91500 Spironolactone g Usoemsowmioin 50mg Tablet | - £ Keep nlight resistant Compare To: container perUSP Aldactone 50mg Tablet “Siore at room temp of s Phamacautab Linked | 20.25 C (68-77F) #30 Exp: MMYY 3 NDC 7133504011 053411113234
650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3_905_1.jpg Pacbaged by Eryant Rench Biabank. 04 91500 5 YELLOW ROUND AD Spironolactone S 25 mg Tablet £ & store at room temp of Compare To: 2025 C (68-77F) Aldactone 25mg Tablet Keqp all drugs out of Intas Pharmaceuticaks Limited 5 reach of children #30 Exp: MMYY 3 NDC 7133500531 018301114035
650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3_905_2.jpg Pacbaged by Eryant Rench Bunbank. 04 91500 Spironolactone § gt et 100mg Tablet 0£9TTT Follow Doctors Compare To: Instructions AHazbne 100 Tabket "Store atroom tempof | Intas Phamaceutcaks Limted 20-25 C (68-77F) #100 Exp: MMYY NDC 7133503041 040941111630 om
650bf1c1-b7f1-4e5b-a9f0-3a2e31b98dd3_905_3.jpg Pashaged by Eryane Reanch Buabank. @4 91500 Spironolactone g Usoemsowmioin 50mg Tablet | - £ Keep nlight resistant Compare To: container perUSP Aldactone 50mg Tablet “Siore at room temp of s Phamacautab Linked | 20.25 C (68-77F) #30 Exp: MMYY 3 NDC 7133504011 053411113234
650daa9f-aeec-49ce-95b9-5fa20b988afd_39_1.jpg QOuter Packaging Ameluz® T o (aminolewwiinic acid HCY) Gel, 10% Use contencs within i afaroponing Decardafar:_/__/__. Stor rergeratad °0 08487 exrins purmizad o 167G 86T) | Kooy o e s e e i & Soepackage st dieme ot weweo | § & o o Swimrand O i VA o0, ‘ I —e | |ﬂ||| I alll7oezt 110n oG 7082110101 Rxny o Ameluz (aminolevulinic acid HCI) Gel, 10% For Topical Use Only with BF-RhodoLED" lamp. oo Mol gredan:Each rom f e Gl corre 100 of e e oyt i sl i i o Ao e g oaes o i im0 b PO e s e e s P g e et et Outer Packaging = NoToRer o0 ; Ameluz ReGy | 1= {sminaievulnic acid HCI) Gel, 10% [ s conne witin 3 oo opnien Ot/ _/__ s e B4 s o 5SS TAE) Ko e e o e ] 500 ockage raor fo doge it Neewezg Debuten By Barromaranc 25 Eagonar Wk, WA O1B0 Prodet o Swezetand N E} 307, 062111011005 Boonters 5 Ameluz (aminolevulinic acid HCI) Gel, 10% For TopicalUsa Only with BE-RRodoLED! lamp. Hoaithcaro Profassionsia Only Notwe 29 oo, coap oo b L oo, oy Oy bodue araoo o0 Area for data matrix and human including GTIN, SN, EXP, LOT eadable information ian’s Sample Noc70e21 0130 | RxOnly \ Ameluz® (sminclewiic acid HCI) Gel, 10% Usecontants wiin 3 mench ater opening Dscard afier. _/_/__ Sirerfrgarad 248°C (98°48'F) s s 0 16 -SOC 6 BB ) Koo ot th e and rescn o chicr, r dosogonfommasen, neewezg 560 ackaga nsor H ‘l” ’ PN 3706211701301l Biofrontera A - ~og 7082110130 RxOnly Physician’s Sample Ameluz® notfor (aminolevulinic acid HC) Gel, 10% ey Heatthcare Profossionsis Only Ingroie: Enchgramof Aok Gel o e e s 761 o i s Pt o ‘Area for data matrix and human-readable information. including GTIN, SN, EXP, LOT
6535f200-ffa3-4564-972c-3bdadcde4a9b_755_1.jpg Riwwow RIATRPIANBEVIONEOIGTAES — e o e R TAKEASRECTEDBY. e g 'ENCLOSED PATEENT NFORIATON Rowe 3 SHEETOR AS DRECTEDBY i | i i i i et e e
65f56eff-4f67-4cbf-a801-a632261afc29_886_1.jpg *pasojo Aubiy amoq deay ) wol) 130id ), | eMnjesadiua) Wool Je an)s JIVHOLS “NIUQTIHD 0 HOV3H HL 40 L1O NOLLYDIG3IN TIV NV SIHL 334 LB BUIDSaLY [Py 10} Lesul 505 weposshyd 1nof £q pajaaip e s NOLLYHLSININGY ONY 39¥S0Q WY WEAUEX ‘oYc0ly IR2)S @pIXOIDAH WNDoS “eleph payung O ] DU 90 B2 SURAU0) 90 W21 B2 J0 U IGINI
65f56eff-4f67-4cbf-a801-a632261afc29_886_2.jpg woypei0y 4.96-3.65) .06-0. 51 2IMesadua Woos o B11S JNHOLS NAUATIHO 40 HOV3H 3L 40 110 NOLLYOIGI TTY ONY SIKL 63X 103N Rx Only 30z (850)
65f56eff-4f67-4cbf-a801-a632261afc29_886_3.jpg I L] @)8y/60 104 py e CLE0 8 81585 NI e r - Das00 AN o dooy e 0} g Duzony woyol0id 4.983.65) 0.06-0.51 AINERAWA) W01 E B101S FOVHOLS 'NIOTIHO 40 HOV3Y IHL 40 110 NOLIYOIG3M TV ONY SHHL &3 “woneuLo) Bugusay 11y 0} 50501 035 WIS Ayd 10k G Paoasp 5 250 NOLIVHLSINIWOY ONY 39¥S00 “UIng UBUEX ‘J0U0dIY 1KIBaIS 'apIXOIPAH WNIPOS ajem PG 09k auaIAd0Lg ‘10 1E50UIN ‘IOUO3IY 14029 'S2-NAIToI0Y 'S-U10IE010) “SyuApaIby oo BUMOJO} 84} PUE %01 591 SUEIUOD 5405 WESL) TaI 0 WeD (e ‘SLNFIGIHONI Urea Cream O, 40% For topical use only Not for ophthaimic u: Rx Only 7 0z (198.4q) NDC 42291-849-19
65f56eff-4f67-4cbf-a801-a632261afc29_886_4.jpg nan
65f56eff-4f67-4cbf-a801-a632261afc29_886_5.jpg nan
65f56eff-4f67-4cbf-a801-a632261afc29_886_6.jpg = oo AU B ...,
66152ce9-928e-4271-91a5-d4e6fc6062d9_784_1.jpg NDC 69668-452-01 Mendoxyne XN [EN) Doxycycline Monohydrate Capsules 60 Capsules Rx Only Usual Dosage: See package insert for full prescribing infarmation. Store at 20°to 25°C (68° 10 77°F) [See USP Controlled Room Temperature] Protect From Light Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN. Manufactured for IntraDerm Pharmaceuticals a division of Oculus Innovative Sciences 1129 N. McDowell Blvd., Petaluma, CA 94954 g 6966845201 LOT: J18B02 EXP: 07/2020 = e (01) 1036966845201 855-317-1107 www.IntraDerm.com (21)J18B0200004 (17)200731 Manufacturer Part 494933 - : (10)J18B02 rosonrmz - INtraDerm
662f3e16-bf42-4127-8e56-4eb45780e059_352_1.jpg 23 g & 38 & @& EE g8 =5 i tSe_ cwe 8 xmg e £ S 8sE i 5 2 Bmo £58 S TS Fic & Each film-coated tablet contains [See USP Controlled Room Temperatu Rev. G 9/2015 Dispense in container as defined in the USP, h a child-resistant closure (as requi KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Isracl By: TEVA PHARMACEUTICAL IND, LTD, Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Y 0093-7188-56 ¢ 323K273201015
66407b22-6629-4408-965b-abc5557ca562_138_1.jpg Pacbaged by Eryant Rench Bbank. 04 91508 DICLOFENAC G "Erunce: 9 SOD DR 75 MG TABLET ozerzn Store at room temp of Compare To: 20°25°C (68°77°F) VOLTAREN75MG TABLET-LIB Keep all drugs out of Carkbad Technobgy e reach of children. #1000 Exp: MM/YY om NDC 6362976551 076551121320
669a308e-ce09-4ac8-84d9-ee252c5d3223_582_1.jpg I 15 mg T T (01) 003 60687 15021 5 NDC 60687-150-21 Dextroamphetamine Sulfate 1 Extended-Release Capsules 30 Capsules (3 x 10) PRARMAGIST: Dsparse Wi s sccampany ng Medoaton Guids o each patent” Each Gapsulo Contains: Dextoamphetamine Sulate USP.. 15mg Each extendedralease Gapaule COniins dextroarphaiaTine sulfate, 15 . 5o prapared that an inital dose i reeased Promptly and ihe tamaining medication s reieased gracually over & prolonged period. Ususl Dosage: Sse package nser for fll prescribing niormation: Store at 20" 1025°C 68 10 7°%); excursions permitied btgen T5°1030°C (5810 86'F) [see USP Controlied Room Temperature) DEA Order Form Required. Keep this and al drugs out of reach of chldren. FOR YOUR PROTECTION: Do not use i bister i orn o broken. RxOnly The 6rug product cortained i s package i rom GG # 04065062, Spactn L. Packaged and Disirbuted by Amrican Health Packaging Columbus, Ofio 43217 715021 0415021/0718
669a308e-ce09-4ac8-84d9-ee252c5d3223_582_2.jpg 527 Desroempratamine . Qextoanphetamne £=: =i | §? e e & [ B o & £ i Hne CF i E LOT: o ] = § Pane. - 35E Deuosmppetamine Dotrosnpeaine <= = W s = - k [ — Seade 3 Expis ok g ¥mg i Emg LOT o e B Beners. 523 Duromhaiine - = Eitnceo Rolsase S o | BE: = gl g & o= 1 Lo, < LOT o o B EXPRY g i § Dextroamphetamine S [ BEECLL Spme € £ e @ mg i i Gty T e S=® Dexrcemphetamine £:. Dextroampnetamine. =E gymreeenee oL L g 2 Etended Release., 12 £2 Extended Reloase Ehm €4 I 825 L0 xove & I . 4 PSR
66d2c555-2880-4ac6-80f8-69a00f1fbc4c_124_1.jpg Exch capslecontin: Fenofbate, USP (icronized) 67 g [Dolekr Bt g Fenofibrate Capsules, USP . mg [MMylan® O Dispense in a tgh, ightresistant = containeras defind i the USP usinga chid-esitant closur. Keep conainer gty cosed Keep this and all medication out of the reach of hildren. Store at20° o 25°C (68° o 77°F). [See USP Controlled Room Temperature.] Protect from maisture. Usual Adult Dosage: See accom- panying pecerbing nformation. Mylan Pharmacouticals inc. Morgantoum, WY 26505US A [MMylan® Mylan.com RMBG28MM1
66d2c555-2880-4ac6-80f8-69a00f1fbc4c_124_2.jpg = = | S oo on— Ne— == Exchcopaue ontais: Fenoibate USP (mictonizet) 134mg = XY 10T [Ty Bl R g Fenofibrate Capsules, USP . [MMylan® e Dispense in a tgh, ightresistant = containeras defind i the USP. usinga chid-esitant closur. Keep container gty cosed Keep this and all medication out of the reach of hildren. Store at20° o 25°C (68° o 77°F). [See USP Controlled Room Temperature.] Protect from maisture. Usual Adult Dosage: See accom- panying preserbing nformation. Mylan Pharmacouticals inc. Morgantoum, WY 26505US A [MMylan® Mylan.com RMBG2OMM1
66d2c555-2880-4ac6-80f8-69a00f1fbc4c_124_3.jpg € N Exch capus ortaie: Dispense i g, ght resitant o o) 20 ALl A (e e 5 usinga hild-esistant clesure. Fenofibrate e, out of the reach o RMBG30MM; Usual Adult Dosage: See accom- panying pescribing nformation. Capsules, USP . Store s120° 025° (8° o TR, 560U Conrlled Hoom Tempertir] Mt Pharmaceticals n. Mt R s [MMylan [@Mylan® Prtect from meisturs. A Mylan.com £ i ¢ XN NS XXX NI v 1)=0$98-8/¢0
6727d5d4-e8ec-4a85-bc82-ec70b641eecf_367_1.jpg Capsules USP 0.5mg NDC 0172-5241-60 Anagrelide PLATELET-REDUCING AGENT B only Each capsule contains 0.5 mg anagrelide base (as anagrelide hydrochloride, US| DOSAGE AND ADMINISTRATION: Starting dose of 1 capsule up to 4 times daily or as presoribed by the physician. Dosage may require adjustment. Total daily dose should not exceed 10 mg. See package inserl. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature], Dispense in a tight, light-resistant container as defined in the USP, resistant closure (as Rev. A 11/2014 KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN, Code No: GO/DRUGS/536 Manufactured In India For: TEVA PHARMACEUTICALS USA, INC, North Wales, PA 19454 207620 N 3 0172-5241-60 1 i
6727d5d4-e8ec-4a85-bc82-ec70b641eecf_367_2.jpg NDC 0172-5240-60 Capsules USP 1mg Anagrelide PLATELET-REDUCING AGENT Each capsule contains 1 mg anagrelide base (as anagrelide hydrochloride, USP). DOSAGE AND ADMINISTRATION: Starting dose of 1 capsule up to 2 times daily or as prescribed by the physician. Dosage may require adjustment. Total daily dose should not exceed 10 mg. See package insert. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Code No: GO/DRUGS/536 Manufactured In India For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 3 0172-5240-60 & Rev. A 11/2014 207621
674ea285-8f84-4603-9655-82200c523fe5_191_1.jpg nan
674ea285-8f84-4603-9655-82200c523fe5_191_2.jpg nan
675e6738-a39c-209d-0f05-aa120f0a0695_313_1.jpg Packaged by Evyant Ranch. Burbank, G 91504 = BROWN/CLEAR CAPSULE E5254 Phendimetrazine < ER 105mg L3 Capsule(Clll) 3 2| store atroom temp of Compare To: 20-25 C (68-77F) Bontrl SR 105mg Capsule(CIl) Keep all drugs out of EpicPharma LLC 2 reach of children #28 Exp: MM/YY g NDC 6362930511 030511107244
68064989-47ea-4ed5-a20e-43c4ef6ec271_285_1.jpg NDG 65862-670-01 Rxonly Repaglinide Tahlets, USP 0.5mg £ AuroBDO 100 Tablets Each tablet contains: Repaglinide USP 0.5 mg. Usual Dosage: See package insert for ull prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Keep bottles tighly closed. Keep out ofreach of children. Dispense in a tight container with child resistant closare Distributed by: Aurobindo Pharma USA, 279 Princeton-Hightstown Road East Windsor, NJ 08520 * *Over printing Zone Made in India P1421759 Code: TS/DRUGS/19/1003 Coding Area 45175 mm) Ootedine et to b ed #1002929859¢N
68064989-47ea-4ed5-a20e-43c4ef6ec271_285_2.jpg NDG 65862-671-01 Rxonly Repaglinide Tahlets, USP /9 AUROBINDO 100 Tablets Each tablet contains: Repagiiide USP 1 mg. Usual Dosage: See package insert for full prescribing information. Store at 20° o 25°C (68° to 77°F) [see USP Controlled Room Temperature] Protect from maisture. Kesp bottles tigfly closed. Keep out of reach of hildren. Dispense in a tight container with child resistant closure. Distributed by: Aurobindo Pharma USA, 279 Princeton-Hightstown Road East Windsor, hJ 08520 I *Over printing Zone Made in India Ine. P1421760 Code: TS/DRUGS/19/1002 Coding Area @sx15mm) Dot st e LL012929859¢EN
68064989-47ea-4ed5-a20e-43c4ef6ec271_285_3.jpg NDG 65862-672-01 Rxonly Repaglinide Tahlets, USP /52 AUROBINDO 100 Tablets Each tablet contains: Repagiiide USP 2 mg. Usual Dosage: See package insert for ull prescribing information. Store at 20° o 25°C (68° to 77°F) [sse USP Controlled Room Temperature] Protect from moisture. Keep bottles tigfly closed. Kesp out of reach of ohildren. Dispenss ina tight container vith child resistant closure. Distributed by: Aurobindo Pharma USA, ightstown Road 279 Princeton East Windsor, NJ 08520 * *Over printing Zone Made in India P1421761 Code: TS/DRUGS/49/1993 Coding Area @615 mm) Dotied ines o obe prited 81022929859¢N
68fcc228-5f06-4ece-94f3-59b5b33c3325_744_1.jpg NDG 65862-672-01 Rxonly Repaglinide Tahlets, USP /52 AUROBINDO 100 Tablets Each tablet contains: Repagiiide USP 2 mg. Usual Dosage: See package insert for ull prescribing information. Store at 20° o 25°C (68° to 77°F) [sse USP Controlled Room Temperature] Protect from moisture. Keep bottles tigfly closed. Kesp out of reach of ohildren. Dispenss ina tight container vith child resistant closure. Distributed by: Aurobindo Pharma USA, ightstown Road 279 Princeton East Windsor, NJ 08520 * *Over printing Zone Made in India P1421761 Code: TS/DRUGS/49/1993 Coding Area @615 mm) Dotied ines o obe prited 81022929859¢N
6909596e-4bf7-4e11-8029-b89740a30aec_560_1.jpg 2G/101 2y6120VVd 9'6a1] Sv00g 1 Isau0g e Aupduuog ez @ eAdsoH ka pevnausia Tl 01 - (SSH) POV Jog 6720 15t Storeat controlled rom temperature 20° fo 25°C (68° 10 77°F) [see USP. Protect from fight. DOSAGE AND USE: See accompanying prescribing Information Each L contains testosterone cypionate, 100 mg. Also conains benzylbenzoate, 0.1 mL; benzyl alcohol added as presenative, 9.45 ma; n cotonseed ol 735 mg. O NOC0MT-01 Mitpl-Dose R Testosterone Cypionate Il:{'ection, UspP 100 mg/mL [ For intramuscalar use only Rx Hospira o
6909596e-4bf7-4e11-8029-b89740a30aec_560_2.jpg s S Dol = e NION Ad032 ON HSINHYA ON AVM SIHL SOV3IH One 10 mL Vial Muliple-Dose Testosterone Cypionate Injection, USP 100 mg/mL E" For intramuscular use only Hospira PAAD78823 Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP]. Store product in this carton 10 protect contents from light. | | | | | DOSAGE AND USE: ! Ses acoompanying i presciibing information. | | | | | Each mL contain testosterone cypionat, 100 mg. Alo contains benzyl benzoate, 0.1 mL; benzyl alcchal added as preservative, 9.45 mg; in cottanseed of, 736 mg. One 10 mL Vial Multiple-Dose Testosterone Cypionate Injection, USP 100 mg/mL |n €01)00504096557012 For intramuscular use only ety Hospr, aPizer Company Hospira Lake Fort, L 60045
6909596e-4bf7-4e11-8029-b89740a30aec_560_3.jpg dx3/101 2¢£9980VVd [SSH) paxaels leg eleq | NDC 0409-6562-01 1 mL Vial RL-5248 Testosterone Cypionate I:" Injection, USP _ DOSAGE AND USE: See accompanying. 200 mg/mL Nos@u resciong nfomition, itrbued by Hasie, a Plizer FOr IM use only Single-dose Company, LakeForest, 60045 Rx only
6909596e-4bf7-4e11-8029-b89740a30aec_560_4.jpg 90 s “JuyBu 00z dsn ‘uonoslu apeuody auosaposal One 1 mLVial Single-dose Testosterone Cypionate Injection, USP 200 mg/mL [ For intramuscular use only Holpira PAADBEG33 Store at controlled room temperature 20° to 25°C (68 t0 77°F) [see USPL Store productin this carion to protect contents from light. See accompanyng prescribing informaion. Each mlL contains testosterone cypionate, 200 mg. Al contains benzy benzoate, 0.2 mL; benzyl alcohol added as preservative, 9.45 mg; In | | i | | e | | | | | | 1 cottonseed oil, 560 mg. | oz | oe ot i 3 Single-dose | o | 2 Testosterone | > Cypionate | S Injection, USP | S 200 mg/mL Eu | e | For intramuscular ‘ SOy | o | [ | Vs, e Conyary Hospira | Ll Forest, L G005 LOT/EXPISH: IMPRINT AREA READS THIS WAY NO VARNISH
6909596e-4bf7-4e11-8029-b89740a30aec_560_5.jpg 86812 001 (551 PRI G 520 159 03 10040071 97 oK A panaLy 5 o Sl zage o Store at controlled room temperature 20° to 25°C (68° 10 77°F)[see USP. Protect from light. DOSAGE AND USE: See accompanying prescriing Information. Each mL contans testosterone cypionate, 200 mg. Ao cotains benzyl benzoate, 0.2 mL: benzyl alconol agded as presenvtive 9.45 mg; in cottonseed ol 560 mg. l 3] TomLval NOG0#0656220 Multiple-Dose RL-5249 Testosterone Cypionate Injection, USP 200 mg/mL [ For intramuscufar use only Holpha Rxonly
6909596e-4bf7-4e11-8029-b89740a30aec_560_6.jpg One f0mLVal Multiple-Dose Testosterone Cypionate Injection, USP 200 mg/mL [ For inframuscular use only Hospira Store at controlled room temperature 20° 0 25°C (68° 0 T7°F) see USP). Store product i this carton o protect contents from light. 'DOSAGE AND USE: See accompanying prescrbing information Each ml conains tetosterone cypionate, 200 mg. Hiso contains benzyl benzoate, 02 mL benzyl akcohol added as presenvative, 945 mg; in cotionseed of, 560 g mcumsEen | One 10mL Vial Multiple-Dose. Cypionate Injection, USP | | | Testosterone | | | 200 mg/mL i | For intramuscular use only Holpira IMPRINT AREA = - - =
691e4fd7-3df6-5709-e053-2a91aa0aa874_831_1.jpg Soaar 2o 77 S s? oo rcwten, Ltn_ oo oo o Prkmutty Oonramai: e 3 Cephalexin Capsules, USP PO 05O RxOnly smo
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_1.jpg AUROMEDICS Rxonly NDC 55150-212-01 Distributed by: AuroMedics Pharma LLC E. Windsor, NJ 08520 Made in India Code: TS/DRUGS/13/2010 2L Paricalcitol Injection, USP 2 mcg per mL — — o For Intravenous Use g 1mL Single Dose Vial &
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_2.jpg = SOITEANONNY ¢/ sjeIA 8s0@ 9|BuIS TW | X 67 sjuag 5 snoushexu| o4 qu Jad Bow Z 3 dsn ‘uonoafuj 10-Z1T-05155 9aN Ajuo xy B0EEL0I. I 1 » Rx only NDC 55150-212-01 | | Rxonly NDC 55150-212-01 [Each mL contains: Paricalcitol USP, 2 mcg; propylene glycol, 30% (v/v); | 1 and alcohol, 20% (v1). Paricalcitol ] | Paricalcitol Usual Dosage: See Package Insrtfor full prescribing information By - ] | 2 3 USE ASEPTIC TECHNIQUE Injection, USP ] | Injection, USP i | 1 Remove cover from vial and cleanse stopper with antiseptic. i A \Zmcaipernity Distributed by: Code: TSDRUGS/132010 e persL g e . For Intravenous Use e L i For Intravenous Use Store at 20°to 25° (68°to 77°F). [Sse USP Controlld Room Sterile 251 mL Single Dose Vials | E. Windsor, NJ 08520 Sterile 25 x 1 mL Single Dose Vials | Temperature] ' AUROMEDICS Made in India Sils s s ollz 1z 010l ' AUROMEDICS ‘The vial stoppers are not made with natural rubber latex. . y =, \\\\ - .~ \\\\\\/\///
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_3.jpg Rxonly NDC 55150-213-01 Distributed by: AuroMedics Pharma LLC E. Windsor, NJ 08520 Made in India Code: TS/DRUGS/13/2010 Paricalcitol Injection, USP 5 mcg per mL S el =i For Intravenous Use I 1mL Single Dose Vial & |
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_4.jpg & SOIAENONNY ¢/ sieiA ssoq 3iBuis Tw | X 67 aiuas asn snousnenu Jog - 1ad Bow g R RV L0-€1Z-05155 9N Auo xy ALEId Rx only NDC 55150-213-01 | Rx only NDC 55150-213-01 | Each mL. contais: Paricacitol USP, 5 mog: propylens alcal, 30% (4h); i and alcahal, 20% (v/). Paricalcitol ] Paricalicitol UsualDosage: Ses Package Insert fo ulpescribing iformation = 5 | - : Injection, USP | Injection, USP SRR T ] Remove cover fom valand cleanse stopper ith antseptc 5 mcg per mL. L 5 mcg per mL N’ Code: TSDRUGS/132010 Yoo O Boust s fynfia Fouinmavenoils Yse 270 Princston-Hightstown Rd For Intravenous Use Store at 20° to 25°C (68° to 77°F). [See USP Gontrolled Room Sterile 251 mL Single Dose Vials | E. Windsor, NJ 08520 |III|||| ||l |||| I " Sterile 25 x 1 mL Single Dose Vials | Temperature] /R AUROMEDICS Madein India ST ol s 00 s /2 auroMEDICS “The vialstoppers are not made with natura rubber atex.
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_5.jpg AUROMEDICS Rxonly NDC 55150-214-02 Distributed by: AuroMedics Pharma LLC = s E. Windsor, NJ 08520 Paricalcitol 3 s Made in India T T coce: TsimRUGS/13/2010 10 mcg per 2 mL \ (5meg/imL) For Intravenous Use 2mL Single Dose Vial
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_6.jpg SOIQENONNY ¢/ SieiA 3s0Q 9BUIS W Z X 6T asn snouanenu| Jog / (quyBowg) qui Z 45d Bowi o} dsn ‘uonoafuj [ TEe] =T I=F | 20-412-05155 AN = \ s Ajuo xy 90EEH0d Paricalcitol Injection, USP 10 meg per 2 mL \_(5meg/mL) ) For Intravenous Use R auroveEDICs Rx only NDC 55150-214-02 Sterile 25 2 mL Single Dose Vials Distributed by AuroMedics Pharma LLC 278 Princeton-Hightstown Rd . Windsor, NJ 08520 Made in India Code: TS/DRUGS/132010 Rxonly NDC 55150-214-02 Paricalcitol Injection, USP 10 meg per 2 mL \_ (5meg/mL) / For Intravenous Use Sterile 25 x 2 mL Single Dose Vials R AUROMEDICS Each mL contains: Paricacitol USP, 5 mg; propylene alycol, 30% (v} ‘and alcohol, 20% (vA). Usual Dosage: See Package Insert for full prescribing information. USE ASEPTIC TECHNIQUE Remove cover from vial and cleanse stopper with antisepic Discard unused porton, Store a1 20° 10 257G (68° 10 77°F).[See USP Controlled Room Temperature | The val stoppers are not mads with natural ubber latex
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_7.jpg Rx only NDC 55150-215-02 Distributed by: AuroMedics Pharma LLC " " E. Windsor, NJ 08520 Paricalcitol E - Made in India TR coce: T5i0RUGS 1372010 10 mcg per 2 mL \ (5meg/imL) For Intravenous Use 2mL Multi Dose Vial AUROMEDICS
6937c596-9ca4-480e-9090-b9d8a3c271c8_13_8.jpg o SOIqENONNY ¢/ SIEIA 2500 BINN TW Z X 6T sls asn snousnenu Jog /[ (quBowg) \ qui Z 15d Bowi o}, SRR (] (TR BT F=2 | 20°512-05155 OGN Ajuo xy Um0 e ISR 1EEId NDC 55150-215-02 Paricalcitol Injection, USP 10 mcg per 2 mL \_(5meg/mL) For Intravenous Use . 25 2 mL Multi Dose Vials AP AUROMEDICS Rx only Sterile 279 Princeton-Hightstown R E. Windsor, NJ 08520 Made in India Code: TS/DRUBS/132010 sl 27502 5150 |/ Rx only Sterile NDC 55150-215-02 Paricalcitol Injection, USP 10 meg per 2 mL \_(5meg/ml) / For Intravenous Use < 25 x 2 mL Multi Dose Vials /R AUROMEDICS Each mL contains: Paricalcitol USP, 5 mcg; propylene alycol, 30% (viv): and alcohol, 20% (vA). Usual Dosage: Ses Package Insert or full prescribing information. USE ASEPTIC TECHNIQUE Remove cover from vial and cleanse stopper with antiseptic Store at 20°t0 257G (68° 10 77°F).[See USP Gontrolled Room Temperature The val stoppers are not made with natural rubber latex
693da40b-26d4-40d6-87d1-158e256f40ab_968_1.jpg A =X7] g 5 @52 & S E=8_ ¢ oﬂlﬂdclgw S =0 = E 2 SRS QL _E S 3B 2o = 2 >cWw = S =EXoOor = Each capsule contains 150 mg mexiletine hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Canada By: TEVA CANADA LIMITED Toronto, Canada M1B 2K9 Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N e = 3 0093-8739-01 T == Rev. D 3/2015 361-32-768116240 Rev 04
693da40b-26d4-40d6-87d1-158e256f40ab_968_2.jpg D A, =W g s g 5 @52 £ SE=8_¢ o..lulnlmclgw s =02 EE %xrs = > S 3B 2ot I Q >Oo u 2 SETON E & Each capsule contains 200 mg mexiletine hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Canada By: TEVA CANADA LIMITED Toronto, Canada M1B 2K9 Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. D 3/2015 361-32-768126240 Rev 04 N - = 3 0093-8740-01 7 (T
693da40b-26d4-40d6-87d1-158e256f40ab_968_3.jpg D O, sSw g T S=8_¢ o:lulnlmclgw s =02 EE %xrs = g B 2o & Q SO L u S=ETOq = Each capsule contains 250 mg mexiletine hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Canada By: TEVA CANADA LIMITED Toronto, Canada M1B 2K9 Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N - — 3 0093-8741-01 , A Rev. D 3/2015 361-32-768136240 Rev 04 100 CAPSULES
6971241c-8323-456e-91a4-a404a9e100de_173_1.jpg NDC 55154-2074-0 D 7 O HYDROXYCHLOROQUINE SULFATE TABLETS, USP 200 mg 10 TABLETS Each tablet cortains: Hydroxychloroguine sulfate, USP 200 mg Usual Dosage: See product inset for complete prascribing information, precautions and wamings, STORAGE: Stare at 20° to 25° T (68° to 77° F) [See USP Controlled Room Temperature] RX ONLY WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN If dispensed for outpatient use, chid-resistant container should be utiized PHARMACIST- Children are especialy sensitive (o this medication. Tablets should be kept out of their rezch The drug product contained in ths package is from NDC # 88382-096, Zydus Pharmaceuticals (USA) Inc. Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 americanhealtrpackaging com An AmerisourceBergen Company AMERICAN HEALTH PACKAGING® Distributed by Cardinal Heatth Dublin, OH 43017 143672560316 LOT #: XXXXXXXXXX EXP. DATE: XX/XX/XX
6a0e9cb3-21ae-4ac7-9643-5e045a29e62f_483_1.jpg Pacbaged by Eryant Rench Bbank. 04 91506 5 YELLOW CAPSULE SHAPEDR22 Olanzapine ODT g 10mg Blister | Pack 2 & store at room temp of Compare To: 20-25 C (68-77F) Zyprexa 10mg ODT Bister Pack Keep all drugs outof Dr.Reddys Laboratories Limited reach of children #30 Exp: MMYY NDC 6362975141 075141116149 om
6a22beb6-57e8-480d-97b5-44d9dbfabf93_546_1.jpg Usual Dosage: See accompanying prescibing information. Constiute to 100 my/mL* with 4.8 mLof Sterle Water for Inection “EachmL contans azitromycin monchydrae, USP equivalent o 100 mg of azitvomycin, 769 mg of ciric acid, and sodum hydroxide for pH adjustment. Must be further diluted before use. For appropriate diluents and storage recommendations, refer to prescribing information. The sodium contentis 114 mg (4.96 mEQ) per via. NDC 62756-512-40 Azithromycin for Injection, USP of azithromycin Sterile FOR INTRAVENOUS INFUSION ONLY \ Rx only 6||5 1 240|I|| 5 75 N N 3 Storeat20° to 25°C (68° 10 77F); exursions permitied between 15° and 30°C (59° and 86°F) [see USP Contrlled Room Temperature). Distributed by: ‘Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceuical Industries Ltd. Haol-Baroda Highway, Halol-389 350, Gujarat, India. PJLB13148 PJLB1314B 1SS. 06/2014 GUYDRUGS/28/396 Batch No.: Bxp.
6a22beb6-57e8-480d-97b5-44d9dbfabf93_546_2.jpg g eI b 005 X 01 \ mxu-n.vm AINO NOISNANI SNONIAVHLNI HO4 Awoxy L Pa3ap S PAINYISU0A! UaYM UOAN|OS JO ,Tw/Bu O} praif oL = unfwoipze jo VLT - neem dsn ‘uonasluj 1oy uphwoiypzy ¥¥Z15-95229 30N [ ‘ o e T i NDC 62756-512-44 NOC 62756.-512-44 NDC 62756-512-44 Lchasiplran ooy o SO Azithromyein for Injection, USP Azithromycin for Injection, USP Azithromycin for Injection, USP e O 500 [ | 500mgperVial | 500 7] i st o, g Mot WAL | S00mgperVial | welladd L) e e ot ommenn popem— o S 0102 8 773 s et - 6 5 TR MR o s o S o o yield 100 mg/mL* of solution when recansiituted as directed TR 0o e W S e e e W o O | s © FFOR INTRAVENOUS INFUSION ONLY B s iy o \ llll!lll | oo B\ e SON iz o Pt i . TR S e
6ab99d12-03a6-478e-b976-0a8031d94dcc_400_1.jpg recams Fony Cleansmg Wash (Sodium Sulfacetamide 10% and Sulfur 4%) Ina Urea Vehicle For Topical Use Only Acella 161z (473t} INDICATIONS: For e toical etment o acne rosac, e vl 30 se0ThEG eTrals DIRECTIONS: Vs afciedaenorcs il or s dieied by your oy, Avidconatwih e o mugous meivares, e sk an bl apely 0 25 0 5 sharst, Tasafe oy s or 0205t woring ol e e orougly anc . | cying ocurs, 1 may b conalled by g f oo o Lsing s o, Ses packae set for Ul prescribing ormation, WARNINGS: FOR EXTERNAL USE ONLY, KEEP AWAY FROM EYES, KEEP OUT OF REAGH OF CHILDREN, K2y sl INGREDIENTS:Ech mof S Slaceace 10% and Sul €% conians 100 g ofsodum sultami nd 40 g o ulrnanemolsio e conining s 10%, bl fonokes bl Geton 1 iy amico MEA sulosscinat, el st and PEG 100 seatls, g akainu s, ety barate Sopparioen, pred wee sod mcoeml se s, s el cocoyl e, sdrs sk, stz ot i et and entan . Storeat contrlled room temperature 15°30" €(59°46" Protc o eezg. Forcontol e and expiatin a lJ'z'! 005 Wasisa Parkway Ablret, GA20005 s s botom of o,
6ad58928-f21a-0673-e053-2a91aa0af990_116_1.jpg NDC 60760-181-30 Amitriptyline Amitriptyline Amitriptyline Amitriptyline ﬁmdtmhne Hydrochloride Hydrochloride Hydrochlonide Hydrochloride yar londe o Tablets USP Tablets USP Tablets USP Yaclets usp Tablets USP 3 75mg 75mg 75mg 75mg 75 3 QrY: 30 QTY: 30 Qry: 30 Qry:30 mg = RX# 000000000000 RX# 000000000000 RX#000000000000 RX# 000000000000 ary:30 T NDC 60760-181-30 NDC 60760-181-30 NDC 60760-181-30 NDC 60760-181-30 LoT#?7277777 S LOT# 2222222 LOT#272227? LOT# 7222772 LOT#?722227? EXP 77 EXP 77-22 EXP 22-2? EXp 7277 EXP 22-7? RX#000000000000 MANUFACTURED BY: (01) 00360760181303 1 USE AS DIRECTED et (10) 2772772 Intas Pharmaceuticals Limited, Ahmedabad-382 213, INDIA |, PACKAGED BY; S St. Mary's k. ﬂrgﬁ 10360 MAVINEE DR, ~=— 7 ROVALEY,AZ85 MANAGED PHARMACY PROGRAMS Rxonly STORE AT CONTROLLED ROOM TEMPERATURE 15°- 30° C (59°-86°F)
6af2e092-e59c-44d4-ab71-286886431211_841_1.jpg nan
6b000266-aa36-4b0f-b4d1-f38e59d35c61_604_1.jpg COMPRESSED GASES, OXIDIZING, N.O.S. (OXYGEN, CARBON DIOXIDE) UN3156 = NON-FLAMMABLE _____ % CARBON DIOXIDE, USP % OXYGEN, USP WARNING: Administration of this gas mixture may be hazardous or contrain- dicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of gas mixtures, and is familiar with the indications, effects, dosages, methods and frequency and duration of administration, and with the hazards, contraindications and side effects, and the precautions to be taken. DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. MAY INCREASE RESPIRA- ‘TION AND HEART RATE. Do not handle until al safety precautions have been read and understood. Keep and store away from clothing and other combusti- ble materials. Keep valves and fittings free from grease and oil. Use and store only outdoors or i a well-ventilated place. In case of fire: Stop leak f safe to do so. Use a back flow preventive device in the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. Open valve slowly. Close valve after each use and when empty. Protect from sunlight when ambient temperature exceeds 52 °C (125 F). Read and follow the Safety Data Sheet (SDS) before use. CAS: OXYGEN 7782-44-7 CARBON DIOXIDE 124-38-9 NET CONTENTS Contains Cubic Feet at 70°F and PSIG DO NOT REMOVE THIS PRODUCT LABEL. P 2= Ne X .si' Distributed by nexAir, LLC » www.nexAir.com 1385 Corporate Ave. * Memphis, TN 38132 « 888-639-2474
6b08d806-eb1f-4b25-9995-ae8321a6ff78_814_1.jpg Bowgz/bwso (e opense Yonie reaoe uepun o) o 3anbnueasr 1eggz zs X Jod s Rxonly N 5254423631 Jevantique Lo (norethindrone acetate/ echinyl estrachol tablets) 0.5mg/2.5mecg Thiscaroncontains 3 pouches Eachpouchcontans 1 bste ardof 2 tbles. . b ol o5 g e e 1 mcr et = ol Dot e it ety s ki R g e o . | Jevantique Lo (norethindrone cetate et estrodio tables) 0.5mg/2.5mcg Ths arton contas 3 pouches. Eochpouchconans 1 bister o of 2 ol om0 g ot o o St 25°C 7 s e 55 o) e oot o Tenpein Seecnapfor o e and o e R O mim
6b28c424-0b7e-4b75-b090-f116b113554e_801_1.jpg 0, 0E-082€-2000 ¢ 65) 1)9,52 18I0l ‘Uopeuuoju aBesop Joj ainjesa)| Bulfueduoaoe aes anjsou Wwos 19j0id pue pasord KB daay “syuaijed o} pasuadsip aq 0} s| 9PINg uoyiealpO No. 3230 30 CAPSULES Symbyax Olanzape and Fuoretme Capstles o Las, NDC 0002-3230-30 Rx only 3mg/25mg 3 mg olanzapine and 25 mg Each capsule contains Do not use if Lill inner seal is missing or broken. *Each capsule conti 0300023230500 YLOT6IDAMO1 Exp, DatelContol No/Seial o,
6b28c424-0b7e-4b75-b090-f116b113554e_801_2.jpg 0€-182€-2000 o { A fomypiadusa) wooy payone) dsn ] (4.98-65) 1)9,52 e 0ls uediuoooe 235 amjsiow we 1 pue pasop ARy deay “syuaijed o} pasuadsip aq 0l s| aping uonealpa M gmw g m Ef: ¢S o &8 K|E ¢ g =285 fxE B S| © 85 Do notuse if il inner seal s missing *Each capsule contains. GTIN: 0030023231307 YLO7IDAMO1 Exp.DateContol No.Serial o B
6b28c424-0b7e-4b75-b090-f116b113554e_801_3.jpg 0€-2€2€-2000 anisiow “swatjed o} pasuadsip aq 0} 5| apIng uoREAIPA gl £ g m, Do not use Rx on 30 CAPSULES YLOTBIDAMOT Exp.DateContol o -4
6b28c424-0b7e-4b75-b090-f116b113554e_801_4.jpg 0€-€€2€-2000 My [aunyesaduay woo payoRu0) s 88s) (4. 51 0 papuag SUOSINOKS (1, 11) 0,62 1 31015 ampesoyy Gukueduoooe so5 anysow wou osjoid pue p3sa G dsay o) pasuadsip aq o} st aping uoneaIpA : NDC 0002-3233-30 No. 3233 Rxonly 30 CAPSULES Dono GTIN: 0300023233501 YLOTOIDAMO1 Exp. DateConto o Sl o
6b28c424-0b7e-4b75-b090-f116b113554e_801_5.jpg 0€-¥€2€-2000 Rx only 51 B 95z B £ Do not use ifLill inner seal is missing or broken, “Each capsule contains 50 mg fluoxetine as 30 CAPSULES Each capsule contains 12mg olanzzpine and 50 mg GTIN: 0300023234308 YLOZ0IDAMOT Exp. DatelConto o Seral . B
6b601eaf-4f3a-4a8b-8cd8-1000defa9822_383_1.jpg NDC 45802-390-00 Tacrolimus Ointment 0.03% 30 ATTENTION: DISPENSE WITH ENCLOSED MEDICATION GUIDE Perrigo® Dublin 12, Irland ABARCCS Rev07-18 4§ 45802-390-00 4 NDC 45802-390-00 Tacrolimus Ointment 0.03% 30 ATTENTION: DISPENSE WITH ENCLOSED MEDICATION GUIDE Perrigo® ] praat) l FOR DERWATOLOGI USEORY. o gt s, 5 gramof Tl O ortans ) O08% s atse | e ot e A A oy e, e B | S st st 2577 s prts Y | Dosage: Aply twiice daly. See packag insert for dosage information. | | r o o - TS | ] i Distributed By : ! ! " : ! Meruactured by Perrigo il i 0 aboraais AH:ganM\bsnm i a5 Coel Rond e i igh P 8ge
6b601eaf-4f3a-4a8b-8cd8-1000defa9822_383_2.jpg NDC 45802-700-00 Tacrolimus Ointment [0:1%| 30/g ATENTION:DISPENSE WITH ENCLOSED MEDICATION GuIDE Perrigo® Manufactured by: LEO Laboratores Ltd 285 Cashel Road Dublin 12, Ireand NDC 45802-700-00 I TN P FOR DERMATOLOGIC USE ONLY. ot foroohtalic se. WARNING: Keep 0t ot reach o e, isbuted By Perrigo® M.ew 250 o PRMRCCS ey 07-18 4 s5802-700-00" 1 Tacrolimus Ointment 0 1% T e p——— Perrigo® Each am o Tacrofimus Ontment contan (/) 0.1% of arofs i a base of minera o, parafin, rogfons carbonat, white pfiolaum and e wa, Storage:Stre at oo emperatre 25°C 77°F);poursons permitd o 15°-30°C (80°86°, Dosage: Aol twice daly. See ackage inser fordosage normation. NDC £5802-700-00 e Tacrolimus Ointment 0.1%
6b81a843-7788-4660-afe7-dd8f7eb1687a_249_1.jpg Imipramine HCI 25 mg Tablet arv: 30 ID #: EP;134 Expires: NDC #: 70518-0127-00 Shape: Round LOT #: Ref #: 64125-0134-01 MFG: Excellium Pharma, Fairfield, NJ 07004 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
6b9c60e9-b0d2-4aec-a04b-ccc7a62c822b_97_1.jpg Do not accept ff seal over bottle opening NDC 27241-01 9_03— 18 is broken or missing. 5 wz Each blue and pink capsule contains: ~ © La nso p razo I e 15 mg of Lansoprazole, USP as @B enteric-coated granules. g Delayed- Release Dispense in a USP tight container. & Usual Dosage: See enclosure for full = capsules usp O PZ A rea prescribing information. = Store at 25°C (77° F); excursions S m rermll(ed 0 15° o 30°C (59° {0 86°F). % 30 x 28 mm See USP Controlled Room TENPETB‘““‘-] & Pharmacist: Dispense the accompanying Keep out of the reach of children. Medication Guide to each patient. N Bhama UsA g anta janta Pharma nc. 7 Bidgenates N 0880 g By 5o Capsules 4/ Made n India 8 ‘
6b9c60e9-b0d2-4aec-a04b-ccc7a62c822b_97_2.jpg Do not accept i seal over bottle opening. NDC 27241-020-03 -: s broken or missing. | Each green and pink capsule contains: E I.a n SO p I'aZ l.'l I e luz 30 mg of Lansaprazole, USP as g | enteric-coated granules. 2 Delayell Release I N Usual Dosage: See enclosure for full & | prescribing information. % Capsules usp | OPZ Area :: Serliees. . HLO 00 | : ermitted to 15° lo 30°C (59° to 86°F). o! FSee USP Controlled Room Temperature] g : 3 0 X 2 8 mm | i Keep out of the reach of children. & Pharmacist: Dispense the accompanying [ Marketed by - @ Medication Guide to each patient. I Ajanta Pharma USA Inc. B . { Bridgewaler, NJ 08807, g By 30 capsules HAHA | | 3 Made in India _ | |
6bcbb839-1489-3b3f-e053-2991aa0aecfd_172_1.jpg OXYGEN, COMPRESSED USP UN 1072 DANGER: MAY CAUSE OR INTENSIFY FIRE, OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED, 0 nothandie e sfety prcautions hve b e andundersiood. Keepsndsoe away fom cohngsnd thercombustiemters Keep s s it 1 fom € nd s and s oy oors o el ventoted pace In o of . 1o e st to 6o Us a ck owprsertie device 1 h ppng,Usc oy with squmet of compatle it of construcion nd atd forder s s oy it cauprent ceaned o cygen service.Open e ol Close Ve afer o i s nen mpty Pt fom s e st Exceds 52°C(125°F)Resdand olow th Sty OnaSht 4 P CASNO: T782-447 DONOT REMOVE T PRODUCT LABEL Contenis | _size Tialters | O M4 WARNING.or cmegencyus nly when e e o by proery e pesonnefor ygendeiency sndsciaton. for sl ther el sppicston, Re o, | 255 Liters | 0 C Uninegted e of ghconcenusvonsofgencws a5 Urers | 3 D Ao i b oo e e et witost oy e bt St aptto | 880 Uters | 1 E e s e g i et = el sadomtin ool U B ety Representative Labeling pursuant to 21 CFR 207.3 (10) Company name and contact information are printed in this box
6bcbb839-1489-3b3f-e053-2991aa0aecfd_172_2.jpg OXYGEN, REFRIGERATED LIQuID usp UN 1073 CONTENTS: LITERS 1 ALWAYS KEEP CONTAINER IN UPRIGHT POSITION. & AWARNING: DO NOT CHANGE OR FORCE FIT CONNECTIONS EXTREMELY COLD OXIDIZING LIQUID AND GAS UNDER PRESSURE VIGOROUSLY ACCELERATES COMBUSTION. NO SMOKING IN THE PRESENCE OF OXYGEN OR A FIRE MAY RESULT CCOMBUSTIBLES IN CONTAGT WITH LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. CAN CAUSE SEVERE FROSTBITE. Keep oil, grease, and combustibles away. Use only with equipment cleaned for oxygen service. Store and use with adequate ventilation. Do not get liquid in eyes, on skin or clothing. For liquid withdrawal, wear face shield and gloves. Do not drop. Use suitable hand truck for container movement. Avoid spills. Do not walk on or roll equipment over spills. r Close valve after each use and when empty. e Use in accordance with the Material Safety Data Sheet (MSDS). AFIRST AID: IN CASE OF FROSTBITE, obtain medical treatment immediately. AWARNING: For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, Rx Only. Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effect on oxygen content of arterial blood, may be harmful. Use only with pressure reducing equipment and apparatus designed for oxygen. Do not attempt to use on patients who have stopped breathing, unless used in conjunction with resuscitative equipment. Produced by Air Liquefaction DO NOT REMOVE THIS PRODUCT LABEL. Representative Labeling pursuant to 21 CFR 207.3 (10) Company name and contact information are printed in this area CAS NO: 7782-44-7
6c015f72-5ce3-4f56-8237-776fc2165b0c_497_1.jpg No Vamished Area (Do Not Print) (18 x41 mm) L R Meloxicam Tablets, USP ‘Attenion Dispenser: Accompanying Medicaton (Guide MUST be dispensed with this product 500 TABLETS 73 zydus Rx only Each tablet contains: Meloxicam, USP .... 7.5 mg Usual Dosage: See package nsertfor complete prescribing informaton, Store at 20° 0 25°C (66° 10 77°F) See USP Conirlled Room Temperature] Keepinadry plce. Dispense in tignt contaner KEEP THIS AND ALL THE DRUGS OUT OF THE REACH OF CHILDREN. Code Nos HPIH7204 Mantacurea by s Caia Healicars Lid. India 22 ibuted by Zydus Pharmaceuticals (USA) nc. Penningion, NJ 08534
6c015f72-5ce3-4f56-8237-776fc2165b0c_497_2.jpg No Varmished Area (Do Not Print) (18x50.5 mm) NDC 68382:051-05 A Each tble contins Meloxicam =i om Usual Dosage: See package insertfor Tablets, USP e Store at 20° 0 26°C (68° 10 77°F) [See USP Controlie Room Temperature) ‘ | | | | | | | | | | | | | | | Keepina dry place. | Qi | | | | | | | | | | | | | | ‘ OUT OF THE REACH OF CHILDREN. Code No: HPI72/04 ‘Atention Dispenser: Accompanying Medication (Guide MUST be dispensed with tis product Manufactured by: Cadia Healthcare Lt India Lm0y ST 500 TABLETS ~ Distibutedy: Ky Roony AT
6c4b2675-6b23-4364-90fa-10aee45d3270_311_1.jpg BER e e | RIS Betie, dSRTHREES = EELTER, auew o VRS | . EE., we__w § EEIELL wed s meERDRor s = 2 e P ;1w Smaee = Py EEEL e S | yams
6c6fa857-4b6f-482b-afd8-4bedd729e6bb_435_1.jpg or. Roday's orso e s or Vo e : Snvaora } TSI Store at2 -8 °C Do not freeze
6c789378-0ec7-4874-aa42-e3418e859f86_616_1.jpg list 6346) 04A909R1 Eo. Lot Do not accept ifseal over bote opening s broken o missing. Pratect tablets from lightto prevent fading. EAALLIIT s STEARATE FILM-COATED TABLETS Btora bekow M, ) Each tablet contins: ERYTHROMYCIN STEARATE oy i TABLETS, USP 25 mg buored it sodum s Erythromycin Usual AdultDose: One tabist 250 MG activity every six hours. See enclosure {ortul prescring nfornaton. Ao Parmaceuticasnc. Borly sator il
6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8_35_1.jpg PRESS 0)fospen iy antelpotiie und shapdbtin e ing Sotn poutlstr aionopnendol el Ol ete e crtad o et e G e Each Tablet Contaln:Buprenarphine hyckochoride USe, cquialent to2mo of buprenorphine base Nalawone hycrochionde Sy USF equvalent 1005 ma ofmloxone base UsualDosage: See pescribing information Storeat 20° 0 25°C (68° 10 77°) 5ee USP Contolled Room Temperature] KEEP OUT OF THE REACH OF CHILDREN TAMPER.EVIDENT: Do ot use thi product f lastcshelis not Intact, lsterbacking appears o be disturbed, orf ncvidual Blster Ut re brokan or ton, CHILD-RESISTANT: Do not separae dosage card fom proective Plastic shell Return card o case afer use RxOnly rocons3isen em Buprenorphine Soinguat bkt e W Distibutedy At P o P Chldren ahoacdetally take this g fevouns poduct il eed emergency medical re. S . Keepoutof theresch of hidren. 3 0228-3154-73 o PHAIACST Dispnsethe accampanying Hediation Gudetoeschpaint, ) Unvarnished Coding Area - (Contains one dosage card of 30 tablets)
6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8_35_2.jpg ETET I al si2(ge). [enbuiigns. I 1 | | uoxojen pue auiydiouaidng | | q D wssiemoon | . 8ma2mg AN Sma2ing RxOnly RxOnly grambiaconsns jEntiy NDC 0228-3155-73 0 NDC 0228-3155-73 I x",m",f B z e ing Buprenorphine Buprenorphine e e and Naloxone and Naloxone izt Sublingual Tablets Sublingual Tablets et mg/2mg 8mg/2mg EE:‘::“;’Z%:% wnevoe: ok Ems Children who acddentally take this drug B s Children who acddentally take this drug Do, ‘product will need emergency medical care. S ‘product will need emergency medical care. B, Keep out of the reach of children. :Vm"’“’”““ Keep out of the reach of children. Sormaat. PHARMACIST: Dispense the accompanying. [ PHARMACIST: ispense the accompanying s etk Medication Guide to each patient. Medication Guide to each patient. 30Tablets (Contains two dosage cards of 15 tablets) 30Tablets (Contains two dosage cards of 15 tablets) ;!!!!ll,
6cf60077-dc91-41e5-8d6f-22589a66e6c5_747_1.jpg nan
6cf60077-dc91-41e5-8d6f-22589a66e6c5_747_2.jpg oz o 095222452 2191 XL '00m YO WIHIANI 1022 —_— _—mmmm "T38V1 191004 SIHL IAON3Y 10N 00 L6121 'SYD u 51 01032 (505) 1aug eieg i) od yBudn 2 Jaye aen as0f) atuey 10N 00 PIoo eamn s pue sy ‘Poojsiapun pue jun apuey jou og. NOLL V00405 Qldvi 381VD GNY NIBAXO 30Y1dS10 AV “ANPNT 6O SNENG 91 “N3DOAKO 3SM1VO AV ‘SO GIVH30I453H SNIVLNOD ‘SNINKYM UBYE| 80 0} SUONESaId 54l PUE 199} 3D U e ssq aney suopneoad ) LLGINN 4N ainbn 031v43914434 ‘NIDOULIN aindI a31vy3viy43y
6d3b4049-2bfd-4874-b984-8fb231bff27c_656_1.jpg € PHARMACIST.Dispense te accomparying Medicaton Guide 0 each patent, NDC 0093-0058-01 1 only 50 mg GTIN 0030093005801 Each tablet cortains 50 mg tramatol ydrochloride, USP. Usual Dosage: See pckage inseit forfull prescriing inormation, Store at20° 1025°C (68° 0 77°F) [See USP Gontrolkd Room Temperatur Dispense n 3 tight, cortaine as dafind in the USP, witn achikresistant losure (3 requied). o KEEP. Rov. L 1212016 Manufacturod In Czoch R Tea Pharmaceuticals US/ North Wales, PA 19454 N 3 0093-0058-01 1
6d8d2c47-95d9-42d2-98d9-98e33b7dc38f_349_1.jpg i eISI 665 U 260 S UOIOS SSOIN 880U 0] | wognps opdesiue sEIns | U sieddors 2001 MBI 181 J8e SIUaLIco Buelsel pEOSp | 0 '10 512 SI00L y LM 10 A2BP IO POOY MO JeIUE, B 5pun | SPTDIE UISIBCD 21fU5 BUSASq SSTOMEEIOESE 851 :ONINEYA | i wnewop Buqwses [ o) s sbexoed se 3OYSOALINGY VSN | sowenesslousuno) | PO UIPOS P SEUOGEIG UNPOS WHM FEINPE | (02 @ GG 86ue)) Hd “s'b uowel) o) Jaem Ul i 1570 9mIS3 Upos ) B 005 Py 30E0SY SR 03 | i i i . - Ascorbic | i . | i i - Aci 1 1 Injection, USP i } 500 mg/mL i i ! For Intravenous, Intramuscular | I orSubcutaneous Use | i i i i i 4FLON ! | (aborotories LC ! NDC: 7141411501 SN: 123456789 Exp: 0510912021 Lot ABG1231A 01 Ay WooSqBOI AN VSN 22009 3N wonia 9T1s0HCIRIqEINOTS 1o} painelnue ONIMYHGHLM NIHM 34¥0 350303 FOVHOLS NON dOT3NI AVI FHNSSIt IO O3 193108 ‘281 ux (un UOYEO U 810K “(4:97 0L %) 9.801:Z NIIM L3 IHOLS. 1 jon, USP 500 mg/mL For Intravenous, Intramuscular or Subcutaneous Use 4FLON Laboratories LLC. Ac Injection, i Ascorbic
6da2c381-057b-456a-b57b-464f8b383371_106_1.jpg [Wh]iEv£ Tablets 10 mg PHARMACIST: Dispense the Medication Guide provided separately to ach patint. 100 Tablets Rx only UPSHER-SMITH Each table contains: Clobazam 10 mg Usual Dose: See package nser for full rscribing information Storage: Stor at20° 1o 25°C (68°to 77°F) [See USP Contraled Room Temperature). Dispense in tight,ght-esstant contaier vith achld-resistan closure. Protec from moisture. KEEP OUT OF REACH OF CHILDREN. Manufactured for UPSHER-SMITH LABORATORIES, LLC Maple Grove, NN 55369 ©2017 Upsher-Smith Laboratories, LLC Made in New Zeakind ||| 1 52-0580-11 725 ROIT
6da2c381-057b-456a-b57b-464f8b383371_106_2.jpg 20 mg PHARMACIST: Dispense the Medicallon Gulde provided separalsly 1o sach pallenl. 100 Tablets | Rx only Eachtabletcantains: Clobazam 20 mg Ustal Dose: See packge inser fr full presciing informition. Storage: Store a 20°t0 257G (68°to 77°F) [5ee USP Controlled Room Temperature]. Dispenseina fght,ight esstant continer witha iresitant losure, Prtect fom mosture. KEEP OUT OF REACH OF CHILDREN. Manufactued for UPSHER-SHITH LABORATORIES, LLC Maple Grove, MN 55369 ©2017 Upsher-Smith Laboratores, LLC Made i Now Zealand 7256 RO6HT
6da96f18-c056-45c2-a1c8-f86484e69d08_454_1.jpg NDC0591-2171-01 Tablets, USP 2.5mg/325 mg PHARMACIST: Dispense the Medication Gulde provided s«p.xatdytn each patient. Hydrocodone Bitartrate and Acetaminophen 100 Tablets EachTablet Contalns: Hydrocodone Bitartrate 25mg. Acetaminophen 325 mg Dispenseln atight ghtresistant contaner witha child-rasstant Closure Keepthisand allmedication out of thareachof hidren. Usual AdultDosage: Oneortwo. tablatsevey ourto sxhours, asnaededforpain. Totaldaiy dosage shouldnot xceed sight tabats. Seeingertforll prescrtinginformaton. Storeat 20025 (681077 (50 USP Catolled Poom Temperatusl, Manufactured by: Warner Chicott Company, LLC Nanat, Puerto Rco00874 Distributad by: ActavisPharma,Inc Parsppany, N 07054 UsA Rev 016 25461 5 I05912I17101|||| 3
6da96f18-c056-45c2-a1c8-f86484e69d08_454_2.jpg V' / nocosar217201 EachTablet Contalns: | S \ [/ ,Hydrocodone (I 2 ] Bitartrate and e | v s meatonont | /Acetamlnophen T o B | ablets every four to sx hours. N~ ‘ Tablets, USP e / 5mg/325mg Ermemees = e o = HARM, Storeat 20710 5°C (8°10 77F) [See s OF / RapeTamene < EmeRee =0 y o [ & ) wpanieiytoeachpatient. \ [ R —— o w 100Tablets prtmeany — ] : b = / Actavis RXONly Ao w | | _ et e
6da96f18-c056-45c2-a1c8-f86484e69d08_454_3.jpg NDC 0591-2605-01 Each Tablet Contalns: Hydrocodone C ey 10 Dispensein atight ghtresstant Parsppony, ) 07054 UsA SRR \ \ \ e e Sresoont Bitartrate and o = | . Keepthisand all medication out o Acetaminophen otereoraen. 2 | it Dosagoroneta e v Tablets, USP e ° | ) B by e | e TN PHARMAGST:Dlspensethe (0 559 Conpaleatoan fampeoted, s i | Medction Guide provided Vaniuced oy =3 separatelyto each patient. 3203 WamerChilottCompany UC e o W 100Tablets Distributed by: =0 | Actavis RXOny At ne | ! \
6da96f18-c056-45c2-a1c8-f86484e69d08_454_4.jpg NDC0591-2612:01 Each Tablet Contalns: drocod . FUTaEE, ona rocodone aminophen 325 mg :,{a,.trate“d C g Acetaminophen S Tablets, USP cveryfourtosihours. s needed for ain Tota dallydosageshould ] g oo Storeat 20025 (681077 [520 PHARMACIST: Dispense the USP Catrolled Room Temperaturel, Medcation Gulde provided Manufactured by: Lty B Jorw SlotCmpmiuc W 100 Tablets Distributed by: Acevis Tl piatnn Parsppony, N 07054 UsA _ e s 4 05912761201 3
6dd657ba-46dc-4106-9f6a-dfa0ecf85752_534_1.jpg Pacbaged by Eryant Ranck. Bunbank. CA 91504 Meclizine Hel |G Mo 12.5mg Tablet 10° L2syTT Store at room temp of Compare To: 20-25 C (68-77F) Aniver 12.5m Tt e r—— #30 Exp: MMYY NDC 7133501531 017891114527 Keep all drugs out of reach of children om
6dd657ba-46dc-4106-9f6a-dfa0ecf85752_534_2.jpg Packaged by Bvyant Ranch Biabanb. CA 950G Meclizine HCL ~ §/®\o"am=! 25mg Tablet 10° May Cause Drowsiness Store at room temp of Compare To: 20-25 C (68-77F) Antivert 25mg Tablet “Keen all drugs outof #90 Exp: MMYY NDC 7133505031 012661113588 88GETT Keep all drugs out of reach o children om
6eaa0a4a-3c0f-48ea-bbc7-0f7a2d2dd3b0_322_1.jpg NDC: 50436-0916-2 CITALOPRAM | HYDROBROMIDE 20 MG MFG BY: TORRENT PHARM 30 TAB 3000000 MEG NDC: 13668-0010-05 sanstc: MG LOT: 000000 Kato ot or psack or cuionex LOT:I00000CK EXP:3000000K SToE AT (20250 ( GOTI'F ) bhg by.Onse bose Sarvicass Lie
6eda7c38-6193-4005-9476-fe0137c36098_286_1.jpg Each Tablet Conts NDC 0228-2980-11 C gzﬁxm;:::n‘ﬁr;lnuaa use. 31155 :g © e i Oxycodone and ;fﬂugmeﬁwmer = ¥ st o S e o e R0 Acetaminophen ST, o sl Dosogesse pckage oubertfor | Tablets, USP rpentietes =3 . Soren 20 BTy 2.5 mg*/325 mg Viheiciions permiledbetien et MULTIPLE STRENGTHS: DONOTDISPENSE (onoladtosmTonpenirs) e O o UNLESS STRENGTH IS STATED. DEA ORDER FORM REQUIRED. = 8 Manshcursa by g M 100 Tablets RCcisesc S Actavis RxOnly Eiesbein 1107207 Ush g Disiuiedb S T o nc = MM WA Pariopony. ) 07054 USA Rev. 04116
6eda7c38-6193-4005-9476-fe0137c36098_286_2.jpg $1118628220500 NILD 58620001 NDC 0228-2981-11 Oxycodone and Acetaminophen Tablets, USP MULTIPLE STRENGTHS: DO NOT DISPENSE UNLESS STRENGTH IS STATED. . 100 Tablets Actavis RxOnly EachTablet Contains: Onycodone Hydrochloride,UsP 5 ma Acctaminophen, USP. s5mg *s mg oxycodone K s quiaknt to 44815 mg of xycodone. Dispenseina tight ght reisant container a5 defined in the USP witha chid esitantcosureas requied) UsualDosage: See package outsert forfullrescibinginformatin. Storeat 20° 1o 25C 68°t0 77 wih excursions permitted between 15710 30°C (55086 sea USP Contoled Room Temperature]. 'DEA ORDER FORM REQUIRED. Manufactured by: Wamer ChikottCompany, LLC Manat Puero Rico00674 Distrbutedby: Actavi Pharm, nc Parsppan NIOTOSAUSA Rev.07/17 5 1 o I ~ | © & ~ 5 A
6eda7c38-6193-4005-9476-fe0137c36098_286_3.jpg EachTablet Contans: NDC 0228-2982-11 C Qe tyiecionde U6 TS mg* Oxycodone and 75ms wraowmnmm\enﬁu ¢ ‘ngofomcocone. Acetaminophen %ﬁ:;::;z;;gmm:azm. Tablets, USP UnilDesagt S pciags ot forfull esbing ot Storeat 2010 5 68 1a77F): Wihexcursons pemited beteen MULTIPLE STRENGTHS: DO NOT 150 S BT e U5F Controlled Room Temperature]. DISPENSE UNLESS STRENGTH IS STATED, Sontolled oo Temperture 100 Tablets Manufactured by: Wormer Chikott Company LLC Mana Pueto Rico 00674 Distrbutedby: Actavs Pharma, I = Parsippany, NIOTOS4 USA Rew.07/17 0228-2982-11 M 21128628220500 NI1D 22050001 3 ke ﬁmmdmnmwmeadnnm
6eda7c38-6193-4005-9476-fe0137c36098_286_4.jpg 611£8628220500 NILD £20£0001 NDC 0228-2983-11 Oxycodone and Acetaminophen Tablets, USP 10mg*/325mg MULTIPLE STRENGTHS: DO NOT DISPENSE UNLESS STRENGTH 1S STATED. . 100 Tablets Actavis RxOnly PHARMACIST: Dispense the Medication Guide provided separately to each patient. Each Tablet Contains: Guycodone Hydrochioride, SP.....10mg* Acctamincphen, UP. 325mg +10mg arycodone HCl s aquivaient to 89637 mgof orycodone. = Dspemsehatghtfontesiant corainr s ckimed the (vith S i esisant dosye psrequied). ——— sl Dospge: sapockageoutertio l pescing nformatin. — Store st 010 25 68 10777 ‘with excursions permitted between —_— T Controlled Room Temperature]. ] DERGRDERFORM REQUIRED: == Nanufactredby: _— WarmerChcot Company LLC = Nanai Puetoico 00974 e Ditbutedby: Reaui Phams, nc Pasppany NIGTOSAUSA Rev 0717 0228-2983-11 N 3
6ee3107c-6cd3-4171-aef7-a7ac033ab3b1_397_1.jpg nan
6f6c592a-6c87-461c-929f-77cba42029c8_720_1.jpg tovarest namu gz gisauny pues 103 Rs 107 NI Bupoaien e umnn ) T dsn ‘uonoaful sulpiwolepawxaq TTEOEBBLSOGN e et T X ST 25X2ML Srgecomeripmopvias NDCSTES430912 | sEachimL contain 118 meg of dexmedetomicine ' T | ydrochioidecquvalent o 100 meg of dexmedetomidine. | i ! ! i 25K2ML Sogetone i vite Dexmedetomidine Injection, USP :ff;:ﬂi:ﬂﬁiﬂﬂfﬂfﬂlﬂ"ﬁnﬂ?“x.7. Dexmedetomidine Injection, USP chemical tabilzers. ph s 450 7.0 Distrbuted by: R Ly Usual Dosage: See package insertfor dosage information. 200 meg (base)/2 mL ‘eVenus Pharmaceutical [ Storage:Soreat 5°C 17, excursions permitted between LN Laborstoresnc, ' Rxoniy 15710.30°C 69"t 867 IS0 USP Controlled oom 1 ! Rconly | 506 Camegie Center, Suie 10, | Forirmenous e [HUSTE DILTED B | emperure] [ foitmvencususe. [WUSTBEDIUTED | rinceton NIOBSH0USA i . Lampungang fangsu 222047, China ! i ! | banctctredy i | Danoas e i o i, 7] ! i Discard unused portion. 1 Sec, Mo yrogenc s Presremsoeree Discard e porson
6f6c592a-6c87-461c-929f-77cba42029c8_720_2.jpg wazy i seauny pues G PR 107 N1LD BupoaRI0 Tt frdn iy 0w LSt e it Ve exmedetomidine Injection, USP 10x2mL single-dose FiptopVials NDC 57884-3091-3 Dexmedetomidine Injection, USP 200 mcg (base)/2 mL (LT CEEs Rx only For Intravenous Use. MUST BE DILUTED Sterile, Non-pyrogenic and Preservative-Free Discard unused portion 7 S0 ‘o3 lul sulpioR@pauNeq ks s L Dexmedetomidine Injection, USP “Each mL contains 118 meg of dexmedetomidine hydrochioride. equivalent to 100 mcg of dexmedetomidine and 9 ma of sodium chloride in water for injection. The solution s preservative-free and contains no additves or chemical stabilzers. pH1s 45 10 7.0. Usual Dosage: See package insert for dosage information. Storage: tore at 25°C (77°F), excursions permitted between 15°1030°C (59°to 867F). [See USP Controlled Room Temperature] Discard unused portion. Manufactured by: Siangsu Hengrul Medicine Co. Ltd, Lianyungang, Jiangsu 222047, China Distributed by: Venus Pharmaceutical Laboratories Inc. 506 Carnegie Cente, uite 100, princeton, NJ 08540 USA 1052 Se-dse i Vs Dexmedetomidine Injection, USP P T [
6f7b7487-e7b3-4255-ab65-a51268f7490f_930_1.jpg Fenofibrate Tablets 145mg Generic for: Tricor Each tablet contains' 145me fenofibrate Pkg Size: Exp Date Lot#. Batch# Ins. Mfg Perrigo New York Inc Prod# W ‘arning 5 S, \“W't" oS 1o B 01 Directions English Take Tablet(s) time(s) a day CAUTION: Federal law PROHIBITS transfer of Aneneen ¢ this drug to any person other than the patient for whom it was prescribed. = = S wo i58 ioD = O'm © iIca .g v £ |9 = > Cada Fenofibrate Tablets 145mg Qy Lot#. Ba# Prod# (NDC) Fenofibrate Tablets 145mg Qu: lns Lot Baté, Prod# (NDC) (F)clmﬁbnllc Tablets 145mg 1ty Insurance NDC Loté: Batd Fenofibrate Tablets 145mg Qu. Ins Lot# Bat# Prod# (NDC) e Chart Log Billing Patient
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_1.jpg ¥S20TS MOT39 'dX3/101 L1/L0°N3Y #S0L0 (N Aueddisieq U] ‘'euniey siAepy :Ag painquisiq ‘2unysiow pue 16| wolj 13101 (4,98 -,65) 406 - 55 | 0} PaRIWLIad SUOISINIX3 {(4,££) I,ST V@ 2I04S | “13UIRJUOD Jue)sisal-ybi| ‘jooidpjiy> Juapins-1adwe) ‘pajeas e ul asuadsiq *UBIPJIY JO el 3y} Jo3no dasy ‘uonedipau e yum sy :bujutep "P3AIOSSIP 10 paysn. ‘pamalp aq JON pInoys sajnsded 95092 -PapUAX djey|ns aulydow wouysya|pd ay | ‘uonewwojul buiquosaid bukueduwiodde 335 :39yS0Q TVNSN ‘sy9|jod aseajai-papuaixa se ajeyns aulydiow bw o | *SNIVINOD 31NSdVI HOV3 -juanjed yoea o) Apjesedas papiroad 3pIng uonedIpa asuadsip sea|d :LSIDYWYYHd ROnly G Extended-Release Capsules, USP g 60 capsules Ine NDC 0228-3501-06 Morph Sulfate
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_2.jpg MO134 'dX3/101 1/£0°72Y #50£0 (N ‘Aueddisied| U] ‘ewieyq snepy :Ag painquasiql “3Injsiow pue 361 Wwoy 131014 (4,98 -,65)! 0€ -5 1 0} PaRIULIRd SUOISINIXA {(4,£) ),ST Je 103! “1aureyuod juesisal-jyby! “Jooidpjiy> quapias-sadwie) ‘pajess e ul asuad m_n_, | “ua1ppyp Jo yeai | auy3jonodasy ‘uonedipatu [je yym sy :burusep! ! vg_gmi ! 10 paysn.p ‘pamayp aq LON PInoys sajnsded, | 35eaRIPAPUBI3 Jjeyns Bu ydiow woy sajjed w.E “uopeuwoju| Buiquosaid Buikuedwonde 335 :39¥S0Q TYNSN| | 's12)j2d aseajai-papuaixa se ajeyns auiydiow bw gz| I *SNIVINOD F1NSdYD HOV3 “juaned yoea 03 Apjesedas papinoad| | 3pIND uonedIP3| 3suadsip 3sea|q:. ...m.U<Ez<In, ROnly G Extended-Release Capsules, USP I mg 60 capsules Ine Morphi Sulfate NDC 0228-3502-06 , | | | | | | | | | |
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_3.jpg .i||1|||4111|4|1| = , | 4, | | % , | | W | [ 7,90£065,£8220,, £ H . lsersae MOT38 dX3/101 [ 121720 Moy 500 (N ueddisieq U ‘ewieyq snepy Ag painqusiq r ‘aunisiow pue 361 woy 330l (4,98 -,65) | 12406 - o1 0} PaRIWLIE SUOISINDXD !(4,££) D57 18 3105 ( “J3ule3u0 Juesisal-jybi| [ I ‘ooidpjiy> quspins-1adwey pajeas e u asuadsiq ( *u3lp|iy> JO Yoeal [ 3y} Jo 30 dady ‘UuonedlpaLl [|e Y3m sy :Bulutep [ ‘PIAJOSSIp 10 paysnid ‘pamaLp aq JON PInoys sajnsded | |2sea21-papuaixa ajeyins auiydiows wioy sajjad 3y “uogeuLojul, || Buqudsaid burkuedwonde 235 :39¥S0A TYNSN | | 's19y12d aseajar-papuaixe se ajejns auiydiow b og| ‘SNIVINOD 31NSdYD HOV3 *juaned yoea oy Ajp3esedas papinoad 3pIng uoped P3| 3suadsip 3se3|d 1SIDYINYYHA S>fl=)o $ 225 3 B8, & gy &gv S s £ 2 =28 g Su%§ E 2823 SAZS
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_4.jpg bng90%06,£82 £ , 20 ! N | | | | | | £520TS MO39 'dX3/101 | | LL/L0 N3y #50£0 [N ‘Aueddisieq | U] ‘eusieyd siaeydy :Ag paanqusiq) | “aIn}siow pue 3y woiy 133014 (4,98 -65)! 240€ - 5§ 0} PanIuLIad SUOISINIXD (/L) J,ST 18 10| “13uIRUOD Juessisal-Jybyyl ‘jooidpjy> Juspina-1adwe} ‘pajess e uj asuadsiq “ualpjiyd Jo ypea! 31 Jo 1n0 daay|‘UoRedIPA [[e YUM Sy &5525“ “PANOSSIP, 10 paysni> ‘pamayd aq JON PInoys sansded; a5eajal-papuaxa ajeyns aulydiow wouy sajjed 3y ‘uojewwopul buiquosaid buikuedwode 335 :39y50Q TYNSN! 'sy9]j2d aseajai-papuaixe se ajeyns aulydiow bw og| *SNIVINOD F1NSdYD HOv3! quaped yoes o} Apjesedss papinoid! 3pIng uonedIpaly asuadsip seaid 1SDYWHYHd! | | | | | | | | | | | | | | | | ROnly G Extended-Release Capsules, USP mg 60 capsules NDC 0228-3504-06 Morphine Sulfate
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_5.jpg 90606, £822 852025 MO138 'dX3/101 L 1/£0 "y 50£0 N “Aueddisieq| U] 'eulieyd SRy :Ag panquisiq "aanysiow pue 3y B woly 1923014 (498 ~65)! 206 - 5§ 1 03 PaRILIRd SUOISINOKG {(4,/£) ),ST 18 240S| “13ujRUOD Jue)sisal-ybil ‘Jooidpiiyp Juapirs-1aduie) ‘pajess e uj asuadsiq' “UaIp|IY> Jo Ypeal 34340 1n0 da3y‘UoNEIIPAU [[B YIIM Sy umc_EmB_ “PaA[OSSIP, 10 paysnud ‘pamay aq JON PInoys sajnsde, 3sea|a1-papua)x@ agyns auydiow woysiajied ay “uoijeuLIojul| Buiquosaid buikuedwodde 335 :39y50Q TYNSNI *s39|jod aseajas-papuaixa se ajeyins aurydiow bui g9l *SNIVINOD 1NSdYD HOV3! quaped yoea 0} Kjpjesedas papinoad| aping uonesipajy asuadsip aseald :ISPYIWYYHJ! | ROnly Morphine @ Sulfate Extended-Release Capsules, uspP 60 capsules NDC 0228-3505-06 60 mg
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_6.jpg 6520-25 MO138°dX3/101 | LL/L0""Y $50£0 N ‘Aueddisieg U] ‘ewieyq siey :Ag paanquysiq “aanysiow pue 3y6i| woiy 133014 (4,98 ~65) 206 - .5 L 03 panLIad SUOISINIXS (4./£) .57 18 310} “J3UIRJUOD JuBsISal-1yb| “Jooidpyiy> Juapirs-1aduie) pajeas e ui asuadsiq ‘UIp|Iy Jo Lpeal 3 Jo 3o daayj ‘uonedipaw [[e yum sy :Buiwiep PaA|OSSIP 1o paysni ‘pamayd aq JON pInoys sajnsde. aseaja.-papua)xe ajejins aulydiow woyy syajed ay) ‘uoljeusioul buiqinsaid buifuedwode 335 :39yS0d TYNSN! | 's12]j2d aseaja1-papuaixa se ajeyns auiydiow Hwi og *SNIVINOD F1NSdYD HOV3 quaged yoea 0} ApPjesedas papinoid wv.:mv uonedpajy 3s :wmm__u ases|d :ISDYWHYHd 3 i 3 O F 3 - Dl g 8 @ Oa S S £ =2 os s Z98¢ £ Qw25 S e g SA5S
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_7.jpg 2 __ooxom £8220 0 ¢ 0920-2§ MO0138 'dX3/101 | LL/L0°NY 50£0 [N ‘Aueddisied U] ‘ewiey siAeldy :Ag panquasiq) “aanysiow pue Jybi| woiy 133014 (4,98 ~65)! 206 - 5§ 03 PanIULIad SUOISINIX® {(4,/) J,ST 12 10N “I3UIRJUOD JUR)SIS3I-) “Jooidp|iy> Juapirs-1aduie) ‘pajess e ui asuadsi “ualpjiy Jo yoeal! 34 Jo 1n0 daay‘uonedIpaw [je Yyim sy :burus m>>“ "PAA(OSSIP| 10 paysnud ‘pamay aq JON PInoys sajnsded, 95e3[21- papua)Xe ajeyins aulydiow woysyvRd 3y, “uoljewoul| Buiquosaid buikuedwonde 335 :39y50Q TYNSNI *SNIVLNOD F1NSd¥D HOV3! quaned yoea o} Apjesedas papinoid| 3pIng uopedIpaly asuadsip aseald :LSDYWHYHd! | « Extended-Release Capsules, USP | I i @é | o = S = & 60 capsules Morphine Sulfate NDC 0228-3507-06
6fe62c06-5bab-4fc8-b546-ff015a1fc40c_202_8.jpg 6, w90805,£822 W 1920-2S MO39 "dX3/101 1 L1/L0°AY +50£0 (N ‘Aueddisieq h u| ‘euwieyq siAey :Ag paanqusiq | “aanysiow pue 3y6i| woiy 133014 (4,98 ~65) 2,06 - o5 | 03 PaRIuLIad SUOISING !(4,££) JST 12 2I0IS “13UlejuoD Jue)sisal-Jybiy | yoosdppy> Juapirs-1aduie) ‘pajeas e ul asuadsiq | “UBIP|IY JO Lpeal I 3y Jo 1no daey ‘uonedipauu jje yum sy :burwepy : PanjossIp 10 paysnId ‘pamayd aq JON pinoys sajnsden, ‘aseajai-papua)xa ajey|ns aulydiow woy sp|Rd ay) . “uoijeuwioyuy Buiquosaid buikuedwonde 335 :39y500 TYNSN [ [s19)j2d aseajas-papuay@ se ajeyns aulydiow bwi 0oz | *SNIVINOD J1NSdYD HOV3 quaged yoes 0} pjesedas papinoid | 3pIND uopedIPa|Y asuadsip aseald :1SDYWHYHJ " | S wn sS{= mmCm 28, 25 So U M% gL 5% = £339 m.:mnw 0=s8a A& =adsd
70156824-e5dd-42b1-9b4f-a49acb28d316_481_1.jpg SobiM RELEASE TABLETS
70156824-e5dd-42b1-9b4f-a49acb28d316_481_2.jpg SoowM 75 ma RELEASE TABLETS
706e7a68-9d0a-48d2-88f6-9d55bbacd83f_108_1.jpg "Pharmacist: Dispense in a tight, light-resistant container with a child-resistant closure. Storage: Store at controlled room temperature, 15°C to 30° C (59°F to 86° F). 3|Ls72 138 116 Manufactured by: Mikart, Inc. | Atlanta, GA 30318 NDC 46672-138-11 Phendimetrazine Tartrate Tablets, USP Reihle 1000 Tablets Rx only Mikart & Each tablet contains: Phendimetrazine Tartrate 35 mg Usual Dosage: 1 tablet (35 mg) two or three times a day, taken one hour before meals. See package insert for complete dosage recommendations. Warning: Keep this and all medications out of the reach of children. Rev. 08/16 Code 698711 )
7098944b-0e23-83b7-e053-2a91aa0ad6f0_147_1.jpg GABAPENTIN GABAPENTIN GABAPENTIN GABAPENTIN T GABAPENTIN S5 || CAPSULES,USP capsuies, Use CArsuLES, USP CAPSULES, Use GhEAPENTIN B o= e G S S=Elurw arv an oTv-an arv-so 300Mg E=| Yty wH,, me B o EE| R BB T ST LOTE XXXRXXX L LO 1 KXOORAXA 1OT# XXXXXXX LOT#XXXXXXX LOT# 3000000 e ety PACIAGED B SP wr, Stmans fargs wganinesin — sy TARAGED PRIRIACY PROGRALS R only STORE AT CONTROLLED ROOM TEMPERATURE 15° 30° G (59"86°F)
7115f8c5-9613-4cdc-8cfe-78ef922c3acb_699_1.jpg fjug xy NDC 59088-701-00 Rx Only ESOMEP-EZS" Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg 30 Capsules Pill Swallowing Spray 2floz/59 mL PharmaPure| = & Rx Only ” [ =T - L = =] 7 Ll Rx Only ESOMEP-EZS" Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg 30 Capsules Pill Swallowing Spray 2floz/59 mL See enclosed Inseri(s) for ull prescribing Inormation Store at 20° 0 25°C (68 to 77°F) see USP Gontrolled Room Temperature] Keep this and all medicatlon out of reach of children st e s s oeusan Pt o Sl CASTID @ Sl e 3 HESGENOTGHN BL3
71614c04-f8b8-d2ed-e053-2995a90a9ecb_23_1.jpg NOC 6076026315 Tizanidine Tizanidine il Tablets USP g 4G g arv: 15 4 MG ° RX¥ 7rrrrm ary: 15 8 NDC 60760 263-15 Lot xoo0x & = | Lome o000 BXPOXXXX @ EXP XX-XX R T MANUFACIURED BY b, PACKAGED BY: Stz Says S lary’s s == OROVALLEY RETT AUAGD HASIACTFROGTAIS Tizanidine Tizanidine Tablets U™ Tablets USP 4MG 4MG arv. 15 arv:1s Rt PO R v NDC 8076026315 DG go760.263.15 LOT#00000X LOTH XKKKIXK. Exp 00X EXP_XXXX TAKE AS DIRECTED MAY CAUSE DROWSINESS iz, Rxonly STORE AT CONTROLLEY ROOM TEMPERATURE 15°- Tizanidine Tablts USP 4MG NDG 6076026315 LOTHXXX00X EXP_xotxx 0° C (59°-86°F)
71815e8f-33ed-4f36-a8ec-d4443151a9d8_585_1.jpg Doxazosin 2 mg Tablet arv: 30 ID #: C7 Expires: NDC #: 70518-1560-00 Shape: Round LOT #: Ref #: 16729-0414-01 MFG: Accord Healthcare, Inc., Durham, NC 27703 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
71cf3309-e182-473c-8b0b-280cabd0e122_588_1.jpg Store at 25°C (77°F); ‘excursions permitied to 15°C-30°C (s9°F-86°F). [see USP Controlled Room Temperature] DOSAGE AND USE See accompanying prescribing infomation © Disbutadty Exai b Wooekif e, NI 07677 701491 NOC62856-272-90 90 tablets Rxonly Fycompa (perampanel) tablets @ ATTENTION PHARMACIST: Dispense the accompanying Medication Guide to each patent L LOT/EXP AREA cmEmine
71cf3309-e182-473c-8b0b-280cabd0e122_588_2.jpg Storeat 25°C (77°F); excarsions permitied to 15°C-30C (S9°F-86°F). see USP Controlied ‘Room Temperature] 'DOSAGE AND USE ‘See accompanying prescribing information © e T 701493 NDC 62856-274-90 90 tables Rxonly Fycompa- (perampanel) tablets @ ATTENTION PHARMACIST: Dispense the accompanying Medication Guide to each patient. LOT/EXP AREA
71cf3309-e182-473c-8b0b-280cabd0e122_588_3.jpg Store t 25°C (77°F); excursions permitied to 15°C-20°C (5°F-86°F). {see USP Controlied ‘Room Temperature] 'DOSAGE AND USE See sccompanying prescribing © i T 701495 :: HTM 90 tablets Fycompa- (perampanel) tablets € bmg ATTENTION PHARMACIST: Dispense the Medication Guide 0 each patient. LOT/EXP o AREA
71cf3309-e182-473c-8b0b-280cabd0e122_588_4.jpg Store t 25°C (77°F); excursions permitied to 15°C-20°C (5°F-86°F). {see USP Controlied ‘Room Temperature] 'DOSAGE AND USE See sccompanying prescribing © i T 701495 :: HTM 90 tablets Fycompa- (perampanel) tablets € bmg ATTENTION PHARMACIST: Dispense the Medication Guide 0 each patient. LOT/EXP o AREA
71cf3309-e182-473c-8b0b-280cabd0e122_588_5.jpg Store t 25°C (77°F); excursions permitied to 15°C-20°C (5°F-86°F). {see USP Controlied ‘Room Temperature] 'DOSAGE AND USE See sccompanying prescribing © i T 701495 :: HTM 90 tablets Fycompa- (perampanel) tablets € bmg ATTENTION PHARMACIST: Dispense the Medication Guide 0 each patient. LOT/EXP o AREA
71cf3309-e182-473c-8b0b-280cabd0e122_588_6.jpg Store t 25°C (77°F); excursions permitied to 15°C-20°C (5°F-86°F). {see USP Controlied ‘Room Temperature] 'DOSAGE AND USE See sccompanying prescribing © i T 701495 :: HTM 90 tablets Fycompa- (perampanel) tablets € bmg ATTENTION PHARMACIST: Dispense the Medication Guide 0 each patient. LOT/EXP o AREA
71cf3309-e182-473c-8b0b-280cabd0e122_588_7.jpg 1] Ju/bw g0 i NOISNISNS W40 (Buediuessd) Duyoady =y s o | Fycompar ‘ (perampanel) ORAL SUSPENSION a 0.5 mg/mL PR — [LTeyerer———— P 340 mL [ S JRSe—— NOISN3dSNS TvHO (eueduesad) Schuoody Dateofstopeniog__/_/_. Discard unsed porbon 90 days st st opening. D0 ot sore sbowe 3°C (67 D0 ot ez, DOSAGE AND USE Sea ccompanyig prescrting mormasen 02018 Emi sostse2us 1 [— mowy pa (perampanel) ORAL SUSPENSION @ 0.5 mg/mL By T [P P —— T (R ——— e 8 [ > JO— < Q
71e087d2-b148-444d-b2d7-09a4cd3d228f_980_1.jpg WARKING: For emer e By t ey s oy hen agTe by ngted For aloter medica appications, R al. Ut p oo 08 X ‘montorin ts efect o oygen cotet breathg uniess vsed ih o s e R L NTENSIFY FRE; OKQIZER. CONTAY rcations a2 8 e vavesand itigsfe hom TSt ki sftodoso. e 10 of consuction and reed 10 siowy.Ciose vaie fief 0 SE o Data et 8 (25'F). Read and oo e S
71e087d2-b148-444d-b2d7-09a4cd3d228f_980_2.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED Liquip usp UN1073 LtRs: ] CONTENTS: _ = cuFt[]) WARNING: For emergency use only wihen administered by properly trained persommel for oxygen deficency and resuscilation. For all other ‘medical applications, B, only. Uninterrupted use of high concentra- tions of oxygen over a long duration, without moitoring tseffect on xygen content o arerial blood, may be harmful. Do not atemp o use on patients who have stopped breathing unless used in conjunc- tion with resuscitative equipment. Keep out of reach of chidren. Federal law requires that this container be reiled with oxygen USP only by establishments registered as a drug manufacturer in accordance with the Federal Food, Drug, and Cosmetic Act. Produced by Air Liquefaction. DANGER: ~ MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS REFRIGER: ATED GAS: MAY GAUSE CRYOGENIC BURNS OR INJURY. COMBUS- TIBLES IN CONTAGT WITH LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. Do not handle unti all salety precautions have been read and understood. Keep and store aviey from clothing and other combustible materials. Keep valves and fiings free from grease and oi. Use and stre only outdoors or in a wel-ventiated place. Wear cold insulaing gloves, face shied, and eye protecton. In case of fire: Stop leak i safe 10 do so. Use a back low preventive device n the piping. Use only with equipment of compatible mateials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. DO NOT change or forc fit connections. Avoid spills. Do not walk on or roll equipment over spils. Close vlve after each use and when emply. Aluays keep contaner in upright position. Read and folow the Safety Data Sheet (SDS) before se. FIRST AID: IF ON SKIN: Thaw frosted parts with lukevarm water Do not rub affected area. Get immediate medical advicefattention CAS: 7780-44-7 DO NOT REMOVE THIS PRODUCT LABEL MINNEAPOLIS OXYGEN COMPANY 3842 WASHINGTON AVENUE, N « MINNEAPOLIS, MN 55412 612-588-8855
71e90e1c-a6b6-4726-93aa-59cf9efc85cf_591_1.jpg WM ~u109 FUROSEMIDE INJECTION, USP 40 mg/4 mL (10 mg/mL) 5 x 4 mL SINGLE-USE VIALS FOR INTRAVENOUS or INTRAMUSCULAR USE. Sterile, nonpyrogeric. Each mL contains furosemide 10 mg; sodium chloride sufficient {o render solution isctonic. Sontains sodium hydroxide ‘and may contain hydrochloric acid for pH adjustment pH9.0 (8.0t 93). Usual Dosage: See product insert fer prescribing information, precautions and warmings. Use Aseptic Technique. Remove cover from fiptop vial and cleanse stopper with antiseptic. 'STORAGE: Store at 20 to 25° C (6€ to 77° F). [See USP Controlled Room Temperature.] Discard unused portion. Frotect from light Do ot use if solution is discolored or contains particulate RX ONLY WARNING: This Uit Dose package is not chid resistant nd is Intended for Institutional Use Only. Keep this and all drugs aut of the reach of children. Manufactured by Hospira, Inc., Lake Forest, IL 60045 USA M+ and NOVAPLUS are registered trademarks of Vzient, Inc. NOVAPLUS® Distributed by Cardinal Healtn Dublin, OH 43017 51706340318 LoT : XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
71feffd5-4056-2b53-e053-2995a90a5b73_246_1.jpg icorpareied " icorpordied icarpardicd 7 icorpareied 7 Tacorpareied , USP INDAPAMIDE taBLETS 100 tablets See package insert for dosage information Store 3120710 25°C (@871 77°) (526 USF Cantaled Roam Tempersture] 1 S < N 2 ~ o < - 0 Q 0 =z 5140702401 - Eachtablet contains: Indapamide USP 195 mg Keep containertightly closed. Avoid excessive heat. . Dispense in a tight, light-resistant container as defined in the USP using achild-resistantciosure . KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Manutactured by AN Pharmacautiols, Ine Baudete, N 50623 Packaged by GSMS, Incorporated Camailo, CA 83012 USA.
71feffd5-4056-2b53-e053-2995a90a5b73_246_2.jpg NDC 51407-025-01 INDAPAMIDE TABLETS, USP 100 tablets See package insert for dosage information. [See USP Gontroled Room Temperatur], 5140702501 » Each tablet contains: Indapamide USP ... 2.6 mg « Keep container tightly closed. Avold excesslve heat. » Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. « KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. 3 L 8 S & 9 i S %] O B S 8 S g 9 & = O ™ X 8 S & 9 & = % O R 3 s S E S 5 S s O B L 8 S £ 9 5 S %] O Manufactured by ANI Pharmaceuticals, Inc. Baudette, MN 56623 Packaged by GSMS, Incorporated Camarlllo, CA 83012 USA
723b16bd-274d-a29e-e053-2991aa0abd63_417_1.jpg NOC B0760-824-15 __ Celecoxib Celecoxib Celecoxib Celecoxib Capsules Capsuies Capsules Capsules g o 200m 200 mg mg £ e e e arvos o A T Brien | o D arv e oo R S s 8 S s R 807 e B 0o i e oo PACKAGED 8Y: ST Sy Jargs s, — s MANAGED PRARMACY PROGS s
7276cfbf-294d-464d-b8f4-e33da8a15658_254_1.jpg Do Kot NoC0527-221537 INTERCHANGE: Fomulafions equivalent w = ot s Metolazone S -+ USP,or o Zgoxayn i Tablets, USP N N2 sfiould nof be techonged g e (502 pucknge drculo). m o INDICATIONS & 2 DOSAGE: _ 9 See pockage dicl. sibutd by: BeOnl Lopng Compony_ne. 100 TABLETS Philadelphia, P4 19154 Stare at 25°C 77°R); excusions pemitted fo 15°30°C (59°86°F) [See USP Controlled Room Temperotte]. Pofed from ight. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18
7276cfbf-294d-464d-b8f4-e33da8a15658_254_2.jpg 22250ms 28912 Do NoT INTERCHANGE: mulafions equivalent mefolozone fablefs, P ot fo Tarokahn®, ond formulations equivalent fo Mykiox® should it be inerchonged see package circlon). INDICATIONS & SAGE: e podkage dialar Distributed by: Lonnett Company, Inc. Phladelpin, P4 19154 Metolazone Tablets, USP R iy 100 TABLETS DC 0527-2218:37 Store @t 25°C (77°F); eauisions permitted fo 15°30°C (59°86°F) [See USP Controlld Room Tempenture. Potect fom fof. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18 L67878
7276cfbf-294d-464d-b8f4-e33da8a15658_254_3.jpg Do xot NoC 0527-221737 Stare of 25°C (77°F); g TROMNCE s pened 1 15°30°C (59°86°F) S iy Metolazone [ 19 ol Roor d farmulaf ‘ Temperature]. Potect o Tablets, USP Fis o n should not be nterchanged the reach of children. T e o O 10 mg : INDICATIONS & o DOSAGE: 5 - 2 See pocoge . £ 2a Dbt by: B nly g g3 < Lomnett Compony, e, 100 TABLETS 2 EG Phlodlti, P4 19154 Lannett
7276cfbf-294d-464d-b8f4-e33da8a15658_333_1.jpg Do Kot NoC0527-221537 INTERCHANGE: Fomulafions equivalent w = ot s Metolazone S -+ USP,or o Zgoxayn i Tablets, USP N N2 sfiould nof be techonged g e (502 pucknge drculo). m o INDICATIONS & 2 DOSAGE: _ 9 See pockage dicl. sibutd by: BeOnl Lopng Compony_ne. 100 TABLETS Philadelphia, P4 19154 Stare at 25°C 77°R); excusions pemitted fo 15°30°C (59°86°F) [See USP Controlled Room Temperotte]. Pofed from ight. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18
7276cfbf-294d-464d-b8f4-e33da8a15658_333_2.jpg 22250ms 28912 Do NoT INTERCHANGE: mulafions equivalent mefolozone fablefs, P ot fo Tarokahn®, ond formulations equivalent fo Mykiox® should it be inerchonged see package circlon). INDICATIONS & SAGE: e podkage dialar Distributed by: Lonnett Company, Inc. Phladelpin, P4 19154 Metolazone Tablets, USP R iy 100 TABLETS DC 0527-2218:37 Store @t 25°C (77°F); eauisions permitted fo 15°30°C (59°86°F) [See USP Controlld Room Tempenture. Potect fom fof. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18 L67878
7276cfbf-294d-464d-b8f4-e33da8a15658_333_3.jpg Do xot NoC 0527-221737 Stare of 25°C (77°F); g TROMNCE s pened 1 15°30°C (59°86°F) S iy Metolazone [ 19 ol Roor d farmulaf ‘ Temperature]. Potect o Tablets, USP Fis o n should not be nterchanged the reach of children. T e o O 10 mg : INDICATIONS & o DOSAGE: 5 - 2 See pocoge . £ 2a Dbt by: B nly g g3 < Lomnett Compony, e, 100 TABLETS 2 EG Phlodlti, P4 19154 Lannett
7276cfbf-294d-464d-b8f4-e33da8a15658_729_1.jpg Do Kot NoC0527-221537 INTERCHANGE: Fomulafions equivalent w = ot s Metolazone S -+ USP,or o Zgoxayn i Tablets, USP N N2 sfiould nof be techonged g e (502 pucknge drculo). m o INDICATIONS & 2 DOSAGE: _ 9 See pockage dicl. sibutd by: BeOnl Lopng Compony_ne. 100 TABLETS Philadelphia, P4 19154 Stare at 25°C 77°R); excusions pemitted fo 15°30°C (59°86°F) [See USP Controlled Room Temperotte]. Pofed from ight. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18
7276cfbf-294d-464d-b8f4-e33da8a15658_729_2.jpg 22250ms 28912 Do NoT INTERCHANGE: mulafions equivalent mefolozone fablefs, P ot fo Tarokahn®, ond formulations equivalent fo Mykiox® should it be inerchonged see package circlon). INDICATIONS & SAGE: e podkage dialar Distributed by: Lonnett Company, Inc. Phladelpin, P4 19154 Metolazone Tablets, USP R iy 100 TABLETS DC 0527-2218:37 Store @t 25°C (77°F); eauisions permitted fo 15°30°C (59°86°F) [See USP Controlld Room Tempenture. Potect fom fof. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18 L67878
7276cfbf-294d-464d-b8f4-e33da8a15658_729_3.jpg Do xot NoC 0527-221737 Stare of 25°C (77°F); g TROMNCE s pened 1 15°30°C (59°86°F) S iy Metolazone [ 19 ol Roor d farmulaf ‘ Temperature]. Potect o Tablets, USP Fis o n should not be nterchanged the reach of children. T e o O 10 mg : INDICATIONS & o DOSAGE: 5 - 2 See pocoge . £ 2a Dbt by: B nly g g3 < Lomnett Compony, e, 100 TABLETS 2 EG Phlodlti, P4 19154 Lannett
7276cfbf-294d-464d-b8f4-e33da8a15658_999_1.jpg Do Kot NoC0527-221537 INTERCHANGE: Fomulafions equivalent w = ot s Metolazone S -+ USP,or o Zgoxayn i Tablets, USP N N2 sfiould nof be techonged g e (502 pucknge drculo). m o INDICATIONS & 2 DOSAGE: _ 9 See pockage dicl. sibutd by: BeOnl Lopng Compony_ne. 100 TABLETS Philadelphia, P4 19154 Stare at 25°C 77°R); excusions pemitted fo 15°30°C (59°86°F) [See USP Controlled Room Temperotte]. Pofed from ight. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18
7276cfbf-294d-464d-b8f4-e33da8a15658_999_2.jpg 22250ms 28912 Do NoT INTERCHANGE: mulafions equivalent mefolozone fablefs, P ot fo Tarokahn®, ond formulations equivalent fo Mykiox® should it be inerchonged see package circlon). INDICATIONS & SAGE: e podkage dialar Distributed by: Lonnett Company, Inc. Phladelpin, P4 19154 Metolazone Tablets, USP R iy 100 TABLETS DC 0527-2218:37 Store @t 25°C (77°F); eauisions permitted fo 15°30°C (59°86°F) [See USP Controlld Room Tempenture. Potect fom fof. Keep out of the reach of children. PT# CIPT0119 Rev. 08/18 L67878
7276cfbf-294d-464d-b8f4-e33da8a15658_999_3.jpg Do xot NoC 0527-221737 Stare of 25°C (77°F); g TROMNCE s pened 1 15°30°C (59°86°F) S iy Metolazone [ 19 ol Roor d farmulaf ‘ Temperature]. Potect o Tablets, USP Fis o n should not be nterchanged the reach of children. T e o O 10 mg : INDICATIONS & o DOSAGE: 5 - 2 See pocoge . £ 2a Dbt by: B nly g g3 < Lomnett Compony, e, 100 TABLETS 2 EG Phlodlti, P4 19154 Lannett
72e5ae2e-efb4-4ac9-9b43-4aac600334c9_545_1.jpg Image unavailable
72e5ae2e-efb4-4ac9-9b43-4aac600334c9_545_2.jpg Image unavailable
72e5ae2e-efb4-4ac9-9b43-4aac600334c9_545_3.jpg Image unavailable
7332ea0c-a7ff-cca0-4c47-39c721b47edd_703_1.jpg (d) £1/90 "3 AV 00-6102: Lv8E NI, U] ‘FHVIY 10} painoejauely SNEHOIHO 40 VU 40 100 ) 18ujejuCa JuEls! woneuoyul 1onpoud ajeidwos U 6eoed 695 :39¥S00 VNN uejUend bus | pOip/y aupejueng SUIR03 10|08 (2e3 01 uBteAba dgN o ine uspP Rx Only Guanfac Tablets, 90 Tablets l
7332ea0c-a7ff-cca0-4c47-39c721b47edd_703_2.jpg (d) £1/90 “noy AY 00-G102-LL "y DN 10} panaejnuely NIHOTIHO 40 HOVZH 40 10 d33) “1ourejuca Juersisal-y 140y & vy esuasig “[aimeiaduia) wooy pejjonuo] SN 298] (4oL 01589) 9.52 0 .02 ¢ 210} uoleuoyul 10npoId alalduwod 104 asu| abexoed 295 39¥S00 TWNSN aupejuend Bus 2 01 3uBRAINDE 4SN ‘BPUOYICIPAY BuIdBUENY 09 J9]qe} Yoe3 i o z 2 E3 @ ¢ < 9 @ ¥2a §ES 2 5 B= s 235 & o8 8 l
736c9b80-682c-4cda-bf18-61b18de0bd39_188_1.jpg B3I US|UIeA UOU 2190 woommuns AN “aiens auydious bu g SUIEIOD ) palRo2-Ul) oe3 e TR @.Ms 82 m = &s. = T it = C s Dme 2 @ EEs: O S W HETE g SEmapdzce 8 WM.I BEE o ] E85-2 = ESSEs st Eg=s = = a8 Manuactured by Ohm Laboratories Inc New Brunsvick, N 08901 Ditributed by Sun Phamaceutial Industries, I (. Cranbury, N 08st2 N ¢
736c9b80-682c-4cda-bf18-61b18de0bd39_188_2.jpg wcssdsto @ MORPHINE SULFATE EXTENDED-RELEASE TABLETS Wie _ohm 5142853 sllle3S0%la s 101 non varnish area s vt vant sungbamacom, 4
736c9b80-682c-4cda-bf18-61b18de0bd39_188_3.jpg BAIB USIUIRA UOU e g sbesa) ) 450 s oo B 09 A0S e PN 3 ncssn 75801 (@ TABLETS ohm* ATONON s Dme ook el o e Axonly EXTENDED-RELEASE oy it e = = = 2 £ = g 2 00 Tabes e Brunewc N g0t Diibutty: S Pharmatetc Industies, b, Coanbury, U 08512
736c9b80-682c-4cda-bf18-61b18de0bd39_188_4.jpg NDC 63304-452-01 @ MORPHINE SULFATE EXTENDED-RELEASE TABLETS ATTENTION DISPENSER: Dispense the accompanying Medication Guide to each patient upon dispensing* 5142855 10680 N 0 Swallow tablets whole. istant container. ee USP £ g 0° -25° C (68° - 77" non varnish area Rx onl 100 Ta{llels ehm’ 5% £3 8g BE EH zE éﬁ ES = Dispenseina Us! pre Do
736c9b80-682c-4cda-bf18-61b18de0bd39_188_5.jpg eale ysiulen uou 5142856 “00UM SJ2]} MO|[EMS Buifuedwoooe dsn ‘ajeyins suiydiow bw gz SUIEIUOD J3{qE} Pajeod-ul Yoe3 e MORPHINE SULFATE RELEASE TABLETS ohm"” NDC 63304-453-01 to each patient upon dispensing* ATTENTION DISPENSER: Dispense the accompanying Medication Guide EXTENDED- Rx only 100 Tablets 0617
741ff3e3-dc1a-45a6-84e5-2481b27131aa_881_1.jpg 3 0310-0668-60 7 Each tablet contains 100 mg of olaparib, USUAL ADULT DOSAGE: See package insert. Keep out of the reach of children. Store at 20°C 0 25°C (68°F to 77°F), excursions permitted 10 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in original bottle to protect from moisture. AstraZeneca Do NOT take more than 4 Tablets a day. 60 Tablets Rx only Lynparza- (olaparib) tablets ‘Attention: Lynparza Tablets and Capsules are NOT substitutable. NDC 0310-0668-60 00-00000 LYNPARZA is a trademark f the AstraZeneca group of companies. © AdtrazZeneca 2017 Mfd. for. AstraZeneca Pharmacsuiticals LP, Wimington, DE 19850 By: Abble Deutschiand GmbH and Co. KG, Knolstrasse, 67061 _ Ludwigshafen, Germany ] Bt ot e GTIN 00303100668607
741ff3e3-dc1a-45a6-84e5-2481b27131aa_881_2.jpg NDC 0310-0 2 Lynparza- (olaparib) tablets Attention: Lynparza Tablets and Capstles are NOT substitutable. Do NOT take more than 4 Tablets a day. 120 Tab 221629001£0£00 NILD 110U D 00 PUB H 00000-00 AstraZeneca 1l 8Beel £ 2L-6290-0150 2
741ff3e3-dc1a-45a6-84e5-2481b27131aa_881_3.jpg 3 0310-0668-12 6 Each tablet contains 100 mg of olaparib. USUAL ADULT DOSAGE: See package insert. Keep out of the reach of children. Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperaturel. Store in original bottle: fo protect from moisture. Attention: Lynparza Tablets and Capsules AstraZeneca are NOT substitutable. Do NOT take more than 4 Tablets a day. 120 Tablets Rx only Lynparza* (olaparib) tablets NDC 0310-0668-12 LYNPARZA s a trademark of the AstraZeneca group of companies. © AstraZeneca 2017 Manufactured for: AstraZeneca Phamaceuticals LP, Wimngton, DE 19850 By: AbbVie Deutschland GmbH and Co. KG, Knolistrasse, 67061 Ludwigshafen, Germany Product of Switzerand 5 GTIN 00303100668126 00-00000
741ff3e3-dc1a-45a6-84e5-2481b27131aa_881_4.jpg Attention: Lynparza Tablets and Capsules are NOT substitutable. Do NOT take more than 4 Tablets a day. o1 (=] N = wn 8 ) o © B ° = D a - < 00-00000 | Gt the AsiraZeneca group of
74355cd2-b50e-0dc2-e053-2a91aa0aa164_372_1.jpg TABLETS, USP 50 mg 100 tablets See package insert for dosage information. ACETATE 2w o ®A 52 N — §3 ol O A L Z Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. 5140701801 » Each tablet contains: Flecainide Acetate USP ... 50 mg * Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). * KEEP THIS AND ALL MEDICATION OUT] OF THE REACH OF CHILDREN. Manufactured by ANI Pharmaceuticals, Inc. Baudette, MN 56623 Packaged by GSMS, Incorporated Camarillo, CA 93012 USA s X S S & 3 R S A O R X 8 S & 3 5 S A O R X s S & 3 5 S A O ™ X 8 S & S 5 S A O ™ X S S & S S S A o
74355cd2-b50e-0dc2-e053-2a91aa0aa164_372_2.jpg NDC 51407-019-01 FLECAINIDE ACETATE TABLETS, USP 100 mg 100 tablets See package insert for dosage information. Store at 20° [See USP Controlled Room Temperature]. 5140701901 « Each tablet contains: Flecainide Acetate USP ... 100 mg » Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). « KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Manufactured by ANI Pharmaceuticals, Inc. Baudette, MN 56623 Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
74355cd2-b50e-0dc2-e053-2a91aa0aa164_372_3.jpg NDC 51407-020-01 FLECAINIDE ACETATE TABLETS, USP 150 mg See package1 inosgrtlll:‘oartgt!seagf information Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. 5140702001 » Each tablet contains: Flecainide Acetate USP ... 150 mg * Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). * KEEP THIS AND ALL MEDICATION OUT| OF THE REACH OF CHILDREN. Manufactured by ANI Pharmaceuticals, Inc. Baudette, MN 56623 Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
74702340-19bf-467e-80cd-68dca9d374d2_296_1.jpg £ Each film-coated tablet contains: Dispense in a tight ight-resistant = = P 05r 1 ke el (ot T oo § S Paliperidone s sees — @ Extended-Release — Tablets Store 31 20° 10 25° (8° 0 7T, M= tpe 52 Contled s I E 4 Protect from maisture. 0! H r.m,nm be wallowed widle. e s il 1 5 Donot i, cruh,orchew. g Awiistion o = Papeidone ccnderlase ok Mylan Pharmaceutials . e g2 shoubetaken Norgann ) 505U SA ‘once daiy. » - i 7 [[MMylan @Mylan: O Mylancom |
74702340-19bf-467e-80cd-68dca9d374d2_296_2.jpg £ N 6 £6=6165=8/50 Each flm-coated ablt contais: Paiperidone, USP O 10T ARAXION AT Y S ORI 3mg usinga chidesitantclosure. Pahperldone i G Extended-Release X mdallned LA m;:z:zw:;:@g : Tablets Sora st 20 10257 (80T, u See USP Gontroled Room, PD3 Temperature ] Pt rm . i S8 ol sk sl wick. R e e e o e Nkt i e day. Mylan® My [MMylan® Rx only 30 Tablets Mmav\ com
74702340-19bf-467e-80cd-68dca9d374d2_296_3.jpg € N Ech i costed sl oo Depersen st it st = P U5 s MAAkA A Coiore o dnc e e g = Paliperidone s omsmrigsy o Extended-Release Yoo tisand all medication Tablets Store ot 20° 0 25° (8 1 7). . See USP Gontroled Room Temperature.] Protect from moisture i E £6-086£-8/20 XY 10T ASAXIONAXT Usual Dosage: See accompanying r.msnmu beswallowed whole. Do no divide rush, or chew. :y":::’:ml:::u £ Paprn e s et e once daiy. @ Mylan® Mylan” L0 EREL BN Mylan.com S
74702340-19bf-467e-80cd-68dca9d374d2_296_4.jpg € N Fineoise oy ML Rl e i e = == 4 : using a child-resistant closure. g o Paliperidone ‘amcwnes 2 g o e g i & $;gé?ded Release ot moeatoromiae = s v et ) — B Gt 9 o e 00 < Protect from moisture. e —— Tablesshouid be swalowed whole. el D o moctivatyiny | — ey sresrbin fomatn. & seiaclee . RS = o B weair () Mylan® z
7483423c-695c-4b62-b3cd-4e475f30b857_840_1.jpg Tretinoin Cream, For Topical Use Only Usual Dosage: See package insert. Store below 80°F. WARNING: Keep out of reach ofchldren. Manutschured or: Sper Demaology Products Randol, 1 07660 USA By:sleant Parmaceuticls nrnatonal, . Lol uebee H7L 45, Canaa Prodetof Canada 57730 Tretinoin Cream, For Topical Use Only Usual Dosage: See package insert. Store below 80°F. WARNING:Keepau of rach of chidrn. Each gram conain:Tretinin 0.025%, st acd Eopmop myist, polyony 40 et eyl aloha,sarthan qum, soricacid, byt ydroytolene, nd prfed wate. Important The opeingof this rouct s coered by metl el I s el has been punchured o & nat i, donot s and retumproduct o pace of urchase. o Open: T puncte theces revese the cap and placs thepunchieto ottt Push down fy ut sl open.To e, st hecapback ot the ube. Rev.04/17 3! 66530|25345 & NG 66530-253-45 Rx only NetWt. 45 g NDC 66530-253-45 Rx only NetWt. 45 g s01081640.
7483423c-695c-4b62-b3cd-4e475f30b857_840_2.jpg SPEAR s Tretinoin Cream, 0.05% For Topical Use Only Wi Usual Dosage: See package insert Store bekow 80°F. ly WARNING: Keep autof each of chicren. NetWt. 45 g - Monuacurd o Sper Domaogy Prodcts Fandopn 07663 (5A By:Valeant Phamaceuticals International, nc. K Ul G L 48, Cort Proetof Cansts s [ 3 q NDC 66530-254-45 Tretinoin Cream, 0.05% ey Ry WARNIN: Keep oot of each o sidrn. Net Wt. 45 g Exch gram contains: Tetoin 0.05%, steric aci,sopropy| mytstte,polyoy| 4 terte, ety bl carifun gum, ortic acd,bultedhyirytoluen, and urfed wate: Important:Th opning of s prductis covred by a mea sl s sl has b purctured r ot vible,do 1o sz and retu product o placeof urchase. ToOpen: Topurcure the s, eerss hecap and pcethe puncure-oportothe e, Push down iy unlsal s open. To dos,scren the cap ack ot b,
7483423c-695c-4b62-b3cd-4e475f30b857_840_3.jpg NG 025840 Tretinoin Cream, 0.1% For Topical Use Only. Usul Dosage:See pockage insert.Sore below OO'F. WAMING: Kop autof reoch ofcikden. Manufactured or: Sper Demnaology Poducts Randolp, 107060 USA By:leant Parmaceuticals nrmatonal . - Uil bz 7L 440, Canaa Prodctof Canada i s ! hevur 3 5545118 6653 NoC 66500 255 45 Tretinoin Cream, 0.1% For Topical Use Only Rxonly Usual Dosage: See package inset Store helow 80'F. NetWt.45 ¢ Each gram contains:Trinin 011, stearic i, sopopl myritte, ooyl 4 tarte, eyl loha, sathan gum,sric aci, bty ydroytohene, nd purfed et 1 Important The opeingof tis roduct s coered by metl e, i el has boen punchred o & not i, g0 0o s ardreumproduct o place o urchase. o Open: T unchre e sl rewese o e plac he o et 1 Pushdown iy uni el ope.Tocase s e cap back s the e
7483423c-695c-4b62-b3cd-4e475f30b857_840_4.jpg | — 1 SPEAR Tretinoin Gel 0.01% For Topical Use Only Usual Dosage: See package insert. Store below 86°F. Rx only WARNING: e outof reach ofchidren, NetWt.45 g '66530%25645'™ s Manuscusd for. SparDumtlgy Pt Rl N 07863 5 3 o Wt Promacascs st o L Gusbechr. o, Conni Protutof Gt SPEAR Tretinoin Gel 0.01% For Topical Use Only Usual Dosage: Se package insert. Store blow 86°F. WARNING: Keep out of reach o hildren. Ench gram containe: Tretinoin 0.01%n gel veice of byt hycoytouene, hyoxypropylcelose rea for ‘and alcohol (denatured with tert-buty alcohol and brucine sulfate) 90% wiw. Are Rl Important: The peningof s prouct i coered by a metal sl I s seal has been Serial ialization punctured or is not visible, do not use and retum product to place of purchase. ot/Exp ‘o Open: To punciurethe sea,reverse th cap and lacethe punctre-top oo the ube, Lot Pushdown ol ur see i open. Toclos,screw the cap backcno the b
7483423c-695c-4b62-b3cd-4e475f30b857_840_5.jpg / p—— SPEAR [a—— Tretinoin Gel 0.0257 For Topical Use Only Ustual Dosage: See package inset. Store below S5°F. Rx only. WARNING:Keepau of rach of chidrn, Net Wt. 45 g Manutctrd o ‘Spar Doy Pt o, ) 0720 5 sr ot Promocauics szt . Lo, Ot 7. 468, Cra Pt of o g 3! 2 s s 5745 SPEAR Tretinoin Gel 0.0257 For Topical Use Only Ustual Dosage: See package inset Store below 85°F. Rx only WARNING:Keepautofreach ofciren. NetWt. 45 g Each am conins Teiin 0.025% in e velic ofbutedhyirytsire, hydmoypopyl olubse andscoldenaturd with et alohol and brcin sl 0% wiv. Itk Ths coering of s rodut i oveed by et . is s e T et ol o o . To Open: Topuncure the eareveseth capand place the purctare-op oo th e, Push downfrly ] o s cpen. Toclsescre thecap backoto the e,
74c092e7-126c-57e3-e053-2a91aa0a6b94_327_1.jpg ‘CAUTION: fadoal Law PROHIBITS he uansie o tis drug o anyons oher then the person whom proscried and prohibts cipansing wihouta pescrpton, Unises OTC. S ouaer foracd] ix . KEEP GUT OF REAGH OF CHILDHEN Stors i & 05l iy place ot 65-77 F uniass prites e, 52959-0103-00 GENTAMICIN OPTH - SOL GENTAMICIN OPTH - SOL 5mi NDC: 52958-0103-00 arv:sm Exp. 0000 Lots: ABOOCD MFG NDC 17476.0283-10 Gompare: Garamycin Exp. 00100 Lot#: ABOOCD MIg. AKORN 17478-0283-10 GENTAMICIN OPTH - SOL AACCOUNT: 00-0000 NDC: 52968-0103.00 Exp. 0000 Use As Directed by Physician MFG NDG 17478-0283-10 GENTAMICIN OPTH - SOL. NDC:52059.0103.00 arv:sm g Lot#: ABOOCD MFG NDC 17476-0283-10 T GENTAMICIN OPTH - SOL NDG: 52958.0103.00 arv:sm Exp.0000 Lots: ABOOCD MFG NDC 17478-0283-10 Ropack:H.J. Harkin Co. In. Grover Bsach, CA 03433
74c3a01e-9451-0f2f-6aab-8348047cb1f5_889_1.jpg ‘CAUTION: fadoal Law PROHIBITS he uansie o tis drug o anyons oher then the person whom proscried and prohibts cipansing wihouta pescrpton, Unises OTC. S ouaer foracd] ix . KEEP GUT OF REAGH OF CHILDHEN Stors i & 05l iy place ot 65-77 F uniass prites e, 52959-0103-00 GENTAMICIN OPTH - SOL GENTAMICIN OPTH - SOL 5mi NDC: 52958-0103-00 arv:sm Exp. 0000 Lots: ABOOCD MFG NDC 17476.0283-10 Gompare: Garamycin Exp. 00100 Lot#: ABOOCD MIg. AKORN 17478-0283-10 GENTAMICIN OPTH - SOL AACCOUNT: 00-0000 NDC: 52968-0103.00 Exp. 0000 Use As Directed by Physician MFG NDG 17478-0283-10 GENTAMICIN OPTH - SOL. NDC:52059.0103.00 arv:sm g Lot#: ABOOCD MFG NDC 17476-0283-10 T GENTAMICIN OPTH - SOL NDG: 52958.0103.00 arv:sm Exp.0000 Lots: ABOOCD MFG NDC 17478-0283-10 Ropack:H.J. Harkin Co. In. Grover Bsach, CA 03433
74c3a01e-9451-0f2f-6aab-8348047cb1f5_889_2.jpg e S \DC 0378-4472. e s a wz o 05 e T § 4oty = Doy s Mycophenolate &emswionace: 3 v Keep this and all medication = . Mofetil e o e 3 Tablets, USP 3 Hrse L o ; J CAUTION: Specil Handing and C Disposal nsirucions - see- prescrbing normaton. This contaner s no ntended for [PHARMACIT: Dspese e socompanyog | ispensing for ovsehold use. [Nedoaton Gude o cach et Mylan Pharmaceuticls fnc. o WS A [MMylan: Rxonly 100 Tablets | 0-2/%%-82¢0 Y 107 5AX10Y AT 6 O S OO NI
74d007e9-9604-0941-e053-2a91aa0a29c4_113_1.jpg NDC 0163-9784.01 FLUMAZENIL ¥ INJECTION, USP. stee FORIV USE ONLY Bomy SmLMutpleDeso Vil Eschmi conin .1 mp offumazsl Conpoandadwits 13 nemiparshr St O chor e it i e i gty oo st andrnecessay s i USUALDOSAGE S package mor. Strs s T e pariesd I 0 o B (s U Conrlod oo Toeersrs. M A FMACOTCA FORTUSAL S R PLBS 14 WES/
74d007e9-9604-0941-e053-2a91aa0a29c4_113_2.jpg NDC 0163-9784.01 FLUMAZENIL ¥ INJECTION, USP. stee FORIV USE ONLY Bomy SmLMutpleDeso Vil Eschmi conin .1 mp offumazsl Conpoandadwits 13 nemiparshr St O chor e it i e i gty oo st andrnecessay s i USUALDOSAGE S package mor. Strs s T e pariesd I 0 o B (s U Conrlod oo Toeersrs. M A FMACOTCA FORTUSAL S R PLBS 14 WES/
74d8bb7a-9e7a-105f-e053-2a91aa0aec92_110_1.jpg 50 mL single-dose 8.4% Sodium Bicarhonate Inj., USP B ony 50 mEq (1 mEqg/mL) 4.2 grams (84 mg/mL) 'HOSPIRA, INC. LAKE FOREST, IL 60045 USA NDC 0409-6625-02 Each mL contains sodium bicarbonate, 84 mg. 2 mOsmol/mL (calc.). pH 7.8 7.0 to 85). Single-dose container. Contains no bacteriostat. Discard unused portion. Do not resterilize. For intravenous use. Usual dose: See insert. Sterile, nonpyrogenic. Use only if clear and seal is intact and undamaged. Do not use the injection if it contains precipitate. RL-0059 (4/04) Hospira €01) 0 030409 662502 5
74d8bb7a-9e7a-105f-e053-2a91aa0aec92_110_2.jpg (01)00351662125618 2 (17)190701 (21)36450208546 (10)79-240-EV See manufacturer's package (nsert Distributed by HF Acquisition Co.. LLC Mukiiteo, WA 98275 2 &
74f84173-a43f-7788-e053-2991aa0a8fb2_402_1.jpg DOSAGE AND USE: 2mL Act-0-Vial® NDC 0009-0011-03 o = See accompanyingprescriingInformation. 2§ 2- Licedincontaer, Solu-Cortef® = "Each 2 mL (when mixed) contains hydrocortisone sodium i i © [ et cuaient o 00 mgctytrocartone. (hydrocortisone sodium #~ MM protect solution from light. Discard after 3 days. succinate for injection, USP) "o o W Reconstuted — = Z @ Distrbuted by Pharmacia & Upjohn Co ForIMor IV use o =2 Divison ofPzernc, WY, NY 10017 Preservative-Free Rxonly
74f84173-a43f-7788-e053-2991aa0a8fb2_402_2.jpg (01)00351662126110 (17)200131 (21)402978378862 10)569499 See manufacturer's package insert. Distributed by HF Acauisition Co.. LLC Mukilteo, WA 98275 RXONLY
7524da98-b0a5-3db8-e053-2a91aa0a6ff1_100_1.jpg ovop:oweqdxa - sonsd Obkong BllPink Copile Imprtec o ok oy Each capsui contans Capsules Finish 91 hes mecication ‘500 Amoacil USP 25 the T uriess orwise rected by prescrber. Amoricilin 500mg NDC 68071-4548-6 #8 Lot #: 000000 Exp. Date: 00-00 @ NuCare Pharmaceuticals, Inc. 68071-4548-6 (MY o0svarL 08 021028899 90N BIW Loseziez KXy 000000 4101 idMy ouBrayL 1080 oroo:engdrs sonsded ey Swoo 90-440-28888 SON Bk Loscziee g 000000 1% 101 Ret 23123901 meeRATURE 555677 ER Rx Only WARMIG: KEEP U O REACH OF HRLOREN STORE AT CONTROLLED T juct #: PO764006! Prod
754a1ea1-1233-066f-e053-2991aa0a33a9_104_1.jpg ® NuCare Pharmaceuticals, Inc. NDC 68071-4553-1 BEROIING g o NDC 68071-4553-01 AWP: Lot # 000000 Exp. Date: 00-00 o2 ¥ 00000 fox # 23127216 *2 A N | | m BT L ooy ol e . #100 Tablets Atenolol 50mg 4100 Tamets ExpDate:00-00 See manutacturers label NDC 68071 9553-01 AW Al =t o e I Atenolol 50mg V100 Tabiet Exp Date:00.00 N sabTaeasss-o1 Product #: R0231100 Mg NDC_64380-438-01 Lot #: 000000 Rx #23127216 s Rx Only Rx# 23127216 WARNING: KEEP OUT OF REACH OF CHILDREN. STORE AT CONTROLLED TEMPERATURE 63-77 °F. el 520 333 i3 BleUg es8oNN “Aep ® sow|}) sinoy——Aisae *au] 'sj@oINE3) 000000.,000000,00
7560c201-9246-487c-a13b-6295db04274a_826_1.jpg Two yellow EpiPen® One grey Trainer Auto-Injectors R
7560c201-9246-487c-a13b-6295db04274a_826_2.jpg (1 J—— blue safety release by pulling straight up without bending or twisting it Swing and push firmly the orange tip against outer thigh so it “clicks” . Ud Hold firmly in place for 3 seconds. to deliver drug o GETEMERGENCY MEDICAL HELP §
7560c201-9246-487c-a13b-6295db04274a_826_3.jpg EPIPEN 2-PAK® | 5+ (epinephrine injection, USP) Auto-dnectors 03mg | NDC 49502:500-02 for Al Emerencis pnaphyas) Rxonly Wyan’ EPIPEN 2-PAK® ol (epinephrine injection, USP) Eﬁg‘ | Auto—ln]ectorsOBmg &é: | L ———— gi| | Al njctors " '-"_-.ig‘ i b RN b DG B | Register your EpiPen® Auto-njectors at www.epipen.com 10 receive free refil reminders Rece dcene. S 61077 EPIPEN 2- PAK° Fome Ilﬂlm i (epinephrine m,emo]n, Auto-Inec ® £ X £ ® & - apuosas § 0y aoeydut A roH 3 i 2ueso a1 310 e 0 s135un e nod 1 53130 seio Waried PO 235 oo o Jo1n S0 P 341 310N LTI NI s sy s o sy ey
7560c201-9246-487c-a13b-6295db04274a_826_4.jpg Two green EpiPen Jr® One grey Trainer Auto-Injectors P = b
7560c201-9246-487c-a13b-6295db04274a_826_5.jpg (1 J—— blue safety release by pulling straight up without bending or twisting it Swing and push firmly the orange tip against outer thigh so it “clicks” . Ud Hold firmly in place for 3 seconds. to deliver drug o GETEMERGENCY MEDICAL HELP §
7560c201-9246-487c-a13b-6295db04274a_826_6.jpg For Allegic Enesencis aphylai) EPIPENJr 2-PAK® (epinephrine injection, USP) Auto-Injectors 0,15 mg Fach carton contains: Two green EpiPen Jr* One grey Trainer "Auto-Injoctors Register your EpiPen Jr* Auto-Injectors at www.epipen.com (EPIPENJL' 2-Pak " Seplce i o, St st 68 077 (epinephrine injection, USP) Aum-lnjednlso.igumg iy oSeso sy 3310 pury 0 133501 gt 04 1d 59N iy 820 a4 0 110 s0ui oo 31 Pl o roceive frea refil reminders (Mylan® oy s s e | e jecion, U mwﬁw EPIPENIr 2-PAK® e s
758aba8b-1114-f10d-e053-2a91aa0af287_834_1.jpg For Allegic Enesencis aphylai) EPIPENJr 2-PAK® (epinephrine injection, USP) Auto-Injectors 0,15 mg Fach carton contains: Two green EpiPen Jr* One grey Trainer "Auto-Injoctors Register your EpiPen Jr* Auto-Injectors at www.epipen.com (EPIPENJL' 2-Pak " Seplce i o, St st 68 077 (epinephrine injection, USP) Aum-lnjednlso.igumg iy oSeso sy 3310 pury 0 133501 gt 04 1d 59N iy 820 a4 0 110 s0ui oo 31 Pl o roceive frea refil reminders (Mylan® oy s s e | e jecion, U mwﬁw EPIPENIr 2-PAK® e s
758b3b9b-1a4f-c150-e053-2991aa0a182d_753_1.jpg Amlodipine and Valsartan Tablets 0Tavlets RxOmy
758b3b9b-1a4f-c150-e053-2991aa0a182d_753_2.jpg d w, 55 @ & S0 28 ‘ X8 EE s i3t £ 19 ; <2 l
758b3b9b-1a4f-c150-e053-2991aa0a182d_753_3.jpg Amlodipine and Valsartan Tablets N Tablets RxOmy
758b3b9b-1a4f-c150-e053-2991aa0a182d_753_4.jpg KARE. | Amlodipine and Valsartan Tablets Y
759d580a-bf25-5182-e053-2991aa0a9d8f_480_1.jpg nan
75a0d6b3-7a5d-3458-e053-2a91aa0a702e_787_1.jpg NDC 51407-078-90 ATORVASTATIN CALCIUM TABLETS 10 mg* See package?\(s)er!c:%rbdlc?sgge information Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. 5140707890 % Each film-coated tablet contains: atorvastatin calcium equivalent to 10 mg atorvastatin. * Dispense in a tight, child-resistant container. * KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. * PHARMACIST: Dispense the accompanying Patient Information to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
75a0d6b3-7a5d-3458-e053-2a91aa0a702e_787_2.jpg NDC 51407-079-90 ATORVASTATIN CALCIUM TABLETS 20 mg* See package?\?er't:faolr)dloesgge information Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. 5140707990 % Each film-coated tablet contains: atorvastatin calcium equivalent to 20 mg atorvastatin. < Dispense in a tight, child-resistant container. * KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. « PHARMACIST: Dispense the accompanying Patient Information to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
75a0d6b3-7a5d-3458-e053-2a91aa0a702e_787_3.jpg NDC 51407-080-90 ATORVASTATIN CALCIUM TABLETS 40 mg* See packagea(s)erlszlr)dloesgge information Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. 5140708090 % Each film-coated tablet contains: atorvastatin calcium equivalent to 40 mg atorvastatin. « Dispense in a tight, child-resistant container. « KEEP THIS AND ALL MEDICATION OUT] OF THE REACH OF CHILDREN. « PHARMACIST: Dispense the accompanying Patient Information to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
75a0d6b3-7a5d-3458-e053-2a91aa0a702e_787_4.jpg ATORVASTATIN CALCIUM TABLETS 80 mg* See package?w(s)erit:%rbdloesgge information NDC 51407-081-90 Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. 5140708190 % Each film-coated tablet contains: atorvastatin calcium equivalent to 80 mg atorvastatin. * Dispense in a tight, child-resistant container. * KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. « PHARMACIST: Dispense the accompanying Patient Information to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
75b03dd6-3d4e-7f9a-e053-2a91aa0ad45f_208_1.jpg 25 mg 100 capsules See package insert for dosage information. CAPSULES °C (77°F), excurslons permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Store at 25 1 2 N~ ™ i) N~ o 4 T 0 O Qo Z 5140713701 » Each capsule contains: 25 mg of zonisamide, USP. « Keep this and all medication out of the reach of children. Store in a dry place and protect from light. « PHARMACIST: Please dispense with Medication Guide provided separately to each patient. Manufactured by Sun Pharmaceutical Industries Ltd. Halol-389 350, Gujarat, India Packaged by GSMS, Incorporated Camarillo, CA 93012 USA N ] s S & S 9 5 S A O = 2 i S & g W S A O R 2 S S & 3 5 S A O ~ ] £ S & S 2 5 S A O B 2 S S IS S o S A O
75b03dd6-3d4e-7f9a-e053-2a91aa0ad45f_208_2.jpg 50 mg 100 capsules See package insert for dosage information. ZONISAMIDE CAPSULES NDC 51407-138-01 Store at 25°C (77°F_); excursions permitted to 15°-30° [See USP Controlled Room Temperature]. 5140713801 ¢ Each capsule contains: 50 mg of zonisamide, USP. » Keep this and all medication out of the reach of children. ¢ Store in a dry place and protect from light. * PHARMACIST: Dispense with Medication Guide provided separately to each patient. Manufactured by Sun Pharmaceutical Industries Ltd. Halol-389 350, Gujarat, India Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated GSMS Incorporated GSMS Incorporated GSMS Incorporated GSMS Incorporated
75b03dd6-3d4e-7f9a-e053-2a91aa0ad45f_208_3.jpg N * S S & g w5 S A & N ] S S & 2 i S A ) N ] = S & 3 S B A O = & N S & S o8 = A O N X S =~ N S © R S A O n w - > 0 o < O F), excursions 100 capsules See package insert for dosage information. S w @ a w2 N~ SO 0 Z nDuO O N Store at 25°C (77° 5140713901 * Each capsule contains: 100 mg of zonisamide, USP » Keep this and all medication out of the reach of children. * Store in a dry place and protect from light. *PHARMACIST: Dispense with Medication Guide provided separately to each patient. Manufactured by Sun Pharmaceutical Industries Ltd. Halol-388 350, Gularat, Indla Packaged by GSMS, Incorporated Camarillo, CA 93012 USA permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature].
75b34c11-ee74-792c-e053-2a91aa0a5cbf_813_1.jpg NuCare Pharmaceuticals, Inc. 000000.000000.08.£08997 1 £089 A pebeyosg 800822 $UIY 'BUDIUBN ‘P1Y $910j010qET 18BAON 9z 28 a2 &3 o% >3 B3 I 22 23 £ 5 2 & *Aq poniowinuByy 0£07890d WARNING: KEEP OUT OF REACH OF CHILDREN. NDC 68071-4558-3 . Date:00-00 Lot #: 000000 E NIFEdipine %mg #30 E R Tablets Each Extended-Reiease film-coated tablet contains: 90mg Nitedipine. Usp Round Brown Tablet Debossed ‘Novast” on one side 39" on the other side Product # P0684030 e Rx Only NIFEdipine 90mg #30 E-RTablets Exp Date: 00-00 NDC 68071453803 AWP: $99.58 Do NDC 20743 633-01 Lot #: 000000 o # 23133576 MFEMI& 90mg E-R Tablets Exp Date: 00-00 NDC 68071453503 Awe: 350,58 Mig NDC 50742-622-01 Lot#: 000000 Rx#23133576 NIFEdipine S0mg #30 TERTabids Exp Date: 00-00 NDC 63071.4535-03 AW: 39958 oot s iy Lo 2 Goo000 e # 23133576 NIFEdipine 50mg 730 TERTabldls Exp Date:00-00 NDS 68071453503 Tty NDC 20743 623-01 TR+ Gon000 R 23133576 Rx# 23133576 STORE AT CONTROLLED TEMPERATURE 68-77°F.
75c2fc3e-28ac-c1b1-e053-2991aa0aee9f_879_1.jpg 10 mL Single-dose NDC 0409-5921-01 = X Each mL contains aminophylline (calculated = Am|n0phy”|ne as the dihydrate) 25 mg (equivalent to Injection USP 19.7 mg/mL of anhydrous theophylline). 950 2’5 L May contain an excess of ethylenediamine mg (25 mg/mL) I only g4 pH adjustment. pH 8.8 (8.6 to 9.0). Sterile, Protect from light. nonpyrogenic. Discard unused portion. DO NOT USE IF CRYSTALS HAVE ~ For V. use. Usual dose: See insert. ﬂ SEPARATED FROM SOLUTION. HOSPIRA, INC, LAKE FOREST, IL 60045 USA RL-02773 (6/04) Hospira
75c2fc3e-28ac-c1b1-e053-2991aa0aee9f_879_2.jpg (01)00351662120415 I\(I ﬂl)ll.llw‘l 10)76-328-0K See manufacturer's package insert Distributed by HF Acauisition Co. LLC Mukiiteo, WA 98275 ~= -
75c8673d-5068-1b23-e053-2a91aa0ab9cb_40_1.jpg @ NuCare Pharmaceuticals, In oyuy Ke, sanoy BUBI0 g 976 Ul '$18ORNSI8LLIS 4 218DNN Aq pabeoeg £ z Lot #: 000000 Exp. Date: 00-00 Metiormin HC| 00mg WARNING: KEEP OUT OF REACH OF CHILDREN. NDC 68071-4560-1 #100 Tablets See manutaciurer's label for full list of ingredients. Product # R0551100 C.RxOnly ~ Metformin HC| 500mg #100 Tablets | Exp Date:00-00 NDC 68071-4560-01 AWP: Mg NDC_23155-102-01 oo #: 000000 fox # 23135139 Wetformin HCI 500mg #100 Tablets NOC 68071-4560-01 AWR: Mg NDC 23155-102-01 L2 #0000 ox # 23135139 Metformin HCI 500mg #100 Tablets Exp Date:00-00 NDC 68071-4560-01 AWP: Iatg NDC_23155-102-01 102 % Gos000 " ox # 23135139 Metformin HC) 500mg #100 Tablets NDC 58071-4560-01 Mg NDC_23155-102-01 o8 $ 00000 ot # 23135139 Rx# 23135139 Exp Date: 00-00 ‘Exp Date:00-00 STORE AT CONTROLLED TEMPERATURE 59-36 °F.
75c902e8-50e7-a337-e053-2991aa0a2093_971_1.jpg 50 mL single-dose 50% Dextrose Injection, USP 25 grams/50 mL (05 g/mL) Hospira, Inc. Lake Forest, IL60045 USA Hospira NDC 0409-6648-02 Rxonly Each mL contains dextrose, hydrous 0.5 grams. May contain NaOH and/or HCI for pH adjustment. 2.53 mOsmol/mL (calc). pH 42 (32 to 65). Sterile, nonpyrogenic. Cleanse stopper with antiseptic. Aseptically add to a suitable ‘solution in I.V. container or use undiluted. Use only if clear and seal is intact and undamaged. Contains no bacteriostat; use prompty;discard unused porion For intravenous use. Usual dosage: See insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] RL3040
75c902e8-50e7-a337-e053-2991aa0a2093_971_2.jpg (01)00351662121511 (17)180801 (21)136838362815 (10)80-169-DK > See manufacturer's package Insert z Distributed by HF Acquisition Co., LLC = Muliiteo, WA 98275
75d5611a-f9e0-1841-e053-2991aa0af415_919_1.jpg 10 mL Single-use vial Reonly NDC 0409-6102-20 2 Do not use if solution is discolored Furosemide o i pricuie. o mi Injection, USP contains furosemide 10 mg; sodium L chloride sufficient to render For INTRAVENOUS or INTRAMUSCULAR use. Hospira Hospira Inc., Lake Forest, IL 60045 USA RL-4986 Lot/Exp.
75d5611a-f9e0-1841-e053-2991aa0af415_919_2.jpg (01)00351662122617 ® (17150601 7% < (21)63109887035 (10)84-337-0K See manufacturer's package insert Distributed by HF Acduisition Co., LLC Muliiteo, WA 98275
75d68f19-4208-109e-e053-2991aa0ac857_213_1.jpg L e Sii’i"#is!;,g, B \ T ik Tiglutik Y Tiglutik |~ T riluzole riluzole cralssspansion S0mg/ O (my/n) SR For Oral Administration Only <= For Oral Administration Only 00 . (wo en 300 L nch) Vot To B Disersed Separy
75d68f19-4208-109e-e053-2991aa0ac857_213_2.jpg Ve Date offirstopening: /___/ Discard unused portion 15 days after first opening. § 70726 03032 3 Lot Exp. WITFPharmo_ Manufactured for: ITF Pharma, Inc, Berwyn, PA 19312 USA TIGLUTIK is a licensed trademark of ltalfarmaco SA, ©208 ITF Pharma, Inc, Al ights reserved, TTLO420% NDC 70726-0303-2 Ry only Tlglutlk riluzole oral suspensnon 50 mg/10mL (5mg/mL) For Oral Administration Only Shake gently before use 300 mL Contains: TIGLUTIK™50 mg/10 mL (5 mg/mL) oral suspension is a slightly brown, opaque, homogeneous suspension when mixed, containing 50 mg of riluzole per 10 mL of suspension, Storage and Use: The bottle must be gently shaken for at least 30 seconds by continuously rotating the bottle 180° until the visual appearance of the suspension is homogeneous. Store TIGLUTIK™ at controlled room temperature between 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F), and protect from bright light. Do not freeze. Store upright. Once opened, the bottle of TIGLUTIK™ should be used within 15 days. Keep bottle tightly closed between each use, Dosage: The recommended dose is 10 mL of TIGLUTIK™ oral suspension, containing 50 mg of riluzole, taken orally twice daily, every 12 hours. Before use, please read the enclosed Prescribing Information, Keep out of reach of children.
75d68f19-424c-109e-e053-2991aa0ac857_597_1.jpg NDC 0409-6102-19 == 2mL Rx only Furosemide inj, usp 20 mg/2 mL (10 mg/mL) . RL-4988 Hospira, Inc. Lake Forest, IL 60045 USA ~ Hospira == Lot/Exp.
75d68f19-424c-109e-e053-2991aa0ac857_597_2.jpg (01)00351662122716 (17)150501 (21)49718410030 (10j83-352-DK See manufacturer's package insart t5 Distributed by HF Acquisition Co.. LLC Mukilteo, WA 98275 R
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_1.jpg yellow EpiPen® Auto-Injectors b V=
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_2.jpg Remove the blue safety release by pulling straight up without bending or twisting it Swing and push firmly the orange tip against outer thigh so it “clicks” Hold firmly in place for 3 seconds o deliver drug a1 o GETEMERGENCY MEDICAL HELP | e O
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_3.jpg Remove the blue safety release by pulling straight up without bending or twisting it Swing and push firmly the orange tip against outer thigh so it “clicks” Hold firmly in place for 3 seconds o deliver drug a1 o GETEMERGENCY MEDICAL HELP | e O
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_4.jpg green EpiPen Jr® Auto-Injectors P EECes
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_5.jpg Remove the blue safety release by pulling straight up without bending or twisting it Swing and push firmly the orange tip against outer thigh so it “clicks” Hold firmly in place for 3 seconds o deliver drug a1 o GETEMERGENCY MEDICAL HELP | e O
75e96faa-545b-52d6-e053-2991aa0a8fb8_984_6.jpg (01)00351682132515 (17)180831 See manufacturer's um‘lmun Distributed by HE Acquishio Co.lic Mukilteo, wa 98275
7611e508-6da2-3a2f-e053-2a91aa0a9f40_158_1.jpg . ey RXONNY NDC 0409-1966-06 10 mL wuliple-dose Lifeshield™ Vial yor Fo NHALATION ___FORDRUG DILUENT USE OMLY. Bacteriostatic 0.9% Sodium Each mL contains sodium chloride 9 mg and benzyl : - alcohol 9 mg added. Sterile, nonpyrogenic. Chloride Injection, USP Hospir, Ic. Lake Fores L 60045 USA RL-4473
7611e508-6da2-3a2f-e053-2a91aa0a9f40_158_2.jpg 1030409 196612 0 10 ML vt emstad™ vl Rronly 25 Units/NDC 0409-1966-12 NOT FORINHALATIO! Bacteriostatic WARNING: NOT FOR Tl FORDRUG DAUENT USEONLY, Chloride Injection, USP Ity V0 55009 1 o1 01 ot ‘an1enasaid e se pappe b 6 002 wWwaunsnlpe Hd 1o} Pe SUOIYPOIPAY UEW0) Aew Wz pue Bl 6 3PN WNIpOS SUIEANO) W e Store at 200 25°C (68 to 77°F).[See USP Controlled Room Temperature] al needle to access vial. U0 351 SNusbosduou ‘auais £ Remove cover from Flptopvial and dieanse topper with antiseptic. Use serle syringe and LifeShield™ Use Aseptic Technique Blunt Cannulaor conventt SEYEW exdson EIRICIRLTET JTT [T o 30 vania msais LYNOIN NI3Sn o e LAY m B ETTEN Y] “NOLLVIWNINOILON 21-9961-60¢0 JANSUUN ST AHOXY 1w PRSS® A TUI O
7611e508-6da2-3a2f-e053-2a91aa0a9f40_158_3.jpg 1030409 196612 0 10 ML vt emstad™ vl Rronly 25 Units/NDC 0409-1966-12 NOT FORINHALATIO! Bacteriostatic WARNING: NOT FOR Tl FORDRUG DAUENT USEONLY, Chloride Injection, USP Ity V0 55009 1 o1 01 ot ‘an1enasaid e se pappe b 6 002 wWwaunsnlpe Hd 1o} Pe SUOIYPOIPAY UEW0) Aew Wz pue Bl 6 3PN WNIpOS SUIEANO) W e Store at 200 25°C (68 to 77°F).[See USP Controlled Room Temperature] al needle to access vial. U0 351 SNusbosduou ‘auais £ Remove cover from Flptopvial and dieanse topper with antiseptic. Use serle syringe and LifeShield™ Use Aseptic Technique Blunt Cannulaor conventt SEYEW exdson EIRICIRLTET JTT [T o 30 vania msais LYNOIN NI3Sn o e LAY m B ETTEN Y] “NOLLVIWNINOILON 21-9961-60¢0 JANSUUN ST AHOXY 1w PRSS® A TUI O
76131655-3a87-feac-e053-2991aa0a82a1_649_1.jpg L= FLY) R T LA LD 7 CAUTION: Liquid in glass. Handle with | care. Inspect vial for damage prior to | assembly, 8.4% Sodium T T F G Injection, USP LR LifeShieid” Use Aseptic Technigue Do not assemble until eady to ose, 1.Ramove zaps “om vial & b3w gg E L T LI LA bttt LA with male Juer fock adapter and 18-Gauge protected needle 8.4% Sodium Bicarbonate Inj., USP L0
76131655-3a87-feac-e053-2991aa0a82a1_649_2.jpg | (01)00351662125519 (17)191101 mhssnmma (10)83-037-DK ‘See manufacturer's package Distributed by HF Acquisition Co., e Mukiteo, WA 98275
76131655-3a87-feac-e053-2991aa0a82a1_649_3.jpg 84% SODIUM BICARBONATE . USP.
762ac371-bb8b-47e7-b48f-e80d452c9dd4_287_1.jpg For Topical Use Only. Each gram of EstroGel* contains 0.6 mg estradiol in a hydroalcoholic gelof purified water, alcohol, triethanolamine, and carbomer 934°. Usual dosage and administration: Aoply 125 per day (1 pump depression) to the arm from wristto shoulder, as directed by your healthcare provider. ‘The pump must be primed before first use. see prescribing information. At niialpriming, metered-dose pump capable of delivring thiry 125 g doses of gel containing 0.75 g estradiol per pump depression. Warnir this cont Keep out of reach of children; r is not child resistant. Alcool-based gels are flammable. Avoid fire, flame, or smoking unti gl has dried Store at 20° to 25°C (68° to T7°F): excursions permitted to 15° to 30°C (59° to 86°F). See USP Controlled Room Temperature. whw estrogel.com ©2018 ASCEND Therapeutics® 2018-E6-0016 Manufactured for: ASCEND Therapeutics Hemdon, VA20170 By DPT Laboratories San Antonio, TX 78215 NDC 17139-617-40 ESTROG For Topical Use Only. Amultiple-dose pump containing 50 grams (75 0z) Bony
762ac371-bb8b-47e7-b48f-e80d452c9dd4_287_2.jpg For Topical Use Only. Each gram of Estroel® contains 0.6 mg estradiol in a bydroalcobolic gel of purifed water, alcohol, triethanolamine, and carbomer 934P. Usual dosage and administration: Apply 1.25 g per day (1 pump depression) tothe arm, from wistto shoulder, as directed by your healthcare provider. ‘The pump must be primed before. first use. See prescribing information. After initalpriming, metered-dose pump capable of defivering thirty 1.25. doses of gel containing 0.75 mg estradiol per pump depression. ‘Wamings: Keep out of reach of children; this container is not child resistant. Alcohol-based gelsare flammable. Avid fire, lame, or smoking untigel s dried. Store at 20° to 25°C (68° t0 77°F); excursions permitted to 15° to 30°C (59° to 86°F). See USP Cortrolled Room Temperature. Patient information enclosed. ©2018 ASCEND Therapeatics®. ESTRO wwwestrogel.com 2018-EG-0018 3 W73 L NO COATING IN THIS AREA (Lot , Exp date and P (LY ESTRO! Manufactured for: ASCEND Therapeutics Hemdon, VA 20170 By DPT Laboratories San Antonio, TX 78215 $ASOU LORULIOJU U3ed Od1s3 NDC 17139-617-40 ESTRO For Topical Use Only. Amultiple-dose pump. containing 50 grams (175 02) Biow ESTROS
763ff805-af1a-e8e9-e053-2a91aa0a8253_42_1.jpg For Topical Use Only. Each gram of Estroel® contains 0.6 mg estradiol in a bydroalcobolic gel of purifed water, alcohol, triethanolamine, and carbomer 934P. Usual dosage and administration: Apply 1.25 g per day (1 pump depression) tothe arm, from wistto shoulder, as directed by your healthcare provider. ‘The pump must be primed before. first use. See prescribing information. After initalpriming, metered-dose pump capable of defivering thirty 1.25. doses of gel containing 0.75 mg estradiol per pump depression. ‘Wamings: Keep out of reach of children; this container is not child resistant. Alcohol-based gelsare flammable. Avid fire, lame, or smoking untigel s dried. Store at 20° to 25°C (68° t0 77°F); excursions permitted to 15° to 30°C (59° to 86°F). See USP Cortrolled Room Temperature. Patient information enclosed. ©2018 ASCEND Therapeatics®. ESTRO wwwestrogel.com 2018-EG-0018 3 W73 L NO COATING IN THIS AREA (Lot , Exp date and P (LY ESTRO! Manufactured for: ASCEND Therapeutics Hemdon, VA 20170 By DPT Laboratories San Antonio, TX 78215 $ASOU LORULIOJU U3ed Od1s3 NDC 17139-617-40 ESTRO For Topical Use Only. Amultiple-dose pump. containing 50 grams (175 02) Biow ESTROS
763ff805-af1a-e8e9-e053-2a91aa0a8253_42_2.jpg (01)00351662125915 o (17)180801 (21)126861525366 (10)700134P See manufacturer's package insert Oistributed by HF Acquisition Co., LLC Mukiiteo, WA 98275 -
7640dd80-1a56-9805-e053-2991aa0acbb5_262_1.jpg = = GEFDINIR 250mg/5mi SUSP 60mi Gompare: Omicef Exp. 00100 Lot# ABOOCD Mig. TEVA 00093-4137-64 ACCOUNT: 00-0000 Use As Directed by Physician ‘CAUTION: fadoral Law PROHIBITS e wansio o tis drug o anyon ofer than he person whom prosorioed and prohib cipansing wihout a prscripton. unisss OTC. Sos ouaert o aed Ax . KEEP OUT OF REACH OF GHILDREN Stors i 8 050, iy lacs o 66-77 F uiass prted e, 76519-1214-06 (IR ‘CEFDINIR 250mg/5mi SUSP. NDC: 76518-1214.06 Exp.0000 MFG NDC 000934137-64 ary: som Lot#: ABOOCD ‘CEFDINIR 250mg/Smi SUSP. NDC: 76519-1214.06 Ex.0000 MFG NDC 00093.4137-64 ‘CEFDINIR 250mg/mi SUSP. NDG: 76518-1214.06 Exp.0000 MFG NDC 00083-4137-64 ary: somt Lot#: ABOOCD ‘CEFDINIR 250mg/5mi SUSP NDG: 76519-1214-06 Exp. 00100 MFG NDC 00083-4137-64 ary: somi Lot: ABOOCD Ropack: H.J Harkins . In. Grover Baach, CA 03433
7640dd80-1a56-9805-e053-2991aa0acbb5_262_2.jpg ‘CAUTION: fadoral Law PROHIBITS e vansie o s drug o anyons oher than he person whom proscrioed and prohibta cpansing wihout a prescrpto urisss OTC: Sos outaer foracdl x i KEEP OUT OF REACH OF GHILDHEN Stors i 8 050, dry lacs ot 6677 F uiass pritas e, 76519-1172.06 ‘CEFDINR 125mg/5mi SUSP GEFDINIR 125mg/5mi SUSP 60mi NDC: 76519117208 ar:eom Lotk: AB0OCD Compare: Omnicef e Exp. 00100 Lot# ABOOCD MICREGIOn B Mig. TEVA 00093-4136-64 ‘CEFDINIR 125mgmi SUSP NDC: 76519117206 &6p.0000 MFG NDC 00093.4136.64 AACCOUNT: 00-0000 Use As Ditected by Physician ‘CEFDINIR 125mg5mi SUSP NDC: 76519-1172.06 ary: eoml Exp. 0000 Lots: ABOOCD MFG NDC 00093413664 N ‘CEFDINIR 125mg/5mi SUSP. NDG: 76518-1172.06 ary: somi Exp. 0000 Lots: ABOOCD MFG NDC 00093-4136-64
76513627-0960-e049-e053-2a91aa0aa7d2_513_1.jpg @ NuCare Pharmaceutical a5-4388% QN B rsonicz px 0000 :# 107 wsomer sy 000000 107 a0 g 3 T o o JET M $s o1t jnt 8 Simil fg f SSE mmmﬁl g ﬂmm.rm 3 § g gg 2 ET 5 g 10 Redt 2340942 Rx Only KEEP OUT O REACH OFGHLOREN. STORE AT CONTROLLED TEMPERATURE 68777
765d726b-fd4b-4ef7-afd7-9e7e9bf8cae6_223_1.jpg NDC51862-015-01 +Each Capsule Contains: Nortriptyline Hydrochloride equivalent . . t010mg Nortiptyine i Nortriptyline Dispense ina tohtcontainer,as defined £ . intheUsp wihchidredstart dosure, S 5 Hydrochloride Ul Dosge Sopecoge ey D T csage sl ekeong nfomaton, § et 10 Capsules, USP Store at 20°to 26°C (66" 10 77°F) [See i = AN i OSP Contod Room Tempersurel, 5 Medication Gulde provided -ET Moty 5 - separateyto each patint. = Vo Slcens Gos 403753 MOIA = 100Capsus CodotcODROEHTH — RxOnly Rone ! == Gl e 2734 = Rev.01/16 232060
765d726b-fd4b-4ef7-afd7-9e7e9bf8cae6_223_2.jpg NDC51862-016-01 Nortriptyline Hydrochloride Capsules, USP PHARMACIST: Dispensethe ‘Medication Guide provided =g separately to each patient. Ss 100 Capsules RxOnly +Each Capsule Contains: Nortrptyline Hydrochioride equivalent to25mg Nortriptyline Dispense i tight container, as dafined in'the USP, with child-esisart losure. Usual Dosage: see package insert for dosage and full prescibing information. Storeat 20°to 25°C (68°t0 77°F) [see USP Controllad Room Temperature). Manufctursd by: Wattonpharns PrteLiited Ve Skste o 303752 NDIA CodeMo GOIDRIGS 741 Disrbuted by: s Greerle N 27834 = Rev 0116 232062 3 Love 0w 51862-016-01 3
765d726b-fd4b-4ef7-afd7-9e7e9bf8cae6_223_3.jpg NDC51862-017-01 Nortriptyline [y Hydrochloride Capsules, USP PHARMACIST: Dispensethe MediationGudeprovided = Z g separatelytoeachpatient. & < 100 Capsules “Each Capsule Contains: Nortrptyline Hydrochioride equivalent to50mg Nortriptyline Dispense ina tiht container, as dafined in'the USP, with child-esistart losure. Usual Dosage: see package insert for dosage and full presciibing information. Storeat 20°to 25°C (68°t0 77°F) [see USP Controllad Room Temperature). Manufctursd by: Wattonpharmns PrteLimited Ve Skste o 303752 NDIA CodeMo GOIDRIGS 741 Distrbuted by: v Greerll N 27834 = Rev 0116 232065 0 Love seon 51862-017-01 3
765d726b-fd4b-4ef7-afd7-9e7e9bf8cae6_223_4.jpg NDC 51862-018-01 Nort Hydrochloride Capsules, USP 75 ptyline Uik PHARMACIST: Dispense the Medication Guide provided separately to each patient. 100 Capsules RxOnly *Each Capsule Contains: Nortriptyline Hydrochlor equivalent to 75 mg Nor Dispenseina tight container, as defined in the USP, with child-resistant closure. Usual Dosage:See paciage insertfor dosage and fullprescribing information. Store at 20° to 25°C (68" to 77°F) [See USP Controlled Room Temperature]. Manufactured by: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Code No. GO/DRUGS/741 Distributed by: Mayne Pharma. Greenville, NC 27834 Rev.01/16 LOTIEXP. BELOW 232067 7 51862-018-01 3
7663c49d-1b1d-755d-e053-2991aa0a4ee3_602_1.jpg (] Adrenalin® epnepte ictn, U5 1 mg/ml. o [ty HOT b s U inL oo Do g £ s e 30037786 = L i 48 £ 3 i
7663c49d-1b1d-755d-e053-2991aa0a4ee3_602_2.jpg (01)00351662129012 (17)190531 (21)162321958294 (10)305131 See manufacturer's package insert Distributed by HF Acquisition Co., LLC Muklngo, WA 98275
767a1504-1e04-1e06-e053-2a91aa0aa4b6_235_1.jpg I (3184inS josayngye) V4H uljojusp [ PATINTS WSTRUCTIONS FOR USE A S e s Ao Th s s s oo s marg o o e O Il st B N 1 L o e Soe B . T ol o L0 The oot v cun o EEEV NG 0 ) ol 0 10 1y o changs i b e e counie off 1 motal canitor. ot ool el EETS st 9 YT et i kst s e v s, o ¢ 1 Ll o T, S Fgur A The s <235 10 5 e s Dot s e it ot el o o k. 0 ot ATOLH A ot i 3 ot o P Yo mast e the e 1 gt 1 et amount o e, P 1 e D0 s 9 0 s 1 e e oyl | o . 3 3 f L b s ke s s el S | U e Ao o S Ly e he 1 o . Fllon e tap very e You e VENTOLI R e e e st s 9 . o o sl SN o o ) o Shaks e s wal s SR ey T Yo of o o sk ‘i P oSS DM i, ke o a0 5. 2 o ol e s o, Wt ol ouen ot v ans s v i e SIS Pl aipeta S M 0 s B s U35 g & Pl 1 ool s cortrall sy down Wil st 1 ety Sy 0 o o4 i 5 e Lot s e o g i s s e ) 1<, o A UL 0 st o . 0ty bt o bout 10 econcs, AR et au iy 5 v 7 My baaltear proidr has oy S S s i g B o s e o, 5 ocesprags, vt e o (comd 0 et saot) e o~ zv @ o ° Eo Mt & e epescanve T s e RS 1 nlor T o 1 e, o o e e kel oL i sy Ll o o B st oo coan o ol s BosCaES Tl e anrer S e S T rmbhen AT S S 012 e S e vl o ki cesnrg e, When tr comtrrncs Tl g O o ekt et e A Gcp e o BT s oow s inlg awag Rty e 12 ety g e st B kv 1 er St e ot O T i T o b e [ e s 27 g o camprise T ouoiey | | otags7a | 60 Metered inhalations HDC 0173-082-24. Ventolin” HFA (albuterol sulfate) Inhalation Aerosol 90 meg per actuation FOR ORAL INHALATION ONLY For use with Ventolin” HFA actuator only. Gontents: Each carister contains a micracrystaline suspension of albuterol sulfate in propelant HFA-134a 1,1,1,2-tetraluoroethane). kach actuation delivers 108 mog of albuterolsulfale equivalent to 90 mog albuterol base fom the metfoiece. Attention Pharmacist: Dotach the Patient Information leaflelIrom pac<age insert and dispense with inhaler With Counter Reonly LA 0SAGE: s e it by WARNNGS: 4 st BT S Mo el S 1003 105 Sndlorsons sl o e i T i Bt o entr o ey o e il 1yt et Ao, S ) B0l s s e 0 st by o Sae s i ik SR el s, Important: sy oS e, Kespout ot ot f ik, g v, Gontnts U Prssur: Do e ot c B e g oo S vy At e T it St e e B BB o P i it o F st SRt e s i b G gt s Stk 1 o el v ey 0173-0682-24 o i 1000000145574 Rev 617
767a1504-1e04-1e06-e053-2a91aa0aa4b6_235_2.jpg DOSAGE: Use by your doctr ) = 010 WARNINGS: The VENTOLN® e sulfate) Inhalation Aerosol should astup 1041 6 hours and therefore i shi not be used more frequently than recommended. Do not increase the number or frequency of doses without consulting your doctor. If symptoms get worse, consult your doctor immediately, Other inhaled medicines should TR Jterol suffte) e ﬁ?zsa% fhalation Aerosol e : Important: Read accompanying ) neg peractuation AN outof reach of chidren. Aodryigneyes ._w“_a._..s.r:.si AR B HAATON LY sl e Fr st i Vel A actato ol y i 120°F may cause bursting. Never throw canister into fire or incinerator. U Store at room ture between 66°F and 77°F (20°C HF Acquisition Co.. LL 98275 1)0035166212671 1)220214350028 anufacturer’s pacl Ins ek 0173 = = < o = = = = 8 M RLRINARL R L S 126714 o 3 B 4 = package (nsert z - sy -0682-24 & )181130 Distributed by Mukiiteo, WA LT 3 0 1 @ (a See mi
767a1504-1e04-1e06-e053-2a91aa0aa4b6_235_3.jpg nan
768dc21a-b7d9-144c-e053-2991aa0af889_652_1.jpg g = IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII 10 mL Single-Dose Syringe Atropine Sulfate injection, usp NDC 0409-1630-10 Reonly 1 mg/10 mL (0.1 mg/mL) Hospira For Intravenous, Intramuscular, Subcutaneous or Endotracheal use. Hospira, Inc, Lake Forest, IL 60045 USA €01)00304091630109.
768dc21a-b7d9-144c-e053-2991aa0af889_652_2.jpg Dewuis| aBoped puesdeidU s de3jl AIEIPAUOUOU sns AUIGOLE B L0 SUEIEY VI e HuSB0.duou pue s ied pny DU LoD [aimeidus, ooy p1u0) 651 35] (93 e : SO0 HT O WUGUOUSOCOUMIIGEIR] ) 20 e st I et (o1 R 10 DR YIS J/PUE PPOIDAY LITPOS UEAUGY AW 0 565) 35701 0712 21 UOREUIY Duigsaid 55 o s bt s stos IEAZ | AP Rt (ol S oz s 2 | - = [ 5 S - s .59 £ £ | i M PR 5 ¢ < = B SHE g S - sg8s o = 3 | Sl “HA- bER - - EZ5% & : | Bl: HAEE G g RS- Es5E 7 2 = ShEE = N ESITE8S s i s S (25 - BESE £ g I S 2 - =T ad @ m = | / E & x barrel forward to relleve any resistance that may be present. g £ § 3 2. Hold plunger and push N CA-4560 MADE IN GERMANY Use Aseptic Technique 1. Remove luer cover. Hospira, Inc.
768dc21a-b7d9-144c-e053-2991aa0af889_652_3.jpg (01)00351662128916 (17)190701 (21)197752968887 (10)79-023-EV See manufacturer's package insert Distributed by HF Acguisition Co., LLC Mukilteo, WA 98275 1aepe 00| ) aju
76a2dcaf-7b75-2f53-e053-2991aa0addf5_5_1.jpg NDC: 70934-163-30 LEW 8 o s o s PG, TOo 8230 s owne I e emosses Escitalopram Tablets, USP SShEkauret. SR g T U1 g e o o e e 5 e e W e o e oo v [——— ot 5
76a3504c-f992-a7f8-e053-2a91aa0a2ea4_986_1.jpg NOC: 70934-165-30 LM G TOOSAASED0 e atans et Diclofenac Sodium Delayed-Release Tablets, USP 75m 30 Tablets Rx Only i e
76caa413-1058-154e-e053-2991aa0ade1a_330_1.jpg are Pharmaceuticals, Inc. §29z3 NDC .68071-4575-1 Orreeyaing IC Mo 23 ég’g Lot #: 000000. _Exp. Date:00-00 Noc G807 275 01 A ::8a%8 Ph d Hm m Lot 3. 000000 o # 23147311 o Phenazopyridine HCI 200mg 305 Phenazopyriding HC)200my S S5 T3 e o g2 #10 Tablets e e 52 Se Each tablet contai Phenazopyridine S g8 s beu;zuwmn:r%l,usp 200mg #10 Tablets mm: 00-00 $3 8 ound Reddish-Brown Tablet Debossed R NDC 00357588 SV Sig 113" on one side. Lot #: 000000 Rx # 23147311 2% 3 Phenazopyridine HCl200mg s o #10 Tablets Exp Date: 00-00 : NDC 68071-4575-01 ; Wt NDC 6536716308 Product #: P0162010 Lot #: 000000 Rx # 23147311 p— x Onl Rx# 2147311 WARNING: KEEP OUT OF REACH OF CHILDREN. ~ STORE AT CONTROLLED TEMPERATURE 59-86°F.
76df0435-a920-8851-e053-2991aa0a758c_171_1.jpg z2 oz B0 2 oo aQ 2 s2sfiiss 2 ©3 »3 Bofiz 2CfEiEE i3 e 000000.000000:01++0£L97 42089 “ou] ‘s|ealini @ NuCare Pharmaceut 031y n NDC 68071-4577-1 Lot # 000000 Exp. Date: 00:00 NealPoly B Suftest % —1omL Oftic Susp.. See manufacturer's & Tor ful st of moredients Product # RO304010 ~ RxOnly VE8L XL ‘oM od "oul Tl WARNING: KEEP OUT OF REACH OF CHILDREN. icals, Inc. STORE AT CONTR( NeolPoly B SulfatesiHc 1% 10mi OticSusp. ExpDate:00-00 NDC 68071-4577-01 AWP: $36.55 Mafg NDC_61314-645-11 Vot #: 000000 Rox # 23148926 NeolPoly B SulfatesHc 1% Jomi OticSusp. ExpDate:00-00 NDC 68071-4577-01 AWP: $36.55 Mig NDC_61314-645-11 Lot #: 000000 Rx #23148926 NeolPoly B Sulfatesitc 1% 10mi OticSusp. Exp Date: 00-00 NDC 68071-4577-01 AWP: $36.55 Mfg NDC_61314-645-11 g 5 000000 Rx#23148026 NDC 68071-4577-01 Mig NDC_61314-645-11 e 000000 Rx #23148926 Rx# 23148926 OLLED TEMPERATURE 5877 °F
76e273f4-8782-3fe3-e053-2a91aa0ad4cf_717_1.jpg n 089714088 ‘uvja18Ayd anok Aq Po320.1p 8% Ajuo o8 op13 iodes faw o o0 1ok | 498286 v ‘eBue. q pabe> PRI ouony = “2u] ‘sjeopn 1008 WARNING: KEEP OUT OF REACH OF CHILDREN. imL @ NuCare Pharmaceuticals, NDC 68071-4580-1 Lot #:000000 Exp. Date: 00-00 * Dexameth. Sod. Phos, dmgimL Injection See manufacturers jabel” for full list of ingredients Product # R1183001 ~ Rx Only Inc. Dexameth. Sod. Phos. 4mgiml. Imi NDC 65071 4580-01 NBC 63323 165 02 N800 Rc# 23151200 Exp Date:00-00 NDC 68071-4580-01 AWP:00.00 NBC 63323165 02 020985332 boxw 23151200 NDC 68071-4580-01 NDC 63323 165 02 150005 oxe 23151200 Dexameth. Sod. Phos. 4mgimL i Tnjection Exp Date:00-00 NDC 680714580-01 Awp:00.00 NDC 63323 163 0 o832 hca 23151200 Rx# 23151299 * STORE AT CONTROLLED TEMPERATURE 68.77° F.
76f5eff8-698f-2753-e053-2991aa0ae7f9_34_1.jpg GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated NDC 51407-047-27 GABAPENTIN CAPSULES, USP 100 mg 270 capsules See package insert for dosage information. Aq peimoejnuepy YSN Z2L0E6 VO ‘oliuewen pejelodioou] ‘SNSO Aq pebeyoeyd "uaJp|iyo Jo yoeal VSN 88211 AN ‘ebneddney *oU| ‘S[EONNSDELLIRYd USDSI0S . s . O - AT 255 S0 'U_.‘maz' Sea@g w2003 p&="0 :N:’%: i gg|o LoD a2 =6(D'c° .Y 3283|192 Do agos8|O -0 o 31 Hh o232 pppCo|N SRRDENIN O-‘g-u =~ So%- a 2c = e = o= S&a —— o ® Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
76f5eff8-698f-2753-e053-2991aa0ae7f9_34_2.jpg GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporatea NDC 51407-048-27 GABAPENTIN CAPSULES, USP 300 mg 270 capsules See package insert for dosage information. Aq peinjoenuep VSN ZLOE6 VO ‘Oliuewe) pejelodiodu] ‘SINSD Aq pebexoed ‘ualp|iys jo yoeal V¥SN 88LLL AN ‘eBneddney 9y} JO }NO uoNBdIpaLW || pue SIy) das)y| « *9U| ‘S|BONEORUWIEY USDSIDS - m 0 o = o D o » £ o O o =3 - 8 = !l! o — > o N (=] 5 oo N N w o o 3 ——— ] «Q — o — =h I (g I o —— m — 8 — E-: I > I - I a" |N— 'U I . I I I I . Q0 Z5 =3 ] ] Lo [T &3 S ™ e O oo o —- Eq o @35 —~ Lo ‘_”1: 39 c g 33 Qm = Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59" to 86°F) [See USP Controlled Room Temperature].
76f5eff8-698f-2753-e053-2991aa0ae7f9_34_3.jpg GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated Aq pasnjoejnuepy VSN 2L0g6 VO ‘olllewed pajesodioou] ‘SNSO Aq pabexoed ¥SN 8811 AN ‘eBneddney *ou| ‘smauneaamqu usnys|og "uJpIyo Jo yoes. e . ogbh 23ISR (DE%OO U.(DB:' ':'r"agcg w2007 0 d=gn :m’%: a.g_mo.aq-. mo:"_m — =200 9| gZe8|o 30’-—*:: pcom=z | 030589 a~2_315 Vo Ce|Q 505078 sgem o 2ces -5 R %80 e e ® NDC 51407-049-27 GABAPENTIN CAPSULES, USP 400 mg 270 capsules See package insert for dosage information. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
76f5eff8-698f-2753-e053-2991aa0ae7f9_81_1.jpg , USP F) to 86°| [See USP Controlled Room Temperature]. CAPSULES 100 mg 90 capsules See package insert for dosage information. to 30°C (59° ABAPENTIN G o % N~ < < N~ - 4 0 O O Z Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° 5140704790 * Each capsule contains: 100 mg of gabapentin, USP. = Dispense in a tight container with a child-resistant closure (as required). « Keep this and all medication out of the reach of children. Manufactured by ScieGen Pharmacsuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA = .Wn ¥ 3 & 2 & = 5 O B 8 3 S & S R m 1] O R X2 S 3 ) 2 &= m A O R X S 3 & 2 8 S A O S X S 3 & m = S A O
76f5eff8-698f-2753-e053-2991aa0ae7f9_81_2.jpg F) 300 mg 90 capsules See package insert for dosage information. C (59° to 86° CAPSULES, USP to 30° [See USP Controlled Room Temperature]. NDC 51407-048-90 GABAPENTIN Store at 20° to 25°C (68" to 77°F); excursions permitted to 15° 5140704890 * Each capsule contains: 300 mg of gabapentin, USP. * Dispense in a tight container with a child-resistant closure (as required). * Keep this and all medication out of the reach of children. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
76f5eff8-698f-2753-e053-2991aa0ae7f9_81_3.jpg NDC 51407-049-90 GABAPENTIN CAPSULES, USP 400 mg 90 capsules See package insert for dosage information. permitted to 15° to 30°C (59° to 86°F) Store at 20° to 25°C (68° to 77°F); excursions [See USP Controlled Room Temperature]. 5140704990 » Each capsule contains: 400 mg of gabapentin, USP. Dispense in a tight container with a child-resistant closure (as required). » Keep this and all medication out of the reach of children. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 USA Packaged by GSMS, Incorporated Camarillo, CA 93012 USA GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated ~ GSMS Incorporated
77140634-9f32-40ca-8c83-9fcc3e373c16_356_1.jpg "ONGE DAILY Mesalamine Delayed-release Tablets 30 Tablets (5 x 6) (000w (01) 0 03 60687 397 25 2 ONGE DAILY Mesalamine Delayed-release Tablets 30 Tablets (5 x 6) Each Delayed-Release Tablet Contains: Nesalamine, USP. 129 Usual Dosage: S packaga nsetfor ful prascriving infarmation Storet 2011026 65: o 71 ercurlons permited Bewaen 1510 30°C 59" 5 86 (e UsP Conioled toom Temperaiure] Koep this and all drugs out of reach of childron. FOR YOUR PROTECTION: Do not use f blister s tor or broken. RxOnly Tne drug product contained i this package s from NDC'# G8362.711, Zycus Pharmacastcals USA) e Distributed by: American eaith Packaging Columbus, Ohio 43217 4 730725 0439725081805
77269609-fb89-47c7-97cc-22e0183e91ae_625_1.jpg nan
77269609-fb89-47c7-97cc-22e0183e91ae_625_2.jpg nan
77269609-fb89-47c7-97cc-22e0183e91ae_625_3.jpg nan
776b3591-50b3-1999-e053-2991aa0a42bf_455_1.jpg NuCare Pharmaceuticals, In oqeL *Aep © sawyy Kione sanoy z z o @ 3 o > ® S 5 S o £ o 2 @ 5 ¥ 2 ro See manufacturer's label for full ist of ingredients. : NDC-68071-4585-1 E Lot #: 000000 Exp. Date: 00-00 Tamsblosin HCI 0.4mg 100 Capsules ‘Product # R1630100 s . Rx Only WARNING: KEEP OUT OF REACH OF CHILDREN. Tamsulosin HCI 0.4mg #100 Capsules Exp Date:00-00 NDC 68071-4585-01 AWP: Mig NDC_ 65862-598-01 Lot 7 500000 Fox # 23158213 Tamsulosin HC1 0.4mg #100 Capsules Exp Date:00-00 NDC 68071 4585-01 AWP: Mig NDC_65862-598-01 Lot #: 000000 Rx # 23158213 Tamsulosin HCI 0.4mg 4100 Capsules Bxp Date:00-00 NOC 68071-4585-01 AWP: Mg NDC_ 6586359801 Vor 7 B00000 - Fox ¥ 23158213 Tamsulosin HC1 0.4mg #100 Capsuies Exp Date:00-00 NbC 68071-4585-01 i NDC_65862-598-01 o2 500000 Rox # 23158213 Rx# 23158213 “STORE AT CONTROLLED TEMPERATURE 68-77 °F.
776e2147-e29c-87c0-e053-2991aa0af9b0_752_1.jpg (H 8101 AV 91/60 A4 OIN 10} pAMIBIUE o doay 18U12IUC0 WEISSELPILP Ul BsuedsiQ 40 841U paguosap 2 siaueluc0 paSOR-{@h Uy ssuadsiq njeladu) wooy palloguoy s 8as] (4oL 01 .88) .52 01 .02 10 OIS uopeus 110 abeyoed 68 SEESOQNODY ‘4sn ‘upeoyoney 100U 052 SUEWOD oKE| PaR00 Wiy 1923 Rx Only KARE. NDC 42291.406-50 Levofloxacin 50 Tablets Pharmacis: Dispense he Medcation Guide provided separatly 0 each patient Tablets, USP l
776e2147-e29c-87c0-e053-2991aa0af9b0_752_2.jpg (I 810k AY. 91/60 Aoy O o} paimoBuEIY UOIpIIYD 0 4oBa1 041 Jo 0 doay ulssuadsig +89) 252 01 402 10t o SBESG HHBY e 4s uoeoyoNs] 1014 005 SUIRIO9 9IGE PoIe03 Wl U3 Lo "TREY | E 2 X H=E x5 O T o e D°I KME 250 25| 8 o R s 32 [ [
776e2147-e29c-87c0-e053-2991aa0af9b0_752_3.jpg (Y8101 AV 94160 oY ‘DI SLYBENL DiSEIng 01 “IUHAY TSRO WRISSS-PIND Ul 85UBdSIQ 1 paguosap U asuadsig wogeuy 11 0 esu aetoed 65 iesad ‘4sn ‘udeojoNel 1010w 032 sulEwoD 91 Pale0d Wi 4363 ca [d. wis 22 o |55 £ %" ¢ 5 O 1 (5] 80 50 Bl s §95 02 2o | % - - =3 & l
777edd2f-8eaa-38ea-e053-2991aa0aa5bf_85_1.jpg NuCare Pharmaceuticals, In peydeIp s Ajuo esn) gE et NDC 68071-1824-2 S835 %% Lot#:000000 Exp. Date: 00-00 Souz 29 . £ Bicillin L-A fimg ¢ 2mL Injectable Susp. ? g See manufacturer's label oas for full list of ingredients. “au 10029804 Product #: R0867001 o Rx Only Bicillin L-A 2mL Injectable Susp. Exp Date:00-00 NDC 68071-1824.02° AWP:00.00 'NDC 60793-701-02 #:000000 Rx# 23158466 Bicillin L-A 2mL Injectable Susp. Exp Date:00-00 NDC 68071182402 AWP:00.00 'NDC 60793-701-02 #:000000 Rx# 23158466 Bicillin L-A 2mi Injectable Susp. Exp Date:00-90 NDC 68071-1824-02 AWP:00.00 NDC 60793-701-02 #:000000 Rx# 23158466 Bicillin L-A 2mL Injectable Susp. Exp Date:00-00 NDC 68071-1524-02 _ AWP:00.00 NDC 60793-701-02 #:000000 Re# 23158466 Rx# 23158466 WARNING: KEEP OUT OF REACH OF CHILDREN. STORE AT CONTROLLED TEMPERATURE 36-46° F.
777f21c1-0ca2-3f4d-e053-2991aa0ac7eb_470_1.jpg 5] b4 £ NDC 68071-4587-2 £ Lot# 000000 Exp. Date: 00-00 Cephalerin 125mgf5mL 00mL Oral Susp. See manufaciurer's label for full st of ingredients mok 18 ‘8BuBIQ ‘S18013n80BILIIBLG 8J8DNN Aq peBexoed 3 wgN SI9ONINEORALIU W01 “auj Product # R0251200PED B Rx Only 000000,000000.002.20,88Y+089 are Pharmaceuticals, Inc. Cephalexin 125ma/5mL 200mL. Oral Susp. — Exp Date:00-00 NDC 68071-4585-02 AW: $31.00 Wi NDC_ 0093417574 Lot #: 000000 fox # 23160658 Cephalexin 125mel5mL 200mi. Oral Susp. . Exp Date:00-00 NDC 68071-4587-02 AWP: $31.00 Mg NDC 0093417574 Lot #: 000000 . Rx ¥ 23160698 Cephalexin 125mgi5ml. 200mL Oral Susp. Exp Date: 00-00 NDC 68071-4587-02 AWE: $31.00 Wiy NDC 0093417574 Lot # 000000 - Tox # 23160608 Cephalexin 125mgi5mL 200mL Oral Susp. Exp Date:00-00 NDC 680734585-02 Mg NDC_0093-4175-74 Lot #: 000000 Rox # 23160698 Rx# 23160698 WARNING: KEEP OUT OF REACH OF CHILDREN. STORE AT CONTROLLED TEMPERATURE 63-77 °F.
7782cdf0-3642-421d-e053-2a91aa0af366_142_1.jpg (NN G R E e e ee S 1S SeVESEE o Diltiazem HC 120mg LTTEHILIE O e L £ sigiisl T A 400 s A s g ggesiis = e s : fiomeil Diltiazem HCI 12(]mg B e g o L g £ #30 Tablets i - 8 ~e . Diliazem HC1 120mg. = £ |20mg Diltiaze Hydrochlonde. USP g S RS F0RC yellow 46 aluminum ke L e g g : BT & g @ Oblong Orange Scored Tablet Debossed: Lot #: 600000 Rx # 23162694 S oo " and "321° on the scored side mwl'm £ £ 7 DHEGRHCITON oo 3 3 NDC 68071-4591-03 2 3 Mfg NDC 0093-0321-01 it Product #: P1876030 Lk - oigons = 42314205 £F e Rx Only Rcr 23162694 WARNING: KEEP OUT OF REACH OF CHILDREN, ~ STORE AT CONTROLLED TEMPERATURE 63-77°F.
779ece39-b6fa-4977-8df5-d018d39d4d0d_340_1.jpg (NN G R E e e ee S 1S SeVESEE o Diltiazem HC 120mg LTTEHILIE O e L £ sigiisl T A 400 s A s g ggesiis = e s : fiomeil Diltiazem HCI 12(]mg B e g o L g £ #30 Tablets i - 8 ~e . Diliazem HC1 120mg. = £ |20mg Diltiaze Hydrochlonde. USP g S RS F0RC yellow 46 aluminum ke L e g g : BT & g @ Oblong Orange Scored Tablet Debossed: Lot #: 600000 Rx # 23162694 S oo " and "321° on the scored side mwl'm £ £ 7 DHEGRHCITON oo 3 3 NDC 68071-4591-03 2 3 Mfg NDC 0093-0321-01 it Product #: P1876030 Lk - oigons = 42314205 £F e Rx Only Rcr 23162694 WARNING: KEEP OUT OF REACH OF CHILDREN, ~ STORE AT CONTROLLED TEMPERATURE 63-77°F.
779ece39-b6fa-4977-8df5-d018d39d4d0d_340_2.jpg Each tablet contains: 5 mg of Dexmethyiphenidate HCI DOSAQE: See package insert for complete prescribing Information. Dispense in a tight, light resistant container as defined In the USP with a child-resistani closure. Store at 20° o 25°C (68° to 77°F) [S8e USP Controlled Pratect from light and molsiurs. KEEP THIS AND ALL MEDICATION QUT OF THE REACH OF CHILDREN. This bottle has been sealed for your protection. m Temperature]. NDC 0527-1900-01 Dexmethylphenidate Hydrochloride Dispense -I|i| Medication Gulde attached or provided separately. Bconly 100 TABLETS 2 Distributed by: Lannett Company, Inc. PA19154 Philadglpl 0527-1900-01 =
779ece39-b6fa-4977-8df5-d018d39d4d0d_340_3.jpg Each tablet contalns: 10 mg of Dexmethylphenidate HCI ggmfm Insert for lete e e Insert for com) pmgﬁglng Information. P Dispensa In a tight, light resistant container as dafined In the USP with a child-resistant closum. Store at 20° to 25°C (68° to 77°F) [Sea USP Gontrolled Room Temperature]. Protact fram light and moisture. KEEP THIS AND ALL MEDICATION QUT OF THE REACH OF CHILDREN. This bottle has been sealed for your protaction. NDC 0527-1901-01 Dexmethylphenidate Hydrochloride Tablets @ Dispense with Mei ion Guitla atiached or provided separately. R onty 100 TABLETS Distributed by: inett Company, Inc. Philadslphia, PA 19154
77bdaf2b-4505-115e-e053-2991aa0ad5ec_230_1.jpg LIDOCAINE 5% OINT 50gm Gompare: Xylocaine 5% Exp. 00100 Lot# ABOOCD Mig. ASGEND LAB 67677-0473-80 AGGOUNT: 00-0000 Use As Directed by Physician ‘CAUTION: fadoral Law PROHIBITS he uansio o tis drug o anyone oher than he person whom prescribed and proibts cipensing wthout a pescripton. unisss OTC. See outsert fo a0dAx . KEEP OUT OF REACH OF CHILDREN Stors i & 00l iy lacs ot 66-77 F uiass prited 52959-0993-50 QTR LIDOCAINE 5% OINT NDC: 52959-0993.50 Exp.0000 MFG NDG 67877-0473-80 ary:sogm Lots: ABOOCD LIDOCAINE 5% OINT NDC: 52966-0963.50 Exp. 0000 MFG NDC 67877-0473-80 LIDOCAINE 5% OINT NDG: 52959.0993.50 Ex0.0000 MFG NDC 67877-0473-60 arv:sogm Lot: ABOOCD LIDOGAINE 5% OINT NDC: 52959.0893.50 Exp. 0000 MFG NDC 67877-0473-80 arv:sogm Lot: ABOOCD Rapack: H.J Harkin Co., Ino. Giover Baash, CA 03433
77d07165-8e89-41f4-bdc1-1940968bf1b3_633_1.jpg Pacbaged by Eryant Rench Bnbank. @4 91508 5 BLUE ROUNDLAN 1252 Dicyclomine HCL S 20mg Tablet | £ 5 May cause dizziness or Compare To: drowslness Bentyl 20mg Tablet Store at room temp of LammettCompany e . 2025C@8TTR) #30 Exp: MMYY 3 NDC 7133501601 012991114626
77d07165-8e89-41f4-bdc1-1940968bf1b3_633_2.jpg Pacbaged by Eryant Rench Bunbank. ¢4 91500 T i 5, LUGHT TURQUOISE BLUE OPAGUE Dicyclomine HCL S cwsuzuvianst: uviantsn 10mg Capsule o £ May Cause Drowsiness S Store at room temp of Compare To: 20-25 C (68-77F) Bentyl 10mg Capsule Keep all drugs out of Wen Pramaceuicab e | reach of children #30 Exp: MMYY & NDC 7133505881 033411114610
77d8d04b-dd5a-4cf1-8740-53e65c13014d_646_1.jpg Potassium Chloride 1500mg(20mEq K) . Tablet, ER ary: 30 ID #: ABRS;123 Expires: NDC #: 70518-0890-00 Shape: Oval LOT #: Ref #: 62037-0999-10 MFG: Actavis, Sunrise, FL 33325 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
77d8d04b-dd5a-4cf1-8740-53e65c13014d_646_2.jpg Potassium Chloride 1500mg(20mEq K) . Tablet, ER ary: 60 ID #: ABRS;123 Expires: NDC #: 70518-0890-01 Shape: Oval LOT #: Ref #: 62037-0999-10 MFG: Actavis, Sunrise, FL 33325 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
77d8d04b-dd5a-4cf1-8740-53e65c13014d_646_3.jpg Potassium Chloride 1500mg(20mEq K) . Tablet, ER ary: 90 ID #: ABRS;123 Expires: NDC #: 70518-0890-02 Shape: Oval LOT #: Ref #: 62037-0999-10 MFG: Actavis, Sunrise, FL 33325 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
77f6270f-af0b-f1fa-e053-2991aa0ab7e8_36_1.jpg @ NuCare Pharmaceuticals, Inc. 000000,000000,08.£0789%1 2099 0 *Aep v sow sinay A1aAe ‘aBueiO ULRUd 480NN q pebexoed 26 V' 01850 N "UOIAQ 3u1 ‘YN BuUilBg OPUIGOINY .98 1] Lot #:000000 Exp. Date: 00-00 WARNING: KEEP OUT OF REACH OF CHILDREN. NDC 68071-4594-3 Ondanseiron 0DT dmg #30 Tablets See manufacturer's label for full list of ingredients Product # R1194030 Rx Only Ondansetron 0DT 4mg #30 Tablets Exp Date: 00-00 NDC 68071-4594-03 AWP: Mfg NDC_65862-390-10 Lot #: 000000 Rx # 23167703 Ondansetron ODT 4mg #30 Tablets Exp Date: 00-00 NDC 68071-4594-03 AWP: 147 NDC_65862.390-10 Vod 27 000000 Rx # 23167703 Ondansetron ODT 4mg #30 Tablets Exp Date:00-00 NDC 68071-4594-03 AWP: bty NDC_65862-390-10 Lot #: 000000 Rx # 23167703 Ondansetron DT 4mg #30 Tabiets Exp Date:00-00 NoC 680714594-03 Whig NDC_65862-390-10 Lot ¥ 000000 Rx # 23167703 Rx# 23167703 * STORE AT CONTROLLED TEMPERATURE 5§9-36 °F.
78101030-ef1d-44b9-e053-2991aa0a158d_179_1.jpg Lot 000606 i B 9 0o " Silnall [100mg #10 Tablets g Each film coated tablet contains & Citrate, USP equivalent n 100mg of Sikdenafil g Round-Shaped White Colored Tablet " on one side 55 onfeGiher sce = Product P2189010 — Rx Only - oun ‘siwoynéSSEEND 0 mawzd 9UDUI'950 009 “PPGRIOPAH poy = Sildenafil 100mg #10 Tablets - Exp Date: 00-00 NDC 68071.4599-01 xawi: g NOC 317535 1 20 Lot #: 000000 R 23169813 Sildenafil 100mg #10 Tablets Exp Date: 00-00 NDC 68071-4599-01 AwP: Mig NDC 31722-711-30 Lot#: 000000 R # 23169913 Sildenafil 100mg #10 Tablets Exp Date: 00-00 NDC 68071-4599-01 AwP: Mfg NDC 31722.711-30 Lot #: 000000 Rx # 23169913 Sildenafil 1 #10 Tablets ExpDate:00-00 NDC 68071-4509-01 Mig NDC 31722-711.30 Lot #: 000000 R # 23169913 Rx# 23169913 WARNING: KEEP OUT OF REACH OF CHILDREN. ~ STORE AT CONTROLLED TEMPERATURE 68-77°F.
7813e930-2cca-42be-b1b2-c5fc86040cf3_63_1.jpg CLINICAL solutions WHOLESALE Minocycline HCI 100mg Capsules ND 118-0484-8 Qty: 30 Mig.NOC: 13668-0484-05 GTIN: 00356118048484 Mig. Lot # SAMPLE123 Batch #: SAMPLE4S6 Mg By: Torrent Pharmaceuticals Limited Exp.: Oct 2019 Basking Ridge, NJ, USA, 07920 ‘SN: YYMMDDO00000O Ty ey P e, .5 P N300 U5
7821bd40-4c84-4984-951b-6436ae20421a_750_1.jpg KEEP OUT OF REACH OF CHILDREN ach et contts 75 g ke, S H2TGL 25C 6T TR sz <Viberzi earsa0 -~ S (elwadolne) blets € vy 75MG PER TABLET R 88 e Irvine,CA 92812 Dispense the accompanying 210 oy, s Medication Guide 1o each patient #z:Allergan. 60 TABLETS | Im‘i‘i‘" = ez NILD
7821bd40-4c84-4984-951b-6436ae20421a_750_2.jpg KEEP OUT OF REACH OF CHILOREN. E2eh able ontais 10 g ezadolne SoRHZIT T (T 07T W s pomitd o 1510 37 (0¥ 086 Dosage snd Mdminisratr. O bt ity wih s See 1 Prescngforation. o rmomw formaton. pease call1-800-678-1605 Distrbuted by Allergan USA. nc. e, CA 02812 ©2016 Alargan. Al ightsreserved -E,’%Alkrgun. RxOnly NOC 61874-100-60 <Viberzi (elvadoine) tables € 100 MG PER TABLET Dispense the accompanying Medication Guide 1o each patient 60 TABLETS nli‘lvl—iii”l"wli NILD
78221eab-66fd-4cd8-9c81-af52eb83671c_1_1.jpg FH 25 : H iR u i3 ER i !z K i G i H § & | , e
78221eab-66fd-4cd8-9c81-af52eb83671c_1_2.jpg nan
78221eab-66fd-4cd8-9c81-af52eb83671c_1_3.jpg £53 —| (= |
78221eab-66fd-4cd8-9c81-af52eb83671c_1_4.jpg — e | aunss [p— 1 oA | o oy
78221eab-66fd-4cd8-9c81-af52eb83671c_1_5.jpg [ s Oral Transmacesal o ) i i T Jmomua — & |
78221eab-66fd-4cd8-9c81-af52eb83671c_1_6.jpg i Oral Transmucosal ot 1000 meg i e
78445dbf-c7cd-419f-a7be-72821e496628_908_1.jpg Gabapentin 400 mg Capsule arv: 30 ID #: 214 Expires: NDC #: 70518-1469-00 Shape: Capsule LOT #: Ref #: 67877-0224-05 MFG: Ascend Labs, LLC, Montvale, NJ 07645 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
78475aff-f72b-a6a1-e053-2a91aa0a3ae6_198_1.jpg NOC: 70934-051-30 (0% 0 e gue oo s MEG: AMBIGIS0 Ao A1 Gt Ibuprofen Tablets, USP 800mg 30 Tablets RxOnly S 2 SR v B arectin) .. B sl i e e Aty T, 052 oty T o Erpoar st T, 5 ey B S ' et 5 ey
78736e89-2fd2-a4d6-e053-2991aa0a355a_993_1.jpg \e=TC aceuticals, Inc ; <o > y PPieggzsis NDC 68071-4604-3 T N e bbbt ZH2:39255 Lot# 000000 Exp. Date:00-00 NDC 68071450403 AWP: & sHz:Zw2:8 <UL - . Ry NOE 0586300208 g ‘ :8088¢2 CIta| m1lm Lot 52 000000 ox # 23173942 5 §iomcit 0pra Gitdopram 1 3 o Haivs 3¢ p A oo g e fed | Noe 58071-4604-03 AWe: i=2iH:i8 1 __ #30 Tablets St s s g ach tablet conains: Citalopram 2 Zq italopram Hydrobromide USP equivalent ol T g | s 10 10mg Citalopram base NDC 68071460403 AWP: g 1 £B - HiNee Bse2'00s o 2 2 ound Shaped Peach Colored Tablet 50000000 RN%23173942 g Debossed: ‘A" on one side 05 i E=as e otnr o SRPT cep vareco000 £ 452 can3seoe-03 Mig NDC 65862-005-05 Product # P1299030 Lok #: 000000 Rx # 23173942 e Rx Only Re# 23173902 WARNING: KEEP OUT OF REACH OF CHILDREN. STORE AT CONTROLLED TEMPERATURE 59-86°F
7896052c-2a72-ca89-e053-2a91aa0ae86e_436_1.jpg TO OPEN — TEAR AT NOTCH Each 100 mL contains dopamine hydrochloride 160 mg; dextrose, hydrous 5 g in water for injection; sodium metabisulfite added 50 mg. May contain hydrochloric acid and/or sodium hydroxide for pH adjustment. 269 mOsmolfliter (calc.) pH38(251045). Single-dose_container. Discard unused portion. For IV, use. Usual dosage: see insert. WARNING: CONTAINS SULFITES. Drug additives should not be made to this solution. The overwrap is a moisture and oxygen barier. Do not remove unit from overwrap untl ready for use. Visually inspect overwrap for tears or holes. Discard unit if overwrap is damaged or if solution is darker than slightly yellow or discolored in any other way. Use unit promptly when overwrap is opened. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature] Protect from freezing. See insert. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard solution s sterility may be impaired. @) SR @1 0 030409 780922 6 250 mL NDC 0409-7809-22 1600 mcg/mL micrograms/mL I DOPamine HCI in 5% Dextrose Injection, USP 400 mg Total Single-dose container ©Hospira 2006 F WR-0168 (1/06) Printed in USA HOSPIRA, INC., LAKE FOREST, IL 60045 UsA ~ Hospira B oy 1600 meg/mL micrograms/mL I DOPamine HCI in 5% Dextrose Injection, USP 400 mg Total B WR-0168 (1/06)
7896052c-2a72-ca89-e053-2a91aa0ae86e_436_2.jpg nan
78c25911-0042-664e-e053-2a91aa0a57a1_740_1.jpg 30—6 25—=h ~ | | | = 10 mL Single-dose INFANT NDC 0409-5534-34 4.2% SODIUM BICARBONATE v, usp 5 mEq (0.5 mEq/mL) B only For LV. use. Usual dosage: See insert. Sterile, nonpyrogenic. 1 mOsmol/mL (calc.). pH 8.0 (7.0 to 85). Hospira, Inc., Lake Forest, IL 60045 USA RL-0058 (4/04) €01) 0 030409 553434 2 15—3 20—4 > L6y < 40—s ~ ] o mEq Approx. mL 0—0 05—1
78c25911-0042-664e-e053-2a91aa0a57a1_740_2.jpg 2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (05 mEg/mL) With male fur lock adapter and 20-Gauge protected needle ~. m..u ._.m.a ._.l...l...l”.l. 1.0 ] e St I Mukiiteo, WA 98275
78ebea72-fd01-0552-e053-2a91aa0a698b_815_1.jpg yd anok Aq onN Aq poBexos, Pe}2041p w8 Ajuo esp 3 i i : 3 a0 WARNING: KEEP buT OF REACH OF CHILDREN. Laianoprost 0.005% 2. SmL Ophth. Soln. ‘See manufacturer's abel for fulllist of ingredients, ”.Pfo’aucr# Ri1558025 - RxOnly (=T T3ToN NDC 68071-4612-2 Lot #: 000000 Exp. Date: 00-00 0.005% 25mi . Soln. * Exp Date: 00-00 NDC 68071461202 AWP: Mfg NDC 24208-463-25 Lot #: 000000 R # 23179461 S e g ootm 0000 NDC 68071461202 Awp: Mig NDC_24208-463-25 Lot #: 000000 Rx # 23175461 S % oot 0000 NOC 68071-4612-02 Awp: - Mfg NDC 24208-463-25 Lot #: 000000 Rx # 23175461 Latanoprost 0.005% 2.5mi Ophth. Soin. ~ Exp Date: 00-00 NDC 68071-4612-62 Mig NDC 24208 463-25 Lot #: 000000 Rx # 23179451 Rx# 23179461 STORE REFRIGERATED BETWEEN 3646°F.
78ec0be1-b770-e670-e053-2991aa0af1e3_989_1.jpg NDC: 67296-1038-2 CEFADROXIL 500MG Rx Only 20 Capsules Lot: B7020A 1 Exp: 10119 Usual adult dosage: See package insert Store at controlled room temperature 20-25 C (68-77 F) Mig By Aurobindo Pharma Limited Hyderabad 500 036 India 65862-085-01 Dist. by Redpharm Drug Eden Prairie. MN 55344 SN 55048 —_— _— —— — 1l 67296 10382 3 3
78fd0e1b-3fd0-59a9-e053-2991aa0ad143_816_1.jpg NDC 68071-4613-9 e e ™ e s 00-00 NDC 68071-4613-09 AWP: Lot #: 000000 Exp. Date: 00-00 o e 00000 ey 23179666 Donepezil HCI 10mg une eZI m #90 Tablets Exp Date: 00-00 NDC 63071-4613-09 AWP: Wig NDC31732.738-50 Lok #: 000000~ Rx # 23179666 Tablets Donepezil HCI 10mg Tablets Exp Date: 00-00 ‘Awp @ sowpy sinoy Kiene™ eoyuy See manufacturer's label ~DC 68071-4613-09 AWP: for full list of ingredients. Mfg NDC 31722-738-90 15247 G000 Re® 23179666 Donepezil HCI 10mg #50 | Tablets Exp Date:00-00 NDC 68071-4613-09 Product #: R1481090 Mig NDC 31722-738-50 Lot #: 000000 Rx # 23179666 K Rx Only Rx# 23179686 WARNING: KEEP OUT OF REACH OF CHILDREN. STORE AT CONTROLLED TEMPERATURE 6877 °F 08! wIPUI 08 808 -
7910895b-eb5f-fc4e-e053-2991aa0ad2ec_511_1.jpg > 2 = 2 =< 2 . i= 32 i= 35 EE w2 E= al = 8 = 2 iI= s g g g £ 8 " 3'09; § WARNING: KEEP OUT OF REACH OF CHILDREN. Product # R0312030 RxOnly > | STORE AT CONTROLLED TEMPERATURE 68.77°F. @ NuCare RIEIEIETTeE ) [[geR NDC 66267-949-30 Lot #:000000 Exp. Date: 00-00 Wil ki Cream See manufacturer's Jabel for ful st of ingredients 30 Cream Exp Date: 00-00 NDC 66267-0949-30 AWP: $23.85 19 NDC_ 0472-0150-50 #:000000 Rx # 23181399 NystatiTriameinolone Acctonide 305 Cream Exp Date: 00-00 NDC 66267-0949-30 AWP: $23.80 NDC 0472015030 o e~ J—, Wystatm/Tramcmotone Acetone 305 Cream Exp Date: 00-00 NDC 66267.0049-30 Awp: 333,05 NDC '0372'0150-30 PG 83 rramzee NystatnTriamesmolone Acetonsde 309 Cream Exp Date: 00-00 NDC 66267094930 Mig NDC 0472-0150-30 Lot #: 000000 Rx # 23181308 Rx# 23131399
7910c69c-9660-69bd-e053-2991aa0aedb4_749_1.jpg NuCare Pharmaceuticals, Inc capsule contains Indomethacin e #7 ER Capsules Exp Date: 00-00 NP §3071-3060.07 AWP: - US98 Obiong Dark Yeliow Cap/Clear Lok #: 000000 Rox # 23181707 Transparent Body Impnnted indomethacis H on cap 105" on body ! a Thmy £001Z10d oz2 NDC 68071-3060-7 Iadomethacin 75m8 30255 Lot#.000000 Exp. Dale:00-00 i sssismns; v o33 & Lot #: 000000 Rx # 23181707 g3 Indomethacin 75mg i - 5 #7 E-RCapsules fmecimssa? ~e ) sxiendec relecen Indomethacin 75mg ” g 2 #7 R Capsules Exp Date:00-00 NDC 68071-3050-07 Mfg NDC 31722-565-60 Product #: P0121007 Lot #: 000000 Rx # 23181707 e Rx Only R 23181707 WARNING: KEEP OUT OF REACH OF CHILDREN. STORE AT CONTROLLED TEMPERATURE 63-77°F 000000.000000.£-L0080¢ 1£088
7924d56f-943c-76bd-e053-2a91aa0a1099_718_1.jpg jeonéd X = 8 3 > @ pomIwnUE @ NuCare Pharmaceu NDC 68071-4616-9 Lot #: 000000 Exp. Date: 00-00 e 5Bz g #90 = WARNING: KEEP OUT OF REACH OF Capsules “Each capsule contans: Amlodipine Besylate USP === equivalent lo Amlodipine 2.5mq ‘and Benazepril Hydrochloride USP 10mg ‘Oblong White Capsule Imprinted- I on cap ‘96" on body Product #: P1883090 ~ Rx Only CHILDREN. ife= S g (e Amiopane 2 Sma/Benazepr HCI 10mg 50 Capsules Exp Date:00-00 NDC 68071-4616-09 AWP: Mfg NDC_65862-582-01 Lot #: 000000 Rx # 23182922 Armkodspine 2 Smo/Benazepni HC) 10mg #90 | Capsules Exp Date:00-00 NDC 68071-4616-09 AWP: Mfg NDC_65862-582-01 Lot #: 000000 R # 23182922 Aemkodipme 2 Smo/Benazeptt HC 10mg #50 Capsules Exp Date: 00-00 NDC 63071-4616-09 AWP: Wig NDC_65862-582-01 Lok #: 000000 Rx # 23182922 Amiodpine 2 Semo/Benazeped HCI 10mg #50 Capsules Exp Date:00-00 NDC 68071-461609 Mig NDC 65862-582-01 Lot #: 000000 R # 23182922 Rx# 23182922 STORE AT CONTROLLED TEMPERATURE 68-77°F.
79303879-f59d-4f06-b8dc-273c7c67adf4_627_1.jpg Do not use if inner seal is missing or broken. Each tablet contains: Olanzapine, USP 2.5 mg, Usual Dosage: ee package nser or complete dosage information Storage: Storeat 20°t0 25°C (68°to 77°F); excursions peritted 0 15°10 30°C (59°to 86°F)[see USP Controled Room Temperaturel Dispenseina tight,light-esistant container with achid-resistant closue. KEEP CONTAINER TIGHTLY CLOSED. KEEP ALL MEDICATIONS OUT OFTHE REACH OF CHILDREN. NDC 69807-2011-1 Olanzapine Tablets, USP PHARMACIST: Dispense the accompanying Medication Guide to each patient. 30 Tablets Rxonly ‘_;’ Manufactured by: Jiangsu Hansoh PharmaceuticalGroup (o, L, Lianyungang,Jangsu 222069 China Distributed by: eVenus Pharmaceutical Laboratories, Inc, Pinceton, N 08540 USA Rev.01 69807 3' Lot Exp.
79303879-f59d-4f06-b8dc-273c7c67adf4_627_2.jpg Do ot use f inner seal s missing or broken. Each tablet contains: Oanzapine, USP S mg. Usual Dosage: ee package nsert for complete dosage nformation Storage: Storeat 20°t0 25°C (68°to 77°F); excursions pemitted 0 15°10 30°C (59°to 86°F)[see USP Controled Room Temperature]. Dispenseina igh,light-teistant contaner with achild-resistant losure. KEEP CONTAINERTIGHTLY CLOSED. KEEP ALL MEDICATIONS OUT OFTHE REACH OF CHILDREN. NDC 69807-2012-1 Olanzapine Tablets, USP PHARMACIST: Dispense the accompanying Medication Guide to each patient. 30Tablets Rxonly ‘_d-’ Manufactured by: Jiangsu Hansoh PharmaceuticalGroup o, L, Lianyungang,Jangsu 222069 China Distributed by: eVenus Pharmaceutical Laboratories, Inc, Pinceton, N 08540 USA 20121 Rev.01 89807 Lot Ex
79303879-f59d-4f06-b8dc-273c7c67adf4_627_3.jpg Do ot use f inner seal s missing or broken. Each tablet contains: Oanzapine, USP S mg. Usual Dosage: ee package nsert for complete dosage nformation Storage: Storeat 20°t0 25°C (68°to 77°F); excursions pemitted 0 15°10 30°C (59°to 86°F)[see USP Controled Room Temperature]. Dispenseina igh,light-teistant contaner with achild-resistant losure. KEEP CONTAINERTIGHTLY CLOSED. KEEP ALL MEDICATIONS OUT OFTHE REACH OF CHILDREN. NDC 69807-2012-1 Olanzapine Tablets, USP PHARMACIST: Dispense the accompanying Medication Guide to each patient. 30Tablets Rxonly ‘_d-’ Manufactured by: Jiangsu Hansoh PharmaceuticalGroup o, L, Lianyungang,Jangsu 222069 China Distributed by: eVenus Pharmaceutical Laboratories, Inc, Pinceton, N 08540 USA 20121 Rev.01 89807 Lot Ex
794aa355-66de-41b8-aedf-f2c40f6bc664_952_1.jpg Comtalen: N (22 i sy [ O packags o 4 Daposs s — Butrans’ ([ ! T (buprenorphine) Transdermal System e Systemic defvry of mog per haur of uprenorphine for seven cays. | bt ‘ath Because serious or fe-threatening breathing problems could result, DO NOT USE BUTRANS for: pain that can be treated with immediate release opioids or non-opioid analgesics « intermitent (on an as nesded basi) pain Ry Only Butrans C (buprenorphine) Transdermal System 'NHQTIHO 40 HOV3H 40 110 4331 0000t o P e . 0,57 oy s 5 o 0y orot oy o om0 & e v ] ey ‘051 o3 Apeo1 uun yonod 1o pousdoun u| swoIsAs uEIoy ‘2udiouadng Jo Bu § SEINCO wWaISKS [BusaPSUS) 0E3 wiayshg [eunsapsuel | (uiydiouaidng) sueqng r082-1 1068 9ON
794aa355-66de-41b8-aedf-f2c40f6bc664_952_2.jpg oname:. B oaanIaTs. | T § Tanadorna Syesms o oo o4 Dapenl Ui o ATTENTION b HSEr: Butrans EIEE (buprenorphine) Transdermal System delivery o1 7.5 meg per hour of buprenorphine for seven days. o sorlous or life-threatening breathing problems could result, DO NOT USE BUTRANS for: pain that can be treated with immediate release opicids or -opicid analgesics. « intermitent (on an as necded basie) pain Butrans {buprenorphine) Transdermal System ‘NIHTTHO 40 HOVA 40 100 a3 485001 e o 42 057 308 oo e e ks ke e s o v g v ‘951 01 AP 14 Yonod 10 pouocioun uf SwRISAs uEtow ‘ouydiouaidng jo Bul 52 SUEHUIOD WSlSAS [BuLISPSUEI U9 wishg [euapsuel | (puiydiouaidng) suenng 9025211065 20N
794aa355-66de-41b8-aedf-f2c40f6bc664_952_3.jpg Contains: NDC 5901175104, 7)) oo besesa s — Butrans' /10 meghour C Y (buprenorphine) Transdermal System T s Metasion ide ST beproded Systomic dolivery of 10 meg por hour o buprenorphine for soven days. | yondaperis. Because serious or lfe-threatening breathing problems could result, DO NOT USE BUTRANS for: Rx Only * pain that can be teated with immediate-release opiods o nonopiid analgosics intermitent (on an as-needd bass) pain @“@ o . Butrans' 10 meghour ( : (buprenorphine) Transdermal System o i e 5 e ‘NBHHO 40 HOVS 40 100 d3H 4005051 e e G015 i e e W s oo e s o o 051 01 Apees 11un onod 0} pauadoun ut swersAs ueIol “ounydiousidng Jo Bui O} SURIOD WoISAS [OWIIPSUEI 1OE wyshg [euapsuer] (duiydiouaidng) : ) moyBow o SURIING ootz 1065 0N
794aa355-66de-41b8-aedf-f2c40f6bc664_952_4.jpg i NDC 55011-758-04. S agerma s ok packags f 4 Dsposs Uns = Butrans' s meghour = (buprenorphine) Transdermal System e Systemic defivery of 16 mg per hour of bupranorphine for seven days. Because serious or lfe-threatening breathing problems could result, DO NOT USE BUTRANS for: « pain that can be reated with immesiate-reloase opiods or non-opioid analgesics « inenmittent on an as-nesded basis) pain Butrans: 15 meg/hour (buprenorphine) Transdermal System Tt iy aaingang sty 5 o1 Apeas 1gun yonod o) pauadoun u SwISAS I ‘SUIUIOUOIANG Jo Bl g1 SUIEIOD WaISAS [ewioPSUA (9E3 wishs [ewsapsued | (uiydiouaidng) moyow g SURIING ¥0-654-11065 OGN,
794aa355-66de-41b8-aedf-f2c40f6bc664_952_5.jpg Contins: NDC 59011.752.04 7) LT s ‘One packegs o Deposa s rTEnTon DISPENSER: Butrans: EomegsiE (buprenorphine) Transdermal System Systomi dolivey of 20 mog pe hour of buprenorphineforsaven days. Because serious o lfe-threatening breathing problems could result, DO NOT USE BUTRANS for: * pain tha can b treated with immediate-elease 0pioids or non-opioid analgesics « intermitent (on an a5-needed basi) pain (buprenorphine) Transdermal System s G B TS NHQTIHO 40 HOVS 40 1010 4 - 0.0 o e ) e e o o 03 s e e s g e I sty gz oty 251 03 Apea1 un yonod 10 pausdoun uf swalsAs usioy “2uIUdi0ueIANG Jo Bul O SUIEIUOD WoISAS [PWOPSUEA UoEI :) washg [ewsapsuel | (upydiouaidng) pwE Ssuesng 028141065 90N
7951139c-b271-45a4-b523-34b23800917b_540_1.jpg o o002 ey APIISO* apriso’ {nesslaming (mesalamine) 0375g Serialization 20cpues Salix@® Area
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_1.jpg Each im-coated tabletcona noc 6586284130 itromyein divydrate USP equivalnt o aztvomycin 250 g Rxonly DOSAGE AND USE: Se¢ Azithromycin e e Tablets, USP Ganbs e it it oo 250 mo J 2 Auromno Soreat 20 025°C 68 077F) {5e2 USP Confroled Room Teperature] 30 Tablets Dispense i tight contaners (USP). Distibuted b: Aurobindo Pharma USA, n. 278 Princeton-Hightstown Acad East Windsor, N 08520 *Over printing Zone Mage nndia Code: TS/DAUGS 2272008 Coding Area esxsrm) Dot e
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_2.jpg dsn ‘siajqel wakwoiyyzy (Dot fines not to b prin UNVARNISH ZONE v Exch . cotod ot conan: Ao Gyt UsP guvalnt o oy 250 . DOSAGE AND USE: o zampanyngprscrbng ormiton 1o a1 2019 25 (3107 5 USPControlad R Tt Yo BT rovdo s b rogaswih Tl rscringoatan for vy vt Use Pasa s presong ormaton sncossa. i pactag s crg st e 2 a2 your st s dosaof oy bt U T ke 1t iy o 4 s Ao s USPKeps on ok Days 61010 oo neaare prowdr bas eescnad abromyci. omycn fales USP 250 mg ar akn oncoagay o 565 * o 2ttty syt ' o, Than ke 1 s on ach ot 06100 2 1o COmpls Your B, - Aoy ais USP can e aken win o wiout 000 * Gesire i you mosiaton,bess 104 gt 00 S o tecton may am . Manypaln o str 5 . oo, o may onn o ot o svereays g your s 0. Acptarmacy s e most common s s of aromy it USP s e (4 1 %), s (%), 310 SCmah PN (2103%). LS a1 o palons Soppad s GG 0 S ot Whta b actas to s g ' s, SO ans o, P kG T, g 200 Al your e procr tightavay. 1 you e a1 qusns 0ot i G o s oSSID i s, stk i your heaticars prov: Rataenes: 1 Ut T smant of bt o Pt utcomes M 10041920 2 D on e, Pt 0. e York, Y. NDC 65862-641-69 Rxonly Azithromycin Tablets, USP EID A full course of antibiotic therapy in 5 daily doses /S AUROBINDO 6 Tablets (1 Blister X Six 250 g Tablets) Azithromycin Tablets, USP hcoace s uss. e Mt i 6 Tablets (1 Bister X ix 250 mg Tablets) oot TSRS 222000
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_3.jpg L0 ) ses0p ke Gu1 Ades agoiquue p asino iy y “ \ s 1 dsn ‘sie|ge] udfwoiyzy o g £9-179-29859 90N szienid Each film-coated tablet contains: Distributed by: Aithromycin dihydrate USP equivalent to azithromycin 250 mo. Aurobindo Pharma USA, Inc. 279 Princeton- Hightstown Road East Windsor, NJ 08520 NDC 65862-641-63 NDC 65862-641-63 Rxonly Azithromycin Tablets, USP Afull course of anibiotic therapy i 5 daily doses Rxonly Azithromycin Tablets, USP Afull course of antbiotic therapy in 5 daily doses DOSAGE AND USE: See accompanying prescribing information. Made in India Code: TS/DRUGS/22/2009 > S soztsines Can be taken with or without food. Store a120° to 25°C (68° to 77°F)[see USP Controlled Room Temperature]. 7 Aurombo 18 5 AUROBINDO 18 Tablels (3 Gators X125 g Tal) s (3 Cartons X ix 250 mg Tablets) This package i hild-resistant.
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_4.jpg NG 65862-642-30 Rxonly Azithromycin Tabhlets, USP /9 AUROBINDO 30 Tablets Each film-coated tablet contains: Adithromyecin dihydrate USP equivalent o azithromycin 500 mg. accompanying prescribing information. Storeat 20°10 25° (68° 10 77°F) [se2 USP Controled Room Temperature] Dispense in tight containers (USP) Distributed by: Aurabindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 *Over printing Zone Made in India Code: TS/DRUGS/22/2009 Coding Area Dakied ins noto b prined L0g2Y9298S9¢N
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_5.jpg (Dotted lines not to be print) UNVARNISH ZONE Each flm-coated tablt cotains: Azitvomycin dihyrate USP equlent 0 azthromycin 500 mg. DOSAGE AND USE: See accompanying prescrbing nformation. $toreat20°t0 25% (68° o 77°F) e USP Cortrlled Room Tempertur] Pleas see full prescrbing ormaton encosed Take 1 tableta da for 3 dys Agithromycin tabets USP keeps on working: Days 41010 Yourhealticarsprovite s ben provided with fl rescrbingoration for ztromycin Tabts USP 500 g Your heattcare providr has presribed azithromyci Aaithromycin Tabets USP 500 mg i a arl antibioic that i aken oncea day for 3 days. © Take 1 tablta tay for 3 ays > Aetvomycintablets USP can b taken withorvithout o © B sureo inish your medication, because fyou qut 00 so0n your nfecton may raturn. The most common sie efects of aathromyoin talts USP are darthea (4 to 5%),nausea (3%), and tomach pain (210 3%). Les than 1% of paents stoppd taking s drug s 10 i s TN While allegic reactions to this drug are rare, should one occur, stop taking tis drug and cal your healicare provider rgnt away. If you have any questions aboust this drug or its possibl side effects please tak with your healthcare provider. This package s chid-resistant Reference 1. Urqunart J. The treatment of bacteral infectons. Patent Outcomes, March 1994: 19-20. 2. Data on fle, Pizer Inc, New York, NY putzs NDC 65862-642-64 Rxonly Azithromycin Tablets, USP A full course of antibiotic therapy in 3 daily doses. dsn ‘sisjqe uakwoynzy (gm0 00 3524 x391910 1) sgeL € /5 AUROBINDO 3 Tablets (1 Blisterx Three 500 mg Tablets) Disrbuted by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Affix harmacy labelnere: N Mate n India 658621164264 Code: TSDRUGS/22/2008
795c13cd-e9ca-481b-9fa9-2890bdf9dac8_231_6.jpg (aomes tu mssaw sz aw 6 P 0D ¢ i 31001 1 s Bty dsn ‘siege] uohwoiygizy o w | wargumseom Each - coate it contalns: Aoy oyt USPoqualnt inazmomon 1 my osmizony: Ao Phama s, o 279 Prcsonsgrsiwn R it Wisor 106520 wass nnga oo TSORKGSZ2200 II||I|I III"l ls5a02hs4 20015 o eseez.542.00 woc 855264210 oy Azithromycin Tablets, USP Al cors ot it berapy 1 3 ay goss. Axomy Azithromycin Tablets, USP Al cous of it erapy I ay oss. 'DOSAGEAND USE: e scampanyg prscring moton Stor0 320257 (3 0 778 USP Contols oom Tongenin] 7 om0 Tabots 3 artonsxTrn 5o my Taba) | TS paage s st Apumcman ©Tas (3 Garan e 50 g Tt
79637c7b-fe7b-436c-892b-6c36abfdcacc_663_1.jpg Rx only Carisoprodol Each tablet contains: NDC 65862-693-01 Carisoprodol USP 250 mg. Usual Dosage: Please sez enclosed full pescribing information. Tablets, USP V Dispense i tight container. /52 AUROBINDO Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room 100 Tablets Temperature]. Distrbuted by: — Aurobindo Pharma USA, Inc. == 279 Princeton-Hightstown Road = E— East Windsor, NJ 08520 f—— Made in India Code: TS/DRUGS/19/1993 *Over Printing Zone Coding Area (@5x15mm) Dotted fines not to be printed
79637c7b-fe7b-436c-892b-6c36abfdcacc_663_2.jpg NDC 65862-158-01 Rx only Carisoprodol Tablets, USP \Y /2 AUROBINDO 100 Tablets Temperature]. Each tablet contains: Carisoprodol USP 350 mg Usual Dosage: Please see enclosed full prescibing information. Dispense in tight container, Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/19/4993 P1422137_ Coding Area (45% 15 mm) Dotted lines not to be printed
79a39fb1-12b7-4b1e-9f28-102af34d0459_350_1.jpg o0 TABLETS
79b3a2f5-db50-4c48-a5c9-3e4ccc92ae9e_700_1.jpg o0 TABLETS
79b42076-359d-4258-b1d8-f40e67ac5424_368_1.jpg NDG 0054-3500-49 100 mL. Lidocaine Viscous {Lidocalne Hydrochloride Oral Topical Solutlon USP) FOR ORAL USE ONLY Composition: lidocaine hycrochloride USP 2%, carboymethylcellulose sodium, flavoring, methylparaben, propylparaben, purified water and saccharin sodum Reonly USUAL ADULT DOSAGE: 15 mL (one tablespoonul), Reduce dose and use extreme caution when administering to children. Consult package insert for complete prescribing information GAUTIONS: Numbness of the mouth and throat increase the risk of food aspiration and biting trauma. Do not eat or chew gurm for 60 minutes following use. Keep this and all medications out of the reach of children. Store at 20°10 26°C (68° 10 77°F). [See USP Controlled Room Temperatre | Dispense in a child-resistant container as defined inthe USP/NF. SHAKE WELL BEFORE USE. SQUEEZE BOTTLE TO DISPENSE CONTENTS, Distr. by: West-Ward Pharmaceuticals Corp. Eatortown, NJ 07724 _— — — —————C o _— — _ — s —— O I | N 3 10003662/05
79b42076-359d-4258-b1d8-f40e67ac5424_368_2.jpg NDC 0054-0548-44 Delivers 15mL EXP. Lidocaine Viscous (Lidocaine Hydrochloride Oral Topical Solution USP) FOR ORAL LISE ONLY Gompostion: lidocaine hydrochioride USP 2%, carboxgmethylcellulose sodium, flavoring, methylparaben, propylparaben, purified water and saccharin sodum Reonty WEST-WARD LOT. USUAL ADULT DOSAGE. 15 i fore abEspoonu]. Recs o and use extreme caulion wien adminstering tochilden. Consult ackage rsert or complee grcribig inforation, GAUTIONS: Humbness of the moih and thriatncrease the ik o fod aspiration and biing tsuma. Do noteat or ity qun for &0 minés ollowng ie. Keep s andall medcations out ofth reach ofchien Store 3120° 10 25°C 58 0 7TF) [see USP Controled Fom Temperatur. | Dispense in ohi-esistant conaiier a5 teined n e USPAVF. SHAKEWELL BEFORE USE. SOUEEZE BOTTLETO DISPENSE CONTENTS, Dt by: West Ward Plarmaceuials Corp. Estontoun, U 07724 LT g (01)00300540543445 10m0EEN2
79ce2ab3-f52e-46e8-a2a5-47d111c21b66_477_1.jpg Olanzapine 15 mg Tablet arv: 30 ID #: R15;0167 Expires: NDC #: 61786-0004-02 Shape: Round LOT #: Ref #: 55111-0167-05 MFG: Dr. Reddy's Labs, Princeton, NJ 08540 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
79ce2ab3-f52e-46e8-a2a5-47d111c21b66_477_2.jpg Olanzapine 15 mg Tablet ary: 28 ID #: R15;0167 Expires: NDC #: 61786-0004-06 Shape: Round LOT #: Ref #: 55111-0167-05 MFG: Dr. Reddy's Labs, Princeton, NJ 08540 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
7a0a851a-f7b2-4fd5-afae-ac2adb809ed8_738_1.jpg Each fim-coated extended-release fablel Distbuted by Made n india NDC 65862-888-30 contais: Glipizide USP 2.5 mg. Aurobindo Pharma USA, Inc. = 279 Princeton-Hightsiown Roag Code: TS/DRUGS2272009 N — 'DOSAGE AND USE ‘East Windsor, NJ 08520 O Sea accompanying prescrting nformaton. o e o — GlipiZIDE Contin FDAG Ylow Mo a5 @ cobr o Extended-Release Tablets =i i i & oo at 20 0 25 66 o 77 [0 0P | i Gontroed Room Temperature], ! oo i i Rxonly 30 Tablets pgotecr FRoM MOISTURE AND HUMIDITY. | io ! = /2 AUROBINDO Dispense i ight conainers USP). i | ‘Over printing Zone Coding Area @515 mm) Dotte s ot 0 be printed
7a0a851a-f7b2-4fd5-afae-ac2adb809ed8_738_2.jpg Exch T oalg exsnge eease it Dt by wetsn v oG 55662-880.a0 . g Lo 5. Ao rarnaUsh, . PR g g 0 TEORUGS 222009 Doskee o use £ W ez St scronpanyog prscrag oton GlipiZIDE o 28z veow Mo = 4 o g Extended-Release Tahlets i 2% i St at 20125 (56 b 77 s 5P | : Cantoea e Tmpurr, | | Rx only 30 Tablels rorec erow MoIsTLRE AND HuMDITY. | i 2 AuRoRINDO ipiss g cononas (159 | | “Overpinting Zone e [ Dot ne ot b e
7a0a851a-f7b2-4fd5-afae-ac2adb809ed8_738_3.jpg B, et 279 Princeon-Httsiown Roag 000 TS/DRUGS 2212008 East Windsor, NJ 08520 NDC 65862-890-30 D0SAGE AND USE o Sessonampaning prescrbing formton GlipiZIDE pang preserong Extended-Release Tablets suwre at20° o 250 (oo o 77 fsce usp i ‘Controlled Room Temperature]. 10 mg 30 Tablets PROTECT FROM MOISTURE AND HUMIDITY. P1421352 Rxonly /5 AUROBINDO Dispense i tight conainers (USP). “Over printing Zone Coding Area s x15 mm) Doted fines not o be prnted
7a1f1e42-e2cf-4545-b82b-85cf491d779d_853_1.jpg N0 (sB3) administrati Cﬁlﬂmusr reventive device in th anﬂe rr’?ied for cylinder p}réssﬁrgl.p‘.‘:ng Defore use. Return with 25 psig- MATHESON ask... The Gas ort whel femperature exceeds 52 1-800-416-25¢ n used bY, ¥ inistration of mnical Air may be I i ang fo ol a icensed pracﬁ\‘i‘nne"‘r‘whn i expe MA iStrapaniar XS"&‘, i“lq%inﬂl‘:gaﬁnn& eﬂti%"‘ diga ons. en. WARNING: cowTAﬁstégé'ﬁm PRE 10N. Do not rect ‘not handle until afl saé%‘{‘\ﬂ fofin equip :“A i INDER MATHESON TRI-GAS 150 ALLEN RORD* BASK ropeny VANe or 0 i azardous O fin the 45° oy 55 vaiye after 8T Figiow 48 2ead and o1 “28 @13225940-0 NG RIDBE. W 01920
7a68d899-2678-43a9-a9c1-ef8f916b562f_809_1.jpg NDCE3323.507-25 PRUISOT2S MEROPENEM FORINJECTION, USP (V) £ el e SE"e s e ¢ Bty
7a68d899-2678-43a9-a9c1-ef8f916b562f_809_2.jpg NDC 63323-507-25 PRX350725 MEROPENEM FOR INJECTION, USP (1.V.) 500 mg/vial Each vial contains: Meropenem equivalent to 500 mg meropenem activity. The sodium content is approximately 45.1 mg (1.96 mEq). For Intravenous Use Only Contains: 26 x 500 mg sterile vials Rxonly PREMIERPrORX®
7a68d899-2678-43a9-a9c1-ef8f916b562f_809_3.jpg NOC 632350826 PRX3S0B25 MEROPENEM FOR INJECTION, USP LV fvsr | e St et sl 07 152 nEy o ot e Oy Cotanzars Serte ™ xony
7a68d899-2678-43a9-a9c1-ef8f916b562f_809_4.jpg NDC 63323-508-25 PRX350825 MEROPENEM FOR INJECTION, USP (I.V.) meropenem gram/vial equivalent Each vial contains: Meropenem equivalent to 1 g meropenem activity. The sodium content is approximately 90.2 mg (3.92 mEq). For Intravenous Use Only Contains: 25 x 1 g sterile vials Rxonly PREMIERPrORX®
7a6967b3-5563-4bed-9eee-d400f800e799_647_1.jpg 22051 1 12052€00(10) 6002/V8E/82/L/SINHA/D *ON 8PoQ "0U| ‘sfeonnadeuLIeyd Juabes | 1020 EIpU| Ul BpEj (vSn) 56109 71 ‘DInquineyos S[eannadelLield INF9VS 10} PIN ['Wasuj 9ag] "(do£2 0} 489) 252 0} 502 1® 810]S ‘Liasul a3g :afieso( [ensn ‘anljenJasald e se |0yoale |Azuaq bw 6’6 puE 8jejapa Wniposip B G0 surepuod osfy ‘bl oG | uloAwepulfo o} JuejeAnba ajeydsoyd utAwepuijo 'SUIeU0D W yoeg - ‘ojuaboifduop ‘aiels S 1016138 Dilute Before IV Us 2 mL Single-Dose Vial Injection, USP Lot & SAGENT® Clindamycin NDC 25021-115-02
7a7ade79-0165-4e31-b84e-667416c00c7e_157_1.jpg szen ) NDC 71858-0005+4 TIROSINT® (levothyroxine sodium) capsules 13 mcg per capsule Do not remove ual capsules from blister packaging until ready to use] ‘Swallow capsulle whole. Do ot <, crush, or chew. Rx Only | 3 blisters x 10 capsules Usual Dosage: See package Insert for dosage information. 0w Tamper-Evident: <% F8q | Donotacceptif inner blister units have been opened. G SnE | storage: AaRE Store at 25°C (77°F); excursions permitted to 15°-30°C B (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. g ® 3. B NDC 71858-0005-4 e < 3 TIROSINT ] 3 H n (levothyroxine sodium) capsules S 2 : 2 ] 5 e § Trom Bhvter packaging untl ready to ure] s Swallow capsule whale. Do not cut, crush, or chew. Rx Only 3 blisters x 10 capsules @ epfectrea oo P by 18R i Siochmicus SA, 915 Pambio-Noranco, Sitzerand Disuted by 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH Il || OF SMALL CHILDREN 2 71858 00054 3 g z g EdU0s1e
7a7ade79-0165-4e31-b84e-667416c00c7e_157_10.jpg sty vsi) TIROSINT® (levothyroxine sodium) capsules TS per capsule Swallow capsule whole. Do not <, crush, or chaw. R Only 3 blisters x 10 capsules NDC 71858-0050-4 or packaging untll ready to use <> Usual Dosage: See package insert for dosage information. Rx Only 3 blisters x 10 capsules - Tamper-Evident: <% §Eg | Donotaccept ifinner blister units have been opened. SO SRk | storage: i d Store at 25°C (77°F); excursions permitted to 15°-30°C S (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. 3 == TIROSINT® NDC 71858-0050-4 9:8 'é (N E & (levothyroxine sodium) capsules EEl 2 S o s 2 150 mcg § "!@ per capsule § Do not remove jual capsules from blister pac until ready to use] 5 Swallow capsule whole. Da not cut, crush, or chew. <> @ liieciuedfor A Pama nc by 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. Distributed 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 KEEP THIS AND ALL OTHER DRUGS OUT OF THE REACH OF SMALL CHILDREN 571858 00504 £z £8 Ed0s1e
7a7ade79-0165-4e31-b84e-667416c00c7e_157_11.jpg sxsey vsn) ££1 3BueIQ 20z Pay 6z 208 e NDC 71858-0055+4 TIROSINT® (levothyroxine sodium) capsules AT ] per cap Do not remove individual capsules from blister packaging until ready to use] Swallow capsule whole. Do o e, crush, or ch Rx Only 3blisters x 10 capsules Usual Dosage: See package insert for dosage information. TampenEvident: Do not accept if inner blister units have been opened. Storage: Store at 25°C (77°F); excursions permitted to 15%-30°C (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. ISLL sajnsdes (unipos auosions] « LNISOYIL NDC 71858-0055-4 TIROSINT® (levothyroxine sodium) capsules ual capsules from blister packaging untllready to use] Swallow capsule whols, Do not cut, crush, or chew. Rx Only J 3 blisters x 10 capsules <> Ve iorssA Prama ncby: 183 it Biochimique SA, 6915 Pambio-Noranco, Switzedand KEEP THIS AND ALL OTHER Distributed 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH I"" OF SMALL CHILDREN 571856 00554 s £z £8 € 10518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_12.jpg cssey s TIROSINT® (levothyroxine sodium) capsules LT T E Do not remove individual cap: Swallow capsule whole. Do not <, crush, or chaw. R Only 3blisters x 10 capsules NDC 71858-0060-4 from blister packaging until eady to use] Usual Dosage: See package insert for dosage information. Tamper-Evident: Do not accept f inner blister units have been opened. Swallow capsule whole. Do not cut, crush, or chew, Rx Only 3 blisters x 10 capsules until ready to use] T S8rm 5% Snd | storage: ‘e Store at 25°C (77°F); excursions permitted to 15°-30°C » (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture = TIROSINT® NDC 71858-0060-4 12 Y (levothyroxine sodium) capsules s Z £ 5 5 e <> > e oA Prams 18SA It Biochimiauo SA, 4915 Pambio-Neranco, Switzedand Distibuted by: 183A Pharma o, Parsippany, NJ 07054 Tl 800.587.3513 KEEP THIS AND ALL OTHER DRUGS OUT OF THE REACH OF SMALL CHILDREN 571858 00804 & z 8 € 10518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_2.jpg cses s NDC 71858-0010-4 TIROSINT® (levothyroxine sodium) capsules P per capsule Do not remove individual capsules from blister packaging until ready to use] ‘Swallow capsule whole. Do not <, crush, or chew. Rx Only 3 blisters x 10 capsules > Usual Dosage: See package nsert for dosage information. Do not remove individual capsules from blister packaging until ready to use) o not cut, crush, or chew, Swallow capsule whole. o Tamper-Evident: 3 g 25 | Do not accept if inner blister units have been opened. 85 SR8 | storage: e e Store at 25°C (77°F); excursions permitted to 15°-30°C N (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. g d ® 3 i = NDC 71858-0010-4 112 | TIROSINT 32 Y (levothyroxine sodium) capsules o _Z_| 25meg § e per capsule Rx Only 3 blisters x 10 capsules @ e o AT 183 it Biochimiaue SA, 6915 Pambio-Noranco, Switzorand Distrbuted by: 1854 Pharma b, Pasippany, NJ 07054 Tl. 800.587.3513 DRUGS OUT OF THE REACH II|||| OF SMALL CHILDREN 271858 00104 5 z608xTS £0E/SY 0518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_3.jpg a6y vsn) TIROSINT® (levothyroxine sodium) capsules 50 mcg per capsule Do not remove ‘Swallow capsule whole. Do not <, crush, or chav. R Only 3 blisters x 10 capsules NDC 71858:0015+4 until readly to use] <> Usual Dosage: See package insert for dosage information. TampenrEvident: Do not accept if inner blister units have been opened. Do not remove Swallow capsule whole. Do not cut, crush, or chew. Ry Only 3 blisters x 10 capsules until readly to use] frm ge5g S Nmd | storage: BRee™ Store at 25°C (77°F); excursions permitted to 15°-30°C ¥ (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. 3. = ® NDC 71858-0015-4 Buli -0015- 25|12 | TIROSINT 2 Z. e (levothyroxine sodium) capsules £8|: = ® 8 5 50 mcg 5§ e per capsule <> © g A B e, ctnd Disrbuted by 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH || II|| OF SMALL CHILDREN 371858 00154 z g € 10518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_4.jpg e NDC 71858:0020-4 TIROSINT® (levothyroxine sodium) capsules 75 mcg per capsule Do not remove individual capsules from blister packaging until ready to use] ‘Swallow capsulle whole. Do ot <, crush, or chew. Rx Only | 3 blisters x 10 capsules 1 Usual Dosage: See package Insert for dosage information. o Tamper-Evident: 92 F8w [ Donotacceptif iner blister units have been opened. 8 SR | storage: NaRE Store at 25°C (77°F); excursions permitted to 15°-30°C b (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. 12 | TIROSINT® Moo 18 E (levothyroxine sodium) capsules s 2 75 mcg § "!J per capsule Do not remove Swallow capsle whole. Do not cut, crush, or chew. Rx Only 3 blisters x 10 capsules Q> ipinciured forESA Parma b 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. Distributed 204 K B o, Prsppany, N1 07054 ol 800573513 DRUGS OUT OF THE REACH II OF SMALL CHILDREN 271858 00 g z g
7a7ade79-0165-4e31-b84e-667416c00c7e_157_5.jpg osses vsi) NDC 71858:0025+4 TIROSINT® (levothyroxine sodium) capsules LT per capsule Do not remove individual capsules from blister packaging until ready to use] Swallow capsull whole. Do not cus, crush, or ch Rx Only 3 blisters x 10 capsules - Usual Dosage: See package nsert for dosage information. o TampenEvident: -8 § 25 | Do not accept if inner blister units have been opened. 9% SR8 | storage: SRR Store at 25°C (77°F); excursions permitted to 15°-30°C N (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. g d ® 3. B NDC 71858-0025-4 1113 | TIROSINT E 2 & (levothyroxine sodium) capsules N 3 = ® s 2 88 mcg 5 ‘; per capsule Do not remove iual capsules from blister packaging until ready to use] Swallow capsule whole. Do not cut, crush, or chew. Rx Only 3 blisters x 10 capsules y @ et oo phama by 18R it Biochimicus SA, 915 Pambio-Noranco, Sitzerand Distributod 2 R e sy st ssosersts DRUGS OUT OF THE REACH II OF SMALL CHILDREN 271858 00 z608xTS £0E/SY 0518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_6.jpg 15861 (vsn) TIROSINT® (levothyroxine sodium) capsules LT ) per capsule Do not remove individual capsules from blister packag) ‘Swallow capsule whole. Do not <, crush, or chavi Rx Only 3 blisters x 10 capsules NDC 71858-0030-4 until ready to use] <> Usual Dosage: See package insert for dosage information. Swallow capstle whole. Do not cut, crush, or chew. Ry Only 3 blisters x 10 capsules until ready to use] o TamperEvident: o8 g 25 | Donotaccept if inner blister units have been opened. % umE | storage: YageT Store at 25°C (77°F); excursions permitted to 15°-30°C S (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. e TIROS NT® NDC 71858.0030-4 il 8 | I g e & (levothyroxine sodium) capsules N S o s 2 £ 4 5 e <> © e A B e, tetnd Distributed by 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH |II|| OF SMALL CHILDREN 571858 00304 z608xCs £08/5Y £ 10518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_7.jpg 2ss6s vsn) TIROSINT® NDC 71858:0035-4 (levothyroxine sodium) capsules 112mcg per capsule Do not remove Ry Only 3 blisters x 10 capsules until readly to use] Swallow capsulle whole. Do not cus, crush, or ch Usual Dosage: See package insert for dosage information. Rx Only 3 blisters x 10 capsules o TamperEvident: 22 P2x [ Donotacceptif inner blister units have been opened. BE ynf | storage: nage Store at 25°C (77°F); excursions permitted to 15°-30°C b (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. = ® 2 . = NDC 71858-0035-4 H 2 | TIROSINT E 3 (levothyroxine sodium) capsules . S 3 g 5 AR T s e per capsule £ £ vl il whole, Do TEt . Sl Sreha <> 4 > Ve iorBsA Prama ncby: 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. Distributed B ot Parsopany. N 07054 Tl 800:587.3513 KEEP THIS AND ALL OTHER DRUGS OUT OF THE REACH OF SMALL CHILDREN 71858 00354 g > z & 410518
7a7ade79-0165-4e31-b84e-667416c00c7e_157_8.jpg TI ROSINT® NDC 71858-0040-4 (levothyroxine sodium) capsules 125mcg per capsule Do not remove ual capsules from blister packaging until ready to use] Swallow capsule whole. Do not <, crush, or chaw. Rx Only | 3blisters x 10 capsules | Usual Dosage: See package Insert for dosage information. Tampen-Evident: Do not accept f inner blister units have been opened. Storage: Store at 25°C (77°F); excursions permitted to 15%-30°C (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. £z gs se9v d (61 9bueIQ 20z oy 6z nlg e S0t v TIROSINT® NDC 71858-0040-4 (levothyroxine sodium) capsules 125 mcg ki H 4 b Bow szl per capsule » LNISOYIL Do not remove ual capsules from blister packaging until ready to use] Swallow capsule whole. Do not cut, crush, or chew. Rx Only 3 blisters x 10 capsules Sajnsciea (wnipos suoiions]) @ epfectreg oo phams by 18R it Siochmicue SA, 915 Pambio-Noranco, Sitzerand KEEP THIS AND ALL OTHER Disuted by 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH III" || OF SMALL CHILDREN 571856 00404 s EdU0s1e
7a7ade79-0165-4e31-b84e-667416c00c7e_157_9.jpg vesey i) NDC 71858-0045:4 TIROSINT® (levothyroxine sodium) capsules 137 meg per capsule Do not remove i ual capsules from blister packaging until ready to use] Swallow capsule whole. Do not <, crush, or chaw. Rx Only | 3blisters x 10 capsules | Usual Dosage: See package insert for dosage information. Do not remove ual capsules from blister packaging untl ready to use] Swallow capsule whole. Da not cut, crush, or chew. o Tamper-Evident: o8 i 25 | Donotaccept if inner blister units have been opened. 38 x w& | storage: SRR Store at 25°C (77°F); excursions permitted to 15°-30°C S (59°-86°F). (See USP Controlled Room Temperature). Protect from light and moisture. T | ® 2. = NDC 71858-0045-4 ol - 2 | TIROSINT ] Y (levothyroxine sodium) capsules Ll : 2 137 mcg § "!@ per capsule Rx Only 3 blisters x 10 capsules @ e oA rama e 1BSA Institut Biochimique SA, 6915 Pambio-Noranco, Switzerland. KEEP THIS AND ALL OTHER Disributed b 18SA Pharma fnc, Parsippany, NJ 07054 -Tol. 800.567.3513 DRUGS OUT OF THE REACH I|I| OF SMALL CHILDREN 571858 00454 1 Z 8 € 10518
7ac30fc2-7d82-4395-bab6-778333d2d9c2_570_1.jpg NOC: SO436-5181-1 NDC: 50436-5181-1 = oPIERRERR LEVOTHYROXINE SODIUM A 50 MCG (0.050 MG) / 30 TAB NDC: 5043651811 Each tabet contains: Mg for: G S et (050 4y 0 levothyroxine sodium, USP 50 meg Sandoz, Inc. LOT: 0000 BXP: XXPOPXX Store in a tight, light-resistant container. Princeton, NJ 08540 HOC: 5043651811 MFG NDC: 0781-5181-92 Bl G (om0 78 Proect from ght and maisure. 0T oo e S MFG LOT: X00000K WARNING: KEP OUT OF READH OF GHLDREN, STORE 25°C (7747 LOT: XOOK BC0PONX e ssesiors CONTROLLED ROOH TENPERATURE Pighy: Ui DoseSevices,LC Do, FL 3008 UG EVOTTRONNE SEE PAGKAGE INSERT FOR DOSAGE INFORHATION. Rev. RXONLY SODIM” 50 MGG (50 ) (3 TAD
7ac30fc2-7d82-4395-bab6-778333d2d9c2_570_2.jpg NOC: SO436-5181-1 NDC: 50436-5181-1 = oPIERRERR LEVOTHYROXINE SODIUM A 50 MCG (0.050 MG) / 30 TAB NDC: 5043651811 Each tabet contains: Mg for: G S et (050 4y 0 levothyroxine sodium, USP 50 meg Sandoz, Inc. LOT: 0000 BXP: XXPOPXX Store in a tight, light-resistant container. Princeton, NJ 08540 HOC: 5043651811 MFG NDC: 0781-5181-92 Bl G (om0 78 Proect from ght and maisure. 0T oo e S MFG LOT: X00000K WARNING: KEP OUT OF READH OF GHLDREN, STORE 25°C (7747 LOT: XOOK BC0PONX e ssesiors CONTROLLED ROOH TENPERATURE Pighy: Ui DoseSevices,LC Do, FL 3008 UG EVOTTRONNE SEE PAGKAGE INSERT FOR DOSAGE INFORHATION. Rev. RXONLY SODIM” 50 MGG (50 ) (3 TAD
7ac30fc2-7d82-4395-bab6-778333d2d9c2_570_3.jpg NDC: 50436-5183-1 LEVOTHYROXINE SODIUM 88 MCG (0.088 MG) / 30 TAB Each tablet contains: Mfg for: levothyrodne sodium, USP 88 mcg Sandoz, Inc. Princeton, NJ 08540 Store in tight, lightresistant container. MFG NDC: 0781-5183-92 CHILDREN. STORE 25 ° C (77 °F ) LOT: XXXXX EXP: XX/XX/XX SEE PAGKAGE INSERT FOR DOSAGE INFORMATION. Revd RXONLY alOE e TEvOTIRON i G Gomy 070 o0a B R ol e TEVOTARDINE GBS S e (G088 20 e LOT: X000 BB XX NG S04365183-1 R L VDTRONINE OB 580G (0689 ) 308 LOT: 000 B . o somesiens R e Lol v R NS (G880 8
7ae80b51-b62d-4adf-be6a-9d320cd97c76_56_1.jpg CEFOXITIN FOR INJECTION, USP T DA
7ae80b51-b62d-4adf-be6a-9d320cd97c76_56_2.jpg CEFOXITIN FOR INJECTION, USP =
7bca1d24-a317-44c4-8db2-68030eb961ed_783_1.jpg (USUAL DOSAGE: See package insert for complete dosage recommendations. light-resistant container with a child-resistant closure. STORAGE: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. WARNING: Keep this and all medications out of the reach of children. Manufactured by: Mikart, Inc. Atlanta, GA 30318 Code 378216 Rev. 09/16 O — S N U —_ 3 6 o = o 7 PHARMACIST: Dispense in a tight, NDC 46672-561-16 C \ Acetaminophen and Codeine Phosphate Oral Solution USP Each 5 mL (teaspoonful) contains: Acetaminophen................ 120 mg Codeine Phosphate........ 12 mg (WARNING: May be habit-forming.) IICONO. oz e rsmssionmasiesssring % Dispense the accompanying Medication Guide to each patient. Rx only 16 fl. oz. (473 mL)
7c242f6e-06a9-44cd-8aec-2d90ece44f44_119_1.jpg T aon ot coen TR V0 S 005 e e, S XSO WELOING, 8 GAS PR
7c242f6e-06a9-44cd-8aec-2d90ece44f44_119_2.jpg s — NITROGEN RIGE LIQUID NE RATED AUIL » UN 1077 Ui ALWAYS KEEP CONTAINER IN UPRIGHT POBITION. EXTREMELY COLD LIQUID AND GAS UNDER PRESSURE CAN CAUSE RAPID SUFFOCATION. CAN CAUSE SEVERE FROSTBITE a0 use with adequate ventiiation 0t get lquid in eyos, on skin o clothing. IN GASE OF FROSTRITE, o Wreatment immadiataly. PLEASE REFER TO THE MATERIAL SAFETY DATA BHEET FOR SAFETY AND PRODUCT INFORMATION.
7c650dc8-43f6-4257-81ed-c93b00202d06_19_1.jpg NDC 63187-020-15 R RX Only Prednisone 5mg #15 Tablets Each tablet contains: Prednisone, USP 5mg White, round, scored, imprinted with TL172 Product ID: PP002015 Mfr. By: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA Store at 20°-25°C (68°-77°F) Keep medication out of the reach of children Lot #0000 Exp. 00/00/00 RX# MASTER Prednisone 5mg #15 Tablets Rt MASTER Lot 00000 ExpO00N00 NOC 63187020-15 Prednisone 5mg #8 JBRS RAWSTER Lot 00000 Exp000000 NDCE3187.020-15 ¥ Prednisone Smg #15 Tablels RaMASTER Lot #00000 ExpO00000 NOC 63187-020-15 Packaged By Poficent Rx LP Thousand Oaks, CA 91320
7cb3ab09-ac05-40b6-a324-b7d639149ebb_823_1.jpg Pacbaged by Eryant Rench Bunbank. 04 91500 METFORMIN § HCL 1000MG TABLET Store at room temp of Compare To: 20°25°C (68°77°F) ‘GLUCOPHAGE 1000MG TABLET-LIB Keep all drugs out of Ascend Laboratories LLC reach of children. #1000 Exp: MM/YY NDC 6362976041 0769410000 om
7cbefee1-1b23-4e9b-8527-ec357a9dbcb6_210_1.jpg s, e IR o Sk, | edgergm § TR s G R TRKE CAPSULE oM B mesao i Gk B SR | = | - R e,
7cbefee1-1b23-4e9b-8527-ec357a9dbcb6_210_2.jpg R e, o . SED TR meeme Sadne DETCLOMNE T TBLETE PR B e I S e i R THE { TABLET PN e Ry AmiEsAoN i R ] Aspemen I = e P i B 1
7d1d5963-8b7f-4d8d-807a-6b9f896c7171_861_1.jpg e o - e W‘ c\%uf“ g mn«»»”fﬂ‘:”fw“’yw:w‘;‘gfy i ,,,,,a,w»-" I G ity conrnie) “"Wdﬁw}wﬁ:&mg&v e ISR e 22 hen TED. WAY OF SioEh! M“"“'p"'dww * Nnuuvﬂﬂ%,@.&m-ﬁwﬁ;& VR S - ot = 2 back flow p'¢ _—" s P e e . et = P W P oo 7 3o Nor 'm“““,..wm‘-‘
7db10b76-4520-496e-b450-66a662cc95f6_360_1.jpg WARNING:KEEPTHIS:DUTIDRTHEREACHIORCHILDREN] R VLY DT TR el = ) Ve [ o [ S WHITE NDC: 43063-785-90 PIGIBLESDERE 100 T 43063-785-90 43063-785-90 43063-785-90 busPiRane busPIRone busPIRone : b PlR HCL USP HCLUSP HCLUSP g UsFInone 10 MG 10 MG 10 MG = HCL USP 90TABLETS SOTABLETS 90TABLETS = ReOrder # 110356 ReOrder # 110356 ReOrder # 110356 ‘E m Y d LOT 1i8cas LOT 1L8C25 LoT 118C25 ; o 10 M G_ EXP 11/19 EXP 11/18 EXP 11/19 g S Z . CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS, 2 5 90TABLETS YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE__TABLET(S)___TIMES A DAY. TOME__TABLETA(S) VECES AL DIA. Each TABLET Contains: BUSPIRONE HYDROCHLORIDE usp 10 MG RECT/BRKLINC o Bl {01)10343063785904 (21)113C25000002 {17) 191130 {10}118€25 10Z0Z062LYT VIINI GVBVOIWHY Q3LIWIT VIYYHL SYLNI
7de92dd2-4555-4663-88b8-afe654c3c045_82_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. NDC: 43063-394-56 GREEN/BLUE PHARMACEUTICALS IINCORPORATED® Oklahoma City, OK = 73127 CLINDAMYCIN CLINDAMYCIN CLINDAMYCIN & HCL USP HCLUSP HCLUSP 2 150 MG 150 MG 150 115 2y HCL USP 56 CAPSULES 56 CAPSULES 56 CAFSULES § m ReOrder # 104310 ReOrder # 104310 ReOrder # 104310 :..-._’ E LoT G18D94 Lot G18D94 Lot G18D94 §2 150 MG EXP 11/19 EXP 11/19 EXP 11/19 2% < CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. © g 56 CAPSULES YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE CAPSULE(S) TIMES A DAY. TOME CAPSULA(S) VECES AL DIA. Each CAPSULE Contains: CLINDAMYCIN HCL EQUIVALENT TO 150 MG CLINDAMYCIN = (01)10343063394564 (21)G18D34000002 (17)181130 {10)618094 CAPSULE b9STEEEIOEYE B O O 0 [OZBETLISO0 "IN 'ANVAINDD LLINNVT
7e4b94e3-b4fb-4968-bfce-9ad508eea78b_490_1.jpg nan
7e6fbb4b-06fb-4405-b170-db905836a0e3_102_1.jpg R e T SEeTHE Mame [ 5 FESEE e Eofho R wermaeony i PR ame b o ORASDRECTED. s 1 FAGISIO ki o 2 b [p— o1 e b :
7e9f0a1b-3b77-44b3-b629-0b287f4f154b_32_1.jpg WARNING: Kesp oil and grease away. O G AR S SsUe A\ Use in upright position: (MO Che A A ETES WARNING--For e oy S orygen deficiency a0t Erl WA R%{UTI&N: A L3 ING: urinterrupted use ot (Y el LT 51 g’e';se TG R EEULS AT el e G
7ea5ac79-79a7-442c-9c34-3b6477367928_623_1.jpg Humalog Insulin Lispro 100[iU)/ 1mL Injection arv: 3 ID#:. Expires: NDC #: 70518-1388-00 Shape: . LOT #: Ref #: 00002-7510-17 MFG: Lilly USA, LLC, Indianapolis, IN 46285 RX ONLY Directions For Use: See Package Insert Store at 2-8°C (36-46°F); excursions permitted to 0-15°C (32-59°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
7ea701ce-e7d3-4349-a9c2-642a501d45c8_885_1.jpg uopod pasnun pressia 51914 950p-21BuIS 3jUa1S T SUIBIUO) KINO NOISN4NI SNONIAVALLNI HO4 wom3fu oy awosody (FugeiRU pue UDIGRIONNYG) ~SO3aXAA ‘See presaribing information for complete directions for use. Reconstitute with 19 mL o serile water for injection. Carefully swirl the contents of the vl for S minutes. Resulting suspension contains 22mg of DAUNOrubicin and 5 mg of cytarabine per mL of Vyxeas. Reconstituted product must be further diluted prior o use. Discard unused portion. Description: Cytotoxic agent. Sterlle. Lyophilized. No preservatives. Each vl contains 44 mg DAUNOrubicin and 100 mg cytarabine, and the following Inactive ingredients: istearoylphosphatidylcholine 454 mg, distearoylphosphatidylglycerol 132 g, cholesterol HP 32 mg, copper ‘gluconate 100 mg, triethanolamine 4 mg, and sucrose 2054 mg. Store refrigerated 2t 2°C 10 8°C (36°F t0 46°F) inan upright position. Storeln carton to protect from light. FRAGILE Do not drop Serialization Information to be printed at packager NDC68727:745-02 Vyxeos~ RxOnly (DAUNORUicnand ytaabie) Tiposome orinection 44 mg/ 100 mg per vial Ul NDC68727:745-02 Vyxeos~ (DAUNOrubicin and cytarabine) liposome forinjection FOR INTRAVENOUS INFUSION ONLY Must be reconstituted, then diluted. Do ot interchange with other di containing DAUNOFublcin o cytarabine Contains 2 terile Single-dose vials Discard unused portion RxOnly | NDC68727745-02 RxOnly Vyxeos- (DAUNOTubicnand cytaraine) liposome for injection EeL AL DT T g e Distributed by: Jazz Pharmaceutical, Inc. Palo Alto, CA 94304 @) sarsmansas
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_1.jpg NDC 6838271506 Zolmitriptan Orally Disintegrating Tablets, USP 25mg 7‘9 PHARMACIST: Dispense the Pafiont Information provided separately fo each pafient. 30 Tablets 7 '4}..'.”-”'.'..s Rxonly Each ol dsegatng bt contane 25 mg of Zolmitrptan, USP. Usual Dosage: See package insert for complete. prescibing momaton Phenylketonurics: Contains Phenylalanine 251 mg Per Tablet. ‘Store at 20° 1o 25°C (68° 1o T7°F) {8ee 03P Contoted Roam Temperature]. Prtectfrom gt and mosure. Dispense in a tight hght-resistant closed container. KEEP THS AND ALLDRUGSOUTOF THE 3 REACH OF CHILOREN g Manufctured by:Cadia Healbrare Lt 2 Hbmedshad e Distributed by: Z, Pharmaceuticals (USA) Inc. Pemngion N
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_2.jpg Zolmitriptan onaly’ Zolmitri | i M. m Orally Disintegrating usp lmf-';:
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_3.jpg NDC 68382715-86 251mgPorTall. Manssctusay. Cotis st 1 et nba Disbuteaby: Pangon N 0354 Usial Dosage:Seopackage msatfor Campts e s 2yt Pamacauticls USA) . Each ol diiayaing it cntains 25 mgof Zomitan, USP. Phenyetonuric: Cortans ranyaine Slore 12010 25°C 68 0 77°F) {528 USP Convoted Roon Tamperatr], Prtctfom gh and i, KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHLOREN, Zolmitipun Ora Disntegrating Tabets, U Zolmitriptan Orally Disintegrating Tablets, USP D 6(1x6) Unitdose tablets g Zydus Rxonly Zolmitsipan Oral Disinegrating Tablts, USP
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_4.jpg NDC 68382715-86 251mgPorTall. Manssctusay. Cotis st 1 et nba Disbuteaby: Pangon N 0354 Usial Dosage:Seopackage msatfor Campts e s 2yt Pamacauticls USA) . Each ol diiayaing it cntains 25 mgof Zomitan, USP. Phenyetonuric: Cortans ranyaine Slore 12010 25°C 68 0 77°F) {528 USP Convoted Roon Tamperatr], Prtctfom gh and i, KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHLOREN, Zolmitipun Ora Disntegrating Tabets, U Zolmitriptan Orally Disintegrating Tablets, USP D 6(1x6) Unitdose tablets g Zydus Rxonly Zolmitsipan Oral Disinegrating Tablts, USP
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_5.jpg NDC 68382715-86 251mgPorTall. Manssctusay. Cotis st 1 et nba Disbuteaby: Pangon N 0354 Usial Dosage:Seopackage msatfor Campts e s 2yt Pamacauticls USA) . Each ol diiayaing it cntains 25 mgof Zomitan, USP. Phenyetonuric: Cortans ranyaine Slore 12010 25°C 68 0 77°F) {528 USP Convoted Roon Tamperatr], Prtctfom gh and i, KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHLOREN, Zolmitipun Ora Disntegrating Tabets, U Zolmitriptan Orally Disintegrating Tablets, USP D 6(1x6) Unitdose tablets g Zydus Rxonly Zolmitsipan Oral Disinegrating Tablts, USP
7fc95729-2f5d-4d5c-b26c-3a13854f73e3_748_6.jpg Each ol diieyaing it catin 5 mgof Zimipn, USP. Zolmitriptan Orally Disintegrating Tablets, USP Usual Dosage: Saopacage nsetor ot e s Phenyhetonurics: Contans Pranyaanne 501mg Por Tt Stre w2025 680 (528 USP Contoted Roon Tamperatrs], Potctom ghtard e KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHLOREN, e ® lomaion rosdedspasy e puas Recaly 3(1x3) Unit-dose tablets Zomitipan Oraly Disiagratng Tablts USP
7ffd89f1-43ae-4092-8575-d404311da716_870_1.jpg e NLITSIERIP LRV Do i = ws = hydrochloride, USP 25 mg 2 using a chid-resistant doswre, & ol * clomiPRAMINE Coaionyoms £ & . . B | Hydrochloride et ] tion o — : = & CapsuiesU5P ] g Wi Temperature.] = s8sg [25 mg s e — BH: Usual Dosage: See accompanying L 7 I G mnie] | P = g | (s e B e [Mylan® [MMylan® f Q R Myiancom
7ffd89f1-43ae-4092-8575-d404311da716_870_2.jpg b LITOTER R g i = oo 52 &0n9 o1 o i DRAMINE ;::::’:;\‘:xm::;m £ N RM3050A ol & : ! N— : Hydrochloride _ &mith v C0 — ‘Store at 20° 025°C to 77°F). | — @ Capeules, USP e ol Snvie Temperature] g 8848 &s e e o= 5H: " sual Dosage: See accompanying | — PHARNACIST: Dispense the accompanying | Peescribing information. o g g odcsion Gide o schpart, ot ot S A6E Morgertonn, WV 28505 USA g ([Mylan® Rxonly 100 Capsules
7ffd89f1-43ae-4092-8575-d404311da716_870_3.jpg we [t TR Ve oo e = T Shememrel E o * clomiPRAMINE Couiviiions 2 & ; £ = Hydrochloride o e madtoiiaen: ] Oopiles, UsP B oot oo g Temperature] S l |t w1 - Usual Dosage: See accompanying | — PRRRNACIST: Dispense the sccompanying | Prescrbing information. = ™) [Ei i o= Nviane ST w (IMylan [Mylan® R Mylan.com
8108496d-a5d0-45cc-bbbe-93d905bde167_547_1.jpg Somicienis BACTRACINROLLS GFRTILGNT — e gu;:':‘”-"_"m"’ APPLY T0 AFFECTED T, E1ES) THES A DAY e CRASORECTED. 5ot e o o R o Onclanerer
812ddacc-9562-4dde-8d52-d06ae06e07e9_712_1.jpg Prezista Darunavir 800 mg Tablet arv: 30 ID #: 800;T Expires: NDC #: 70518-1483-00 Shape: Oval LOT #: Ref #: 59676-0566-30 MFG: Janssen, Gurabo, PR 00778 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
8135b917-882f-4b4c-99b7-fa8ea54af4bf_255_1.jpg Each capsule containg 25 mg cyclophosphamide USP (calculated as anhydrous) USUAL DOSAGE: See Package Insert for Complete Prescrbing Information Swallow capsules whole. Do not open, chew, of crush capsules. Store at20° 10 25°C (68 10 77°F) [S¢é USP Controlld Room Temperature | Dispense in a (Nt contaer as defined in the LISP/NF Distr_by. West-Ward Pharmaceuticals Corp Eatontown, NJ 07724 NDC 0054-0382-25 100 Capsules Cyclophosphamide Capsules CYTOTOXIC AGENT Wear gloves when handling container and capsules. ¥ wEST-WARD R only i S¢~¢RE0 %S00 v 10008218/03
8135b917-882f-4b4c-99b7-fa8ea54af4bf_255_2.jpg Eash capsule contains 25 g eyclaphosphamide LSP ealoulated as anhydrous) USUAL DOSAGE: See Paskage Insert for Gomplete Prescribing Information Swallow capsules whole. Do ot open, chen, or crushcapsules. Store at 20°C 10 25°C (B6°F 0 77°F). [Se USP Controlled Room Temperature | Dispense in a tight container as defined n the LISP/NF Distr. by West-Ward Phamaceutials Corp. Estontown, N 07724 NDC 0054-0382-13 30 Capsules Cyclophosphamide Capsules € N CYTOTOXIC AGENT Wear gloves when handling container and capsules. P WEST-WARD R only €£1L-2820-%500 L £50000001/01
8135b917-882f-4b4c-99b7-fa8ea54af4bf_255_3.jpg Each capsule contains 50 mg cyclophosphamide USP (calculated as anhydrous). USUAL DOSAGE: See Package Insert for Complete Prescribing Information. Swallow capsules whole. Do not open, chew, or crush capsules. Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight container as defined in the USP/NF. Distr. by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724 NDC 0054-0383-25 100 Capsules Cyclophosphamide Capsules I CYTOTOXIC AGENT Wear gloves when handling container and capsules. R only ¥ wEsST-WARD PUARMACEUTICALS € §2-£8€0-9500 10008217 /03
8135b917-882f-4b4c-99b7-fa8ea54af4bf_255_4.jpg Each capsule cortains 50 mg cyclophosphanide USP (salouleted as anhydrous) USUAL DOSAGE: See Package Insert for Gomplete Prescriing Iformation. Swallow: capsules whole. Do not open, chew, or crush capsules. Store al 20° 10 25°C [B6F 10 77°R. [See ISP Controlled Room Temperature Dispense n a tight container as defined in the LSPAVF Distr. by West-Ward Pharmaceuticals Corp. Eatontawn, M 07724 NDC 0054-0383-13 30 Capsules Cyclophosphamide Capsules € I|| | CYTOTOXIC AGENT Wear gloves when handling container and capsules. P WEST-WARD R, only ¢L-£820-9500 3 5000000201
816b110f-36e5-4b1e-9db4-f82c87191bc6_684_1.jpg NDC 69668-453-01 Mondoxyne:[\H 100 mg Doxycycline Monohydrate Capsules 60 Capsules Rx Only i ”||||||||||||”||||| |||||m| Store at 20° t0 25°C (68° to 77°F) 69668 45301 {sge USP Controlled Room emperature] Protect From Light Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN. Manufactured for IntraDerm Pharmaceuticals a division of Oculus Innovative Sciences LOT: J18B02 EXP: 07/2020 1129 N. MDowell Blve,, Petaluma, CA 94954 (01)10369668453017 B55-317-1107 www.IntraDerm.com (21)Z979900004 (17)200731 Weanutacturer Part #34035 i (10)Z9299 LSO A2 IntraDerm BT
819f828a-b888-4e46-83fc-94d774a28a83_320_1.jpg ) SN/ | 7/ & ™ N -~ Cerdelga . (eliglustat) capsules b 84mg* ¥ *Each capsule cortains4mg of efhustat whichis 7 equilalentto 100 mgofelilusattariate & ' L0220 89ves _§ 6110 Jo Anunod ‘pueRI| ‘PIojIaIEM uol ssd1n195 1oddns BWAzZua peoy uspesuiy pio £uondo £tbi-5vL (008)L soomias uoddng o ied feusnpu) val WOy ebRpI MMM P11 puefal SwAzZuED g paunpehiieny "4:98-65) D,06-51 03 ANYANOD HONYS ¥ panjuIIad SUOISINX® (4,££-89) DoST-0Z 18 2103 oBeiols ‘uonensiuwpe pue abesop ioj11asul abexded 205 NDC 58468-0220-1 Cerdelga’ (eliglustat)capsules 84mg* *Each capsule contains 84 mg ofeliglustat which is equivalent to 100 mg of eliglustat tartrate Dispense the enclosed Medication Guide to each patient Four cartons of 14 capsules each Rx Only NN e e S Cerdelga’ (eliglustat) capsules - 84mg* *Eachcapsule contains 84 mg of eliglustat whichis equivalentto 100 mg of eliglustat tartrate 7 Lot: B N
81a70f82-9fa1-4751-b81f-1c622045634f_8_1.jpg nan
81a70f82-9fa1-4751-b81f-1c622045634f_8_2.jpg GRLC-COUSP-WAD1-PK2SO (92/16) - L el LILRETTLET LY 1-866-937-8247 Wi wostairgases.com
81e639d7-352e-4eaa-87d9-582da68b9728_745_1.jpg mom CitraNatal EIEEE R S it 300 DA S | citronatol com e R Prenatal Supplement Tablet R Prenatal Supplement Tablet and 300 mg DHA SoftGel | and 300 mg DHA Soft Gel WHEN YOU NEED MORE ROK e ——— 0 v Far s dsion | So0m e otias 159 m3 Com cadum Gl CitraNatal EUEEE CitraNatal EOEER:
82a644f9-d9f6-4398-83db-8a1446c183e0_996_1.jpg R e S i S e e ] e b Y E Efe R e g F o me SR B [ty . . EETE e T § | EEEL e 1 sames ! T
82a7d24c-75be-4384-b5bb-860877f1d4e5_884_1.jpg traMADOL Hydrochloride cv 50 mg Tablet arv: 30 ID #: 377 Expires: NDC #: 70518-0258-00 Shape: Capsule LOT #: Ref #: 57664-0377-18 MFG: Sun Pharma, Cranbury, NJ 08512 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
82a7d24c-75be-4384-b5bb-860877f1d4e5_884_2.jpg traMADOL Hydrochloride cv 50 mg Tablet arv: 120 ID #: 377 Expires: NDC #: 70518-0258-01 Shape: Capsule LOT #: Ref #: 57664-0377-18 MFG: Sun Pharma, Cranbury, NJ 08512 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
82eb62ca-c32b-4ff8-9f71-43219b240480_153_1.jpg Bumetanide Tablets, USP 100 Tablets Rx only Each tablet contains 0.5 mg of Bumetanide, USP. Usual Dosage: See package insert for complete prescribing information Store at 20° to 25°C (66° to 77°F) [See USP Controlled Room Temperatre]. Dispense n a tight,light resistant container (USP). KEEP TIGHTLY CLOSED. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadila Healthcare Ltd Baddi, India 81/50 A8
82eb62ca-c32b-4ff8-9f71-43219b240480_153_2.jpg . Bumetanide s Tablets, USP i Store at 20° to 25°C (66° to 77°F) [See USP Controlled Room Temperature]. Dispense n a tight,light resistant container (USP). KEEP TIGHTLY CLOSED. KEEP THIS AND ALL DRUGS OUT OF "THE REACH OF CHILDREN. 100 Tablets Manufactured by: zydu: Cadila Healthcare Ltd ..j.,...-..f Rx only Baddi, India 81/90 “18y o~ o
82eb62ca-c32b-4ff8-9f71-43219b240480_153_3.jpg ? Bumetanide csuqueis Tablets, USP i st Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense n a tight,light resistant container (USP) ~ KEEP TIGHTLY CLOSED. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. 815010y Manufactured by: 100 Tablets Cadila Healthcare Ltd. A 7 zydus Rxonly gagdi india
82fb6c54-3571-4ea1-9a1b-c21418133e84_934_1.jpg LAl s Entacapone Tablets 200 mg i Lol ra Rl Entacapone Tablets B e g S L T SRd e [IMylan|sooncon s
82fb6c54-3571-4ea1-9a1b-c21418133e84_934_2.jpg T ok s ki e B e e fLtrrh et e ek TR LU Dituedby e it N
837c447f-bee9-4773-9850-cdbdf6c6c046_371_1.jpg Metoprolol Tartrate, USP NOC# 71610015560 Metoprolol Tartrate, USP = 50mg 90 Tablets T e M By, Rubcon st s Limiod e s Pty g rarns Metoproll Tarvate,USP 50mg 90 Tablets
8397251f-131f-4dcb-add1-7751993a66a1_737_1.jpg mportant: The oening of s roduet i overe by el amper-rescant . s s has been punctredo is ot visble,donotus and rtum product o plae f purhase. T { Topen ottt e e . gt i don iy i s pen. i To lose Sre e cap ks et i i | NDC 0378-8190-15 Clobetasol Propionate Ointment, USP For Dermatologic Use Only Not for Ophthalmic Use %500 Ll UETTT o) LI LESERN) — I Contains: Clobetisolproponats 0.05% n an et b o of gopen 3, srb s s, i Keep thisand all medicaion out o the reacofcildren. 117432047 DPTAOn A Usun Dosages S aocampanyin rscig ot i Store boheen 15" and 30°C (55 and B e USP Contold oom ! Temperaure] o o fieate. i Nonstcars ottty i § ; 5 0278-2190-15 i Hylan Phamaceutcals . DPT Laboratories Ld. Morgnton, W 25505 US A Son Avonio, D TE215 US A NDC 0378-8190-15 Clobetasol Propionate Ointment, USP For Dermatologic Use Only Not for Ophthalmic Use. Rxonly
8472bdf6-d01a-4ee4-9081-6e0ff5da3c97_18_1.jpg Loperamide HCI 2 mg Capsule arv: 5 ID #: TEVA;0311 Expires: NDC #: 70518-0072-00 Shape: Capsule LOT #: Ref #: 00093-0311-05 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
8472bdf6-d01a-4ee4-9081-6e0ff5da3c97_18_2.jpg Loperamide HCI 2 mg Capsule arv: 30 ID #: TEVA;0311 Expires: NDC #: 70518-0072-01 Shape: Capsule LOT #: Ref #: 00093-0311-05 MFG: Teva, Horsham, PA 19044 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
84a20017-344b-4684-a915-c85a55fcbbcb_70_1.jpg / MONO-LINYAH Wi 4 i Estodl. Tt 1971 [ = e MONO-LINYAH Vst i T s MONO-LINVAH MONO-LINVAH | MONCNEN, Yot it Vonsinse pigsneenga | T 5P Lot Tl 57 s e §
8515df41-1936-4f3b-86ba-d2bb2a8441fb_61_1.jpg b e viummm i 8 Tt s A1) 1L S o g wastonso a0 51 3 A OB 18 aopodiuipssy 0 104 sbpmess oape e g Ty [T T ey SIUTHASOUDIW Sui | (9 auikoouiw unsary SIYIHISOUDIW 0 | [o auofoouw 100 sgspidouisouss oy s g onn o s o Sopim patisn bt S tosad a0 S5 3o A IS & 00 e 1021 minocycline HCl 1 mg MICROSPHERES 3 g g = e T 2resestabe ol pouches b St 2 cartridges per pouch 1 mg of minocycine per caridge Axony OrAPHARMA minocycling HCI 1 mg = MICROSPHERES Tocndr 868 AGST 273704 o . { T e e Akt evas o Arestin
859685ca-83b6-829f-5ef3-22a72eeddbc9_151_1.jpg NDC 50268-531-15 Metformin Hydrochloride Extended-Release Tablets, USP Rx Only 50 Tablets (5 X 10) Unit Dose 5026853115 NDC 50268-531-15 Metformin drochloride Extended-Release Tablets, USP Rx Only 50 Tablets (5 X 10) Unit Dose 5026853115 PHARMACIST: PLEASE DISPENSE WITHATTACHED PATIENT INFORMATION LEAFLET. Each extended-release tablet contains: Metformin Hycrochioride, USP . 500mg Usual Dosage: Se enclosed package | dosage information. Store at 20° to 25°C (68° to 77°F); excursions permitied fo 15° to 30°C (59° o 86°F).[See USP Controled Room Temperature]. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Manufactured for: AVKARE, Inc. Pulaskd, TN 38478 Mfg. Rev. 03-2018-02 AVRev. 10/18 (P)
859685ca-83b6-829f-5ef3-22a72eeddbc9_151_2.jpg NDC 50268-532-13 Metformin Hydrochloride Extended-Release Tablets, USP 30 Tablets (3 X 10) Unit Dose 5026853213 NDC 50268-532-13 Metformin Hydrochloride Extended-Release Tablets, USP - 750mg Rx Only 30 Tablets (3 X 10) Unit Dose 5026853213 PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET Each extended-release tablet contans: Metformin Hyarochlorids, USP ... .750mg Usual Dosage: See enclosed package insrtfor dosage information. Store at 20° o 26°C (68° to 77°F); excarsions permitted fo 16° 1 30°C (50° o 86°F) [See USP Conirlled Room Temperature]. Keep this and all medications out o thereach of chidren. Manufactured for: AVKARE, nc. Pulasid TN 38478 AVPAK APRODUCT OF AVKARE Mig. Rev. 09-2015-01 AVRen 01/18 )
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_1.jpg “Each extended-release capsule contains: Venlafaxine hydrochloride: USP equivalent to venlafaxine 37.5 mg NDG 65862-52747 Venlafaxine Hydrochloride Extended-Release Capsules USP ! PHARMACIST: Dispense the Medication Guide provided separately o each patient. 2 AuRoBNDO Usual Dosage: See accompanying Store at 20°t0 25°C (68° 0 77°F) [See USP Controlled Room Temperature | 15 Capsules SEALED FOR YOUR PROTECTION Distributed by: Aurabindo Pharma USA, Inc. 279 Princeton-Hightstown Road B Code: TS/DRUGS19/1993 Made in India “Over Printing Zone v Coding Area (45 15 mm) Dotted lines not to be printed
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_2.jpg I asn soinsded osealay-papiar ApuOloIpAY suNeR I e 2710 Venlafaxine Hydrochloride Extended-Release Capsules USP p & gD PHARMACIST Dispense e ecicaton o provees Soprte o s pater 2 auronoo 001 i SRR iy Venlafaxine Hydrochloride Extended-Release Capsules USP S samtn om0 000 S0 so[msie asesjay-papusky U OPOIp i aupejEUa ds samsie) aseajay-papuang U0 301Dk AU Nefe A\ oo BRG] samin 0 vn 10000 v
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_3.jpg “Each extended-release capsule contains: Venlafacine hydrachioride USP equivalent o venlafaxine 75 mo. NDG 65862-528-47 Usual Dosage: See accompanying Venlafaxine Hydrochloride Extended-Release Capsules USP g Dispense the Medi provided separately o each pat Store at 20°t0 25°C (68° 0 77°F) [See USP Controlled Room Temperature | 2 AuosDo 15 Capsules SEALED FOR YOUR PROTECTION Distributed by: Mage in India Aurabindo Pharma USA, Inc. z 279 Princeton-Hightstown Road o 2% et s Code: TS/DRUGS/19/1993 e = o s o i* o — ! N——] —— *Over Printing Zone o v Coding Area (4515 mm) Dotted fnes not o be printed
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_4.jpg e 2810 Venlafaxine Hydrochloride Extended-Release Capsules USP mg* PHARMACIST: Dspens h Modlcaton Gula proided Soparatay o cac patot. 29 AuroBNDO 010 e 1010210 unt e cpes [t e S, Venlafaxine Hydrochloride Extended-Release Capsules USP Ty cm g ' e et e s i et r ity s e 2 emn [ ——— dsn »pstegsseajay-ppuapy @ U0 H201pAH suxejelusn dsn sainsde) aseapy-papuang APUO|POIPAH aUrKElE[Ua st s o1
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_5.jpg NDG 65862-69747 Rx only Venlafaxine Hydrochloride Extended-Release Capsules USP provided sepaatly 0 sach patnt. 2 auwonno 15 Capsules “Each extended-release capsule contains: Venlafaxine hydrochioride USP equivalent to venlafaxine 150 mg. Usual Dosax information, : See accompanying Store a1 20°to 25° (66°to 77°F). [See USP Contralled Room Temperature | SEALED FOR YOUR PROTECTION Distrbuted by: Aurabindo Pharma USA, Inc. 279 Princeton-Hightstown Road e Code: TS/DRUGS/19/1093 Made in India Over Printing Zone ) v Coding Area (45x 15 mm) Dotied fnes not to be printed
85d3ce8b-8966-45d9-bdaf-f6f0475096e1_415_6.jpg o Venlataxine Hydrochloride Extended-Release Capsules USP PAARAGST,Dipasa e st e provisss s s e e 7 AuRoBINDO 10601y 010110 vt s ot EEISTIELE oo ong Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg* i e evmi e ke £ i ety z sz 3 [ €I % ' dsnsamsde) ase: U201 MK @ s sainsdeg asearay: dsn sapisde) asealay-papualy M UONIOIDAY AU Xeje[UD] st sm st
86841382-4229-4e03-958e-3ac22639efd4_93_1.jpg ey torvastatin alcium Tablets PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET B only NDC 0093-5056-98 A c 10 mg* GTIN 0300935056982 Each film-coated tablet contains atorvastatin calcium equivalent to 10my atorvasttin. Usual Dosage: See package insert forfull prescribing information. Store at 20°to 25°C (68°10 77°F) [See USP Controlled Room Temperature Dispense n atight,light-resistant container as defned inthe USP, with achild-esistantclosure (2 required), KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By TEVA PHARMACEUTICAL IND. LTD, Jerusalem, 9777402, Israel Manufactured For TEVA PHARMACEUTICALS USA, ING. North Wales, PA 19454 Iss. 6/2015 323K353170517 N 3 0093-5056-98 2 LoT EXP.
86841382-4229-4e03-958e-3ac22639efd4_93_2.jpg PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET Calcium Tablets ¥ only 20 mg* @ P o 0 o ] @ 4 S S © 2 = GTIN 0300935059983 Atorvastatin Dosage: See packa prescribing i Store at 20° to 25°C (68° 1o 77°F) See USP Iss. 6/2015 KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In “TEVA PHARMAGEU Jerusalem, 9777402, Manufactured For “TEVA PHARMACEUTICALS USA, INC, North Wales, PA 19454 323K353180517 N 3 0093-5059-98 3 Al LOT EXP.
86841382-4229-4e03-958e-3ac22639efd4_93_3.jpg NDC 0093-5058-98 Atorvastatin Calcium PHARMACIST: PLEASE DISPENSE WITH AATTACHED PATIENT INFORMATION LEAFLET B only Tablets 40 mg* GTIN 0300935058986 Each film-coated blet contains aforvastatin calclum equivalent to 40 mg atonasiatn Usual Dosage: See package nser for fll ing irformtion 20° 10 25°C (68° 1o KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMAGEUTICAL IND. (TD. 9777402, red For TEVA PHARMACEUTICALS USA, ING, North Wales, PA 19454 w 0093-5058-98 Iss. 612015 323K353190517 90 TABLETS, LoT
86841382-4229-4e03-958e-3ac22639efd4_93_4.jpg J NDC 0093-5057-98 Atorvastatin Calcium PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET B only Tablets 80 mg* GTIN 00300935057989 Each film-coated tablet contains atorvastatin calcium equivalent to 80 mg atorvastatin Usual Dosage: See package nsert for prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined closure (i ). KEEP THIS AND ALL MEDICATIONS OUT OF THE REAGH OF CHILDREN Manufactured In Israe! By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N 0093-5057-98 i mn Iss. 6/2015 323K353200517 LoT EXP.
86aad85d-5460-4c38-9761-a225e6bce190_177_1.jpg 1o [ DG 40502-425-00 SYFFILO HJIllllllllllﬂﬂ (efavirenz, lamivudine, and tenofovir disoproxil fumarate) tablets B R Note o pharmacit Do ot cover ALERT o with pharmacy e A g s S L0 106 40502.426-09 oy h X4 SYMFILOD (efavirenz, lamivudine, and tenofovir disoproxil fumarate) tablets f e Mot o phrmacit Dot coer ALERT bo wihphamacy label o - SYMFILO (efavirenz, lamivudine, and tenofovir disoproxil fumarate) tablets T L i Keep s and all medicaton outci e reach of chldren. Stare below 30°C (85 Dipense iy n il contine Kenp continer ey cloed.
86d9ad02-bef9-4131-a717-3ab7c18c6bc9_62_1.jpg i wBow 000't) wnoshl uajojoeg e o Baclofen Injection (5,000 meg/mt) For nrthacs Uss Only Discard Unused Porion e | o i e CHIRUSA (MMylan® Mimcon e Baclofen njoction EE e 1000 meg/mt) Raonty SogloDosoVel o i
86fd7d4d-20d4-4483-8e45-f2942503f367_839_1.jpg Depakote Divalproex Sodium 500 mg Tablet, DR arv: 30 ID #: a;NS Expires: NDC #: 70518-1456-00 Shape: Oval LOT #: Ref #: 00074-6215-13 MFG: AbbVie Inc., North Chicago, IL 60064 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
8774b30c-d7d4-49fb-9dcb-db5b991f641b_592_1.jpg NDC 51862-271-01 Each Tablet Contail Clozapine ... . Usual Aduit Dosage: See accompanying prescribing information. Clozapine Store and dispenae at 300 25°C (68° to 77°F) [See USP Controlied Room Tablets, USP [0t e cutorhe reschot children. Dispensing should be contingent upon ANC Lot/Exp Below results and should not exceed limits as specified in the full product labeling. Manufactured for: e S 34 reenville. ReOnly @mn Made in Spain 100 Tablets Rev. 0472018 233694-2
8774b30c-d7d4-49fb-9dcb-db5b991f641b_592_2.jpg NDC 51862-272-01 Each Tablet Contain: Clozapine Usual Ad 1g¢ " cl s prescribing information. ozapine Store and dispense at 20° to 25°C = (68° to 77°F) [See USP Controlled Room 3 — Ta b lets U S P Temperature]. FH—N y Keep this and all drugs out of the reach of = & ==ty children. = Dispensing should be contingent upon ANC & R ehonk Rotera s = specified in the full product labeling. =2 Manufactured for: e 3534 reenile, ReOnly ewm Made in Spain 100 Tablets Rev.04/2018 236228-1
8774b30c-d7d4-49fb-9dcb-db5b991f641b_592_3.jpg NDC 51862-273-01 Clozapine Tablets, USP Rx Only 100 Tablets e Each Tablet Contait Clozapine Usual Aduit Dosage: See accompanying prescribing information. Store and dispense at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Keep this and all drugs out of the reach of children. Dlspensmg should be contingent upon ANC results and should not exceed limits as specified in the full product labeling. Manufactured for: Mayne Pharma Greenville, NC 27834 Made in Spain Rev. 04/2018 LoUExp Below 233696-2
8774b30c-d7d4-49fb-9dcb-db5b991f641b_592_4.jpg NDC 51862-274-01 Clozapine Tablets, USP e 100 Tablets Each Tablet Contains: Clozapine .. ] Usual Adult Dosage: See accompanying prescribing information. 7 Store and dispense at 20° to 25°C —_— (68° to 77°F) [See USP Controlled Room — Temperature]. = Keep this and all drugs out of the reach of & =—=tu/ children. = Dlspensln§ should be contingent upon ANC resuits and should not exceed limits as specified in the full product labeling. Manufactured for: Mayne Pharma Greenville, NC 27834 Made in Spain Rev. 04/2018 236230-1 Lot/Exp Below 1862
88a548d1-97c0-46d0-825a-75ef689d6470_444_1.jpg Naproxen 500 mg Tablet arv: 30 ID #: G;32;500 Expires: NDC #: 70518-1516-00 Shape: Capsule LOT #: Ref #: 68462-0190-05 MFG: Glenmark, Mahwah, NJ 07430 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
88a548d1-97c0-46d0-825a-75ef689d6470_444_2.jpg Naproxen 500 mg Tablet ary: 12 ID #: G;32;500 Expires: NDC #: 70518-1516-01 Shape: Capsule LOT #: Ref #: 68462-0190-05 MFG: Glenmark, Mahwah, NJ 07430 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
88a548d1-97c0-46d0-825a-75ef689d6470_444_3.jpg Naproxen 500 mg Tablet arv: 14 ID #: G;32;500 Expires: NDC #: 70518-1516-02 Shape: Capsule LOT #: Ref #: 68462-0190-05 MFG: Glenmark, Mahwah, NJ 07430 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
88a548d1-97c0-46d0-825a-75ef689d6470_444_4.jpg Naproxen 500 mg Tablet ary: 60 ID #: G;32;500 Expires: NDC #: 70518-1516-03 Shape: Capsule LOT #: Ref #: 68462-0190-05 MFG: Glenmark, Mahwah, NJ 07430 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
88aaa2a1-13be-4f56-ace6-66e899028007_491_1.jpg Irbesartan/HCTZ 300mg/12.5 mg Tablet arv: 90 ID #: 327;HH Expires: NDC #: 70518-1550-00 Shape: Capsule LOT #: Ref #: 43547-0331-09 MFG: Solco, Cranbury, NJ 08512 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
88e0f275-dd7b-447d-b9d3-316a06da934f_98_1.jpg NDC 66490-650-20 Rx Only Diastat C (diazepam rectal gel ) Rectal Delivery System TWIN PACK y = Contains two pre-filled, unit dose, rectal delivery systems v VALEANT with lubricating jelly and instructions for use Each Diastat (aepam recta gel ectel delverysystem Gellers 2.5 g diazspam in 0.5 ml. Diatat gl, Eacn Distat ectel delvery ystom ki contair: ropylene ghal, sty akohol (10%),soelum benzote, benzy alcohol (1.570), benzor i, Pyronypropyl metrylcellese, and prted water, Rx Only Caution Federal b proibisthe tansterofthisdru 1o ary person other than the paten for whor It vas prescribed.
89057c93-8155-4040-acec-64e877bd2b4c_315_1.jpg NOLLYZITVIYIS R ELLALERR] gz W VALEANT NDC 0187-0065-01 (lorazepam) 100 Tablets [0 Each tablet contains 2 mg lorazepam. Usual Dosage: One to six mg per day, given in divided doses. See Dosage and Adi ration section of the prescribing information. Keep tightly closed. Store at 25°C (77°F); excursions permitted to 15°- 30°C (59°-86°F) [see USP Controlled Room Temperature]. Dispense in tight container. Manufactured by: MEDA Manufacturing GmbH Cologne, Germany D-51063 For: Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA| Product of Germany 9507400
89057c93-8155-4040-acec-64e877bd2b4c_315_2.jpg BRI PROTECTION 2= =2 = b o [=] e NDC 0187-0064 100 Tablets 1 [Each tablet contains 1 mg lorazepam. Mm:n_ Dosage: One to six mg per day, isection of the prescribing information. fa% ightly closed. Store at 25°C (77°F); hxn__a_ozm permitted to 15°- 30°C (59°- 86°| [see USP Controlled Room Temperature]. s_muc:wm in tight container. ,z_wzamoz_‘ma by: MEDA Manufacturing GmbH (Cologne, Germany D-51063 For: Valeant Pharmaceuticals North America LLC idgewater, NJ 08807 USA ﬁSg uct of Germany 9507300
89057c93-8155-4040-acec-64e877bd2b4c_315_3.jpg Feomooo\.w_\ommo m n__vh -01 B LAV PROTECTION NDC 0187-0063 I AOZ 0 (lorazepam) 100 Tablets Each tablet contains 0.5 mg lorazepam. Usual Dosage: One to six mg per day, given in divided doses. See Dosage and Adi ion | ‘section of the, prescribing information, [Keep tightly closed. Store at 25°C (77°F); ! excursions permitted to 15°-30°C (59°-86°F) \[see USP Controlled Room Temperature]. Dispense in tight container. 1 Manufactured by: MEDA Manufacturing GmbH (Cologne, Germany D-51063 ! For: Vialeant Pharmaceuticals North America LLC | Bridgewater, N 08807 USA | Product of Germany 9507200 | Vi dussessawsseasausrasis %
897dac69-a59b-423c-be16-6301c7e504d9_913_1.jpg Pashaged by Eryane Reanch Buabank. 04 91500 5 VHITE OVAL B3 Buspirone Hel 9 10mg Tablet | B & "Store at room temp of Compare To: 2025 C (68-77F) Buspar 10mg Tablet Keep all drugs outof Intas Pharmaceuticaks Limited 5 reach of children #30 Exp: MMYY 3 NDC 7133502221 030471113522
897dac69-a59b-423c-be16-6301c7e504d9_913_2.jpg Pacbaged by Eryant Rench Bunbank. 04 91500 2 5, WHITE UHITETO OFF WHITE Buspirone HCL S cisutesiseeosss: zes 15mg Tablet o R 2 Store at room temp of Compare To: 2025 C (68-77F) Buspar 15mg Tablet Keep all drugs out of Catlbeaticare Unted | rech of children #30 Exp: MMYY 3 NDC 7133502721 017471114270
897dac69-a59b-423c-be16-6301c7e504d9_913_3.jpg Pashaged by Eryane Reanch Bunbank. 04 91500 Buspirone Hel G MEcwsussiwa i 30mg Tablet o V66211 Store at room temp of Compare To: 2025 C (68-77F) Buspar 30mg Tablet Keep all drugs out of PilaHnaslados reach of children #60 Exp: MMYY NDC 7133505521 033331112994 om
89a46a68-4da0-4666-8e0f-60a8a36b6107_24_1.jpg NoVarmished rea (D0 NotPrt) (18241 mm) Cinacalcet b ¥ T ! ! i | | | | ! — | 5 (equvaent 033060 mg. o i Hydrochloride = = 0257 . | | Tablets O S oo ! ! Dispense in a ight, ight-resistant — ! o 2 e U5 = | 1] 4‘!9 Vst Dosage: eePacage et | | KEEP THIS AND ALL DRUGS OUT ! ! OF THE REACH OF CHLDREN | | 30 Tablets ~ Manufactured by 5 ! ! Gl Heahcars it 3 | G aydus Reony b i
89a46a68-4da0-4666-8e0f-60a8a36b6107_24_2.jpg o Varnihed Area (Do ot Pr) (18241 mm) Cinacalcet S : P ) Hydrochloride — crissis ; ‘ ‘ ‘ ‘ ‘ ‘ ] i i St oioer T e { ‘Controled Room Temperature] | Tablets = Terpes, 4 Dispense ina tght, ghresstant ‘ T : @ o e ‘ P —— ! (OF THE REACH OF CHILOREN. ‘ ‘ i I 30 Tablets Manacuredsy 4 Zydus Reonly Anmessted, inds Revtsre
89a46a68-4da0-4666-8e0f-60a8a36b6107_24_3.jpg No Vamished Area (Do ot Pr) (18241 mm) Cinacalcet e Hydrochloride =552 Tablets oLy o e e O sl Dosag: S Paage et KEEP TS 0 AL DR OUT OF THE REACH OF CHUDREN . 30 Tablets Manacuredny 5 Py Rxonly Ahmedatas, : ; | | | i ‘ ‘ | i 3 ; o s ‘ | ‘ | | | ‘ i |
89b5687a-6e21-47cd-9c05-d9c9f4f8cf49_146_1.jpg Y FLUDROCORTISONE ACETATE TABLETS USP 0.1 mg 10 TABLETS Each Tablet Contains Fiucrocortsone acetate 0.1 . Usus Dosage: Sa product nser for i prescrbing eformation precaions and warige Warming:Potent g STORAGE: Store at 20° 10 25° € (68" 10 77* F): excursions. sermited between 15° to 30° C (53" to 86" ) (see JSP Controled Room Temperature] Avoid excess heat RXONLY WARNING. This Jrit Dose package s not chid resistant anas ntended for nsttutonsl Lse Only. KEEP THIS AND ALL DRUGS OLT OF THE REACH OF CHILDREN. I dspensad for outpatent use, s chidresitant corvainer shoud be utized FOR YOUR PRCTECTION: Donct use i bister st or boken. The orug product contained in t package i flom NDC #0115-7033, Impax Genercs Disirbuted by: amenican Healtr Packaging Columbs, Obio 43217 amercanheattpackaging com an AmersourceBergen Compary. AMERICAN HEA_TH PACKAGING® Disirbuted by Cardinal Healt Dubin, OH 43017 Léga0a7s0218 LOT #: XXXXXXXXXX ~ EXP. DATE: XK/XXIXK
89ccfc76-245f-4604-bc1d-9115c657c340_780_1.jpg e s e G "E R i e § e B T e s b e om b THGE ADRY 2 1 o =, ORASDRECTED. EE s e - I R, e :
89ccfc76-245f-4604-bc1d-9115c657c340_780_2.jpg o o, Rl DCLOFEMACH SNOORTIRIER ¥ o e $ ! ipmme omoe R, Ao 1 . e oo ORASDRECTED. g E s e - § 4 R e !
8a9b0cb5-3236-4de4-a97d-eb247c6c7c68_280_1.jpg o o e s TR ons aNDSUPT AKE 3045 EAST Y/ S
8a9b0cb5-3236-4de4-a97d-eb247c6c7c68_280_2.jpg OXYGEN,REFRIGERATED LIQUID USP UN1073 T ALWAYS KEEP CONTAINER IN UPRIGHT POSITION CONTENTS: LoTe: ! WARNING: Forsmargancy uss ank hen scnirnistored b propsrly ' tranzd parsommel fof oxsgen defiire and asussitation. For | allother macieal spicons, Rxonly Urinterrupte use o highconcaryations of rygan vist lang duraon sithoutimanitoing s sfct on grgen contart of artaria oo, ma bs armful. Uss ony with prsurs {aducing squipmart and apparate dssgned fo Gvgen. 00 ot St 0 Use on patarts wha hoksstopped Ssathing unlses sl CONUEUON wih F36USCITte aqipmart Progused by A Linuefaction WARNING: EXTRENELY COLD 0XIDIZING LIGUID 4HD GAS UNDER, PRESSURE VIGOROUSLY ACCELERATES COMEUSTION COMBUSTIELES I CONTACT WITH LIQUID DXYBEN AV EXPLODE 01 IGHITIOH OF IMPACT. A CAUSE SEVERE FROSTEITE. e ol rass2 and combustiizs ava; Uss only it sauipmant clsanss or o Stote and vsa wih oceguats vsrtation Do o gatguid i s, o1 skin o cling Forllud ithdranal ear faca e and glvee. Do nt drop. s> suitsble e truck fr sontsine! movement ok spills. 0o not vk on o ol equpmant izt sile Gl tmpeiatura shouid ot 2casd 32°C 1125 Close slvg far each se and whan s sz backflow sz devie I he iping. Uia I accardance i he Materil Sataty Data Shast {HisDE) FIRSTAID: [N CASE OF FROSTRITE, obtain medical treatment inmeditely. OAS 7782447 DO NOT REMIOVE THIS PRODUGT LABEL. GAS AND SUPPLY 3945 EAST LAKE BLVD. BIRMINGHAM, AL 35217 205-849'5947
8a9b20e4-82e6-4151-9c9d-39aaf2a767e2_37_1.jpg NDC 0093-0661-16 Albuterol Sulfate Syrup 2 mg/5 mL B only Each 5 mL (1 teaspoonful) contains albuterol sulfate 2.4 mg, equivalent to 2 mg albuterol. Usual Dosage: See package insert for full prescribing information, Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. This s a bulk package. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN, Manufactured In Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA Ontario, Canada L5N 6L6 Manufactured For TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 NDC 0093-0661-16 Albuterol Sulfate Syrup 2 mg/5 mL 38332-100057 0093-0661-16 7 3 Rev.J 92015
8aab1dce-0699-4866-8707-33b4e2177bdd_449_1.jpg Dosage Adutsand adolescens 12 y0ars of agoand older: 110 2 tablets sublingually. Dose may be repeated three or four times a day,thirty minutes to one hour before meals and at bedtime, the dosage being adjusted as needed and tolrated. See package insert for complete prescribing information. KEEP THIS AND ALL DRUSS OUT OF THE REACH OF CHILDREN This dispensing package s inended for professional use only. Dispense In tight,lght resistant container as defined i the USP/NF, with a chilc-resistant closure. Store at contrlled room temperature between 20°-25°C (68°-77°F), see USP Controlled Room Temperature. Distrbuted by: Aoella Alpharetta, GA 30022 400812 Rew 0572013 NDC 42192-339-01 Hyoscyamine Sulfate SL Sublingual Tablets Each sublingual tablet contains: Hyoscyamine Sulfate .. 0.125 mg Rx Only 100 Tablets 9 42192-33901 N 3 | LotExp. date:
8aff9f54-62e1-4ce7-8cc0-dea1195e4006_476_1.jpg £ L 95-05%9-£600 NDC 0093-6450-56 i Delayed-Release Capsules USP 'hmwmll’ wooy pagonuog dsn 5| (4u2£0,89) 2,57 0 02 1 2015 00K BuRused Yy ) 20 mg* % PHARMACIST: Dispense the accompanying Medicaton Giide 1o each patent. KE46 B Rev. A 7/2014 1 only _ S0CAPSULES
8aff9f54-62e1-4ce7-8cc0-dea1195e4006_476_2.jpg 3y (a2 04 ,89) 3,52 01 02 ¢ IS § Nocoosaastse % ESOMEPRAZOLE “[anesodud w00y peOUO) dS 84S MAGNESIUM Delayed-Release i 3 é Capsules USP 9. 40 mg* PPHARMACIST: Dispense the accompanying Medication Guide to each patient. 1 only 30 CAPSULES - SHOLLYOIGIN TIY QWY Sl 33X 035070 ALLHOLL HINIVINOD d33X Taantes ) s s o € U ST ) U1 puEp e U001l € U Fsuads )
8b9c7f0b-0df9-429e-bc36-342ac4fde037_655_1.jpg mnén 2E8E 455Ky © Bagict 52 g2g28gt B2, gizviel L@ Sizscee & B o 85F mw BB E aa558 = S SQAE 23.5,28 8582 50t 2 8o s8885E: Each soft gelatin capsule contains 05 mg dutasteride. Usual Adult Dosage: 05 mg once a day. See_package insert for full prescribing inform Store3120° 10 25°C (68° 10 77°F) [See USP Contolld Room Temperature]. < Dispense in a tight, light-resistant & container s defined in the USP. with = achidesistant losure as required). D0 not use i safety seal under capis < broken or missing. g KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured B PHARACELTICS INTERNATIONAL, INC. Hunt Valley, MD 21031 Manufactured For TEVA PHARMAGEUTICALS USA, INC. North Wales, PA 19454 % 0093-5655-56 7 mmm R 799-32-100564 B only
8c166755-7711-4df9-d689-8836a1a70885_413_1.jpg . : e Singulair® 4 mg (Montelukast Sodium) NDC 0006-3841-30 ORAL GRANULES For Pediatic Patients § months to 5 years of age. Singulair" 4 mg gnnmelukast Sodium) RAL GRANULES For Pediaric Patiens § morths to 5 years of ag. Kesp this and il drugs out of the rach of chidren. "DIRECTIONS FOR USE: See accompanying Package Insert. Once apensd, use N 3 ~3841-30 6 the contents ofthis packet within 15 minutes (with or without mixing with food). Discard any unused porton. Rxanly L - Nl ‘a6 1o siaf ¢ 0] SO g sWaTE SIS 103 STINNVYY TVHO (uwnipos Jsexnjajuopy) fw p Jieinbuig Singulair® 4 mg Singulair® 4 mg (Montelukast Sodium) (Montelukast Sodium) ORI GNP ORAL GRANULES oe Pesiiyelent 6 moths 15 yeam g For Pediatric Patients 6 months to 5 years of age. ‘equivalent to 4 mg Montelukast. ‘Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F) [see USP ol e e Sees o Copyigh © 314 MrckShar D Cr. sy of Marek & o. . A s e 7003436100 30 Packets GTIN 0030063841306
8c166755-7711-4df9-d689-8836a1a70885_413_2.jpg urel. Potect fom mol Storeat 25°C (77°F) excrsonspermited 1 15-30° (59867 NDC0006-171131 Singulair® (Montelukast Sodium) CHEWABLE Tablets % 7004048400 | 5 GTIN 0030006171131 For Pediatric Patients 2-5 Years of Age Phenylketonurics: ontins phenyblanine (acomponentof asprtame) 0.674 g per +-mg chewable ablt Exch tablet cotains 42 mg MonteluastSodum equlent to4mg Montebast. Reonly 30Tablets
8c166755-7711-4df9-d689-8836a1a70885_413_3.jpg NDC 0006-9275-31 . o Singulair (Montelukast Sodium) CHEWABLE Tablets 5mg For Pediatric Patients 6-14 Years of Age Phenylketonurics: contins phenylalrine s componetof st 0362 mg e ‘5-mg chewabletablet Exchtablet cotains 5.2mg Montelukast odium equivalent tosmgNontelukast Reonly 30Tablets 7004055800 6TIN 00300069275310 s permittedto 15.30°C (59 l pakage. USUALDOSAGE See Package hser. Storeat25°C (77 g
8c166755-7711-4df9-d689-8836a1a70885_413_4.jpg NDC 0006-9117-31 7004055600\\ —_— Singulair° (Montelukast Sodium) Tablets (LY For Adults 15Vt;ars of Age and Older Each ablet contans 104 mg MontekukastSodum = ‘equivalent to 10mg Montelukast. o 37 (5996°) anperaure.Potect from misture adae. USUAL DOSAGE:See Package nsett. GTIN 0030006917313 11731 s pemitte Rxonly E 3 £ 30Tablets
8c6b984d-2ace-4534-b441-c2db959a1da1_763_1.jpg nan
8c6b984d-2ace-4534-b441-c2db959a1da1_763_2.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED LiquiD usP UN1073 LTRs: [ CONTENTS: CUFT: WARNING: For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, B only. Uninterrupted use of high concentra- tions of oxygen over a long duration, without monitoring its effect on oxygen content of arterial blood, may be harmful. Do not attempt to use on patients who have stopped breathing unless used in conjunc- tion with resuscitative equipment. Keep out of reach of children. Federal law requires that this container be refilled with oxygen USP only by establishments registered as a drug manufacturer in accordance with the Federal Food, Drug, and Cosmetic Act. Produced by Air Liquefaction. DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS REFRIGER- ATED GAS; MAY CAUSE CRYOGENIC BURNS OR INJURY. COMBUS- TIBLES IN CONTACT WITH LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. Do not handle until all safety precautions have been read and understood. Keep and store away from clothing and other combustible materials. Keep valves and fittings free from grease and oil. Use and store only outdoors or in a well-ventilated place. Wear cold insulating gloves, face shield, and eye protection. In case of fire: Stop leak if safe to do so. Use a back flow preventive device in the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. DO NOT change or force fit connections. Avoid spills. Do not walk on or roll equipment over spills. Close valve after each use and when empty. Always keep container in upright position. Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF ON SKIN: Thaw frosted parts with lukewarm water. Do not rub affected area. Get immediate medical advice/attention. CAS: 7782-44-7 DO NOT REMOVE THIS PRODUCT LABEL ey e In case of emergency involving this malerial call INFOTRAC at 1-800-535-5053 CRUMPTON WELDING SUPPLY & EQUIPMENT, INC. 1602 N 34™ STREET « TAMPA, FL 33605 « 800-229-69?77 - 1 (01/15)
8c9bb449-6341-4f24-9d38-6ca952e07122_622_1.jpg NDC 65162-284-03 Irbesartan Tablets, USP e Rx only 30 Tablets Each tablet contains: 75 mg of irbesartan, USP. See package insert for dosing information. Store at 20° to 25°C (68" to 77°F); excursions permitted between 15" to 30°C (59 to 86'F) [see USP Controlled Room Temperature]. Mifg. Lic. No. G/25/1941 Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Anhmedabad 382220, INDIA Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 08-2018-01 65162 28403 4 3 Non-Varnish Area (For Lot And Exp. Date)
8c9bb449-6341-4f24-9d38-6ca952e07122_622_2.jpg Each tablet contains: 150 mg of irbesartan, USP. See package insert for dosing information. NDC 65162-285-03 Irbesartan St 1t 20" to 25°C (68" to 77°F); il Tablets, USP niciininis owe s won [see USP Controlled Room Temperature]. Mfg. Lic. No. G/25/1941 iy Anmedabad 382220, INDIA S0 Tablets Digtributed by: - Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 08-2018-01 ( o Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. 1 65162 28503 ] 3 Non-Varnish Area (For Lot And Exp. Date)
8c9bb449-6341-4f24-9d38-6ca952e07122_622_3.jpg NDC 65162-286-03 Irbesartan Tablets, USP Each tablet contains: 300 mg of irbesartan, USP. See package insert for dosing information. Store at 20" to 25°C (68" to 77°F); excursions permitted between 15 to 30°C (59° to 86F) [see USP Controlled Room Temperature]. Mfg. Lic. No. G/25/1941 Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad 382220, INDIA Distributed by: ~ Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 08-2018-01 8 65162 28603 3 Non-Vamish Area (For Lot And Exp. Date)
8d937ca3-3351-40f1-8192-348ba0c68162_418_1.jpg GTIN: 000 Lot ooux MMYYYY No Varnished Area (Do Not Print) (18505 mm) NDC 66382:353.05 ] 'ONCE-DAILY buPROPion 5O mon oo Use Hydrochloride Usual Dosage: Take one tabletdaily oras L - Extended-Release plt presrong Store at20° 10 26°C (68° 0 77°F) Tablets, USP (XL) (seeuse conrolea Room Tomporatuel Dispense i a figh,ghtresistant : ! ‘ ! | | ‘ | | | | ‘ | | ‘ | T ‘ el s | (RN &) oo | Zyoan® s the registered trade mark ‘ | | j | ‘ ‘ | ! | | ‘ ‘ 'WARNING: Do ot use in combination with Zyban® or ofCiosmiiine. ‘any other medicines that contain bupropion hydrochloride. RRCST S i 00500, o sopmatly o eachpatent B Ahmedabad, India 500 Tablets ~Distibutedby: 2 Zyaus Phamaceuticals (USA) Inc. 3 Zydus Rxonly Femington NJ 08534 a0y
8d937ca3-3351-40f1-8192-348ba0c68162_418_2.jpg Over Coding Template No Varished Area (Do Not Prinf) (18x50.5mm) LR ONCE.DAILY, Each extendedelease tablet contains buPROPion 500mg f PGP on hytocorie Us? Usual Dosage: Take one tablet daily o as Hydrochloride Seistomete o camre for complete prescribing information. Extended-Release seax vz orrn [See USP Controled Room Temperature, Tablets, USP (XL) o roeommn: containr as defined in the USP. | | | | | | | | | | | | | | | | | | 5, KEEPTHIS ANDALL DRUGS OUT | "@ ‘OF THE REACH OF CHILDREN | Zyoan® is the registered trade mark. | of Garosminiine 1 [ VARG o ot s corbision v brr 1y cver modiies i bigrpn oo, | PGS Dot i e X edaion Catla Helthcare Li. | e provid separasly s xhpasen. e | | | | | | Distributed - B0 Tablts Do e Rxonly Pemningon, NJ 08534 a0y
8da22eb1-0965-4d4e-b15d-91db7193548e_275_1.jpg RL-5181 TmL NDC0409-7241-60 Hospira, Inc., Lake Forest, IL 60045USA Rxonly Hospira
8e1493da-6e00-441b-a785-416c123e3c1a_251_1.jpg ALCOHOL OR ALCOHOLIC BEVERAGES SHOULD NOT BE CONSUMED WHILE TAKING THIS MEDICATION. MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALERTNESS. R A S A S G e I e N A 2 8 D AN A TR 30 NDC: 43063-239-20 e4] ‘e PHARMACEUTICALS ~{INCORPORATED”, =] Oklahoma City, 0K = 73127 PINK 43063-239-20 43063-239-20 43063-239-20 - = = - 5N i & — 1 - 3 D — » = 2 - —_— —_— —_— S— —_— — m— — METAXALONE METAXALONE METAXALONE o M T AX A LONE o = 800 MG 400 MG 800 MG = 20 TABLETS 20 TABLETS 20 TABLETS s, ReOrder # 103605 ReOrder # 103605 ReOrder # 103605 o u;-r; Lot G18D20 LoT G18D20 LoT G18D20 E s 800 MG EXP 12/19 EXP 12/19 EXP 12/19 g - CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS, g & 20 TABLETS YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: METAXALONE 800 MG (01)10343063239209 (21)618020000002 (17)181231 (10)618D20 OVAL NYMIVL NI 30V 271 VINUVHIINOD DITZEDOZLYI
8e41e42c-3ae0-4091-970b-bc0086755f1d_474_1.jpg N\ 1105102¢101800 NLLD. Each 1 mL contains: 101mg ofaconazde i an agueossobsor. Dosage: For informtion concening dosago and administaton of raconazole Oral Soltion, please see accompanying Package Inert ‘Storage: Sore btte ator bekow 25°C (77°F. Do no reeze, Keep out of reach of chikdren. For any questions concering tis product please cal: 1-800-667-8570 PATRIOT Each 1 mL contins: 10mg faconazde i an agueous sk, I uonnpos [ei0 uybuiol ajozeuodely] INDC 10147-0150-1 Itraconazole Itraconazole ltraconazole Itraconazole Oral Solution Oral Solution Oral Solution Oral Solution 10 mg/mL 10 mg/mL 10 mg/mL 10 mg/mL Each 1 mL contains: 10mg o taconazole nan agueous soluton. ‘Storage: Store botte at o below 25°C (77°).Do not frecze. Rxonly 150 mL 4PATRIOT Each 1 mLcontalns: 10mg f raconazok nan aqueous sclton. Prciosoen Wanuacy Soer Pty [ty st Pai ramacdied LG T, P80 ©2018Patit ramacedtidb L0 685008
8e4b636e-ee9c-4111-779d-28c8369d283b_671_1.jpg g | 101 NDC 0173-0517-00 Each viel contans FLOLAN® Smmoy (epaqms!ennl sodium) égds w: hene 2930 for Injection ol Sedhom yroudamey | ‘have been added to acjust pH, (NG LT R Vs Oose: oo prosrong . Mustbe reconstituted, For ntravenous S10® & 15°1025°C (56° 0 77°F). § Infusion after clution. Protect from lght, = GlaxoSmithKine RTP, NG 27709 Rev,4/16
8e4b636e-ee9c-4111-779d-28c8369d283b_671_2.jpg gl E NDC 0173-0519-00 FLOLAN® (epoprostenol sodium) for Injection LR Must be reconstituted. For intravenous S‘m!‘i‘hzs‘ﬁﬁ‘wﬂﬂ nfusion afer dlktion. B vlcorare epopeosinclsodum bt to 155 (300050 et o, Soc chbride and S0 g Irannfol Sox hyoxde may e e riormator, Protectfom| mmmnm s oy o o ‘securely ited. GlaxcSmithkdine RTP, NC 27708 Rev. 4/16 & £ =
8e4b636e-ee9c-4111-779d-28c8369d283b_671_3.jpg V3dv 1NIHd43A0 50 mL NDC 0173-0518-01 STERILE DILUENT for FLOLAN® Containg crug diluent for use only (epoprostenl sodium) Torimecton. ¢ ! Each vial contains 94 mg glycine, 73.3 mg sodium chloride, sodium hydroxide (added 10 adjust pH), and Water for Injection, USP. Ronly ditinil For reconstitution information see package ingert for FLOLAN® (poprosianol soduim) for Injection. Store at 15° 10 25°C (59° to 77°F). DO NOT FREEZE. GlaxoSmithKline Research Triangle Park, NC 27709 Made in England 1000000002396 Rev. 1/06 N10301730518016
8e4b636e-ee9c-4111-779d-28c8369d283b_671_4.jpg NDC 0173-0857-01 @ pH 12 Sterile Diluent for FLOLAN® Use only with FLOLAN® (epoprostenol sodium) for Injection ingle-Use Vial. Discard Unused Portion. 50mL Ronly For reconstitution information see ackage insert for FLOLAN® (epoprostenol sodium) for Injection, Store at 15° to 25°C (59° to 77°F). DO NOT FREEZE. Do not accept if plastic overseal is missing or not securely fitted. GlaxosmithKline, RTP, NC 27709 Made in England 1000000013560 Rev.3/15 N 1030173 0857 01 6
8e86a610-45ef-4be7-a3ab-f656f5b32706_596_1.jpg IEW ps7 DIVALPROEX SODIUM 125 mg* Delayed-release Capsules, USP. (Sprinkle) Valproic Acid Activity 10 CAPSULES “Each Capsiie Contains: Divelproex sodum, USP equvaient o valproic acid 125 mg Usual Dosage: Capsule may be swallowed whoe or opened and contents placed on food for admiistration. See product insert fo full prescribing information, precautions. nG warnings. STORAGE: Store at 20° to 25° C (68* to 77° FJ; excursions. permitted between 15° to 30° C (58" to 86° F) [see USP Controlled Room Temperature] RXONLY WARNING: This Unit Dose package is not chid resistant andis Intended for Insitutional Use Oriy. KEEP THIS AND ALL DRUGS GUT OF THE REACH OF CHILDREN, If dispensed for outpatient use. a chid-resistant cantainer should be utiized FOR YOUR PROTECTION: Do not use i bister s torn or broken. PHARMACIST. Dispense the Medication Gude to each patien. The diug product contained in his package = from NDC # 68382-106, Zydus Pharmaceuticals USA Inc Packaged and Distrbuted by American Heath Packaging Columbus, Ohio 43217 amercanheathpackaging.com An AmerisourceBergen Company AMERICAN HEALTH PACKAGING® Distribted by Cardinal Health Oublin, OH 43017 La7287660218 LOT # XXXXXXXXXX EXP. DATE: XX/XX/XX
8f433e01-8554-4b05-84b1-d21c21ba68bd_512_1.jpg NDC 25021-301-02 Rconly = 1023612 . 3 - —_ EHOSIne g E —§ Zea Mfd. for: WESTTMIETA & ;. & =3 I SAGENT pharmaceuticals S @ . 3 == schaumburg, IL 60195 (USA) 6 mg per 2 mL 2% 8.5 F =g Madein India cQ 2 &, L O ©2014 Sagent Pharmaceuticals, Inc. (3 mg per mL) SE 8 SH TS Code No:KNDRUGSKIK28/280/19%5 For Rapid Bolus SO QL == ' Intravenous Use T oS o mm® i 22D R0 EXpy 2mL Single-DoseVialw o D v O = ,
8f433e01-8554-4b05-84b1-d21c21ba68bd_512_2.jpg | gt E Mfd. for: -~ g SAGENT Pharmaceuticals 2014 Sagent Pharmaceuticals, Inc. Schaumburg, IL 60195 (USA) Code No.: KR/DRUGS/KTK/28/280/1995 1023611 Made in India © £/010€12052€00(10) 31v439I443H 10N 00 "y6udn al0)g [raamesadwa) wooy PajIonu0Y dsn 98] *(doLL 0} .89) 0.62 0} ,0Z 1€ 3101S ‘uoneuLiojul abesop 1o} pasu) abexoed aag :abiesoq Jensn *9a.J~3AljEAIaSld ‘9)uaboihduoy ‘ajualg Beonly 4 mL Single-Dose Vial (3 mg per mL) For Rapid Bolus Intravenous Use 12 mgper4 mL NDC 25021-301-04 /
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_1.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_10.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_2.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_3.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_4.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_5.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_6.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_7.jpg A\ | FENTORA" @ Gt s e GO e
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_8.jpg nan
8f549d95-985b-f783-1ebb-ef57bd2ecb05_883_9.jpg nan
90164bec-3ff3-4c82-8e16-ca951ef7ac59_68_1.jpg Lo PAMOATE 25 MG 20 CAPSULES.
9020cdeb-65fe-458f-bbbd-69265a49906e_645_1.jpg NDC 44567-435-24 50 mL LEVOFLOXACIN Injection in 5% Dextrose 250 mg (5 mg/mL) Rxonky 250 mg in 50 mL 5% Dextrose INFUSE OVER 60 MINUTES _ Use immediately once removed from the overwrap. No further dilution is necessary. Each 50 mL contains a dilute solution equivalent of 250 mg of levofloxacin (5 r‘?ImL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8 to 5.8. Additives should not be added or infused simultaneously through the same intravenous line. Single-use container. Any unused portion should be discarded. Usual Adult Dosage: See insert. Use only if solution is clear and container is undamaged. Must not be used in series connection. Attention Pharmacist: Dispense the accompanying Medication Guide to each patient. Sterile, nonpyrogenic. Manufactured for: WG Critical Care, LLC, Paramus, NJ 07652 Made in Switzerland Rev. 12/2015 | o1 EXP BH61USLFXS500
9020cdeb-65fe-458f-bbbd-69265a49906e_645_2.jpg NDC 44567-436-24 100 mL LEVOFLOXACIN Injection in 5% Dextrose 500 mg (5 mg/mL) Rxonly 500 mg in 100 mL 5% Dextrose INFUSE OVER 60 MINUTES Use immediately once removed from the overwrap. No further dilution is necessary. Each 100 mL contains a dilute solution equivalent of 0 500 mg of levofloxacin (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, ',3 NF to adjust pH to 3.8 to 5.8. Additives should not be added === 0rinfused simultaneously through the same intravenous line. . Single-use container. Any unused portion should be discarded. Usual Adult Dosage: See insert. Use only if solution is clear and container is undamaged. Must not be used in series connection. Attention Pharmacist: Dispense the accompanying Medication Guide to each patient. Sterile, nonpyrogenic. Manufactured for: WG Critical Care, LLC, Paramus, NJ 07652 Made in Switzerland Rev. 12/2015 LoT EXP BH61USLFX100
9020cdeb-65fe-458f-bbbd-69265a49906e_645_3.jpg NDC 44567-437-24 150 mL LEVOFLOXACIN Injection in 5% Dextrose 750 mg (5 mg/mL) Rx only 750 mg in 150 mL 5% Dextrose INFUSE OVER 90 MINUTES Use immediately once removed from the overwrap. No further dilution is necessary. Each 150 mL contains a dilute solution equivalent of 750 mg of levofloxacin (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8 to 5.8. Additives should not be added or infused simultaneously through the same intravenous line. Single-use container. Any unused portion should be discarded. Usual Adult Dosage: See insert. Use only if solution is clear and container is undamaged. Must not be used in series connection. Attention Pharmacist: Dispense the accompanying Medication Guide to each patient. Sterile, nonpyrogenic. M Manufactured for: WG Critical Care, LLC, Paramus, NJ 07652 Made in Switzerland Rev. 12/2015 Lot EXP ricalCere BHTUSLFX150
903d7aba-277e-6d28-4fee-fd2d605ab6a9_756_1.jpg NDC 60505-6193-1 0.25 mL (0.05 mg/mL) For intravenous injection only. 5 mL single-dose sterile vial. Discard unused portion. R Only APOTEX CORP. Store at 20°C to 25°C (68°F to 77°F) Protect from light. Manufactured by: Qilu Pharmaceutical (Hainan) Co., Ltd. Haikou, 570314, China Manufactured for: Apotex Corp. Weston, Florida, USA 33326 34120014404A
903d7aba-277e-6d28-4fee-fd2d605ab6a9_756_2.jpg (B s0'0) Tw gBw sz Contents: *Each mL of aquaous solution contains palonosetron hydrachioride equivalent to 0.05 mg palonosetron. Each mL also Gontain 41.5 mg mannitol, 3.7 mg sodlum citrte, 1.56 my cltrc ackd menchydrate and water for injection {e5. 10 1.0 mL). Hydrochloric ackd or Qllu Pharmaceutical (Hainan) Co., Ltd. Haikou, 570314, China Manufactured for: Apotex Corp. Waston, Florida, USA 33326 | sodium hydroxide may have besn 34120014401A added to adjust pH. | 0.25 mg/5 mL (005 mgimLy | ot carter ani e ciusn: | 0.25 mg/5 mL .05 mgimLy | I Stors at 20° o 25°C (68° to 77°F); .| | | exoursions permitied between 15°10 | | For Intravenous Injection only. | mﬁ:‘,:ﬂﬁqm?ﬂf@ | For Intravenous Injection only. | S mL single-dose sterlle vial. | Protsct from light. | 5 mL single-dosa sterila vial. | Discard unused portion. | Usual Dosage: Soepaokage insert | Discard unused portion. 0505/619311l3 ‘ | for dosage and admirisiration Information. | | BOnly | | | | | | | APOTEX CORP.
90b94524-f913-48b3-3771-7b2fcffd888a_123_1.jpg s s =
90b94524-f913-48b3-3771-7b2fcffd888a_123_2.jpg s i vty e L [
90b94524-f913-48b3-3771-7b2fcffd888a_123_3.jpg nan
90b94524-f913-48b3-3771-7b2fcffd888a_123_4.jpg nan
90b94524-f913-48b3-3771-7b2fcffd888a_123_5.jpg = F‘\““”““ e vy o
90b94524-f913-48b3-3771-7b2fcffd888a_123_6.jpg ) cotwices 1600 MY i B ==t e
911783eb-91a8-4ef4-bd6f-809211e207d6_164_1.jpg MU Rronly & | Palonosetron HCI Injection 0.25 mg/5 ml (0.05 mg/mt) For v jcton Ony. 5L Siog-tss Stk Yol [ —— ek 515 ent 30 f s st e b SO e, s 15w B s e, e vatam i s A i st ol i eds S i b i S e . Somaor S 2L ) S e o s o o Pt i, womis et TP .00 e ST el [y T PS5 | el 7 WO Ry Palonosetron HCI Injection 0.25 mg/5 mL (0.05 mg/mt) Frloeavesces Wicton ok 5l Sig-tss St Vol Discardunsed prion, 12345 87890 Sty e e - B 3 0703-4094-01 ¥ 5
9135e7db-cba4-4150-a69c-fdf2a347a785_239_1.jpg Mirtazapine 15 mg Tablet arv: 30 ID #: 0;8A Expires: NDC #: 70518-1397-00 Shape: Capsule LOT #: Ref #: 57237-0008-30 MFG: Rising/Citron, Saddle Brook, NJ 07663 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
916d802c-91b6-4015-9e57-7ebf7e9bb5ee_821_1.jpg €ONIL000£201S 8 0093-2931-01 pamaejnuey 60027 0 e 671/ Qd/SINHU/HI “ON ap0g “NIHOTIHD 40 HOV3H 3HL40 10 SNOLLYOIGIW 1TV ONY SIHL 33 i | abeyoed a5 abesoq “(snophyue se paEjofes) dsn ‘edopifugaus Bur oGz SuEN0d BIGE UE3 METHYLDOPA Tablets USP 250 mg NDC 0093-2931-01
916d802c-91b6-4015-9e57-7ebf7e9bb5ee_821_2.jpg NDC 0093-2932-01 METHYLDOPA Tahlets USP 500 mg ains 500 mg methyidopa, USP (calculated B only Rev. C4/2009 MEDICATIONS OUT OF THE 0093-2932-01 2 Code No.: MHDRUGS/PDA49 510270003IN03
918925cc-8da9-4016-998c-c06ed4676ae4_162_1.jpg Azithromycin for Injection, USP 500 mg/vial For Intravenous infusion only Sterile NDC 0409-0144-10 Rxonly Each vial contains azithromycin monohydrate equivalent to 500 mg of azithromycin, 413.6 mg citric acid and sodium hydroxide for pH adjustment. After reconstitution, each mL contains azithromycin monohydrate equivalent to 100 mg of azithromycin, 76.9 m of citric acid, and sodium hydroxide for pH adjustment. Usual Dosage: See insert. Constitute to 100 mg/mL with 4.8 mL of Sterile Water for Injection. Must be further diluted before use. For appropriate diluents and storage recommendations, refer to insert. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Hospira, Inc., Lake Forest, IL 60045 USA Hospira RL-4225
918925cc-8da9-4016-998c-c06ed4676ae4_162_2.jpg 10 Vials Azithromycin for Injection, USP For Intravenous Infusion only. Sterlle Toyietd 100 mg/mL ofsoluton when reconsttute s dected R only NDC0409-0144-10 500 mg/vial Hospira Azithromycin for Injection, USP For Intravenous infusion only Sterlle Hospira
918925cc-8da9-4016-998c-c06ed4676ae4_162_3.jpg CA2292 @1 03040 01441 Exch vl cntns st monchyie ot 0 s00mact oy, i s shd s o e ettt ol i ZAfrome ey et o mget ctomyn 700 ) e S oy o i Ssment. Disctons orReconstuon: A 45t St Ve Fr mcion Whenreconturad. 0 ol 5 pteey e 4o oo gt Hosp e, ke Forst L oo 5 Mt frther dtedbor . Forsgpoptt vt e et e o INTRAVENOUS USEONLY St 201025 (10 7 [0 50 Contetd oo Tarmpastare]Rcemmnded sy o Ul Dosage et Hospira Azithromycin for Injection, USP For Intravenous nfusion only Sterlle Hospira
91a738da-96c7-44f2-8878-df6a75abdf08_245_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. 43063-778-10 43063-778-10 43063-778-10 VALACYCLOVIR VALACYCLOVIR VALACYCLOVIR usp usp UsP 500 MG 500 MG 500 MG 10 TABLETS 10 TABLETS 10 TABLETS ReOrder # 110336 ReOrder # 110336 ReOrder # 110336 Lot J18C65 Lot 118C65 LoT 118C65 EXP 10/20 EXP 10/20 EXP 10/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: VALACYCLOVIR HYDROCHLORIDE USP EQUIVALENT TO 500 MG OF VALACYCLOVIR BLUE ORGANOLEPTIC MARKINGS: CIPLA 153 OBLONG NDC: 43063-778-10 &PD-Rx PHARMACEUTICALS | INCORPORATED® = |8} Okiahoma City, 0K » 73127 VALACYCLOVIR USP 500 MG 10 TABLETS (01)10343063778104 (21)J18C65000001 (17) 2012031 (10)118C65 YOTBLLEIOEVE SO0 VIGNI vO9 "YNH3A ‘aLvidio ZOESTOLB069
9253f6a9-2cf7-412d-b7a5-d9292d7b97fd_276_1.jpg NDC 0168-0270-15 ougera® MOMETASONE FUROATE ICREAM USP, 0.1% \sustDosage: S package nsert s socomiarying Gractons cachuly Store st 25°C (17-F): xcursions permiad o 15710 30° (5" lo o' 500 US Coniraled [Room Temperaturl Avod excassive heat. [T produet s seaiefor your prtecton Do ot usef the sei s broken or miseng and rturm to pisce o purchase. 70 GPEN: Unscrow cap an il hetab. Soacrimp end o tubofor ot nmbor and & civison o Fougera Prarmaceuticals in. o, New~ork 11747 (opiraton dato. E FougERA & co. N Eonly FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. KEEP OUT OF THE REACH OF CHILDREN, NET WT 15 grams. Each gram contains: 11mg ol momelasono fuoato, USP ina WS o of Wi craam b ofhexylane Gicol, phosphoric acd, propyena ool monostcarae, ssaryl alconol and Gatcareh 20- anium dioude, abminum starch ocenyisuccinato, boesia, Wit petritum, and purfiod war ULsesdc Rodis Il 0168-0270-15
9253f6a9-2cf7-412d-b7a5-d9292d7b97fd_276_2.jpg See crimp end of tube for lot number and expiration date. o16. a -2 7 0- NDC 0168-0270-15 monly FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. fougera® KEEP OUT OF THE REACH OF CHILDREN. MOMETASONE FUROATE CREAM USP, 0.1% NETWT 15 grams Usual Dosage: Soo package nsart This product is sealed for your ! Road accomparying direciens cartuy protaction. Do not uss f the sal | Store 2t 25°C (77°F);sxcursions parmittad to 15°to 20°C 12 broken or missing and retum | (61086 (sse USP Conraled Room Temparatr 1 placa of purchasa. ‘Avoid sxcessive heat. | crouEEA O OPEN: Unscrew cap and pull the tab. Adivision of Fougora Pharmacaticals Inc., Mohle, Now Yok {1747 NDC 0168-0270-15 m ‘ Each gram contains: 1 mg of mometasone. fougera® oy MemiE ougerd ‘propylena giyool monostearate, stearyl alconol and colsarcth 20, arsum s, MOMETASONE FUROATE i ot g v CREAM USP, 0.1% NETWT 15 grams
92a81a1f-698b-4db0-b5a6-f7562abd9a32_410_1.jpg MO g101 BUTALBITAL, ACETAMINOPHEN and CAFFEINE TABLETS, USP 10 TABLETS 50 mg/325 mg/40 mg Each Tablet Contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Cafeine, USP 40 mg. Usual Adult Dosage: 1 or 2 tablets every four hours as needed, Total daly dose shouid not exceed 6 tablets. See product insert for full prescribing information, precautions and warnings. STORAGE: Store at 20° to 25° C (68° to 77° F); excursions permitted between 15 to 30° C (59° to 86* F) [see USP Controlied Room Temperature] RXONLY WARNING: This Unit Dose package is nat child resistant and is Intended for Insttutional Use Orly. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILOREN. If dispensed for outpatient use, a chid-resistant contziner should be utiized FOR YOUR PROTECTION: Do not us if biister is tom or broken. The drug product contained in this package is from NOC # 06032544, Par Pharmaceutical. Packaged and Distributed by. American Health Packaging Columbus, Ohio 43217 americanhealthpackaging.com An AmerisourceBergen Company AMERICAN HEALTH PACKAGING® Distributed by Cardinal Health Dublin, OH 43017 L52816130218 LOT #: XXXXXXXXXX ~EXP. DATE: XX/XX/XX
92bb2354-5592-4f16-b193-f34306d7bc39_169_1.jpg GeloPROKOTT R — e O o e e APPLY TOAFFECTED AREA TWGE A DAY ORAS DRECTED. R G uemm e wesmme e w T Gt
92fc188d-4f3e-4d18-aaf1-c9e76b12b75b_897_1.jpg Each gram contains: 100,000 USP nystatin units and 1 mg triamcinolone acetonide in a cream base containing ‘aluminum hydroside, cetearyl alcohol and ceteareth 20, glyceryl monostearate, methyparaben, plyetiyiene glycol monostearate, polysorbate 60, propylene glycol, propyiparaben, purified water, simethicone emuision, sodium hydroxide, sorbic acid, sorbito,ttanium ioide, and white petrolatum. Usual dosage: Apply toaffected area twice daily. S package insertfo ullprescribing information. ‘Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Avoid freezing. For lot number and expiration date, see flap of arton and/or rimp of tube. NDC 45802-880-94 Nystatin and Triamcinolone Acetonide Cream, USP For External Use Only. Not For Ophthalmic Use. NETWT 30 Keep this and al medictions ot f the reach of cidren. Directions for puncturing tube seal: ‘Remove cap. Tum cap upside down and place puncture ip onto tube. | | } Push cap uniltube end is punctured. Screw cap back on to reseal tube. = i | Vo Pemigos } s EMEER TRy 4 745802-880-94 9 NDC 45802-880-94 Nystatin and Triamcinolone Acetonide Cream, USP For External Use Only. Not For Ophthalmic Use. NETWT30Q Keep tis andallmedications out o the reach of cilden. Perrigo® nn e NDC 45802-880-94 Nystatin and Triamdnolone Acetonide Cream, USP NETWT30g
930f1974-c050-404f-b720-72befdd6e3b9_802_1.jpg NDC: 53149-4911-1 FORTOPICAL USE. locaine Ointment USP, 5% Donot use i the eyes NET WT 35.44 g RXONLY Rev1 CONTAINS:Ldocainebose 5% na waterscuble base consisng o plethyiene vcol 300 snd pvetyine ghcol 1450, Each ram contans iecane USP 50 o USUAL DOSAGE: Se packoge Insert for ful prescrting nformaton. WARNING: Keep ot of reach of hiren. DIRECTIONS: To open, push don on cap e tring counterclckwise. o cose, push down on cap whie tuming cockwse STORE AT 20-25 ° C (68-77 F) CONTROLLED ROOM TEMPERATURE. EXCURSIONS PERMITTED T0.15-30 C (59-86 *F). SEE PACKAGE INSERT FOR DOSAGE INFORMATION. Distby et Knght Pharmaceuils o 000X Ripey NS 308 o e e TR N G 05 v MFG LOT: X000 NDC: 5314949111 NETWT 35,448 DRUG: Lidocaine Ointment USP, 5% WOT0x B0 XK NDC: 5314949111 NETWT 35,045 DRUG: Lidocaine Ointment USP, 5% LOTHOX EXP XXX NOC: 5314949111 NETWT 3540 'ORUG: idocaine Ointment USP, 5% TR0 pxp: XXX NDC:S3149.4911-1 NETWT 35,445 ORUG:Lidocaine Ointment USP, 5% LoT 000X BXP: XXX
9333d92f-2585-4b99-aaea-87c01c95125e_190_1.jpg USUAL DOSAGE: See NDC 42806-087-01 Each tablet contains: ‘accompanying literature for Estradio, USP ....0.5 mg £3331 Rev. 02-2018-00 Ax Orly w compiete prescribing infomatin. [Estradiol & Store at 20° t0 25°C (68° 0 77°F) KEEP TIGHTLY CLOSED g ﬁmmicmfmm Room Tablets, USP R ‘emperature] S B vopemoniatr, 0:5 MG MEDEATIONS U7 oF T e ight-resistant container s defined PHARMACIST: Dispense the . 3 inthe USP, with a chi-1esStam. accompanying Patientinformation & == closure, as required. Leafletto each patient. 100 Tablets (S [P PR e aurelton, NY 1
9333d92f-2585-4b99-aaea-87c01c95125e_190_2.jpg USUAL DOSAGE: See NDC 42806-088-01 Ezch tablet contains: ‘accompanying lterature for Estradiol,USP .. 1 mg complete prescribing nformation. [ Egtradiol Store at 20° to 25°C (68° to 77°F) KEEP TIGHTLY CLOSED [See USP Controlled Room Tablets, USP Temperature] KEEP THIS AND ALL ) MEDICATIONS OUT OF THE Dispense contents in a tight, 'REACH OF CHILDREN, light-resistant container as efined pHARMACIST: Dispense the in the USP, with a child-resistant accompanying Patient Information closure, as required. Loaflot to each patient. LE3345 Rx Only Rev. 02-2018-00 100 Tabets 6 P Epic Pharma, LLC ELC Laurelton, NY 11413
9333d92f-2585-4b99-aaea-87c01c95125e_190_3.jpg USUAL DOSAGE: See accompanying iterature for ‘omplete prescribing information. tore at 20° to 25°C (68° to 77°F) [See USP Controiled Room Temperature] ispense contents in a tight, ight-resistant container as defined in the USP, with a child-resistant S 60-680-90829 Rev. 02-2018-00 PRt Epic Pharma, LLC (ENC N AR NDC 42806-089-09 Estradiol Tablets, USP PHARMAGIST: Dispense the accompanying Patient Information Leaflet 10 each patient. Rx Only 90 Tablets Each tablet contains: Estradiol, USP ... 2mg KEEP TIGHTLY CLOSED KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
93dccd99-d28b-4c47-872c-c3c0001b8a7f_954_1.jpg Pachaged by Eopant Reeck Zbank. €4 90500 Valacyclovir ~ Qfuscmuesusre 500mg Tablet 060LTT Keep in light resistant Compare To: container perUSP Valtrex 500mg Tablel Siore at room temp of Citon Pharma LLC 20-25 C (68-77F) #15 Exp: MMYY NDC 7133507081 044681117090 om
93ddb66b-6d01-46ad-b14b-045b0f6193bb_96_1.jpg CONTENTS: TeTS: Aa?v”:?;y":,r,':;’“"’“"tyvs:unwmn L o e apphctions, R only. UNMETees m * ™ onitoring its effect on oxyw&:nmm of artorial lood. ™Y e ek ot M@ breathing uni i 1 unless usd in corjnclion W ¢S4 continer be el wih axygen USP only bY 65 e CGER: (i Food, D and Cosmec Act Proguced bY T 'S’ UNDER PRESSURE; MAY EXPLODE P HERTED i R ndersise Keep an store away rom SOV o o areaseand o Lse S S oty oudodrs 80 e o ik low prevenive GV 1 - pmert shzwlx consircion an st o wﬁlr:d!ur recsure, Use oYt e hen 5. Close vl alter e e O hen amaly.Proest 100 -y ol o amastn T Gas aley Data S 08) S MATHESON g‘;ﬂgﬁﬂ&‘é‘:ﬁ.’téﬂua a D o e o rfesionas™ 1-800-476-250° DG,
93ddb66b-6d01-46ad-b14b-045b0f6193bb_96_2.jpg REFRIGERATED LIQU OXYGEN, REFRIGERATED Liquip usp UN1073 —_— N (1 ComunER couTTs: WD NG e o i sy ot . oy et iy o ot o5 e o e OGRS CASE ORI WA X cnrans et AT G TILES W coer i L e oy, e, o i ol - o b B ey ey et ettt ot DT s e 0 Gt ot o 1 s sy o i e, ot o Mo S 55 PRSTAR 1 OKSOM. a cpts 2016 Rove s pooucr e, — e IATHESON MATHESON THI GRS 190 ALEN O BASORDSE Wiz Tt ety g
94eb5927-4194-4dd0-8037-cb7d8d1fbeab_805_1.jpg 750mg T R Generic for: Levaquin Each tablet contains: Levoflosacin 750mg P P~ =Eigy Mfg: Torrent Pharmaceuticals Ltd . = rO5 Mehsana, India w0 Prodé EE z 32 5 pt-mé’(d'ulﬂt{ﬂ;‘?@m“" B £ ‘ Fa S BA 93 =3 Instrucciones Espanol: Toma tableta(s cada horaga( ) pRererreD” CAUTION: Federal law PROHIBITS transfer of Levofloxacin Tablets 7=52eis _ssan cathis drug to any person other than the patient for whom it was prescribed. Levofloxacin Tablets 750mg Quy.ns Lot Ba Prod# (NDC) Levofloxacin Tablets 7S0mg. Qu s Lot#: Bath Prod (NDC) Levoflovacin Tablts 750mg Qn Insurance NDC. Lot Bats. Levofloxacin Tablets 750mg v Ins G "B Prod# (NDC) Billing Chart Log Patient
95365acf-bf22-4d68-ba9b-8f3c1b92bfa2_978_1.jpg Pacliaged by Eryant Rench Saban. 04 91504 7 ORANGE OCTAGON Z585. Levofloxacin g 500mg Tablet & < Finish All This Compare To: Medication Levaquin 500mg Tablet Siore at room temp of Lok Phamaceutials dd. L | 20°25°C (68°-7T°F) #30 Exp: MMYY NDC 7133509651 045261124313
95b15fd3-84e3-4d27-8744-b56af5e265a0_890_1.jpg NDC 55154-1276:5 | 7 5 ERYTHROMYCIN OPHTHALMIC OINTMENT USP, 0.5% (5 mg/g) 5 UNIT DOSE TUBES (1 GRAM) Sterile FOR OPHTHALMIC USE ONLY DO NOT REUSE. ONCE OPENED, DISCARD. Each gram contains: Erythromycin USP, 5 mg in a sterile ophthaimic bese of mineral oil and whits petrolatum. Usual Dosage: See product insert for dosage information, prescribing Information, precautons and warnings. STORAGE: Store at 20° to 25° C (88° to 77° F) [see USP Contralled Room Temperature]. Avoid excessive heat. Protect from freezing DO NOT USE IF BOTTOM RIDGE OF TUBE CAP IS EXPOSED, RX ONLY WARNING: This Unit Dose package Is not child resistant and s Intende for Institutional Use Oniy. KEEP OUT OF REACH OF CHILDREN. Manufactured by: Akon, Inc. Lake Forest, IL 60045 Distributed by Cardinal Health Dubin, OH 43017 143673480218 LOT #: XXXXXXXXXX EXP. DATE: XX/XX/XX
95bafdc2-7846-4152-4860-77e59235939b_71_1.jpg NDC 0591-2315-19 Valsartan and Hydrochlorothiazide Tablets, USP 80 mg/12.5mg PHARMAGEST: Each Film-Coated Tablet Contains: Valsartan, USP. B0mg Hydrochlorothiazide, USP ... 125 mg Dispense in tight container (USP). Usual Dosage: See package insert. Keep this and alldrugs out of the reach of chikiren. Store at 20" 0 25°C (68" 10 77°F) See: UsP Controlled Room Temperaturel. Protectfrom moisture. Manufactured by: Arow Pharm (Malta) L. Birebbugi, 5363000, Maka Distributed by: Actavis Pharma,Inc Parsippany, N1 07054 USA Rev.0215 20882001 05912 31519 N 3
95bafdc2-7846-4152-4860-77e59235939b_71_2.jpg NDC 0591-2316-19 snlsn Fllm-ﬁ:;l-dhﬂll Olsm.aw:sm asaran, mg Valsartan and Hydrochlorothiazide, US7 .. 125 mg mmm— L. Dispense in tight container (USP). —i Hydrochlorothiazide Usual Dosage See package inset — Keep thisand slldrugs outofthereach . | o) Tablets, USP of chkiren HE—F [ Storeat20't025°C G 077 Isee 8 e 5 = PHANACST Dperseshaent Protectfrom malsture = nforaton Lesfletprovided Manufacturedy =3 separatelytoachpatent. Mot =2 A w 90Tablets piSCidy == ctavis Actavis Pharm, I 2 Farippany, N 07054 USA Rev.Gans 20882241
95bafdc2-7846-4152-4860-77e59235939b_71_3.jpg NDC0591-2317-19 e ln-Coned Tl Contans s, mg w Valsartan and Hydrochlorothiazide, UP 25mg s Dispense in tghtcontiner (USP). Hydrochlorothiazide Usual Dosage: See package insert. —_— Keep this and all drugs out of the reach i Tablets, USP of chidren. == [CEEE Storeat 2010 25°C (681077 [see " USP Controlled oo Temperaurel. 5 et PHARMACIT:Disperse thePatint Proectrom maisture = Information Leafiet provided Manufactured by: — 2 separtelytocachpatnt. Arow Prarm Oaka L, =3 W T Sizebbugi, 8863000 Mokt Actavis RXOnly Bt Prarmine Parsippany, NJ 07054 USA Rev.0215 20882401
95bafdc2-7846-4152-4860-77e59235939b_71_4.jpg NDC 0591-2318-19 snlm Fllmﬁhﬂhﬂl\ oam.m;m alsaran, mg o Valsartan and Hydrachlorothiazide, USP .. 125 mg - Dispense i tight container (USP). Hydrochlorothiazide Usual Dosage: See package insert. IS Keep this and all drugs out of the reach —— Tablets, USP Keophisa i =: I Swreat20 wsCE@ 077 B ) UsP Controlled Room Temperaturel. = PHARMACKT:DispensethePatent Protect from moisture = Information Leaflet provided Manufactured by: — separatelytoachpatent. Atow Pharm (Maka) L i N Sizebhugi, 8863000 Walt Actavis Rt P parsippany, N1 67054 USA Rev.0215 20882641
95bafdc2-7846-4152-4860-77e59235939b_71_5.jpg NDC 0591-2319-19 e n-Coned Tl ontins| saran, mg o Valsartanand Hydrochlorothiszide, USP ... 25 mg o Dispense ntight container (USP). Hydrochlorothiazide Usual Dosage: See package insert. — Keep this and all drugs out of the reach | Tablets, USP of chidren. : - 320 mg/25 mg Storeat201025°C @ 077Aee ) USP Controlled Room Temperature] == AR Depee et Protect from mojsure = bformateon Leaet provided Wanufacuredi 5 separatelywexchpatent. o Pt ) L — W Bizebhugi, 88G3000 Mol Actavis R oot e Parsippany, NJ 67054 USA Rev.0215 2088271
964fd565-25db-472a-bbf6-abdc81f1ef0b_806_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALERTNESS NDC: 43063-863-30 BROWN <hE & = = o — R i S WARNING:KEEPTHISIOUT. OFTHEREACHIDECHILDREN < = eV DOSAGE and STORAGE=SEE PACKAGENNSERT, 1= ovtahoma City, 0K+ 73127 ] 43063-863-30 43063-863-30 43063-863-30 = AMITRIPTYLINE AMITRIPTYLINE AMITRIPTYLINE & AMITRIPTYI.INE == HCL USP HCLUSP HCL USP 2 I, 25 MG 25 MG 25 MG = HCL USP — 30 TABLETS 30 TABLETS 30 TABLETS 2 = ReOrder # 110570 ReOrder # 110570 ReOrder # 110570 o = Lot J18E09 Lot 118E09 LoT J18E09 8- 235 EXP 02/20 EXP 02/20 EXP 02/20 2 - =58 = J a2 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. 2 Y YCU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 2 30 TABLETS § 2R © N 2R TAKE TABLET(S) TIMES A DAY. (01)10343063863305 8 § TOME TABLETA(S) VECES AL DIA. (21)J18E09000001 =z Each TABLET Contains: AMITRIPTYLINE HCL = (171200928 g 5 USP 25 MG £ " s 2 (10)J18E09 o
96b0a506-ae49-4338-80cd-f1493222e335_566_1.jpg nan
97095119-28e7-4c9b-8727-ad5ea6010f7e_923_1.jpg CLINICAL solutions WHOLESALE Olanzapine 5mg Tablets NDC: 58118-3111-8 aty: 30 Mfg. NDC: 60505-3111-03 ‘GTIN: 0035811831181 Mig. Lot # SAMPLE123. Batch #: SAMPLE4S6 ig_By:Apoex Cor. Exp: 02010 Torot, K, anace, ML 170 SN: WMMDDO00OD0 Repcned anor Dt b it S Ui LLC
97330579-8790-c2a8-af59-fe46ce39c58a_175_1.jpg Packaged by Eryant Ranch Burbank, O 91504 Bupropion HCL G Mieromoweisss ER(12h) 100mg Tablet & |May Cause Drowsiness & | Store at room temp of Compare To: 20-25 C (68-77F) Wellbutrin SR(12h) 100mg Tablet Keep all drugs out of ACTAVIS LABORATORIES FL.ING reach of children #60 Exp: MM/YY NDC 6362931961 031961106899 swox
97431ce3-85a9-41c3-817d-68963f9536cc_425_1.jpg NDC 0781-5022-01 ‘Each tablat contains: Methyiprednisolone 4 mg Ususl Dosage: Sea accompanyng peserting " MethylPREDNIsolone £555 Kespper v e e it g, it rsistent contsiner oc Dper Tablets, USP definedinhe USF: Sor ot 20 10 25°C (e 1 et , 5 ShoveaTt & e AL AlGS ST S Tk e =n KEETae AT Manactredty & o R = e o, ossto Mmm=— il 5 e =T e . 4 SANDOZ
976be6e3-a9db-49c6-9b02-1ab168cf17b1_725_1.jpg LAl a bR = ) 9 PrenyTEeToNI T ot 1301 o it e Bl 5 ] St w0, BESURY oo hem Tenpsare) bt nacnse e okt teatigzn Bt AR s ) o o o e vl ot g Nttty i eyt e Mg WomZUSh [IMylan] syencon
976be6e3-a9db-49c6-9b02-1ab168cf17b1_725_2.jpg T ok s ki e B e e fLtrrh et e ek TR LU Dituedby e it N
976be6e3-a9db-49c6-9b02-1ab168cf17b1_725_3.jpg NDC 51079-288-04 Clozapine Orally Disintegrating Tablets (100 mg] &) [PionyIKeRNUTIs: Grare i, [ 5amgpe i Lo el R Clozapine Orally Disintegrating Exhntis e aagen. 5 1oomg Ul Vg S smppa et Ul e S wcmpnpgpetg Swestar w2t (e oo, [ R ot s eparghgstoube st i D s gt SO o e s et rolng ot it v o S (Mylan | sncon simo
976be6e3-a9db-49c6-9b02-1ab168cf17b1_725_4.jpg T ok s ki e B e e fLtrrh et e ek TR LU Dituedby e it N
991b445a-8cdc-4b99-bfd4-7da833f3f5c7_366_1.jpg Metoprolol Tartrate NOC# 71810014760 Metoprolol Tartrate 50mg 90 Tablets g § 3 x __eema WS pxon Metoproll Tartate 50mg 90 Tabets
993a5325-cd10-4450-b5ea-1c0a90510df6_709_1.jpg pN > £ s, Z g g £ msl. 88 v o £2gZ © = o oW re] A G = 1 > £8 48 &5 2e 2 - »n Bz Ea TES fEg == S O =S o5 26 S = =S 85 O s mMﬁ o o =2 =8 = e @8O s 2o = X0~ a= oo Each capsule contains 10 mg acitretin, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). PROTECT FROM LIGHT. AVOID EXPOSURE TO HIGH TEMPERATURES AND HUMIDITY AFTER THE BOTTLE IS OPENED. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. PHARMACIST: Do not cover the LOT and EXP. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Y 0093-1135-56 R only 30 CAPSULES Rev. A 5/2015 ~ o © o o N @ o > 2 8
993a5325-cd10-4450-b5ea-1c0a90510df6_709_2.jpg = £ £ & 8 £ 8¢ SE B o 229 8 N =s = i s W S o © = S AW o e o - «n gs Ea T EoooS R ) e T LS |m Q eummn ac S N IS P S = D sSs§g WHo o _— T ES8S @= = ca-IM.w Mﬂ =2 LXOr™a= Sa Each capsule contains 17.5 mg acitretin, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with o= achild-resistant closure (as required). PROTECT FROM LIGHT. AVOID EXPOSURE TO HIGH & TEMPERATURES AND HUMIDITY S AFTER THE BOTTLE IS OPENED. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. PHARMACIST: Do not cover the LOT and EXP. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Y 0093-1138-56 o A'5/2015 ev. 799-32-10
993a5325-cd10-4450-b5ea-1c0a90510df6_709_3.jpg = 2 s z g g £ 8¢ SE B o 28 o2 © ;aluh EN 0 D 89 W= 28 wWo o - S AW ™ 22 T =9 s Ea T o= =35 g ) e Tl LS |m S =S =8 26 S rsmA.m DR = [= - SRE WHo o =2 =S = QOO <3 2 a f8 =o = LONaT= Sa Each capsule contains 25 mg acitretin, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure (as required). PROTECT FROM LIGHT. AVOID EXPOSURE TO HIGH TEMPERATURES AND HUMIDITY AFTER THE BOTTLE IS OPENED. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. PHARMACIST: Do not cover the LOT and EXP. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 ¥ 0093-1136-56 Rev. A 5/2015 © o~ © o 799-32-10 5
9955aced-ac32-43e6-b39a-c6c023a50dc3_607_1.jpg i uelAn i) swas 1008y opo1oK S [F5n S407q PoVnIP 6q Ve OB A0 uorsnyul mousae Y Jog (o o | ETTYEE uopoafuf uejjnsng ) Er Rk i mion. Ll e ¢ Busulfan Injection [JOTTA LT (6 mo/mL) For Intravenous Infusion Only. [Cauiion: Must bs diuied bafor NDC 67457-893-08 " Busulfan |njecti°n 60 mg/10 mL @ For Intravenous Intusion oniy (6 mg/ml) [Gation: Wust bs dlsted befors use e Cytotoric Agont, [MMylan® ey xoooooooos R Sterile SN XO0DON000 Sterile (i Mylan* EPARYITY Feonly Fxonly SRR LOT XXonae
99d6ba1a-1599-48a3-8dbd-a8b06af20fe1_658_1.jpg L0-221%=8.¢0 £ g o fim-coate vt contas TN SRVRTE- R DY X0 VRN Dicpense i a i, lii-resisant cortaner a5 = 4.8 mg of albuterol suffate, USP defined In the USP using a child-resistant closure. cquaent o4 mg of bt e e = Albuterol Flscran.. — o reach of hidren. = Extended-release | SEERIES, o rmnmwisr — Tablets, USP Controlied Room Temperature.] = spuo Usual Adult Dosage: See accompanying == 95:¢ prescribing informatin. Tablets must be = g B g = swallowed whole it he aid of uics = 00 ot chew or cush, = fi7 é (oral) iyl Phamacestcals . = 9& Myl Horgaoun, WY 26505 US A ] g Vi [Mylan® 7 Rxonly 100 Tablets Mylan.com
99d6ba1a-1599-48a3-8dbd-a8b06af20fe1_658_2.jpg 9.6 mg of albuterol suffate, USP DL Cars i ‘defined In the USP using a child-resistant closure. RAMA12483 cqubalent o g of e Keep cortaner gty cose. o= Albuterol [Ze=nc= ... — ed each o chilaren. o Extended-release | giretient, (68" o T7°F). (Sce USP — Tablets, uspP Controld Room Teperature.) i Usual Adult Dosage: See accompanying N—— LR prescribing information, Tablets must be NiE— B ‘swallowed whole with he aid of iuids. ) 284 I Do not chew or crush — (<Jra ) Mylan PharmaceuticalsInc. = A st Magattoun, i 5505 US A 4 = Z ylan m Myla n g R Mytan.com
9a448534-99cc-47d2-8472-3383c64cb14e_614_1.jpg NDC 43063-896-90 PD-Rx gl = PHARMACEUTICALS | 2=— 8==sg INCORPORATEDY) &_—— =9 Oklahama City, OK « 73127 = 43063-896-90 43063-896-90 43063-896-90 2==3 5 .. PIOGLITAZONE PIOGLITAZONE PIOGLITAZONE n=° E? - USP USP USP o= 25— 45 MG 45 MG 45 MG e e 90 TABLETS 90 TABLETS 90 TABLETS § =3 USP Eg = REORDER #110643 REORDER #110643 ~ REORDER #110643 =28=— ©— LOT 118C02 LOT [18C02 LOT I18C02 ga=x &5 = EXP 09/20 EXP 09/20 EXP 09/20 EL= g E = — CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. ! = > . o iy 3= 1 — YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 — 90 TABLETS = TAKE TABLET‘S) TIMES A DAY 1 = Each Tablet Contains: S il il ' ===0 PIOGLITAZONE HYDROCHLORIDE s . % USP EQUIVALENTTO o TOME__TABLETA(S)__VECES AL DIA, 8 PIOGLITAZONE 45 MG S ORGANOLEPTIC MARKINGS: WHITE ROUND PIO45 T —]
9a6c8116-396d-413b-b8e7-5eb321781bd5_765_1.jpg < N Each film-ccated tablet contains ‘Dispense in a ight, light-resistart &I ) o it 157 LTS D i £ | equiclent to 5 mg esctalopran. using chidresistant clesure. o Esc |ta|opra MY | ity o § ) — Yoot el maiston. = o Tablets, USP outofthe reach of children. | L. Store st 20°t025°C (8" 1 77°F). o @ e B o ge: Usu Bosage: See acompnyvg | 1 g5 5 PERRBCST: Dispens T ccompanyng | Prescribinginformation ) g j Medication Guide to each patient. Mylan Pharmaceuticals Inc. 3 + b it — g [MMylan® o g [MMylan® O] P Mylan.com
9a6c8116-396d-413b-b8e7-5eb321781bd5_765_2.jpg Each flm-coated tablt cortans escitalopram oalats, USP. equivalet o 10 mg sscalopram, s N o! ) — = = i 5 5355 & A*gg 0 g g NDC 0378-3856-77 Escitalopram Tablets, USP 1 [PRRIARCET Disgens the accomparyin| st Gde o each paten [MMmylan® g 90 Tablets ] Dispense n a g, foht resstant container a5 defined n the USP. usinga chidesistantclosure. Keep conainer gty cosed Keep this and all medication out of the reach of hildren. Store 5t20° o 25°C (68° o T7°F). [See USP Controlled Room Tomperature.] RM3856MM2 Usual Dosage: See accompaning prescrbing formation Mylan Pharmacouticals in. Morgantown, W 28505 U5 [MMylan® Mylan.com
9a6c8116-396d-413b-b8e7-5eb321781bd5_765_3.jpg = B . Each film-coated tablet contains Dispense n a tight, lght-resistant &Y | o ot 15 NDC 0378-3857-77__ Ressbiybuidiersy equivalent to 20 mg escitalopram € N g i s o Esc|ta|opram s § — Kesptis and ll medicaton = — Tablets, USP out of the reach of childre | St 120° 10 25°C (68° to 77°F).. o - m BT 0o ~———— Temperature ] o W oo 1 PRRRNACIST Disperse theaccompanying | Prescibing information. 5 oty o s s, N — Horgantown, W 26505 054 i [MMmylan MMylan® &0 90 Tablets Mylan.com
9a84e50c-504a-4e7d-8595-ebce7d78d127_951_1.jpg Q 4 e 05 ISLAND SUPPLY HWY 30 *
9a84e50c-504a-4e7d-8595-ebce7d78d127_951_2.jpg A s - st uﬂ\"\ﬁ“ﬁn‘:‘ ,}‘;\Taﬂ‘“& " 5 o o o i e 2 &M ;@\54 m“% = s e, @&w% Cosmetic Act -ﬂmnmgmm\lﬂ‘“"‘ e o \‘\g&“ Gl At PO ,mm-wd“s‘ AT W“@M wmms it wnits wm,g\\\t.w\‘\ﬁ A oS O e iuD P GEN WAL unmeomwﬁ\““.?}s\'\ﬁ.\\ éﬂ““““‘ o« mw:“lm‘s o s ‘“:qs‘ cstoos. Kot ‘mﬂﬂw,‘m\wﬁ‘;\\“ws‘ - ieares ¥ “wm‘“‘ T with opleakTefte I 83 S ‘Mmm\““ ‘“MWWNI : S okt P g ,ﬁn\d\mﬂ\\wm\v“"‘x‘" v equpme mm o O, u‘f;n“‘:,;\?;?ex‘:;;ﬂﬁ UW;\;:M‘:;‘“% ko o' et o e e i ‘sﬂmﬂ Sheet (SDS) ) betore use. S e are. Gt Immetise
9af396b8-ff66-4b2a-ac2b-588549072f4c_394_1.jpg st e, ' SUPPLIES. st 5 g m A z & 2z £ & <
9b5101ee-fc34-4ad3-be3f-d898b4aebf7e_785_1.jpg Nortriptyline Hydrochloride 10 mg Capsule arv: 30 ID #: TARO;NTP10 Expires: NDC #: 70518-1395-00 Shape: Capsule LOT #: Ref #: 51672-4001-05 MFG: Taro Pharma, Haifa Bay, Israel 26110 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
9ba391c5-c3d7-4bbe-bbb7-353a2b528012_54_1.jpg NDC:50436-0183-3 HYDROCHLOROTHIAZIDE 25 MG/ 90 TAB Exch aie conans: Hycrochoraiaze,USP 25 g Dipene n g ot resistont containr 25 defed i USP sing i rstant cosure Keep crtaines tty coses VIARNING: KEEP OUT OF REACH OF (CHILDREN, STORE AT 20.25°C (6877°F) ‘CONTROLLED RDOM TEMPERATURE, SEE PACKAGE INSERT FOR DOSAGE INFORMATION. Mig by: Infas Pharmaceuticals Limited ‘Abmedabad - 382 210, India MFGNDC: 16729-183-17 MFG LOT: XX00000X LOT: Y0000 EXP: Pkg by: Unit Dose Services, LLC Dania, FL 33004 howd X00000¢ RXONLY NOC: SD436:0183:3 25 MG /90 TAB DRUG! HYDROCHLOROTHIAZIOE LOT: 00000 BXP: 20000 NOC: 50436-0183.3 251G/ 0 TAS. DRUG, HYOROGHLOROTHIAZIDE LOT: 00000 EXP: 100000 DG SO136:0183.3 25146 /90 TAB DRUG, HYDROGHLOROTHIAZIOE LOT: 000000 EXP 200000€ NOC: 5043601833 25 G /90 TAS DRUG: HYDROGHLOROTHIAZIDE LOY J000K. = J05000%.
9c78512e-7f5d-46d8-a121-f10ca2339a23_667_1.jpg NDC:50436-0183-3 HYDROCHLOROTHIAZIDE 25 MG/ 90 TAB Exch aie conans: Hycrochoraiaze,USP 25 g Dipene n g ot resistont containr 25 defed i USP sing i rstant cosure Keep crtaines tty coses VIARNING: KEEP OUT OF REACH OF (CHILDREN, STORE AT 20.25°C (6877°F) ‘CONTROLLED RDOM TEMPERATURE, SEE PACKAGE INSERT FOR DOSAGE INFORMATION. Mig by: Infas Pharmaceuticals Limited ‘Abmedabad - 382 210, India MFGNDC: 16729-183-17 MFG LOT: XX00000X LOT: Y0000 EXP: Pkg by: Unit Dose Services, LLC Dania, FL 33004 howd X00000¢ RXONLY NOC: SD436:0183:3 25 MG /90 TAB DRUG! HYDROCHLOROTHIAZIOE LOT: 00000 BXP: 20000 NOC: 50436-0183.3 251G/ 0 TAS. DRUG, HYOROGHLOROTHIAZIDE LOT: 00000 EXP: 100000 DG SO136:0183.3 25146 /90 TAB DRUG, HYDROGHLOROTHIAZIOE LOT: 000000 EXP 200000€ NOC: 5043601833 25 G /90 TAS DRUG: HYDROGHLOROTHIAZIDE LOY J000K. = J05000%.
9c78512e-7f5d-46d8-a121-f10ca2339a23_667_2.jpg NDC:50436-0183-3 HYDROCHLOROTHIAZIDE 25 MG/ 90 TAB Exch aie conans: Hycrochoraiaze,USP 25 g Dipene n g ot resistont containr 25 defed i USP sing i rstant cosure Keep crtaines tty coses VIARNING: KEEP OUT OF REACH OF (CHILDREN, STORE AT 20.25°C (6877°F) ‘CONTROLLED RDOM TEMPERATURE, SEE PACKAGE INSERT FOR DOSAGE INFORMATION. Mig by: Infas Pharmaceuticals Limited ‘Abmedabad - 382 210, India MFGNDC: 16729-183-17 MFG LOT: XX00000X LOT: Y0000 EXP: Pkg by: Unit Dose Services, LLC Dania, FL 33004 howd X00000¢ RXONLY NOC: SD436:0183:3 25 MG /90 TAB DRUG! HYDROCHLOROTHIAZIOE LOT: 00000 BXP: 20000 NOC: 50436-0183.3 251G/ 0 TAS. DRUG, HYOROGHLOROTHIAZIDE LOT: 00000 EXP: 100000 DG SO136:0183.3 25146 /90 TAB DRUG, HYDROGHLOROTHIAZIOE LOT: 000000 EXP 200000€ NOC: 5043601833 25 G /90 TAS DRUG: HYDROGHLOROTHIAZIDE LOY J000K. = J05000%.
9c78512e-7f5d-46d8-a121-f10ca2339a23_667_3.jpg NDC:50436-0183-3 HYDROCHLOROTHIAZIDE 25 MG/ 90 TAB Exch aie conans: Hycrochoraiaze,USP 25 g Dipene n g ot resistont containr 25 defed i USP sing i rstant cosure Keep crtaines tty coses VIARNING: KEEP OUT OF REACH OF (CHILDREN, STORE AT 20.25°C (6877°F) ‘CONTROLLED RDOM TEMPERATURE, SEE PACKAGE INSERT FOR DOSAGE INFORMATION. Mig by: Infas Pharmaceuticals Limited ‘Abmedabad - 382 210, India MFGNDC: 16729-183-17 MFG LOT: XX00000X LOT: Y0000 EXP: Pkg by: Unit Dose Services, LLC Dania, FL 33004 howd X00000¢ RXONLY NOC: SD436:0183:3 25 MG /90 TAB DRUG! HYDROCHLOROTHIAZIOE LOT: 00000 BXP: 20000 NOC: 50436-0183.3 251G/ 0 TAS. DRUG, HYOROGHLOROTHIAZIDE LOT: 00000 EXP: 100000 DG SO136:0183.3 25146 /90 TAB DRUG, HYDROGHLOROTHIAZIOE LOT: 000000 EXP 200000€ NOC: 5043601833 25 G /90 TAS DRUG: HYDROGHLOROTHIAZIDE LOY J000K. = J05000%.
9cc32777-1f3b-4309-b2eb-ca165ad56aca_657_1.jpg NDC 62037-524-01 Each Tablet Contains: Fydtocodone Barrae ... 75 mg Hydrocodone Toupioten e 2 Dispense na gt ight resistant Bitartrate and continer. Usial Adubt Dosage:See package et Ibuprofen Streat 01025 61077 500 5 Tablets Controlled Room Temperaturel, L £ P I B e Fort Liderda, FL 35314 UsA ~w 100Tablets (e Actavis RXOnly Wi prama,nc Py 67058 USA e 0216 2262251
9cdd9d7e-f0b9-4d81-8f20-a16e687b479e_448_1.jpg (USUAL DOSAGE: See package insert for complete dosage recommendations. PHARMACIST: Dispense in a tight, light-resistant container with a child-resistant closure. STORAGE: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. WARNING: Keep this and all medications out of the reach of children. Manufactured by: Mikart, Inc. Atlanta, GA 30318 Code 866216 Rev. 09/16 3 672"64216' "3 NDC 46672-642-16 @ ) Hydrocodone Bitartrate and Acetaminophen Oral Solution 7.5 mg/325 per Contains Per. SmL 15mL Hydrocodone Bitartrate 2.5mg 7.5 mg (WARNING: May be habit-forming.) Acetaminophen 108 mg 325 mg Alcohol % % Dispense the accompanying Medication Guide to each patient. Rx only 16 fl. 0z. (473 mL)
9d07a3eb-e7b7-40da-8849-4650566aa785_16_1.jpg SRR MRS s LR e Bimmn. e SR Peiten ADAY FOR 10DAYS - L S G
9d07a3eb-e7b7-40da-8849-4650566aa785_16_2.jpg owvron soonre
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_1.jpg { , AD o Ts0co ey Wi o osuadsig Wb wo owlg {amessdusy wooy pajonuep g5 ses] L2101 89) 52 0.2 12 201 WP Joyoeal o o doay Bupuie uogeuo Buausan BuAducos sas s pue oBesoq 50foropen Bu 2 suewoo e e NOC 50742-178-01 Nadolol Tablets, USP Rorly 100 Tablets Manutactured for: Ingenus Pharmaceutials, LG Orlndo,FL32835-6408 Manutactured by: ngenus Pharmaceuticals N LG Farfied, NJ 07004 o \_rorsnsar
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_2.jpg 2] 10 A ‘_— _— | “BURIU00 eSS0 WD) 14 ujasuadsig [ foamesoduiog wooy pajonu0 dsn aos] (Hall @ 89) D552 O 02 1 24O BIPIL 0 UOE J0 10 dody :BunLIEm wonewiou Guquosad Buiueduiood aas :asn pue obesogq 450 0opeN Bu (7 SRIU09 1908 uoE3 o e Z D - 2= 2 T S w» HE c 9 A Ll 558 8 -g H:=35 = g —- Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Manufactured by: Ingenus Pharmaceuticals NJ, LLC Fairfield, NJ 07004 178-10 v1/06-2017
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_3.jpg By & uy asuadsig 01193101 “[amesaduial wooy paljoRL0Y dsfl 23s] (d4oLL 01 89) 0oSZ O} 02 JE 21015 “UBIPIIYD JO Uoea1 J0 10 daay Bupusem “uopeuLIouy Buiguosasd Buuedwoaoe sog :asn pue abesoq dSN ‘1010peN B 0y suieluod jajqeL yoe3 Nadolol Tablets, USP K only 100 Tablets LT NDC 50742-179-01 Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Manufactured by: Ingenus Pharmaceuticals NJ, LLC 1d, NJ 07004 \1 79-01 v1/06-2017
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_4.jpg —_ _— | JaU/E103 W1SIS0- 61| 1461 U O5UdSIq SioU woy Wel0k {aumeiadus] wooy pajoae) dsn 905 (dol @ 589) 052 O 02 & 2JOIS. a0 Jo ol o 1o Gary Bunuie wopewioju 6uiquosaid Guiueduwiood aos :asn pue obesoq 451009°N B 0y U0 19101 3 . 2= @ He2% 2 |8 = N o0 gles 3 S T = SlE s |8 MN” - 2 — Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Manufactured by: Ingenus Pharmaceuticals NJ, LLC Fairfield, NJ 07004 179-10 v1/06-2017
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_5.jpg S N / a ) 101 1 4 € _ _ Z 39U[EIU00 Ue3SISaI-JUB1I WO} © U) Bsuadsq WO woumold fomesaduay wooy pojouo) dsn 05| oL 01,99) 0,52 01 o2 12 A0IS UBIPIYD 10 43w Jo 10 dasy Bupwem uopewioy Buuosaid Buyiueduoae aas :asn pue abesoq SN l0opeN Bu 0g suEIU00 JaigeL e O is3 2 HES B E M ¢ = BE I E8E 8 “ls H i3z g =S ——— Ingenus Pharmaceuticals LLC Oriando, FL 32839-6408 Manufactured by: Ingenus Pharmaceuticals M, LLC Fairfield, 107004 N \ 180-01 v1/06-2017
9d265c44-32fe-4962-a1b1-aacb64b6e82d_508_6.jpg wa an Ze oueon wye ujssuedsy "Wy woy ooy faumpsdus] woog poyonuog g5 o) o 01 591,501 % O WOPIND 04200110 10 dooy Bt iy Buqosaid Buueduosos 035 a5 pue oBEsoq 450 Tolopen Bu 05 suuc0 o o3 8omg NDC 50742-180-10 Nadolol Tablets, USP Manutactured for: Ingenus Prarmaceuticals LLO Orlando, FL32839-8408 Manutactured by: Ingenus Pharmaceutcals NJ, LLC Faifield, NJ 07004 18010 v1/06-2017
9d525542-655c-db2b-046b-572a3017a1bf_781_1.jpg ¥ 80285 08210 €N -8p0dJeq Jdf ysiuep [arata ON | oni *UBIPYD 4O YIBBI 3} J0 1N pue Pasof ARYGY doay ‘dSN 8y} Ul paulyap se siaureod anseyd 134 10 ssejf jueysisa-Jubi| ‘b1 i asuadsiq :isioeULIBYd = ] 335 e B85 sEE o hpn ) 2ew P w o E momh E 2EIES Beuf B SS|e 838z § 2 52 = 2 s @ il S 8 = 3 LQofEll Scf % g8 =< A8 2 T2 N g E o9 = S =0 g ac = a. L058208 01 Rev 008120
9d6a052b-b032-4d72-9bd1-e6c895b12472_690_1.jpg Store ol contralied room NOC 62175 88046 femparaiure 20°-25°C T o 7 Atorvastatin Diprs I g s (157, Calcium ISUAL DOSKGE Son oo ol Tablets resstig e, vt et o m olonestufin cdum equivalent fo 10 mg ciorvasiatin, Hulnnd!r Plogse diponse Lnnmr tam e g et Hibloph, %154
9d6a052b-b032-4d72-9bd1-e6c895b12472_690_2.jpg Store ol contralied room NOC 62175 88046 femparaiure 20°-25°C T o 7 Atorvastatin Diprs I g s (157, Calcium ISUAL DOSKGE Son oo ol Tablets resstig e, vt et o m olonestufin cdum equivalent fo 10 mg ciorvasiatin, Hulnnd!r Plogse diponse Lnnmr tam e g et Hibloph, %154
9d6a052b-b032-4d72-9bd1-e6c895b12472_690_3.jpg Stors at controlod room HOC 62175-89245 fomparutura 20°-25°C s T e ], Atorvastatin Dspesein it o (ISP, Calcium gu:(w.:.mm Tublels prescribing infumation. *Fach filn<oated toblet cntuins ‘aforvesiafin calcium equivaknt o 40 mg atorvestatin, Disibuted by: u"mmﬂ%m
9d6a052b-b032-4d72-9bd1-e6c895b12472_690_4.jpg e B om o (8°-77°F) [soo LSF]. Dispense in tight contuiners (USF). USUAL DOSAGE Sea pockage insat forful prasaribing information. *Euch fimtoated oblet cantains atorvstutin ok equivaat fo 80 mg uforusiin, Distributed by: Lonnett Omﬁ ) Inc. Phildephin, P4 19154 Noc 62175- 89745 Atorvastatin Calcum Tablets [ o Belnly 90 TARETS
9e0b10b8-457a-4229-bdeb-36acaae2fecb_312_1.jpg wBMaloT NDC 0904-6696-61 Unit Dose: PYRAZINAMIDE TABLETS, USP mg Rx only 100TABLErs _ OMAIOR NDC 0904-6696-61 Unit Dose PYRAZINAMIDE TAI}lETS usp E0 mg Pyrazinamide tablt fo oral i st . " Usust Acl Dosager 15.30 mokg onca iy ot o xcoed 2. Conaut procuc oo or mors S prdacroing niormanon. procasions “ondwarminge. seE seaT EouND AT W MASORPHARIUACEUTIGALS.COM Store a1 20°-25° (68°7T°). [See USP. Cantolid Foom Tamparsture, Dispense n igh. ght-esisant conainr 20 dofinedn o USP sing a cnkesitant costre. Keep this and sl mediction ot ofthe reach ofchdren. This Unis Dose package s not ld resistant and s itended for nsttutionl Use Only: Revon/1a z m‘k‘:’ ! 3
9e1805c3-8bce-45b5-974f-ff77893077aa_788_1.jpg Packaged by Evgant Ranch Berbank. @A 91504 METRONIDAZOL & "™ fourvss E 250MG TAB 10° 2 I = Store at room temp of Compare To: 20°25°C (68°-77°F) FLAGYL250MG TABLET-LIB Reepall drgsatof Wabon Pharma Privake Limied | reach of children. #28 Exp: MMYY ¢ NDC 7133508741 077541120418
9e48dba7-c706-44fc-b04b-0fdcb2d72bc4_502_1.jpg Dosage: . Sos makiog oseit NDC: 24338-200-16 100z for complete dosage instructions. sz Nymalize: Polyethylene Glycol 400, Glycerin, Purified Water, Sodium Heon, st st nimodipine) oral solution Dibasig . 60 mg/20 mL Keep out of reach of children. Store between 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C For Oral Use Only (59°F to 86°F). [See USP] Protect from light. Store at room temperature. Distibuted by: Made in Canada earhor NIM-TL16-4 Rev. 04/17 Atianta, GA 30328 ©2017 Arbor Phamaceticals, LLC
9e48dba7-c706-44fc-b04b-0fdcb2d72bc4_502_2.jpg Nymalize® (nimodipine) oral solution 30 mg /10 mL For Oral Use Only Usual Dose: See package insert for complete dosage instructions Keep out of reach of children Package not child resistant Store at room temperature between 20°C to 25°C [See USP] Protect from light RN 2433820510 One 10 mL Unit-Dose Cup Rx Only One Oral Syringe EXP:10/14/16 Lot # ST2015-09 Mg For Arbor Pharmaceuticals LLC, Atanta, GA 30328 Pk By Safecor, Columous, OH 43204 NIOWI0-0L REVO7AS
9e4c5295-1fe9-4da3-90f9-04204e3e72e4_365_1.jpg nan
9e4c5295-1fe9-4da3-90f9-04204e3e72e4_365_2.jpg (Ui [upsbearmeppes , DUIILLID A B Femring® (e gt i) (Cotios 248 i s b i ot (e e [ P .L,:Allergan Lo Full Prescribing L LI ¥ 56 ! E I 4 I Lol Femring® [estradiol acetate vaginal ing) 0.10mg/day 7 Femring® ]
9e9e9ced-6960-4d2f-bb23-ef8b2435da75_30_1.jpg HoG 4358 71901 Chlorthalidone Tablets, USP 25mg Rxanly 100 Tablets DrReddys & Each tabot contains: Chorthaidone, USP 25 g Dispnse i gt gt esistant continra deied n tha USPusing achi osistant closure. Kesp contane iaht cosed Kaop this and all madication out of th reah f childon. Storeat 20°to25°C (68°t0 1) S84 USP Controlad Room Temperatre, Prtect fromlight Ustal Adult Dosage: oo accomparying prescrling nfomitin, Wanufsctured by Manutactrod or: Aepco Prarma LC D Reddy s Laboratries e Piscataney, NJ 068 USA Pricoton K 02540 USh Rox oovaia 200268 NO VARNISH
9e9e9ced-6960-4d2f-bb23-ef8b2435da75_30_2.jpg NDG 43508-719-10 Pharmacy Package Only Chlorthalidone Tablets, USP 25mg R only 1000 Tablets Dr.Reddy’s Ech bl contans Chortabdons, U525 g e Ogeiont g s o st i g e core. Ko cntivr ity ks Ko sl mcistion ot s echof e, BT rotect from ight - sl Dsag: e scompani P R Mot it it 0 s U5k [ BB it o Fican, 156540 4 [ Sy NO VARNISH = = =
9e9e9ced-6960-4d2f-bb23-ef8b2435da75_30_3.jpg H0e 43598 720.01 Chlorthalidone Tablets, USP 50 mg Rxonly 100 Tablets Dreddys &% Each tabletcontans: Chonhaidone, USP 50mg Dispense i tigh, gt eistant containera defied n he USP using chi-tesistant closue, Keep continer gty cosod. Keepthisan all mediction aut f the eachcirn. =o Storoat20°t025°C 60 77°) {560 USP Contoled Room Temperature, %3 Manufacturedby: Manufctured for: = Bnelly R, R e imson et = o 508 20029 NO VARNISH
9ebedd36-523a-4f92-8fe9-33beaf7288f9_523_1.jpg (ajua15) uonnjos wadnwaq dwreqydo 9,57 asojjwosdAy a1e}01u0n ‘Each mL Contains: Active: Hypromelioss 25mg 25%: Inactives: Benzakonium Chioride, Boric Acid. Edetate Disodium, Sodium Borate, Water for njection. Hydrochioric acid and/or sodium ‘hydroxide may be added to adjust pH (6010 7.8). 'NOTE: this solubon dres on optical suraces, et them stand incool water before cleansing. INDICATIONS: Fo pofessional s i gonioscapic ‘exaninations. DIRECTIONS: Fil gonioscopic prism wih solton as necessary. WARNINGS: To avod conarmination do ot fouch i of contaner o any surface. Replace cap after using. Not for use n conunchion it hotaser reatment, I solution changes clor of becomes cloudy, ot use. 'KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILREN. ‘STORAGE: Store at room temperature 15°- 30°C (59°86°F) 0007 U MPATED SEAL o P s ToR. BRoKeN o wssaic NOC 5939018213 0 1P 5 oniota Hypromellose 2.5% Qm?)::uitﬂ Ophthalmic Demulcent Solution (Sterile) Solution (Sterile) For Professional Use In Gonioscopic Examinations For Use In The Eyes Only | foFressemaiteen ForlUse I The Eyes Oy &) “ ’ o117 Void Aqueous Ro317
9fb78667-7db9-4d98-b8a2-0de60458de11_299_1.jpg HEL s e . BER WEEmEmL S | FE R e i B, iAoy . - g | v | i
9fb78667-7db9-4d98-b8a2-0de60458de11_299_2.jpg AR O3 A REDTFALER] e A A s WAL PUFE THGE A DAY
9fd48eec-aa24-4888-b99f-d409ada958a7_571_1.jpg o seuzONTS HI0ZZ1 'S vo9saST “Each L of Desmopressin Acetate Infcton, USP conans 4 g desmopressi aceta, USP 5 mg of ehlorobutan, § mg soum chionde, ydrochionc 36410 adustpH B &, and wafo incton g0 1 mL Ustal Dosage: Se package insertfor dosage formaton, WARNING: Kesp 0t of each ofchiden. Storerefigeraed 2°108°C G610 46¥). Presene n tgh cantaners, NDC 62756-529-40 Desmopressin Acetate Injection, USP L AL [ NDC 62756-529-40 Desmopressin Acetate Injection, USP Y R [ NDC 62756-529-40 Desmopressin Acetate Injection, USP 40 meg/10 mL (4 meg/m psted rom gt il B enten. FOR INTRAVENOUS/ FOR INTRAVENOUS/ FOR INTRAVENOUS/ SUBCUTANEOUS USEONLY | SUBCUTANEOUS USE ONLY | SUBCUTANEOUS USE ONLY Refrigerate Refrigerate Refrigerate Rx only Rx only Rxonly One 10 mL. Multiple-dose Vial | One 10 mL Multiple-dose Vial | One 10 mL. Multple-dose Vial Dttty Sun Pharmaceutcl nustes, . Crnbury, 08512 @ o sov | [N Halol-Baroda Highway, PHARMA : 3 Haoi565 50 Gk |l ) woce27e 52840 Desmopressin Acetate Injection, USP e R Rrony One 10 mL Multple-dose Vial \_ J — g
9fffdcd3-e3c7-4fe6-ba6d-374335bc7655_58_1.jpg Saunr SUNTRPTIN GG TRELET BTSSR 4 e RX TAKE ASORECTED A ONPACKAGE. R AR o e g
9fffdcd3-e3c7-4fe6-ba6d-374335bc7655_58_2.jpg s SURTRRTIN GG TIBETS ey B, RO TAKE AS DRECTED Seren T PR RIS et e o ooner
9fffdcd3-e3c7-4fe6-ba6d-374335bc7655_58_3.jpg S JAwsmEE TR L n Foo, B wesonem - S e S5t s P =k BE T Eoy oo I
a0288919-75bf-4752-975f-40579572c0f7_583_1.jpg Depakene Valproic Acid 250 mg Capsule arv: 30 ID #: DEPAKENE Expires: NDC #: 70518-1459-00 Shape: Capsule LOT #: Ref #: 00074-5681-13 MFG: AbbVie Inc., North Chicago, IL 60064 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
a0949773-c75f-4ef0-a69c-1abd978340d0_651_1.jpg Depakene Valproic Acid 250 mg Capsule arv: 30 ID #: DEPAKENE Expires: NDC #: 70518-1459-00 Shape: Capsule LOT #: Ref #: 00074-5681-13 MFG: AbbVie Inc., North Chicago, IL 60064 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
a0949773-c75f-4ef0-a69c-1abd978340d0_651_2.jpg Y AR T LS00 L9 L ||||I|| ||I || IH R PoSOI0 A4BLL JeufeiuoD deay “feimieseduia) woos Pafjonuo ds 98] (4:98 01 o6S) De0E OF 4G F PeRILLIEd ‘SUOISINOX® YlIM (oL L O} 488) DuSZ OF 502 1€ 01015 S3A3 FHL NI 3SN HO LON -ATNO 38N TYNHILXT HOH € e a3084€ 0} A| B ot () Y CR RSP A I S e W L VAT JTL A)goo e i i i i | 1 21-580-04 191 OAN sanL B ozh | ! 120 g Tube NDC 16110-035-12 | Cordran Flurandrenolide Cream, USP | 005% Usual Dosages Appy to affected area 2 o 3 times aday. e ueipiod eqnL 6 oz dSN ‘weaip apyousipuenty Each gram contains: flurandrenolide 0.5 mg (0.05%), cetyl lcohal, citrc acid, mineral o, polyoxyl 40 stearate, propylene glycol, sodium citrate, stearic acid and purified water. Sea package inser. Invert cap to punture seal in tube. Capis Not Child Resistant. Keep Away from Children.
a0949773-c75f-4ef0-a69c-1abd978340d0_651_3.jpg Usual Dosage: Apply to affected area 2 or 3 times a day. See package insert Each gram contains: flurandrenolide 0.25 mg (0.025%),cetyl alcohol, citrc acid, mineral oil, polyoxyl 40 stearate, propylene glycol, sodium citrate, stearic acid and purified water. ﬁ QJA Store at 20 to 25°C (68" to 77°F) with excursions permitted to 15° 10 30°C (59° 10 86°F) [See USP controlled room temperature] Keep Tightly Closed and Protect from Light IMPORTANT: Do not use if seal has been punctured or is not visible s Cap is Not Child Resistant. Keep Away from Children. See Crimp for Expiration Date and Lot No. Manufactured by DPT Laboratories, San Antonio, TX 76215 N For Aqua Pharmsceuticals, an Almiall Company, Exton, PA 19341 106776 3 120g NDC 16110-034-12 40.025% cordran Flurandrenolide Cream, USP
a0949773-c75f-4ef0-a69c-1abd978340d0_651_4.jpg R VeIV ENs V=) g C] upJP.IOD %SZOOR ; eapLLL 9 1C L|:"'€||0l"’(') L"li 9l ﬁ 17651 v ou o feinuly v Sfeouneoeuieg by 104 i Naw flhim S1Z8L X1 ‘oopy Ues ‘s3uojeioge 1qq Aq paimioejnuey Aueduwio [jejwy 9 ue SIVOLAIVIIVIE V S$3AF FHL NI 35N YO LON - AINO 38N TYNYILXT ¥04 ARV EET e lVEN NN T §[e¥[e3l0)s) ELUTRA (A5 Rl NDC 16110-034-12 120g Tube @egelgoln Flurandrenolide Cream, USP FOR EXTERNAL USE ONLY - NOT FOR USE IN THE EYES Usual Dosage: Apply to affected area 2 or 3 times a day. See package insert. Each gram contains: flurandrenolide 0.25 mg (0.025%), cetyl alcohol, citric acid, mineral oi, polyoxyl 40 stearate, propylene glycol, sodium citrate, Stearic acid and purified water. Store at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) [See USP controlled room temperature]. Keep Container Tightly Closed. Invert cap to puncture seal in tube. Cap is Not Child Resistant. Keep Away from Children.
a0949773-c75f-4ef0-a69c-1abd978340d0_651_5.jpg NDC 16110-026-60 Cordran Flurandrenolide Ointment, USP 0.05% i FOR EXTERNAL USE ONLY - NOT FOR USE IN THE EYES USUAL DOSAGE: Apply to affected area 2 or 3 times a day. See package insert, Each gram contains: flurancrenolide 0.5 mg (0.06%), white wax, cetyl alcohol, sorbitan sesquioleate and white petrolatum. Store at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) [See USP controlled room temperature]. Keep Tightly Closed and Proteot from Light. AQUA s e IMPORTANT: Do ot use i seal has been punctured or is not visible. & Alrirall compury Cap is Not Child Resistant. Keep Away from Children. = Seu G b xten i Lk |||||m|“||||| |||| - N Wttty O Lo, S TXTRZS 5 381101028801 5 For g Pt an Al Cmpan B, PA 19341 -
a0949773-c75f-4ef0-a69c-1abd978340d0_651_6.jpg “UBIDUD o Kemy GooY SISy PO 10N 51 deg “0an 1 1263 onjound o1 ded penu| uosuf eBeoEd e unejned OY4M pu S1EBoInbsss UeyqI0s foyoof Ko XM O} (5650°0) B G0 SPIOUAIPUEIN] SUE0D WEIE LoBT VGRSV eI L T RN Y BT f T e 0/0900 dsn ‘uaunuiQ apijousipuen|4 ueipiod i 00-020-0L19} OON °qny 6 09 Flurandrenelide Ointmart, USP Cordran (010 T A PP FOR EXTERNAL USE ONLY~ NOT FOR USE IN THE EYES Store at 20° 10 25°G (68° o 77°F) with excursions parmitted to 15° 10.30°C (59° to B6°F) [Sea USP conirollad room temprature]. Kasp Gontaine: Tightly Closed Fe ks oo, ALl oo . 1636 16110'02660 i
a0d01539-8413-4703-94cc-d221918630a1_192_1.jpg T Egp. Store af controlled 20Tles NDCOIZB850020 894082 room femperature — 2025°C (6877°F) (see labeling) Usual Dosago (finidazole fablets) S oy B omion 01788l5002 Son Ankrio, 0782301335 Mkt o, Ao, GA 30318 1850020 COI v 004060 Mision Phomorel Cony Mandochrsd by Mandochrsd or 3
a0d01539-8413-4703-94cc-d221918630a1_192_2.jpg nan
a0d01539-8413-4703-94cc-d221918630a1_192_3.jpg Store a conirolled room femperature 20:25°C 60 Tablets NDC 0178-850040 (6877°F) {see labeling) Vel Dossge T AN See accompanying tinidazole tablets) I Rx only ID17EE'5CID&D || mmmsson 894C46 Mission Pharmacal Company San Anfonio, X 78230 1355 Manufactured for Manufactured by: CO1 Rev 006060 Mikart Inc., Afanfa, GA 30318 1850060
a13ae145-5c5e-422b-d0a5-6cf34c1b8262_543_1.jpg T ||||I“||||I||||| 2 mL Single-use | Carﬂ:uecl"‘ NDC 0409-1276-03 Sterile Cartridge Unit with Luer Lock Fentanyl Citrate Injection, USP @ 100 mcg Fentanyl /2 mL (50 meg/mL) 1 FOR INTRAMUSCULAR OR INTRAVENOUS USE Rx only. PROTECT FROM LIGHT. A Hospira, Inc., Lake Forest, IL 60045 USA Hospira
a13ae145-5c5e-422b-d0a5-6cf34c1b8262_543_2.jpg NOLHVD OLNI dV14 LH3SNI3S01D OL dVT4 1411 N30 0L 1 eudsop] (qu/Bow gg) quz/ jAueay Bow ggi| dsn ‘uonaaluj ajennq [Auejuay 00T Jam yum syuf) abpuvie) uaig yoaindieg gy asn-aibuis Jw g THISEND UP B> A @ Hospira 10 Carpuject™ Sterile Cartridge Units with Luer Lock Fentanyl Citrate Injection, USP mL Single-Use NDC 0409-1276-32 10 Carpuject™ Rxonly Sterile Cartridge Units with Luer Lock Needle not included SLIM-PAK™ Tamper Detection Package Fentanyl Citrate (IC Injection, UsP 10 Carpuject™ Sterile Cartridge Units with Luer Lock Fentanyl Citrate Injection, USP 2mL Single-use 10 Carpuject™ Sterile Cartridge Units with Luer Lock Needle not included Fentanyl Citrate (IL Injection, usp 100 mcg Fentanyl /2 mL (50 meg/mL) For Intravenous or Intramuscular Use | Carpuject Cartridges are to be used ONLY with Carpuject Holders. Sterile Aqueous Injection Each mL of this sterile solution contains fentany| (as the citrate) - - 50 mcg, adjusted to pH 4.0-7.5 E 00 mcg Fentanyl /2 mL E with sodium hydroxide. ™ 50 meg/mL) o Protect CARPUJECT from light ; = Retain in carton until time of use. B or Intravenous or s Store at 20 to 25°C (68 to 77°F). s ntramuscular Use s [See USP Controlled Room § — & 2 — 5 Temperature. f, = = rpuject Cartridges are to be used P L= For usual dosage and route 2 = E INLY with Carpuject Holders. 2 = E of administration, see package = 2% £ o> insert. @» E o % E &1 to8 & LA = Hosgira, nc. ~ - 2 Hospira ~ =8 Lo Farsy 1L 60045 USA Hospira —__2000LY3
a16297df-3158-48db-85e5-5cd506885556_439_1.jpg NDC 0591-5713-01 Amoxapine Tablets, USP PHARMACIST: Dispense the Medication Guide provided separately to each patient. W Actavis 100 Tablets RxOnly Each Tablet Contains: Amoxapine, USP 25mg Dispense n a tight container with childresistant dlosure. Dosage: See package insert for dosage and full prescribing information. Store at 20° 0 25°C (68° 10 77°) [See UsP Controlled Room Temperature]. Manufactured by: Wation Pharma Prvate Limited Vere, Salctte Goa 403 722 INDIA Distributed by Actais Pharma Inc Parsippany, K) 07054 USh Code No. GO/DRUGS/741 Rev.02/15 LOTER. BELOW 190825-1 o " ~ n o n o
a16297df-3158-48db-85e5-5cd506885556_439_2.jpg NDC 0591-5714-01 Amoxapine Tablets, USP PHARMACIST: Dispense the Medication Guide provided epataeh tocachpant . W 100 Tablets Actavis Rx Only Each Tablet Contains: Amoxapine, USP 50 mg ~ Dispense in a tight container with = child-resistant dosure. = Dosage: See package insert for 3 dosage and full prescribing — information H—N Store at 20° to 25°C (68° 10 77°F) [See B ==" USP Controlled Room Temperaturel. & ———in Manufactured by: = Watson Pharma Private Limited = Verna, alcette Goa 403 722 INDIA =1 Distributed by Actavis Pharma Inc. — Parsippany, NJ 07054 USA = CodeNo GO/DRUGS/741 Rev.02/15 190826-1
a16297df-3158-48db-85e5-5cd506885556_439_3.jpg NDC 0591-5715-01 Amoxapine Tablets, USP PHARMAGIST: Dispense the Medication Guide provided separately to each patient. 5715 W 100 Tablets Actavis RxOnly Each Tablet Contains: Amoxapine, USP 100 mg o Dispense inatight container with chidresistant closure = Dosage: See package insert for —_—O dosage and full prescribing = information =- — Store at 20° t0 25°C (68" 10 77°F) [See USP Controlled Room Temperature]. LOTERR BELOW, 05915 Manufactured by: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed by: Actavis Pharma. Inc | Parsippany, NJ 07054 USA il Code No. GO/DRUGS/741 Rev.02/15 190827-1
a16297df-3158-48db-85e5-5cd506885556_439_4.jpg NDC0591-5716-30 Amoxapine Tablets, USP PHARMACIST: Dispense the accompanying Medication Guide to each patient. W Actavis 30Tablets RxOnly Each Tablet Contains: AMOXapin, USP .............. 150 mg Dispense in atight container with child-resistant closure. Dosage: See package insert for dosage and full prescribing information. Store 3t 20°to 25°C (68°t0 77°F) [see UsP Controlled Room Temperaturel. Manufactured by: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed by: Actavis Pharma Inc. Parsippany, NJ 07054 UsA Code No. GO/DRUGS/741 Rev.02/15 Lo, BELOW 190828-1 6 71630 05915
a2f31909-3cda-4580-adfa-e9992d8c0885_76_1.jpg NDC 60687-325-01 ONGE-DAILY Lisinopril Tablets USP 100 Tablets (10 x 10) RxOnly [ I (01) 003 60687 325 01 9 NDC 60687-325-01 ONGE-DAILY Lisinopril Tablets USP 100 Tablets (10 x 10) Rx Only Each Tablst Can ExfopilUse. 10my Usual Dosage: Soe package nsari for i prescro g normation. Storo at20° 10 25°C 68 {o TT°F) excursions pemiled betveen TE1 S0°C 15+ 0.8 e USP Contraled Hoom Tamperaurel. Prtact from o, reszing an excassie e, Keep this and all crugs out o each of chldren. FOR YOUR PROTEGTION: Do o se f5isers trnor b, T g ot contaned n s picae s rom B 80580 Lo Evarmacesteaie ne Packaged and Dtroutacty e AR s G, Oha 4327 732501 ocazstiote
a2f31909-3cda-4580-adfa-e9992d8c0885_76_2.jpg onceonty o onceoty Ehopiraveuse £2 2 hcairavetuse e g8 drin i, i f ‘ e $E EE ey onczoALY 5 onceony Uisinopril Tablet USP =% % ¢ Lisinopril Tablet USP 10 mg 83 % § 0 mg =z 52 ¢l i onosenerszams 55 &3 Gnomeosrazsnis oneeoaLy o onczony Uisinopri Tablet Usp =% ¥ Lisinoprl Tablet USP sher B Cpimr # g 7 ¢ @ asoonsr 15 £ 53 Ghomemans onceonty ° e sioari Tablet USP ¢ & % Lisinopril Tablet USP e g% iy i I oEd i mmmeeys B 8 cemmnn oncEOALY onceouy {inop Tabet UsP mg § [snopr TabietUsP oo 101 g X o cosanear 25 11 ¢ P EXPIRY: sk
a2f31909-3cda-4580-adfa-e9992d8c0885_76_3.jpg NDC 60687-333-01 ONCE-DAILY Lisinopril Tablets USP 100 Tablets (10 x 10) RxOnly (01) 0 03 60687 333 01 4 NDC 60687-333-01 ONCE-DAILY Lisinopril Tablets USP 100 Tablets (10 x 10) Rx Only Esch Tablet Gontains: ESfopiUse, 20ms Usual Dosige: Sea pickage mser ol reserioing nformaton Store a120° 1025°C 68"t 71°F): oxcursons pormited Detween, S5 507 5510 67 (o4 ISP Cantroras Boom Temperatr Protec rommalsturs reving and oxcossie heat. Kaop this and al drugs out of aach ofchildron. FOR YOUR PROTECTION: Do ot u f e fonor roken, The drup produc contanec i s package i rom NBC K B8R60-581, Lo Prarmace eais, e Packaged snd Dtibuted by Arancin gah Fagkagng Calimbus, G 45511 733001 o430 1018
a2f31909-3cda-4580-adfa-e9992d8c0885_76_4.jpg oncEDALY. Lisinopri Tablet USP 20mg i y I e ONGEDALY Lisinopri Tablet USP 20mg (o1 00300587 538113 Cisinoprl Tablet USP 20mg 0% 003 607 333113 oncEDALY Lisinopri Tablet USP 20mg Tt A oet), oNeEDALY Lisinopri Tablet USP 20mg 0100350587 333113 swoncee 101 00 AU o000t 301 o0 R H ONCEDALY. Lisinopri Tablet USP 20mg Lot oooooc {o1) 0350857 338113 EXPIRY: xcex ONGEDALY Lisinopri Tablet USP 20mg Lot oo I @0 003 s 535113 EXPIRY: i Cisinopril Tablet USP 20mg EXPIRY: xuix Lot oonick ? (o nsenner 333113 ONCEDALY Lisinopril Tablet USP 20mg Lot oo EXPIRY: i ONCEDALY Lisinopril Tablet USP 20mg | mif i Lot oo EXPIRY:
a3244d1a-45b0-4e4c-bd96-f0632d761a1f_445_1.jpg nan
a3244d1a-45b0-4e4c-bd96-f0632d761a1f_445_2.jpg e Plenamine™ 15% Amino Acids Injection PHARMACY BULK 1000mL HAGK_ROT 28 BIBRAUN S s el i BaRcODE < ex SET
a3244d1a-45b0-4e4c-bd96-f0632d761a1f_445_3.jpg Date of Entry: A Time of Entry: ___AVjPM Discard ___ hours after initial entry.
a3eb7294-f913-434b-896c-da028bfebc73_307_1.jpg NDC 0591-0347-01 b Hydrochlorothiazide Capsules, USP 1 mg Xopatof ochof i oty o s Watson. 100 Capsules Rxonly Colo GDRGSTH
a3eb7294-f913-434b-896c-da028bfebc73_307_2.jpg NDC 0591-0347-05 Each capsule contains: Hydrochiorotiazide USP. 125 mg Usual dosage: See package fnert for ol prescnbing mformation Hydrochlorothiazide oispense naur, i esson containes as defined i the USP Capsules, USP Store at 20°25°C (68°-77°F) [See USP controlled oom temperature Protectfrom hght, maistue and froezing 12.5 mg Xeepout of reach of chidren. Manacured By Watson Pharma Private Linited Vema Sactie Goa 403 722 NDIA Walson.™ 500 Capsules Rxonly Code o GODAUGS7E1 1747901
a3eb7294-f913-434b-896c-da028bfebc73_307_3.jpg ACTAVIS LABORATORIES FL, INC. BoxNo: 1 13300 NW 2ND STREET SUNRISE, FL 33325 Hydrochlorothiazide Capsules USP 12.5 mg Balch No.: O0000000X Expiry Date: MM/YYYY 1 22HHYYXXRXHANN D = Uprght NOC: 0531 0347 00 (1 3 9120385918347084 Nel Weight: 5.000 Kg GTIN: 20306310347004 SNz Ttem No.: 0347 Store at 20°C ~ 25°C (68°F ~77°F) [See USP Controled room temperature). Protect from light, moisture and freeing, ~20°C (~4°F) CAUTION : For Further Repackaging Only. Rx Only. Product of India. Manufactured By: Walson Pharma P Lid. Vera, Goa, India. 483722
a3ff93ad-86ed-4324-ae86-7e7ed3a49db8_86_1.jpg EACH TABLET CONTAINS: NDC 42192-327-01 [6VOthYraXiNg (Tg) ..ceeveveveeremmernininas 9.5 meg liothyroning (Tg) .oo.vvevevriicnaan 2.25 mcg ) DIRECTIONS FOR USE: See Outsert. “OI( USUAL DOSE: 15 mg - 180 mg once a day. NP Thyroid is a natural product with a strong, characteristic odor. TherId Tablets USP Store in a tight container protected from light ’ and moisture. Store between 15°- 30° C (59°- 86°F). 1/4 grain (1 5 mg) MANUFACTURED FOR: Acella Pharmaceuticals, LLC Alpharetta, GA 30022 e 1-800|-5zi1 -4802 Rx Onl 100 Tablets g 3'M42192"32701" "6 pIHAniMAgm%A!SI,a
a4121191-72d7-48ea-abae-1842ca9f6f3d_22_1.jpg Pacliaged by Ergant Raech Biaban. 04 91506 Fenofibrate ~ §'*™o** 48mg Tablet g | R Store at room temp of Compare To: 20-25 C (68-77F) Tricor 48mg Tablet “Keep all drugs outof | #30 Exp: MMYY NDC 7133505781 072131106802 Keep all drugs out of reach o children om
a4121191-72d7-48ea-abae-1842ca9f6f3d_22_2.jpg Pachaged by Eopant Raeck Bankank. 04 91504 Fenofibrate e 145mg Tablet 192121 Store at room temp of Compare To: 20°25°C (68°77°F) Tricor 145mg Tablet “Keep ail drugs outof Coatig Pl I reach of children. #30 Exp: MMYY NDC 7133509031 073161121261 om
a454cd24-0c6d-46e8-b1e4-197388606175_465_1.jpg W u1os ELIQUIS® TABLETS 2.5 mg Apixaban 10 TABLETS Each tablet contains 2.5 mg apixaban. Usual Dosage: See product insert for full dosage information, prescribing information, precautions and warnings. STORAGE: Store at 20° C to 25° C (88° F - 77* F); excursions permitted between 15° C and 30° C (59° F and 86° F) * [see USP Controlled Room Temperature]. RX ONLY WARNING: This Unit Dose package is not child resistant and is Intended for Insttutional Use Only. Keep this and al drugs out of the reach of children If dispensed for outpatient use, a chid-resistant container should be used, DISPENSE WITH MEDICATION GUIDE Do not use if any printed biister units are opened or torn Marketed by. Bristol-Myers Squibb Company. Princeton, NJ 08543 USA and Pizer Inc New York, NY 10017 USA Product of Switzerland Distributed by Cardinal Health Dublin, OH 43017 1505320203184 LOT #: XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
a454cd24-0c6d-46e8-b1e4-197388606175_465_2.jpg NDC 55154-0613-0 I I 9 9 ELIQUIS® TABLETS 5 mg Apixaban 10 TABLETS Each tablet contains § mg apixaban. Usual Dosage: See product insert for ful dosage information, prescribing information, precautions and warnings. STORAGE: Store at 20° C to 25° C (68° F - 77° F); excursions permitted between 15° C and 30° C (59° F and 86° F) [see USP Controlled Room Temperature]. Do ot use if any printed biister units are apened or torn RX ONLY WARNING: This Unit Dose package is not child resistant and is Intended for Insfitutional Use Only. Keep this and all drugs out of the reach of children. If cispensed for outpatient use, a chid-resistant container should be used| DISPENSE WITH MEDICATION GUIDE Marketed by: Bristol-lyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc New York, NY 10017 USA Product of Switzerland Distributed by Cardinal Health Dublin, OH 43017 L52817950318A LOT #: XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
a454cd24-0c6d-46e8-b1e4-197388606175_465_3.jpg Sy 8€1980,VGLGS ;€ A | Usual Dosage: See product insert for full dosage information, prescribing information, precautions and warnings. Store at 20°C to 25°C (68°F-77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. DISPENSE WITH MEDICATION GUIDE Do not use if inner seal of bottle is broken or missing. Bulk Manufacturer NDC 0003-0894-21 Marketed by: Bristol-Myers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc New York, NY 10017 USA Product of Switzerland Distributed by: Cardinal Health Dublin, OH 43017 = T3 = 3 v == Em 5o — 22 @n % 3 o 2 WMS& £ S | — ] 2 g : : N B Ee 2F==3 £ N - 8 e = e e O o 8 - X ——— L) 5 m.m gw.mmm.mlc T s —— L.Wmmm.omm" g = WaEWn 5= 171920718 Lot No.: Exp. Date:
a4a6bb74-4633-41f5-a04d-de5a8a53a22b_326_1.jpg Clonazepam C-Iv 2 mg Tablet arv: 30 ID#:C;2 Expires: NDC #: 70518-1559-00 Shape: Round LOT #: Ref #: 16729-0138-16 MFG: Accord, Durham, NC 27703 RX ONLY Directions For Use: See Package Insert. Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
a4b188d4-f467-470c-ad7b-25ffbdd8862a_549_1.jpg [e1p es0g-olBuIS L = e 536761V onola o upoeres) 218454 YAVH3IX Eachvial provides 50mg NOCTITTO50.05 Rxonly sravacycling aquivalent t063.5 mg aravacycine divydrochloride. Inactive ingradiants: mannitl, e XERAVA RAVA o e, | leravacycine) fornection (eravacyelie] for injection Before raconstitution, 50 mg per vial i rafrigerate at 2°C to 8°C i ] s Praserton wusTeE wusrae Rt e s ReconsTITUTED RecoNsTITUTED until use. ‘THEN DILUTED. ‘THEN DILUTED. B miotits || Wrusesia i el S | oty St e Ses Frascion et Wiyt e e S ettt i e ) sl ! . Discard unused portion. 1 Single-Dose Vial 1 Single-Dose Vial e S N e Pt products should be inspacted I e e Ir | g3 verraguase, | w E3rernanyase, u
a4ddf68d-1502-4242-89aa-c96436bdcbf6_877_1.jpg NDC 45802-098-51 Mesalamine Rectal Suspension, USP Enema SHAKE WELL BEFORE USING ey i 8 e T Carbommer G347, edtate lSo0, potaESHT Scetae, potassium metablsulte. . puted water SodLem benzoate anC zarnan qum. Unit-Dose Eeere For Rectal Use Only o Pt oo Do Pttt o e . NOTE: rouet contts i cau sting o mst et ctatsuraces. St 025 077 LS9 Cotot o Terpets, xpercn crgna e ke pension, /60 mL 7 Pack . e 760 mL UNIT-DOSE BOTTLES Perrigo® =" Mesalamine Rectal Sus S © £ @ = o o @ =} 2 £ 3 2 z NDC45602-098-51 [F3i]
a5235fe4-ac6d-45a8-8917-0a607a848926_698_1.jpg Dicyclomine HCI 20 mg Tablet arv: 30 ID #: WATSON;795 Expires: NDC #: 70518-1596-00 Shape: Round LOT #: Ref #: 00591-0795-01 MFG: Watson PharmafActavis, Corona, CA 92880 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
a526ad73-d3c1-40b7-8e71-426b01cdea27_347_1.jpg Each mL Contains: clobazam ................... 2.5 mg See package insert for full prescribing information Store/dispense in original container in upright position. Discard 90 days after first opening. Store at 20 to 25°C (68" 10 77F) [see USP Controlled Room Temperature]. Shake the bottle well before each use. FOR ORAL ADMINISTRATION ONLY. Rev. 05-2017-00 1 NDC 69238-1535-2 Clobazam € = Oral Suspension =— FOR ORAL ADMINISTRATION ONLY. DISPENSE THE ENGLOSED MEDICATION GUIDE AND INSTRUCTIONS FOR USE WITH EACH PRESCRIPTION. Rx only 120 mL =i 69238 15352 2 amneal
a526ad73-d3c1-40b7-8e71-426b01cdea27_347_2.jpg p=TErETETL I I Non-Varnish Area | I | | for Lot No. & Exp date i NDC 69238-1535-2 ! i NDC 69238-1535-2 : | Clobazam @ ! Clobazam € | Clobazam @ ! Clobazam € Oral Suspension | Oral Suspension | Oral Suspension ;| Oral Suspension | ? : . (EE B0 25mg/mL M A | STORE AND DISPENSE ORAL | | SUSPENSION IN ORIGINAL CONTAINER | | IN AN UPRIGHT POSITION, : ! | Use within 90 days of first opening, | : ! Each mL Contains: ClODaZan .............26mg | "hen disoard any remainder. i i | ot e, | SSAATEETETGT - FOR ORAL ADMINISTRATION ONLY. | i :\A,Tuvaft::aa by: il | Shake the bottle well before each use. + DISPENSE THE ENCLOSED MEDICATION i neal Pharmaceuticals ' ' ' | Branchburg, NJ 08876 i For oraL AommisTRaToN oy, ¢ GUIDE AND INSTRUCTIONS FORUSE ¢ i e . . 1 WITH EACH PRESCRIPTION. : | Rev.05.2017-00 | This product is an oral suspension ! ; ! liquid and is supplied with two 10 mL | © oral syringes for administration. 6923815352 1 Rx only 120 mL 2 amneal®
a5594006-8e37-459e-8e85-7e2a83d7a57e_503_1.jpg =Rising® noc57237-099-60 Cefdinir Capsules, USP 60 Capsules Distributed by: Rising Health, LLC Saddle Brook, NJ 07663 Each capsule contains: 300 mg of cefdinir USP. Usual Dosage: See package insert for full prescribing Made in India information. Code: TSDRUGS/78/1996 o= Revised: 08/2018 © — Keep this and all drugs out of the reach of children. Store at 20° to 25°C (68° to 77°F) excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. 2040 Preserve in tight, light-resistant containers *Over printing Zone Coding Area @5x20mm) Dotied nes nt o beprited
a5741ef6-0599-4657-8cda-2902ded4f680_431_1.jpg sje|qeL wnipog ajeuocspueq| Lo comanty Ibandronate Sodium Tablets iy Ibandronate Sodium Tablets opzAREA X335 mm s 150 mg* W
a5741ef6-0599-4657-8cda-2902ded4f680_431_2.jpg 50 mm NoG ez 15001 O oty Ibandronate Sodium Tablets One 150 mg* Tablet Once- Moy Pk — R 3 e SRR, Sills sjo|qeL Wnipog o ajeuoupueq| one s A= o 150 mg* PHARMACISTS: DISPENSE INTACT THS AREA FOR PRESCRIPTION LABEL Instuctions or paning st Pack ww G°€Z X 0§ V34V ZdO »e ww 0g ww gz wwgyz
a5a3db93-de47-4685-9c20-dbf0ff30047a_925_1.jpg [XEIM 1nhalation Therapy Co. T Glifton, N, 07015 973-478-5100 IMABLE GAS, Compressed gas, oxidizing, n.o.s. (Carbon Dioxide, Oxygen) UN3156 Medical Gas Mixture 5% Carbon Dioxide, USP. cAS: 124.38-9 95% Oxygen, USP CAS: 7782-44-7 P e A T e 50 NOT REMOVETHS PRODUCT LABEL. Forodical Use rly. Lo #:AGL-8.0-25.4 0VZi16 Ver. 67 Latho ~voume: oL L sorL s W CLIFTON. N, 07015
a5cf7d9a-0014-44df-b6b9-d6f54f541bb7_599_1.jpg CLINICAL solutions WHOLESALE Risperidone 1mg Tablets NDC: 58118-0077-8 Qty:30 Mig. NDC: 68382-0114-14 GTIN: 0035611007788 Wi Lot - SAVPLE123 Batch SAMPLEAS6 MigBy: 2ydus Pharmaceuticals (USA) Inc. .00t 2019 Pennington, N, USA, 08534 SH: WMMDDOOD000 Resciod st Giteuted b it S sl LLC
a5cf7d9a-0014-44df-b6b9-d6f54f541bb7_599_2.jpg CLINICAL solutions Bt 5 WHOLESALE i Risperidone 2mg Tablets 1 NDC: 58118-0078-8 5§§ i o 0 o 11505 S cosorsoms 145 Mig. Lot #: SAMPLE123 Batch #: SAMPLE4S6 ,Eé Mg By: 2ydus Phamaceuticals (JSA) Bp: 002018 12 Pennington, N, USA, 08534 ay:30 EE : Repcia antor it b Cirict Sckos sl 1LC Sy o o B, G S P TSI A wons
a5cf7d9a-0014-44df-b6b9-d6f54f541bb7_599_3.jpg ; CLINICAL solutions 8 WL i Risperidone 3mg Tablets £ NDC: 58118-0080-8 ;;i i o G s 11505 Ermm— Mg, Lot #: SAMPLET23 S £SAMPLEASS 3 22 Mig. By: Zydus Pharmaceuticals (USA) Exp.: 0ct 2018 Penington, 3, USA. 08534 v & : oo antr it by il Sos ol LLC iy i o B, G S5 P TSI S wons
a5cf7d9a-0014-44df-b6b9-d6f54f541bb7_599_4.jpg v R CLINICAL solutions 2 WL i Risperidone 4mg Tablets 11t NDC: 56118-0081-8 ;;i T — !s’ o G s 01705 S comorsoure 185 Mg, Lot #: SAMPLET23 S £SAMPLEASS 3 22 Mig. By: Zydus Pharmaceuticals (USA) Exp.: 0ct 2018 e e o SN { iy i o B, G S5 P TSI S wons
a6bb4f0a-1555-4550-a7a4-99609674b1e7_105_1.jpg Paroxetine Tablets, USP (N T s 500 TABLETS R only “Each tablet cortaine Paroceine hydtochorde, USP. equaent o paroreine 10 mg. Usual Dosage: See package nsertfor complet prescriing nformaton. Store at 20° (0 25°C 68" 0 77°F) [See USP Contoled Room Temperature], Dispense i atgh, Iohtesisan cotainer Important:Use ety cosures when. dispensing s product nles otherise ireced by physcan o reauested by purchaser. KEEP THIS AND ALL THE DRUGS OUT ‘OF THE REAGH OF GHILDREN. Code No: HPIT204 Manufactured by: Cadll Heaircar Lt Badd Inda Distributed by: Zydus Phamizceuticals (USA)In. Pennington, NJ 08534 w0y
a6bb4f0a-1555-4550-a7a4-99609674b1e7_105_2.jpg QLA SO Paroxetine Tablets, USP EIfl < mm&msr PLEASE DISPENSE w\m VEDICATION GUIDE| 90 TABLETS s R only “Each tablet cortaine Paroeine pydtochorde, USP. equulent toparoxeine . 20mg Usual Dosage: See package nsertfor complet prescribng nformaton. Store a1 20° (0 25°C (68" 0 77°F) Se2 USP Contoled Room Temperature], Dispense i atgh, Ightesisant cotaincr Important: Use ety cosures when dispensing s product nles otherise direced by physician o reauesied by purchaser. KEEP THIS AND ALL THE DRUGS OUT ‘OF THE REAGH OF CHILDREN. Gode No: HPT204 Manufaciured by: Cadll Healhcars Lt Baddl, Inda Distributed by: Zydus Phamizceuticals (USA) In. Pennington, NJ 08534 1r0:70y
a6bb4f0a-1555-4550-a7a4-99609674b1e7_105_3.jpg I O — OO E— o — fe—1 N \oi— \Om— o= 68382-099-10 Paroxetine Tablets, USP EL » PHARMACIST. PLEASE DISPENSE WITH MEDICATION GUIDE 1,000 TABLETS Rx only “Each tabet contains Paroxetine hydrochiorice, USP equivalent o paroxetie .. 30 mg Usual Dosage: See package insert for ‘complete prescrbing information. Store at 20° 0 25°C (66° 10 77°F) [See USP Controled Room Temperature], Dispense in a ight, lght resistant container. Important : Use sty closures when dispensing this product unless otherwise directed by physician orrequested by purchaser KEEP THIS AND ALL THE DRUGS OUT ‘OF THE REACH OF CHILDREN, Code No: HPI72/04 Manufactured by: Cadila Healthcare Ltd, Baddi, India Distributed by Zydus Pharmaceuticals (USA) Inc. Penningon, NJ 08534 Liwoney LizR0r
a6bb4f0a-1555-4550-a7a4-99609674b1e7_105_4.jpg Qe R Paroxetine Tablets, USP 7 | | | | | | | | | | | i | * | et RS | ) | | | FUECST AESE TSRO | AEDGHTON Qe | | | | | | e 30 TABLETS s Rxonly “Each tablet cortaine Parotetne pydtochorde, USP. equualent o paroxeine 40 mg Usual Dosage: See package nsertfor comletsprescrbing nformaton. Storeat 20° (0 25°C 68" 0 77°F) See USP Contoled Room Temperature], Dispense i atgh, Ightesisant coaincr Important: Use saely cosures when dispensing s product unles otheise direced by physcan o reauested by purchaser. KEEP THIS AND ALL THE DRUGS OUT OF THE REAGH OF CHILDREN. Gode No: HPIT204 7 Manufactured by: 2 Cadll Healhcare it 824 nda = Distributed by: e Zydus Phamizceuticals (USA)Inc. Pennington, NJ 08534
a74239bf-4684-424c-ba4e-6087e363265b_843_1.jpg - NDC 55154-6892-0 Y 1 O 9 AMLODIPINE BESYLATE TABLETS, USP 5mg* 10 TABLETS *Eaoh tablet contains: Amiodipine besylate, USP equivalent to amiodipine 5 mg Usual Dosage: See product insert for complets prescribing information, precautions and warnings. SEE INSERT/LEAFLET FOUND AT WWW.MAJORPHARMACEUTICALS,COM STORAGE: Store at 20° to 25° C (68° to 77° F) [See USP - Controlled Room Temperature]. = Protect from ight Dispense in tight, light-resistant container. RX ONLY WARNING: This Unit Dose package Is not chid resistant and is Intended for Insitutional Use Only. Keep this and all drugs out of the reoh of children. PHARMACIST. DISPENSE WITH PATIENT INFORMATION LEAFLET Manufactured by. Distributed by. Cadila Healthoare Ltd. Zydus Pharmaceuticals USA Inc. india Pennington, NJ 08534 Distributed by. MAJOR® PHARMACEUTICALS 17477 N Laurel Park Dr., Sufe 233 Livonia, MI 48152 USA Distriouted by Cardinal Health Dublin, OH 43017 150532650218 LOT #: XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
a74239bf-4684-424c-ba4e-6087e363265b_843_2.jpg " *F87 NDC 55154-6875-0 AMLODIPINE BESYLATE TABLETS, USP 10 mg* 10 TABLETS “Each tablet cantains: Amlodipine besylate, USP equivalent to amlodipine 10 mg Usual Dosage: See product insert for complete prescribing information, precautions and warnings. SEE INSERT/LEAFLET FOUND AT WWW.MAJORPHARMACEUTICALS.COM STORAGE: Store at 20° to 25° C (88° to 77° F) [See USP - Controlled Room Temperature. Protect from light, RX ONLY WARNING: This Unit Dose package Is not chid resistant and is Intended for Insttutional Use Only. Keep this and all drugs out of the reach of children. Dispense in tight,light-resistant container. PHARMACIST: DISPENSE WITH PATIENT INFORMATION LEAFLET Manfactured by Distrbuted by. Cadia Heatheare Ltd, Zydus Pharmaceuicels USA Inc india Pennington, NJ 08534 Distributed by, MAJOR® PHARMACEUTICALS 47177 N Laurel Park Dr., Suite 233 Livonia, Mi 48152 USA Distributed by Cardinal Health Dublin, OH 43017 148669660218 LOT #: XXXXXXXXXX ~EXP. DATE: XX/XX/XX
a761feea-86b6-44f0-8f9a-50d29ebb60e9_75_1.jpg NDC 42192-144-16 Sodium Sulfacetamide 9% - Sulfur 4'5% Wash In a vehicle containing Green Tea and Aloe Rx Only Net weight 16 oz Acella PHARMACEUTICALS, LLC Indicatons:Fr e opcal conol o ace vigas s 0528 19 sebonte TS Diretons: foly S Sufaccanice % - Sur 4% Washance o icoa oy i T S el ) e s ot e B o SHlor 1o A soconds: woriag 1t e v ougty and Gy s eyt ol by s of Sk S 6 T r i . o o et o o ‘Wamings: Forsxera e ol Avidcoctach wihees. KEEP OUT OF REACH OF CHILDREN, Koep bl Uy cloed ‘Contraindications: Sodum Sufacsanidy % -Sul 45% Wash s containgidad o s g o et o Sl s ey cOmponet o s pregaaion Sodm Sulaslamids 5 - Sl 5% Besh s 1o et b alns it Ky Gsese. Ingredients: Ech gramof Sodum Sufictaide % - Sl 45% Wsh onans 0 Mg of st sulctamis a4 g of sl na orrton conaning uried wat, ot cocry s, magresi aginum i, Gsodu deaTido MEA sulsucinat,sodum ey cocyi v, o s (and) PEG-100 sart, sy alcol, byl acao, ety parabn, proy| paraen, buyaed oo, ranten gum, sodiur iosulde, e s o, s vz, o EDTA, 2 faganc. Sloreal 20 19 259 (65 1 7°F), excursions et tevesn 15°C and 3°0 bz o and 56, rc ot foeing Sofum Sulaoeiide 5% - Sufur 45% Wash s supliedn 218 o et (NDC BTG PG namoet o xpratin e s bt of bt Alrecipion bt or ormepitnusig s prode e et oSl and ) S pplcate NOTE: This s not an Orange Book product.No representalion is made s o generi satus or biaegvalency.Pese s pckags et o ore HfITaion ! llm 5 Manutsctured for: dosla Pamaceess, LG pfeta, GR30022 TR0 541 482 e 0113
a7c093c2-3eef-4956-8a14-c36aada0304f_53_1.jpg NDC 68180-410-06 Usual Dosage: See package insert for prescribing Irbesartan iomaion. Storage: Store at 25°C_(77°F); excursions Tablets USP remitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. 3> Manufactured for Manufactured by: Each tablet contains Lupin Pharmaceuticals, Inc. ~ Lupin Limited irbesartan USP 75 mg. Saltimore, Maryland 21202 Pithampur (4,8) 454 775 Em—mt oy United Sates INDIA 30Tablets code No. 221143 LUPIN
a7c093c2-3eef-4956-8a14-c36aada0304f_53_2.jpg NDC 68180-411-06 ] Usual Dosage: See package insert for prescribing Irbesartan infomaton. . £ Storage: Store al 25°C_(77°F); excursions £ Tablets USP remitted to 15° to 30°C (59° to 86°F) [see USP S Controlled Room Temperature]. * Manufactured for: Manufactured by: Each tablet contains. Lupin Pharmaceuticals, Inc. Lupin Limited irbesartan USP 150 mg. Baltimore, Maryland 21202 Pithampur (V,p) 454 775 S ! sy Urited States INDIA g Topi 30Tablets coce No. 2211445 5 &
a7c093c2-3eef-4956-8a14-c36aada0304f_53_3.jpg NDC 68180-412-06 Irbesartan Tablets USP €D Each tablet contains irbesartan USP 300 mg. Rx only LUPIN 30Tablets Usual Dosage: See package insert for prescribing information. Storage: Store at 25°C (77°F); excursions permitted to 15°to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States 11x28 mm Manufactured by: Lupin Limited Pithampur (M.£) 454 775 = 3 INDIA I = Code No. & 5 &
a7f0801c-96de-4d28-b221-627372f2bebd_838_1.jpg NAPROKEN TS TABLETS —— o T o s TAKE1TABLET THGE A DAY ORAS DRECTED.
a7f0801c-96de-4d28-b221-627372f2bebd_838_2.jpg e T —— GaraEn e W R O B B THE TRBLET 300 ] EmED e ot " ey “TWICE A DAY 7 § l - — = 5 ORASDRECTED. B L e ST cmeosm T Dy ERERL e i, i i i B 1
a7f0801c-96de-4d28-b221-627372f2bebd_838_3.jpg e Raow APROGN ZOUSTASLETS ——— i s AT 53 TAKE1 TABLET23 THESADAYOR ASDRECTED. S pE e LI e wecmme s B Coctene e
a8c46363-f739-4f6e-bca8-1ce5e8d3f78d_650_1.jpg eipulJo pNpoig Ajuo xy “UIDIIYD J0 U2E1 §0INO UOIEDIPAL 2 PUE SILp 3oy “UonewsojuI BuIquasaId BuiAuedwWODIE 35 ‘UoeWI0}u) 8esOp 03 oot S0 ‘2j0zEpuaGaU 'SUIEI03 121921 Pe3 SN 1eigE) SlgemaLR (elozepusqeLL) JUIDAWT 0£-699-96879 2AN NDC 64896-669-30 w 20" and 25°C Emverm® 68°and 77°F (mebendazole) chewable tablet, USP 100 mg Each tablet contains: mebendazole, USP 100mg For dosage information, see accompanying prescribing information. Keep this and all medication out of reach of children. Rx only ‘This carton contains one e e 2£98%2d
a91f119c-9765-4a6f-b636-4470d11dc3d2_331_1.jpg _ Buy dSN ‘5391981 UOOSINIUAIAON o 6300100501 MethylPREDNISolone Tablets, USP Bui y d4sn sepqeL 2uojoSINGI¥IAHIN ®@BluePoint 21 Tablets LABORATORIES Unit of Use 1050010089 20N i Bu p 4sn 9leL SuojosINGIIAIN foimessduay wooy| “uepshid 0 Uonenisgo 50p. 45 ‘Soeiosupa A 10 Bl ulewies 1
a91f119c-9765-4a6f-b636-4470d11dc3d2_331_2.jpg Dosage Directions 1stday To remove tablet, press from this side Take 2 tablets before breakfast, 1 tablet after lunch and supper, and 2 tablets at bedtime. 2nd day Take 1 tablet before breakfast, 1 tablet after lunch and supper, and 2 tablets at bedtime. 3rd day Take 1 tablet before breakfast and 1 tablet after lunch, after supper, and at bedtime. 4th da % Unless i otherwise Take 1 tablet before breakfast, after lunch, and at bedtime. directed by your physician, all six (6) tablets 5th day in the row labeled 1st Take 1 tablet before breakfast and at bedtime. 6th day Take 1 tablet before breakfast. day should be taken the day you receive your prescription, even though you may not receive it until late in the day. All six (6) tablets may be taken immediately as a single dose, or may be divided into two or three doses and taken at intervals between the time you receive the medicine and your regular bedtime. 21Tablets Methylprednisolone Tablets, USP 4mg Unit of Use
a91f119c-9765-4a6f-b636-4470d11dc3d2_331_3.jpg Methylprednisolone Tablets, USP 4 mg Unit of Use 21 Tablets Rx only AINVLSISIY dTIHD 1ON IDWIDVd
aa0815bb-8916-4c2c-9201-b04eb78e91fa_323_1.jpg 0.25mg DosagesSes accoprying prescting Hormaton. U NovaRTIS i/ e AON Q bw 520 r sajnsden) (easjodo)) | NLLWYDAH (‘toporecan Capsules 0.25mg T it U NovARTIS
aa0815bb-8916-4c2c-9201-b04eb78e91fa_323_2.jpg 0.25mg DosagesSes accoprying prescting Hormaton. U NovaRTIS i/ e AON Q bw 520 r sajnsden) (easjodo)) | NLLWYDAH (‘toporecan Capsules 0.25mg T it U NovARTIS
aa13261f-46a7-4381-8084-b3ad46221e2f_305_1.jpg BLUE NDC: 43063-855-30 W — PD'RX A PHARMACEUTICALS | & — WARNINGEREEP THISIOUTIOF-THE REACHIDFICHILDREN® |IINCORPORATED"/ & mmm e R A R O et a Al A AL AR | Okiahioma City, 0K » 73127 == 43063-855-30 43063-855 30 43063-855-30 = SERTRALINE SERTRALINE SERTRALINE & — HCL USP HCL USP HCLUSP g SERTRALI NE = 50 MG 50 MG 50 MG = — 30 TABLETS 30 TABLETS 30 TABLETS E HCL USP = ReOrder # 110540 ReOrder # 110540 ReOrder 4 110540 E & = Lot 118868 Lot 118868 LoT 118868 & - EXP D5/20 Exp 05/20 3% 05/20 g SIR\Y(€ % g g < m o CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g £3ER YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 i 30 TAB LETS S § 2 = Zc TAKE TA BLET(S) TIMES A DAY. g (01) 1034306385530 >E>§ TOME TABLTA(S) _VECES AL DIA. g (21)118868000002 5 Each TABLET Contains: SERTRALINE HYDROCHLORIDE g USP EGUIVALENT TO = (17) 200531 SERTRALINE 50 MG 9 (1018868
aa3d32ae-3b44-e77b-6c9c-b07b6ac1ff64_456_1.jpg AVKARE. NDC 42291.833.90 TraZODONE HYDROCHLORIDE Tablets USP 90 Tablets Rx Only PHARMACIST:
aa3d32ae-3b44-e77b-6c9c-b07b6ac1ff64_456_2.jpg AVKARE. NDC 42291.93410 TraZODONE HYDROCHLORIDE Tablets USP 1000 Tablets: RxOnly i e G16P)
aa3d32ae-3b44-e77b-6c9c-b07b6ac1ff64_456_3.jpg Noc: TraZODONE HYDROCHLORIDE ;: Tablets USP 1000 Tablets RxOnly.
aa3d32ae-3b44-e77b-6c9c-b07b6ac1ff64_456_4.jpg € 109€8 Léz2y £ ... ; w " ui 5 e 2ES% g < 227 X:@ 083 3 3 3823 : 2 a8 : HYI
aa88f583-4f5f-433b-80b4-1f4c9fb28357_261_1.jpg v meliEE ] TR o Ty [EER R P T T (uonoalul eyeleoe Jeueield) 0y ANOXWVdOD "= BT T 30 Singl-Dose Pre-illed Syinges Exh el i s 1L COPAKTNES slen P iy ety i) I o[0TV (o] N @ (glatiramer acetate injection) FOR SUBCUTANEOUS INJECTION ONLY ONCE DALY COPAXONE (glatiramer acetate injection) [ T
aa88f583-4f5f-433b-80b4-1f4c9fb28357_261_2.jpg L 30 Singlo-Dose Pre-Filed Syringes D vy recaisseu Jup iy =) ‘ONCE DAILY COPAXONE mg/ml copﬂﬂBNE (glatiramer acetate injection) P T (gltiamer acetate jection) T T T ] RS A e P
aa88f583-4f5f-433b-80b4-1f4c9fb28357_261_3.jpg dopisn s by ok v e r—— studpop ayosog oS 1 — ez s {—\ \ —I ] 125l Dosoro Fled e hn-:-ln-m &‘_:AXONE ‘acetate jecton) 1on st macTom ooy SR . Py o i - = ‘-l)n'n-av 3 ., s
aa88f583-4f5f-433b-80b4-1f4c9fb28357_261_4.jpg s 125 gl osoProfilldSyinges mSerpomim e SRR ST
aa88f583-4f5f-433b-80b4-1f4c9fb28357_47_1.jpg v meliEE ] TR o Ty [EER R P T T (uonoalul eyeleoe Jeueield) 0y ANOXWVdOD "= BT T 30 Singl-Dose Pre-illed Syinges Exh el i s 1L COPAKTNES slen P iy ety i) I o[0TV (o] N @ (glatiramer acetate injection) FOR SUBCUTANEOUS INJECTION ONLY ONCE DALY COPAXONE (glatiramer acetate injection) [ T
aa88f583-4f5f-433b-80b4-1f4c9fb28357_47_2.jpg L 30 Singlo-Dose Pre-Filed Syringes D vy recaisseu Jup iy =) ‘ONCE DAILY COPAXONE mg/ml copﬂﬂBNE (glatiramer acetate injection) P T (gltiamer acetate jection) T T T ] RS A e P
aa88f583-4f5f-433b-80b4-1f4c9fb28357_47_3.jpg dopisn s by ok v e r—— studpop ayosog oS 1 — ez s {—\ \ —I ] 125l Dosoro Fled e hn-:-ln-m &‘_:AXONE ‘acetate jecton) 1on st macTom ooy SR . Py o i - = ‘-l)n'n-av 3 ., s
aa88f583-4f5f-433b-80b4-1f4c9fb28357_47_4.jpg s 125 gl osoProfilldSyinges mSerpomim e SRR ST
aaf0eb2a-f88a-4f26-a445-0fd30176c326_342_1.jpg i usEs v o a1 st e doy S m s i 181wy et wojn oy o w s e oD 03 451 951 L1 4691061 3 0.2 % o5 asunavLET ¥om m i ey oy 23 >.0460 e 3 g s une s BN om0 N0 9UBAE A RUADS T RO ey YR e D3 ) ) L N O NI B8 Do 5 & 8 e N 53 s BT B L AR D B AR g aeve 1 @"W? Lltta o Is2ng Usualdose: Soe package insert NDC 0073-5858.01 Rxonly Liletta (levonorgestrel-releasing intrauterine system) 52 mg Insert LILETTA no later than the expiration datsprintsd on this carton. Li % Each carton contains one sterile uritof LLETTA (levonorgestrol releasing iletta inrauterine system) 52 mg, Physician Labeling, and one Patient Information Iboppteb ek e negeei 2y Booklet containing a Consent Form and Follow-Up Reminder Card
ab55383f-1a58-4758-87e0-83b316215e7a_328_1.jpg i usEs v o a1 st e doy S m s i 181wy et wojn oy o w s e oD 03 451 951 L1 4691061 3 0.2 % o5 asunavLET ¥om m i ey oy 23 >.0460 e 3 g s une s BN om0 N0 9UBAE A RUADS T RO ey YR e D3 ) ) L N O NI B8 Do 5 & 8 e N 53 s BT B L AR D B AR g aeve 1 @"W? Lltta o Is2ng Usualdose: Soe package insert NDC 0073-5858.01 Rxonly Liletta (levonorgestrel-releasing intrauterine system) 52 mg Insert LILETTA no later than the expiration datsprintsd on this carton. Li % Each carton contains one sterile uritof LLETTA (levonorgestrol releasing iletta inrauterine system) 52 mg, Physician Labeling, and one Patient Information Iboppteb ek e negeei 2y Booklet containing a Consent Form and Follow-Up Reminder Card
ab55383f-1a58-4758-87e0-83b316215e7a_328_2.jpg DESCRIPTION NOC 0577253037 O 4001493 2 : Fochtablet cotains ethylphenide hydiochbiide, USP 10 mg. M elhyl phenid ate USUAL DOSAGE: Se ochog il Hydrochlorid s PHARMACIST: Dgerse no figh, I ydrochioride IT ==o et contaner s defed i e (5P wih Tablets, USP —_— achidsan dhsve. = St 3 0250 s m == E;!ﬂ'fp o o], AModeaon Gl rerd o sy pscon o, I e out o e reach of . Pl e compangghecition Gue. —n Sl B Oily 2 nneft Company, Inc. il 1015 100TAREE o 1 L6797 Rev_06/18
ab55383f-1a58-4758-87e0-83b316215e7a_328_3.jpg DESCRIPTION: Eoch bkt contoins ethyphens hdochoics, U520 mo. USUAL DOSAGE: o prkogecc. PHARMAGST: Dijence ino fight g resitan cortaie as defned i the USP with achitesistont chsue. Store ot 20°- 25°C B&‘l"— TI°R: sursions ermitted fo 15° 30°C (59°- 86°F r{ﬁee USPCoirolls Pogn Fnperturel. eep out of the reach of cildren. Dbt by et Ccmpony, I Piiehin, P 1154 NC 0527- 253237 Methylphenidate Hydrochloride == Tablets, UsP L. = Adbedeation Guds s requived fr every prescipon disersed. Pl e accompanying Weion Gude. ROy 100 TABLETS ™ ™~ M N M n ~N ~ N n o ™) 4001493 @ L6798 Rey_06/18 "
ab6349b2-682d-4a4f-90cb-31dff90fea85_795_1.jpg nan
ab6349b2-682d-4a4f-90cb-31dff90fea85_795_2.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED Liouip usp UN1073 WARNG: For emryscy s ey s s by oy s ot e i .o 3 ot i R trigs it ot of e o 3 o it ot oo e on g e b v e Rt B ot et 0 s wo b s iy s it o o i s o 54 s oo s o oo e o e U9y b g 3y i e e o O st ot Prcedy e Uacion. OANGER: MAY LS R NTEASEY . SR, ENANSRGGETD G CAECRYOROUC RS ORBARY COUBLSTES CONACT Wk L00D GRYGeN MY SEADDK OF TN 8 et ot o iy s e o st K s vy o e e e i Ko s s o g Lo s oy s i ki ot 5 st g, s o, o Incan o St ok oG5 Uk o vt bt b U oy W st ot s o corinion v i e o s, sy s ces o g e 00T ot o 5O vk o1 o e ot 58 o e st s v sy Ry e o g rson e o B oty O S (19 el 1. FIRSTAID: 1 OF S Thw st e s Dt s G o s s st s DO NOT REMOVE TS PRODUCT LASEL MABSCOTT SUPPLY COMPANY 140 WHITESTICK ST. » MABSCOTT, Wy 25871 3042527305 s @ns)
ab6349b2-682d-4a4f-90cb-31dff90fea85_795_3.jpg T T OXYGEN, REFRIGERATED Liguin usp UN1073 WARNIG: For sy s o vhn s by ety Vs e o e s e o For 8 e o . ittt s of o g i o Rkt o e 27 S,y R Dt et s n s e s S s i n oo e g, e o4 4 o o s ot s o b g o 59 ot o 2 v e 0 S e e G o K Procady Ar Lqwcion ORIGER: 1 CALSE R TS PR 00D CONTAIS EFREGRATED IS, A CAECALGENC U R IARY COMBLETRLES EINDT Wk LGUD GIYGo MY DAGGE O GHTHN G it Dot ot e cins o e s et s vy g s o e, o s et i e o o et s i e Ve 0 i e, 4 e o e e Sk ke ko et e B . L ) O e ol o o e o ey W e cee oG e 00T e 4t & oo e 5 Utk on o o Do e e 0w gy v o o & o . s o o P S 13 St 519 e FRSTAD: O S0 o o b s e s 0NOT REMOVE TH PRODUCT LSEL MABSCOTT SUPPLY COMPANY 420015 AVE, SUTE 208 + NITRO, WV 25143 04755365 - s
abb9570f-3866-4f6c-befc-2ca9f1f0902b_443_1.jpg 01G9€ 26leh. € | Mnscured o ScesFhamacauical LC Apharea GA 0022 frrtoty fevons e Eo b Each film-coated tablet cont; SALSALATE. s00mg Inactive Ingredients: Hydroxpropyimetiy Celllose, Wagnesiu Stearate, Wicrocrysaline Cellose, Fobethyiene Giyeol Dispense contens ith a child-esistan closure (as requied) and i a tight containeras defined i the UsP. KEEP OUT OF REACH OF CHILDREN. Store at 15° - 30°C (59°- 86°F)[see UsP]. All prescription substitutons andior ecommendations using ths product shll be made subject t0state and el sttutes s applicable NOTE: This is not an Orange Book product. No representation is made as to generic status or bioequivalency. See package nset for o detal. NDC 42192-365-10 QLG 100 tablets Acella PHARMACELTALS, 1LC
abb9570f-3866-4f6c-befc-2ca9f1f0902b_443_2.jpg [ — ScasPhamacautcal UC Apharea GA 0022 onoisr R e £o Do Each film-coated tablet contains: SALSALATE, 750mg Inactive Ingredients: Hydraxpropyimetin Cellulose, Wagnesiu Stearate, Microcrysaline Cellose, Folethylene Giyeol Dispense contentswith achild-resistant cloure (as requied) and ina tiht container as defined in the UsP. KEEP OUT OF REACH OF CHILDREN. Store at 15 30°C (59°- 86°F)[see UsP], Al prescrptionsubstitutionsandior ecommendations Lsing i roccshll be made ubjct 0 st and {edee st s applestie NOTE-This i ot an Grange Book product.No representation s made 3 to generic status o bioequvalency. St package mert fof more detai. NDC 42192-366-10 750 MG LN Reorly 100 tablets Acella PrARMACEUTEALS, 116
ac6c19c2-db32-45a3-8a34-a5f459640935_88_1.jpg CLINICAL solutions WHROLESALE Metronidazole 500mg Tablets Qty: 30 Mg, NOC: 29300-0227-01 ‘GTI: 0035118052788 Wi Lot i SAVPLE123 Batch SAMPLEAS6 Mig_By: Unichem Pharmaceuticals (USA), .00t 2019 Hasbrouck Heighs, N USA, 07604 SH: WMMDDOOD000 Ty ey P e, . 51 P TNSRSTUSA maTonsairs
ac897a5a-677b-4a6e-abb1-b810470200fc_674_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALER INESS. TIZANIDINE TABLETS ARE NOT INTERCHANGEABLE WITH TIZANIDINE CAPSULES. i ”R : | WABNINGEREER THIS OUT OF THE REACH DB CHILDREN! e AL STORAGE: SEE PACKAGE INSERT : RS 43063-455-30 43063-455-30 tiZANidine tiZANidine uUsp use 4 MG 4 MG 30 TABLETS 30 TABLETS ReOrder # 108879 ReOrder # 108879 LOT Jjiscss LOT J18C85 EXP 10/20 EXP 10/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: 4576 MG TIZANIDINE HYDROCHLORIDE USP EQUIVALENT TON NS TITARNININT nACT TU U LAl L baLl WHITE 43063-455-30 liZANidine usp 4 MG 30 TABLETS ReOrder # 108873 LoT 118C85 EXP 10/20 ORGANOLEPTIC MARKINGS: R 180 A DAY. O\ AL/Q-5CET SCR NDC: 43063-455-30 | PHARMACEUTICALS 4 Oklahoma City, OK = 73127 tiZANidine UsP R\V/[€] 30 TABLETS ..,':,.. (01)10343063455302 (21)118C85000001 {17)201031 K (10)ii6065 TOEESPEIOEVE 00 00 A STOBTOTITES VIONI 60% ZES WYTNAYAINS Q3LIWN '8Y1 5,A0034 "¥a
ac976282-fb68-4db0-912a-28f075b0716c_263_1.jpg Mirtazapine NOC'# £3353.0378.15 Mirtazapine 30mg 15 Tablets Mitazaping 30mg 15 Tablets
aca7768e-28a7-4027-b1d8-e66247665f79_683_1.jpg @etroﬁde* 0.25 mg (cetrorelix acetate for injection) — Sterile - for subcutaneous use only Rx only Store refrigerated, 2-8°C (36-46°F). One carton contains one packaged tray which contains: 1 vial with lyophilized powder for reconstitution 1 pre-filled syringe with diluent 1 20-gauge needle 1 27-gauge needle NDC 42087-1225-1 §&R8no
acaef5a6-b740-40e3-8ffe-74a75c74745c_361_1.jpg |<— 2.0625” —>| |<-.125” NDC 50633-210-11 Voraxaze® (Glucarpidase) For Injection JUal Ty
acaef5a6-b740-40e3-8ffe-74a75c74745c_361_2.jpg LL6G J ll [CETETTT 900 SUz00 SRy 9BZBXRIOA (TD1z-6c905 0N A ebis a3031 St packagersu for dusagsand o rlomatin single Vial NOC 50633-210-11 Eachvial f Voarare® conilng Voraxaze® Voraxaze® Voraxaze® 1000 Une ol gusapis, iose i) Gueapisy Guearss ‘monohydrate (10 mg), Tris-HCI Injecton Fot bection (@) and e ot o oz, 000 Uil o o, L Mo ULS. Standard of Potency. Package contains one vial R . Package contains one vial 1000 Units/vial RO Verutacted by N gl use v, o b et win 1 1L O erisad parion. | 0% Sooom Cherie jcicn Brertnood TN 37027 F Tk B o et US.Liense . 1851 vomues: @ DTG nemaonal 6. 5T Store w312 0 °C 5610 46°) Wt Corshabacken. P 19178 Do et oe 0 . Lot 000000 swoion Bony Ear Principal Rt . 212 Display Panel gi <[ oo foveeraf 7 [ o] IR 30 Pocnt s . ] o st | o e e ot sy
acc05043-acbd-4b7b-bb4a-8fb9e05cb3ed_940_1.jpg Packaged by Evyant Ranch Berbank. @A 91504 Enalapril/ HCTZ G ¥ (oo 10/25mg Tablet 10 ;ause dizziness or drow: Keep all drugs out of Compare To: reach of children. Veseretc 1025mg Tabket 98Y021 Store at room temp of GaW Laboraores nc 20°25°C (68°-77°F) #30 Exp: MMYY NDC 7133508701 032171120486 om
ace9a43b-f9bd-4896-abfe-0ef4fec67ddf_466_1.jpg ) p/6w 0oL uonasfu| (1oH sunsnwepuaq) VYX3dN3g < Auo xy 0-8v€-65v29 JAN Cytotoxic Agent-Use caution during handling and preparation. Use of gloves and safety glasses is recommended to avoid exposure. See package insert for details. 3 63459-348-04 o NDC 63459-348-04 Rx Only Sterile Multi-Dose Vial © BENDEKA (bendamustine HCI) Injection ETZE (25 mg/mL For Intravenous Infusion Only Must be diluted prior to administration. Distributed By: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454 T Product of India GUJ/DRUGS/G/28/1304 Store in refrigerator, 2° to 8°C (36° to 46°F). Retain in original carton until time of use to protect from light. Usual Dosage: See package insert for dosing and dilution information. Each mL contains 25 mg bendamustine hydrochloride, 0.1 mL propylene glycol, USP, 5 mg monothioglycerol, NF in polyethylene glycol 400, NF. Sodium hydroxide, NF to adjust pH of polyethylene glycol 400. Iss. 11/2015 E03C01/3-01 L NDC 63459-348-04 Rx Only Sterile Multi-Dose Vial © BENDEKA (bendamustine HCI) Injection TR L (25 mg/m For Intravenous Infusion Only Must be diluted prior to administration. Unvarnished Area LotExp Unvarnished Area
ace9a43b-f9bd-4896-abfe-0ef4fec67ddf_466_2.jpg (/NG 63459-348-04 Mufi-Dose Vial Store in rfrigerator, 2° 0 8°C Sterile Rx Only (36° to 46°F). Retain in original s BENDEKA carton until time of use to protect 2 g e from light. See package insert for 5 (bendamustine HCI) Injection dosing and dilution information. E Distributed By: 3 LA Teva Pharmacouticals USA, Inc. 3 (25 mg/mL) North Wales, PA 19454 8 Must be diluted prior to administration. Product of India \ For Intravenous Infusion Only GUJ/DRUGS/G/28/1304 % q0mm Aseptically withdraw the volume needed for the required Hi dose based on 25 mg/mL concentration as per Table A NGE | (see package insert) and immediately transfer to a N0 copy 50 mL infusion bag (see package insert). Do not use if area solid or particulate matter is observed. = BENDEKA™ (bendamustine HCI) Injection 10 mm 100 mg/4 mL (25 mg/mL) i CAUTION: Concentrate Solution — 25 mg/mL no copy Must be diluted prior to administration area (see package insert for instructions)
ace9a43b-f9bd-4896-abfe-0ef4fec67ddf_466_3.jpg Cytotoxic Agent-Use caution during handling and preparation. Use of gloves and safety glasses is recommended to avoid exposure. (RUTITE7A) N ZLITT uonoefu] (1o aupsnuepusq) Y)3dN3g 9 Huo xy 0-8v€-657€9 JAN NDC 63459-348-04 Rx Only Sterile Multi-Dose Vial Store in refrigerator, 2° to 8°C (36° to 46°F). Retain in original carton until time of use to protect NDC 63459-348-04 Rx Only Multi-Dose Vial . from light. b B E N DEKA Usual Dosage: See package insert (bendamustine HCI) for dosing and dilution © BENDEKA (bendamustine HCI) Injection LTz (b 0T For Intravenous Infusion Only Must be diluted prior to administration. See package insert for details. 0.1 mL propylene glycol, USP, 5 mg monothioglycerol, NF in Must be diluted prior to REV. 3/2018 administration. 06USA101 Injection information. _ Each mL contains 25 mg 100 mg/4 T polyethylene glycol 400, NF, Sodium hydroxide, NF to adjust pH “l“ll || |‘ ‘l ||H‘ Distributed By: Teva Phamaceuticals USA, I N North Wale, A oa5a 7D bendamustine hydrochloride, For Intravenous Infusion Only of polyethylene glycol 400. 3 63459-348-04 o Product of ltaly Lot. F117C006 Exp. 02/2019
ace9a43b-f9bd-4896-abfe-0ef4fec67ddf_466_4.jpg NDC 63459-348-04 Multi-Dose Vial ~ Store in refrigerator, 2° to 8°C Sterile Rx Only (36° to 46°F). Retain in original B E N DEKA carton until time of use to protect . o from light. See package insert for (bendamustine HCI) Injection dosing and dilution information. 100 mgM mL Distributed By: et Teva Pharmaceuticals USA, Inc. Must be diluted prior to administration. North Wales, PA 19454 For Intravenous Infusion Only Product of Italy Rev. 3/2018 (01)00363459348049 06USE101 Aseptically withdraw the volume needed for the required dose based on 25 mg/mL concentration as per Table A (see package insert) and immediately transfer to a 50 mL infusion bag (see package insert). Do not use if solid or particulate matter is observed. BENDEKA® (bendamustine HCI) Injection 100 mg/4 mL (25 mg/mL) CAUTION: Concentrate Solution — 25 mg/mL Must be diluted prior to administration (see package insert for instructions) LOT. F117C006 D WPIPI ]
ad0c3dc9-ae13-4853-bc8c-a66e2a69cc10_387_1.jpg NDC 63459-348-04 Multi-Dose Vial ~ Store in refrigerator, 2° to 8°C Sterile Rx Only (36° to 46°F). Retain in original B E N DEKA carton until time of use to protect . o from light. See package insert for (bendamustine HCI) Injection dosing and dilution information. 100 mgM mL Distributed By: et Teva Pharmaceuticals USA, Inc. Must be diluted prior to administration. North Wales, PA 19454 For Intravenous Infusion Only Product of Italy Rev. 3/2018 (01)00363459348049 06USE101 Aseptically withdraw the volume needed for the required dose based on 25 mg/mL concentration as per Table A (see package insert) and immediately transfer to a 50 mL infusion bag (see package insert). Do not use if solid or particulate matter is observed. BENDEKA® (bendamustine HCI) Injection 100 mg/4 mL (25 mg/mL) CAUTION: Concentrate Solution — 25 mg/mL Must be diluted prior to administration (see package insert for instructions) LOT. F117C006 D WPIPI ]
ad20e6ff-98bc-47e6-aa00-7fb441edd2b0_72_1.jpg Coagulation Factor X (Human) Coagadex Storage: * Store between 36°F - 86°F (2°C - 30°C). * Do not freeze. * Keep the vial in the outer carton to protect from light. IR 84208-7762-1 PRNUS2C NDC: 64208-7752-1 Coagulation Factor X (Human) Coagadéx LYOPHILIZED POWDER FOR SOLUTION FOR INJECTION FOR INTRAVENOUS USE ONLY Rx ONLY x3pebeor) (uewnH) X 101084 uone|nbeod T A Coagulation Factor X (Human) Coagadex * Dosage and administration - read enclosed package insert. Use within one hour of reconstitution/dissolving. * This product contains no preservatives. Not made with natural rubber latex. The product carton contains: 1 Vial Coagadex® 250 IU Range 1 Transfer Device (Mix2Vial™) 1 Vial of 2.5 mL Sterile Water for Injection 1 Package Insert 'When reconstituted with Sterile Water for Injection, Coagadex® contains nominally (approximately) 100 IU/mL coagulation Factor X and the following inactive ingredients: chloride, phosphate, citrate, sucrose and sodium. Coagadex* is a trade mark of Blo Products Laboratory Limited registered in the U.S. Patent and Trade Mark Office
ad20e6ff-98bc-47e6-aa00-7fb441edd2b0_72_2.jpg Coagulation Factor X (Human) Coagadéx Storage: Store between 36°F - 86°F (2°C-80°C). * Do not freeze. * Keep the vial in the outer carton to pi i I 64208 FXSNUS2C Coagulation Factor X (Human) Coagadex ¢ Dosage and administration - read enclosed package insert. Use within one hour of reconstitution/dissolving. * This product contains no preservatives. * Not made with natural rubber latex. 1ge NDC: 64208-7753-1 Coagulation Factor X (Human) Coagadex LYOPHILIZED POWDER FOR SQLUTIO‘N FOR INJECTION FOR INTRAVENOUS USE ONLY Rx ONLY x3pebeo) (uewny) X 401084 uone|nbeo) 1-€522-802v9 :0AN The product carton contains: 1 Vial Coagadex® 500 IU Range 1 Transfer Device (Mix2Vial™) 1 Vial of 5 mL Sterile Water for Injection 1 Package Insert When reconstituted with Sterile Water for Injection, Coagadex® contains nominally (approximately) 100 IU/mL coagulation Factor X and the following inactive ingredients: chloride, phosphate, citrate, sucrose and sodium Cox a trade mark of Blo Products Laboratory Limited registered in the U.S. Patent and Trade Mark Office
ad4cb6e0-8dc5-4fbc-9ea1-6ec64e4b2f4f_195_1.jpg CLIN \CALmlunom WHO Diltiazem 60mg Tablet NDC: 58118-1007-8 Qty:30 Mig.NDC: 68682-0007-10 GTIN: 0035611810076 Mig_Lot # SAMPLE123 Balch #: SAMPLEASE Mig.By: Oceanside Pharmaceutcals B 0ct 2019 Bridgewater, NJ, USA, 08807 SH: YYMMDDOOOD0O
ad5a77e1-cd4c-48da-8b65-f3e97433e5df_739_1.jpg Store al 20° t0 25°C (68° 10 77°F) [S60 USP Controlled Room Temperaturel, Store n original package. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Rev. € 12/2016 72699-03 Distributed By: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454
ad5a77e1-cd4c-48da-8b65-f3e97433e5df_739_2.jpg 6w p “dsn sapnuesy Jeig wnipos isexnjajuoly sean250090 NDE 0093788755 Montelukast Sodium Oral Granules USP, 4 mg* a5
ad5a77e1-cd4c-48da-8b65-f3e97433e5df_739_3.jpg NDC 0093-7487-56 Montelukast Sodium Oral Granules USP, 4 mg* % Each packet contains 4.2 mg montelukast sodium, USP equivalent o 4 mg montelukast, For Pediatric Patients 6 months to 5 years of age. DIRECTIONS FOR USE: See package insert for full prescribing information. Once opened, use the contents of this packet within 15 minutes (with or without mixing with food), Discard any unused portion, N PHARMACIST: PLEASE DISPENSE WITH ATTACHED PATIENT INFORMATION LEAFLET 3 0093-7487-56 2 B only
ad65c43d-91c7-4c7c-b16f-5025c764cad6_803_1.jpg Afeditab' CR T INFEdiplne i, Extended-Release Tablets) sariiw cisri s i @ = _ o Smmmm L 3y
ad65c43d-91c7-4c7c-b16f-5025c764cad6_803_2.jpg Nocomi 19401 Afeditab CR (NIFEdipine Extended-Relcasa Tablots) gl g s 7;‘:%" O
adc072b9-e48b-470d-9eb1-fd7b52c1f122_771_1.jpg = WHTEROUND 625 Baclofen 20mg g Tablet E Take with food 8| Keepall drugs outof Compare To: reach of children. Lioresal 20mg Tablet “Siore at room temp of Rt Pt L | 2°25°C 687TF) #90 Exp: MMYY ‘NDC 7133509491 031931123236
adf500ae-ccb6-4605-88f4-1392e1b0882d_561_1.jpg NOC# 71610015145 Metoprolol Succinate ER, USP 25mg 45 Tablets e e s e M . AL L. . Pttt 7 oty b rarns Gt T 3500 Vekobl Sacrae £ USP 2y 8 Tt 20 Metoprolol Succinate ER, USP % awen Lare 2 9
aeaed9cb-b629-4019-88d2-a916179427de_742_1.jpg BREAK SEAL AND MIX BEFORE USE 3 (o EZPB0042 NDC 0338-9151-30 0.9% Sodium Chloride Injection USP MINI-BAG Puus Swete Doss Connnca Exch 50 uL cowrans 450 ws Sooum Cruonte USP mEq/50 uL Sooum 8 Chuonne 8 Srente Sce prescaaG EORMATION ADDITE COMPATERITY CONSICT PraruAGT FoR ITRAVENDLS U STORE AT Roow Teueeaane (25°C) Avon Excesshe Haar R Ony Baxter Baxren Heauicase Cosponarion Desario IL 60015 USA "Maoe w lreLawn B-35-04-478 opsssian
aeaed9cb-b629-4019-88d2-a916179427de_742_2.jpg - 0% Sodum choride MINI-BAG Puss Smcis Dost Conmmen Eacx 100 mi. cowtans 900 mg oo Cauomac USP mEQ/100 M. Sooum 15 Caomex 15 Sroms Sz - PREscRENG s noN Acomne cowpaTERTY consua PesaMeCsT Fo Tharouus s STos A7 Roou Towrsaunes (25°C) Avom Excesse Hour R Oy Baxter Buxren Homouss Comommon Deswao IL 60015 USA Mgk w0 C8-35-04-479
aee307d6-b3fa-424f-8656-1f30ff413e95_565_1.jpg WAHIN w07 ATORVASTATIN CALCIUM TABLETS 80 mg* 6 TABLETS “Each fim-coated tablet contains atorvastatin calcium, USP equivalent to 80 mg of atorvastatn. Usual Dosage: See product Insert and Patient Information Loaflet for prescribing information, precautions and warnings. STORAGE: Store at 20° to 25° G (68° to 77° F). [8ee USP Controlled Room Temperature.] RXONLY WARNING: This Unit Dose package s not child resistant and s Intended for Institutional Use Oniy. Keep this and all drugs out of the reach of children Code No.: MHIDRUGS/25/NKD/BY Manufactured for: Myian Pharmace(cals nc. Morgantown, WV 26505 U.S.A, Distributed by: hiylan insilutional Inc. Rockford, IL 61103 US.A. Made in India Mylan.com Mylan® Distributed by Cardinal Health Dubin, OH 43017 150532510218 LOT i XXXXXXXXXX ~ EXP. DATE: XX/XXIXX
af433fd8-b1cd-4c11-85a7-bfee7d6bba9e_411_1.jpg For intramuscular use only. 1 Rx only ach 1.5mL of | NDC 57665-002-01 Single-Dose Vial. Discard solution contains 2.4 mg . unused portion. ' | elapegademase-lr, sodium | ' i chloride (12.75 mg), sodium | DOSAGE: See package insert Revcovi i i Revcovi” for complete prescribing mase-lvir) | heptahydrate (12.7 mg), I mase-lvir information. (elapegademase-lvir) | hertan rosphat o | (elapegademase-lvir) iect drate (381 mg), and iecti Discard if cloudy or frozen. Injection onchyirae (51 mol, an i Injection Wate jection, USP. Store at 2°C - 8°C (36°F - 46°F). ater for Injection, Mid, by Leadiant Biosciences, Inc, No U.S. standard of potency. 2.4 mgA.5 mL (1.6 mg/mL) Gaithersburg, MD 20878 OGN | BSRIONT | e ropmanat | s DO NOT FREEZE | DO NOT SHAKE = REFRIGERATE Leadiant SINGLE-DOSE VIAL Biosciences PIELE TRV TEEL R T C-004-11-US-B
af513233-3ad2-4e96-80d8-e3dde684dde2_392_1.jpg 750 4G 20 TABLETS
af513233-3ad2-4e96-80d8-e3dde684dde2_392_2.jpg 001G coTABLETS
af6ba619-4a99-4834-b637-86edab765de5_768_1.jpg NDC 0517-1825-01 Methocarbamol Injection, USP 1,000 mg /10 mL (100 mg /mL) For Intravenous or Intramuscular Use 10 mL Single Dose Vial RxOnly \verican REGENT, INC. SHIRIEYNY 1197 , at maximum rate of 3 mL per minute, or diluted , than 5 mL undiluted in each gluteal region, Each mL contains: Methocarbamol, USP 100 mg; Polyethylene Glycol 300, NF 0,5 mL; Water for Injection, USP q.s. pH adjusted, when necessary, with hydrochloric acid and/or sodium nydroxide, AFTER MIXING WITH INTRAVENOUS INFUSION FLUIDS, DO NOT REFRIGERATE. Directions: Intravenous Injection - undiluted with sodium chloride injection or 5% dextrose injection, Intramuscular Injection - not more 0305171825016 (01 Usual Dosage: See Package Insert. Store at 20° to 25°C (68° to 77°F); excursions permitted 10 15° to 30°C (59° to 86°F), [See USP Controlled Room Temperature.] RN1095-00 Rev.
af6ba619-4a99-4834-b637-86edab765de5_768_2.jpg 951 seinosnuieaug 1o snousKo J0J (u/ 3w 00T) TW 0T/ Hw 000'T i dsn ‘uondeful st ss0a ogus JoweqiedsoyIoN Swotrov 0752514150 99N Ml oo e, 15 o0 i ot 0. = NOG 0617-1825-10 | i s i i o MM RS | e Methocarbamol Injection, USP 1,000 mg /10 mL (100 mg /mL) 5T e 7 G e ot For Intravenous of muscular Use. 1010 mL Single Doso vials
afbc8ef1-ebf2-47fb-84dd-5d2c4dd1cfbf_621_1.jpg NI 14 CLONIDINE HYDROCHLORIDE TABLETS, USP 0.1 mg 10 TABLETS Each tablet contains 0.1 mg of clonidine hydrochioride, USP. Usual Adult Dosage: See product insert for prescribing information, precautions and warnings. STORAGE: Store at 20" to 25° C (68" 10 77° ), (See USP Contralled Room Temperature.] Protect from light RX ONLY WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of chidren. Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U S A Distibuted by Wylan Instiutional Inc Rockford, IL 61103 U.S.A. Mylan.com Mylan® Distributed by Cardinal Health Dublin, OH 43017 129065680218 LOT #: XXXXXXXXXX EXP.DATE: XX/XX/XX
afbc8ef1-ebf2-47fb-84dd-5d2c4dd1cfbf_621_2.jpg NDC 55154-5662-0 *M15 CLONIDINE HYDROCHLORIDE TABLETS, USP 0.2 mg 10 TABLETS Each tablet contains 0.2 mg of clonidine hycrochloride, USP. Usual Adut Dosage: See product insert for prescribing information, precautions and warnings. STORAGE: Store at 20° to 25° C (66° t0 77" F). [See USP Controlled Room Temperatre.] Protect from light RXONLY WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of chiidren Manufactured by: Myian Pharmaceuticals Inc. Morgantown, WV 26505 U S A. Distributed by Wylan insttutional inc. Rockford, IL 61103 US.A Myian com Mylan® Distributed by Carcinal Health Dublin, OH 43017 29085760218 LoT : XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
afbc8ef1-ebf2-47fb-84dd-5d2c4dd1cfbf_621_3.jpg ] K37 NDC 55154-5570-0 CLONIDINE HYDROCHLORIDE TABLETS, USP 0.3 mg 10 TABLETS Each tablet contains 0.3 mg of clonicine hydrochloride, USP. Usual Adult Dosage: See procuct insert for prescribing information, precautions and warnings. STORAGE: Store at 20 to 25 C (88 10 77 F). [See USP Controlled Room Temperature | Protsot from light RX ONLY WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Kaop this and all drugs ot of the reach of hidren. Manufactured by. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Distributed by: Mylan Institutional Inc. Rockford, IL 61103 U.S.A. Mytan.com Myian is a trademark owned by its respective owner. Repackaged by Cardinal Health Zanesville, OH 43701 135118210817 ornxooc I ero.onre: ane [N
afde17e7-b95b-4cd5-97eb-e361724014bd_152_1.jpg FOR ORALUSE ONLY. Maartreg or: s o s s gz e o mic NOC 16714-695.01 g e SR s gt S L. of eSS . P 05 TSI B S U e Manufactured by: Fluconazole for Oral use o se psosgs rsen or escrang omston hurpongs s imtes i oo s o0, Suspension USP e s s s v e et 10mg/mL el g 15D NUSED PORTIN KFen 2 WS P1419178 when reconstituted v 35 mL when reconstituled seos Reconsttston: sior rygonesr s 2070 257 (6510 77 58 USPConrses oo Temperzu), Ao Rsconstaton: s s suspersion s (41772025 77 Prfct o oz ML 19HOAPRSFR * Over Printing Zone . v Coding Area (45x 15 mm) Dotted fine not to be printed
afde17e7-b95b-4cd5-97eb-e361724014bd_152_2.jpg FOR ORALUSE ONLY. Maartreg or: s o s s gz e o mic NOC 16714-695.01 g e SR s gt S L. of eSS . P 05 TSI B S U e Manufactured by: Fluconazole for Oral use o se psosgs rsen or escrang omston hurpongs s imtes i oo s o0, Suspension USP e s s s v e et 10mg/mL el g 15D NUSED PORTIN KFen 2 WS P1419178 when reconstituted v 35 mL when reconstituled seos Reconsttston: sior rygonesr s 2070 257 (6510 77 58 USPConrses oo Temperzu), Ao Rsconstaton: s s suspersion s (41772025 77 Prfct o oz ML 19HOAPRSFR * Over Printing Zone . v Coding Area (45x 15 mm) Dotted fine not to be printed
afde17e7-b95b-4cd5-97eb-e361724014bd_152_3.jpg om0 usc o s i s conans vt g e sty NSy s i, e E36h S L of ecostd usponsion confs: corarla 2005 NatSa eatare Holdngs UC NDC 16714-696-01 FIUCONAZOIE TOF OTal tnat o s s s pran s s s SusponslonUSP SEERL i i omgmL e when reconstituted :ﬁ;umﬂm R SiE 35 mL when reconstituted setoe Reconsuton: tor ry powsr s 20 o 257 (6810777 {58 P Cotoled Ao Teportre), Ao Roconsttaon: s o suspansion b 4177 20025 (77°) Pract rom ez MLNO: 19HOAPSFR * Over Printing Zone ) Coding Area (45 %15 mm) Dotted line not to be printed
afde17e7-b95b-4cd5-97eb-e361724014bd_152_4.jpg om0 usc o s i s conans vt g e sty NSy s i, e E36h S L of ecostd usponsion confs: corarla 2005 NatSa eatare Holdngs UC NDC 16714-696-01 FIUCONAZOIE TOF OTal tnat o s s s pran s s s SusponslonUSP SEERL i i omgmL e when reconstituted :ﬁ;umﬂm R SiE 35 mL when reconstituted setoe Reconsuton: tor ry powsr s 20 o 257 (6810777 {58 P Cotoled Ao Teportre), Ao Roconsttaon: s o suspansion b 4177 20025 (77°) Pract rom ez MLNO: 19HOAPSFR * Over Printing Zone ) Coding Area (45 %15 mm) Dotted line not to be printed
afe1ca86-1b9d-44b8-85be-a8a737a12aa1_892_1.jpg i NDC 70860-605-4 1 W}( 2 Mfd. for Athenex Schaumburg, IL 60173 (USA) Made in China ©2018 Athenex. 15UA04 Lot: For Intravenous Use MUST BE DILUTED Discard unused portion 2 mL Single-Dose Vial (01)00370860605418
b0115c7b-48e6-4a8c-8e35-52a757cadfac_140_1.jpg nan
b02472d8-ee0f-4218-8693-0d7970532ce9_972_1.jpg NITROUS OXIDE usp wasms: WA FRSTAI: UN1070 curT] conTenTs: uress & Only. {dminstaton of g Ok, may b o o contaEtt. or s ol by o e iion s oy IR 1ot O 13 i i ol 2 Aot it o 800 o SIS, b Wi 1 e, ConaNIE S S s o 08 g o Yo o s, VSR Ie LB A e TIAYCAUSE FROSIOTE ol g s Somang s e e, Ko otnd s Uil e o oy s o e s, D01t gy, i e ot o S 1257, Gpan i sy Gl e fr 5 s nd o ey Ui ko ot e 1 i i e i Ml Sy Dt e (1508, IEMALED, omes o ot e, gl s, s it ghe G e NEASEOFFROSTOTE, i s ety oas: 10024572 DONOT REWOVE THI PRODUCT LABEL BLUEWATER INDUSTRIAL PRODUCTS INC. 37280 GREENST. - NEW BALTIVORE, M1 48047 (888) 725.6300 r ]
b02472d8-ee0f-4218-8693-0d7970532ce9_972_2.jpg e R w1 o e i & i Smoguarst e
b02f3f85-8f9b-4d06-8eae-73e592626f3e_868_1.jpg W00 002007 oy Exch vl ot Punprl. 4 m Pantoprazole Gutins i omie Sodium for Injection paags insn for dosaye panoprazols pr v Surle w ARG porTUGa 5. Diabaaty W WESTAWARD B
b02f3f85-8f9b-4d06-8eae-73e592626f3e_868_2.jpg PLe0ss wes)) NDCO0143-9284-10 Rxonly Pantoprazole Sodium for Injection Equivalent to pantoprazole per vial Sterile For Intravenous Infusion Only Single-dose vial-Discard unised poriion No iltr roquired Contains 10 Vials PROTECT FROM LIGHT To open - Cut seal long doted lne. Each vl contain: Pantoprzol. 40mg (squialentts 451 g of paricprazoe sodum) Partoprazole Sodum fornectionis inteded for Inrayenous use only. Reconsttution needed. See package nset for dosage and acmiistrton. Store at 20°-25°C (68°77°F)_excursions permitted lo 15°-30°C (59"-36°F) [See USP. Conbralled Room Temperature]. Poec vils o lgh s o il caron is CONTATS: o (10 Partopzl o o Infcton vis and 1 copy ofthe package et Manstchredby HIKHA FARMACEUTICA [PORTUGAL), 5. Dised by Y WEST-WARD Eatonown, 0 07724 USA
b0886e4e-5710-4053-9270-4d7de34068e7_145_1.jpg Each film coated tablet contains: Eplerenone 25 mg Usual Dosage: See accompanying prescribing information. Store at 26°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Manufactured for: Accord Healthare, Inc., Dutham, NC 27703. Manufactured by Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA. NDC 16729-293-10 Eplerenone Tablets 30 Tablets I accord Rx only INLOS3 Mfg. Lic. No.: G/1339 108768 0651444 I 2931 0Mllls Keep area blank & vamish free for overcoding Lot and EXP & Data matrix 45X22 mm
b0886e4e-5710-4053-9270-4d7de34068e7_145_2.jpg Each film coated tablet contains: Eplerenone 50 mg Usual Dosage: See accompanying presciibing information. Store at 26°C (77°F); excursions permitted to 15°C 10 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by Intas Pharmaceuticals Limited, Ahmedabad - 332 210, INDIA NDC 16729-294-10 Eplerenone Tablets 30 Tablets I o Rxonly 3 u INLOB8 Mfg. Lic. No.: 6/1339 1087750651499 sIlTe? 2oz 4100l 2 Keep area blank & varish free for overcoding Lot and EXP & Data matrix 45X 22 mm (0
b0ea8a87-f0b7-4bdb-bd80-c1c40d5a213d_95_1.jpg BOCOIPASIG Cabiuoied mtn o iteie pintis R et b o s - Guanfacine (I iUl T — Extended-Release st 70 25 (o o 175 seo s S e AT T e 5 Tablets iereiint £ Rconly 100 Tablets, /4 SANDOZ
b0ea8a87-f0b7-4bdb-bd80-c1c40d5a213d_95_2.jpg NDC 0781-5452.01 ‘Each extendad-reksass tablet contains: quaniscne. P Guanfacine G e Extended Release S5 o2 500 Co" 777 o o = Tablets ﬁwmﬂml’;‘"’m’i’m e G e R TR Eroman s o A e - ‘Sandoz inc. Princeton, NJ 08540 = e ey - T > o . £ = 4 SANDOZ
b0ea8a87-f0b7-4bdb-bd80-c1c40d5a213d_95_3.jpg WCHIRCONON. Cubtvid ki diosdie st Guanfodne oSeoTeimiEls ey Extended-Release Slore 212010 25°C (68" fo TTF) [ses USP —_— Tablets S S B e SR eg e 6 -0 5 SRS B S Nty 0 Tovmtg e, B o oo e o . Reonly 100 Tablets 5 3 4 SANDOZ =
b0ea8a87-f0b7-4bdb-bd80-c1c40d5a213d_95_4.jpg NOCORIEATS G oskaiel olcin Chistrbeias grssie: e faine B ERE— » i Extended-Release S5 o5 250 o 775 o o mumm= Tablets ﬁ‘}:g«mﬂmiﬂ;%'i’; Ty — 1 T el = R e A Saa=h ‘Sandoz Inc., Princeton, NJ 08540 = e e - e e e IS = 4 SANDOZ
b118a40d-6b56-cee3-10f6-ded821a97018_132_1.jpg @ @ VENCLEXTA® (venetoclax tablets) 10 mg, 50 mg, and 100 mg Starting Pack /A\WARNING Contact your doctor when you receive this medication. It may be necessary to take your first dose in the presence of your doctor to prevent a potential serious side effect. DISPENSER: Each time VENCLEXTA is dispensed give the patient the enclosed Medication Guide.
b118a40d-6b56-cee3-10f6-ded821a97018_132_2.jpg ® @ VENCLEXTA® (venetoclax tablets) 10 mg Dispense the accompanying Medication Guide to each patient. | | | | | | | 14 Tablets 4 | | | | | | | | | | i
b118a40d-6b56-cee3-10f6-ded821a97018_132_3.jpg NDC 0074-0566-11 . @ VENCLEXTA® (venetoclax tablets) 50 mg | 1Tablet 7 Dispense the accompanying Medication Guide to each patient. i | i | i i i i i i | i i ] ] ....................................... |
b118a40d-6b56-cee3-10f6-ded821a97018_132_4.jpg Exp.: Lot: 04-C715-R3 g& 20023392 NDC0074-057622 Rx only ‘VENCLEXTA' onatodiax tabiat 100 mg obbvie Genentech Do not accept f seal over bottle opening is broken or missing. Each fiim-coated tablet contains 100 mg of venetociax Keep out of reach of children. Store at or below 86°F (30°C). See Package Insert for full Prescribing Information. Manufactured and Marketed by: AbbVie Inc. North Chicago, IL 60064 and Marketed by Genentech USA, Inc. AMember of the Roche Group South San Francisco, CA 94080-4990 ©2018 AbbVie Inc. ©2018 Genentech, Inc.
b11f1c74-23da-4273-b504-0a2ca22c4b5a_762_1.jpg Packaged by Bvyant Ranch Biabank. @A 91504 Fenofibrate "o cPhe 48mg Tablet 168021 Store at room temp of Compare To: 20°25°C (68°-77°F) Tricor 48mg Tablel Keep all drugs outof Ciph Limted reach of children. #30 Exp: MMYY NDC 7133508911 072131120891 om
b127d3fc-be5e-4c12-8026-205766bf8e7f_28_1.jpg NDC 0904- aﬁasm D HYDR( OEORIDE P ETS, US| Ellm: (T Do s e Dyt ol FHARMACIST: DISPENSE WITHT DR ATION CUDE: Rx only 100 TABLETS | IyMAJOR 'NDC 0904-6635-61 Unit Dose BuPROPion HYDROCHLORIDE TABLETS, USP A S e o TG, o e SEEnsETNEDBUDE soNDAT S0 2120°G 19.25°C (B8F 0 7T):sxcurions permited o 157G 1 30°C (50° 1 567 [S00 "USP Conotied Foom Tampsratrs], Froret fom maetre Dsporssin 1ttt e Zyant i ot vatomak f G Sitine. Keep this and sl drugs ot f reach of childen. This Unt e packa s not chid restantand s nended o it U Oy Rev. 07718 Nt b Mottt for: Disributed b MAIORPPHARVACEUTICALS \7177 Rt Bl S 0 |§zuu v I [I 09046 63561
b127d3fc-be5e-4c12-8026-205766bf8e7f_28_2.jpg GHMAJOR NDC 0904-6636-61 umu iDow HVP R LORIDE ETS, USP @ [WARNING: Do nat e i combimion Wil ZVBANS. o any oiher modicines tht conain Bupropion ydrochiorde PHARMACIST: DISPENSE WITH 'MEDICATION GUIDE Rx only 100 TABLETS ZMAJOR 'NDC 0904-6636-61 Unit Dose BuPROPion HYDROCHLORIDE TABLETS, USP g Exch ablt contans 100 mg, upropion ydrochlorde Uaual Dosage: Sos product et for presering riormaion,prscaions and warnings Stors ¢ 20°G 19 25°G (B8 to TP axcursions. pormited from 15°G 10 30 (56°F 10 85F) (5o U5 Contoled Foom Tamperatre] Prote: from meiette Dispense i ight, ght esisan:conianer fosa Dr1 2t ostrd oo St Keep tisand al deugs 0wt of reach o chidren. i Uit D e ol chid et 1 . ntended fo Instiutionsl Use Oy Rev0718 My [ i e o an2e R o Al 17177 % Laune bark D, Sute 253 ionis um m IIIIﬂQOAS 6366 A8
b1bd0d02-eccb-4449-82b9-9b552835029e_184_1.jpg Warfarin Sodium 2.5 mg Tablet arv: 30 ID#:TV2,1;2,1714 Expires: NDC #: 70518-1492-00 Shape: Oval LOT #: Ref #: 00093-1714-10 MFG: Teva, Frazer, PA 19355 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
b25b34ab-9cf1-4a2b-bdf2-5eaf66625999_501_1.jpg NDC 0024-2794-10 Rx ONLY Ferrlecit’ sodium ferric gluconate complex in sicrose injection 62.5 g clemental iron/5 m.Serie single-use I FOR INTRAVENOUS USE ONLY 10 x 5 mL Single Use Vialk SJeIA 950 2ffuls W § X 0L AINO 35N SNONIAVHLNI 404 R osr-18uss ajuais 1w q Juoi [eyudWa|d Sw S 029 uorpalu1 asoins ui xajduwiod 1DUOINS ki) winjpos D9 AINO Xy 0L-P6LZ-¥Z00 JAN e e e o et T e irvestane i T o, S Bod Boom Toages PREMIERFYORX" s & resgsteret ek of Presies Heakhcare Ko s NDC 0024-2794-10 Rx ONLY Ferrlecit sodium ferric gluconate g o : g ?g i 3 complex in sucrose injection R 3 % £E £8 ¥ E § 5 i 62.5 mg elemental iron/ §&§§a !i. g E %5 Eg 5 mL Sterile Single-use —_ FOR INTRAVENOUS USE ONLY = 2 10x 5 mL Single Use Vials PREMIERProRx"
b283d662-9be1-49c7-be03-cb21055314c1_673_1.jpg Pachaged by Eepant Raeck Znbank. €4 91500 Ciprofloxacin G "™ S 250mg Tablet 2 Store at room temp of Compare To: 20°25°C (68°-77°F) Cipro 250mg Tablet Keep all drugs out of Carkbad Techmbgyle. | reach of children, #20 Exp: MM/YY 5 NDC 7133508361 013261119666
b2a44879-6ab7-5d62-0f96-2bec51eefc57_77_1.jpg L0=-l5lg=-8/250 9 o e bt cor e 15 Do, usp B XY 10T A5AXI0Y AT AT S OO I 0mg pizide and Metformin HCI Tablets, USP 4 PRARACT:Dispencs e sccompanyin Paint fomation st o eachpaent. [MMylan® Rxonly 100 Tablets Dispensoin a tight, gt esstnt 3 cortaner 3 dened nthe ISP = usingachi-resisant dosure, & 2 Keen conaine tighty cosed. Keep this and all medication outof the reach of hildren. Store at 20° 0 25°C (6810 77°F). [See USP Controlled Room Temperature] Usual Dosage: See accomparying prescrbing nfomation. Hiylan Pharmaceuticals In. Morgenionn, WV 28505 USA [ Mylan® Mylan.com
b2a44879-6ab7-5d62-0f96-2bec51eefc57_77_2.jpg Each flm-ccated tablet contin: Glpizide, U5P 25mg Wefforin hydochioide, ISP 500mg FCCCRRNONY IS Glipizide and Metformin HCI Tablets, USP [PRARICSE Dipree e sccompanyiog Paien Iformatio Leaf o each ptent. [MMylan® Rxonly 100 Tablets Dispenss ina tight lightresistant container 2 defned nthe USP usinga chilesistart cosure. Keep conaine tighty close. Keep this and all medication out of the reach of hildren. Store at 20°10 25°C (69° o 77°F). [See USP Controlled Room. Temperature] g Ususl Dosage: See accompanying prescrbing nfrmation. Mylan Pharmaceutcals fn. Magartown, W 28505 USA [MMylan® Mylan.com i
b2a44879-6ab7-5d62-0f96-2bec51eefc57_77_3.jpg Each fim-coated tablet contin: £ = Glpizide, ISP Wethrmin ydrochloride, USP o: W o D W; e o ;gpg =i e 55;5 é 2 g Stmg Glipizide and Metformin HCI Tablets, USP t ¢ L FRARRACISE Dsenee e scconpanying Patent nfmaton Lol o sach patent. [MMylan® 100 Tablets L] e IR E ] Dispense n a tight, ghtresistant contineras dfincd i the USP. usinga chid-esistant closure Keep conainer tightly dose, Keep this and all medication out of the reach of childrer Store at 20° 0 25°C (65° o 77°F). [See USP Controlled Room Temperature] 3 g Usual Dosage: See ascompanying preseribing nformation. Nylan Pharmacouticals Ic. Morgantoun, W 25575 U5 . [MMylane Mylan.com
b2f73c64-b92c-49bf-ad39-e32ac83e4d3d_613_1.jpg HSIN"HVA ON 6 %208 4 N = ’ “dSf) 841 U] PaUY2D SE JoUIRIUD WO © U} asuadsiq U J0 Y3681 9L J0 110 UOYEOIPALY 2 PUE SIy} oy [oumpesaduay. wooy payoiog dsn 9] (.42 0.80)0.52 01 02 12 810K ‘uogeuwioj Buiquasaid i 10} pasu; adiyoed oag. sfep 10} 100y 14610 fuena soynsde) om :asn pue abesog 6w pze S ‘ajeyng aujung 'SUIEjU0) Bjnsde) 4oe3 Sulfate ingenus: NDC 50742-238-30 inine Capsules, USP MEDCATION GLIDE TO EACH PATIENT Rx Only 30 Capsules Qu PHARMACIST: DISPENSE THE ACCOMPANYING Manufactured For: Tngenus Phermaceuicals, LLC Orlando, FL 32833-6408 238-30 v1/08-2017
b344c76d-5ba1-4e1e-9560-deda154e43fe_894_1.jpg NDC 70529-049-01 Corvatrol 0.9% Injection System Contents: 1- 30mL Bacterioslatic 0.9% Sodium 1- 21 Gauge 2in Chloride Injection USP Needle [Administer) 1- 3ce Syiinge w/ 18-22 Gauge 1- 3x3Gauze Sponge 1-11/2in Needle (Draw) Sterile Square 1- Sce Syiinge w/ 18-22 Gauge 1- Bandage 1x3in 1-11/2in Needie (Draw) Storage: Store in a cool ¢ 77F diyplace ot 25°C (77°F). P Excursions permitied fo 15-30°C (59-86°F). See USP o cotmoms comp O Snde MG EClons ramperaioe ‘Controfled Room foruse imigions Temperature. 1L 111617 -1-18 Lot/Bxpiation ~ Assomblod and Dtibulod by 13 Medical, LLC 190 E Stacy Road: STE 306298 Allon, X 75002-8734 For quesions or commants: info@IT3-Medical.com, www.T3 Medical.com ©2017 113 Medical, LLC. Assembled in the USA.
b348b1cf-6250-4ab6-b2bf-3bff86628c53_731_1.jpg Diatrizoate Meglumine and Diatrizoate Sodium Solution USP 37% Organically Bound lodine For Gastrointestinal Radiography Not For Parenteral Use Rx only Lot: Mig Exp Store at 20°to 25°C (68° to 77°F) [See USP Controlled Room Temperature]; Avoid excessive heat. Each mL contains 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium. Each 30 mL contains approximately 11 grams arganically bound odine pH adustedto o 76 with sodtm hydroxide. Inactive ingredients: Edetate Disodium Dihydrate, Lemon-Vanilla Flavor, Sodium Citrate, Sodium Hydroxide, Sodium Saccharin, Water for Injection. Single-Unit Container » Dilute Before Use Discard unused portion « Protect from light Usual Dosage: See Package Insert. Dispense in Tight, Light Resistant Containers. Oral or rectal use only. Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616 MademUsa" 0 Guerbet 11030916 019418160 I|g
b3d24364-f4fc-4aac-ac5c-651ae7f6f9b6_981_1.jpg NDC 68084-42: Oxandrolone @ Tablets, USP 30 Tablets (3x 10) Fxonly NI | T 01)003 68084 424 212 NDC 68084-424-21 Oxandrolone (' Tablets, USP 30 Tablets (3 x 10) RxOnly Each Tablet Cantain Gxandrolons, USP. 25mg Usual Dosage: See package insert orfull presoribing nformation Storo a1 20° 1025°C (68" 0 77°F); excursions permittd between 15°16.30°C (59" 0 85°F) [soe USP Controled Room Tomperaturel, Keep this and sl drugs out of resch of hildren. FOR YOUR PROTECTION: Do ot use I bt is torn orbroken, The drug roduet contane n tis package i from NDC # 48284-901, Par Pharmaceusios. Packaged and Disiruted by: American Health Packaging. Columbus, O 43217 oa2e2 o2eaziioEs -—
b3d24364-f4fc-4aac-ac5c-651ae7f6f9b6_981_2.jpg Oxandrolone of 55 Oxancrolone Tedet USP o §E £ Tabet Use ] 25mg i ii25mg ] wrausers fF 5] Loruse - Servions 5 B BeRT e = Oxandrolone ~ gf Oxandrolone v Tavlt, USP 25mg $25mg . 28 £ Lom zaesemn EPRY e B SRR Oxandrolone g 75 Oxandrolone Tobet USP (o 5 2 Tabkt, UsP 25mg i ij25mg ] Lo 2457 55 Lom zaesene - B, e Pormvan = - : <55 Oxandrolone Oxandrolone 552 TableL UsP (o Tabel, UsP E2smg € 25mg € 558 wor s Lo zaesmn = R Ehiy e Oxandrolone gf 5 Oxandrolone ToeL UsP o 34 L5 Tavit,Usp 25mg i fi25mg Lo zuasere £5 Lon zaesere B, e 1 B
b3d24364-f4fc-4aac-ac5c-651ae7f6f9b6_981_3.jpg NDC 68084-42! Oxandrolone |Tab|ms, USP @ mg 20 Tablets (3 10) N0 1 (01)0 03 68084 425 21 & NDC 68084-425-21 Oxandrolone Tablets, USP 111 30 Tablets (3x 10) RxOnly 10mg 00 package nser o full prescribing informaton. 1025°C (8" 10 77°F) xcursions permitted between 15°16:30°C (58 10 86°F)fso0 USP Controlled Foom Temgerature Keep this and alldrugs out of each of il FOR YOUR PROTEGTION: Do not use bister s torn orbroken. The crug produot contained n s package s from NDC # 48584302, Par Pharmaceutica. Packaged and Disirluted by: American Hesit Packaging Golomews, Ohio 43217 oazs21 o2uasz1ineTE
b3d24364-f4fc-4aac-ac5c-651ae7f6f9b6_981_4.jpg Oxandrolone §§ §§ Oxandrolone - TaeLUse @ Ji ] Te e 35 10mg L 5 tomg £ Wimox & 85 10T oo : Brmvom 4 BeReme Ocandroione ¢f f5 Oxandrolone = Tablet,USP (£ Tablet, USP, S iomg €5 1% 10mg e = LOT: sooox 2 § LOT. xooox 5 Bk & 1 v Oxandrolone ¢§ §5 Oxandrolone TaaUse @ i £ el UsP 10mg 5 1omg LOT. oo B3 oneom Brilime B 8 BeRvo Oxandrolone g £ Oxandrolone 3 e use @ [ ] Tl e B2, 10 mg 2 it tomg = LOT. oo 2 LOT oo e @ § 8w B8 Owndobne of §; Owandrolone IZE TavetUsP o 3f Tebel USP iy = 10mg o ié 10 mg i ook B BE LOTxoum 22 e 4B B
b4959352-85dd-456e-9521-e1f94b76511c_1000_1.jpg nan
b4e8ffce-7680-fd9d-df6b-5bd872ba3c09_332_1.jpg Topiramate Tablets @D Reonly 5026875015 Topiramate Tablets @I Reonly 10)Uni Dose Iy 015 T s e e K o ot e
b4e8ffce-7680-fd9d-df6b-5bd872ba3c09_332_2.jpg Topiramate Tablets - S0mg Rxony 50 Tablets (5 10)Unit Dose Iy 5026875115 Topiramate Tablets Reony 507ables (5 10)Unit Dose 5026875115 e e s e Bt s ot v o o ot b s AVPRK
b4e8ffce-7680-fd9d-df6b-5bd872ba3c09_332_3.jpg Topiramate Tablets 100 mg Reony. S0 Tablets (5 10)Unit Dose i Soz 6 Noc sozes 75215 Topiramate Tablets 100 mg Rxony 50 Tabets. Do 5026875215 e e e AVPRK
b4e8ffce-7680-fd9d-df6b-5bd872ba3c09_332_4.jpg Topiramate Tablets 200 mg Rx oty 50 Tablets (6 10) UnitDose Uy 5026875315 Topiramate Tablets 200 mg Reonly 50 Tablets (6 10)Unit Dase N D BT = e e e AVPRK
b4f98f74-198c-4745-a2b6-4e588898e79f_90_1.jpg RS e S e ey S SRERmmE S . TRAE LT FE R T eieus § 8 | e we At g TWICE A DAY 5 g l - B ORASDRECTED. I Tonue, = Ty R o e Lo S i B i
b5a81d5a-4648-4c7a-951d-33c014a63c7e_492_1.jpg NDC 0173-0867-10 Rx Only TRELEGY Luipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) 100 mcg/62.5 mcg/25 mcg FOR ORAL INHALATION ONLY TRELEGY ELLIPTA contains 2 foil strips of 30 blisters each Each blister on one strip contains 100 mcg of fluticasone furoate and lactose monohydrate. Each blister on the other strip contains 62.5 meg of umeclidinium, 25 mcg of vilanterol, magnesium stearate, and lactose monohydrate. | B containing 30 doses (60 blisters total) l
b5beccb6-f64b-4b88-b1c4-9a5ab738de19_399_1.jpg Enalapril Maleate 5 mg Tablet arv: 90 ID#T5 Expires: NDC #: 70518-1564-00 Shape: Round LOT #: Ref #: 51672-4038-03 MFG: Taro Pharma, Hawthorne, NY 10532 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
b6985be4-86b4-41ad-bd4d-a5d25c77062a_991_1.jpg [ e 0o 1671440802 LARIN' (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP) ‘ [ Tr—— TR | s e ed00 | e i ok oo 140803 . LARIN' LARIN" {71Y) LARIN ) LARIN (Noethincrone Acetateand mn‘mmn&mmmrmum (Nrethincrone cetateand |~ (Norethindrone Acetate and - e | = EthinyEstradil Tablets USP) - Ethiny] Estradiiol Tablets, USP) i Qb ot i e [ il e I || R i | R M, | e e TR oo | b Dot | o vt R G Sy vt i iy RxOnly - | weouy - zem 00880218
b6a9ffeb-9818-46ed-bd8e-53316c5ab149_626_1.jpg T e o o TR S
b78ad43f-f132-4f03-8c85-2cf9b3ab555b_552_1.jpg nan
b7b8ae08-3fb0-4c6c-af02-89f0f6f40ffb_569_1.jpg Setlakin” ST D v wondibe (Levonorgestel and Eviy Estadil Tats, USP) 015mg/0.03 mg e Setlakin {Levonorgestel and Eviny Estracol Tabets, USP) 015mg00m St s s Setlakin (Levonorgestrel and Ethinyl Estradiol Tablts, USP) 015mg/0.03mg e i weo . et s e s e Setlakin* gt 9] e o [t SEmEs. L
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_1.jpg NDC 59011-271-60 € 09-122-11065S m g0-¢16e0e 11610690 L9 ‘Plojwerg *d"] ewlieyd enpind (4:98-:69) 0.06=GH usamlag papiwied suoisInoxs ((d,//) 0,62 1e 9101S “Joureuod juelsisal-1ybll by e ul ssuadsiq A = —K O D M > mMAIQ g2 |£ 83 W S5 g2 |05 ® s = m 822 x€ ¥ E_ @+ £S5 =0 sag 32 o0 288 0 C — o = = . o2 555 2% nom §s5 o T L =& S.T.b. mm OO 32| 2 = ¢ sce nnmbWuW o S22l o © °%09 IS5 £5E| ® =83 28 25 |5 S<3 > =< o o L <% = 13 &8s ‘0v2'808'8 PUB £99'/¥9'8 1026 HSS'8 ‘8V6'625 '8 '66Y'L9E'8 1000'605'8 €82'EEL'0 '£96'88F'9 "SON WUsled 'S'N ‘alnjesay| Buigquosaid Bulfuedwoooe pesy :abesoq jensn dX3%® LO1 dx3 HSINYVA ON 1071 210682959521 N/S
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_2.jpg NDC 59011-271-60 € 09-122-11065S m g0-¢16e0e 11610690 L9 ‘Plojwerg *d"] ewlieyd enpind (4:98-:69) 0.06=GH usamlag papiwied suoisInoxs ((d,//) 0,62 1e 9101S “Joureuod juelsisal-1ybll by e ul ssuadsiq A = —K O D M > mMAIQ g2 |£ 83 W S5 g2 |05 ® s = m 822 x€ ¥ E_ @+ £S5 =0 sag 32 o0 288 0 C — o = = . o2 555 2% nom §s5 o T L =& S.T.b. mm OO 32| 2 = ¢ sce nnmbWuW o S22l o © °%09 IS5 £5E| ® =83 28 25 |5 S<3 > =< o o L <% = 13 &8s ‘0v2'808'8 PUB £99'/¥9'8 1026 HSS'8 ‘8V6'625 '8 '66Y'L9E'8 1000'605'8 €82'EEL'0 '£96'88F'9 "SON WUsled 'S'N ‘alnjesay| Buigquosaid Bulfuedwoooe pesy :abesoq jensn dX3%® LO1 dx3 HSINYVA ON 1071 210682959521 N/S
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_3.jpg NDC 59011-273-60 90-71LSE0E ¢ 09-¢222-110665 £ 1£1E-10690 LD ‘plojwerg *d"] ewlieyd enpind "(4.98-,69) 0.0~} usamlag papiwied suoisInoxs ((d,//) 0,62 1e 91015 “Jouleuod juelsisal-1ybll ‘b e ul ssuadsig N £ —K O L P > HMA|V g2 | £ 48 W S5 EE, 03T ¢ s = ® 22l x££ % o S E5g| ' 3 052 gz g Sm _—® oD <23 2 o2 s si:| 2 o9 m g8 2 9 c St 52Z| S5 o FEE| o 2, amm OO 5a 2 2 = 0 w82 25| © 232 00 s25l o © °%9 S5 EEE| = =88 °g £ |E S¢3 > << {4 o LE3 =12 &8s ‘0v2'808'8 PUB £99'/¥9'8 102G 155’8 ‘8Y6'62S '8 '66Y'L9E'8 1000'608'8 '€8.2'EEL'0 '£96'88F'9 "SON WUsled 'S'N ‘ainjesay| Buigquosaid Bulfuedwoooe pesy :abesoq jensn dX3%® 101 dx3 HSINYVA ON 1071 21068/90¢HCZL N/S
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_4.jpg NDC 59011-273-60 90-71LSE0E ¢ 09-¢222-110665 £ 1£1E-10690 LD ‘plojwerg *d"] ewlieyd enpind "(4.98-,69) 0.0~} usamlag papiwied suoisInoxs ((d,//) 0,62 1e 91015 “Jouleuod juelsisal-1ybll ‘b e ul ssuadsig N £ —K O L P > HMA|V g2 | £ 48 W S5 EE, 03T ¢ s = ® 22l x££ % o S E5g| ' 3 052 gz g Sm _—® oD <23 2 o2 s si:| 2 o9 m g8 2 9 c St 52Z| S5 o FEE| o 2, amm OO 5a 2 2 = 0 w82 25| © 232 00 s25l o © °%9 S5 EEE| = =88 °g £ |E S¢3 > << {4 o LE3 =12 &8s ‘0v2'808'8 PUB £99'/¥9'8 102G 155’8 ‘8Y6'62S '8 '66Y'L9E'8 1000'608'8 '€8.2'EEL'0 '£96'88F'9 "SON WUsled 'S'N ‘ainjesay| Buigquosaid Bulfuedwoooe pesy :abesoq jensn dX3%® 101 dx3 HSINYVA ON 1071 21068/90¢HCZL N/S
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_5.jpg NDC 59011-273-60 90-71LSE0E ¢ 09-¢222-110665 £ 1£1E-10690 LD ‘plojwerg *d"] ewlieyd enpind "(4.98-,69) 0.0~} usamlag papiwied suoisInoxs ((d,//) 0,62 1e 91015 “Jouleuod juelsisal-1ybll ‘b e ul ssuadsig N £ —K O L P > HMA|V g2 | £ 48 W S5 EE, 03T ¢ s = ® 22l x££ % o S E5g| ' 3 052 gz g Sm _—® oD <23 2 o2 s si:| 2 o9 m g8 2 9 c St 52Z| S5 o FEE| o 2, amm OO 5a 2 2 = 0 w82 25| © 232 00 s25l o © °%9 S5 EEE| = =88 °g £ |E S¢3 > << {4 o LE3 =12 &8s ‘0v2'808'8 PUB £99'/¥9'8 102G 155’8 ‘8Y6'62S '8 '66Y'L9E'8 1000'608'8 '€8.2'EEL'0 '£96'88F'9 "SON WUsled 'S'N ‘ainjesay| Buigquosaid Bulfuedwoooe pesy :abesoq jensn dX3%® 101 dx3 HSINYVA ON 1071 21068/90¢HCZL N/S
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_6.jpg NDC 59011-276-60 8 09-92¢2-L106S _m_ g0-216€0¢€ 1£¥E-10690 L9 ‘Plojwerg *d"] ewlieyd enpind (4:98-:68) 008G} usamlag pajiwied suoIsINOXe ((d,//) D.62 1e 2101 “Jouleuoo juelsisal-ybi| ybiy e ul ssuadsig e 3 = —K O D M > JMA|Q g2 | £ 93 W S5 gEs]o0 o8 = Em o 855| x££ 5 £ ...‘m..n_w m ESE DnW.m a.US g2 0w o = © s = o D1ce ges| 2% o9 gcg o o c3S geZ| 85 o FEE| o + 2 amm OO Sl 8 =0 sce =58 bWuW o T S2s] 0 020 IS5 E8E| © =88 g8 22| 5 Scs < = o ° s T4 = 12838 ‘0v.'808'8 PUB £09'/¥9'8 102G 1SS'8 '8Y6'62S '8 '66Y'L9E'8 1000'60S'8 :€82'CEL'0 '£96'88F'9 "SON 1Uled 'S'N ‘ainjesay| Buigquosaid Bulfuedwoooe pesy :abesoq [ensn dX3%® 1071 dx3 HSINYVA ON L1071 2L06829SHS2L N/S
b7d23ac2-e776-9f62-3290-c64c2d6eb353_850_7.jpg NDC 59011-277-60 90-815€0€ s 09-222-1 _,oom 1£1E-10690 19 ‘Plojwerg *d"] ewlieyd enpind "(4.98-,69) 0-0€~SGH usamlag pajiwied suoisINoXs ((d,//) 0,62 1e 2101 “Jouleuoo juelsisal-ydi| by e ul ssuadsig Ao = —K o B > 2o g2 | £ g3 W S5 EE5| 05O = == x £ 2 = m; = Ec2 =g gog| T 32 0w 2385 0w S Iea S - FE iy 2% o9 g=g Q0 < §g5 T = C oo gf=| , 85 - OO0 s3] & =g v 338 s£5| 3 B3z 00 S22 o] & © 90 IS5 252| ® =353 28 23| £ 8 Es > << (=] o L <% 212385 ‘0v.'808'8 PUB £99'/¥9'8 102G 1SS'8 ‘8Y6'62S '8 '667'19E'8 1090'60€'8 ‘€8L'EEL' '£96'881'9 "SON W9led 'S'N ‘alnjesay| Buigquosaid Bulfuedwoooe pesy ebesoq [ensn dX3%® LO1 dx3 HSINYVA ON L1071 21060/9¢HETL N/S
b7d601f2-5378-429a-8b65-fb6a8aef4347_949_1.jpg Clonidine ER § 0.1mg Tablet Store at room temp of Compare To: 20°-25°C (68°-T7°F) Kapvay 0.1mg Tablet “Keep ail drugs outof | Actavis Elizabeth Inc: reach of children. om #30 Exp: MMYY oo easaorzesi | Orresioooo |
b80a4906-01a4-4815-8f8f-e77e64d21efb_689_1.jpg CLINICAL solutions WROLESALE Famotidine 20mg Tablets Qty:30 Mg, NOC: 65662-0859-01 (GTIN: 0035611808504 Mig_Lot - SAMPLE123 Batch #: SAMPLEASE Mig.By: Aurobindo Pharma Limited Exp. 0ct2019 East Windsor, N, USA, 08520 SH: YYMMDDOO0D00 Recios st et by it S sl LC neandnmarenann
b8114d53-aa6c-4abf-998e-9db86e4b4338_575_1.jpg HEHE LT A OXYGEN, REFRIGERATED Liquip usp / UN1073 7 — N L ALWAYS KEEP CONTAINER 1N UPRIGHT POSITION, T D0 NOT CHANGE OR FORCE FIT CONNECTIONS, s =8 i v st S e i ey PR i e i L e e e Prcced by Ar et OANGER: e custon v e, oxogen o BT G e v MU Wi wn o orvac uay U008 O 1 05 A A ) R PIRSTAD: 1 00 S T ot st e e, ot U o P e ST oA D0 NOT REwov Tius pRooucr LREL.
b8114d53-aa6c-4abf-998e-9db86e4b4338_575_2.jpg HEHE LT A OXYGEN, REFRIGERATED Liquip usp / UN1073 7 — N L ALWAYS KEEP CONTAINER 1N UPRIGHT POSITION, T D0 NOT CHANGE OR FORCE FIT CONNECTIONS, s =8 i v st S e i ey PR i e i L e e e Prcced by Ar et OANGER: e custon v e, oxogen o BT G e v MU Wi wn o orvac uay U008 O 1 05 A A ) R PIRSTAD: 1 00 S T ot st e e, ot U o P e ST oA D0 NOT REwov Tius pRooucr LREL.
b82f163b-c913-431d-88cf-8b6e08d1b42a_389_1.jpg nan
b82f163b-c913-431d-88cf-8b6e08d1b42a_389_2.jpg ey NITROGEN, REFRIGERATED LiQuiD NF UN1977 CONTENTS; LOT NUMBER: Ronly. ARNING:Adinistcaton of Wogen s tou o vt ‘ed. For use only by or under the supervision of a licensed rcions wholo S o e s somttiono Riogenand's vt o s, s o, sy a1 oo sl 210 i s, SonvARGesions i i i rcatons 05 ARNNG:CONTANS REFRGERATEDGA; Y CAUS CRYOGEN SURNS 08 M A DISPLAGE OXYGEL KD CALSE RAPID SUFfOGATON Donotbunde il s pracaions v e s 3nd oo U st ny tdors o a et i, Vit cold e v, S, v oy e, Uss nckfow rTive o oo, DONOTchangor s ot Gos e ahr 3w . v e ot 1 g ot R ad oo e Sl G e (85) b . FIRST AID: IF INHALED: Remove person o rsh ar and eep comforable for breating. 1F ON SKIN: Thaw fosted parts with lkewarm vater. D0 ot afected area. Got Immediate mdlca aiclatenton RS 7727-97:9 DO NOT REMOVE THIS PRODUCT LABEL. 772 MARION ROAD COLUMBUS, OH 43207 877-935-3377 sy
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3_165_1.jpg OG0T 1050 Naablets Invokano® (canagliflozin) Tablets [T Dispense with Medication Guide Eschiablecontains 100 mg canaghifiozin Koop outofreach of chikiren. ey (o)) i i § o Sn s et ot Storwat s 7 5 i acurirs PR e Sartesn € N 6-071-85708 e e, v by -t 0%, G, PAETTS e g L . s b, Tl N 050 owrrd i Tt PmaCopmon
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3_165_2.jpg oo 2y e o o 4750458-141-90" 0 st s o i i s oy oo e g s e owy ks :| Invokanae® ®| (canagliflozin) Tablets EITIT 2 i 2 i g i i wmiiza G aasoeasn o i, )0 5
b93fae8e-2b76-421e-95bc-ba08c211a7ea_594_1.jpg o RN NDC &2373-673-21 rceres (U 1 IO Hydrodhloride 3 63323-673-21 5 suie Injection B st Ao - gl Dot o b chgw e o e L B R aadct o S o i s i (0.05 mg* per mb) fido gt Wit For ntevenous jecon Oy, SUEITOSCEHUIT) s i Discard Unused Porton. " [asl5PCatddiombnpae] i Ly Vet it Mkndit 5mL SngleDase yrnge Lor: Rx only B
b93fae8e-2b76-421e-95bc-ba08c211a7ea_594_2.jpg Noc 2267321 Palonosetron Hydrochloride Injection (005 my” permy) Forlntaveousrecion O Dkcarwsd oon, Rcony 1x5 L SingleDos Syringe
b93fae8e-2b76-421e-95bc-ba08c211a7ea_594_3.jpg .. NDC 6332367389 Palonosetron Hydrochloride Injection e 005 ng"permt) Fetamarmetgesatny. S s ity
b9487a8c-5b28-4592-a994-3e378635983f_467_1.jpg @ % 555 £s 8 33 2 88anz g EESE = g so2 & g E>®S g IITET =& Exchtabet contain 400 g ethambutol hydrochloride, USP. Usual Dosage: See package nsert ing informaton. 25°C (68* 10 77°F) rolld Room Comemon § Ao e S ™ < ‘TEVA PHARMACEUTICALS USA, INC. = Pkl g 8 ¥ i 0555-0923-02 2 I
b955054b-b37d-4079-4fed-5939b763ecb4_822_1.jpg NDC 50268-144-15 Bulprenorphine and Naloxone Sublingual Tablets 50 Tablets NDC 50268-144-15 Bulprenorphine and Naloxone Sublingual Tablets @ 50 Tablets, lw 502 PHATMACIT:PLEASE DISPENSE WITH MEDCATN GUIDE PROVDED SEPARATELY g it oo Jprenomins 2m oo o5my sl Dose: 55 kg e o prescibing iomaton. Sore a2 w2 0(65 0771y gsions pomied ebnen 1510 30°C 9" o 6 s USP Contled oom B By et AVKARE, Inc. AVeRK APRODUCTOF AVKARE Mg, Rew 01-2017-02 e 0/16.7)
b955054b-b37d-4079-4fed-5939b763ecb4_822_2.jpg NDC 50268.145.15 Buprenorphine and Naloxone Sublingual Tablets @ 8 mg*/2 mg* NDC 50268.145.15 Buprenorphine and Naloxone Sublingual Tablets @ 8 mg*/2 mg* RxOnly 50 Tablets (5 x 10) Unit Dose iy UM PEASE DSPEUSEWTH MEDCATON GIOE FAONDED SRR ach gl bl i S s e et i Tomprsor il et ot il mere st KEEP S AN AL DR LT OF THEGEACH O CHLDRE. Mt R = PAK APRODUCTOF AVKARE i e 09 201501 winep
b98c5463-7f38-440d-928c-c0fa722b28ae_459_1.jpg (norethindrone tablets USP) 0.35 mg THIS PRODUCT (LIKE ALL ORAL CONTRACEPTIVES) IS INTENDED TO PREVENT PREGNANCY. IT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. n s 3 51862-100-06 4 VAYY HSINHYA ON. /1N1Ed ON 799-30-100989 Non Vamnish Area For Lot/Exp $5100989 8600108 Non Varnish Area For Lot/Exp 28R prie i e i i = | TSI Tet I I Err f (norethindrone tablets USP) | (norethindrone tablets USP) 035mg i 0.35 mg 3 : ‘ : ‘ ‘ ‘ i i Store at 20° 1 25°C (6E° 1o 77°F) [See USP Controlad | Each yllowtalet conains .35 mg norethindione, USP. | Room Temperature]. | Usual Dosage: One table daily as directed. See enclosed package nsert. | KEEP THIS AND ALL MEDICATIONS OUT OF THEREAGHOF | important: The *Patient Instructions” which are packaged inside each | CHILDREN. | foll pouch bear imporiant instructions for the patient. Please supply | | theseinstuctions to the patient when dispensing. | ‘ ‘ ‘ | | ‘ i | ‘ ‘ ‘ ‘ : | Manutactured by: e | “TEVA PHARMACEUTICALS USA, INC. o ' North Wales, PA 19454 ! | B | A s | ‘
b9c7597b-3371-487e-9f63-eaf97660f364_163_1.jpg e, e e s S s e Wwwg:ﬁﬁwwﬁwmﬁ o I i %ﬁ*ﬁ‘mw\“ﬁ“&%}“‘v el W@Mﬁvﬁﬁﬁi‘ﬁ‘” D B "o akon. WARNING: O 5 SIS CE e R A e o his S g 08 g e RS i L 5 . o . SR £ S nanE s PROD
b9c7597b-3371-487e-9f63-eaf97660f364_163_2.jpg Nitrogen, Refrigerated Liquid, NF o NON-FLAMMABLE (e UN1977 Rx ONLY Rx ONLY. WARNING: Administration of Nitrogen may be hazardous or contraindicated. For use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Nitrogen and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, contraindications and side effects, and the precautions to be taken. WARNING: CONTAINS REFRIGERATED GAS; MAY CAUSE CRYOGENIC BURNS OR INJURY. MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION. Do not handle until all safety precautions have been read and understood. Use and store only outdoors or in a well-ventilated place. Wear cold insulating gloves, face shield, and eye protection. Use a back flow preventive device in the piping. DO NOT change or force fit connections. Close valve after each use and when empty. Always keep container in upright position. Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF INHALED: Remove person to fresh air and keep comfortable for breathing. IF ON SKIN: Thaw frosted parts with lukewarm water. Do not rub affected area. Get immediate medical advice/attention. CAS: 7727-37-9 DO NOT REMOVE THIS PRODUCT LABEL ILIVIORE South EL Monte, CA91733 LIGUID AR COMPANY (626) 443-1361 GLA-33 E15
ba79d7ec-a781-c617-beee-909ea2f0672b_593_1.jpg Packaged by Enqant Ranch Burbank. A 91504 Metoprolol éw"“m“"bw Succinate ER 100mg Tablet & & Keep in light resistant Compare To: container perUSP Toprol XL 100mg Tablet S ST EMpGE Or Restys Lo i 20-25 C (68-T7F) oy #30 Exp: MM/YY NDC 6362943871 043871108975
baf9f88a-776a-44e7-82cc-8f0ca419572f_489_1.jpg Caffeine 60 mg per 3 mL [T Forintravenous use only. Prasorvative free. 3L single DoseYial Rxonly
baf9f88a-776a-44e7-82cc-8f0ca419572f_489_2.jpg Caffeine Citrate Injection, USP 60 mg per 3 mL [CORGIET 8] For intravenous use only. Preservative free. R only 3mL FRESENRIS Single Dose Vial th 2=
bb0d9cf1-4229-4d10-91cd-16a71c8af704_794_1.jpg nan
bb0d9cf1-4229-4d10-91cd-16a71c8af704_794_2.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED LIQUID usp UN1073 T ALWAYS KEEP CONTAINER IN UPRIGHT POSITION. T DO NOT CHANGE OR FORCE FIT CONNECTIONS. ums: 0 CONTENTS: cuFr O WARNING: USP For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, Rx only. Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effect on oxygen content of arterial blood, may be harmful. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment. Produced by Air Liquefaction. DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS REFRIGERATED GAS; MAY CAUSE CRYOGENIC BURNS OR INJURY. COMBUSTIBLES IN CONTACT WITH LIQUID OXYGEN MAY EXPLODE ON IGNITION OR IMPACT. Do not handle until all safety precautions have been read and understood. Keep and store away from clothing and other combustible materials. Keep valves and fittings free from grease and oil. Use and store only outdoors or in a well- ventilated place. Wear cold insulating gloves, face shield, and eye protection. In case of fire: Stop leak if safe to do so. Use a back flow preventive device in the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. DO NOT change or forcefi connections. Avoid spills. Do not walk on or roll equipment over spills. Close valve after each use and when empty. Always keep container in upright position. Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF ON SKIN: Thaw frosted parts with lukewarm water. Do not rub affected area. Get immediate medical advice/attention. CAS: 7782-44-7 DO NOT REMOVE THIS PRODUCT LABEL. KENT WELDING SUPPLY 66485 Hwy. 51 » Fluker, LA 70436 9857489418
bb20c158-87af-4d19-bc07-16dbd8e6e1f0_348_1.jpg Code B0042 50 ml Baxter MINIBAG PLUS s cieiee 0.9%... Sterile — Nonpyrogenc — Isatonio Solution for Infusion Single dose Each 50 mi contains ‘mmol (approx) Sodium Chloride 450mg Nar* 150 Water for njections _qs 150 Pl 5 (approx) - 308 mOsm/1 Hydrochioric Acid / Sodium Hydraxide q s For intravenous administration Read direction sheet prior 1o use Do not use unless solution is clear, free from visible particies and container s undamaged Check additive compatibiliy before useFor use under medical supervision Store out of reach and sight of children Store below 25°C Discard any unused portion Do not reconnect partally used bags vun;x container Baxter Healthcare Ltd Thetford Norfolk = By ot 083502450
bb20c158-87af-4d19-bc07-16dbd8e6e1f0_348_2.jpg Code 0043 100 m Baxter 'MINIBAG PLUS oot 0,9%.. Sterile — Nonpyrogenic - Isofonic ‘Solution for Infusion Single dose Each 100 mi contains. ol (epprox) Sodum Chioride 900mg Na* Water for Injections _qs O b1 pH 5 (approx) — 308 mosm/l Hydrochioric Acid / Sodium Hydroxide a's For intravenous administration Read direction sheet prior to use Do not use unless solution is clar,free from visible partcles and container 3| is undamaged Check additive compatbility before use For use undor medical supervision | Store out o reach and sight of children 8 Store below 25°C Discard any unused porton Do not reconnect partaly used bags VIRFLEX container ‘Baxter Healthcare Ltd o Thetford Norfolk Bt England PLOMG/557 Tt SR iy
bb34ee82-d2c2-43b8-ba21-2825c0954691_724_1.jpg TR OCRTTERTTI™ e A R R 4 SN IS oo P o [ s i R s For deltod or ghuteal intramuscular injection only SRR XX PLEASE READ COMPLETE INSTRUCTIONS PRIOR TO USE. RS Lot s ey v e 510>t e ‘|I'||'i’i'|siu § T:llnx:r:-:smswr:”}51‘11\:_::‘9“1’:;:‘:::“-; A acraesoon ) asowroon 0 neneini 0 0 g e oy 13 a3 o o e e g 3¢ g Loty i w0 i S o 33 o] A s el —— s e S e S LTEC] Lyl e o 4 12.5mg Dose Pack 250 0L 401N SNOLLONKISHI 31314H03 0V3Y 35¥A1d S it e AT KL KRXEREE, PR e RRXRIKXOK ——— Ehi 0 VisNOOppiedsRy XKKEK B Risperdal CONSTA -,/ TiSPENDONE tong-Acting Injection . DOSE PACK CONTNTS: One 125 mg vl rsperidoe xcens-sns micshers o eson + One e T inge g 2 . of One it Acpir One 214 UTW 1 S 3 sty sl o el ci ~ Ont 20 b TW 3 Teer St 3 ey e s gl s Do not substiute any components o th dose pack. eltoid o gutealintramuscular nfecton oly iy Each necton should b adnitistered by hesRhcare rofesional. Sy PLEASEREAD COMPLETE INSTRUCTIONS PRIOR T0 USE. P =_B = P Dose Pack
bb34ee82-d2c2-43b8-ba21-2825c0954691_724_2.jpg tsporcs For dektid or gutealintramuscular injection nly PLEASE READ CONPLETE INSTRUCTIONS PRIOR T0 USE, s B e o e 1 e oy i ul Loemni, SepiRiS e s iR S S e s Lok o 8 4 i § st o oo sttt ok o SRS © pLes0sssrog e o £ 1101530 o e o, R o e gy e T DG TONE s L o o oriany ey A e o 555 ) ASPA A 0d i o e s i e o e o s T Guucorston) s o 40 ooy 020 A P Emsz S s e oo 4 350 01 0K SNOLLINYLSHE 313140 OV3Y ISV uouogool easnuau e 10 Py 103 e TR Og A XXXHXXXX BRRKRRES e s Risperdal CONSTA ;/ TiSOEMDONE tong-acting Injection i e DOSE PACK CONTENTS: +'One 23 mg o opeeoe e e e e e e e i yige coranng 2k et * Onevt e * Gne 21 g UTW - T 3 ety e fordelo cn © Gn 20.gnge T e St 2 ey e o g et Do ot subsiie an components o the dose pck. For dehod o guteal intramuscularinjection nly N Each njctionshould be acministered by a ealthare professiona, Sy PLEASE READ COMPLETE INSTRUCTIONS PRIOR T0 USE. Lre Griseasousanstie
bb34ee82-d2c2-43b8-ba21-2825c0954691_724_3.jpg g RREEERLEAEELNLE BRRRRRRRS Pt e PLEASE READ COMPLETE INSTRUCTIONS PRIOR T0 USE, Bt [— ot e an e *wed as0q LSS R e T R S SR SR e 23 S - 5 “.wi;,n § e st S S ||I‘|| R i o 411555 S ) || e s o i s s HOGTONE s P = R oo atsaon) oL e s o wERE T e visNOOIopiedsiy 250 0L HOIN SNOLLONULSHI A3TdHOD OYH ISV Q00 vonsalu e3snueAu 1e313 10 PSR 103 e LA e 0 o 5045830711 37.5mg Risperdal CONSTA [EEET DOSE PACK CONTENTS: One 375 mg v rspro e ke icsphers o o O e 11 yenge cntaring 2 o v e i cotr One 2. gauge UIW 1o e ey el For ot mjction - 0 20 gge W 2 e S ey e For ghee cson Do ot subsice any components of the dose pack. For dekaid orglutealitramuscular njecton orly Eachnection shouki be administered by a heallhcare professional. PLEASE READ COMPLETE INSTRUCTIONS PRIOR T0 USE.
bb34ee82-d2c2-43b8-ba21-2825c0954691_724_4.jpg X v AR XX o | '—m asv0g ¢ g B RS Fhpedaconn '/,_P“_ For deltoid o glutealintramuscular njction ooy PLEASE READ COMPLETE INSTRUCTIONS PRIOR 10 USE. o 1 et 2300 ok e s 410355 st o gt b o S e T e o 285 S e P 0 e SR et Lo 458 e T AR Loy oy g s s unges e oy S e S S ey e s i o e oS 7 e S etz o) o % 2 e a0 2 LRSI S e oG, 4 d B KRR XRIKRRES BB LA Emos soeg as0q PR {1 09 [Eer moy Sl any 350 0L HOIN SNOLLONUISHI 3131403 0V3 3S¥31d Ao uopasfu sefrasnue:ju [eain o poyap 103 ———— Risperdal CONSTA 7, risOEDONE tong-Acting injection g e D0SE pACK CONTENTS: * One 50 mg v raprdoe xende e micrphres for i + On e T g contanng 2. of k. * One o epr © One 2T gauge UTW 1 ramo G 3 sty e o ek cion Ore 20 gaug T - e S 3 ey e For gt iecton Do ot subsiute any componenc ofthe dose pack. For dekoid o glteal intramuscular in Each nfction should be administered by a heahhcare professional PLEASE READ COMPLETE INSTRUCTIONS PRIOR T0 USE. Sl X E Rz fssiRaes) 0s R frasssaRd
bbf3e782-d163-49c8-0e81-4eeabef48190_935_1.jpg NDC 00743161 90 Trilipix® Fenofibric Acid Delayed Release Capsules Lt S0Capsules & Rxonly obbvie Do not acceptf seal over bt ring s brakon o missing. ~ Encn Buayed rnses ool contans: choios enofato equvaent 1 45 of Storo at25°C (76 excursions permitted to 15:30°C (55.66°F) see USP Gontrotled Room Temporaturel Protoct from mosture. Sco packoga st o Al resciong iormaton, Mdachrd o A6V Norn Cricagn I 60064, USA o Fourir Libcratora aand L oo, Carighiond, Co. Cor, et ProguctofFanco e [
bbf3e782-d163-49c8-0e81-4eeabef48190_935_2.jpg Lot SN: GTIN: 0300743162905 NDC 0074-3162-90 Trilipix” Fenofibric Acid Delayed Release Capsules PR T 90 Capsules Rxonly abbvie Do not accept if seal over bottle opening is broken or missing. * Each delayed release capsue contains: Choine fenofbrate equivalent to 135 mg of fenofibric acid. Store at 25°C (T7°F); excursions permitted 10 15-30°C (69-86°F) [see USP Controlled Room Temperature]. Protect from moisture. See package insert for ul prescibing information. Manufactured for ADDVEe nc. North Chicago, IL 60064, USA by Fourner Laboratories Ireand Ltd Anngrove, Carigiwonil, Go. Cork, Ireland Product of France 04c753R2
bbf3e782-d163-49c8-0e81-4eeabef48190_935_3.jpg B0, Lot N e 2 %5 (GTIN: 0030749642906 NOCO07A 564290 Trilipix® Fenofibric Acid Delayed Release Capsules Dispense Medication Guide (seepackage insert) with product. 90Capsules Rxorly. 0 not accept i soal ovor botto opaning Is roken or missing. Each dayed ieaso capsu conans: i onoforto ocuant 1 450 of oot aca. Storo at25°C (17 oxcursons pormited 1o 15:90°C (50-66°) se0 5P Gontrolled Room Temporature. Protact from moisture. Seo packog nsat for A reserong lomaron, Mandachaed o Ao nc North Gricag, I 60064, USA by e Labonatens rend Lt Ao, Gariivd, Co. Cork, oans ovgesRT -
bbf3e782-d163-49c8-0e81-4eeabef48190_935_4.jpg Bxp. Lot Product of N GTIN: 0300749189906 NDC 0074-9189-90 Trilipix” Fenofibric Acid Delayed Release Capsules 135 mg* Dispense Medication Guide (sec package insert) with product. 90 Capsules Rxonly ~ cbbvie Do not accept if seal over bottie opening is broken or missing. * Each delayed release ‘capsule contains: Choline fenofibrate equivalent to 135 mg of fenofibric acid. Store at 25°C (17°F); excursions permitted t0 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Protect from moisture. See package insert for ul prescribing information. Manuactured for AbbVie Inc. North Chicago, IL 60064, USA by Fourner Laboratories. Ireland Lid Anngrove, Garigtwohil, Co. Cork, Ireland See opposite sice of abel for Gustoms Country of Origin. 0488297
bc12bd87-5ef0-4ebe-bc00-cbd7896ce08c_233_1.jpg NoC 60567-309-21 Linezolid Tablets 600 [ Rxonly 1 1 (07)00360687 309 21 7 NDC 60687-309-21 Linezolid Tablets 30 Tablets (3 x 10) RxOnly 600mg Usual Dosage niormation Storo at 20" 1025°G (68" 1o 77°F): excursions permitted between S371350°C (59" 1o 6'F) 666 USP Contralea Room Temperature] Keep this and all drugs out of reach of chidren. FOR YOUR PROTEGTION: Do not use i biter s tom o broken T cug product ontained n i package s from NBCH 1722785, Camber Prvmabeut og, e Packaged and Distriuted by: Amencan igath Eackagng Coimous, Ono 43217 0 package insert for fulprescrioing 730321 oas0ezi/e1a
bc12bd87-5ef0-4ebe-bc00-cbd7896ce08c_233_2.jpg Linezolid Linezolid &g g‘, gammg o L I R i 5y 5y B T LI L T T S5 l O 003 0887 309115 g % e onaseoseTIR e &8bmg 58 E5 fomg e gi 3 T §E Szl Il {01) 003 60887 309 11 8 E &4 onasecseTsRie Wﬁmﬁﬁﬁﬂﬁ é i {o1) 00360897309 115 o1 a03e0087 30915 o0t e Expiry: x Lot oo
bc5b255a-052a-4d3f-baa3-10b20dbfb99d_214_1.jpg CLINICAL solutions WROLESALE ‘Tamsulosin HCI 0.4mg Capsules Qty: 30 Mg, NOC: 00228-2996-11 GTIN: 0035611003086 Mig_Lot : SAMPLE123 Batch #: SAMPLEASE Mig.By: Actavis Pharma, nc Exp. 0ct2019 Parsippany, NJ, USA, 07054 SH: YYMMDDOO0D00 Resckasator st by it Sos sl LLC
bc751403-94f2-4f9d-b533-cf6186a40ceb_79_1.jpg 7 NDC 59762-0073-1 [13754701 50 Tablets Store at controlled room temperature 20° to 25°C (68° 10 77°F) [see USP]. ¥ Dispense i tight (USP), w child-resistant containers. a ‘Warning — This potent drug. ‘must be used only under the T direct supervision of a physician. DOSAGE AND USE: a See accompanying prescribing C information. Each tablet contains 5 mg hydrocortisone. G Distrbuted by Greenstone LLC eapack, NJ 07977 5 GREENSTONE® BRAND hydrocortisone tablets, USP 6200731 z 1 o = o o GTIN: 003597 & 3 2 CE
bc751403-94f2-4f9d-b533-cf6186a40ceb_79_2.jpg 7 Store at contrlled room temperature 20°to 25°C (68° 10 77°F) [see USP]. Dispense i tight (USP), child-resistant containers o0 Warning - This potent drug must be used only under the directsupenvision ofaphysician. & DOSAGE AND USE: See accompanying prescribing information Each tablet contains 10 mg hydrocortisone. G Distrbuted by Greenstone LLC Peapack, NJ 07977 NDC 59762-0074-1 100 Tablets [13754401 GREENSTONE® BRAND hydrocortisone tablets, USP ik o 3 a GTIN: 0035762007414 & 3 2
bc751403-94f2-4f9d-b533-cf6186a40ceb_79_3.jpg , M3 N NDC 59762-0075-1 13754801 |} 100 Tablets Store at controlled room temperature 20° o 25°C (68° to 77°F) [see USPL. Dispense n tight (USP) ohild-resistant containers. Warning - This potent drug must be used only under direct supervision of a physician. DOSAGE AND USE: See accompanying prescibing information. Each tablet contains 20 mg hydrocortisone. G Distrbuted by Greenstone LLC Peapack, NJ 07977 GREENSTONE® BRAND hydrocortisone tablets, USP N00359762007513 NO COPY & 3 2
bcdb72e2-6f06-492e-9968-26d372b96aeb_111_1.jpg CAHOTRIGHE o0 TRBLETS —— TR TR 433 TAKE _THBLETS)_ THES ADAY ASDRECTED BY YOUR PRESCREER.
bcdb72e2-6f06-492e-9968-26d372b96aeb_111_2.jpg e LOTRGIE 08 TRRLETS = A e s Eefie ROV e ey _ e THES A DAY ASORECTED L BYYOURPRESCRBER
bce46b86-5ad8-4375-b04d-b25ce488ae29_859_1.jpg C
bce797cf-54a1-40c7-9ca5-1356878472e4_541_1.jpg seioq dx3 #1071 ¥00£0 N ‘Ploiyo] ST1 N s[ouneoouwbyg snusBu) :Ag painppjnuow 91/80 Aoy 9€0§ “[eaniosedwa) wooy pajjonuc) dsn 295] "(40££-089) DoST -0 #° 21015 © Q SEE8 o [, 20 ESD g >3 SwzrhSI Ob 228G 8nd 8 3 S EO0OON X|o g5nr| ™ E g 0ga®™ DhV:G NPH-I “Burssiuw Jo usjouq s [oesseuu Jtog pajuud 1 9sn jou oQ sjupgiodw) *ueup|iy> jo yonai ayy 0 §no suoypdipew ||p pup sy} deey *a1ns0[> 2 O YA ‘4SN Y4 Ut pauyep so JouIpjUOD WBY D Uy esusdsiq HSPPWIDYY “uoyowou; Buiguosesd sjo[dwoo Joj piesur eBoyo0d B e25 :9Bpsoq 4|NpY [PNSN “(es0q suiisjuayd jo B Og of jus|pAINba) B G/€ dSN SPHOJYo0IPAY sulLIBjUBYY SuIDjuOd §3|qp} Yon3 |
bce797cf-54a1-40c7-9ca5-1356878472e4_541_2.jpg ‘sioq dxg #101 ¥00£0 N ‘Ploiyo] ST1 N s[ouneoouwbyg snusBu) :Ag painppjnuow 91/80 Aoy ££0S “[eaniosedwa) wooy pajjonuc) dsn 295] "(40££-089) DoST -0 #° 21015 © Q s 05 A RETA 5 [q IS ELP E2S 2 EL w0 T 2 ESTL S oE 00N Xle gSHrI o c Cedb3 - 2L 50 Za g “Burssiuw Jo usjouq s [oesseuu Jtog pajuud 1 9sn jou oQ sjupgiodw) *ueup|iy> jo yonai ayy 0 §no suoypdipew ||p pup sy} deey *a1ns0[> 2 O YA ‘4SN Y4 Ut pauyep so JouIpjUOD WBY D Uy esusdsiq HSPPWIDYY “uoyowou; Buiguosesd sjo[dwoo Joj piesur eBoyo0d B e25 :9Bpsoq 4|NpY [PNSN “(es0q suiisjuayd jo B Og of jus|pAINba) B G/€ dSN SPHOJYo0IPAY sulLIBjUBYY SuIDjuOd §3|qp} Yon3 |
bce797cf-54a1-40c7-9ca5-1356878472e4_541_3.jpg ~ ‘eioq dxg #101 L hva z289zs ¢ ¥00£0 [N ‘Plolyo] ST1 N s[pouneooubyg snusBu] :Ag painpoynuoy L1/70 oy £805 “[eanjosadwa) wooy pajjonuc) dsn 295] "(40££7089) DoST -0 #° 810i5 © [] mmm”dsg 2 2ic ES2 E >3 0wl & = e L |'o 2l e 0°G L2 O |- @ SEOON X8 % & & =N Q S o E g 0ga™ - DhV:d ND.H-I “Burssiuw Jo usjouq s oesseuu Jtog pajuud 41 9sn jou oQ sjungiodw) *uaup|iy> jo Yonai ayy 0 §no suoydipew ||p pup sy} deey “a1nso[> 2 O YA ‘4SN Byt Ut pauyep so JouIpjUOD WYBY © Uy esuadsiq HsPPWIDYY “uoyowsopuy Buiguosesd sjo[dwoo Joj piesur eBoyo0d B °2g :9Bpsoq 4|NpY [PNSN “(es0q suiisjuayd jo Bu Og of jus|pANba) Bl G/€ dSN SPHOJY0IPAY sulLIBjUBYY Juod Jo|qp} YoP3 | S i i i b s |
bd405eab-ac43-4590-975d-d0d1e8f78833_242_1.jpg NTROUS OKBE usp uN1070
bd77ec6e-c58c-440b-81d6-8a462b2fdc9c_642_1.jpg Metoprolol Succinate Extended-Release Tablets, USP 100 Tablets Rx only *Each fim coated extended-release tablet contains metoprolol succinate 2375 mg equivalent to metoprolol tartrate 25 mg. Usual Dosage: See package insert for complete prescribing information Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a tight container (USP). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadia Healthcare Ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 81160 749y
bd77ec6e-c58c-440b-81d6-8a462b2fdc9c_642_2.jpg Metoprolol Succinate Extended-Release Tablets, USP 100 Tablets Rx only *Each fim coated extended-release tablet contains metoprolol succinate 47,5 mg equivalent fo metoprolol tartrate 50 g Usual Dosage: See package insert for complete prescribing information Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a tight container (USP). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadia Healthcare Ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 B1/60:1Y
bd77ec6e-c58c-440b-81d6-8a462b2fdc9c_642_3.jpg Metoprolol Succinate Extended-Release Tablets, USP o é = 100 Tablets Qbf._._”...s Rx only *Each fim coated extended-release tablet contains metoprolol succinate 95 mg equivalent to metoprolol tartrate 100 mg Usual Dosage: See package insert for complete prescribing information Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a tight container (USP). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadia Healthcare Ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 81160 A0y
bd77ec6e-c58c-440b-81d6-8a462b2fdc9c_642_4.jpg Metoprolol Succinate Extended-Release Tablets, USP [— —— ) oW 100 Tablets é?,.._z-v du__s Rx only “Each film coated extended-release tablet contains metoprolol succinate 190 mg equivalent to metoprolol tartrate 200 mg. Usual Dosage: See package insert for complete prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Dispense in a tight container (USP). KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 8160 'A%y
bd79aebb-b221-4844-8e4a-f848b7c52f16_687_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. oINK NDC: 55289-890-20 iz PD-Rx PHARMACEUTICALS INCORPORATED®, Oklahoma City, OK = 73127 55289-890-20 55289-890-20 55289-890-20 CLINDAMYCIN CLINDAMYCIN CLINDAMYCIN 5 CLINDAMYCIN HCL USP HCL USP HCLUSP g 300 MG 300 MG 300 MG 2 HCL USP 20 CAPSULES 20 CAPSULES 20 CAPSULES g ReUrder # 103057 ReOrder # 103057 ReOrder # 103057 E - LOT J18A47 LoT 118AA7 Lot J18A47 HE EXP 10/19 EXP 10/19 FXP 10/19 2" 300 MG < CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. e YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 2 20 CAPSU LES TAKE CAPSULE(S) TIMES A DAY. TOME CAPSULA(S) VECES AL DIA. (01)10355289890201 (21)118447000002 Each CAPSULE Contains: CLINDAMYCIN HYDROCHLORIDE 4 EQUIVALENT TO 300 MG 2 (17)191031 CLINDAMYCIN g (10)118A47 10206668259E IRV A0V TJTEGLIBS00 VIONI VD9 ILLIITVS vNLIA QL1 3LVAE YWEYHS NOSIYM
bda86975-8c2f-4c4e-9a4c-a1a959f9336a_898_1.jpg Capsules USP = g X s 2 18 E & g o 6TIN 0030033196017 100 CAPSULES 1 only KEEP TIGHTLY C Rov. B 612011 KEEP THIS AND ALL OUT OF THE REACH 333-32-101075 ¥ 0093-3196-01 i
bdb44c79-222a-4216-9f26-da9560329e1a_933_1.jpg o Vamished Area (00 Not Prit) (1841 mm) NoC 6832:21241 AT Zonisamide Capsules Dispense the accompanying 73 zydus “ATTENTION PHARMAGIST: Medicaion Guid fo each patent 100 Capsules R only £ apsdecois: Zonsamss - Zomg Usual Dossge: See packse et Complste ek oo, S 2120 025°C 681077 524 USF Conpoled oom Temperases] 2y pace anpoecied Fom ght. KEEP THS AND ALL THE DRUGS OUT OF THE REAGH OF GHILDREN. Manutsctured by Cosi Festncat 44 Smsdokad s Distriutod by: Zydun Phamscautias (USA) . Penningn, N) 06558
bdb44c79-222a-4216-9f26-da9560329e1a_933_2.jpg NoVamished Aea (Do Not Prin) (18 x1mm) NDC 68382-213-01 — Zonisamide — =EtEE Capsules - LR 522 057 Conroled o Temparoses] 2y pace andpotecied Fom gt © v KEEP THS AND ALL THE DRUGS OUT OF THE REAGH OF GHILDREN. ATTENTION PHARMACIST [—— Dispense theaccompanying Cotia Hestneze L1t Medication Guide fo each patent Fnmsdokad s 100 Capsules Distributed by: = s P aves ok . il
bdb44c79-222a-4216-9f26-da9560329e1a_933_3.jpg Grver Coing Templt No Varrished Avea (Do Nt i) 2905mm) Each capsue cotains: Zonisamide =-*" UsualDosage: Ses package nsetor Capsules ~ ==smssss Storeat20° 10 570 (66° 0 77°F) e USP Contoled Room Temgerature] i dy pace and protcted rom ight KEEP THS AN AL THE UGS o e NEAGH o e ETORRIRGET Mamtacturdy: Py e [ ftee e b B 7 " i ayus 0SS B a2 w2 Rxonly Pennington, NJ 0853¢
be514be6-727a-4d6c-993b-52144f8e6de8_99_1.jpg ;Eaa;ih vial geh\‘/jers ;mL su\u\mdn containing NDC 62756-218-40 'é 375 mg ibandronate monosodium : . = monohydrate, equivalent to 3 mg free acid; “)ﬂﬂdrﬂnate sﬂdlllm |ﬂ]8ﬂ|ﬂﬂ EE = sodium chioride, 25.8 mg; sodium acetate 2g g trihydrate, 3.315 mg; glacial acetic acid, K mg EL® (1 mg/mL) 22 s 0.516 mg and water for injection, quantity Sterile E 2 =5 sufficient to 3 mL. Discard unused portion. FOR INTRAVENOUSUSEONLY =E B8 Usual Dosage: For intravenous administration Ry gnly 2 *'é 2 E over a period of 15 to 30 seconds. See \ 3 mL Single-Dose Vial E = E = accompanying prescribing information. HB=3 Distributed by: AN 08512 Inc PJLB1285A PJLBI285A 185.05/2015 _ GUJ/DRUGS/28/3%
be514be6-727a-4d6c-993b-52144f8e6de8_99_2.jpg IeiA esog-ofuis Jw g g Auoxy \ ol KIND 351 SNONIAVHINI HO4 fur 1) Jw g/,6uw ¢ uonaalu wnipog ajeuoipueq) 0v-812-95£29 AN PUSEOS38A. PUSBOS3BA PSBOS38A “Each vial deivers 3 mL soluton cortaining 3,875 mg barcronate monosodium monohyerate, equivalentto 3 m free acid; sodium chioride, 25 8my; sodum acetate rhydrate, 3 315 m; olacial acetic acid, 0516 mg and waer for inection, quartty suffcentto 3 mL_ Usual Dosage: For intravenous administration over a period of 1510 30 seconds. See Dosage and Administation section of accompanying prescibing information fo directions for use. Store at20°to 25°C (68°to 77°F); excursions permited between 15° and 30°C (59° and 86°F) see USP Controled Room Temperature] Discard unused portion. Distibuted by: Sun Pharmaceutical Industres, Inc. Cranbury, NJ 08512 Mandactured by: Sun Pharmaceutica Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujaral, ndia PUSBOS3BA 155.05/2015 GUIDRUGS 2839 NDC 62756-218-40 Ibandronate Sodium Injection 3 mg*/3 mL (1 mg/mi Sterile FOR INTRAVENOUS USE ONLY Rx only One 3 mL Single-Dose Vial - G\ PHARMA PHARMACIST: Please dispense with Medication Guide provided separately. NDC 62756-218-40 Ibandronate Sodium Injection KH T R Sterile FOR INTRAVENOUS USE ONLY Rx only One 3 mL Single-Dose Vial
be632668-3a68-42a4-9082-d0e24848d7e8_551_1.jpg Doxepin HCI 10 mg Capsule arv: 30 ID #: MYLAN;1049 Expires: NDC #: 70518-1525-00 Shape: Capsule LOT #: Ref #: 00378-1049-10 MFG: Mylan, Morgantown, WV 26505 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
bf92a7d7-395b-4e2c-a3c4-66ebdbfd1052_354_1.jpg STORAGE Before Reconstitution: Store at 20° to 25°C (68° to 77°F).[See USP Controlled Roo Temperaiure ] After Reconstitution spersonats® i 5° (41 1077°F)_Proect from freezing. SHAKE WELL BEFORE EACH USE. DISCARD UNUSED PORTION AFTER 2 WEEKS. MIXING DIRECTIONS Tep bottle lightly t0 loosen powder, Add 24 mL of distiled water or Purifed Water (USP) to the botle Shake well USUAL DOSAGE: See Package |nsert for Complete Prescribing Information Distr by West-Ward Pharmaceuticals Corp. Eatontown, N 07 NDC 0054-0002-85 35 mL when teconstituted Fluconazole for Oral Suspension USP 10 mg/mL *each teaspoonful (5 mL) contains 50 mg [ R e This package contains 350 mg fluconazole USP in a natural orange-flavored mixture. FOR ORAL USE ONLY. ¥ WESTWARD R ony $8-2000-%500 ¢ s 10001542/06
bf92a7d7-395b-4e2c-a3c4-66ebdbfd1052_354_2.jpg STORAGE Bofore Reconstilution at20° 10 25°C (66° 1o ee 1SP Controlled Room Temperature | Afer Reconsttution Store suspen 55 (41 o B o sy SHAKE WELL BEFORE EACH USE. DISCARD UNUSED PORTION AFTER 2 WEEKS MIXING DIRECTIONS. Tap bott fght o locsen powcer Add 24 L d water of Purfied Water BBl e otte S wel USUAL DOSAGE: See Package Inse for Complete Presoribing Information Distr_ by West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724 7 NDC 0054-0003-85 35 mL when reconstituted Fluconazole for Oral Suspension USP 40 mg/mL *each teaspoontul (5 mL) contains 200 mg flucanazole USP when reconstituted. This package contains 1400 mg fluconazole USP in a natural orange-flavored mixture. FOR ORAL USE ONLY. ¥ WEST-WARD R, ony $8-¢000-%S00 ¢ 2 10001543/06
bf94fb3f-67fd-4175-b343-a4b7f912c4b4_775_1.jpg Mobic Meloxicam 15 mg Tablet arv: 30 ID #: M;15 Expires: NDC #: 70518-1580-00 Shape: Oval LOT #: Ref #: 00597-0030-01 MFG: Boehringer Ingelheim, Ridgefield, CT 06877 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
bfbe19cd-eb95-44b8-ad2e-34fb7f50d455_222_1.jpg Packbaged by Eryant Ranch Bibank. @A 9504 15, BLUE CAPSULE SHAPED GLEAD 01 Truvada 200/300mg Tablet 10 8z1z1 Store at room temp of Compare To: 20°25°C (68°77°F) Tiwada 20000mg Tabkt “Keop all drugs outof Giead Scieces ne reach of children. #3 Exp: MMYY NDC 6362975811 075811121287 om
bfdfe235-d717-4855-a3c8-a13d26dadede_267_1.jpg L -0L7-LLO6& MMM .z T 3§ B 21t nores 250 Rx ([ chlorice) Only codone hydro i extended-release tablets Wng 100 Tablets xyCont Purdue Pharma L.P. NDC 59011-410-40 0 oy “aAJ0SSIP 10 ‘YSNI0 “MaYD Yeaiq N3 Jou 0 9[OLM SIRQE) MO|[EMG SInEl Buueduioooe pesy ebesoq [emsn dXILOT gx3 HSINSYAON | 97 21068295221 N/S
bfdfe235-d717-4855-a3c8-a13d26dadede_267_2.jpg |m_‘.~|_‘—.ooﬁ £ Stmbord, CT 06901-3831 Purdue Pharma LP. 0997700 Ry w ([ chloride) Only codone hydro i extended-release tablets xyCont Purdue Pharma L.P. NDC 59011-416-10 0 oy 100 Tablets “BA[OSSIP 10 ‘YSNI0 ‘Mayp Yealq N3 Jou 0( 9[OLM SIR|CE) MO|[EMS aim uiguoseld Buikueduoooe pes ebesoq [ensn IXI/LOT gx3 HSINSYAON | 97 210682959221 N/S
bfdfe235-d717-4855-a3c8-a13d26dadede_267_3.jpg _Flcmcl_‘vooa n 66U 8L Y0 6L STV SO WA 511 (4:88-,65) 0:08<5t Usamaq PoIULB SUOISINGXE '(4,£7) .53 18 BI0IS JowEI00 WeIS B D1 ¥ Ul esuecsi @ chloride) 2 100 Tablets the patient upon dispensing xyCont Attention Dispenser: Accompanying Medication Guide must be provided to (oxycodone hydro extended-release tablets Ong NDC 59011-420-10 0 "BA[OSSIP 10 ‘YSNID ‘MaYd ‘yealq 2 J0U 0( "9[OLM SIBQE} MO||EMS ainieiey| BUqosaid Buikueduioaoe peay -ebesog jenspy IXILOT gx3 HSINYVAON | 97 2L068295%¢€2L N/S Purdue Pharma LP. Ry, Only Stamford, CT 06901-3431 302678-0D Purdue Pharma L.P.
bfdfe235-d717-4855-a3c8-a13d26dadede_267_4.jpg (4:88-68) 0051 Uamaq oK@ (41 4) 055 18 21015 1B D © Ul s Stamford, CT 06901-3431 Purdue Pharma LP. 302079-0D il = nlve £ IM% o T 25 Do =8 o E3y E 3 o v O o @ T E = g Q2 22 Q5w 23 = 5 g = ige % bs B S g 2 O 5% ed “aAJ0SSIP 10 ‘YSTID ‘WAL YYealq 12 10U 0( "2JOLM SR} MO|[EMG ainigsey| Buigoseid BuikLieduioaoe pesy eBesog fensn IXILOT gx3 HSINSYAON | gq 2L068295Y¢2L N/S
bfdfe235-d717-4855-a3c8-a13d26dadede_267_5.jpg 8OL-0%%-LL06 ﬁ £ g DO Tuegm s w15 L S ST AR 51 (4:98-65) 040831 UsBMaq poNUIE SUOISINONS ‘(407 1) 0.5 18 81015 ToUEwo0 WErse R BT U ssuedsid @ chloride) mn g S s Cont ycodone hycror extended-release tablets NDC 59011-440-10 Ox (o “2A[OSSIP 10 ‘YSNI0 ‘Mayp Yyeaiq N3 Jou 0( "S[OLM SIBQE) MO||EMG Buikuedu0o0e peay :eBesog [ensp IXILOT gx3 HSINSVAON | 97 2L068295%¢2L N/S Purdue Pharma LP. Stmord, CT 06901-3431 50298000 Only Ry 100 Tablets H s £ 5 2 o ® 3 3 5 a
bfdfe235-d717-4855-a3c8-a13d26dadede_267_6.jpg B0 e 092 0089 682 P25 9V 21 L TS0 S SON WAk 11 (.88-65) 00839} UaamIsq ponLBd SUOISINXE (4o47) 0.5 I 81015 JouEon yes B0 1 ssuedsy @ odone hydrochloride) extended-elease tablets OxyConti NDC 59011-460-10 {oxyc “@AOSSIp 10 YSNIO ‘MY Healq 10 J0U 0( "2[OLM SI9[q 2} MO|[EMG s BLIfLEd1I000E PEsy IXILOT gx3 HSINSYAON | 9q 2L068296%¢2L N/S Stmiord, CT 06901-3431 Purdue Pharma LP. 302081-0D Only 100 Tablets Ry
bfdfe235-d717-4855-a3c8-a13d26dadede_267_7.jpg -08%-1106 = 32 BE e (4.98-65) 0,085k Usampq mm & pouLLod SUORINGN (4o /) 3,551 91013 B B & e e esiedsi] £8 & C@ S o S22 £ 8= o = = sESZ ME O 2 =8 < 2 Qo £ = =5 @ 1Q ks " S P~ o S HSE = 2O 8% 8 “3AJ0SSIP 10 “YSIID ‘WAL Yealq 13 10U 0( "2JOLM SIRIQR) MO|[EMG Bulktiediioooe pesy eBesoq [ensn IXILOT gx3 HSINSYAON | 9q 2L068295%¢€2L N/S
bffdad28-c3a2-4498-b037-e73672db7801_78_1.jpg Dextrose 50% 25¢/50 mL Injection for L.V. Use arv: 50 ID#:. Expires: NDC #: 70518-1427-00 Shape: . LOT #: Ref #: 00409-7517-16 MFG: Hospira, Inc, Lake Forest, IL 60045 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
c075c688-67f1-44d2-933d-11b50afb3b14_532_1.jpg Pachaged by Eogant Raeck Bnbank. €4 91504 Verapamil HCl §feommmanas ER 120mg Tablet 10° 8121 Keep in light resistant Compare To: container perUSP Calan SR 120mg Tablet Store at room temp of Wi Prarmeceutakive. 2025 C 8-T7F) #30 Exp: MMYY & NDC 7133507031 047171117218
c075c688-67f1-44d2-933d-11b50afb3b14_532_2.jpg Pacbaged by Eryant Ranch Bunbank. 04 91500 Verapamil ER 5 Mecsrsuesweonn 240mg tablet & [ & store at room temp of Compare To: 20°25°C (68°-77°F) Calan SR 240MG Tablel “Keep al drugs outof Wn Phormaceuicabine. | reach of children, #30 Exp: MMYY 3 NDC 7133507571 030521118035
c0acc97d-3d8d-4a7f-8acd-99050b0af2f1_270_1.jpg ALCOHOL OR ALCOHOLIC BEVERAGES SHOULD NOT BE CONSUMED WHILE TAKING THIS MEDICATION. 2= § Lo e A VAN B o) = 8:8 55289.972-90 55289.972.90 55289.972.90 E =_—-:'§ PARoxetine PARozxetine PARl?xetine L USP USp SP o =—a 20 MG 20 MG 20 MG %"’ == 90 TABLETS 90 TABLETS 90 TABLETS g2 =] REORDER #100370 REORDER #100370 ~ REORDER 4100370 Z=8=—; LOT [18C80 LOT [18C80 LOT 118C80 g8=H EXP 11/19 EXP 11/19 EXP 11/19 EL= == CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. E g ::§ YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 i =% — TAKE__TABLETIS)_TIMES A DAY, 5e é -1 TOME__TABLETA(S)_VECES AL DIA. 8 ORGANOLEPTIC MARKINGS: WHITE ROUND/BISECT ZC 16 NDC 55289-972-90 |PD-Rx PHARMACEUTICALS | & 0 INCORPORATED® EE Oklahoma City, DK « 73127 E = S PARoxetme E= i _gz-' — = MG = = 90 TABLETS — Each Tablet Contains: § —_— PRofIE s g= PARORETINE 20 MG = < o=
c11994cf-e88b-4cbe-a2b0-c06eae3a09aa_845_1.jpg NG 1671485201 “Each fim coated extended-release tablet ‘contains metoprolol succinate 23.75 mg = equivalent to metoprolol tartrate 25 mg. Metoprolol Succinate . e se pciage ner o complete prescribing information. Extended-Release greesimroe fner Tablets. USP [See USP Controlled Room Temperature], s Dispense in a fight container (USP). KEEP THIS AND ALL DRUGS OUT OF ‘THE REACH OF CHILDREN. Manufactured for: Northstar Rx LLC Memphis, TN 38141 100 Tablets manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Product of India 155092018 ‘GUJIDRUGS2511932 0 SOUPOH eleeeH SO 50020 (LI T
c11994cf-e88b-4cbe-a2b0-c06eae3a09aa_845_2.jpg NOC 16714-853.01 *Each film coated extended-release tablet contains metoprolol succinate 47.5 mg 8 . g equivalent to metoprolol tartrate 50 mg. d Metoprolol Succinate o ocue: seemrcge erio | complete prescribing information. 7 Extended-Release St A 7 R T F [See USP Controlled Room Temperature]. i Tablets! USP Dispense in a tight container (USP) 3 KEEP THIS AND ALL DRUGS OUT OF g THE REACH OF CHILDREN. 8 Manufactured for: Northstar Rx LLC §3 Memphis, TN 38141 100 Tablets manutactured by: Cadila Healthcare Ltd. Ahmedabad, India. Product of India 152092018 GUJDRUGS25/1932 M T
c11994cf-e88b-4cbe-a2b0-c06eae3a09aa_845_3.jpg NDC 16714-854-01 “Each fim coated extended-release tablet contains metoprolol succinate 95 mg gu=z - E g quivalent to metoprolol tatrate 100 g : Metoprolol Succinate icie sopaos st n complete prescriing informafion = Extended-Release ks e F [See USP Controlled Room Temperature] 1= Tablets, USP Dispense in a tight container (USP). o o — = KEEP THIS AND ALL DRUGS OUT OF fo==i 1 00 m g THE REACH OF CHILDREN. 3 Manufactured for: Northstar Rx LLC §% Memphis, TN 38141 100 Tablets manutactured by: Cadila Healthcare Ltd. Ahmedabad, India Productof dia Iss 092018 GUJDRUGSI25/132 *NORTHSTAR;
c11994cf-e88b-4cbe-a2b0-c06eae3a09aa_845_4.jpg NDC 16714-855-01 “Each fim coated extended-release tablet contains metoprolol succinate 190 mg equivalent to metoprolol tarirate 200 mg. fe= Metoprolol Succinate usuipesage: see ackage nsrton g complete prescribing information. S o — Extended-Release Store at 20° to 25°C (68° to 77°F) g = Tablets. USP [See USP Controlled Room Temperature]. Fees t ’ Dispense in a tight container (USP). g KEEP THIS AND ALL DRUGS OUT OF o= THE REACH OF CHILDREN. g o Manufactured for: E— Northstar Rx LLC SE Memphis, TN 38141 Manufactured by: Cadia Healthcare Ltd 100 Tablets 5ievabe, Inde. Product of India 1550812018 GUJDRUGSI25/1832
c1293d51-b633-486c-8e13-fcf60063faeb_743_1.jpg ‘uop2afuy 0 21em pue ‘Hd SpE 03 apPOIPAY WINPOS BIeydsoyd WINPoS 21seqP PuE (SEqOUO SILBIPRIGU| A DR 1016 DU 57 01 3US] ANba a1eatewy fcu SU eRuo> T e pouadoua2q 5oy 26020 1§ 4 124D (UL IO UM 57 WO WO} D201 BUIZ221) WO DO (1,98 010651 DF OVt “aniniadu3) woo 10 (noday) o) Yun pasnunzicls. o SN YILAY ATILVIAIWWI NOILYOd 3SNNN advosIa ~asuy sbesped Buikuedwone 935 :30¥S00 LINAY VNSN 3500 LINNTWED X0 (/B 3¢ @yesie folow1L) JueieAInba fojou L (NOLLI0S INIVHLHAO (35N3dsi) AAVN 010D #3S0ANDO U! DILdOWIL Kjuo xy §Z-86¥1-£810DAN NDC 0187-1498-25 Rx only TIMOPTIC® in OCUDOSE® 1MOLOL MALEATE (DISPENSER) PHTHALMIC SOLUTION) Timolol Equivalent (Timolol Maleate 3.4 mg/mL) 6003 mL UNIT DOSES FORTOPICAL APPLICATION IN THE EYE PRESERVATIVE-FREE STERILE OPHTHALMIC SOLUTION BAUSCH-+LOMB NDC0187-1498-25 Rx only TIMADTIC® (v Y 1LIDNCE®
c1293d51-b633-486c-8e13-fcf60063faeb_743_2.jpg e S e 301§ XEP3 SUIEIN0 | 1205 ‘BU3ND E1 3P IZ J9IIUN AOIRICqE) :Aq paimejnueiy S0 20880 1N 501M3BPLIg T] E3LBY ULON SEXII23ULIRUG 1IN J0 UOISAP © QUIOT +pSneg :i0y Pamdeueiy on 25U 10} 13 PUEHd ISP 31X A LTS 1 dSOd LN oS ISEQp pu e FStoUOL 1UB|pa bl o] 1010 BU § 0} Ua[EANba BIEBfew [O1CL) SUIEO3 T Y3 'pauado 0230 soy 620 10) 2 124D U0 U0 UM 25) B Was} D20 BUZE0Y WO DRI 98 ) 5) ) O 01,51 “anoiaduz wool 10y od aya y3ion pRsnUn il m"lll'l'l "ISN HALAY ATALVIAIWINI NOILHOd d3sNNN advosia “uasul abeyed Buifueduwiodde 235 :39¥S0A L1NAY WNSN $3500 LINN W £0X09 (B '3 @3ealeN ofowLL) oleAinba ojouwL (NOILMOS JIWTVHLHAO (y3sN3dsia) AYITYW T0T0WIL) #350AND0 U! ,JILdOWIL Auoxy 50-96% L-£810 2N NDC 0187-1496-05 Rxonly TIMOPTIC® in OCUDOSE® (TIMOLOL MALEATE (DISPENSER) (OPHTHALMICSOLUTION) Timolol Equivalent (Timolol Maleate 6.8 mg/mL) 6003 mL UNIT DOSES FOR TOPICAL APPLICATION IN THE EVE PRESERVATIVE-FREE STERILE OPHTHALMIC SOLUTION BAUSCH¥LOMB
c2822937-778d-4a2e-8f65-86bc8b92c1f8_639_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. PEACH 43063-638-10 43063-638-10 43063-638-10 levaFLOXacin levaFLOXacin levaFLOXacin & usp usp usp 2 500 MG 500 MG 500 MG = 10 TABLETS 10 TABLETS 10 TABLETS g ReOrder # 109063 ReOrder # 108063 ReOrder # 109063 E nﬁ LOT J18ES8 LOT J18ES8 Lot J18ES8 g = EXP D4/20 EXP 04/20 EXP najzo Q CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: 500 MG OF LEVOFLOXACIN usp OBLONG NDC 3063 638-10 8| Okiahoma City, OK « 73127 levoFLOXacin USP 500 MG 10 TABLETS < 01)10343063638101 (21)418E58000001 (17) 200430 (10)J1BES8 TOTBESEIOEPE JIONI'HS3aVEd TYHIYNIH "aLTVYWHYHY SG0IDVIN BOZZOOZVEEE
c2ae1141-4b73-469f-a14b-f1a52628c2d2_381_1.jpg - NDC 71205-109-50 Lot &00000 et Exp. 00/00/00 & ProficientRx > e EMASTER RX Only Ondanseon g /mL ﬁr:lm%ai Solution ;ﬂxﬂﬁ;\)sﬂr’gg o Ondansetron 4mg / 5mL etz o . Ond: A SmL. 50ml Oral Solution Ea“;m‘“sﬂ",‘f“;,mmmm Lol Exp:00/0000 Each 5ml contains: 5mg of ondansetron HCI dihydrate NOC 71205-108-60 F equivalent to 4mg of ondansetron Ondansetron 4mg / SmL See package insert, 50ml__ Oral Solution Rk MASTER Lot #00000 ExpO0R000 Product ID: SO010950 ST Mit. By: Silarx Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc. Carmel, NY 10512 Made in USA Relabeled By: Proficent Rx LP Store at 20°-25°C (68°-77°F) Keep medication out of the reach of children ‘Thousand Ozks, CA 91320
c2dc2109-44a6-4797-b04e-18761dd9d45a_955_1.jpg Le8s22 pev 00 08/18 GTIN: 0324478321024 Void Aqueous Quillivant XR® NOC 2447832102 Quillivant XR* NOC 24478-321-02 methylphenidate HCI methylphenidate HCI x . o | e i aare . Quillivant XR Quillivant XR' methylphenidate HCI — melhylphemdate HCI 25 mg/5 mL for exten 50 oral suspension | 25 mg/s mL for extendec 156 oral suspension s mg/m) when reconsiteted (S mpmt) when reconsated 10 SECONDS BEFORE EACH USE. 10 SECONDS BEFORE EACH USE Prarmacit bomaten 25 mg/5 mL Zatetlotrmaten. 25 mg/5 mL C ERTIITAE | (gt whenreconstiuted UL | EREIIESIN | (s mg/mi) whenreconstiuted UL s kg P S SHAKE WELL FOR AT LEAST g SHAKE WELL FOR AT LEAST Tt o g 10 SECONDS BEFORE EACH USE Lo e 0uewman st |10 SECONDS BEFORE EACH USE BRI e v s s - ok ken e T e Pharmacist: Quillivant XR must CIES v e oty dsprc Pharmacist: Quillivant XR must | | D€ recOnslluted with 53 mL Lppmiesaie” 7" || be reconslituted with 53 mL Deerse o Sig kg o of water prior to dispensing, I s . of water prior to dispensing, LI il s s ST ek v, Pharmacist: Dispense the enclosed | *Iilz Sy syeposes | pharmacist: Dispense the enclosed Ve i Medication Guide t0 each patient, | +iior semamts, | Medication Guide to each patient. T Sttt s e KEEP OUT OF THE REACH iaieferan KEEP OUT OF THE REACH ey v s Detmedy OF CHILDREN T (TIMAERY | OF CHIL DREN e IR e s et . Semmcrhmacean e | Ry only e o Sy Rxonly e @Tris Liquux @Tris Quillivant XR® methylphenidate HCI void Aqueous
c2dc2109-44a6-4797-b04e-18761dd9d45a_955_2.jpg Le8s22 pev 00 08/18 GTIN: 0324478321024 Void Aqueous Quillivant XR® NOC 2447832102 Quillivant XR* NOC 24478-321-02 methylphenidate HCI methylphenidate HCI x . o | e i aare . Quillivant XR Quillivant XR' methylphenidate HCI — melhylphemdate HCI 25 mg/5 mL for exten 50 oral suspension | 25 mg/s mL for extendec 156 oral suspension s mg/m) when reconsiteted (S mpmt) when reconsated 10 SECONDS BEFORE EACH USE. 10 SECONDS BEFORE EACH USE Prarmacit bomaten 25 mg/5 mL Zatetlotrmaten. 25 mg/5 mL C ERTIITAE | (gt whenreconstiuted UL | EREIIESIN | (s mg/mi) whenreconstiuted UL s kg P S SHAKE WELL FOR AT LEAST g SHAKE WELL FOR AT LEAST Tt o g 10 SECONDS BEFORE EACH USE Lo e 0uewman st |10 SECONDS BEFORE EACH USE BRI e v s s - ok ken e T e Pharmacist: Quillivant XR must CIES v e oty dsprc Pharmacist: Quillivant XR must | | D€ recOnslluted with 53 mL Lppmiesaie” 7" || be reconslituted with 53 mL Deerse o Sig kg o of water prior to dispensing, I s . of water prior to dispensing, LI il s s ST ek v, Pharmacist: Dispense the enclosed | *Iilz Sy syeposes | pharmacist: Dispense the enclosed Ve i Medication Guide t0 each patient, | +iior semamts, | Medication Guide to each patient. T Sttt s e KEEP OUT OF THE REACH iaieferan KEEP OUT OF THE REACH ey v s Detmedy OF CHILDREN T (TIMAERY | OF CHIL DREN e IR e s et . Semmcrhmacean e | Ry only e o Sy Rxonly e @Tris Liquux @Tris Quillivant XR® methylphenidate HCI void Aqueous
c2dc2109-44a6-4797-b04e-18761dd9d45a_955_3.jpg 26 rey 00 08718 Void Aqueous. Quillivant XR® | Mwezsmazos Quillivant XR° NOG 24478-323-05 methylphenidate HCI . mal'wiphnmnl(u NCI for axtancec-release oral susoansio 103 axtandecokase n 750 mg/150 m. total volume Qu“'lvant XR QUIlllvant XR for e valgaosoril et 25 mg/5 mL G @ 5 mgmt) whenreconstiiss {5 m/ml whenreconstited g 750 mg/150 mL total volume Y [ niypamsmmns 750 mg/150 mL total volume ryesstsra L (LSRN | S ctconos SErOnE EAch use ey P b P 25 mg/5 mL 25 mg/5 mL ST (5 mg/m) when reconstituted SEMIEEHANI | @ mo/m) when recontiuted Pt etn o i S e == = e iy o i i ‘SHAKE WELL FOR AT LEAST s swwtoyeness | SHAKE WELL FOR AT LEAST B 10 SECONDS BEFORE EACH USE o 10 SECONDS BEFORE EACH USE S PO TR e Phamacist: Quillvant XR must Dupense = 0ng 2 pack ying arde be reconstituted with 131 mL of be reconstituted with 131 mL of e e reens g, water prior to dispensing. water prior to dispensing. o et o s e Pharmacist: Dispense the enclosed | kit ocry s v Pharmacist: Dispense the enclosed Stare 21 25 (77°F): excursions permitnd Medication Guide to each patient. T tord cow e town e wi Medication Guide to each patient. T e e o ok g KEEP OUT OF THE REACH et o KEEP OUT OF THE REACH Distrivsne by OF CHILDREN mmm QULLIANT IR ety OF CHILDREN Rxonly s | Rxonly et @Tris / Void \ / \ Aqueous
c2dc2109-44a6-4797-b04e-18761dd9d45a_955_4.jpg i b0saTa2ca0s void Aqueous Quillivant XR* methylphenidate HCI ) NDC 24478-324-06 Quillivant XR* methylphenidate HCI Jod-release or: Qumlvant XR" idate HCl ) s NDC 24478-304-06 Quillivant XR° methylphenidate HCI R € B s @ SHAKE WELL FOR AT LEAST 900 LI TAEVRIRE R TN | siaxe weLt FoR AT LEAST 900 mg/180 mL total volume 10 SECONDS BEFORE EACH USE ot el 10 SECONDS BEFORE EACH USE (decmimmusnadusrdueuelnsens o | 25 MY/5 ML o psmoprase | 23 MY/ ML e (6 mg/mt) when reconsttuted St I | @ mam) when reconstiuted e st S et o sl ‘SHAKE WELL FOR AT LEAST e ‘SHAKE WELL FOR AT LEAST e e P 10 SECONDS BEFORE EACH USE o T 10 SECONDS BEFORE EACH USE e s ok Bt or g o o oy S ‘Pharmacist: Quillivant XR must | | %, Pharmacist: Quillivant XR must Capmiy ety e be reconstituted with 158 mL be reconstituted with 158 mL v icbaet e g e+ of water prior to dispensing. of water prior to dispensing. ki s 3 P e Pharmacist: Dispense the enclosed | * Pharmacist: Dispense the enclosed S Medication Guide to each patient. | - Medication Guide to each patient. KEEP OUT OF THE REAGH g:":" EEP OUT OF THE REACH R oo et v, Rxonly EEENEEEEST | Axonly 2Tris Liqu 2Tris Quillivant XR, methylphenicate HCY @ i \ / mmwmmlmlmh_ iz / Void \ / gty / e
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_1.jpg ajeq dx3 3 #107 104 eIy PaysiueAUp ‘Wi g X g 021 20-810¢-20 Ny "VIONI UT 9pepy 10880 N “8emabpLig 971 Sagualasolg jeauwy :Aq siq 66 1/8/9 'ON ‘91 “BIy "Hasul aag :abesoq [ensn *UOLIBD Ul [BIA 810G "ajelabiliyal 10 92331} 10U 0( ‘||9M 3)eYS *asn [eoayjespul Jo ‘jeinpida ‘rejnaoexul ‘qj ‘Al 40} 10N table Suspension, USP -1 Rx only lone Acetonide Injec riamcinol 40 mg per 1 mL NDC 70121-1049. Intra-articular use only For Intramuscular or T
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_2.jpg UCHED Y9Ba U0 ‘ou [eLas anbjun pue dx3 ‘107 ‘NILD JO BIEP 3|qRLIEA NDC 70121-1049-2 Triamcinolone Acetonide Injectable Suspension, USP 40 mg per 1 mL For Intramuscular or Intra-articular use only 1 mL Single-Dose Vial Read all sides “pajuuid aq [leyS Xpjew eep az WM Space for UPs No. Each mL provides 40 mg triamcinolone acetonide with 0.65% sodum chioride for isooricty, 0.99% (w/) benzy alconal added asapresenvatie, 0.75% carboymethylcsiulose Sodium, and 0.04% polysorbate 80 in an agueoLs Suspension; sodfum hyerodde orhydrochiorc acd may be present to adust pH 10 5.0t 7.5 Shake well before using. NOT FOR INTRAVENOUS, INTRADERMAL, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE. Usual Dosage: See insert for dosage information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature], do ot refrgerate, avoid freezing and protect from light. Store val in carton. NDC 70121-1049-2 Triamcinolone Acetonide Injectable Suspension, USP 40 mg per 1 mL For Intramuscular or Intra-articular use only 1 mL Single-Dose Vial Read all sides NDC 70121-1049-2 Triamcinolone Acetonide Injectable Suspension, USP 40 mg per 1 mL Mfg. Lic. No. /28/1539 Manufactured by Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit Anmedabad 382213, INDIA Distributed by: Amneal Biosciences LLC Bridgewater, NJ 08807 Rev. 10-2018-01 121 I 10452 e 70
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_3.jpg Size: 95 x 45 mm. (L x W) Variable data of GTIN, Lot, Exp and unique serial no. on each carton with 2D data matrix shall be printed. Space for UPs No. siep e g-abus w | x5z uo asn sejnon -enuy 1 @ pOSHWEY 03 RN v dsn ‘uoisuadsng sjqe3dafu] 9pIu0332y SuojoudWELl | SO0L- 210200 1 DG 7012110495 Exch ml pices 40 mg biamcinclone acetoride with 0.65% sodium chlorde for isotoricty, 0.99% fuh) benzylacohol | adiod 2 2 presevatie, 0.75% crboxymetylose sofium,and ) 04% polsortete 80 nan agueous cspension + sodium hyroside o hydochionc acid may b present 1 adust p 105010 75, ' 1 Shake wellbefre using. NOT FOR INTRAVENOUS, INTRADERMAL, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE. Triamcinolone Acetonide Injectable Suspension, USP P i B ——— 1 U Do oo st g st 261 mSingle-Doss Vs e 2 7 ok B Wi ol S i Read all sides. ! Sere vt ' Reonly | NOC 70121-1049-5 Triamcinolone Acetonide Injectable Suspension, USP 40 mg per 1 mL For Intramuscular or Intra-articular use only 251 mL Single-Dose Vials Read al sides 1 Mig Lic. No. 62811539 i | Maniactyed by | Amneal Pharmaceuticals Py, Lid. 1 Parenteral Unit | Anmedabad 387213, NDA | Disuiedby 1 Arneal Biogiences LG 1 Bidgowatr O3R! ! Rev 07201803 104¢ i 012 i 5 H7 N| 3 5
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_4.jpg ajeq 'dx3 B #07 104 ealy paysieaun “ww Q1. X 0g 921§ 189LL g L2L0L €0-810¢-20 "od ‘VIONI Ul 8pei /0880 N ajemabplg 971 S39Ua19s01g [EauULY :Aq painquisia 6EGH/82/9 0N 91BN “uoReLLiojul abelo)s pue afiesop Joj yasul 833 :abesoq ensn “UOLD Ul [BIA 810G "ajesabiLyal 10 azaaly Jou 0( '[|aM aXeYS "asn [edL AU IO ‘leanpida ‘“4ejnaoesu ‘gl Al 104 10N Rx only 1 lone lamcino Acetonide Injectable Suspension, USP 200 mg per 5 mL (40 mg per mL) 5 mL Multiple-Dose Vial NDC 70121-1168 For Intramuscular or Intra-articular use only Tr
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_5.jpg Space for UPs No. ‘pajuud aq ||BYS XiqeW Bjep gz yum UoMEI YoEa Uo "ou [elas anbiun pue dx3 07 ‘NILD Jo Ejep ajqele NDC 70121-1168-1 1 Mig. Lic. No. 6/28/1539 Manufactured by: Amneal Pharmaceuticals Pvt. ' NDC 70121-1168-1 ¥ Each mL provides 40 mg triamcinolone ' ¥ acetonide with 0.65% sodium chioride 1 1 for isotonicity, 0.99% (wA) benzyl : : 1 alcohol added as a preservative, : . Triamcinolone 1 0.75% carboxymethyicelulose Sodium, Triamcinolone ktadr-m B Acetonide Injectable | a1004% pysorbete 80 inan Acetonide Injectable | anmedabad 382213, NDIA W ¥ aqueous suspension; sodium hydroxide o Suspension, USP ¥ or hydrochloric acid may be present to Suspension, USP Distributed by: 1 adjust pHt05.0t0 7.5. 1 EEE T ST 3 Shake well before using. Amneal Biosciences LLC 200 mg per 5 mL Bridgewater, NJ 08807 1 1 : (40 mg per mL) : NOT FOR INTRAVENOUS, (40 mg per mL) : Rev. 07-2018-04 1 For Inh?muscnlar or 1 mmﬂ%ﬁ#ﬂﬁgﬁgﬂ%ﬁ For Intramuscular or 1 1 Intra-articular use only 1 . Intra-articular use only 1 1 1 Usual Dosage: See insert for dosage 1 1 5 mL Multiple-Dose Vial 3 information. 5 mL Multiple-Dose Vial 1 ¥ Read all sides ' Store at 20° to 25°C (68° to 77°F) Read all sides ! [see USP Controlled Room Temperamrs], do not refrigerate, avoid freezing and protect from light. Rx only i ! Store vial in carton. 70121 11681 NI 3 Rx only Triamcinolone Acetonide Injectable Suspension, USP T ] (40 mg per mL) For Intramuscular or Intra-articular use only 5 mL Multiple-Dose Vial 2 amneal
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_6.jpg P T T e, ajeq "dx3 % #107 404 Baly paysiuieaun ww Q) X Gz 921§ __ 16911 o 12l0L €0-810¢-20 'Ned "VIANI Ul 8pepy /0880 N ‘Ielemabpug 977 Sa9ualasolg [eauwy “Aq painguasia 625 1/82/9 0N 211 By ‘uolpeuLiojul abeI0}s pue abesop o} Hasul 983 :a6eso(] [ens() "UOHRD Ul [eIA 810]G "9)e.Jahl1ja1 10 3zaaly Jou 0( '|Iam 3)eys *asn |[eaateljul Jo ‘leanpida “enaoenui ‘qj Al 104 10N Rx only lone 1amcino Acetonide Injectable Suspension, USP 400 mg per 10 mL (40 mg per mL) Intra-articular use only 10 mL Multiple-Dose Vial NDC 70121-1169-1 For Intramuscular or Tr
c38dcd37-9840-4f71-a5c9-97380c8107f2_377_7.jpg Space for UPs No. *pajund aq |[eys Xiew ejep gz Wim UOLIRY 4983 U0 "o [e1as anbjun pue dx3 707°NILY J0 Elep ajqeuieA ] ' NDC 70121-1169-1 ¥ Each mL provides 40 mg triamcinolone ! NDC 70121-1169-1 1 Mfg. Lic. No. G/28/1539 ¥ ¥ acetonide with 0.65% sodium chloride 1 R ! 1 for isotonicity, 0.99% (w/v) benzyl 1 1 V. i 1 = s ¥ alcohol added as a preservative, 1 . i 1 Amneal Pharmaceuticals Pvt. 1 Triamcinolone ' 1 Triamcinolone ) Ltd. g i | 0.75% carboxymethyicellulose sodium, ! | Parenteral Unit 1 Acetonide Injectable | ggge%‘?:z‘:‘g;e'{fs%""a‘;’ogm ﬁ;‘ ‘oige 1 Acetonide Injectable | Amedavad 382213 o Suspension, USP ¥ or hydrochioric acid may be presentto 1 Suspension, USP Distributed by: 1 adjust pH10 5.010 7.5. 1 Amneal Biosciences LLC (40 mg per mL) 1 NOT FOR INTRAVENOUS, t (40 mg per mL) Bevil7- 2080 INTRADERMAL, INTRAOCULAR, 1 For lmmnsculav or VEPIDURAL, OR INTRATHECALUSE. ! For Inlv_amuscnlar or 1 § Intra-articular use only 1 ) 1 Intra-articular use only 1 1 3 Usual Dosage: See insert for dosage 1 1 1 10 mL Multiple-Dose Vial 3 information. 1 10 mL Multiple-Dose Vial 1 y Read all sides ! Sfﬂle at20°t0 25°C (68°t0 77°F) ! Read all sides ! ! [see USP Controlled Room ' ¥ ! Tempelalure], do not refrigerate, ! ¥ X avold freezing and protect from light. ! Ty Rx only Stnle vial in carton. : 370121711691 Triamcinolone Acetonide Injectable Suspension, USP E T L (40 mg per mL) For Intramuscular or Intra-articular use only 10 mL Multiple-Dose Vial P
c3b4fb4e-db70-407f-8481-8ae934ef73f0_967_1.jpg PHARMACIST: Dispense the accompanying Medication Guide to each patient. R only NDC 0093-5378-56 Buprenorphine Sublingual Tablets 2 mg* * Each tablet contains 2.16 mg of buprenorphine hydrochloride, USP equivalent to 2 mg of buprenorphine base. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light=resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. C 2/2015 799-32-100581 ¥ 0093-5378-56 5
c3b4fb4e-db70-407f-8481-8ae934ef73f0_967_2.jpg mg* PHARMACIST: Dispense the accompanying Medication Guide to each patient. R only NDC 0093-5379-56 8 *Each tablet contains 8.64 mg of buprenorphine hydrochloride, USP equivalent to 8 mg of buprenorphine base. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. C 2/2015 799-32-100582 ¥ 0093-5379-56
c40f66cc-6f4a-4b29-84ba-d265e4848735_338_1.jpg Each capsule cortains: NDC 62756-299-83 Phenytoin Sodium, USP 200 mg wsatong maton Extended Phenytoin et st Kred i bt Sodium Capsules, USP e permittedto 15 o 30°C (59°F to 86°F) see USP Controlled Room Temperature]. e m Dispense i atigh,ght resistan continer as defined inthe USP. Mandactund by Sun PharmacsuicalIdustis L. HallBaroda Highway, Hall39 350, Guaat, I PALSEME PLIOMB 7LBTNE 299 62756|| 83|I||2 S Keep cortainer tihty cosed. Rx only @ sunRssTS Keepthis and all medication aut of the 30 Capsules e ofaiden ko 2N P zm 9.
c40f66cc-6f4a-4b29-84ba-d265e4848735_338_2.jpg Each capsule cortains: Phenyton Sodium, USP 300 mg Usual Dosage- See accompanying prescribing information. Store at 25°C (77°F); excursions permitiedto 15 1o 30° (59°F to 86°F) see USP Controlied Room Temperature]. Protectfrom light and moisture. Dispense i a tigh,ght resistan continer 25 defined nthe USP Keep container tghty losed Keepthis and al medicaton out of the ez of chiken NDC 62756-432-83 Extended Phenytoin Sodium Capsules, USP Rx only 30 Capsules g Distbutedby: Sun Pharmaceutca ndusts, . Cranbury, W 08512 Mandactur by Sun Pharmaceutcal Industrs L4 HaloBaroda iy, Halo- 389 350, Guarat, I 2 PLBOMB 715S 5. 0yt awoReETE Bxne. e
c42ed494-2d4d-424c-9663-fb51872a638e_33_1.jpg Packaged by Begant Rancl Burkank, G 91504 = WHITE (buff opaque) CAPSULE. Doxepin 10mg S uvian s uvian i Capsule - s 8 & | store atroom temp of Compare To: 20-25 C (68-77F) Sinequan 10mg Capsule Keep all drugs out of Mylan Pharmaceticals Inc. 5 reach of children #30 Exp: MM/YY g NDC 6362932211 032211105966
c4a21f67-7812-4634-beba-f8e85c63c5f2_80_1.jpg ESCOPUIRUBYEUUOB MM s o fronion ¥1/80 05920 TN ‘eEW VS0 “ou] SEoImasTLT Ul 10} poImOR e 89559140109 EIpUI '£15E07 €09 Z3pIEg-ORNOD “PYT STTORNaOT T Ul Aq paimpenuey saseoind £q pasenbel 10 ugaIsAyd Aq parsesp aspay0 Ssajun 1onpoid sy Buisuadsp W 21150 Ayes a57) uenodu| o000 1By € Uy Bsuadsiq ‘Mo e W00y 0}.89) 0.2 01 02 1€ 2101 Buiguasaid bulfeduicooe 035 39YS00 2 1591 UOIMSSIQ dSN S 1Pl Bu gg)'¢ 450N 0PI SUIEUO0 1Ge) 4263 100 Tablets G glenmark NDC 68462-162-01 CARVEDILOL TABLETS USP Pharmacist: Please dispense with patient information leafet provided separately. Rxonly
c4a21f67-7812-4634-beba-f8e85c63c5f2_80_2.jpg S0 BuEYEWILLIS MMM (888) 1 £5U0SND. _ B0 2P0 TN ‘WmEN VS0 “ou] siEnnadRIT prumal 10} paimoeinueyy YISONH/0 IPUI EISEDy 20D ZPIEG-AEN0Y oq oNi0T g paimpeynuz seseqoind q paisanbal 10 wOKAyd g paap aspnay10 Sseiun 1onpoid Sy Bujsuadsip g saaS0[2 s asf) JueLiodu 180109 1401 € U BSuBS|q ‘BITISIow Wiy w01 ameisdual wooy pay loL2. 01.089) 052 01 02 @ 2l uopeuoju e duoote 523 39VS00 10550 dSN S0 1P0s b 679 451 IOIPSAED SUIBND IgE} €3 21501, o) iz|2 2. i3 -cOa 35]= gz=3miils 2R T OQieimils|:: iz glelis Eg® i o s H E
c4a21f67-7812-4634-beba-f8e85c63c5f2_80_3.jpg ESTWOO BUBBpBLIIRE MMM 44T SL1L-12L(888) | ¢SUOHSIND. i oq — N0 EoTITohE _ 3 7__ v1/80 08520 TN "N VS0 2u ST TSl 10} paInpoEUE BUSINHAI0I DU ‘£1550Y 209 ‘2 ORAIOD P SEoRROT I WU Aq peinpenue saseoind fq paisanbos 1o uEpISAyd g pepalp asymayio ssejun pnpoid sy Busuadsip el seinsop RS 65N WeHodul 190014011 € U BSuBdSI] ‘BT WOy Dai0iq Tomendus] wooy 511205 (4oL 01 89) 0,52 0 o7 el Buiq 0010 Bufueduooe ses 39500 21501 UONMOSSIQ dSN SI99LY POl 451 IOIPBIED SUBIU0O 18I9El 103 . 100 Tablets Pharmacist: lease dispense it patient G Glenmark CARVEDILOL TABLETS USP Information leafletprovided separatel Rxonly
c4a21f67-7812-4634-beba-f8e85c63c5f2_80_4.jpg esnwco BRIy A Frseeoesd SHL12L(838) | ¢5uomsonD o Fovn 0 08R20 N ‘(eE 92100 P SEAIMaITI RIS Aq painjoeinueyy seseqaund fq paisanbos 10 uepISKyd A popaIp et U0 Ssoun npoid S Busuadsip U SaIns0 gjes asn) Juenoduy J80E109 146 € U|DSUBCSIQ “BITISIOL WOl 190101 ‘[oImeiadua] W00y PajoI0Y dSN 995] (4,22 01 ,89) 0,52 01 402 & 8015 ogewio Buguasaid Bukueduooe %S 39vS00 2 1561 LOIMIOSSI] dS) SIaL 1P B G 450 104PIAIED SURICO 10GE) 263 3s 1|2 o el I 28 =2 iz | o mmDS 8212 w5 o enw [} 23 mﬂvm_ i3 o ri EZE e E| S o 2| &
c4d65f28-983f-42b4-bb23-023ae0fe81b2_103_1.jpg S0P Ry sjejqe) (epjweuyes) obepe -ODEREX 469764 il 0EQLIS0XZOON Aoy i Each tablet contains: Rxonly NDC 2750511080 Safinamide....50 mg (equivalent to 65.88 mg safinamide mesylate) Xadago" Store at 25°C (77°F); ‘excursions permitted between (safinamide) tablets 15°C to 30°C (59°F to B6°F). [see USP Controlled Room Temperature] Please see package insert for full prescribing information. tributed by: US WorldMeds, LLC 4441 Springdale Road Louisville, KY 40241 Under LicensefromNewron | o oo/ Pharmaceutical SpA. ev. . ©2017 Zambon SpA. Keep outof reach of children. ) 8 ' Xadagois a registered trademark of Zambon SpA. 40 ‘“'e“us S e GTIN XXXXXXXXXXXXXX EXP MHYYYY LOT XXXXXXXXXX /N XXXXXXXXXXXX
c4d65f28-983f-42b4-bb23-023ae0fe81b2_103_2.jpg siefqel (apjweuyjes) obepex OEhLESOSZOON Aoy 469766 .100mg 131.76mg salfinamide mesylate) Store at 25°C (77°F); excursions permitted between 15°Ct0 30°C (59°F to B6°F). [see USP Controlied Room Temperature] Please see package insert for il prescribing information. Distributed by: US WorldMeds, LLC 4441 Springdale Road Louisuill, KY 40241 Under License from Newron Phamaceutical SpA. ©2017 Zambon SpA. Xadagois a registered ‘rademark of Zambon SpA. Rev.08/17 Rxonly NDC 2750511180 Xadago’ (safinamide) tablets Keep outof reach of children. GTIN XXXXXXXXXXXXXX EXP HNYYYY LOT XXXXXXXXXX SIN XXXXXXXXXXXX | \ ~HIHIHT
c5082be6-fd29-4d56-a76c-ea2ba8ad8b93_107_1.jpg Over Coding Template No Vamished Area (Do Not Print) (1841 mm) NDC 707741-1440-1 y— Clobazam P Tablets @ Ut Dosag: e g Store at 20° G10.25° G (68° F o 77° F). [See USP Contrlled Room Temperature ] This package s child resistant. Dispense in a USP fight container. Keep this and alldrugs out of the reach of children. 100 Tablets Coairimeriss Rxonly Ahmedabad, india
c5082be6-fd29-4d56-a76c-ea2ba8ad8b93_107_2.jpg Over Coding Template No Vamished Area (Do Not Prinf) (1841 mm) NDC 70774-1441-1 ] Clobazam b Tablets @ s Desge S pocage vt Store at 20° G10.25° G (68° Fto 77° F). [See USP Conrolled Room Temperature ] This package s child resistant. Dispense in a USP tight container. Keep this and alldrugs out of the reach of children. ispense the Medication Guide provided separatey o each patient. Manufactured by: - 100 Tablets Cadia Healthcare L 73 2ydus lablets Coflpamrasif
c53c20ed-a944-4b35-b5db-91d9f67240e8_893_1.jpg ot NDC 0378-7100-77 T e i Diense natglt, gt et ataer s Fenofibrate g Koepis and ll mdaton ut Tablets, USP e each o hion, Soreat 2 0 25°C (8 077, e USP Gorrlled Room Tenpeatre] Prolet fom it st Dosag: S oy presci formin, Wi by [Mylan® e Mnfcietor e el st ™ GTIN TOOOOOOOY LOT Xxonnx 0378-7100-77 3 = = —— = RINVT100MM1 3
c53c20ed-a944-4b35-b5db-91d9f67240e8_893_2.jpg Fenofibrate Tablets, USP [MMylan Rxonly R Each fin-ooated et conaine: Fendfibrate, USP Dispense ina gt gt reistantconainer s defind i the USP using a hid-esstantcosure Keop contane iy coced Keep this and al medication ot of the reach of childron. Store at 20°to 25% (68° 77°F). [See USP Gontrolled Room Temperature] Protectrom moistue. Usual Dosage: See acoxmpanying prescibing infomaton, Mty inaGen Phamaceaticals . Happauge, 1 11783 Mt Hyian Plarmacestas, . Morgniom, W 5505 180mg RINVZA01MM1 é P : g EXPADIYYYY LOT Xrnn I 0378=7101=77 o
c548b645-0a3c-436e-9a62-0f5fd295efca_228_1.jpg NDG 60687-356-01 Benztropine Mesylate Tablets, USP 100 Tablets (10 x 10) Rx Only [N 110N (01) 0 03 60687 356 01 3 NDC 60687-356-01 Benztropine Mesylate Tablets, USP 100 Tablets (10 x 10) Rxonly Each Tablet Coni Borairopine ey 05mg Usual Adult Dosage: o parkinsariar, 110 2 dally.For g Ucad oxtapyremIGal SS0raers, 1 0.4 m onoe o ics A 8. S5u'Sackage eort for 1l proscrbing nformation. Store st G (66° 10 7' excursions permited betuween Ta15.30°C (55" 0 86°F) cee USP Contvolis Foom Temperdture]. Keep this and all drugs outof reach of children. FOR YOUR PROTECTION: Do ot use i bister s for or broken. The drug produet contained in tis package i fom NDC ¥ 5803 2437 Par Pramaseunical Packaged and Distutad by Amaritan Hgalt Packaging Colimes, Ono 45217 7asgt osasa0 0TS
c548b645-0a3c-436e-9a62-0f5fd295efca_228_2.jpg BENZTROPINE MESYLATE TABLET, USP i ] g Tt i eywmmmenz 8 ZTROPINE 02 ooo00x 107 ety BENZTROPINE MESVLATE TABLET, USP o= 1 0.5mg g8 ey 52 I I iz @nomam ez 5 ¥ BENZTROPINE HESVLATE TABLET, USP 0.5 mg 3 | I @omssesaniz oooocx 107 e K senzTRoPE BENTRORNE oo Soms £ s L ithi i ENZTROPINE ESVLATE TABLET, USP ozw T I I ENZTROPINE ESVLATE TABLET. UsP ¥ 01)03 50567 35311 2 i z & BENZTROPINE NESYLATE TABLET, USP 0.5mg Expiy: o Lot oo BENZTROPINE MESVLATE TASLET, UsP 05mg & 1 Lot o iy o 101)003 50667 353 11 2 BENZTROPINE NESVATE TABLET, UsP 0.5 mg Lot oouce Expity
c548b645-0a3c-436e-9a62-0f5fd295efca_228_3.jpg NDC 60687-368-01 Benztropine Mesylate Tablets, USP 100 Tablets (10 x 10) (01) 0 03 60687 368 01 6 NDC 60687-368-01 Benztropine Mesylate Tablets, USP 100 Tablets (10 x 10) fxOnly 1mg Ususl Adult Dosage: For parkinsoriam, 162 madal. For drug lsced anlrapyraCal Heerdsrs,© 19 m ancs o1 tuice s 68 packags neon for ol prescrbing narmation Store s120- 10 5 66t T xcursions prmited b S50 50C 55+t 86'F) (506 USP Controled Boom Temperaure. Koep this and all drugs out of reach of childron. FOR YOUR PROTECTION: Do o use I bister s torn o broken. The drug produt contane n s package i rom NBC ¥ GE05 2458, Par Pharmeseutca. Eackaged and Distrbuted by Amencan Hgath Packagng. i, G 43517 730801 043eenifoes
c548b645-0a3c-436e-9a62-0f5fd295efca_228_4.jpg BENZTROPINE WESTLATE TABLET, UsP mg it iR ©) 003 s s 175 ENZTROPINE ESVLATE TABLET, UsSP 9 el 53 . st EE BENZTROPINE HESYLATE TABLET, USP 1mg S | | @0 003 60087368115 [~ oger S BENZTROPINE NESYLATE TABLET, USP 1'mg e o) 003 sos 308 115 aocooc 01 £ BENZTROPINE MESVLATE TABLET, USP i'mg @) 003607 368 115 oocooc 01 oo R BENZTROPINE MESYLATE TABLET, USP 1mg e 01) 00350687 368 115 BENZTROPINE ESVLATE TABLET, USP Xy 1 28 pielien (@1 00360067363 115 BENZTROPINE NESYLATE TABLET, USP 1mg e 0% 00350557 305115 S onomssesarsss 15 BENZTROPINE BEVE TANEET, use § 1mo i o 0100350887368 115
c548b645-0a3c-436e-9a62-0f5fd295efca_228_5.jpg e N NDC 60687-379-01 Benztropine Mesylate Tablets, USP 100 Tablets (10 x 10) Rxonly (01) 0 03 60687 379 01 2 NDC 60687-379-01 Benztropine Mesylate Tablets, USP 100 Tablets (10 x 10) Ax Only Bortbecomans Siopne ey, 2mg Usual Adult Dosage: For parkinsonism, 1 0.2 ma daily For drug. Inde extrapyramical cicordars, 116 mg ancéar twce & day S5 packags muart for il préser bing nformation Store 3t 20° 10257 (38" 0 77°F) excursions permited betwcen, T5°15.30°C (53t 86°F) (500 USF Contralied Hoom Temperatorel Koop this and al drugs outof reach of chidron. FOR YOUR PROTECTION: Do ot use biser & orn o broken, The drug produot contained in tis package s from NBC'# G435 2435, Par Phermacestis, Packaged and Disribuled by: Amerigan Heali Packaging Colimbus, O 43217 757901 ousro0vons -— 7
c548b645-0a3c-436e-9a62-0f5fd295efca_228_6.jpg BENZTROPINE BENZTROPINE. BESEROr wor g 1 BEVENERMEr uoe 2mg 3E2mg et £ | st 33 Wttt BENZTROPINE aenzTROPINE BENIRONE e vee o PEVONOTNEr uee 2mg 5E fx iy e il BENZTROPINE BENZTROPINE RENIROT e use o 3 RESVOMETANCET. Use B 5§ frim fr il Oneseesrarety % F &= @nomsmsTaretit BENZTROPINE. BENZTROPINE SENIRORNE ver g 1, SESIROTANEer v g 5E i g i3 it I el i, g 5o DHLWTN BENZTROPINE BENZTROPINE DENIROPNEr use s BENVDROREer se e 58 i i 22 bedtasin s i Esl s tts %5 55 o otuamaran h
c577af7c-2405-4454-a169-5b6a4fa0c7bf_390_1.jpg Packaged by Begant Rancl Burkank, G4 91504 : 5 NORY OPAQUEWHITE OPAQUE o Doxepin Hel S, CAPSULE MYLAND1ZS :MYLANI125 25mg Capsule - s 2 & | store atroom temp of Compare To: 20-25 C (68-77F) Sinequan 25mg Capsule Keep all drugs out of Mylan Pharmaceticals Inc. reach of children swox #30 Exp: MM/YY NDC 6362950331 050331106996
c5d68b96-14bd-4605-b6d2-2bf8b0c5ca8a_200_1.jpg Ao “Eothuial conains SO molphoon s bose Couvasntio g oot hyrocnonte & SPECTRUM' SersatzsToTR: xcrsonspomitad rom ity ool pockogo e, (SoeUSp ConvradRoom Tamperours. Usoiesoge. S0 Pocingo vert ScoviaRNGS) Furtordtonth st 0% SodumGioride njcton UsPs reied: Seobosom ettt B s Single-Dose Vicl Discard Unused Portion Storte “Eothuil contans Omg nalphlon s bose Cavasntto g melphoin hckochionde & sPecTRUM Reconsttewin @8 mL SForeienormel e Sokiion 09% o Cocdmacton U9, Famcsogne Smaom G o e Smaphaanona 00 maOm Cancentiationof Betodex St Enar S N Frther iion or fionortheprocuct reaimea poor o e aan Pocioe ot i 68152110900 1l
c5d68b96-14bd-4605-b6d2-2bf8b0c5ca8a_200_2.jpg Sz woeseiooco LY S excursions permitied : TR, s Retain in original 50 mg/10 L (5 mg/mL) norminal peckegeiluse Goncentration of melphalan and e USP Controlled 2700 /10 mL concenlration of Room Temperaturel. . Botadex Sulfabuty| Ether Sodium UsualDosage, _For Intravenous Infusion Only . Further cluion (o infusion) (Kheal Doy Single-Dose Vial Discard Unused Portion is required prior to uss (see. See Package Inset Satle Package Insert {See WARNINGS ] Misotacied o Further dilution with sterite _ “Each vl contains 50 mg Spectrum Pharmaceuticals, nc. rormal saline solution | elphalan Irce base equNGIent o e CA 62015 {0:9% Sodium Chloride 56 mg melphalan hydrochloride. LOT: B 1L (01) 003 58152-106-00 3. Injection, USPlisrequired. Ry only orE0.08 I
c5eedb5d-4cab-4056-a14a-ffdf67701355_376_1.jpg Each film-coated tablet contains: Distrbuted by: NDC 65862-049-30 g5 mg of efavirenz Usp Aurobindo Phiarma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 USUAL DOSAGE: See package insert for o Rx only Dosage and Administration. Made in India Efavirenz Tablets USP ot TaDRUGSHSSES PHARMACIST: Do not cover ALERT box LT 1] with pharmacy label. P1420014 ALERT: Find out about medicines that should NOT be taken with Efavirenz Tablets. = ol ol ! o R o; S ! @ o! ®; Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Contralled Room /5 AUROBINDO 30 Tablets Temperature]. “Over Printing Zone Coding Area (@5x15mm) Dotted lines not to be printed
c5eedb5d-4cab-4056-a14a-ffdf67701355_376_2.jpg UNVARNISH ZON Each film-coated tablet contains: 600 mg of efavirenz USP. USUAL DOSAGE: See package insert for Dosage and Administration. 5862"04910 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. | 6 PHARMACIST: Do not cover ALERT box with N 3 pharmacy label. 0 2 P1027164 Efavirenz Tablets USP 30 Tablets (3 x 10 Unit-dose) NDC 65862-049-10 Rx only Efavirenz Tablets USP 600 mg ALERT: Find out ahout medicines that should NOT be taken with Efavirenz Tablets. 52 AUROBINDO 30 Tablets (3 x 10 Unit-dose) dsSn sis|qel zuaiine)g (asop-hun o1 x €) s1ajqeL og & Distributed by: EfaVlrenZ Tahlets USP Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road 600 mg East Windsor, NJ 08520 Made in India 30 Tablets (3 x 10 Unit-dose) Code: TS/DRUGS/19/1993
c64ed4c0-1e27-42b3-9625-fb4e0d31e271_941_1.jpg E:ﬂc:,;x:\—mmd ‘extended-release tablet NDC 0378-4 56! (T B Potassium : et i) Chloride i —— cxpenied matics ot sbsored ndmayte. EXt€Nded-Release tiemeina o gt risant cnsinr e oo g i Storeat 20" 0 25°C 80" 077 e usp | ADIETS, dosure. i) . Protectfrom lght and mistre. ] oo, Wi Pramaceutisls o (600 mg) Wogartoun, WY 26505 US A “Meets USP Assay e nnd sanpi a2 (1) Mylan® " [MMylan® | s RMKISEOMMZ
c64ed4c0-1e27-42b3-9625-fb4e0d31e271_941_2.jpg Each fim-costed extended-releasefabet contans: Potassium chorde, USP 750mg. Usual Dosage: See accompanying prescriing information. Dosage must be adiused f the indivicual needs of each atient. For Patient’s nformation: Be awars tht the expended matixis not sbsorbed and may be. excreted intact i the stoo, Store at 20° 0 25°C (68° 0 T7°F). [See USP Contralled Room Temperature.] Protect from light and maisture. Manufactured for: Mylan Pharmaceuticals Inc. Morgartonn, WY 26505 US A Made in india [MMylan® | wincon A NDC 0378-4561-77 Potassium Chiloride Extended-Release Tablets, USP* 78 N | 3 8=4561=77 5 Keep this and all medication outof the reach of chidren. Dispence i atight, lghtresistat conainer s defined inthe USP using a chid-esitant dosure. Keep conainer ighty losed. Code Ho. MHDRUGS/25/NKD/BY 75085350 0] mEq 1 RG] Yoas srisy () Mylan® ‘Sampe Preparation 2. 0] T (40 x 15 mm) Vamish Free area for Variable Data Coding
c681a1bf-4ddd-4eb2-b87d-53b9f08d55c5_43_1.jpg Packaged by Bvyant Ranch Buabank. CA 91504 Desvenlafaxine ~QP*Foros ER 50mg Tablet B 2 Store at room temp of Compare To: 20°25°C (68°77°F) Pristiq 50mg Tablet Keep all drugs out of Mylan Pharmaceuticaks Inc. reach of children. om #30 Exp: MMYY NDC 7133507981 075251118939
c69b8e5e-c7c3-4883-9cea-f7f435a8ede8_117_1.jpg DO NOT ABRUPTLY STOP TAKING THIS MEDICATION. WITHOUT FIRST CONSULTING YOUR PHYSICIAN. 43063-765-30 43063-765-30 43063-765-30 ATENOLOL ATENOLOL ATENOLOL usp usp usp 50 MG 50 MG 50 MG 30 TABLETS 30 TABLETS 30 |ABLETS ReOrder # 110285 ReOrder # 110285 ReOrder # 110285 LOT G18D67 LOT G18D67 LoT G18D67 EXP 11/149 EXP 1i/19 EXP 11/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: 50 MG ATENOLOL USP ORGANOLEPTIC MARKINGS: WHITE 93752 TEVA ROUND SCORED NDC: 43063-765-30 PD-Rx PHARMACEUTICALS INCORPORATED® Oklahoma City, OK » 73127 ATENOLOL Usp 50 MG 30 TABLETS e i-'f (01)10343063765302 (21)618D67000001 (17}191130 (10)G18D67 TOEGSLETOEVE N 00 0 NANd3Y H23ZD ADYVINOX-VAVD "O'Y'S SIMLSNANI HIZZ) YAIL 10ZSL0€6000
c78e0931-ec79-58e5-8658-7fe692dc3b8b_238_1.jpg mene WG ReTH PIPERACILLIN AND oxea i Fomumug 4 SIS 07
c7c15230-dd37-4eb2-8e0b-46a4f5e4b1df_488_1.jpg CLINICAL solutions WHOLESALE Haloperidol 5mg Tablets NDC: 58118-1079-8 Mig.NOC: 68382-0079-01 GTIN: 00356118107983 Mig_Lot #: SAMPLE123 Batch #: SAMPLEASE Mig.By: ydus Phamiaceuticals USA) nc B 02019 Pennington, N, USA, 08534 ay:30 Ty ey P e i S P N300 U
c8ca72af-cfc1-4c9f-9754-4f98abcffc3f_907_1.jpg 29912052600 - 10) E/BZMUNSONYARIN 0N 8p0) U] ‘S[EONBoBULEY 1Uabes 81028 © S eIpu| Ul 3pey 8 _(vsn) ™ 6609 71 ‘Binquineyog SIEOINEBULRY INIDYS 10} PN m— «IN3OVS Q 'skep 0g ulyyMm sfein pausdo asq) "skep g uIyyM asn = g S 4 abeloys ainjesadwa) woos 0} uonesabuyes woy [eaowsay uodn *320814 J0U 0 (4.9 PUE .9¢) D08 pue .z usamjaq pajesabiyal aiolg ' .uw..T>=u,>..2.9.m ‘ajuaboikduoy ‘ajelg =i
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_1.jpg 5102841714538 Usual Adult Dose: See accompanying lterature. I occ ' NDC 16720-092-03 rd B Mid. for: Accord Healthcare, Inc., Durham, NC 27703. e Gemcitabine For Injection USP Mid. by Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. Mig. Lic.No.- G/281336 3 167291092031 ll6 | | | | | | | | | 200 LA | I Rx Only ! J For intravenous use only ; I Sterile Single Dose Vial ! | cytotoxic Agent | | Lyophilized | | Must be diluted | Unvarnished area for pasting NDC 16729-092-03 Gemcitabine For Injection USP Keep area biank & vamish free for overcoding Lot and EXP. & 2D Matrix 38 x 38 mm I occord B ' NDC 16729-092-03 Y Gemcitabine For Injection USP | | | | | 200 mg/vial I Rx Only ! For intravenous use only I Sterile Single Dose Vial | cytotoxic Agent | Lyophilized | Must be diluted Storage: Prio to and after reconstituton, store at controlled room temperature 20° to 25°C (66°t0 77° F) [See USP]. Do not refrigerate. To reconstitute: Add 5 mL of 0.9% Sodium Chlorde Injction (without preservatives) to make a solution containing 38 mg/mL_ Shake to dissole. Admiister solution within 24 hours. Discard unused portion Gaution: Gemcitabine Hydrochlorde is potentilly cytotondc. Great care shouid be taken to prevent inhaling particles and exposing the skin to it To prepare LV. solution- ‘Seg accompanying lterature. Each vial contains gemcitzbine hydrochioride USP equivaent to 200 mg ‘gemcitabine, 200 mg mannitol, 12.5 mg sodium acetate. Hydrochlorc acid and/ or sodium hydroxide may have been used to adjust pH. o172yt
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_2.jpg Storage: Prior to and after reconstitution, store at controlled foom temperature 20° to 25°C (68° to 77°F) [See USP]. To reconstitute: Add 5 mL of 0.9% Sodium Chloride Injection (without _preservatives) to make a_solution containing 38 mg/mL. Shake to dissolve. Administer solution within 24 hours. Discard unused portion. ) Each vial contains gemcitabine hydrochloride USP equivalent 10200 mg gemcitabine, 200 mg mannitol, 12.5 mg Sodium acetate. Hydrochloric acid and/or sodium hydroxide may have been used to adjust pH. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. ) Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. Mig. Lic. No.: 6/28/1336 NDC 16729-092-03 Gemcitabine For Injection USP Rx Onl 200 mo/ial e . use only Sterile Single Dose Vial Cytotoxic Agent Lyophilized Mastbe dilued Varnish free area 18 x 21 (mm)
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_3.jpg Unvarnished area for pasting Keep area blank & vamish free for overc Lot and EXP & 2D Matrix 52 x 26 mm dsn uoalu| Jog aulgeHawsy 1L 102291 90N I Gemcitahine For Injection USP Rx Only For intravenous use only Sterile Single Dose Vial Cytotoxic Agent Lyophilized Must be diluted 510268 1714534 Usual Adult Dose: See accompanying lterature. Mfd. for. Accord Healthcare, Inc., Durham, NC 27703, M. by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. Mig. Lic. No.: 6/28/1336 slilli'e 7l 729111 rd | Gemcitahine For Injection USP Rx Only For intravenous use only Sterile Single Dose Vial Cytotoxic Agent Lyophilized Must he diluted INCS0B7_V1 Storage: Prior to and after reconstitution, store at controlled room temperature 20° 1025°C (68°10 77° F) [See USP]. Do not efrigerate. To reconstitute: Add 25 mL of 0.9% Sodium Chloride Injction (vithout preservatives) to make a solution containing 38 mg/mL. Shake to dissolve. Admirister solution vithin 24 hours. Discard unused portion. Gautior: Gemcitabine Hydrochloride is potentialy cytotoxic. Great care should be taken to prevent inhaling particles and exposing the skin o it To prepare LV. solution- See accompanying Iterature. Each vial contains gemcitabine hydrochloride USP eqivalent to 1 g gemcitabine, 1 g mannitol, 625 mg sodium acetate. Hydrochioric acid and/ or sodium hydroxide may have been used toadjustpH.
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_4.jpg Storage: Prior to and after reconstitution, store at controlled room temperature 20° to 25°C (68° to 77°F) [See USP]. To reconstitute: Add 25 mL of 0.9% Sodium Chloride Injection (without preservatives) to make a solution containing 38 mg/mL. Shake to dissolve. Administer solution within 24 hours. Discard unused portion. Each vial contains gemcitabine hydrochloride USP equivalent to 1 g gemcitabine, 1 g mannitol, 625 mg sodium acetate. Hydrochloric acid and/or sodium hydroxide may have been used to adjust pH. Manufactured for: Accord Healthcare, Inc., Durham, NG 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. Mfg. Lic. No.: G/28/1336 NDC 16729-117-11 - Gemcitabine = For Injection USP 9 Rx Only = 1 LA For intravenous use only Sterile Single Dose Vial Cytotoxic Agent | Lyophilized Must be diluted I accord l Varnish free area 23 x 20 (mm) INL5026 510128 1714548
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_5.jpg Keep area blank & varnish free for overcoding Lot and EXP. &2 Matrix 58 x 29 mm | ! noc 16720-118-38 For Injection USP Unvamished area for pasting I Sterile Single Dose Vial s uonoalu jog aulqe}away | Gemcitabine | } For intravenous use only J 5102651 7145% \ Usual Adult Dose: See accompanying literature. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured hy: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. M. Lic. No.: G/28/1336 ol | | ! npc 16720-118-38 . - Gemcitahine | | For Injection USP | I I | | I I ! Rx Only : | Forintravenous use only | : Sterile Single Dose Vial : I I I I I I I I | | Storage: Prior to and after reconstitution, store at controlled room temperature 20° to 25°C (68° o 77° F) [See USP]. Do not refrigerate. To reconstitute: Add 50 mL of 0.9% Sodium Chloride Injection (without preservatives) to make a solution containing 38 mg/mL. Shake to dissolve. Administer solution within 24 hours. Discard unused portion. Cautiom. Gemeitabine Hydrochloride is Ppotentially cytotoxic. Great care should be taken to prevent inhaling particles and exposing the skin to it. To prepare |.V. solution- See accompanying literature. Each vial contains gemcitabine hydrochloride USP equivalentto 2 g | } Cytotoxic Agent Cytotoxic Agent gemcitabine, 2 g mannitol, 125 mg I Lyophilized Lyophilized sod\xgﬂaci‘m;e. H{jdmch\o#cacgdand/ | Must be diluted yITRLILLY Must e diluted Sreadln ety v e | | | / /A | /N -7 / \ -4 \ / s ] / / L U
c90cdf38-2b2a-4d8c-a7b5-373787173193_345_6.jpg Keep area blank & varnish free for overcoding Lot and EXP. &2 Matrix 58 x 29 mm | ! noc 16720-118-38 For Injection USP Unvamished area for pasting I Sterile Single Dose Vial s uonoalu jog aulqe}away | Gemcitabine | } For intravenous use only J 5102651 7145% \ Usual Adult Dose: See accompanying literature. Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured hy: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. M. Lic. No.: G/28/1336 ol | | ! npc 16720-118-38 . - Gemcitahine | | For Injection USP | I I | | I I ! Rx Only : | Forintravenous use only | : Sterile Single Dose Vial : I I I I I I I I | | Storage: Prior to and after reconstitution, store at controlled room temperature 20° to 25°C (68° o 77° F) [See USP]. Do not refrigerate. To reconstitute: Add 50 mL of 0.9% Sodium Chloride Injection (without preservatives) to make a solution containing 38 mg/mL. Shake to dissolve. Administer solution within 24 hours. Discard unused portion. Cautiom. Gemeitabine Hydrochloride is Ppotentially cytotoxic. Great care should be taken to prevent inhaling particles and exposing the skin to it. To prepare |.V. solution- See accompanying literature. Each vial contains gemcitabine hydrochloride USP equivalentto 2 g | } Cytotoxic Agent Cytotoxic Agent gemcitabine, 2 g mannitol, 125 mg I Lyophilized Lyophilized sod\xgﬂaci‘m;e. H{jdmch\o#cacgdand/ | Must be diluted yITRLILLY Must e diluted Sreadln ety v e | | | / /A | /N -7 / \ -4 \ / s ] / / L U
c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f_882_1.jpg NDC 0185-0236-01 Each tablet contains: Benazepr Hydrochioride 5mg and Hyarochlorohiazice, USPE.25 mg. . . 1 USUALDOSAGE e scanpenyngHaatrs ot resrg fomtn, Benazepril Hydrochloride szt o777 e 5p oot o e, .. Disense comens na igh, gt esistant conaine s deied i e USP withachi-ressant 5 and Hydrochlorothiazide cotre’reaied i 5 Pt o g 2 Tablets moste S KEEP TIGHTLY CLOSED. iy 7T LT = S Rx Only 100 Tablets Disirbuted by Sandoz bc. — sanpoz i -
c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f_882_2.jpg NDC 0185-0325-01 Benazepril Hydrochloride and Hydrochlorothiazide Tablets RxOnly SANDOZ 100 Tablets g A Esch table cortains:Benazepi Hydrochioride 10 mg and Hydrochirothiazide, USP 12.5 mg. USUAL DOSAGE: See accomparying eratur for ompiee rescrbing infomaton. Storeat 20° 10 25°C (68°1077°F) [s2e USP Controled Room Temperature Dispense crtents i g, gt fsisant containr s defined i the USP withachil-reisant dosur, asrequd. i Protect from fightand moishre, KEEP TIGHTLY GLOSED. KEEP OUT OF THE REACH OF CHILDREN. & Gt by S . 3 € Picston, i
c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f_882_3.jpg NDC 0185-0211-01 Each tablet conais: Benazepi Hydrochoride 20 mg and Hydrochlrothiazide, USP 12.5 mg. USUAL DOSAGE: See accomganying Herature for complete prescriing informaton. Benazepril Hydrochloride ' sura 20t 5 g 77 o s Gt o eporat ‘Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant and Hydrochlorothiazide cotre o s Protect from light and Tﬂ“e‘s KEEP TIGHTLY CLOSED. 20mg/12.5mg EPWTOETE N St 5 RxOnly 100 Tablets #o sanvoz L s
c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f_882_4.jpg ( NBGo1s02T 701 Ezchtabet contains: Benazepri Hydrochorde 20 mg and Hydrochiorotiazide, USP25 mg. o . USUAL DOSAGE: See accompanying iterature for complete prescribing information. Benazepril Hydrochloride sersa21to25 - to179) s e o o, . e 'Dispense contents in a tight, light-resistant container as defined in the USP with a child-esistant and Hydrochlorothiazide ~ oiie-sroites P Proect from ightand Tablets moiire. ] e 7 @ 4 e . 'REACH OF CHILDREN. & RxOnly 100 Tablets @'q g & Dttty S, |_sanpoz g P 0 Gt 0185-027
c9f74c57-3fe9-470b-9096-31d0acb22f7e_229_1.jpg NDC 62037-696-30 Tazt|a XT® zem HCl Extended- Release Capsules, USP) ONCE-A-DAY-DOSAGE W 30 Capsules Actavis Rx Only Each Capsule Contain: Diltiazem Hydrochloride, USP ... 120 mg Dispense n tight containers with safety closures, Keep this and all medication out of the reach of children. Usual Dosage: Administer once daily, see insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP. Controlled Room Temperature]. Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Rev.01/15 1725431 B 69630" Lo, seLow 62037
c9f74c57-3fe9-470b-9096-31d0acb22f7e_229_2.jpg NDC 62037-697-30 1 80 Each Capsule Contain: Diltiazem Hydrochloride, USP .... 180 mg » Dispense in tight containers with safety TaztiaXT® 0 o Keep this and all medication out of the i reach of children. (Diltiazem HCl Extended- ({015, e Rimirister once caily, see = Release Capsules, UsP) insert for full prescribing information. g Store at 20° to 25°C (68°to 77°F) [See USP 'ONCE-A-DAY-DOSAGE Controlled Room Temperature]. § y Manufactured by: S Actayis Laboratories FL Inc. Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Rev.01/15 204793-1 ~w Actavis
c9f74c57-3fe9-470b-9096-31d0acb22f7e_229_3.jpg NDC 62037-698-30 Taztia XT°® (Diltiazem HCI Extended- Release Capsules, USP) ONCE-A-DAY-DOSAGE W . 30 Capsules Actavis RxOnly Each Capsule Contais Diltiazem Hydrochloride, USP .... 240 mg Dispense in tight containers with safety dlosures. Keep this and all medication out of the reach of children. Usual Dosage: Administer once daily, see insert for ful prescribing information. Store at 20° to 25°C (68 to 77°F) [See USP. Controlled Room Temperature]. LOTEXP. BELOW Manufactured by: Actavis Laboratories FL Inc. Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Rev.01/15 N 3 204795-1 69830 62037
c9f74c57-3fe9-470b-9096-31d0acb22f7e_229_4.jpg NDC 62037-699-30 Taztia XT°® (Diltiazem HCI Extended- Release Capsules, USP) ONCE-A-DAY-DOSAGE 00mg W Actavis 30 Capsules RxOnly Each Capsule Contai Diltiazem Hydrochloride, USP .... 300 mg Dispense in tight containers with safety closures. Keep this and all medication out of the reach of children. Usual Dosage: Administer once daily, see insert for full prescribing information. Store at 20°to 25°C (68° to 77°) [See USP Controlled Room Temperature]. Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA Rev.01/15 LOTER. EELoW 204797-1 6 69930 62037
c9f74c57-3fe9-470b-9096-31d0acb22f7e_229_5.jpg NDC 62037-700-30 Taztia XT® (Diltiazem HCI Extended- Release Capsules, USP) ONCE-A-DAY-DOSAGE ~w 30 Capsules RxOnly Actavis Each Capsule Contain: Diltiazem Hydrochloride, USP .... 360 mg pense in tight containers with safety closures. Keep this and all medication out of the reach of children. Usual Dosage: Administer once daily, see insert for full prescribing information. Store at 20 to 25°C (68" to 77°F) [See USP Controlled Room Temperature]. Manufactured by: Actavis Laboratories FL, Inc Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Rev.01/15 204800-1
ca6aec33-6127-462a-8934-ec07cdfbcbc3_928_1.jpg Packaged by Evyant Ranch Bunbank. CA 91504 Methylphenidate G ™ ®&mouoszne HCl 10mg Tablet(Cll) TIL6TT Store at room temp of Compare To: 20°25°C (68°77°F) ialn f0mg Tabk1Cl) TKespall dnigrouiof | Sandoz ne reach of children. #30 Exp: MMYY NDC 7133508381 032791119711 om
caf22ccb-df75-45ea-a1d0-ccb2d37272fb_579_1.jpg Auoxy mpuog avas 136N JoV%OV4I3S TIMIQUIHINS 38 1SN NOUNLISNOO3H U3 L3¥ osnsnow Az IO s uonosiul 0} apLiojyoopAH uioAwoosuep T ECrET] = R [ . e | Emmme - , I IH Vancomycin Hydrochloride | &= Vancomycin Hydrochloride DML £ | for Injection, USP i | for Injection, USP AT i T T § PR PR 250 mg*/vial oo PRS2 2| Forintravenous use ey | For inravenous Uso | AFTER RECONSTITUTION MUST BE *"'?'”'"““‘F gy AFTER RECONSTITUTION MUST BE FURTHER DILUTED. SEE PACKAGE INSERT. e FURTHER DILUTED. SEE PACKAGE INSERT. [Mylan® Snt Powder Sir Powder Rx only PR [Mylar | peonly PR
caf22ccb-df75-45ea-a1d0-ccb2d37272fb_579_2.jpg L R S B C L ST A TS Aw xy Jopmoq aials @,uBMw “LHFSNI FOVHOVd S “EINI0 HEH NS 38 1SN NOLLAL ISNCO3H EB L3V s nauseau] 103 dsn ‘uonoeluj toy apuojyos04pAH uoAwoouep PR RTTEnT & # o MPORTANY - EAD PACKAGE NSERT FOR PRECAUTIONS AND DIRECTIONS BEFORE USE. Lo hradne “Each singledos vl cotan: et e mneom | \Jancomycin Hydrochloride i, Usual At Dosage: S Package et s Reconstite contents with 15 mL Sterie Water for for Injection, USP Cods No: TNDRUGSTNOO00S234 oo Siorge Prir o econsituton, store st 27 o - 5SSt 17 o U ot o, R ] For Intravenous Use Afer reconsttution, ay b soed i a refigerstor g (LR Vancomycin Hydrochloride for Injection, USP For Intravenous Use AFTER RECONSTITUTION MUST BE o4 ey b San s f pkcy AFTER RECONSTITUTION MUST BE FURTHER DILUTED. SEE PACKAGE INSERT. [MMylan® | gosies FURTHER DILUTED. SEE PACKAGE INSERT. [MMylan® Sterlle Powder Rxonly 10x 750 mg Single-Dose Vials s Sterile Powder [ Mylan* Rx only 10 x 750 mg Single-Dose Vials
caf22ccb-df75-45ea-a1d0-ccb2d37272fb_579_3.jpg 8 L h R R AR Apo xy sepmod siuars uelAN (i) “LUISNIJOVIOVd 33S "GALNTIO HIHLLNI 38 1SN NOILALLLSNOO3H HaLdv 25 snouaAenu| 04 dsn ‘uooafu] Joy apuojyo0ipAH upAwosuep T IWPORTANT - READ PACKAGE INSERT FOR 'PRECAUTIONS AND DIRECTIONS BEFORE USE. “Each single-dose il contins: Vancomyn ydrchiore, USP equivalent 0 125 0 wancomcin. Usuat Aduit Dosage: SeePackage rsrt. Reconsfute contntswith 25 mL Sterle Waler o ctin. ‘Storage: Pro o reconstuton, store at 2°C 1o 25 (88%F to T7°F). [Se USP Controlled Room Temperatre] Aftrreconstiution, maybesiored n a efrertor for 18 days witoutsgnicant ossof ptecy Lyophized NDC 67457-823-99 Vancomycin Hydrochloride for Injection, USP | For Intravenous Use AFTER RECONSTITUTION MUST BE FURTHER DILUTED. SEE PACKAGE INSERT. [MMylan® Sterle Powder Rx only NDC 67457-823-99 Vancomycin Hydrochloride | for Injection, USP T e LS EE Myiam For Intravenous Use AFTER RECONSTITUTION MUST BE FURTHER DILUTED. SEE PACKAGE INSERT. Sterile Powder Rx only 10x1.25 g Single-Dose Vials (MMylan®
caf22ccb-df75-45ea-a1d0-ccb2d37272fb_579_4.jpg T ELTC LR Ao xy sopmod ape1s <uel AW iil) “LHISNI 3OVHOW 335 TALMIA HIHLHNS 38 LSTWNOLLNLLSNOD3H tRLIV o5 snousnequLiog dsn ‘uonoafuj Joy apuojyo0ipAH uioAwosuep CR ) oo / MPORTANT - READ PACKAGE NSERT FOR 'PRECAUTIONS AND DIRECTIONS BEFORE USE. e O] “Eachsngl-doso vl conti: e e \fancomycin Hydrochloride NDC 67457-824-99 Vancomycin Hydrochloride for Injection, USP For Intravenous Use et ey Pt b i e e e for Injection, USP B, njection. ninda HMylan e i aeunentl| LT . D S B e Torperatro] For Intravenous Use AFTER RECONSTITUTION MUST BE . After reconstitution, may be stored in a refrigerator for AAFTER RECONSTITUTION MUST BE FURTHER DILUTED. SEE PAGKAGE INSERT. [Mylan: | 5o s s FURTHER DILUTED. SEE PAGKAGE INSERT. [)Mylan® Sterile Powder Lyophilized Sterile Powder K| ooy DT g [MMylan® | px oy 10x1.5 g Single-Dose Vials ] a8
cb0820e8-de07-4403-af3a-13986e86493e_234_1.jpg NDC 42192-112-70 Salicylic Acid 6% Foam Hydrating Topical Foam Rx Only NetWt. 2.5 0z (70 g PHARMACEUTICALS, LLC E BROOKSTONE Dosage and Administration: Apply Salicylic Acid 6% Foam topically {o cover affected skin twice per day, or as directed by a physician. Rub in until completely absorbed Shake vigorously before each application and invert can to administer. Store at room temperature 59° - 77°F (15° - 25°C), See prescribing information for addditional details Ingredients: Salicylic Acid 6%, Dimethicone, Ethylparaben, Glycerin, Methylcellulose, Methylparaben, Phenoxyethanol, Polyoxyl 40 Stearate, Polysorbate 20, Polysorbate 80, Povidone, Propylene Glycol, Propylparaben, Purified Water, Sodium Citrate, Sodium Hydroxide, Stearic Acid, and Trolamine and in propeliants Butane and Propane. Warning: Contains flammable materials. Contents under pvessuve Do not puncture or incinerate. Do not expose o temperatures over 120°F (48°C) even when empty. Keep out of reach of children. Manufactured For: Brookstone Pharmaceuticals, LLC Alpharetta, GA 30009 1-800-541-4802 Rev. 0909v4
cb0820e8-de07-4403-af3a-13986e86493e_234_2.jpg CoH OH
cb1908da-443d-40b8-b8c7-b115bc2d37e0_985_1.jpg ﬁ NDC 71205-105-72 & ProficientRx = RX Only Ketoconazole 2% 40z (120 mL) Shampoo Each bottle contains: Ketoconazole 2% ‘See bottle insert Red-orange Iqui. Product ID: SK010572 For topical application only M By TOLMAR i Fort Clins, CO 80525 Store 2120°25°C (68°77°F) Keep medicalion out o th reach o chidren Lot #0000 Exp. 00100100 RX# MASTER Keloconazolo 2% aa () Srampoo Rk ASTER Latsooo) 000000 NOGTI20810572 Ketoconszola 2% L o RetmASTER ricy Exp0000 Nl fits.0s72 Ketoconszole 2% lax{zom) Shongoo s Lo soo0m E500000 NoC rias 572 Reabeed By, Proient RxLP. Thousand Osks, CA 91320
cb33fc07-e122-4f66-aa43-b659ee150150_559_1.jpg nan
cb8b01b3-bcec-4762-9d67-0db018ef6b22_931_1.jpg 98-8822-16S0 € Each Capsule Contains: 2,29 mg tizanidine hydrochloride, equivalent to 2mg tizanidine base. Madeinlreland Distributed by: Actavis Pharma,Inc. Parsippany, NJ 07054 UsA 100341 Rev. 172018 NDC 0591-2788-86 Refer to package insert for prescribing information. Dispense in containers Tizanidine ‘with child resistant closure. . O Hydrochloride el Capsules Store at 25°C (77°F); excursions permitted to 15°10 30°C (59° to 86°F) [See USP Controlled Room Temperature] Notinterchangy P or Zanallex® tablets, M. 150 Capsules Actavis RxOnly
cb8b01b3-bcec-4762-9d67-0db018ef6b22_931_2.jpg s N 98-6822-16S0 0 Each Capsule Contains: 4.58 mg tizanidine hydrochloride, equivalent to 4mg tizanidine base Madein lrefand Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA 100342 Rev.1/2018 NDC 0591-2789-86 Tizanidine Hydrochloride Capsules LU T T with tizanidine tablets or Zanaflex® tablets. 150 Capsules RxOnly \ Refer to package insert for prescribing information. Dispense in containers with child resistant closure. Keep this and all medication out of reach of children. Store at 25°C (77°F); excursions permitted to 15° t0 30°C (59 to 86°F) [See USP Controlled Room Temperature]. 020597
cb8b01b3-bcec-4762-9d67-0db018ef6b22_931_3.jpg s N o v 0 1 N N 0 o 1 o o 9 Each Capsule Contains: 6.87 mg tizanidine hydrochloride, equivalent to 6 mg tizanidine base. Madein lrefand Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA 100343 Rev.1/2018 NDC 0591-2790-86 Tizanidine Hydrochloride Capsules 150 Capsules Actavis RxOnly Refer to package insert for prescribing information. Dispense in containers with child resistant closure. Keep this and all medication out of reach of children. Store at 25°C (77°F); excursions permitted to 15° t0 30°C (59 to 86°F) [See USP Controlled Room Temperature]. 020599
cc1fd49c-ba64-445e-8d03-f771a7439503_507_1.jpg 10475700 = S e 5 — O — D — e A — L + — | — o ——
cc422f98-2b6d-4cbf-9eab-2a391fb83219_630_1.jpg Packbaged by Eryant Ranch Bibank. @A 9504 Thyroid 60mg 5 UoTmrusr s Tablet 10 628411 Keep in light resistant Compare To: container perUSP Armour Thyrok 0mg Tablet "Store atroom tempof | Acella Pharmaceuticals LLC 20-25 C (68-77F) #60 Exp: MMYY NDC 7133504141 043681114529 om
cc445a39-d84c-4b76-9fb8-ae302e7cd96b_87_1.jpg FINISH ALL MEDICATION UNLESS OTHERWISE ADVISED BY YOUR DOCTOR. 55289-845-21 55289-845-21 55288-845-21 AMOXICILLIN & AMOXICILLIN & AMOXICILLIN & CLAVULANATE K CLAVULANATE K CLAVULANATE K 500/125 MG 500/125 MG 500/125 MG 21 TABLETS 21 TABLETS 21 TABLETS ReOrder # 100211 ReOrder # 100211 ReOrder # 100211 LoT J18B65 LOT J18B65 LOT J18B6S EXP 11/19 EXP 11/19 EXP 11/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: USP 500 MG AMOXICILLIN AS THE TRIHYDRATE AND 125 MG CLAVULANIC ACID AS THE POTASSIUM SALT USP 0.63 MEQ POTASSIUM ORGANOLEPTIC MARKINGS: WHITE 93 2274 OBLONG NDC: 55289-845-21 PHARMACEUTICALS Z|/INCORPORATED?, B-| Oklahoma City, OK » 73127 AMOXICILLIN & CLAVULANATE K (01)10355289845218 (21))18B65000001 (17)191130 {10)118865 BIZSVBERETSSE RO T vavhyl '0LNOYOL Q3LIWIM VOYNYD VAL PEVLZZEEDOD
cc55110f-1ad6-4f97-840d-62b3a5ac415a_542_1.jpg ATTACHED PATIENT INFORMATION LEAFLET PHARMACIST PLEASE DISPENSE WITH 1 only Extended-Release Fluvastatin Sodium Tablets NDC 0093-7446-01 80 mg* ¢ Each extendederelase fim-coated tablet contains flsvastatin sodium (hydrated form) ‘equivalent to 80 m fvvastati. Usual Dosag: S pckage mert for closure (as requird), KEEP THIS AND ALL MEDICATIONS OUT (OF THE REACH OF CHILDREN. ¥ 0093-7446-01 323K553030915 =]
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_1.jpg NDC 65862-702-60 Each capsule contains: Ziprasidone hydrochloride USP equivalent to 20 mg ziprasidone. Rx only Ziprasidone Uil Dneage; " ee accompanying prescribing Capsules USP @ information. - 2 20 mg Store at 20° to 25°C (68° to 77°F) . [see USP Controlled Room /2 AUROBINDO 60 Capsules Temperature]. Distributed by: Made in India =z Aurobindo Pharma USA, Inc. 2 w 279 Princeton-Hightstown Road C°%% TS/DRUGSIZ2/2009 ! oy East Windsor, NJ 08520 := ,,,,,,,,,,,,,,,,, PALRITI0 e e oy z i* i~ i e | Ine— | | O — i | © — i 1 “Over Printing Zone Caling i (45x15mm) Dotted lines not to be printed
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_2.jpg * Over Prining Zone. (Datted fnes ot to be print) 'UNVARNISH ZONE Ziprasidone Capsules USP 20mg Usual Dosage: See accompanying prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. This unit-dose package s not child resistant, I dispensed for outpatient use, a hild resistant container should be used. Sllgs 562070250017 5 Ziprasidone Capsules USP 20mg. Each capsule contains: Ziprasidone hycrochloride USP equivalent to 20 mg ziprasidone. semanid 80 (8 x10) Unit-dose Capsules NDC 65862-702-80 Rx only Ziprasidone Capsules USP 20 mg . bur gz sajnsdeg asop-un (04 X 8) 08 /2 AUROBINDO 80 (8 x 10) Unit-dose Capsules 20mg 279 Princeton-Hightstown Road Sl East Windsor, 1) 06520 Made in India 80 (8:x 10) Unit-dose Capsules Code: TS/DRUGS/22/2009 Ziprasidone Capsules USP Dewbuedw: o \
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_3.jpg B oo Each capsule contains: NDG 65862-703-60 Ziprasidone hydrochloride USP equivalent to 40 mg ziprasidone. Rx only Ziprasidone Usual Dosage: See accompanying prescribing Ca pSulES USP information. /52 AUROBINDO Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room 60 Capsules Temperature]. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 P1421732 “Over Printing Zone Made in India Code: TS/DRUGS/22/2009 Coding Area (45 x 15 mm) Dotted lines not to be printed
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_4.jpg * Over Printing Zone (Datted fnes not o be print) 'UNVARNISH ZONE Ziprasidone Capsules USP Usual Dosage: See accompanying prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. This unit-dose package s not child resistant. I dispensed for outpatient use, a child resistant container should be used. 4 | | || s 5562170380 Ziprasidone Capsules USP semannd Each capsule contains: Ziprasidone hycrochloride USP equivalent to 40 mg ziprasidone. 80 (8 x10) Unit-dose Capsules NDC 65862-703-80 Ziprasidone Capsules USP 80 (8 x 10) Unit-dose Capsules /50 AUROBINDO sajnsdeg asop-un (0} X 8) 08 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India 80 (8.x 10) Unit-dose Capsules Code: TS/DRUGS/22/2009 Ziprasidone Capsules USP Jetbedty e e, \ 1T
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_5.jpg * Over Printing Zone (Datted fnes not o be print) 'UNVARNISH ZONE Ziprasidone Capsules USP Usual Dosage: See accompanying prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. This unit-dose package s not child resistant. I dispensed for outpatient use, a child resistant container should be used. 4 | | || s 5562170380 Ziprasidone Capsules USP semannd Each capsule contains: Ziprasidone hycrochloride USP equivalent to 40 mg ziprasidone. 80 (8 x10) Unit-dose Capsules NDC 65862-703-80 Ziprasidone Capsules USP 80 (8 x 10) Unit-dose Capsules /50 AUROBINDO sajnsdeg asop-un (0} X 8) 08 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India 80 (8.x 10) Unit-dose Capsules Code: TS/DRUGS/22/2009 Ziprasidone Capsules USP Jetbedty e e, \ 1T
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_6.jpg sejnsdeg esop-un (01 X 8) 08 dsn sajnsdeq auopiseidiz = Over Pinting Zone: (Dotted fnes rotto e print) 'UNVARNISH ZONE — - Ziprasidone Capsules USP Usual Dosage: See accompanying prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. This unit-dose package s not child resistant. I dispensed for outpatient use, a child resistant container should be used. WS 5! 7nun|||| seenid Ziprasidone Capsules USP Each capsule contains: Ziprasidone hycrochloride USP equivalent to 60 mg ziprasidone. 80 (8 x10) Unit-dose Capsules NDC 65862-704-80 Rx only Ziprasidone Capsules US /2 AUROBINDO 80 (8 x 10) Unit-dose Capsules Ziprasidone Capsules USP Rt vop 1. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India 80 (8.x 10) Unit-dose Capsules Code: TS/DRUGS/22/2009
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_7.jpg NDC 65862-705-60 Rx only Ziprasidone Capsules USP @ somgC /2 AUROBINDO 60 Capsules Each capsule contains: Ziprasidone hydrochloride USP equivalent to 80 mg ziprasidone. Usual Dosage: See accompanying prescribing information. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/22/2009 P1421736 *Over printing Zone Coding Area 4515 mm) Dot s ot o be pirted
cc5e1c44-79e9-45d3-b1e5-b003f550c508_31_8.jpg i i ! Ziprasidone Capsules USP e Dage: e oo e vt S 20525 (51079t US et R Tt i g il s e, i ki i e Ziprasidone Cai:ul!: usp Ech apl oo s oot P el 1) Ssidon. 00210 Ui o J '\ / NDC 65862-705-80 Rx only Ziprasidone Capsules USP - a /9 auonoo 80 (8 x10) Unit-dose Capsules Ziprasidone Capsules USP pabustr | 27 s ot o Ein WVt Moot 08210 Unicdor Cpaies ot TSI
cccd40ca-5f08-4acb-8548-3cad558388bb_772_1.jpg ¢ 3 dX3a/101 £269-T4 shep gg unym uopoaluf spuwoig wniuoINa0y Jo s "skep g uryum uor wnuoINaoy asn ‘(4,///,G7) Suol -1pu02 aBe10js ampeIaduia) Woo. 0} uoi} -p1abuya1 wouy [enowal uodp 373344 LON 00 ‘(4097 03 9€) 368 01 ¢ ‘Uoiiesa ~614ja1 Japun paio3s aq pjnoys uonaalu| spioIg wi 10/pue PIoe 9828 UM o Hd & 0} pue [geN Tuw/buw 1'g Gim Aouojosi o} parsnipy ‘ajejo9e wnipos buiz ‘apiwolq wniuoino04 B )| SuBI09 qul e ‘ouafioskduou ‘3jua)g “uoneuol Buiguosaid pasopoue peay :afesog s 3 & i | off £z tie FEs===5E £8::20 222558 E2seD BE88EESs f8283 S2SE-5E E3zZg 5= 255.Es 3255 g P38gees S5 < SEEg8ESE 52 SsEdsclEzsis0 Z=xm SSS8ET 23282 £ = ebuhsuydie = sSE BYO oad = = - 2 [INERUN= S~ 2| o= E & S| 82 2 ¢ 2| S E 2 5~ E= 95 E == S St o 52 O=| £ = £&
cccd40ca-5f08-4acb-8548-3cad558388bb_772_2.jpg i CA4BT4 Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) 0x5 mL multiple dose vials i Rxonly NDC 0403-9558-49 Storage: Rocuranium Bromide_Inection Shoud be stored under refgertion, 1o 8°C (36 to 46°F). DO NOT FREEZE. Upon removal from refrigeration to room Xemperature storage condtions (25°CIT), uee Roruronium Bromide Inecton vt 60 doys. Use opened vils of Rocuronium Bromide Ijection it 30 days. Strile, nonpyrogenic. Fach ml contaies: 10 mg oeuronum bromids, 2 mg sodum scetate, Adjsted 1o isotoniy wih 3.1 mg/mL NaCl and to a pH of 4 with acetic acid and/or NoOH. Viade inNetherands NOVAPLUS® x5 mL multiple dose vials ocuronium |T=/Bromide Injection 50 mg/5 mL (10 mg/mL) @sSNIdVA e sopue pos 5208 G o 4 © c pue 8N g i Apiuoost o3 pareripy | amiaos lunpos Bu 7 ‘spuioq wnuginoos b Suibimo i y3e3 imboskdsar ‘sl S45p ¢ 1 vogsaty spuorg bunuonoog o Sfei pavado s S48 03 . Uog3a] piiory oy S50 4oL U2 Socpios aBeics smie ey W0} 3 ogelatjas wor 2o uod) 7M1 0N 00 Uy @ %) 04 2 iogsisbiyas sepun paics 30 prois orfali] spliasg unwbinaoy 1 Dol Ao xy (Tw/Bu g1) Jw 5/6w g5 uoi3d3(u| apiwioig wnjuoandoy S[ei esop ajdjnw Jw g X ey Bugsad saoue pooy sBesoq oA Appepsuiu s uojwadses s 2035y wpissaudsp Aicadss osn) ] NV €01)10304099558495 Rocuronium LT 0x 5 mL multiple dose vials Bromide Injection 50 mg/5 mL (10 mg/mL)
cccd40ca-5f08-4acb-8548-3cad558388bb_772_3.jpg i CA4BT4 Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) 0x5 mL multiple dose vials i Rxonly NDC 0403-9558-49 Storage: Rocuranium Bromide_Inection Shoud be stored under refgertion, 1o 8°C (36 to 46°F). DO NOT FREEZE. Upon removal from refrigeration to room Xemperature storage condtions (25°CIT), uee Roruronium Bromide Inecton vt 60 doys. Use opened vils of Rocuronium Bromide Ijection it 30 days. Strile, nonpyrogenic. Fach ml contaies: 10 mg oeuronum bromids, 2 mg sodum scetate, Adjsted 1o isotoniy wih 3.1 mg/mL NaCl and to a pH of 4 with acetic acid and/or NoOH. Viade inNetherands NOVAPLUS® x5 mL multiple dose vials ocuronium |T=/Bromide Injection 50 mg/5 mL (10 mg/mL) @sSNIdVA e sopue pos 5208 G o 4 © c pue 8N g i Apiuoost o3 pareripy | amiaos lunpos Bu 7 ‘spuioq wnuginoos b Suibimo i y3e3 imboskdsar ‘sl S45p ¢ 1 vogsaty spuorg bunuonoog o Sfei pavado s S48 03 . Uog3a] piiory oy S50 4oL U2 Socpios aBeics smie ey W0} 3 ogelatjas wor 2o uod) 7M1 0N 00 Uy @ %) 04 2 iogsisbiyas sepun paics 30 prois orfali] spliasg unwbinaoy 1 Dol Ao xy (Tw/Bu g1) Jw 5/6w g5 uoi3d3(u| apiwioig wnjuoandoy S[ei esop ajdjnw Jw g X ey Bugsad saoue pooy sBesoq oA Appepsuiu s uojwadses s 2035y wpissaudsp Aicadss osn) ] NV €01)10304099558495 Rocuronium LT 0x 5 mL multiple dose vials Bromide Injection 50 mg/5 mL (10 mg/mL)
cccd40ca-5f08-4acb-8548-3cad558388bb_772_4.jpg x 10 mL multiple dose vials NDT 0409-95 Rocuronium Bromide Injection ning:Rocuronium Bromida jecton Cousa raspratary doprassion. Faciites for arfical respration must be immadiataly vailabe osage: Read enclosed prescribing nomation, Manutactrad b Hospira, nc. Lako Forest, L 60045 USA N and NOVAPLUS aa rgiserad tracamarks of Vit Ine. NOVAPLUS® 2 0 10 mL muftiple dose vials | o Rocuronium Storage: Rocuronium Bromide Injection should - B . ! bostorad undorefigeration, 205°C (w0457, [~ Bromide Injection e omamaroom || oG, e Roswmin Bkt e || oo o s o oo | S i - St vappogic, Exh ol conis g e o Adjusted to isotonicity with 3.1 mg/mL NaCl and toa pH of 4 with acatic acid and/or NaOH. I lamy o d IdVAON i Lok Hoen opue poe e % pue (09 WU LT 1w Ayouoiost | eGP 'V G0 1 Beso] o154 LS4 aSEpUN ‘ogeu0yu Bug 0ss1d pasop s iy ebvsng 0| @pers ferapouu 1 pesnipy 19198 wnpos Bz ‘spuoay umooor | rm 0 sumno W we Eslukde vjpas slep £ UK o g ko) psn 0 Shop @ uuw W sl pung uniny b “(,2,2) swapwo stenis emusdus, oos @ uogueByar wy (smwer wd 73 LON 0049 015¢10 803 7 U eisbes epun patos P nous uogsall opuicig unnimny ‘b quoxy snuoum g B K isonos s osiep Acediees enes o e B ooy S uon3ful prwioig wniuoindoy 06-8556-6000 IAN. s{ein8sop aidninw Tw | X 0L (10X T0mL multiple dose vials | Rocuronium Bromide Injection — CA-487% R I 01)10304099358501 T
cd02d7f0-0fbe-4829-9a05-99a261972805_618_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT. MAY CAUSE DROWSINESS. - - USE CAUTION WHILE PERFORMING TASKS REOUIRING MENTAL ALERTNESS. NDC 4306;61 8-30 ° R X CAUTION; FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG 10 e A%V PEUSON OTHEP THAN TO WHOM IT WACS PDECCRIRED, > l @ AAEUTICALS § LT PHARMAC = R WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN a=g I).( g INCORPORATEDY/ & —— el DOSAGE and STORAGE: SEE PACIKAGE INSERT o==2 =8 [k lahoma City, OK » = o==3 Oklahoma City, 0K = 73127 = 43063-718-30 43063-718-30 43063-718-30 1< & - dja[zjg};AM dia[z]esl;AM diazePAM % s B e A = Pl (= 5 m| 5mg 5m é’g =3 laze E= 30 TABLETS 30 TABLETS 30 TABLETS " * —— REORDER #110028 REORDER #110028 REORDER #110028 =& =" i LOT [18C89 LOT [18C82 LOT I18CS89 §§ = i) EXP 06/20 EXP 06/20 EXP 06/20 = =n — = S m— = -=—— CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. ; g =‘—§"g = YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 i i — ! =) Each Tablet Contaius: : D mms TIKE__TABLET(S)_TIMES A DAY, =" 5 MG OF DIAJEPAN, USP. & e T L= Mt g == n — TOME___TABLETA(S) __ VECES AL DIA, A 2 = ORGANOLEFTIC MARKINGS: ORANGE ROUND/SCORED MYLAN 345 2=
cd24a261-9c15-42b4-8040-89d2dbda174e_295_1.jpg Lot EXP 200mL 241445 NDC 0338-6045-37 Fluconazole in Sodium Chloride Injection, USP 400 mg /200 mL @ngni) 1s0-08oTIC SODIUM CHLORIDE DiLUENT SwaLs-Dose St INTRAVIA cowtann Nowvocsuc +Each 200 mL conTams 400 mg oF FuucouszoLe USP a0 1.8 g or Sooum Chomioe USP i WATER Fo INsEcTio USP Oswouaarry 315 mOsmol/L (cAc) H 5.5 (4.0 10 6.5) No PRESERVATIE 1S ADDED USUAL DOSAGE INTRAVENOUSLY AS DIRECTED BY A PHYSICIAN SEE PACKAGE INSERT CAUTIONS CHECK FOR MINUTE LEAKS BY SOUEEZING CONTAINER FIRMLY |F LEAKS ARE FOUND DISCARD CONTAINER AS STERILITY MAY BE IMPAIRED DO NOT ADD SUPPLEMENTARY MeDicaTIoN MUST NOT BE USED IN SERIES CONNECTIONS Use ONLY IF SOLUTION 15 CLEAR Rx Omy BATER HEALTHGAAE CoRPORATON BATER AND INTRAVA AFE DeEFFELD IL 60015 USA REGITERED TRACEMARKS 0F MacE w USA BATER ITERMTONAL I
cd24a261-9c15-42b4-8040-89d2dbda174e_295_2.jpg Lot: T123456 Exp: JAN 9999 QTY:10 x 200mL Single Dose INTRAVIA Containers - 2 NDC:0338-6045-37 Code: 201445 Fluconazole Injection, USP 400 mg/200 mL 1SO-0OSMOTIC SODIUM CHLORIDE DILUENT mended slorage: Sore bebween 77°F (25°C) and 41°F (5°C). Bre exposure up to 104°F (40°C] does fct. Protec fom fieezing Avoid excessive heat (01)50303386045371 (01)50303386045371(17)990100(21)000000001721 (1 n)dess (17)990100 (2100000001721 PALS® (10)T123456 ot aduerssly affecttne
cd24a261-9c15-42b4-8040-89d2dbda174e_295_3.jpg LOT EXP 100 mL 2J1446 NDC 0338-6046-48 Fluconazole| in Sodium Chloride N Injection, USP 200 mg/100 mL (2mgmL)* 180-0SMOTIC SODIUM CHLORIDE DILUENT Swos-Dose INTRAVIA conramen Stenwe Nowpvaocewc +Excn100 mL cowmas 200 g of FLucouezote USP o 900 mg oF Sooum Geuomioe USP i Waren ror Inggomion USP~_Oswousimy 315 mOSMOIL (cac) #H5.5 (4010 6.5) No PRESERVATIE 15 ADDED USUAL DOSAGE _InTeavevousLy 45 DIRECTED BY A PHYSCUN SEE PACKAGE NSERT CAUTIONS Geck Fo MIUTE LEAGS Y Souezns GONTANER FRUALY IF LEAKS ARE FOUND DISGARD CONTANER 45 STERLTY MaY BE WPARED Do HOT ADD SUPPLEMENTARY. NEDICATION MUST NOT B USED IN SEREES GONNEGTIONS Use onLY F soumon is oLeas Rx Owy 'BAXTER AND NTRAVIA AR REGISTERED TRADEARKS OF BAXTER ITERNATIONAL I Baxter Baxren HeaLHoare Corroration Deieco IL 60015 USA Maoe m USA
cd24a261-9c15-42b4-8040-89d2dbda174e_295_4.jpg Lot: T123456 Exp: JAN 9999 QTY:10 x 100 mL Single Dose INTRAVIA Containers : ey Code: 2J1446 Fluconazole Injection, USP 200 mg/100 mL 1SO-0SMOTIC SODIUM CHLORIDE DILUENT Jorage Store between ). et exposure up to 104F (40°C) does Ly i (01)50303386046484(17)990100(21)0000000007 15(1 (01)50303386046484 (17)990100 (21)000000000715 AL (10)7123456
cd61e902-166d-4aa6-9f3c-a18c1008d07e_553_1.jpg 21 mL Prefiled Autoinectors. AMGEN" £ supdiieke i OHo I (evolocumab) Injection NDC 72511-760-02 140 mg/mL Prefilled Autoinjector For Subcutaneous Use Only Single-Use Only Sterle Soluton - o Preservative Store at 2°C to 8°C (36°F o 46°FJNONORFreeze oF Shake Store in Carton to Protect from g (see side panelfo additonal sto SURIBIGHMNON Koop out of the sight and reacilRehlren This Product Contains Dry Notural Rubber. @ s ee |/ CAUTON, oo packag nsrt for full prescribing information and Instructons for Use: ROnly 1S Uiccs o, 1050 HollS. s of gy
cd61e902-166d-4aa6-9f3c-a18c1008d07e_553_2.jpg 11 L Prfilled Syringe (evolocumab) i 140 mg/mL Prefilled Syringe For Subcutancous Use Only Store at2°C 0 8°C (36°F to 46°F). Do Not FiSSEB OFSHake Stor in Carton to Protet rom Light, {seesid pane for adiona lorage nfor U DG 72511-750-01 Sterile Solution - No Preservative Singlo Use RoOnly CAUTION, S package nsert o ol prescribing informaton and Instuctions for Use T ProductConain Dy Natural ubber Keep out of the sight and reach of children
cd61e902-166d-4aa6-9f3c-a18c1008d07e_553_3.jpg 1x3.5 mL Prefiled Cartridge NDC 72511-770-01 1 On-Body Infusor AMGEN" LR 3.5m &3 Pushtronex® system (evolocuma) 0On-Body Infusor and Prefilled Cartridge For Subcutaneous Use Only Single-Use Only Sterile Solution ~ No Preservative Store refrigerated at 2°C to 8°C (36°F to 463F): Do Not Freeze or Shake. Store in Carton to Protect from Light. (see side panel for additional storage infdfmation) Keep out of the sight and reach of gfilrens A= Keep Dry ) Refer to Instructions for Use ® Do not re-use (®) Do Not Use if Package is Dafiaged 0] Tyne BF Applied Part On-Body Infusor Sterilfzed Relative Humidity Using Ethylene Oxidef Range is 15% to 85% ROnly
cda8bd15-ea6f-44bc-ab17-29768696f9d6_680_1.jpg Packaged by Evgant Ranch Bunbank. CA 91504 Cyclobenzaprine & HCI 5mg Tablet § May Cause Drowsiness & | Store at room temp of Compare To: 20°-25°C (68°-T7°F) Flexeril 5mg Tablet Keep all drugs outof Soko Healthcare U.S. LLC 5 reach of children. #30 Exp: MMYY £ NDC 7133509211 036401122042
cdb957e6-9b8d-47d7-9a1e-bdeddad576e8_533_1.jpg WHEN PRENANCY IS DETECTED DISCONTINUE. ¥ NDC: 43063-787-30 g— @ & = s gt IPD-Rx e > %D YT - s ||PHARMACEUTICALS | & =—= I\ - WARNING KEEP THIS OUT OF THE n.m.cn CLLR INCORPORATED® — S DOSAGE and STORAGE SEE PACKAGE INSERT Dklahoma City, OK « 73127 == 43063-787-30 43063-787-30 43063-787-30 = BENAZEPRIL BENAZEPRIL BENAZEFRIL i == ey g BENAZEPRIL 40 MG 40 MG 10 MG = HCI. Usn — 30 TABLETS 30 TABLETS 3u 1ABLETS =z I — ReOrder # 110363 ReOrder # 110363 ReOrder # 110363 E E —_ Lot 118C28 Lot 1sczs Lot 118czs g« 6 A EXP D3/20 EXP D3/20 EXP D3/20 2 LLORVIe SOF & = o553 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. 2 928 YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 = 30 TABLETS g E § = > TAKE TABLET(S) TIMES A DAY. 5 2 (01)10343063787304 z TOME___ TABLETA(S) VECES AL DIA. (21)/18€28000001 £ Each TABLET Contains: RID g ) : ac ontains LB,EQ'%E,&%L HYDROCHLORIDE g (17) 200331 Z c (10)118€28
ce23d008-6b12-4937-9b87-fea423ac49a8_382_1.jpg nan
ce47777f-8cf7-4f53-b48f-165b83516896_21_1.jpg Each tablet contains: Butalbital, USP. 0 mg Aspirin, USP. Caffeine, USP. 0 mg Usual Adult Dosage: One or two tablets every four hours as needed. Do not exceed six tablets per day. See package insert for full prescribing information. Dispense in a tight, light- Tesistant container using a child-resistant closure. Store at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Rev. 01, 10-17 NDC 42543-098-01 Butalbital, Aspirin and Caffeine Tablets, USP @ 100 Tablets Manufactured for: Vensun Pharmaceuticals, Inc. Yardley, PA 19067 Manufactured by: Pharmaceutics International, Inc. Hunt Valley, MD 21031 3 042543709801 5 on-Varnish Area
ce8ef43b-da24-4f35-928f-1295cb131017_185_1.jpg Pacbaged by Eryant Ranch Baban. @4 91506 Verapamil ER G ¥ o 240mg tablet () S Store at room temp of Compare To: 2025 C (68-77F) Calan SR 240MG Tablel “Keep al drugs outof i . reachofchildren #30 Exp: MMYY 3 NDC 7133500291 030521114346
ce8ef43b-da24-4f35-928f-1295cb131017_185_2.jpg Pacbaged by Eryant Ranch Baban. ¢4 91506 5 BLUEOVAL M 312 Verapamil ER 9 180mg Tablet 2 store at room temp of Compare To: 2025 C (68-77F) Calan SR 180mg Tablet Koo all drugs out of Myian Pharmaceufiab nc. reach of children om #30 Exp: MMYY NDC 7133506381 040731115629
ce8ef43b-da24-4f35-928f-1295cb131017_185_3.jpg Packaged by Evyant Ranch Bibank. @A 91504 Verapamil HC §fweom s ER 120mg Tablet 10° 509221 Keep in light resistant Compare To: container perUSP Calan SR 120mg Tablel Siore at room temp of Mylan Pharmaceuticals . 20°25°C (68°-77°F) #30 Exp: MMYY NDC 7133509271 047171122505 om
ceee4883-6c49-4538-a747-354d0743b221_691_1.jpg ( ExcimtconTams ACTIVE: Desmopressin Aceele, USP 0.1 mg 001%) INACTIVES: Sodum Chiord and Weter for hection. Hydrachiorc Add mey be addedto st pH (4560 PRESERVATIVE ADDED: Chiarobutandl 5%, NDC 62756-161-91 Desmopressin Nasal Spray == Solution, USP 0.01% 5mL REFRIGERATE Rxonly FORINTRANASAL USE ONLY. \_ 50 dosesof 10mog Each actuaton defvers 0.1miL (10meg of desmoprossin acetats). USUAL DOSAGE: Ses Package nserl. Stoage: Size reigerann 29 (5°467) Manufacured by ‘Sun Pharmacoutical Ind. Lt scme Plazz, AnvdherKuri Rozd, Aot (Bast), Muria-400 059, Inda. 150920 PAE0924A RS04 1SS 102011 [GuyRUGS 25789 Batch o £
ceee4883-6c49-4538-a747-354d0743b221_691_2.jpg %H0°0 dSN ‘uohnjos Keadg jesey wissaidowsag 16:191-95229 9N NDC 6275616191 Desmopressin Nasal Spray Solution, USP 0.01% (001 mg/Spray) FOR INTRANASALUSE ONLY Rx only smL 50dosesof 10meg O —— EACH mL CONTAINS: ACTIVE: Desmopressin Acstats, USP 0.1 mg (©01%; ACTIES: Sodum Choide W o pcton Hydoahorc cdmay o a0 0 st pH4560) PRESERATIVE ADDED: o055 Each actuaton doivers 01 mL (10 meg of esmoprossn acotat). USUAL DOSAGE: Read enclosed nsart for complato product nformation Bearaco [ e e o Mo 03053 2 NDC 62756-161-91 Desmopressin Nasal Spray Solution, USP 0.01% (0.01 mg/Spray) FOR INTRANASAL USE ONLY Rxonly smL 50doses of 10 meg o SUN PHARMA Carton Contains: 1 fully assombled unit (pum, actuator with cover, bolte of nasal soluton) KEEP OUT OF REACH OF CHILDREN. Storage: Store n religorator 2. 5'C (36°26°F) KEEP REFRIGERATED AT24°C 06467, MPORTANT: Framasetdeazand dspaspstinsons i pacags et il uez =
cf15569c-5010-4e9b-aef0-7df4de5ed04e_289_1.jpg Divalproex Sodium 500 mg Tablet, DR ary: 30 ID #: 798 Expires: NDC #: 70518-1558-00 Shape: Oval LOT #: Ref #: 62756-0798-13 MFG: Sun Pharma, Cranbury, NJ 08512 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
cf31b8d1-0d19-4529-99b6-1f7366064a3c_487_1.jpg Divalproex Sodium 500 mg Tablet, DR ary: 30 ID #: 798 Expires: NDC #: 70518-1558-00 Shape: Oval LOT #: Ref #: 62756-0798-13 MFG: Sun Pharma, Cranbury, NJ 08512 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
cf31b8d1-0d19-4529-99b6-1f7366064a3c_487_2.jpg 2050276 CAMBER NDC 31722-639-01 ™ Clobazam Tablets C PHARMACIST: Dispense the Medication Guide provided separately to each patient, MR LLLLLLALR LR RN R LR R RN AR R R RN Each tablet contains 10 mg of clobazam. Usual Dosage: See package insert for full prescribing information. Store at 20°C to 25°C (68°F t0 77°F) Isee USP Controlled Room Temperaturel. Dispense in a USP tight container. U.S. Contact Number: 1-866-495-1995 AATATLTTTLTLLRRRRRRRRRRRRRRRRRRNY CAMBER’ NDC 31722-639-01 @ Clobazam Tablets PHARMACIST: Dispense the Medication Guide provided separately to each patient, Mig. Lic. No.: 22/RR/AP/2001/FIR 3 9 31722-639-01 Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 Rx only Rx only By: HETERO™ Hetero Labs Limited, Mecation Gide avaiabl ot Jeedimetla, Hyderabad - 500 055, 100 Tablets it camberpharma comjmedication ides 100 Tablets India. | | | \ | < \ | \ w P \ o \ H | o/ %
cf31b8d1-0d19-4529-99b6-1f7366064a3c_487_3.jpg # ALLLLRRRRRNRRNN NDC 31722-640-01 Clobazam Tablets tim © PHARMACIST: Dispense the Medication Guide provided separately to each patient. Rx only 100 Tablets Each tablet contains 20 mg of clobaza. Usual Dosage: Soe package nsert for fullprescribing information. Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Dispense in a USP tight container. U.S. Contact Number: 18664951995 Medication Guide avaiable at httplcamberpharma comimedication-guides Mig. Lic. No.: 22/RRIAP/2001/FIR Manufactured for: Camber Phamaceuticals, Inc. Piscataway, NJ 08854 By: HETERO™ Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India. 2050279 < 10-0%9-22.1¢ S 40 x 30 mm Un Varnish Area
cf31b8d1-0d19-4529-99b6-1f7366064a3c_487_4.jpg 2050280 CAMBER" NDC 31722-640-01 € Clobazam Tablets PHARMACIST: Dispense the Medication Guide ~provided separately to each patient. Rx only 100 Tablets ALTLTLLLLLLLLLLRLRRRRR LR RN RN RN Each tablet contains 20 mg of clobazam. Usual Dosage: See package insert for full prescribing information. Store at 20°C to 25°C (68°F t0 77°F) Isee USP Contralled Room Temperaturel. Dispense in a USP tight container. U.S. Contact Number: 1-866495-1995 Medication Guide avaiable at hitplcamberpharma.comimedication uides ALTLLLLLLLLLLRRRRRRRRRRRRR RN GCAMBER’ NDC 31722-640-01 G Clobazam Tablets PHARMACIST: Dispense the Medication Guide provided separately to each patient Rx only 100 Tablets Mfg. Lic. No.: 22/RR/AP/2001/FIR 3 31722-640-01 5 Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: HETERO™ Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India. LAY
cf35bff4-af9c-4a59-a5fa-cedacd3d4891_896_1.jpg Each ml contains NDC 0054-0561-50 120mL Shake bottle well before g 25 mg dobazam each use. Use within 90 539 ) Clobazam @ days of firet opening, then USUAL DOSAGE: See e dn 9,1 Package nsert for Complete Q¥ Al SUSpension discard any remainder. Prescribing Information Store and dispense This product is an oral suspension 2.5 mg/m oral sulspension in liquid and is supplied with two 10 mL original container in oral syringes for administration PHARMACIST: Dispense an upright position. Slsedinlt with Enclosed Medication Guide For oral administration only. and Instructions For Use Store al 20° {0 25°C Distr. by: West-Ward with Each Prescription (68° to 77°F). [See Pharmaceuticals Corp. _ USP Controlled Room Eatortown, NJ 07724 W WESTWARD R onty Temperature.] 1001080701 € 05-1950-%500 s
cf970688-cd77-b95c-4bd9-c541590e9722_257_1.jpg el esoq-a(Buig Jw | T dad B g {dsn ‘uoisuadsns ajgeioaful apiuojage alojoUIoLIPLY) ot-.Bojeusy Ao xy Each mL provides 40 mg triamginolone acetonide with 0.66% sodium chloride for isotonicity, 0.99% (w/v) benzyl alcohol added as a preservative, 0.63% carboxymethylcellulose sodium, and 0.04 % polysorbate 80 in an aqueous suspension; sodium hydroxide or hydrochloric acid may be present to adjust pHto 5.0-7.5. Shake well before using. For intramuscular or intra-articular use only. NOT FOR IV, ID, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE. See insert for dosage information. Bristol-Myers Squibb Company Princeton, N.J 08543 USA Product of Spain 1132705A8 Store at controlled room temperature, 20° to 25°C 68° to 77°F); protect from temperatures below 20°C (68°F). Do not refrigerate. Store vial in carton to protect from light. Do not use if vial seal is broken or missing. See bottom panel for lot number and expiration date. NDC 0003-0293-05 Kenalog™>40 (triamcinolone acetonide injectable suspension, USP) 40mg permL For intramuscular or intra-articular use only 1 mL Single-Dose Vial Rx only Read all sides 3 00030293 05 3 GTIN: SIN: Lot: L | 7 - i - S o \\\ | l # \ [
cf970688-cd77-b95c-4bd9-c541590e9722_257_2.jpg 7 ey Nl | - eI Bs0 Q-8 T G (/b o%) g Jad B ppz (dsn ‘uoisuadsns ajgeisal APILO}aoR AUOOUIDUIRL) ot-.Bojeusy Ao xy Each mL provides 40 mg triamginolone acetonide with 0.66% sodium chloride for isotonicity, 0.99% (w/v) benzyl alcohol added as a preservative, 0.63% carboxymethylcellulose sodium, and 0.04% polysorbate 80 in an aqueous suspension; sodium hydroxide or hydrochloric acid may be present to adjust pH to 5.0-7.5. Shake well before using. For intramuscular or intra-articular use only. NOT FOR I, ID, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE. See insert for dosage information. Bristol-Myers Squibb Company Princeton, N.J 08543 USA Product of Spain 1132704A8 QVHLCEl) Store at controlled room temperature, 20° to 25°C (68° to 77°F); protect from temperatures below 20°C (68°F). Do not refrigerate. Store vial in carton to protect from light. Do not use if vial seal is broken or missing. See bottom panel for lot number and expiration date. NDC 0003-0293-20 Kenalog™>40 (triamcinolone acetonide injectable suspension, USP) 200 mg per5mL 40 mg/mL) For intramuscular or intra-articular use only 5 mL Multiple-Dose Vial Rx only| 3 0003029320 6 Read all sides @ Bristol-Myers Squibb GTIN: SiN: Lot: \_[ TR
cf970688-cd77-b95c-4bd9-c541590e9722_257_3.jpg el Bsog-aidanp 1 0} (/6w o) {dsn ‘voisuadsns ajqeizalul ApILojage SUOOUIDUIRLE) ob-.Bojeuay Ao xy Each mL provides 40 mg triamcinolone acetonide with 0.66% sodium chloride for isotonicity, 0.99% (vi/v) benzyl alcohol added as a preservative, 0.63% carboxymethylcellulose sodium, and 0.04% polysorbate 80 in an aqueous suspension; sodium hydroxide or hydrochloric acid may be present to adjust pHto 5.0-7.5. Shake well before using. For intramuscular or intra-articular use only. NOT FOR IV, ID, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE. See insert for dosage information. Bristol-Myers Squibb Company Princeton, N.J 08543 USA Product of Spain 1132703A8 Qve0Leel) Store al controlled room temperature, 20° to 25°C 68° to 77°F); protect from temperatures below 20°C (68°F). Do not refrigerate. Store vial in carion to protect from light. Do not use if vial seal is broken or missing. See bottom panel for lot number and expiration date. NDC 0003-0293-28 Kenalog™>40 {triamcinolone acetonide injectable suspension, USP) 400mg per10m 40 mg/mL) For intramuscular or intra-articular use only 10 mL Multiple-Dose Vial Rx only| Read all sides L 3 0003029328 2 GTIN: SIN: Lot: — | 7 - R { |
cf97a72e-951e-a7db-a574-adac12a6b189_278_1.jpg Nocssan S (5 e, Vi N e GABITRIL (tiagabine hydrochloride) . e 32 2mg i B Z . i
cf97a72e-951e-a7db-a574-adac12a6b189_278_2.jpg Nocsisonn Wb V)0 PaysyuEA uoN
cf97a72e-951e-a7db-a574-adac12a6b189_278_3.jpg 7787 o7 i0g BausiuEA UON NDC 63458-412-30 0 Tabbots [N tiagabine hydrachloride) Tablets 12mg Wobcsiontie v Exc e BT & dusont hapstenta Medesion S Beoaly
cf97a72e-951e-a7db-a574-adac12a6b189_278_4.jpg (mpomsirsagnsia 2 | NDG 6345S-H16-30 St GABITRIL® = hydrochloride) z s Tablets g5 16 mg gk i e pavnta Msdcabon G ) By 63459-416-30
cff0c64a-63f5-4b3c-909a-cdecf6755cbe_619_1.jpg NDC 69344-113-11 Oxaydo’ @ (oxycodone HCI, USP) tablets Do not administer via feeding tube. Swallow whole. 100 Tablets Rxonly Dispense the accompanying Medication Guide to each patient. Each tablet contains 5 mg of oxycodone HCI. Usual Dosage: Read accompanying prescribing information. Pharmacist: Dispense in tight container with child-resistant closure. Protect from moisture. Store at 25°C (77°F); excursions permitted to 15°C - 30°C (59°F - 86'F). [See USP Controlled Room Temperature]. = (Egalet Distributed by: Egalet USInc., Wayne, PA 19087 under patent nos. 7,201,920; 7,510,726; ™ 7,981,439; 8,409,616; 8,637,540 and e LBL#202.02 01/2018 2 GTIN 0036934413112 69344°11311
cff0c64a-63f5-4b3c-909a-cdecf6755cbe_619_2.jpg NDC 69344-113-11 Oxaydo’ @ (oxycodone HCI, USP) tablets Do not administer via feeding tube. Swallow whole. 100 Tablets Rxonly Dispense the accompanying Medication Guide to each patient. Each tablet contains 5 mg of oxycodone HCI. Usual Dosage: Read accompanying prescribing information. Pharmacist: Dispense in tight container with child-resistant closure. Protect from moisture. Store at 25°C (77°F); excursions permitted to 15°C - 30°C (59°F - 86'F). [See USP Controlled Room Temperature]. = (Egalet Distributed by: Egalet USInc., Wayne, PA 19087 under patent nos. 7,201,920; 7,510,726; ™ 7,981,439; 8,409,616; 8,637,540 and e LBL#202.02 01/2018 2 GTIN 0036934413112 69344°11311
d0037303-a025-4dcc-9c24-65bc2b66a010_314_1.jpg R Rxow SOMAZID S TRBLETS —— e O o T TAKE 1 TABLET DALY ORASDRECTED. s s o ooner
d0089df4-37c8-41de-810c-14c9dc06f0c3_272_1.jpg NDC# 71610013253 Carvedilol 3.125mg 60 Tablets e Wi B Aoy s e oo i Feampama e s Carvedilol 3.125mg 60 Tablts Carvedilol B Larssn
d0348cf0-f79a-4579-86c9-a5d25d688659_419_1.jpg NDC 68382-224-06 Each talet conais: Bicalutamide &gmeses Tablets, USP =eerima Store at20° 10 5°C (68° 0 77°F) [See USP Controled Room Temperature] Dispense n a ight containr. KEEP THIS AND ALL DRUGS OUT ‘OF THE REACH OF CHILDREN. Manufactured by Phama 30 Tablets pistributed by: zydus Zydus Phamaceuticals (USA) Inc. s Reonly Plmpmacetls a0 0y
d05200cb-cf29-4bc7-bf0c-b42ab2d20958_281_1.jpg o ol “mcmein nd asn ‘uogoelul pioy 211008y CI R TR (LT Ascorbic Acid Injection, USP | | | i i | i I | | | | | 1 i i i i i | | For mtravanous, | intramuscular or | Subecutanaous Usa | | | | i ostacen STORE BETWEEN 2 TO5'C (' T0 6% Stos ncarton un s of uss. PROTECT FROMLIGHT., PRESSURE MAY DEVELOP UPON STORAGE, EXERCISE. (CARE WHEN WITHDRAWING. et LLC i hagonst ! i i i i i | e | | iyl i | | | | i e ¥ e74s7=118-50 5 (TR Ascorbic Acid Injection, USP ForIntravanous, Inframuscular o ‘Suboutanaous Use Each L. contains: Ascortic Ak 200 g, Disoctum Ecetats 025 mg, Sootum Hycronis 10 mg,n Wate o neton a3, pH ranges5107.0) adjsted wih Socum Eartonats and Sochm Fyrouc. ‘Cortains no pressnates. USUAL ADULT DOSAGE: See accamparying prasrbing nfrmaton. WARNING: Liss asapts tachRR Dispersasntre conrts n allquots undera amier Tow hood wihout sy o Wi 4 hours are nty, or clcariramainng content atr s irraval Prapers stoppers wih asuatle antspt soluon. DO 0t use Lnss soton s e and sl act [Mylan
d06db628-f6f0-48e2-b538-69c0837c49e3_564_1.jpg 500 MG 2V TABLETS
d06db628-f6f0-48e2-b538-69c0837c49e3_564_2.jpg 37500 30 TABLETS,
d1193df2-d53f-4342-bd9d-d9cba7c89709_605_1.jpg i [wevrmopiues: o SRy pussusiode] — = ST e anmns e L Enstilar® {cakipotriene and betamethasone dpropionae] S e Foam, 0005%/0.064% | Epetmgemsea scbeorie | S For Topical Use Only | &5:iioriis [ S werwn. e B . i Enstilar® caciporiene and befamethasone dipropiorate] Foam,0.005%/0.064% Shake before Use. For Topical Use Only. Not fo optthalmc, oal orlniravaginaluse Netwr. 409 S ‘u
d1193df2-d53f-4342-bd9d-d9cba7c89709_605_2.jpg / Bog i [~vovosssoop s “meiodadp —— — —sispuie pizate D) ~Jejlisu3 Attt e .,,‘,m‘_ ETEERS B - sonopat i (calcipofriene and betamethasone dipropionate) Foam, 0.005%/0.064% Physician’s Sample - Not For Sale Shake before Use For Topical Use Only Notfor ophthalmic, oral or intravaginal use: Net Wr. s0g ..muun £ ———— 1 Enstila (calcipofriene and betamethasone dipropionate] Foam, 0.005%/0.064% For Topical Use Only Notfor ophthaimic,oral or intravaginal use: -
d1193df2-d53f-4342-bd9d-d9cba7c89709_605_3.jpg Enstilar® (cakcipofriene and betamethasone: dipropionate} [ Shake before Use For Topical Use Only. Mot for ophalmic, oral or ntavaginal use Nt Wt. 120 (Zems o $00) 2 | (cakipotrene and betamethasone sl EFEEEE | stanstanine EEEEERRTR | For Topical Use Only it | R e Wl e, s
d17e3be5-514f-454a-8347-d804cd5ec37f_203_1.jpg NDC 0517-0020-10 Caffeine Citrate Injection, USP For Intravenous Use Only For single use only; discard unused portion. Each mLcontains: 20 mg caffeine citrate. Sterile, nonpyrogenic, preservative free. Rx Only Store at 20° to 25°C (68° to T7°F). [See USP] Rev.7/18 AMERICAN REGENT, INC. SHRLEY, NY. 11967 Lot / Exp. J
d17e3be5-514f-454a-8347-d804cd5ec37f_203_2.jpg NDC 0517-0020-10 10 X 3 mL SINGLE DOSE VIALS Caffe ne Citrate For Intravenous Use Only discard unused portion 60 mg/3mL@omeg/m) nxomy Usual Dosage: Soe Package Insert, Esch miL contains: 20 m caffeine Gtrate prepared in salution by the adiion of 10 mg caffein annydrous to 5 m of citric acid monohycirate, 8.3 mg socium orate dihycirate and water for injecton. Sterle, Nonpyrogenic, Preservative Free. Store al 20° o 25°C (88" o 77°F), [See USE Mfmm RecenT, INC. ”mm"“l‘ ‘ Injection, USP For single use only: s Lot / Bxo.
d17e3be5-514f-454a-8347-d804cd5ec37f_203_3.jpg NDG 0517.0020.25 Caffeine Citrate Injection, USP For Intravenous Use Only For single use only; discard unused portion. Each mL contains: 20 mg caffeine oitrate. Sterile, nonpyrogente, preservative free. RxOnly Store at 20° to 25°C (68° to TT°F). [See USP] ICAN REGENT, INC. N 1967 i Rev.7/18 Lot / Exp.
d17e3be5-514f-454a-8347-d804cd5ec37f_203_4.jpg HDC 0617002026 25X 3 mL SINGLE DOSE VIALS Caffeine Citrate For Intravenous Use Only Injection, USP 60mg/3mL@0me/ml) mcomy Lot/ Exp. Usual Dosage: Soo Package Each miL contains: 20 mé caffeine ctrate prepared in solution by the adition of 10 mg caffeine anhydrous 1o 5 mg of ctic acid monohydrate, 8.3 mg sodium cirate dinycrate and water for nection. Sterlle, Nonpyrogenic, Preservative et Store at 20° t0 25°C (68" to 77°P). [See Rew7/18 ANERICAN REGENT, INC SHRELNY 11567 Insert,
d17e3be5-514f-454a-8347-d804cd5ec37f_203_5.jpg LOT 0000 EXP JAN 99 GTIN 00305170020101 SN o
d184bf19-d8bd-4543-9ba8-5776c6a096b7_197_1.jpg Metronidazole Tablets, USP IlIIII LI (01) 0 03 68084 216 01 5 Metronidazole Tablets, USP Each Tablet Contains: Matronidazole, USP. 250mg Usual Dosage: See package insert for full prescribing nformation Store at 20° 10 5°C 68" 10 77°F); excursions permitted between 15° 10 S0°C (59° (0 86°F) fsce USP Eortrolied Foom Temperature), Profactfrom g Keep this.and all drugs out of reach o children. RxOnly The diug product containad n his package s rom NDC #0551-2521, Actavis Pharma, nc Packaged and Disrouted by: Amercan Healh Packaging 021601 Colambus, oo 43217 Fev. 0872075,
d184bf19-d8bd-4543-9ba8-5776c6a096b7_197_2.jpg Metronidazola Tablo, USP 250 mg LOT: ooocen EXPIRY wx Metronidszole Tablo, USP 250 mg LOT: e EXPIRY.ox Matronidazole Table, USP 250 mg LOT:sooncx EXPIRY: o Metoridszolo “Tabler USP 250 mg LOT: oocoee EXPIRY: o Metronidazolo Table, USP 250 mg LOT:sooanx EXPIRY. whx | Motonidazole Tavlet, USP § £ 250mg 1 LOT: oot EXPIRY: i = Movenidazole 4 Tablet, USP gg‘ 250 mg fljzeme, EXPiRY e & Metonicazole 58 Toblt, USP. !gg 250 mg fl BT oot Metonidazolo §§ Tablet, USP == i . 5 Metoridazole 148 Tovr USP E§é 250 mg e, EXPIRY. oo | £
d184bf19-d8bd-4543-9ba8-5776c6a096b7_197_3.jpg [T T Metronidazole Tablas, USP RS ) NI T (01) 0 03 68084 966 019 [ ] Metronidazole Tabiet, USP R P S) e Taie Comsine: . sy sl Dosao: S pckag o i sy Stero 5D to 2w 65t 71 s pemitiod e e e T Lo hoom npeie St o igh Keup i nd i crugoou i rsach o chron. FORYOURPROTEGTION:Oa ot o iir s o Sooen oy o i pacag et s SRS B ossey oasa0zIGRS
d184bf19-d8bd-4543-9ba8-5776c6a096b7_197_4.jpg et s i g X o s ot 000000 101 Buw 005 s et 000000101 bw 005 asn oL oSEpuoN 00/00 A¥aE 200000101 bui 005 gsn oL oSzepucIN
d198ad30-90c5-493f-81e7-d3c798ca6d32_364_1.jpg CanisoPRODOL 20 TABLETS nmmm
d307dc62-a7fb-4013-8f3c-28280e2d650b_844_1.jpg Bt i T — ; i, RO . i G R TARE THBLET 3 i Eafen, mEsATN : { = e 5 i = i
d32d074a-f1b6-4a9a-8e10-e19f0e67c61b_277_1.jpg i ~coe DiphenhydrAMINE HCI INJECTION, USP 50 mg/mL HIGH POTENCY 5x1mL VIALS FOR DEEP INTRAMUSCULAR OR SLOW/ INTRAVENOUS USE Each mL contains diphenhydramine hydrochioride 50 mg and benzethanium chioride 100 meg in Water for njection. PH 4,085, sodium hyroxide andjor hydrochloric acid added, i needed, for pH adjustment Usual Dosage: See product nsert for prescribing information, precautions and varnings. STORAGE: Store 2t 20° - 26° C (68° - 77° F) [See USP. Controlled Room Temperature] PROTECT FROM LIGHT: Keep covered unti fime of use. LIGHT SENSITIVE RXONLY WARNING: This Unit Dose package is not chid resistant andis Intended for Insttutional Use Only. Keep this and allcugs out of the reach of children Manufactured by WESTWARD Eatortovn, NJ 07724 USA Distributed by Cardinal Heath Dublin, OH 43017 L25632450218 LOT #: XXXXXXXXXX EXP. DATE: XX/XX/XX
d32d074a-f1b6-4a9a-8e10-e19f0e67c61b_277_2.jpg U, * 55154 ' 51023 DiphenhydrAMINE HCI INJECTION, USP 50 mg/mL HIGH POTENCY 1x1mL VIAL FOR DEEP INTRAMUSCULAR OR SLOW INTRAVENOUS USE Each mL contains diphenhydramine hydrochloride 50 mg and benzethonium chioride 100 meg in Water for Injection pH 4.0-6.5, sodium hydroxide and/o" hydrochloric acid added, if needed, for pH adjustment Usual Dosage: See product insert fer prescrbing information, precautions and warnings. STORAGE: Store at 20° - 25° C (68° - 77° F) [see USP Controlled Room Temperature], PROTECT FROM LIGHT: Keep covered unt| time of use. LIGHT SENSITIVE RX ONLY Bulk NDC 0641-0376-25 Manufactured by WEST-WARD Eatontown, NJ 07724 USA Distributed by Cardinal Health Dublin, OH 43017 LA61550518 Cardinal Health Item # AR6155 LOT #: XXXXXXXXXX EXP.DATE: XX/XX/XX
d38d65c1-25bf-401d-9c7e-a2c3222da8af_958_1.jpg Nz e ey 01693 unz e hammeen vmony, ot S o
d38d65c1-25bf-401d-9c7e-a2c3222da8af_958_2.jpg 1y
d3ce9a73-5f3a-4c1b-a4b7-06f45316d61a_990_1.jpg Packaged by Begant Ranch Bukank, O 91504 Thyroid 1/2 grain 1, BRoW ROUND A 38 (30mg) Tablet 2 2 & | Keep in light resistant Compare To: container perUSP Armour Thyroid 30mg Tablet Store at room femp of Acella Phamaceutioals LLG 20-25 C (68-77F) Ao #30 Exp: MM/YY NDC 6362945561 045561106686
d4360259-6f40-4f79-92c9-d71898f3e92c_916_1.jpg NDC 68094-006-61 Unit Dose oxyCODONE Hydrochloride @ Tablets, USP €L Rx Only PrecisionDose™ NDC 68094-006-61 Unit Dose oxyCODONE Hydrochloride Tablets, USP €D Each tablet contai oxycodone hydrochloride, USP .......30 mg USUAL DOSE: SEE ENCLOSED INSERT. | Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° 10 30°C (59° to 86°F) (See USP Controlled Room Temperature]. PROTECT FROM MOISTURE. KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDRIN. Lci076 RO Manufactured by: Amneal Pharmaceuticals of NY Hauppauge, NY 11788 Packaged by: Precision Dose, Inc. South Beloit, IL 61080
d44e92e6-6fbd-4f14-8d61-ff20c5217359_329_1.jpg = % £ g3 8 =83 g emwm SE26E it EERiix GTIN 00800837206568 Eath fimccabd et contins 15 mgmirtzapin, USP. Usual Dosage: Se package nsrt for full Soreat 2010 25°C 810 77°F)[See USP Contrled Room Temperture] Dispens n g, lghtresistntconting: 15 definedinihe USP, vithachidresstnt closur a5 quied) KEEP THIS ANID AL MEDICATICNS OUTOF THE REACH OF CHILDRENL RevE 112014 323K291400617 : 3 & : = i TEVAPHARMACELTCAL D, LT, 2 i i 0093-7206-56 o £ B £ 2 12 Mot e B
d44e92e6-6fbd-4f14-8d61-ff20c5217359_329_2.jpg w8 E &% g a8y Regit, u.mqum = LK EEERI GTIN 0800837207565 Eah fimccabd et contins 0 mg miazapine, USF. Ustal Dosage: S package nsrt o Soreat 2010 25°C 810 77°F)[See USP Contrled Room Temperture] Dispens n g, lghtresistntconting: 15 definedinihe USP, vithachidresstnt closur a5 quied) KEEP THIS ANID AL MEDICATICNS OUTOF THE REACH OF CHILDRENL RevE 112014 Jesae, TTTAR, sl 323K273100617 Hanectied or S TEAPRRRMACEUTICALS S G 2 Mandachredio sl B TEVA PHARMACEDTICAL 1. 1. W Hort Waks, A 19454 -7207-56 ¢ .
d44e92e6-6fbd-4f14-8d61-ff20c5217359_329_3.jpg | 28 & & g *3f go5h | S BRBEE -0 mmmmmww ESzcg S EEGHHEY 6TIN 00300837208563 Each -t bt contins 45 mg miazgine, ISP, Usaal Do Storet 20°10 25°C (66" 77°) [See USP ContledRoom Temperature, Dgerce ina toh, Tiitresitart cotiner a5 efinad it USF, witachihnsitit s, KEEP MEDICATIONS OUTOF THE REACH OF CHLDFEN. Rev £ 172014 s, 7742l 323K254000617 S Mauetror NorthWaes,PA 19454
d4caa7c6-afb5-43a2-ba38-cf30106b1d62_266_1.jpg v 004G, 20 TABLETS ¢
d5163535-ae09-4efb-97ef-532789cd7540_406_1.jpg NDC 0574-0180-01 Potassium Chloride Extended-Release Capsules USP O LT ¢ 100 Capsules Perrigoe Potassium Chioride Extended-Release Capsules USP 8 mEq contain microencapsulated KCl and are designed to release the active ingredient over an 8-to-10-hour period. Usual dosage: See accompanying package insert. Dispense in a tight container as defined in the USP Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] Made in India Manufactured by: Cipla Ltd., Verna Goa, India JI76A M.L. :536 Manufactured for Perrigo Minneapolis, MN 55427 8Y878RCF1 Rev01-14A 3 0574-0180-01 =z 3
d5163535-ae09-4efb-97ef-532789cd7540_406_2.jpg NDC0574-0181-90 Potassium Chloride Extended-Release Cagsules UsP 90 Capsules Perrigo- Potassium Chloride Extended-Release Capsules USP 10 mEq contain microencapsulated KCl and are designed to release the active ingredient over an 8-to-10-hour period, Usual dosage: See accompanying package insert. Dispense in a tight container as defined in the USP Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] Made in India Manufactured by: Cipla Ltd,, Verna Goa, India J77A M.L.: 536 Manufactured for Perrigo Minneapolis, MN 55427 58775RCF1 Rev01-14A 0574-0181-90 & = 3
d5163535-ae09-4efb-97ef-532789cd7540_406_3.jpg 0 Potassium Chloride Extended-Release Capsules USP 10 mEq contain microencapsulated KCl and are designed to release the active ingredient over —_— an 8-to-10-hour period. — ? NDC0574-0181-01 Usual dosage: See accompanying package insert. —_— 0‘_0 W W Di inatich . fnedinthe ISP Potassium Chloride g ne ot mimeontelst =0 Exte“ded'REIease [see USP Controlled Room Temperature] = . I — Capsules USP N . . o . Made in India =M Manufactured by: Cipla Ltd,, Verna Goa, India JI78A M.L.: 536 Manufactured for Perrigo 100 (apsules Perrlg0® Minneapolis, MN 55427 58778RCF1 Rev01-14A
d5163535-ae09-4efb-97ef-532789cd7540_406_4.jpg N NDC 0574-0181-05 Potassium Chloride Extended-Release Cagsules USP 500 Capsules Perrigo® Potassium Chloride Extended-Release Capsules USP 10 mEq contain microencapsulated KCl and are designed to release the active ingredient over an 8-to-10-hour period. Usual dosage: See accompanying package insert. Dispense in a tight container as defined in the USP Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] Made in India Manufactured by: Cipla Ltd., Verna Goa, India JI79A M.L.:536 Manufactured for Perrigo Minneapolis, MN 55427 5S790RCF1 RevO01-14A 8 0574-0181-05 N 3
d53b9838-f47a-40df-bf6d-71e7166b6101_876_1.jpg NDC 68180-348-01 PHARIACIST:DISPENSE THE MEDICATION GUDE PROVIDED SEPARATELY 0 EACH PATENT Rxonly LupIn 100 Tablets ch bl contins gabapentin USP 60010 anactred o Usea Dosage: e sy L Pramacaitcls. e s oo ok aynd 21308, U St Storage: S 21256 (77 cugons s it 0 0° 59 085+ L Limed 588 USP Contoled Room Temperaure]. Naopu - 447108, WOIA Dipansan 3 U (USP), chi-msisan L. coniners i
d53b9838-f47a-40df-bf6d-71e7166b6101_876_2.jpg J NDC 68180-349-01 Each talet conans gabapentn USP 800 mg. Manufactredfr Usual Dosage:See scsompanying Lupin Pramaceutials, nc. prscribing informaton, Bafimore, Marylnd 2102, Unteg Stts. (17 pursions Manufacured by leg 015" 030°C (9° o gi'F). Lupin Limited 380 USP Contolled oom Temperaual, egpur - 441 108, DA Dispense na tight (USF), chidressant pg1 L continers "PHARMACIST: DISPENSE THE MEDICATION SRR ALY To A | PATIENT. | Ui A reony gl Sae e T00Tables &
d57188d2-c3af-4879-bf17-f37eaf733aca_84_1.jpg Pachaged by Eogant Raeck Bbank. €4 91504 Valsartan Hctz S 320/25mg Tablet Store at room temp of Compare To: 20°25°C (68°77°F) Do R 0BGl oo i ouof - reach of children. #30 Exp: MMYY NDC 7133508531 069231120152 om
d57720ab-9f83-4da9-a57f-0d55e00a605c_660_1.jpg Atorvastatin Calcium 10 mg Tablet arv: 30 ID #: APO;A10 Expires: NDC #: 70518-0224-00 Shape: Oval LOT #: Ref #: 60505-2578-08 MFG: Apotex Corp., Weston, FL 33326 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
d57720ab-9f83-4da9-a57f-0d55e00a605c_660_2.jpg Atorvastatin Calcium 10 mg Tablet arv: 90 ID #: APO;A10 Expires: NDC #: 70518-0224-01 Shape: Oval LOT #: Ref #: 60505-2578-08 MFG: Apotex Corp., Weston, FL 33326 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
d57720ab-9f83-4da9-a57f-0d55e00a605c_660_3.jpg Atorvastatin Calcium 10 mg Tablet ary: 28 ID #: APO;A10 Expires: NDC #: 70518-0224-02 Shape: Oval LOT #: Ref #: 60505-2578-08 MFG: Apotex Corp., Weston, FL 33326 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
d58f1f63-4bb6-413c-9730-ded3e8078618_829_1.jpg 90 Tablets ~ NDC 72205-002-90 Rosuvastatin Calcium Tablets NOVADOZ *Each tablet contains rosuvastatin calcium equivalent to 5 mg of rosuvastatin. USUAL DOSAGE: See accompanying Prescribing information. WARNING: Contains FD&C Yellow No. 5 (tartrazine) as a color additive. As with all medications, keep out of the reach of children. Store at controlled room temperature, 20-25°C (68-77°F) [see USP Controlled Room Temperature]. Protect from moisture. Manufactured by: MSN Laboratories Private Limited, Telangana - 509 216, INDIA. Distributed by: Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 855 - NOVADOZ 668-2369 M.L.No.: 5IMN/TS/2014/FIG D07248-00 LOT : XXXXXXXXXX EXP : MMM.YYYY OT & EXP Details along with variable data shall be Over coded during packing. P Coding area 46x25 mm _>L
d58f1f63-4bb6-413c-9730-ded3e8078618_829_10.jpg /1000 Tablets NDC 72205-004-99‘ Rosuvastatin Calcium Tablets Rx Only NOVADOZ A “Each tablet contains rosuvastatin calcium Manufactured by: equivalent to 20 mg of rosuvastatin. MSN Laboratories Private Limited, USUAL DOSAGE: Telangana - 509 216, INDIA. See accompanying Prescribing information. Distributed by: WARNING: Novadoz Pharmaceuticals LLC As with all medications, keep out of the Flasaawey i Qodbt-5114 reach of children. 855 - NOVADOZ 668-2369 Store at controlled room temperature, 20-25°C (68-77°F) [see USP Controlled Issued: 04/2018 Room Temperature]. Protect from moisture. - -« - -« -eememmamnmnnniia s M.L.No.: 5/MN/TS/2014/F/G N || sili72205l004991 M3 J/ D07270-00 LOT : XXXXXXXXXX _> EXP : MM/YYYY LOT & EXP Details along with variable data shall be Over coded during packing. Coding area 46x30 mm
d58f1f63-4bb6-413c-9730-ded3e8078618_829_11.jpg Rx Only NDC 72205-004-06 Rosuvastatin Calcium Tablets 100 (10X 10) Unit-dose Tablets NOVADOZ *Each tablot contains roswastatn cacium equivalent 0 20 mg of rosuvastatin MI - USUAL DOSAGE: ‘See accompanying Prescribing infomation WARNING: As withall medicatons, keep out of the reach of chidron. DX0OOXX Store at controled room temperature, 20-25°C (66-77°F) [seo USP Contralled Room Temperatue]. Protect rom mojsture. M.LNo: SMNTS?2014/F/G g om § Rx Only Nncmosmm»“ 2 . . g £ Rosuvastatin Calcium Tablets 5 g8 €L &5 ¢ w £ 100 (10 X 10) Unit-dose Tablets Manufacturedby: MSN Laboratories Privals Linied, Telangana - 509216, INDIA. Distributed by Novadoz Pharmacsuticals LLC Piscataway, NJ 088543714 855-NOVADOZ 5682369 Issuec: 042018
d58f1f63-4bb6-413c-9730-ded3e8078618_829_12.jpg Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot e Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot e Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot Ex. Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot &0 Rosuvastatin Calcium Tablet €D NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot Ex Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot Ex. Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboralories Privale Linited Made in India Lot: Exp. Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Linited Made in India Lot: Exp. Rosuvastatin Calcium Tablet NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Liited Made in India Lot: Rosuvastatin Calcium Tablet € NDC 72205-004-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboralories Private Linited Made in India Lot £x.
d58f1f63-4bb6-413c-9730-ded3e8078618_829_13.jpg *Each tablet contains rosuvastatin M.LNo.: SIMNITSI2014/F/G 30 Tablets NDC 72205-005-30 calcium equivalent to 40 mg of rosuvastatin. USUAL DOSAGE: D07251-00 R . See accompanying Prescribing information. WARNING: y N OSUVﬂStatI n As with all medications, Issued: 04/2018 372205100530 keep out of the reach of children. . Calcium Tablets ssssenimee, Room Temperature]. Protect from moisture. Manufactured by: ) 0 m MSN Laboratories Private Limited, LOT : XXXXXXXXXX Telangana - 509 216, INDIA. » EXP: MMM.YYY.Y . . Distributed by: LOT & EXP Details along with variable Novadoz Pharmaceuticals LLC data shall be Over coded during packing. NOVADOZ Piscataway, NJ 08854-3714 O 855-NOVADOZ P Coding area 45x25 mm 668-2369
d58f1f63-4bb6-413c-9730-ded3e8078618_829_14.jpg = - 005. *Each tablet contains rosuvastatin M.LNo.: 5IMNITSI2014/FIG 90 Tablets NDC 72205 005 90 calcium equivalent to 40 mg of rosuvastatin. USUAL DOSAGE: D07287-00 R . See accompanying Prescribing information. WARNING: N Osuvastatl n As with all medications, Issued: 08/2018 3lill72205llo0590!1ll7 keep out of the reach of children. . Calcium Tablets swimssmnsmene,, Room Temperature]. Protect from moisture. Manufactured by: g i m MSN Laboratories Private Limited, i LOT : XXXXXXXXXX Telangana - 509 216, INDIA. : ' EXP:: MM/YYYY‘ ) ) Distributed by: : LOT & EXP Details along with variable Novadoz Pharmaceuticals LLC : data shall be Over coded during packing. N OVAD OZ Piscataway, NJ 08854-3714 % 855 - NOVADOZ : P Coding area 45x25 mm 668-2369 :
d58f1f63-4bb6-413c-9730-ded3e8078618_829_15.jpg /1000 Tablets NDC 72205-005-99‘ *Each tablet contains rosuvastatin calcium Manufactured by: ) equivalent to 40 mg of rosuvastatin. MSN Laboratories Private Limited, Tel -509 216, INDIA. USUAL DOSAGE: elangana - 509 216, See accompanying Prescribing information. Distributed by: Novadoz Pharmaceuticals LLC i ARHE Piscataway, NJ 08854-3714 Ros uvaStatI n As with all medications, keep out of the iscataway reach of children. 855- NOVADOZ Calcium Tablets 6682369 Store at controlled room temperature, lssued: 04/2018 * 20-25°C (68-77°F) [see USP Controlled ™= """""~ 2 40 m g Room Temperature]. Protect from moisture. 1 LOT : XXXXXXXXXX M.L.No.: 5/MN/TS/2014/FIG EXP : MM/YYYY » LOT & EXP Details along with variable data shall be Over coded during packing. D07271-00 P Coding area 43x30 mm J Rx Only NOVADOZ m || 99llllo U
d58f1f63-4bb6-413c-9730-ded3e8078618_829_16.jpg sjo|qeL wnioje) uljeISeANSOY fwon RxOnly NDC 72205.005-06 Rosuvastatin Calcium Tablets 100 (10X 10) Uni-dose Tablets NOVADOZ Each bt contins roswastatincacum oquhalet 1 40 mg o osuvastan USUAL DOSAGE: ‘Son sccompanying Proscribig normatin. WARNNG: As i al madicatons, keep oul of e resch of . Store st conroed oo rperatrs, 2025°C (6677°F) [sea USP Cortrobad Room Temperatire]. Prtect from molstut o%00006¢ MLNo: SMNTS2014F /6. |\ RxOnly voc 120500500 Rosuvastatin Calcium Tablets 100 (10X 10)Unit-dose Tbiets Manutactured by: VSN Laborares Prvat Linied, Tolangana - 509215, NDIA. Ditrbtacby: Novados Pharmacauticals LLC Patanay, NJ088543714 B5-NOVADOZ e Issut: 042018
d58f1f63-4bb6-413c-9730-ded3e8078618_829_17.jpg Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture. VSN Laboratories Prvete Limited Made in India Lot £ Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratores Prvate Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Prvate Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Prvate Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratores Private Limited Made in India Lot £ 2 00511 Rosuvastatin Calcium Tablet NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture MSN Laboratores Private Limited Made in India Lot Exp. Rosuvastatin Calcium Tablet D NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture MSN Laboratores Private Limited Made in India Lot Rosuvastatin Calcium Tablet NDC 72205.005-11 Store at 20-25°C (68-77°F) Protect from moisture MSN Laboratores Private Linited Made in India Lot Rosuvastatin Calcium Tablet @ NDC 72205-005-11 Store at 20-25°C (68-77°F) Protect from moisture MSN Laboratores Private Limited Made in India Lot Rosuvastatin Calcium Tablet ~ NDC 72205-005-11 — Store at 20-25°C (68-77°F) iy Protect from moisture. MSN Laboratores Private Limited Made in India Lot By M.LNo.: SMNITS/2014/FIG. e, | -
d58f1f63-4bb6-413c-9730-ded3e8078618_829_2.jpg 7 Rx Only *Each tablet contains rosuvastatin calcium 1000 Tablets NDC 72205-002-99 l equivalent to 5 mg of rosuvastatin. USUAL DOSAGE: See accompanying Prescribing information. WARNING: Contains FD&C Yellow No. 5 (tartrazine) as a 1 color additive. ROS uvastatl n As with all\ medications, keep out of the reach of children. 1 Store at controlled room temperature, Calcium Tablets St Room Temperature]. Protect from moisture. - Issued: 04/2018 NOVADOZ | | || 3liMl722051l00299Ml9 # M.L.No.: 5/MN/TS/2014/FIG Manufactured by: MSN Laboratories Private Limited, Telangana - 509 216, INDIA. Distributed by: Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 855- NOVADOZ 668-2369 D07268-00 LOT : XXXXXXXXXX » EXP : MM/YYYY LOT & EXP Details along with variable data shall be Over coded during packing. {—Pp» Coding area 42x30 mm
d58f1f63-4bb6-413c-9730-ded3e8078618_829_3.jpg Rosuvastatin Calcium Tablets 400 (10X 10) Unitdose NOVADOZ Each tblt contins rosuvastaincaclum equialont 1 5 mg of osuvastatn USUAL DOSAGE: ‘So0 accompanying Prescibig normatin. WARNNG: ‘Coriains FDAC Yollow No. 5 (atrazne) as acolor afve. s with al medicatons, keep ou ofhe reach of chidren. Stoa at contold room perature, 20-25°C (66-77°F) sea USP Controlad Room Jomperatel. Prtact from molstute VSN Laboraes Prvate rd, Tangara 509216, INOIA Disributed by: Novacoz Pharmaceticsk LLC Piataway, NJ08854-T14 855-NOVADOZ o069 et 208 RxOnly NDC musoozﬁ 03000000 Lo SHNTSONAEES | & 2 | cony voc 10500206 | s < 5 : y g2 Rosuvastatin Calcium Tablets 33 g Smg* 55 i @ £ | 100 (10X 10) Unit-dose Tablets NOVADOZ Manufactured by: o
d58f1f63-4bb6-413c-9730-ded3e8078618_829_4.jpg ( : ) Rosuvastatin Calcium Tablet smg. NDC 72205-002-11 Store a1 20-25°C (68-77°F) Protect from maisture. MSN Laboralories Privat Limited Made in India Lot Exp. Rosuvastatin Calcium Tablet NDC 72205-002-11 =- Store at 20-25°C (68-77°F) = Protect from moisture. =g MSN Laboratories Private Limited " Made in India —x Lot: = Exp. Rosuvastatin Calcium Tablet [ou] NDC 72205-002-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Labaratories Privte Limited Made in India Lot 1 [ 72205000271 Ex. Rosuvastatin Calcium Tablet (Smg) NDC 72205-002:11 Store a120-25°C (68-77°F) Protect from maisture. MSN Laboralorie Privte Limited Made in India Lot NDC 72205-00211 Store at 20-25°C (68-77°F) Protect from moisture. MSN Labaralories Priva Limited Made in India Lot Exp. Rosuvastatin Calcium Tablet (Smg) NDC 72205-002-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Labaratories Privae Linited Made in India Lot Ex. NDC 72205-002-11 Store a1 20-25°C (68-77°F) Protect from moisture. MISN Labaratories Private Linited Made in India Lot Ep. NDC 72205-002-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Labaratories Privae Limited Made in India Lot Exp NDC 72205-002-11 Store al 20-25°C (66-77°F) Protect from moisiure MSN Labaratories Privae Limited Made in India Lot £ NDC 72205-002-11 Store at 20-25°C (68-77°F) Protect from moisture. WIS Labaratories Private Limited Made in India Lot o M.LNo: SMNITSI2014/FIG e ! e
d58f1f63-4bb6-413c-9730-ded3e8078618_829_5.jpg 90 Tablets NDC 72205-003-90 Rosuvastatin Calcium Tablets Rx Only N NOVADOZ *Each tablet contains rosuvastatin calcium equivalent to 10 mg of rosuvastatin. USUAL DOSAGE: See accompanying Prescribing information. WARNING: As with all medications, keep out of the reach of children. Store at controlled room temperature, 20-25°C (68-77°F) [see USP Controlled Room Temperature]. Protect from moisture. Manufactured by: MSN Laboratories Private Limited, Telangana - 509 216, INDIA. Distributed by: Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 855-NOVADOZ 668-2369 M.LNo.: 5SIMNITS/2014/FIG D07249-00 Issued: 0412018 r e 72205100390 3 LOT : XXXXXXXXXX » EXP : MMM.YYYY LOT & EXP Details along with variable data shall be Over coded during packing. —» Coding area 46x25 mm
d58f1f63-4bb6-413c-9730-ded3e8078618_829_6.jpg /1000 Tablets NDC 72205-003-99 *Each tablet contains rosuvastatin calcium M.L.No.: 5/MN/TS/2014/FIG equivalent to 10 mg of rosuvastatin. Manufactured by: USUAL DOSAGE: MSN Laboratories Private Limited, See accompanying Prescribing information, 1elangana - 509 216, INDIA. Distributed by: 2 . T ROS uvastatl n XvsAm:![!ﬁnedications, keep out of the reach NavadozEharmacedticals LLC of children. Piscataway, NJ 08854-3714 C a I ci u m Ta b Iets Store at controlled room temperature, 835 26%\-,2%[;22 20-25°C (68-77°F) [see USP Controlled peemmt e m e s s a . ) Room Temperature]. Protect from moisture. NOVADOZ y ||| |||| || Issued: 04/2018 72205100399 D07269-00 LOT : XXXXXXXXXX EXP : MM/YYYY LOT & EXP Details along with variable data shall be Over coded during packing. Coding area 42x30 mm
d58f1f63-4bb6-413c-9730-ded3e8078618_829_7.jpg R Only NDC 72205-003-06 Rosuvastatin Calcium Tablets 100 (10X 10) Unit-dose Tablets NOVADOZ *Each tablot contans s uvastatn cacium equivalent 0 10 mg of rosuvastatin UI" i USUAL DOSAGE: Seo acoompanying Prescrbing information. WARNING: s with all medicatons, keep out of the reach of children. X000 Store at controlled room temperature, 20-25°C (68-77°F) [soe USP Contraled Room Temperature]. Potect rom mosture. M.LNo: SMNTS?2014/F/G : Q= _; Do Mbcmasnom“ i 28 g . : g £ Rosuvastatin Calcium Tablets * o0 : &gt 10 mg’] 2 25 & . N F(ll‘ g 100 (10 X 10) Unit-dose Tablets Manufactured by: MSN Laboratorics Private Linied, Telangana - 509216, INDIA. Distrbuted by: Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 M| 855- NOVADOZ 682360 Issued: 042018
d58f1f63-4bb6-413c-9730-ded3e8078618_829_8.jpg Rosuvastatin Calcium Tablet @& NDC 72205-003-11 Store at20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Liited Made in India Lot: Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboralories Privale Limiled Made in India Lot Ex. Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at20-25°C (68-77°F) Protect from moisture. MSN Laboratories Privae Limited Made in India Lot Exp Rosuvastatin Calcium Tablet @D NDC 72205-003-11 Store at20-25°C (68-77°F) Protect from moisture. MSN Laboralories Privle Limiled Made in India Lot Exp. Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboralories Privale Limiled Made in India Lot Exp. Rosuvastatin Calcium Tablet @ NDC 72205-003-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Prvate Limited Made in India Lot: En Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Privale Limited Made in India Lot Ex. Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Private Limited Made in India Lot Ex. Rosuvastatin Calcium Tablet @D = NDC 72205-00311 Store at 20-25°C (68-77°F) Protect from moisture. = MSN Laboratores Private Linited Made in India Lot Exp Rosuvastatin Calcium Tablet NDC 72205-003-11 Store at 20-25°C (68-77°F) Protect from moisture. MSN Laboratories Privale Linited Made in India Lot: ) M.LNo: SMNITSI2014/FIG e ! e
d58f1f63-4bb6-413c-9730-ded3e8078618_829_9.jpg USUAL DOSAGE: D07250-00 See accompanying Prescribing information. ROS Uvastati n JURKNG: Is»sued- 0412018 silli72205 As with all medications, keep out of the reach of children. . ; : Calcium Tablets sem=mes, Room Temperature]. Profect from moisture. *Each tablet contains rosuvastatin M.L.No.: 5IMNITSI2014/FIG 90 Tablets NDC 72205'004'90 calcium equivalent to 20 mg of rosuvastatin. ‘| | | || | N 00490 Manufactured by: ' LOT : XXXXXXXXXX MSN Laboratories Private Limited, EXP : MMM.YYYY olangana =509 21GHINDIA: 4 > LOT & EXP Details along with variable Distributed by: . data shall be Over coded during packing. Novadoz Pharmaceuticals LLC Piscataway, NJ 08854-3714 855- NOVADOZ : P Coding area 46x25 mm 668-2369 : Rx Only NOVADOZ
d5bafaec-9a75-4995-bc1d-8a6af18d1bce_290_1.jpg PrecisionDose™ NDC 68094-852-61 Unit Dose HYDROmorphone _ Hydrochloride Tablets, USP (} z g 11 Eme Il & | Rx Only ol ‘ 100 TABLETS |8 NDC 68094-852-61 Unit Dose HYDROmorphone Hydrochloride Tablets, USP (; Elimg EACH TABLET CONTAINS: Hydromorphone Hydrochloride USP..... 8 mg USUAL DOSE: SEE ENCLOSED INSERT. Store at 20°:25°C (68°-77°F). [See USP Conirolled Room Temperature] Keep this and all medication out of reach of children. LCo01 Ro Manufactured by Elite Laboratorics, inc. hvale, NJ 07647 ioued by n Dose, Inc. ressive Lane South Beloit, IL 61080 —-
d621b526-4d9a-48a9-9a3e-d29d6aea2f31_676_1.jpg — TP 250925090%0500 ©NIL9 NDC 0406-0376-05 500 TABLETS Hydrocodone Bitartrate and Acetaminophen Tablets USP 5 mg/300 m Rxonly Dispense the Medication Guide provided separately to each patient. This package s not intended for household use. Mallinckrodt™ Pharmacit: Dispense na tight, ight resitant contanervitha hid rsistant dosue, v g Hpoccons Vi Moy e bt inoghen Use. exceed sighttaces, S package it forfl resciing nformato, Warning: eep thisand al medications autof thereachof chdeen, Manitacuredor iy OIS LS Loy evosamy
d621b526-4d9a-48a9-9a3e-d29d6aea2f31_676_2.jpg S O — Eoe S e — NDCOIs 037705 sonmastets Hydrocodone Bitartrate and Acetaminophen Tablets USP 7.5 mg/300 m Rxonly Dispense the Medication Guide provided separately to each patient. This package is not intended for household use. Mallinckrodt™ €2 Pharmacst: Dlspenseina tight,light resistan contanervith chid resistant dosure bt cocn 5P (e formingiand 3 STORAGE:Sireat ek US? Conte com sec o g USUAL ADULT DOSAGE ornation, Warning Keep this nd ll medicatons outofthereachof children. oemsUss k0
d621b526-4d9a-48a9-9a3e-d29d6aea2f31_676_3.jpg [ T o = o— NDC 0406-0378.05 Hydrocodone Bitartrate and Acetaminophen Tablets USP mg/300 Rxonly 500 TABLETS Dispense the Medication Guide provided separately to each patient. ‘This package is not intended for household use. Mallinckrodt™ s-Do not dispense unless strength is stated. Pharmacist Dispenseina tght,light resistantcontanervitha chid resistant dosue, Exchtabietcortng 10 ydrocodone Brarae USP Warming: Naybe rabst. forming)snd 300mg STORAGE:S e USPContolle o Protctfamght USUAL ADULTDOSAG fourto’ daly dosage noukd ot exceed s i, Seegacage e for bl pesrbing infrmation Warning: Keep thisand al medications autof the reachofchiden, [ uc foves MOB3II9USH Lowion Revon0? i
d64f961a-3e1f-4b04-cf83-604474af2775_375_1.jpg 500 mL NDC 0409-7248-13 6% HETASTARCH in 0.9% Sodium Chloride Injection (01)00304097248131 For intravenous use only EACH 100 mL CONTAINS HETASTARCH, & g AND SODIUM CHLORIDE 0.9 g IN WATER FOR INJECTION. MAY CONTAIN SODIUM HYDROXIDE FOR p ADJUSTMENT. ELECTROLYTES (MEGL): SODIUM 154, CHLORIDE 154. 308 mOsmOlLITER (calc).pH 55 (3570 70, IF ADMINISTRATION IS BY PRESSURE INFUSION, ALL AIR SHOULD BE WITHDRAWN OR EXPELLED FROM THE BAG THROUGH THE MEDICATION PORT PRIOR TO INFUSION. STERILE, NONPYROGENIC. SINGLE-DOSE CONTAINER DISCARD UNUSED PORTION. USE ONLY IF SOLUTION IS CLEAR. USUAL DOSAGE: SEE INSERT. STORE AT 20 T0 25°C (68 T077°F). [SEE USP CONTROLLED ROOM TEMPERATURE] PROTECT FROM FREEZING. SEE INSERT. DO NOT INTRODUCE ADDITIVES INTO THIS CONTAINER Rx ony A &y Y CONTAINS DEHP M-3593 HOSPIRA, INC., LAKE FOREST, IL 60045 USA Hospira 300 400
d652ef6f-2112-43ea-ba01-c3bf4f8d8030_209_1.jpg - Chlorothiazide, USP 250mg NDC 0378-0150-01 mmmerasddmd in the USP Chlorothiazide tesenertony e Keep this and all me Tablets, USP out of the reach of chikdren. Store 3t 20° 0 25°C (69° o 77°F). [See USP Controlled oo Temperature] Usual Adult Dosage: See accom- panying pescribing nformaton, Mylan Pharmacutcals . Magentown, W 25505USA [MMylan MMylan® Rxonly 100 Tablets Mylan.com € RMOTS0 10-0510-82¢0 0
d652ef6f-2112-43ea-ba01-c3bf4f8d8030_209_2.jpg Chlorothiazids, USP 500 mg Wil 162-01 ‘container as defined in the USP. § | = S § I Chlorothiazide fwesmmsis 2 = : S o= | 4 [See USP Controlled Hoom S== 5y g m | Temporatea] omm== =S Usual Aduit Dosage: See accom- V= ¢ e e o = i i s e = WSS [l Mylan® w : (IMy [MMylan g AR R ) Mylan.com
d667ca75-1a17-43fc-9077-f25ce0908f8d_196_1.jpg = — i Swamcans s el Juntelrr (Mm"ﬁmﬂwﬂl? (norethindrone acetate Imines T s 7 o s il E e S E and syl esadiol | ! ! i ! | | | i | | | | |
d667ca75-1a17-43fc-9077-f25ce0908f8d_196_2.jpg Swmaces wowson gt | ot e o and ethinyl estradiol shies 51 fablts USP) 1 mg/5 meg
d66ada00-3ece-4b71-8c59-a0db48a2db80_874_1.jpg R Dlﬂy WARNINGKEEP THISIOUT/OF THEREACHJOFE.CHILDREN D0SAGEand STORAGE: SEE PACKAGE'INSERT: 43063-777-30 43063-777-30 43063-777-30 INDOMETHACIN INDOMETHACIN INDOMETHACIN usp UsP usp 50 mg 50 mg 50mg 30 CAPSULES 30 CAPSULES 30 CAPSULES ReOrder # 110337 ReOrder # 110337 ReOrder # 110337 LoT F18A95 LOT F18A95 LOT F18A95 EXP 09/19 EXP 09/19 EXP D9/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE CAPSULE(S) TIMES A DAY WITH FOOD. TOME CAPSULA(S), VECES AL DIA CON COMIDA. Each CAPSULE Contains: |NDOMETHACIN USP 50 MG INGS: ORGANOLEPTIC MARKI GREEN H 104 CAPSULE NDC: 43063-777-30 INDOMETHACIN USP 50 mg 30 CAPSULES {01)1034306377730 (21)F18A35000001 (17) 190930 {10)F1BAS5 VIGNI 550 005 QVBYYIAAH ‘VILINIOIIM DELLLEIOTYE AT E 0 Q3LIWIT SEV] OY¥3L3H TOCPSOZZLIE
d6b40e39-a57e-402c-b4f6-7041e832f837_118_1.jpg NDC 42858.122.01 Do not accept i seal over botte | opening is broken or missing. Dlla Ud|d® Usual Dose: See package msen.1 Storage: Store at 25°C (77°F); { (hydromorphone HCl) Zee ¥ permitted to Tablets, USP || 15°10 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight,light-resistant container s defined In the USP. ) 5 @ 42858-122-016 Dispense the accompanying Medication Guide to each patient. Marketed By: Rhodes Phamaceuticals LP. Coventry, RI 02616 304367-0A Exp. Lot 100 Tablets
d6b40e39-a57e-402c-b4f6-7041e832f837_118_2.jpg Exp. | Lot T NDC 42858 234.01 Do not accept i seal over bottle ©° — e o opening is broken o missing. =-o Dilaudid® Usual Dose: See package nser. — Storage: Store at 25°C (77°F); ~ (hydromorphone HCI) ZoRg 200 Thisrte M Tablets, USP@ 15° t0 30°C (59° to 86°F) — [see USP Controlled Room = Temperature]. Dispense in a | tight, light-resistant container as | — O defined in the USP. —— A EE—— ol py e % ===_ " | medication Guide to each patient. | Varketed By & — Rhodes Phamaceuticals LP. 2 @"j'““ 100 Tablets Coventry, RI 02816 ) N 3
d6b40e39-a57e-402c-b4f6-7041e832f837_118_3.jpg —_— Do not aceept if seal over bottle | ——— NDC 42858-338-01 opening is broken or missing. =0 g Dilaudid® Usual Dose: See package insert.| | 2 oG (77°] — Storage: Store at 25°C (77°F); () (hydromorphone HCl) excursions permitted to — M Tablets, USP M 15° 10 30°C (59° to 86°F) = m [see USP Controlled Room = ' Temperature]. Dispenseina | — © tight, light-resistant container as — defined in the USP. — LN = 0 E—— Dispense the accompanying 2 | Medication Guide to each patient. | Narketed By 2 Rhod. 100 Tablet Rhodes Pharmaceuticals L.P. Qo odes ablets T
d6b40e39-a57e-402c-b4f6-7041e832f837_118_4.jpg - NDC 428558-416-16 Dilaudid® (hydromorphone HCl) Oral Solution, USP 5mg/5mL (1 mg/mL) One Pt (473 ml) @hodes Rx Only aa7r.08 Exns 1 tesponn) cots: Horemoptors Ayocton: 5y D010t a1 8o cap s ey pashr] bl s Degersa 2 g, eSSt Cotaer s ot [ Wby Hras Pamacts L vy, o2t 42858-416-16 0 N Y
d6b40e39-a57e-402c-b4f6-7041e832f837_782_1.jpg Y0-P6LYOE NDC 42858-122-01 100 Tablets Dilaudid® v@w @ (hydromorphone HCI) 9-10-221-8S82¢-€-00 NILD ? 10=gc)= wmwmem B [ Marketed By: A Phemacticals LF. Coventy, RI02615 Manutactwred by: Hah Phamacsutial hc., Whippary, NJ 07961 Do ot acorpt if sel over bette s roken or issing Usual Dosage: Sos package e, Storage: Stre a 20° 10 25°C 68° 1077°F) [see USP Cortllad Roam Temperature], Disperse in atigh, lgHt-esistet cortner a3 cefined in the USP.
d6b40e39-a57e-402c-b4f6-7041e832f837_782_2.jpg YO0-S6Lr0E mmw% ﬂw 3 g=14 § 910962858246 -00 NLLD 9 L0-y£e-8582% ¢ Marketed By: Arods Mamacaicals LP. Coventy, I 02816 Manufactured by: Hab Phanmaoeutial l., Whippany, NJ 07961 D0 ot acopt f seel over bette s broke or missing Usual Dosages Se package st Strage: Store d 20° 10 25°C/56° 1077°F) e USP Cortolled Room Temperature], Disperse n atight, ight-resistert cortaines a5 deined i the USP.
d6b40e39-a57e-402c-b4f6-7041e832f837_782_3.jpg ¥0-96LP0€E NDC 42858-338-01 Dilaudid® 1-10-86€-8882-€-00 NILD L L0-8££-8682Y .m @:______ Markeked By: Frudes Marmaoaitials LP. Coventy, Al 02616 Manutactured by: Hab Pharmacsutical Inc., Whippary, NJ 07981 T mtaceept fwalover botte ks troken or missing Usual Dosages Ses packag st Storage: Stre t 20° 0 25°C 56° 177°F) st USP Corkrlled Room Temperature]. Disperss 1 atiht, ghtresistant contanie a5 defimdinthe USP.
d6b40e39-a57e-402c-b4f6-7041e832f837_782_4.jpg - NDC 428558-416-16 Dilaudid® (hydromorphone HCl) Oral Solution, USP 5mg/5mL (1 mg/mL) One Pt (473 ml) @hodes Rx Only aa7r.08 Exns 1 tesponn) cots: Horemoptors Ayocton: 5y D010t a1 8o cap s ey pashr] bl s Degersa 2 g, eSSt Cotaer s ot [ Wby Hras Pamacts L vy, o2t 42858-416-16 0 N Y
d6cbb63c-e0b1-43ee-ad6f-408da0772079_567_1.jpg rdxg 07 PONI9800LEOLS 81/60 "oy 104/0d 0N "1 ‘B (¥8.€)9NHA"106'998" | 91880 PN HoImsunig 1se3 *0u] S|eannageuseyd abejuiay 0} paimaejnuei “BIpU| ‘aUng ‘ipeme “PY] S|BINN30RWIRY INIW Aq paimoejnueyy (499-:9€ ‘0:8-:2) HOLYHIIIYAIH ¥ NI HOLS LHISNI 39YXIv¥d Q3SOTINI aY3Y g3 e bz o IS Ll 5= - BB - - ] = W
d6cbb63c-e0b1-43ee-ad6f-408da0772079_567_2.jpg ™ o 0 QONISBO0LEDIS 81/60 A0y ﬁm 101/d 0N a1 B Heritage® (v8.€)9N40'106'998 L AnageuLIRyq ainous3 Aq pamozynuey| TI8YNUNLIH LON suopneoaid pue a5 10} suoRoaIp ‘aBES0p 'SUOTROIPU 0} Viasu abexoed pasojoua peay :39¥S00 WNSN W01 Wi 19801 Uoneyse g aimeiadu) woos o) oA auy BuLEM Ag pON0SSIpal oq AL Aot BAAIESqO AR S[EISALD | 51 0} Joud uoNEwLO} [1SA12 1o} PaUILEXA G PINOUS S|EIA PaIMSUO9AY *(495-69€ '0o8-:2) Uoes26u4a1 J2pun SInoL bz 10} 81 S| NI PEPUALLILIOOS Se UONNLISU0D8) Jaly (4.99-,9¢ ‘0.8-.7) HOLYY3OIH3 V¥ NI 3HOLS ‘S1aul le san0jf seap 2 s . £ g ml s 2 3 " H H 5 (e “w £l m o o E & . 41" 44 H -8 H 8 S & S - = @ |
d6cbb63c-e0b1-43ee-ad6f-408da0772079_567_3.jpg L A == [ S1031008805 WD 23155-261-41 BiCNU (carmustine for injection) 100 mg per vial Rx only Each carton contains: { vl BCNU for inection 100 m, 1 via Steie Diuent fo BCNU 3 mL. For niravenaus nfusion after reconstiution REFRIGERATE IMMEDIATELY. Single Dose Val - Discard Unused Portion e goes at al s when Randlg contaners. STORE M AREFRIGERNTOR 40,3467 NOT RETURABLE. Mendchn o Hortage harmaceutcal b, st Srncuk BTG 690 GTEN g i o-pI01 A e i BiCNU (carmustine for injection) 100 mg per vial Each carton contains: 1 vial BICNU for inection 100 m, 1 via teie it for BICNU 3 mL For niravenaus nfusion ate reconstiution REFRIGERATE IMMEDIATELY. Single Dose Val - Discard Unused Porlion Rx only s, s BN s forfcton) win S L of sl et sppes Sacnd, sty 56427 m. Skt it ringcen USP Each L of st slton ot 3.3mg ofBOAG 1% o Ao ccstvion s comades B i sl o 24 s egrn (79, 56467 Recostule vl shul e camng for eyt formaton e ey ar osees e may b adscved by vamng e vl o ompaas with 2tan Pt o . USUAL DOSAGE: e e pckag s o nccatons, o, eroctons for e, prcaions.
d6f0af28-1e4a-4b06-9ff5-fc15f3f13ea9_871_1.jpg TosTigse0s Potancy Gumranizad NEONATAL PLUS S L R 8 g PRENATAL / POSTNATAL VITAMIN A (RS ACETATE , BETA CARGTENE) _ woremrer 1200 MCE VITAMIN € (ASCORBEC ACID) -~ 20 MG VITAMIN D3 (AS CHOLECALCIFREOL) - 10 MOS VITAMIN E {AS DL-ALPHA TOCOPHEROL ACETATE) -— 9.2 MG VITAMIN B1 (AS THIAMINE MONONITRATE) smrsemserss 184 MG VITAMIN B2 (RIBOFLAVIN) -~ 3 MG VITAMIN B3 (AS NIACINAMIDE) 20 M6 VITAMIN B6 (AS PYRIDOXINE HCL) - 10 MG FOLIC ACD smrerren . 1000 MCG VITAMIN B12 (AS CYNOGOBALAMIN) ON DCP —rae 12MCG CALCIUM (AS CALCIUM CARBONATE) 200 MG IRON (AS FERROUS RUMARATE) 27 MG ZINC (A5 ZINC OXIDE) -~ 2 MG ‘COPPER [AS CUPRIC OKIDE) moemsmsemsmrmsmras 2 MG INOSTOL 28 5 MG CITRUS BIOFLAVONOIDS COMPLEX 50% 2M6 BIOFLAVONOIDS BORON [AS BORON CITRATE) rwmrmmrmssmmere__ 02 MG MIERO CRYSTALLINE CELLULOSE, STEARIC ACITy MAGNESIUM STEARATE, 'CROSCARMELLOSE SODIUM, SLICON DI CXIDE, HPMCELS, HPMC ES/E, PEG - 500K, TALC, FDA RED #.40 (LAKE, FDAC BLUE # 2 (LAKE FDBC YELLOW #5 LAKE. Neo Natal PLUS Tablst is an orally sdministared pranatal/postratal prax supplomant and should be censed medical practfoner. Before, durng and/or aer regnancy, ane tabiet daily, with & mal, or es directed by a lioensad haalthearapra ionarregarcless of etation satus. BTG Acciseotst ovestom o Yon<onming Frodsct i 4 1437 cae of el SOROVR ) e Errker £3065) B >t ey, ‘Gbown.tn cave o ncchetsl oreesioom ol High lavals offolc aid may, sspacially i alder aduls, hida signs of Vitamin B-12 defidency (such es pemicious anemla). condition that can causanervedamage. 15-30 (59-86 ), [Soe USP Cantrolied Room Tamparsturs] Protact fram light and maisturs. Dispansa in » tight, light resktant container. Notice: Contact with moksture may produce surface dacalaration ararasian. Callyourlioensed medical practtoneraboutskle effeet ‘our may rapert it sffect by caling NEDMED 1-631-524-5758 or FDA@1-800-FDA-1088. NEQMED Pharmaceutical 80CalnDr. Brentwood, NY 11717 ROV Lk BB
d6f26c9b-c862-42f2-a6f0-adf9e4e29951_373_1.jpg Sodium Fluoride F18 injection USP 70200 mCi at End of Synthesrs (EDS) Diagnostic—For Intravenous Use Only Storie, Nompyrogenic. Uso within 12 hrs. of EOS Batch EOS Date E0S Time: Activty @ EOS: mei Concentation mCiml Volume: ml Exp. Date, Exp Time: DG #24275-0285-1 |20 ol Wile Dozs Vial [Each ml contains 0:37 GB 1072 GBq (1010 200 mCY of o arer added Sodium Fluoride at EOS in agueous 0 9% sodium onde Store o 25°C (77°F) excursions permied fo 16.37°C (56.66'F)[see USP controlied room temperature] Store upright I shieided cortainer. Aseptcally wihdraw and handie doses Ioo notuse f cloudy orcontains particulate matter. Calculate orrect dosage from dae and ime of calbration Caution: Racioactive Materiai Rx ONLY Manutactured by UCSF Ragiopharmaceuica Facily San Francisco,CA for PRl it - 1087 000000000000
d70152c7-9da5-4096-ac5b-c8118cf48500_461_1.jpg NDC 50111-483-01 THEOPHYLLINE EXTENDED-RELEASE Tablets 100 mg B only _ 100TABLETS
d70152c7-9da5-4096-ac5b-c8118cf48500_461_2.jpg NDC 50111-482-01 THEOPHYLLINE EXTENDED-RELEASE Tablets 200 mg o B only
d70152c7-9da5-4096-ac5b-c8118cf48500_461_3.jpg AUNTIINR NDC 50111-450-01 THEOPHYLLINE EXTENDED-RELEASE Tablets 300 mg B only 100 TABLETS
d70152c7-9da5-4096-ac5b-c8118cf48500_461_4.jpg E NDC 50111-518-01 i THEOPHYLLINE © EXTENDED-RELEASE § Tablets z 450 mg g & Boy 2 o0 o
d72fb3ee-a668-4bd6-b4b0-8db43520597c_199_1.jpg FINISH ALL MEDICATION UNLESS o o OTHERWISE ADVISED BY YOUR DOCTOR. NDC 43063-738-28 ALCOHOL OR ALCOHOLIC BEVERAGES SHOULD NOT BE = PD. Rx = CONSUMED ILE AI(G THIS MEDICATION. U] PHARMAGEUTICALS | &= : ;_=§ 2| NCORPORATED?/ &___ ISAGE‘and STORAGE:SEEF GEINSI E=28 = {B=] Oklahoma City, 0K » 73127 = 43063-738-28 43063-738-28 43063-738-28 | F=8 B metroNIDAZOLE metroNIDAZOLE metroNIDAZOLE 4 —5 G — USP USP UsP 85== metro Eo= 500 mg 500 mg 500 mg & = 9= 28 TABLETS 28 TABLETS 28 TABLETS B3=S USP B — REORDER #110224 ~ REORDER #110224 REORDER 4110224 =& —_ ET= LOT HI8F75 LOT HISF75 LOT HI8F75 g :;E i — EXP 01/20 EXP 01/20 EXp 01/20 Bi= 500 mg = . = —_—ln CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g E_E § = YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 | = 28 T ABLETS 5= TAKE_TABLETS)_TIMES A DAY | ESRE RONDAZOLE Tep “Smm LI [ ' ==0 METRONIDAZOLE USP 500 MG g el S— TOME___TABLETA(S)___VECES AL DIA. g8 Sam ORGANOVEPTIC MARKINGS: WHITE OBLONG U 227 =
d74c1d6c-f144-44a7-99b8-7cfe87e5473a_478_1.jpg TS T T T T T S el GO T T NDC 60429-139-10 | METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS, USP 25 mg* 1,000 tablets ‘e pacragnsen orsossge romaon “[Rx onty
d74c1d6c-f144-44a7-99b8-7cfe87e5473a_478_2.jpg T I T NDC 60429-140-01 METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS, USP 50 mg* 100 tablets ‘e packageeen ot dorage ormaton ~TRx onty
d7718602-43d6-41e5-ba58-a872a18d72dd_12_1.jpg Benztropine Mesylate 1 mg Tablet arv: 28 ID #: N;10 Expires: NDC #: 70518-1447-00 Shape: Oval LOT #: Ref #: 00603-2438-32 MFG: Par/Qualitest, Chestnut Ridge, NY 10977 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
d779e7d5-1035-478a-8ace-d7b1a1cd2f3e_408_1.jpg 43063-298-30 43063-89%-30 43063-898-30 metFORMIN metFORMIN metFORMIN HCL USP HCL usp HCLUSP 500 MG 500 MG 500 MG 30 TABLETS 30 TABLETS 3D TABLETS ReOrder # 110666 ReOrder # 110666 ReOrder § 110666 LOT J18F45 LOT Ji8Fas LoT Jig8Fas EXP i0/20 EXP 10/20 EXP 10/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) TIMES A DAY. Each TABLET Contalns: METFORMIN HYDROCHLORIDE LI5P 500 MG ORGANOLEPTIC MARKINGS; WHITE 102 S0UND NDC: 43063-828-30 PD-Rx PHARMACEUTICALS INCORPORATED® Oklahoma City, OK « 73127 metFORMIN .HCLUSP 30 TABLETS {01)10343063898307 (21))18F45000007 (17) 201031 {10)118F45 LOLBHBEGOLYE IO Y0 O 0 VIONL NI 3y INIWHYHE 3DYVLIN3H TOZCIOSSTET
d779e7d5-1035-478a-8ace-d7b1a1cd2f3e_632_1.jpg PD-RXNET ITEM # 110652 LOT# 118p79 43063-898-90 43063-898-90 43063-898-90 nietFORMIN metFORMIN metFORMIN HCL USP HCL USP HCL USP 500 MG 500 MG 500 MG 90 TABLETS 90 TABLETS 90 TABLETS REORDER #110652 REORDER #110652 REORDER #110652 LOT [18E79 LOT [18E79 LOT I18E79 EXP 09/20 EXP 09/20 EXP 09/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 TAKE__TABLET{S) _TIMES A DAY, TOME__ TABLETA(S)__VECES AL DIA. ORGANOLEPTIC MARKINGS: WHITE ROUND H/102 -00000001 Wl IR LOT: I118E79 EXP: 9 PHAHMACEUTICALS = INCORPORATED') = mmm Oklahoma City, 0K » 73127 - & m— z" —_— o . metFORMN &= HCL USP EE o ?g r— B = S mm = 90 TABLETS Bo= Each Tablet Contains: L= METFORMIN HYDROCHLORIDE o USP 500 MG g m—— S E-
d7871d04-b2a0-48ca-ac56-dc3ea032ef10_754_1.jpg Cinacalcet Hydrochloride Tablets < N _ 30 Tablets 773 zydus Ry only “Each fim-coated tablet contans; Cinacalcet...... 30 mg (equivalent 0 33.060 mg Cinacalcet Hycrochloride) Store af 20° 10 25°C (68° o 77°F) [See USP Controlled Room Temperature], Dispense ina fgh, lghtresistant container as per USP. Usual Dosage: See Package Insert KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cacila Healthcare Lid. Amedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 Rev. 1017
d7871d04-b2a0-48ca-ac56-dc3ea032ef10_754_2.jpg NDC 70710-1001 Cinacalcet e e e Hvdrochloride s y roc orl e Store at 20° fo 25°C (68° to 77°F) [See USP Controlled Room Te tur Tablets Depomema g et container as per USP. Usual Dosage: See Package Insert. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadia Healtcare Lt Ahmedaba, Inda 30 Tablets Distributed by: Zydus Phamaceuticals (USA) Inc. Rxonly Eennington, NJ 08534 Rev. 1017
d7871d04-b2a0-48ca-ac56-dc3ea032ef10_754_3.jpg Cinacalcet (e o s (equivalent t0 99180 mg Hydrochloride — geeees, USP Controlled Room Tem re]. Tablets T ‘container as per USP. Usual Dosage: See Package Insert KEEP THIS AND ALL DRUGS OUT . OF THE REACH OF CHILDREN. Manufactured by: Cadila Healfhcare Lt Ahmedabad, Inda 30 Tablets Distributed by: Zydus Pharmaceuticas (USA) Inc. Rxonly Bennington, NJ 08534 Rev: 10117 N & I@ g “w
d7f4962e-9846-448a-b88b-c1e647b98b5a_186_1.jpg CLINICAL solutions WHOLESALE Trazodone 50mg Tablets NDC: 58118-0429-8 Qty: 30 ig.NOC:50111-0433-01 TN 0035116042966 Mig. Lot # SAMPLE123. Batch #: SAMPLE4S6 Mg By: Teva Pharmaceuticals USA Inc Exp.: Oct 2019 Mot Wae, PA, USA. 19454 SN: WMMDDO00O0 S
d7f4962e-9846-448a-b88b-c1e647b98b5a_186_2.jpg B CLINICAL solutions 2 7SO UHONS i ‘Trazodone 100mg Tablets L 58 'NDC: 58118-0430-8 5§§ i oo N, |- i 0. 011 05405 oo 155 Mig. Lot #: SAMPLE123 S £SAMPLEASS 3 22 Mig. By: Teva Pharmaceuticals USA Exp.: 0ct 2018 ot Wale, PA, USA, 19454 a2 £ e e { iy o o B, S5 P TSBET U s
d7f4962e-9846-448a-b88b-c1e647b98b5a_186_3.jpg 4 CLINICAL solutions 8 WHOLESALE i1 Trazodone 150mg Tablets gig NDC: 58118-0431-8 ;ég moroseme . T [T oot 148 Mig. Lot #: SAMPLE123 o £SAMPLEASS 3 22 Mig. By: Teva Pharmaceuticals USA Exp.: 0ct 2018 North Wale,PA, USA, 19454 a2 £ : Rpcrasanr it . il Skos sl LLC iy ey o D, S 515 v TNSRET USA. s
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_1.jpg Pt 1g Oxacillin Injection, USP NOC 0338-1013-41 %\E‘&! S0mL Code 263538 Container Iso-osmotic Steile Nonpyrogenic Exch 50 L cotains: Oaciin Sodum aquiabt 1 1 g Dl with aprox. 150 Denliosa Hydious, USP adsd 0 20us osmolait and 50 mo S Cials ythous, USP ot o2 bffr p st with g ochioric aid and mayhays b scustad Wi sdum Pickoxis. pH 6.5 (60 03,5 Dosage: nravanously s disetd b physisn. So nar Cantiors: Do ot add suppleentary meication Must ot b usd i s connictions. Chack forminua ok and soon oy R anly. Do fo storsabos -20°C-4°. Tha at room tapetalur (25°C7°F o under, rsiigeatin (s'CAF). 00 HOT FORCE THA BY IHIERSION I VATER BATHS OF BY ICADWAVE RRADIATION. Thased souon s b for 21 days undar oiguation (5°CA41°F)or 48 outs room tmparaie (25" s g v PU200 s Bt namatonalnc st
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_2.jpg 3 “Thaw it foom Bmporaur (25°/77°F) o nder rgetaion (C/41°F), DO NOT FORCE THAW BY EREASIoN I WATER bW O Y MGRIMAVE IRADI oW T stonis o o2 s EFLXCE e QORI (41 4 W o0 amyar (BT D01t . Oxacillin Injection, USP Al 02 ot otTrs w4, et er iy b gk o st 1250 Gl Do G e v ‘Baxtar and Galaxy ars registarad trademarks of Badar Intamational inc. S o SCRARY, Nl oy L 2040 Plastic: oo n ot o amptr(5°/7°) o it gan (/A1) 00 NOTFORGE THAW Y ERETSIoN I WATER bW O oY MICHOMAVE IVADION, T stonio o o2 s EFDXEET 1g GO (- r 4 W B T s (TP, 0811 o, Oxacillin Injection, USP Al 12 ot otnr i 4. ot vuers iy b gk e o st 1250 G Do s o vemoi St st Coprstin ‘BaXtor and Galaxy ars regstarad trademarks o Badar Intamational inc. Oonst stre shove-20°6/#. Do ot refrees. Bl - L oo s
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_3.jpg WDC 0338181341 Code 2G3538 T 20O NDC 033510141 Code 2G3538 O 2O GALAXY Cortarer St onpyrogenic st onan: crchin S ot oaclin A apro 1.5 ofputross o G5 a0 1 s csmoty ad 150 10 SO0 Gl Hyarus, USF afsd 353 D, i adsts VA yOOCHOrc aci 3 ey v o astod Wi sodum ygios. P 55 (010 851 Dosaga: Iniravonously s el by physican, Sea nsa auton. Dt sppsTey e, Mot s s 1 s o, G o iy e Tl i G o Syl Bt US3Unes Soblon B . B oA GALAXY cortarer St onpognic S0 camans: Ol Sofum oqukaset 1.0 Ol i goox. 1.5 o e s, 5P atad s ol a1 3 S il ou,USE gt s AT 11 o e L 4 48 Vs ba, MR W S YA 05 (801 6], Dosaga: Inraousy 2 o by 3 physicn. Sasat, Gaons: Do ot Suppsmarary mdiatn. Must ot s 14 st conmcions. Ghck o et o e ) oy b o
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_4.jpg Baxter 2 g Oxaclllin Injection, USP SALAXY S0ml MO Container Iso-osmotic sterile Nonpyrogenic: Each 50 L contains: Oxasilin Socium squivalent t 2 g Oaciln with appro. 300 mg Dextross Hyirous, USP acded fo adjust osmlaity and 300 mg Sodum Citrate Hyerous, USP added a5 a bufer. pH adjusted with hydrcchlori acd and may have been adjustd withsodium hydroide. pH 6.5 (60 fo .5). Dosage: Inravenously asdirectd by a physiian. See nsert. Gautions: Do not add supplementary medcation. Must ot be used i sries connestons. Cheokfor minute feaks and soluton clary Rxonly. Do not stor above -20°G/<+F. Thaw a room temperature (25°Gr77°F) o under refigeraton (%CA41°F. DO NOT FORCE THAW BY IMMERSION IN WATER BATHS OR BY MICROWAVE IRRADIATION. Thavicd soltion s sablefo 21 days under efigeration (5°C/41°F)or 48 hours at room temperaturs (25°C7T°F) Do not refeeae. Baerand Galuxy ar registersd tademarks of PL 200 Plasts Baxtor Infematonl nc. 73463780 Barter Healthcare Corporation Deerfld, L 60015 USA Made in USA
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_5.jpg “Thaw at oom famparatra (25°G/77°F) or inda riaraion (S°G/41°F). DO WOT FORCE THAW BY WANERSION I WATER BATHS 0 8Y WICROWAVE (RRADIATION Thawad olon 1 st o 21 cays o gaaton (°GA4T°F) o 48 hours at oo Lampetatur (25°77°) D fl ez AN 528 roduc onanas WA g4, Froduc contners may 4 gl 1 h oz e, Bt ang Gy a1 rogtore Hadamars of Bedor fmatoal PL 2040 Pasic Thaw s com mpuratrs (25°/77°) o undr rraton (/417 DO NOY FORCE THAW BY MNERSION I WATER BATHS O 8Y WICROWAVE IRRADIATION, Tawad Solton 1 b o 21 days undor igaration (°C/41°F) o 48 hours at oo tompettur (25777 0 fl ez A 102 roGUC o WA g4, Frodue contners may b8 Tagle 1 h oz s, Bt and Guoy a1 rogtore adamas of Bedor fatoal FL 2040 Pastc | Baxter Oxacillin Injection, USP 12-50 n. g Do Continrs e-semaic Do et st sove20°C1. Do e Baxter Oxacillin Injection, USP 12-50 .Sl Dose Conaiars v semotc Doset e v oo e, 24 Bota ethcare o LSS O Bata Hoathare L S0TS U5
d893e45b-7f18-4c67-b10c-1e2e52a6b3ef_258_6.jpg NDC 0338-1915-41 Code 2G3539 O PSS NDC 0335101541 Code 2G3539 O TS GALAXY contaner st Nongyrogenic 4150t onan: Crchi S a2 0 v aorox 200 g of s oo, G5 s 1 st csmoaty ad 50 10 SO0 ki Hyarus, USF adsd a 3. i e W ycHO1c aci 4 ey e o austod Wi sodum Ty, P 55 (01 8.5 Dosage: vl s el by pysican. Sea nsa Gautions: Donotadd cupplomsntary medcaton. Mustotbs s34 n s comnoctns. cck o it Ty gt T o Y. 1 0 31 oun, CATS 35 1) Ty 08 g 0o ot LS8 Sl B . R A GALAXY Gortaner St Hopyrogeic 2 50 i conlans: OacinSofim squalent o 20 Oacln Wi pprox. 300 g of Daiross ydrous, 05 a0 s s oty and S0 o Sagu G syotos, Uk a3 3 b1 asad Wi Y Gy v boan S0l WA S RYGoXGe. PR 05 B0 6] Dosag: nvnousy 2 el by rysiin See e, Gartons: Do ot uppimantary madicaon. Must ot o s n s camnctions. Coce for i T g gt s, 03 ) T 8 g, G
d8cf50d4-0448-4527-a498-cddd511213f0_271_1.jpg NDC 51672-1311-6 Mometasone Furoate USP, 0.1% FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. Each gram contains: 1 mg mometasone furoate in an ointment base of hexylene glycol, propylene glycol stearate, white petrolatum and white wax. Usual dosage: See package insert for full prescribing information. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature; To Open: Use pointed end on cap to puncture seal ] For lot number and expiry date see crimp of tube. Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1 n Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 LPK-4681-0 0304-0 101 3lIM51672 1311600
d9033965-7cf5-41ef-9efa-d2eec745b43d_631_1.jpg Batch 12000 Tablets g Expiry o be repacked witinsix months from the date of manufacturing NDC 65662-286-53 PLEASE HANDLE CAREFULLY Rxonly Perindopril Erbumine Tablets 2 mg CAUTION:FOR REPACKAGING ONLY. Store at 20° 10 25°C (68° to 77°F); excursions permitted to 15710 30° (59 1o 85F) [see USP Corivolied Room Temperture], Manufacturedby: Aurobindo Pharma Limited Hyderaback500072, Inda SRR 6o b
d9033965-7cf5-41ef-9efa-d2eec745b43d_631_2.jpg Batch 10000 Tablets g Expry To be repacked within sk morths from the date of manufacturing HDC 65862.287-1 PLEASE HANDLE CAREFULLY Rxonly Perindopril Erbumine Tablets 4 mg Eachabetcantis:Prindopi erurin 4 g CAUTION: FOR REPCKAGING ONLY. Store at 20° 1o 25°C (68" to 77°F); excursions pernited to 185 1030°C (59 10 86F) [see USP Contralled Room Temperatre] Manufactured by ‘Aurobindo Pharma Limited Hyderabad-500 072, ndia ol 9 3 65862~ 267 -19
d9033965-7cf5-41ef-9efa-d2eec745b43d_631_3.jpg Batch 5000 Tablets g Expiry o be repacked witinsix mnths from the ate o manufacturing HDC 65662-288-50 PLEASE HANDLE CAREFULLY Rxonly Perindopril Erbumine Tablets 8 mg CAUTION: FOR REPACKAGING ONLY. Store at 20° to 25°C (68 1o 77°F); excursions permited to 15710 30°C (5 1o 86F) [see USP Corirolied Room Temperture], Manutactured by: Aurabindo Pharma Limited Hyderabad-500072, Inda ol 3 65862-288-59 2
d91152c4-66ba-466f-b4f9-0da628d42b1d_247_1.jpg Each tablet contains: Candesartan Cilexetil USP... NDC 62559-650-90 Hydrochlorothiazide USP. USUAL ADULT DOSAGE: See . ® s accompanying prescribing information, ATA‘ AND H‘ T — — O\ Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. (Candesa rtan cilexetil- =0 Keep container tightly closed. h d ro Ch I or Oth s a : d e) —" KEEP THIS AND ALL MEDICATION y 1az1 . OUT OF THE REACH OF CHILDREN, Tablets = :\\nsat?u?cwwd:g: SE-151 85 — ‘aZeneca AB, St~ — Sodertilje, Sweden 16 mg/ 12.5 mg — Distributed by: e— ‘I;NI :hg;mﬁtr:‘esu‘t;ié:%l’s, Inc. I\ audette, _— ATACAND HCT is a trademark of the AstraZeneca lS(Onl)’ Eo group of companies and is licensed to ANI Pharmaceuticals, Inc. m 90 Tablets Manufactured under the license from Takeda Pharmaceutical Company, Ltd. 10111 Rev 05/18
d91152c4-66ba-466f-b4f9-0da628d42b1d_247_2.jpg Each tablet contains: Candesartan Cilexetil USP.........32 mg NDC 62559-651-90 Hydrochlorothiazide USP. 12.5mg USUAL ADULT DOSAGE: See accompanying prescribing information. ATAC AN D H(:T® Store at 20° to 25°C (68° to 77°F) [see . . USP Controlled Room Temperature]. (Candesa rtan cilexetil- Keep container tightly closed. s o KEEP THIS AND ALL MEDICATION hydrochlorothiazide) OUT OF THE REACH OF CHILDREN. Tablets Manufactured by: Sl Sweden 32mg/12.5 mg Distributed by: ANI Pharmaceuticals, Inc. Baudette, MN 56623 ATACAND HCT is a trademark of the AstraZeneca l3(0“1)' group of companies and is licensed to ANI Pharmaceuticals, Inc. aray 90 Tablets Manufactured under the license from Takeda Pharmaceutical Company, Ltd. 10112 Rev 05/18
d91152c4-66ba-466f-b4f9-0da628d42b1d_247_3.jpg Each tablet contains: Candesartan Cilexetil USP. NDC 62559-652-90 Hydrochlorothiazide USP. USUAL ADULT DOSAGE: S¢e ® — accompanying prescribing information. ATA‘ AND H‘ T — — O\ Store at 20° to 25°C (68° to 77°F) [see ESP Cont;o!led ?o?lrttll Telmpedrature]. (Candesartan Ci Iexeti |- =$ eep container tgntly closed. s s I KEEP THIS AND ALL MEDICATION hydrochlorothiazide) = OUT OF THE REACH OF CHILDREN, Tablets = Manufactured by: — AstraZeneca AB, SE-151 85 — Sodertilje, Sweden 32 mg/ 25 m g " Distributed by: e QNI ‘I;I\ralrm’:(’:lesuggzags, Inc. I O\ audette, —_— ATACAND HCT is a trademark of the AstraZeneca ls(onl)’ ;0 group of companies and is licensed to ANI Pharmaceuticals, Inc. M 90 Tablets Manufactured under the license from Takeda Pharmaceutical Company, Ltd. 10113 Rev 05/18
d9c291e0-cd0d-43d2-87b4-defefd531942_863_1.jpg GE Healthcare | CERETEC™ NDC 17156-022-05 Technetium Tc99m Exametazime Injection | Rx ONLY NOT FOR RESALE For the preparation of Technetium Tc99m Exametazime Injection Vial contains in lyophilized form 0.5 mg exametazime, 7.6 mcg stannous chioride dihydrate (minimum stannous tin 0.6 meg; 'maximum total stannous and stannic tin 4 mcg per vial) and 4.5 'mg sodium chioride. Sealed under nitrogen. Store the kit at 15°-25°C (59°-77°F). For intravenous injection after reconstitution with Technetium Tcgom. Not for use in humans until Technetium Tc99m is added as directed in accompanying package insert. Contains no antimicrobial preservative. Store the reconstituted drug at 20°-25°C (68°-77°F) using appropriate radiation shielding and use within time specified in the package insert for the appropriate injection preparation. Do not freeze. 1194438 USA Mfd. for: GE Healthcare, Medi-Physics, Inc., Arlington Hts,, IL 60004, 1-800-292-8514 By: GE Healthcare AS, Oslo, Norway 40-9159H-05LO EXP Lot
d9c291e0-cd0d-43d2-87b4-defefd531942_863_2.jpg NDC 17156-027-01 GE Healthcare Cobalt (") o chloride 6-hydrate | not For RESALE Cobalt stabilizer solution For use only with reconstituted Ceretec™. Not for direct administration. Vial contains sterile, non-pyrogenic cobalt stabilizer solution of 200 mcg cobalt chloride 6-hydrate stabilizer solution in 2 mL of Water for Injection. Use as directed in package insert. Store at 15°-25°C (59°-77°F). Do not freeze. Manufactured for: GE Healthcare Medi-Physics, Inc. Arlington Heights, IL 60004, 1-800-292-8514 By: GE Healthcare AS, Oslo, Norway 1193054 USA Exp.: Lot:
d9c291e0-cd0d-43d2-87b4-defefd531942_863_3.jpg Five-unitpackage GeHealtheore | CERETEC™ Manufactured for: Technetium Tc99m Exametazime Injection Rx ONLY i NOT FOR RESALE Arington Heights.IL 60004 Ceretec is a trademark of GE Healthare 1600-252.8514 GE and the GE Monogram are trademarks of 2.GE Heattncare AS. Osio Norway ‘General Elecric Company. Product of Norwegian Origin. © 2018 General Electric Company - Al ights reserved. 1193055 Ush GE Healthcare CERETEC"1 Technetium Tc99m Exametazime Injection CERETEC™ it e omsme o — Five-unitpackage Five-unit package NDC 17156-025-05 Storage: Store the kit ot 15%-25°C (59°77°F ‘Contents: Each package contains the folowing Afterreconsiituton with Technetium Tcd9m, Five Ceretec vil. Each vial contains a ophilzed form of 0.5 mg exametazime. store at 20%-25°C 68°-77°F. Do not freeze 7,6 mcg, stannous chiride dihycrate minimum stannous tn 06 mcg, marimum total stannous and stannic tin & meg per viall and Use appropricte radition shelding 45 mg sodium chloide. Not for use in humans until technetium Five Cobalt Il chioride 6-hydrate vials. Each vial contains Ted9mis added. sterle, o pyrogeic cobattaizer oution f 200 g B cobal chlride 6 hydrate stabilzer soluton n 2 mL of Water or Inection. or intravenous use a directed. For Dosage and Administratior Ten rodiation labels See Package Isert. One package insert For preparation o Technetium Tc99m Exametazime Injecton see package nsert. o o
d9c5e993-e82a-436f-bd95-8984935c6551_746_1.jpg NDC 42192-121-16 Sodium Sulfacetamide 9% - Sulfur 4% Wash In a vehicle containing Green Tea and Aloe Rx Only Net weight 16 oz. Acella PHARMACEUTICALS, LLC
d9c5e993-e82a-436f-bd95-8984935c6551_746_2.jpg NDC 42192-121-16 Sodium Sulfacetamide 9% - Sulfur 4% Wash In a vehicle containing Green Tea and Aloe Rx Only Net weight 16 oz. Acella PHARMACEUTICALS, LLC
d9cc1327-5474-4136-970a-ec40c41975b2_25_1.jpg Each film-coated tablet contains: Distributed by: NDC 65862-654-01 Entacapone USP 200 mg. Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Rx only Made in India Usual Adult Dosage: See package Code: TS/DRUGS/22/2009 Entacapone insert for dosage information. Tablets, USP e P1420747 . . m Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room /3 AUROBINDO 100 Tahlets Temperature.] “Over Printing Zone 3 v Coding Area (45x20 mm) Dotted lines not to be printed
d9e6b333-852b-4ddc-a3b7-32994201318e_391_1.jpg NDC 17856-0677-01 TRICITRATES SF (Potassium Citrate/Sodium Citrate/Citric Acid) ‘Oral Solution 550 mg/500 mgi334 mg per 5 mL. Unit Dose Delivers 30 mL Cup. A SUGAR.FREE SYSTEMIC ALKALIZER RXONLY FACKAGING INFORMATION: Dossge per Cup 0L up 5 per Cote 80 o oo Soppment Fads G et v CITRATE AND CITRIC AGID ORAL SOLUTION L MEDICINES OUT OF THE REACH OF CHILOREN W pramaces B S8 Repscxagadby. Unk oss Sauors, Inc. Mariaule, NG 27560 Dlevinawd o At Blogcsis Com SN ton pace. Mam L7 Questions or Comments: Call 1-800-509-7592 TorRe: 700 MEG Lot No: X000 Exp Date: KKXXXXXX TN 17856087701
da3d696b-8db7-4487-be86-c2e8cbfbe749_316_1.jpg nan
da3d696b-8db7-4487-be86-c2e8cbfbe749_316_2.jpg nan
da3d696b-8db7-4487-be86-c2e8cbfbe749_316_3.jpg nan
da52e74a-1baf-4a33-a068-b49176700320_696_1.jpg s e DASETTA EEE INoetingione and iy Estadiol Tebets, USP) 05mg0%5mg U70g008ng, g% gem | DASETTA EEE Norstindrore and i EsradiolTables, USP) 15y OrmROing TngNsg e e DASETTA EEE Noteingon end Einy Estail et US) 5 ng0ing, 078y Ingltny DASETTA Bl g e DASETTA EER Rt nd i o T US| TSeaiSeg Usegng | mlAS
da624604-e2bc-4e18-9f30-d764fab4c4f0_89_1.jpg nan
da624604-e2bc-4e18-9f30-d764fab4c4f0_89_2.jpg OXYGEN, COMPRESSED Usp UN1072 Produced by Air Liquefaction WARNING: DANGER: TW, For emergency use only when administered by properly trained personnel for oxygen deficiency and resuscitation. For all other medical applications, R only. Uninterrupted use of high concentrations of oxygen over a long duration, without monitoring its effect an oxygen content of arterial blood, may be harmful. Do not attempt to use on patients who have stopped breathing unless used in conjunction with resuscitative equipment. Keep out of reach of children. Federal law requires that this container be refilled with oxygen USP only by establishments registered as a drug manufacturer in accordance with the Federal Food, Drug, and Cosmetic Act. MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. Do not handle until all safety precautions have been read and understood. Keep and store away from clothing and other combustible materials. Keep valves and fittings free from grease and oil. Use and store only outdoors or in a well-ventilated place. In case of fire: Stop leak if safe to do so. Use a back flowr preventive device in the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. Open valve slowly. Close valve after each use and when empty. Protect from sunlight when ambient temperature exceeds 52 C (125 F). Read and follow the Safety Data Sheet (0) before use, CAS: 7782-44-7 DO NOT REMOVE THIS PRODUCT LABEL. LATEX WELDING SUPPLY, INC. 1234 GRIMMETT DR. SHREVEPORT, LA 71107 « 318-424-9922 40035 01115)
da624604-e2bc-4e18-9f30-d764fab4c4f0_89_3.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED LIQuiD usp UN1073 admin and resusc used in conjunc reach of chidrer Produced by Air Liquefaction DANGER: MAY CAUSE OR INT FY FIRE; OXIDIZER. CONTAIN: NIC BURNS OR INJURY. CO S YGEN MAY EXPLODE ON IGNITION been read and un other combustible ma and fittings free from grease and oil. Use and store only ventilated cold insulal ak if € a back f fe 1o do so ith equipmen der J 0 NOT change o roll equipment over spill U osition. Read and follow FIRST AID: IF ON SKIN: Thaw frosted parts lukewarm water. Do not rub area. Get immediate medical advice/attention e Safe CAS 7782-44-7 DO NOT REMOVE THIS PRODUCT LABEL LATEX WELDING SUPPLY, INC. TW, 1234 GRIMMETT DR SHREVEPORT, LA 71107 = 318-424-9922 41533 (01/15)
db002ae3-f54c-40a4-9cb4-e5681bf426e3_728_1.jpg NDC 62037-710-01 Each Extendec-Release Tablet Provides: Potassium Chloride, USP ... 750 mg Potassium Oupeniain i lopcssnt e epned e, Chloﬂde :'::L Z‘?:?.?,‘miit, scearpany i Extended-Release Store at 20°10 25°C (68" 10 77°) [5ee o eoveoted oan T Tablets, USP ™ Keep tighly dosed Andix Pl s ActavsLabratores FLinc ~ 100Tablets o Laecan 1 5514054 A Actavis RxOnly Disrbuted by: et Pharma Pariapany, NIGTE34 USA e 0315 228459 =c — 5 B 5
db002ae3-f54c-40a4-9cb4-e5681bf426e3_728_2.jpg NDC 62037-720-01 Each Extended-Release Tablet Provides: Potassium Chloride, USP ... 1500 mg Potassium Okpmain s gt sitsars Container s defined inthe US?. 7 Chloride e Extended-Release Storeat 20710 25°C (68" 10 77F) sce U5F Contoted oo Tempersore, & Tablets, USP PN o ot = W [r—— — e et e = ~ 100Tablets o lactemre itaush = Actavis RxOnly ey
db007ac0-020e-4962-8903-7497ab96a74e_126_1.jpg Imipramine HCI 50 mg Tablet arv: 30 ID #: EP;135 Expires: NDC #: 70518-1588-00 Shape: Round LOT #: Ref #: 69315-0135-10 MFG: Leading, Fairfield, NJ 07004 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
db564864-17fc-4ba5-a438-a467ef57a0ca_268_1.jpg € N Each tablet contains NDC 0054-4858-25 100 Tablets 0.125 mg triazolam USP. - o o USUAL DOSAGE: 5o Triazolam S ackage Insert for Complete Sessribing Informanan Tablets USP i Store at 20° to 25°C (68° to ! 77°F). [See USP Controlled - Floom Temperature.] % Dispense in a tight, PHARMACIST: Dispense with - h%hl—ves\stam container as attached Medication Guide. 1 efined in the USPAF . Distr. by West-Ward R only w Pharmaceuticals Corp. WEST-WARD Eatontown, NJ 07724 A htana coxmany © csooooigssol £50000189/01 0
db564864-17fc-4ba5-a438-a467ef57a0ca_268_2.jpg Each tablet cortains 0.95 mg triazolam USP USUAL DOSAGE: See Package Insert for Cormplete Prescribing Irformation Store at 20° to 25°C (68° to 77°F). [See USP Cortrolled Floorn Temperature.] Dispense in a tight, light resistant container as defined in the USP/NF Distr. by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 0772: NDC 0054-4859-25 100 Tablets Triazolam Tablets USP PHARMACIST: Dispense with attached Medication Guide R ony WEST-WARD S§¢=Ra8 Y9800 £ 2 50000138701
db7454bc-4f18-4632-b771-2e86db889bae_598_1.jpg NDC 0517-6510-25 SELENIUM INJECTION Selenium 400 meg/10 mL {40 mcg/mL) 10 mL SINGLE DOSE VIAL Trace Element Additive FOR IV USE AFTER DILUTION PRESERVATIVE FREE Rx Only AMERICAN REGENT, INC. SHIRLEY, NY 11967 Each mL contains: Selenious Acid 65.4 meg, Water for Injection gq.s. pH adjusted with Nitric Acid. Contains no more than 2,500 mcg/L of aluminum. WARNING: DISCARD UNUSED PORTION. Store at 20° to 25°C (68° to 77°F) (See USP Controlled Room Temperature). Directions for Use: See Package Insert. Rev. 10/10 Exp. Lot
db7454bc-4f18-4632-b771-2e86db889bae_598_2.jpg NDC 0517-6510-25 SELENIUM INJECTION Selenium 400 meg/10 mL {40 mcg/mL) 10 mL SINGLE DOSE VIAL Trace Element Additive FOR IV USE AFTER DILUTION PRESERVATIVE FREE Rx Only AMERICAN REGENT, INC. SHIRLEY, NY 11967 Each mL contains: Selenious Acid 65.4 meg, Water for Injection gq.s. pH adjusted with Nitric Acid. Contains no more than 2,500 mcg/L of aluminum. WARNING: DISCARD UNUSED PORTION. Store at 20° to 25°C (68° to 77°F) (See USP Controlled Room Temperature). Directions for Use: See Package Insert. Rev. 10/10 Exp. Lot
db7454bc-4f18-4632-b771-2e86db889bae_598_3.jpg LOT 0000 EXP 01/2099 GTIN 00305176510255 SN O
dbe07049-223d-4e54-b1ab-5b57bb9ad8ae_857_1.jpg NDC 16714-371-02 Lamotrigine Tablets i 25 m | Phamacis: Dispense e accompanyiy "Moicaton (e 1 each paert. 100 Tablets *N ORTHSTAR.™ Each incaated bt contis: Lamorigne USP 25 mg See package ouset for Dosage & Admimstaton, Dispense ina ightconiner Gefned i e USP. Stoe at20 0 25°C (68 10 777), cusan pemited 0 15° 10 3T (69 108 [se¢ USP Cortrolled Roam Temperatr]. oGCaRon GUGe avaabe al W D ES0GC LN orcal 18002067821, Manufactured o:NortstarRx LLC Memphis, TN 38141 Manuscired by, Aembic Pramaceuticals Lime fomusir s age Paela P 0. Tapur, Nea Basi, Tk Hdol Panchmat, Gujat nda| Productof nda. 3 16714-371-02 NSt g, Lic. No. 6/959 = = 20016254 032016 Coding Area NOT PRINTED 15x28 mm
dbe07049-223d-4e54-b1ab-5b57bb9ad8ae_857_2.jpg NDC 16714-372-02 Pramasst Disperss te cconparying "Medicaion Gue 10810 fae. 100 Tablets ‘NORTHSTAI;("‘ Each uncoded talt contans: Lamotngine USP 100 mg Ses packape otertfor Dosage & AGmStaon Disperse na it cortareras Gefned e USF Soreal a1 25 (6 1077F) Borson pemiEd 0 1510 0T (5810 B see USP Cartroled Room Temperatre]. eicam Gide aaiabe & s omprodc 0 cal 1800-2067821 Manufachred for. Northtar Re LLC Memphis, TN 3141 Manutactued by: Aembic Pramceicas Limted famizanDisen) Vitage Pane £ 0. Tipu, Nea Basia Tabia Halo, Panchaal, G, Inda. Productof . -372-02 16714 NSarheaBeae i Mg, Lic. No. 6/959 20016255 032016 Coding Area BE PRINTED 15x28 mm
dbe07049-223d-4e54-b1ab-5b57bb9ad8ae_857_3.jpg NDC 16714-373-04 Lamotrigine Tablets use KT Phamasst Disperss the accongarying "Medicaion Gue 108chjatent 60 Tablets ‘NORTHSTA&"‘ Eachuncoated et contans: Lamotrigne USP 150 mg ‘See package otsartfor Dosage & Adminstaton, Dispensein ot cortaner s defined in e USP. Sforeal 20°10 25C (6 0 7777 excursin pemiEed 0 510 3UPC (59°10.86°F) s USP Cortrlled Room Temperatr]. leticaton Gudeavaiabe a yon 0 DSAXC VOO orcal 1600206721 Manufactured for:Nortta Ry LLC Memptis, TN 38141 Manusctued by: Alembic Pramacauticds Limied (Fomution Divison) Vilage Panda P0.Tipur, Nea Basi, TakHalo, Panchatd, G, ndia Prodictof ndia 2016255 owe 16714-373-04 [rEe——— g, Lic. No. 6/959 Coding Area NOT 70 B PRINTED 15x28 mm
dbe07049-223d-4e54-b1ab-5b57bb9ad8ae_857_4.jpg NDC 16714-374-04 Lamotrigine Tablets us Phamasst: Diperss te acconparying "Medicaion ue 1020hftent 60 Tablets ‘NORTHSTA&"‘ Each uncoated bt contas: Lamotigne USP 200 mg ‘See package otsat for Dosage & Admimstaton, Dispense n 3 ightconine 35 efned i e U Storeat 2710 25°C 6" 10 777 Bxcursin permed 0 T5° 1. 3T (59°0 86 e USP Contoled Roam Tempeatr). ioBtaton Gude avaabe W DDA ConT OB orcal 1800206721 Manufactured for Norstar Rx LLC Memphis, T 38141 Mansitedty: o Pramsoatia i T (eman 0 b e s, Tauke ol Panchmand, Gut, i Prodietof i 20016257 032016 6714-374-04 NSt idegs g, Lic. No, 6/959 Coding Area, NOT PRINTED 15x28 mm
dc420d50-6192-482d-b3da-3be55870a79a_732_1.jpg NDC 47335-531-83 (Once Daily) Tramadol Hydrochloride Extended-release Tablets @’ The tablets should be swallowed whole with Rconly 10uid and notspit, chewed, dissolved or crushed. 30 Tablets PHARMAGIST: Dispense the Medication Guide provided separately to each patie Open for Full Labeling — PULBI476C 155, 12/2016 GUY/DRUGS/25/789
dc420d50-6192-482d-b3da-3be55870a79a_732_2.jpg Each extended-release coated tablet contains 200 mg of tramadol hydrochloride, USP Usual Dosage: Please see accompanying prescribing lterature. Dispense in atight, light-esistant container. WARNING: Keep out of reach of children. Store at 20° to 25°C (68" 0 77°F); excursions permited between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-533-83 (Once Daily) Tramadol Hydrochloride Extended-release Tablets @/ The tablets should be swallowed whole with liquid and not split, chewed, dissolved or crushed. PHARMACIST: Dispense the Medication Guide provided separately to each patient. Re only \ 20 Tablots 5 M 0 5 3.3 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, GUJ/DRUGS/25/789 India. PJLB1480C 1SS. 12/2016
dc420d50-6192-482d-b3da-3be55870a79a_732_3.jpg Each extended-release coated tablet contains 300 mg of tramadol hydrochloride, USP. Usual Dosage: Please see accompanying prescribing literature. Dispense in atight, light-esistant container. WARNING: Keep out of reach of children. Store at 20° to 25°C (68" 0 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-537-83 (Once Daily) Tramadol Hydrochloride Extended-release Tablets @/ The tablets should be swallowed whole with liquid and not splt, chewed, dissolved or crushed. PHARMACIST: Dispense the Medication Guide provided separately to each patient. Rx only \ 30 Tablets SUN M 00 ~ ) i Manufactured by: Sun Pharmacetical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India. GUJDRUGS/25/789 PJLB1484C ISS. 12/2016
dca5ffde-4b95-4f47-b368-c1ad04ec27b7_473_1.jpg oo S0S0RG0E WNONT S ERTE B oo s Gt R THKE TBLET DALY o g ORASDRECTED. R e B Onclaneren
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_1.jpg NDC 6050561460 1 Only Dhtewihasuiaboparnonl [SeeUSPContrled Room W ‘vehicle prior o intravenous infusion. Temperatur Cefepime o (% s, ) Tgam ol csbpme sl for Injection, USP e o B N iy st sre 1 gram/vial Beearn, Single-Dose Reconstituto befor ntramusculs Use, Biuts befor Intravenous Infusion. APOTEX CORP.
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_2.jpg NDC 60505.6147-0 T Only Dt ihasiabepareteral [See USP Confrlled Room i o avenous s, Temperatre] Prtetfom ight. wiz 1 Each vl conans steie Manufactured| Cefepime P et S . ¥ dLagone o for Injection, USP st LI 250101, Chira Ustal Dokoge:See pckage e, e o AptexCop. Inthe dry statesoreat 20° 1o Wesion, Floda, USA 33326 2 grams/vial /7 Bt Conmer 061508 Single-Dose Vial Oitte botors inavenous ifusion. 024Lo1s0c09] APOTEX CORP.
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_3.jpg s ‘vonalu) 10} awndajag ot 0919750509 9N NDC 60505-61460 ROnly || Dkt vt a sutatle NOC 60505.6146.0 parenteral vehicle prio o inravenous infuson, BOnly | Manufactured by: Qilu Pharmaceutical Co,, Ltd, High Toch Zone Cefepime | """, |Cefepime | i for Injection, USP cslopme hyarocloce,sp | 10T Injection, USP Manufactured for: et s g P LA coopmoand cargnnotor [ LETLVATLE I e i, s /1 ot adustmen, Rov 07118 141 gram Single-Dose Vil || Cod rumbr: 34040034301C [/ vssatDosage: e paciage 1 St e Rt amscar s | Dhasbefere s osion, || Dibi efore avenous fsan. ,,,/;/ P o g i In the dry state store at 20° e o T | o itio 1T aae ) USP Controlled Room /) / Tomperature] o 4 . Protect from light.
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_4.jpg a0 xa10dy 251 0 L U ey B W oty etninsnousne g 01 ST o4 SRS 510 S0 tein ssogesfus wesd Lxo1 LV dSn ‘uonoaluj 1oy aundajan [CEY pLgsoses 20K oo wses5146 e ony || rocemsstees pren o = [ —— v Cefepime s Cefepime for Ijection, USP yovbran, Use saseao o || for Injection, USP s i Lo 1 ot L e i LA i sn sz o St oo 21 gram Single-Dose Visks iy st s 201025 1041 gram Singhe-Dose Vi Reconsteblors s s 610775 U Corvelhs Reconsutebetoe s e, Do o, Room Tanpersra] Db oo sion. Pt ron L R o U T s, e LG e n G U i U ] AroTEX CORP. = £
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_5.jpg dSn ‘uonoalu 1o} aundajay Wt p)gs0s09 o0 BOnly || Dite wih a sutasle NDC60505:6147:0 B Orly || Manufactured by: paranteral vahice prio to Qu Pharmaceuscal Co., L. intravenous infusion, High Tech Zone Cefepime s, 25010, hina for Injection, USP NDC 6050561470 Cefepime for Injection, USP Each val contains sterle cefopime hydrochloride, USP bt 2t oot e e M “tenens art g tr Woston, ok, USA 33526 oH adisiment. 7 Rev 07118 1x2gram Single-Dose Visl )/} Cods number: 34040032501C V/ Manufactured for: p— ) vssaroosase: e pacace / bt st | o oba b bisen Poet o i /) Pt i I e ncus Tt/ 1 the dry stte store at 20° | | ResninCarentnTeot e,/ /) ) /] 10.25°C (68" to TT°F). [See / 7 USP Contralled Room / ol Temperature.] Protect from light. /) 3 ls1erolll7
dd641c7f-b857-48ff-bd9d-747e0c3cc89f_900_6.jpg 110 s uoweD U ey 708 wor ool “oreni oA 10380 NG Aein 9s0G-0ms weiB Zx01 [en/swesb z dSn “uonoalu] Joj aundajay rLphgsis 20N NoC 6050561474 Noc s0s0s 1474 o it a sl parrralvoch Manutacurod Cefepime oo o B . i Eacn v o so cep ity e ytocbran, USPcquvaent 02 s amiacure o i o e or 4 Sooun & 2 grams/vial ausment. eston i, Ush 35326 s Dosag: Saopackgs o Rovonts 102 gram Single-Dose Vials I the ay it sore a1 20710 25°C oo rumne ULTONC. Diue betore ravenous busiors (6810777 (800 USP Conrolled Dt ators ravanous bnfusion, Proactfom Lign. Retinn Caton Ut Tumsof Use. Room Temparsirsd e et U T of st for Injection, USP
dd6a2ef6-8780-40c8-bad5-24c2ecd0bf2b_825_1.jpg ov 00 MG 14 TABLETS
dd904490-83f3-4cd3-bb6f-68e28509b4b6_359_1.jpg CARNITOR" SF (levocarnitine) Sugar-Free Oral Solution aunjeiadwiel Woo! PaI0U0D 118 mL (4 fl. 0z.) Active ingredient: L-caritine 1g/10mL Inactive ingredients: Natural Cherry Flavor, D L-Malic Acid, Methylparaben NF, Propylparaben NF, Purified Water, Sodium Saccharin USP MITWATINE Ceagiant (01)00354482148010 Biosciences ‘Ajuo xy “pesu| ebexoed sag :abe: dsn 98s *(0.52) 1 010}3 "BUIZ8a1) WOJ} 198101 ‘JEaY SSEOXE PIOAY. 7 P » N ° 500 82802 QN ‘BINGSIZUIRD “3U] S90S 1UIPEaT] Aq PR Rev173.030818 OSFL(H)-4 06118 ( Unvarnished Datalase
de212757-4232-40e6-b7a2-f5f03251e1b1_304_1.jpg Ezchtabktcontans Phencoarbial’, USP... *WARNIG: May be habit forming. USUAL DOSAGE: See peciag nsert DISPENSE ina vielcosed contaner s defined i the USP STORE t 20°0 25°C (68" t077°F) see USP Contced Room Temperatur, Manufactured for: Steing | KnightPhamaceutak, LLG Ripky, M5 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN L7051-02-5KP FH1808 NDC 69336-115-10 Phenobarbital Tablets, USP 16.2mg [} AR5 ]
de212757-4232-40e6-b7a2-f5f03251e1b1_304_2.jpg Each tabetcontang Phencbrbicl’, USP .. *WARNING: May be habit forming. USUAL DOSAGE: See packege nsert DISPENSE ina welkchsed contaner s cefined n the USP STORE 2t 20°10 25°C (68° t077°F)see USP Contrll Room Terperetre, Manufactured for: Steing | KnightPhamaceuta, LG Ripky, 538663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN LOBTI02-SKP. R-1808 NDC 69336-T16-10 Phenobarbital Tablets, USP WARNING: May bo habit formig 100 TABLETS RxOnly LotNo: Exp. Date
de212757-4232-40e6-b7a2-f5f03251e1b1_304_3.jpg Ezchtabktcontans Phencberbil’, USP. *WARNING: May be habit forming. USUAL DOSAGE: See peciage st DISPENSE ina vieldosed contaner s defined n the USP STORE 2t 20°0 25°C (66" t077°F) see USP ContiBed Room Temperature, Manufactured for: Stering | KnightPhamiaceutcas, LLC Rigky, 1S 33663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN L6881-02-5KP Fr1808 NDC 69336-117-10 Phenobarbital Tablets, USP C "WARNING: My bo habit forming. RxOnly LotNo: Exp. Date .
de212757-4232-40e6-b7a2-f5f03251e1b1_304_4.jpg Each tablet contains Phenobarbital’, USP, 972mg *WARNING: May be habit forming. USUAL DOSAGE: See package insert DISPENSE ina wellclosed cotainer as defined n the USP STORE t 20°10.25° G (68° to 77°F) [see USP Controlled Room Temperature), Manufactured for: Stering | Knight Pharmaceuticels, LLG Ripkey, MS 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN 16891-02-5KP FH1808 NDC 69336-118-10 Phenobarbital Tablets, USP fay be habit forming. 100 TABLETS @ RxOnly LotNo: g g @
de212757-4232-40e6-b7a2-f5f03251e1b1_304_5.jpg Each tablet contains Phenobarbitat’, USP.. *WARNING: May be habit forming. USUAL DOSAGE: See package insert DISPENSE in a well-closed container as defined in the USP STORE at 20°10 25° C (66° 10 77°F) fsee USP Controlled Room Temperature), Manufactured for: Sterfing | Knight Pharmaceticals, LLC Ripley, MS 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN L705L:03-8KP NDC 69336-115-11 Phenobarbital Tablets, USP *WARNING: May be habit forming, TR 7Y:1
de212757-4232-40e6-b7a2-f5f03251e1b1_304_6.jpg @ I Each tablet contains Phenabarbitaf, USP..... . 324mg NDC 69336-116-11 "WARNING: May be habit forming. Ph ba Ibita I, USUAL DOSAGE: See package insert eno DISPENSE in a well-closed container as defined in the Use Tablets, USP STORE at 20°to 25°C (68° to 77°F) [see USP s e @ Manufactured for: Sterling | Knight Pharmaceuticals, LLC Ripley, MS 38663 *WARNING: May be habit forming. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN LotNo: Exp. Date LB871:08-5KP. R1808 1000 TABLETS RxOnly
de212757-4232-40e6-b7a2-f5f03251e1b1_304_7.jpg Phenobarbital®, USP. "WARNING: May USUAL DOSAGE: Sce package insert DISPENSE in a well-closed container as defined in the USP STORE a1 20°10 25°C (68° 10 77° ) [se0 USP Controled Room Temperature], Manufactured for: Stering | Knight Pharmaceuticals, LLG Ripley, MS 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH ‘OF CHILDREN @ R Ll NDC 69336-117-11 Phenobarbital Tablets, USP e *WARNING: May be habit forming. 1000 TABLETS
de212757-4232-40e6-b7a2-f5f03251e1b1_304_8.jpg @ Bl NDC 69336-118-11 Phenobarbital Tablets, USP DISPENSE in a wel-closed container as defined in the USP STORE 2t 20°t0 25°C (68" 10 77°F) [see USP Controled Room Temperaturs). ml IV Manufactured for: Stering| Knight Phamaceuticals, LLC Ripley. MS 38663 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN “WARNING: May be habit forming. 1000 TABLETS
de336c75-566f-4083-a31b-842bad668b6e_20_1.jpg fluoxetine hydrochloride, USP LR ‘container as defined in the USP s il o, 5 g it 010 mg of oste. % ol cmine ilpad s Fluoxetl NE to v oy doed & Koy e lmction — o of e rach of cidrn: o Tablets, USP Store at20° 0 25°C (68" 10 7T°F). ¥ — v Gt Room O m— L Temperotwre] Q== 5548 FA I | prmctimm . o= ji¢° VD camgio = i ST Toper e seompninn| | it — i Medision G 0 sch patent e . & o— fiff MGV W SEBUSA. B e g [MMylane o = B é [Mylan ] 30 Tablets Myian.com £
de336c75-566f-4083-a31b-842bad668b6e_20_2.jpg atight light esitant = defined intholUSP & 735-93 Lo Exch fim-coated tablt contane [E ey SR ) o e | uoxeting e 2 ot o th reschof ciden. Tablets, USP Slore at20°to 5°C (68° ta 77°F). [See USP Controlled Room S Temperoure] L1200 Protectfrom fight. il R e B e et et ot L il @Mylan* Made in ustrln ] ERTT COOCVRNTNY NI
de3441e3-7fd2-4d29-a8b7-0f9b66e35c9c_460_1.jpg —————— s & 2 D - e Ewn @ 58, 2 7 & S = BE = 2 282 £ & S L2 s 3 g g a2 z OOoc = TN 0030083316006 Each capsule contains 300 mg cefdinir, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° o 25°C (68° to 77°F) {See USP Controled Room Temperature]. Dispense ina Rev. 8772014 AND ALL MEDICATIONS OUT OF THE REAGH OF CHILDREN. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 33332101059 N 3 0093-3160-06 3
de4a660b-172b-4c72-9e38-5634fd03cfa7_424_1.jpg Pachaged by Eopant Reech Bnbank, €4 91504 Metformin Hel B ™ carutesuas g ER 500mg Tablet 8 2 Store at room temp of Compare To: 2025 C (68-77F) Ghoopheg BN T e e ourof TAGIPhamalre. . reachofchildren #60 Exp: MM/YY & NDC 7133507201 028831117204
de4a660b-172b-4c72-9e38-5634fd03cfa7_424_2.jpg Pachaged by Eopant Reech Bnbank. €4 91504 Metformin ER g "™ o= 750mg Tablet 10 g 8 "Keepall drugs outof Compare To: reach of children. oo RTINS T g oo et g5 GgTTR) #30 Exp: MMYY & NDC 7133507761 048101118492
de7a700d-2757-40c2-8e50-9a6b106ab011_519_1.jpg NDC 60750,1,6_30C|V Zolpidem Tartrate Zolpidem Tartrate Zolpidem Tartrate ~ Zolpidem Tartrate i — || Extended-Release Extended-Release Extended-Release Extended-Release éﬁ’f"ggdngamm= Tablets Tablets Tablets Tablets S nSease 12.5mg 12.5mg 12.5mg 12.5mg aviels 8 QTY: 30 QTY: 30 QTY: 30 QrY:30 12.5mg 3 RX# 0000000 RX# 0000000 RX# 0000000 RX# 0000000 Qry: 30 = NDC 60760-116-30 NDC 60760-116-30 NDC 60760-116-30 NDC 60760-116-30 LOTHXXXXXXX & LOTIOOXXXX LOTHXXOXXXXX LOTHXXXXXXX LOTHXXXXXXX EXP XX-XX s EXP XX-XX EXP XX-XX EXP XX-XX EXP XX-XX RX# 0000000 MANUFACTURED BY: Anchen Prarmaceuticas, Inc. = Inine, CA 92618 USA PACKAGED BY: W, StMay's /Y 340850 MAVINEE DR 0RO VALLEY, 2 85737 MANAGED PHARMACY PROGRAMS TAKE AS DIRECTED Rxonly STORE AT CONTROLLED ROOM TEMPERATURE 15° 30° C (59°-86°F)
defc1205-8e90-4b1e-b862-05e4c35c7364_817_1.jpg Store at 20°C to 25°C NDC 24478-074-01 Distributed by: (68°F to 77°F); excursions i ® NextWave permitted from 15°C to Quil |Ch¢w ER ‘ 1L Pharmaceuticals, Inc, 2 & 30°C (59°F o 86°F) [See (methylphenidate HCI) A subsidiary of 39 jo= ¢ Cosvalod ooty extended-release chewable tablets Tris Pharma, Inc. oN = Temperature]. Monmouth Junction S 2 e Dispense in tight (USP), NJ 08852 ~ === DOSAGE AND USE Each scored 20 mg QuilliChew ER® Tris Pharma, Inc. N o See acf)‘.""”.a;‘y'"g i extended-release chewable tablet contains Monmouth Junction, | o &3 ;‘ S ':::shmtal:lnegl 'C':):;:‘:S'gg' 1 approximately 3 mg phenylalanine. NJ 08852 o©° O m— ! 5 : M .. = ;re\::":‘l’r‘alig::’:gﬂ“; ZY:'SCN“"“E Pharmacist: Dispense the accompanying | ggs30 Rev.00 0=z — . TaGgE e B z === ilybrendai e base, Medication Guide to each patient. 08/2018 85 N - 100 Tablets KEEP OUT OF REACH OF CHILDREN. g Tr.l§ Rx only
defc1205-8e90-4b1e-b862-05e4c35c7364_817_2.jpg TTNDC 2447807501 T T T T T T T T T T Distributed by~~~ ] i NextWave | (68°F to 77°F); excursions i ® C . | " o Pharmaceuticals, Inc, pitnizcs QuilliChew ER” (L fumestessve ggl' l:(ontrolled Room (methylphenidate HCI) Tris Pharma, "‘Ci | = Temperature]. extended-release chewable ~ MommouthJunction | =5 i3 NJ 08852 1 8~ Dispense i tight (USP), tablets Manvfacturedby: | O & child-resistant containers. Tris Pharma, Inc. } o l:f Monmouth Junction, | < gg s:?ci:\" IaJnui?»E o NJ 08852 | oy - b Dm,gm,gam" Each scored 30 mg QuilliChew ER® Pl prescrioing " extended-release chewable tablet 1Bes31 Revod | _ S * Each tablet contains 30mg contains approximately 4.5 mg 08/2018 kM methylphenidate hydrochloride - phenylalanine. o= (equivalent to 25.9 mg e . i i Pharmacist: Dispense the accompanying | 9= melnylpheridat fee b2ss). e ication Guide to each patient. e KEEP OUT OF REACH 100 Tablets | OF CHILDREN. 1
defc1205-8e90-4b1e-b862-05e4c35c7364_817_3.jpg Store at 20°C to 25°C NDC "24478-076-01 Distributed by: (68°F to 77°F); excursions NextWave zpsietice’ QuilliChew ER° (@ mioese- °C (59°F to 86°F) [See 3 & Al iWiwmmmen (methyiphenidatoHC) — ier, | 2% Temperature]. extended-release chewable yJogss 2 ny===== Djispense in tight (USP), ) o i: = child-resistant containers. tablets Mgnmaclured b o R — Tris Pharma, Inc, ol o=—=== DOSAGE AND USE Monmouth Junction, S ——— T accompanying NJ 08852 > & e prescribing information. Each 40 mg QuilliChew ER® extended-release | gooay poy 0o = g o * Each tablet contains 40mg chewable tablet (not scored) contains 08/2018 o Qm===== nmethylphenidate hydrochloride approximately 6 mg phenylalanine. n 2 = (gquivalent to 34.6 mg . ~ 0 = methylphenidate free base). Pharmacist: Dispense the accompanying o = Medication Guide to each patient. KEEP OUT OF REACH 100 Tablets OF CHILDREN. - @ -.':'.-.I§ Rx only
e0141598-0bb2-4cf0-c9b8-6867b34bbb17_891_1.jpg Store below 30°C (86°F). Prtect from moisture. Dispense ina wel-closed container.Each film-coated tablet ontains 0.3 mg esterified estrogens. Dosage and Use: See accompanying prescribing information. Dispense with patient package insert. Important: Use: safety closures when dispensing this product uness otherwise directed by physician or purchaser,Distrbuted by: Plizer nc, New York, NY 10017 MADE IN NETHERLANDS @ NDC 61570-072-01 Menest’ (esterified estrogens tablets, USP) 100 Tablets Rx only TN 0361570072010 LOT/EXP./ SN 2z o o ) S| o T = 14270202 IMPRINT AREA Reads This Way - No Vamish
e0141598-0bb2-4cf0-c9b8-6867b34bbb17_891_2.jpg Store below 30°C (86°F). Protect from moisture. Dispense ina well-closed container. Each fim-coated tabletcontains 0.625 mg esterified estrogens. Dosage and See accompanying prescribing information. Dispense with patient package insert. important: Use: safety closures when dispensing this productunless otherwise directed by physician or purchaser. Distrbuted by: PfizerIn., New York, NY 10017 MADE IN NETHERLANDS w NDC 61570-073-01 Menest’ (esterified estrogens| tablets, USP) 100 Tablets Rx only| FPO UPC @ 70% T 0036157073017 LOT/EXP./ SN 14270502 IMPRINT AREA Reads This Way - No Varnish
e0141598-0bb2-4cf0-c9b8-6867b34bbb17_891_3.jpg Store below 30°C (86°F). Protect from moisture. Dispense ina wel-closed container. Each film-coated tablet contains 1.25 mg esterified estrogens. Dosage and Use: See accompanying prescibing information. Dispense with patient packageinsert. Important: Use: safety closures when dispensing this productunless otherwise diected by physician or purchaser. Distributed by: PizerIn, New York, NY 10017 MADE INNETHERLANDS @ NDC 61570-074-01 Menest’ (esterified estrogens tablets, USP) 100 Tablets Rx only FPOUPC @ 70% GTIN: 0361570074014 O /EXP./ ST 14270302 IMPRINT AREA Reads This Way - No Vamish
e0141598-0bb2-4cf0-c9b8-6867b34bbb17_891_4.jpg Store below 30°C (86°F). Protect NDC 61570-075-50 o from moisture. Dispense ina ‘well-closed container. Each ® film-coated tablet contains 2.5 mg esterified estrogens. Dosage and Me '.‘.eSt Use: See accompanying prescribing | (€Sterified estrogens| information. Dispense with patient package insert, Important: Use: tablets, USP) salety closures when dispensing this productunless otherwise directed by physician or purchaser. Distrbuted by: Pizernc., New York, NY 10017 MADE INNETHERLANDS 50 Tablets Rx only| GTI; 00361570075600 LOT/ BXP. /SN FPOUPC @ 70% il gg £ 14270602
e07b3574-9259-4f64-a9ae-f4e0e64800b6_524_1.jpg HYOROCHLORIDE 50 ExTenbED
e07b3574-9259-4f64-a9ae-f4e0e64800b6_524_2.jpg 50 ExTenbED
e08de794-9b7e-aae6-9c89-a0c0d090cc76_358_1.jpg Sildenafil Tablets conly 50 Tabes (5X10) Uit Dose i Sv2esr1e1s NoC soz68-717:15 Sildenafil Tablets e only 50 Tabls (5 10) Unit Doso . Mooy ;.."‘.'.,."&‘J.“.w.".m A AR R
e0a9ab78-2e79-488c-a9d5-59b109298661_129_1.jpg Levemir Insulin Detemir 100 [iU)/1mL Injection, Subcutaneous arv: 10 ID#:. Expires: NDC #: 70518-1462-00 Shape: . LOT #: Ref #: 00169-3687-12 MFG: Novo Nordisk Inc, Princeton, NJ 08540 RX ONLY Directions For Use: See Package Insert Store at 2-8°C (36-46°F); excursions permitted to 0-15°C (32-59°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
e0e6412f-50b4-4fd4-9364-62818d121a07_888_1.jpg GTIN: Store at 20°C to 25°C L NDC 0069-0187-21 (68°F to 77°F); excursions 00300690187211 permitted between S 15°C to 30°C (5°F to 86°F). ® Dispense in tight (USP), |bral‘lce child-resistant containers. Bk DOSAGE AND USE (paIbOCICIIb) 9 ) See accompanying QN; capsules <y » PAA072956 prescribing information. Each capsule contains 75 mg of palbociclib. Distributed by Pfizer Labs Division of Pfizer Inc NY, NY 10017 MADE IN IRELAND 21 Capsules Rx only SN
e0e6412f-50b4-4fd4-9364-62818d121a07_888_2.jpg Store at 20°C to 25°C (B8°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Dispense in tight (USP), child-resistant containers. DOSAGE AND USE See accompanying prescribing information. Each capsule contains 100 mg of palbociclb. Distributed by Pfizer Labs Division of Pfizer Inc NY, NY 10017 MADE IN IRELAND @ @ NDC 0069-0188-21 1S ) ] Lo e Ibrance® (palbociclib) capsules 21 Capsules Rx only N3 0069-0188-21 8 GTIN: 0030090188218 PAA072957
e0e6412f-50b4-4fd4-9364-62818d121a07_888_3.jpg Store at 20°C to 25°C (B8°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Dispense in tight (USP), child-resistant containers. DOSAGE AND USE See accompanying prescribing information. Each capsule contains 125 mg of palbociclb. Distributed by Pfizer Labs Division of Pfizer Inc NY,NY 10017 MADE IN IRELAND [7fi:e Pﬁzer [7/i:od @ NDC 0069-0189-21 Ibrance® (palbociclib) capsules 21 Capsules Rx only B Lot SN N3 0069-0189-21 5 GTIN: 00300690189215 PAA072958
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_1.jpg IR SISISEERRS ISLRLLS SEKELLRRS BERRRLELLIRRRIEEEEEEA PRI RASARAARACAIAAIAX AN epinephrine injection, USP auto-injector i o) S 1510 i & i i 70 e : il ik g dsn ‘uongafu aunydauida @i it e oo
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_2.jpg IMPORTANT: Read Instructions for Use carefully before use AFTER ADMINISTRATION, LIGUID WILL REMAI IN THE AUTO-NJECTOR WHICH CANT BE USED. For intramuscular or subcutaneous use. For allergic emergencies (anaphylaxis). Each 0.15 mL contains: 0.15 mg epinephrine, 1.3 mg sodium chiorde, 0225 mg sodium bisulite, not more than 0.75 mg chiorobutanol. Store at 20°C-25°C (68°F-77°F) with excursions permitted 1o 15°C-30°C (59" 86°F). Protect fom ight. Do not refrigerate. Rx only Dist. by: Impax Generics, Hayward, CA 94644 2016 Impax Laboratories Inc., Hayward, CA 94544 9102120 1o 100881 fedwy _ONOVNIHY I Joo1udt pozuouiny Jopalur-oime s ‘wonoefu auuydauide Tesodsip 1adoid Joj Jepinoid i0UyEaY 0} 10}oslul-OMe Posn s 77%% 19800 9520 DUl T022(U-One PoIoGE] Olu! J0199(uI-OINE J0 pUB 10 pUB BIPEAU-UOU JonD Al poau apIS Aje.eD 20RuNS ey 520 BUIRLED J0 Jley PBIBBIUN UsNd 0 5D BLIALED JO Jl2U PafRaE! AE1 fesodsia/esn ey ®
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_3.jpg NDC 0115-1695-30 epinephrine injection, USP auto-injector FOR ALLERGIC EMERGENCIES In patients weighing 33 Ibs to 66 Ibs Impax, Rev. 07/2016 1878-01
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_4.jpg A RS ISR ISR S RIS BRSRST Coco0o00e POEX XXX 09:9.9:9.9.9.9. PSR R ARXKL S.imk epinephrine injection, USP auto-injector 03mg FORALLERGIO EMERGENCIES inpatent weihingover 66 bs i s 5 ™ g i3 s 4 (G Jelliiile o 8 i el Wmmmwmwmw L3 85 1% it Esisacrr [k R P BHIRR g m. ,mm £33 $82883888 i : IR i 8 wm > ie ,,w g il 55 © 033
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_5.jpg IMPORTANT: Read Instructions for Use carefully before use AFTER ADMINISTRATION, LIQUID WILL REMAN IN THE AUTO-NJECTOR WHICH CANT BE USED For intramuscular or subcutaneous use. For allergic emergencies (anaphylaxis). Each 0.3 mL contains: 0.3 mg epinephine, 2.6 mg sodium chioride, 0.45 mg sodium bisulite, not more than 1.5 mg chiorobutanol Store at 20°C-25°C (68°F-77°F) with excursions permitted to 15°C-30°C (59" Protect ffom fight. Do not refrigerate. Rx only Dist. by: Impax Generics, Hayward, CA 94544 ©2016 Impax Laboratories Inc., Hayward, CA 84544 6°F). 9102120 7o Losss fody _+ONOVNIHOY. I 101Ut poziouiny sopolurone s ‘vonosfus aupydoude. esodsip 1edoid o, sopiroid auouaY 0} 0308lU-0InE pasn oD = =Y Towalu-one 10 pUB 8[pasU-OU 19RO ALl ‘@520 BuIkireD JO Jley pelaqelun Usng 19109 9520 DU pejaqE oju1 10109[ul-01nE JO pus lpeau apis AinjIe) oeNS el U0 2520 BUIALED JO JleY pafoql e fesodsia/esn 2y @
e13f05f1-7d21-49bb-b8d5-24bf9301c3d7_193_6.jpg NDC 0115-1694-30 epinephrine injection, USP auto-inlector FOR ALLERGIC EMERGENCIES In patients weighing over 66 Ibs lmpax Rev. 07/2016 1879-01
e19636a4-3c5e-4b75-b394-003098f74d48_922_1.jpg XO0OKXKX *Each capsule contains 2.29 mg tizanidine NDC 69420-1502-1 hydrochioride USP, equivalent to 2 mg tizanidine base USUAL DOSAGE: See accompanying prescribing 2 i ifomaion. popa ey Tizanidine *Zanaflex® s a registered trademark of Acorda Hyd roch Ioride Therapeutics Inc. KEEP THIS AND ALL MEDICATIONS OUT OF THE Capsules REACH OF CHILDREN. Dispense in a tight ightresistant container [see USP]. - Dispense in containers with child resistant closure, Store at 20° to 25°C (68° to 77°F); excursions = permitied to 15° to 30°C (59° to 86°F) Not interchangeable with [See USP Controlled Room Temperature). IZI:am';img”h:hb‘ e:sr naflex” tal . Manufactured by Jubilant Generics Ltd. Roorkee - 247661, India 150 Capsules Ronly For: SA3, LLC Los Angeles, CA 90064 SA3,LLC Neutral Code No.UK/Drugs/58/UA007 NVZ XXX
e19636a4-3c5e-4b75-b394-003098f74d48_922_2.jpg XH0OKKIKX *Each capsule contains 4.58 mg tizanidine ' r hydrochioride USP, equivalent o 4 mg tizanidine base. NDC 69420-1504-1 USUAL DOSAGE: Se b . 5.5 USUALDO; e accompanying prescribing Tizanidine “Zanaflex”is a registered rademark of Acorda Hyd rochloride Therapeutics Inc. KEEP THIS AND ALL MEDICATIONS OUT OF THE Capsu les REACH OF CHILDREN. Dispense in containers with child resistant closure, Store at 20° to 25°C (68° to 77°F); excursions permitied to 15° to 30°C (59° to 86°F) Not interchangeable with [See USP Controlled Room Temperature]. tizanidine tablets or Zanaflex™ tablets. Manufactured by: Roofcs_ 276, i 150 Capsules R only For: SA3, LLC Los Angeles, CA 90064 SA3,LLC Neutral Code No.UK/Drugs/58/UA007 M XXX
e19636a4-3c5e-4b75-b394-003098f74d48_922_3.jpg 0000 *Each capsule contains 6.87 mg izanidine hydrochloride USP, equivalent to 6 mg tizanidine base. USUAL DOSAGE: See accompanying prescribing information **Zanaflex® is a registered trademark of Acorda ‘Therapeutics Inc. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Dispense in a tiht,light resistant container [see USP]. Dispense in containers with chid resistant closure. Store at 20° to 25°C (68° to 77°F); excursions permitied to 15° t0 30°C (59° to 86°F) [See USP Controlled Room Temperatre]. Manufactured by Jubiant Generics Lid Roorkee - 247661, India For SA3, LLC Los Angeles, CA 30064 Neutal Code No.UKDgSS8IU2007 NDC 69420-1506-1 Tizanidine Hydrochloride Capsules Not interchangeable with tizanidine tablets or Zanaflex”" tablets. 150 Capsules R only SA3,LLC NVZ
e1e95608-832c-4b13-81d3-bd4b7e6b2073_428_1.jpg OXYGEN, COMPRESSED USP UN 1072 DANGER: MAY CAUSE OR INTENSIFY FIRE; OXIDIZER. CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED. Do not handle until all safety precautions have been read and understood. Keep and store away from clothing and other combustible materials. Keor valves and fittings free from graase and oll.Use and store oy outdoors or In 2 well-ventilated place. in case of fire: Stop leak If zafe ta 4o so. Use a back flow preventive device In the piping. Use only with equipment of compatible materials of construction and rated for cylinder pressure. Use only with equipment cleaned for oxygen service. Open valve slowly. Cloze valve after each use and when empty. Protact from sunfight when amblent tamparature exceads 52 °C (125 *F). Read and follow the Safety Data Sheet CAS NO: 7782-44-7 (SDS) before use, o . - Contents Size /O NOT REMOVE THIS PRODUCT LA TS Liere ot WARNING: For emergency use only when administered Ton Lieis e o by properly trained personnel for axygen deficiency L= and resuscitation. For all other medical applications, Ax only. | 256 Liters, =] Uninterrupted use of high concentrations of oxygen over %es Citerar—— a long duration, without monitoring Itz affect on txygen jistas Litera: | ;D) content of arterial blood, may be harmful. Do not attemptto | 680 Liters, o uze on patients who have stopped breathing unless usad n T conjunction with resuscitative equipment. Produced by Alr 7080 Lix E LIQUETACHION. Sappted o Hasthcnr Ravorman 2014 o Liters Jernigan Healthcare 901 Decatur Highway Fultondale, AL 35068 205-631-1520
e235ef89-3592-4ca1-8c13-d7ce84b1001c_536_1.jpg DO NOT CRUSH OR CHEW. z NDC: 43063-743-90 _ — g 5= 3 PD-Rx L = PHARMACEUTICALS |2 == IR o1 WARNING: KEEP THIS OUT OF THE REACH OF CHILOREN INCORPORATED"/ o et DOSAGE and STORAGE: SEE PACKAGE INSERT =% Oklahoma City, OK = 73127 = 43063-743-90 43063-743-90 43063-743-90 : = OMEPRAZOLE OMEPRAZOLE OMEPRAZOLE o — DR USP DR USP DR USP oy OM EPRAZOLE — 20 MG 20 MG 20 MG =7 = 90 CAPSULES 90 CAPSULES 90 CAPSULES 2 § DR USP — ReOrder # 110202 ReOrder # 110202 ReOrder # 110202 e ; = Lot F18A62 Lot F18A62 LoT F1BA62 8 20 MG oy EXP 06/20 EXP 06/20 EXP 06/20 2 E : E e ZRe CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. g g8 YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 i 90 CAPSULES Eg 2 TAKE CAPSULE(S) TIMES A DAY. -;;J: (01)10343063743504 %3 TOME CAPSULA(S) VECES AL DIA. 211F18A62000002 d Each CAPLETS Contains: DELAYED RELEASE l ) OMEPRAZOLE LISP 20 MG {17) 200630 CAPSULE (10)F18A62
e23d135c-7aea-405a-804e-5c4f82179e96_256_1.jpg NDC 65162-115-10 Hydrocodone n Bi)f':artrate and C Acetaminoghen Tablets, US VLT Dispense the accompanying Medication Guide to each patient. Rx only 100 Tablets amneal Each tablet contains: Hyd06000ne BItartrate, USP .. .5 G Acetaminopher, USP ...... e 325 Y USUAL ADULT DOSAGE: One tablet every four o ix hours, as needed for pain. The tota cally dosage should not exceed 6 tablets See package insertfor full prescribing nformation. WARNING: Keep this and all other medications out of the reach of children. STORAGE: Store at 20° 10 25°C (B8° to 77°F}; [see LUSP. Controlec Room Temperature]. PHARMAGIST: Dispense i a tight ight-resistant cortainer with a chic-resistant closure. Protectfrom ight 'DEA ORDER FORM REQUIRED. Manuactured by Amneal Pharmaceuticals of NY LLC Brookhaven, NY 11719 Rev. 02-2017-02 9 11510| for Lot and Expiration 65162
e2eed126-cb82-42b1-9b48-9cbeb6873b50_29_1.jpg Ml «y43 NDC 55154-9553-5 HALOPERIDOL INJECTION, USP 5 mg per mL 5x 1 mL SINGLE DOSE VIALS (For Immediate Release) For Intramuscular use. Sterlee. Each mL contains: 5 mg haloperidol (as the lactate); with 1.8 mg methylparaben, 0.2 mg propylparaben and lactic acid for pH adjustment between3.0 to 3.8 Usual dosage: See productinsert for prescribing information, precautions and warnings. STORAGE: STORE AT: 20° to 257 C (68° to 77° F) [see USP Controlled Room Temperature] Protect from light. Do not freeze. The container closure is not made with natural rubber latex. RXONLY WARNING: This Unit Dose package is not chid resistant and is Intended fcr Institutional Use Only. Keep this and all drugs out of the reach of children. Zresenius Kabi _ake Zurich, IL 60047 v fresenius-kebi.us Distributed by Cardinal Health Dublin, OH 43017 136062620718 Lot XXXXXXXXXX ~ EXP. DATE: XX/XX/XX
e33053a5-38cd-4a34-8566-208f94f55714_457_1.jpg NDC 0409-0106-01 Daptomycin for Injection 500 mg per vial MUST BE REFRIGERATED | For Intravenous Infusion Hospira, Single dose vial - Discard Unused Portion Rxonly Must be refrigerated, store at 2°t0 8°C (36° to 46°F). Reconstitute Daptomycin for Injection with 10 mL of 0.9% sodium chloride injection, USP. See package insert for dosage information. Inc. Lake Forest, IL 60045 USA Hospira RL=6877
e33053a5-38cd-4a34-8566-208f94f55714_457_2.jpg NDC 0409-0106-01 Daptomycin for Injection 500 mg per vial MUST BE REFRIGERATED | For Intravenous Infusion Hospira, Single dose vial - Discard Unused Portion Rxonly Must be refrigerated, store at 2°t0 8°C (36° to 46°F). Reconstitute Daptomycin for Injection with 10 mL of 0.9% sodium chloride injection, USP. See package insert for dosage information. Inc. Lake Forest, IL 60045 USA Hospira RL=6877
e39d2549-b489-426d-b576-741537e112e7_976_1.jpg NDC 0409-0106-01 Daptomycin for Injection 500 mg per vial MUST BE REFRIGERATED | For Intravenous Infusion Hospira, Single dose vial - Discard Unused Portion Rxonly Must be refrigerated, store at 2°t0 8°C (36° to 46°F). Reconstitute Daptomycin for Injection with 10 mL of 0.9% sodium chloride injection, USP. See package insert for dosage information. Inc. Lake Forest, IL 60045 USA Hospira RL=6877
e4470b77-8fa1-4317-8bd5-48bc7f42f3e1_240_1.jpg nan
e4470b77-8fa1-4317-8bd5-48bc7f42f3e1_240_2.jpg REFRIGERATED LIQUID OXYGEN, REFRIGERATED Liquip usp UN1073 ts: (] owens__ wm( WARNING: For emerency use ony when aiminstred by proger taied pisanel fo orygen dafincy and esusctan. For ol oer mesical ppicatons, B any. Uninerupted use of g concen- s f g oera ongcuaton,uithut monforng s et on g conen o ater oo, may b barmfl. Do ot aempt o 15 n itk who v soppedbreting unes s inco. {0 v resusctathe equment. Keep ot of raeh of chigen, Federa L e tht i containe b o i axgen USP any by estbistments ragsteed s 3 dup manacuer n acortance with th asral Fod, g andCosmetc et Prodice by Air Lgwlacton. 'DANGER: NAY CAUSE OR NTENSIFY FIRE OXIOZER, CONTAIS REFRIGER- ATEDGGAS: MAY CAUSECAYOGEHIC BURNS 0R IIURY,COBLS - TIBLES I CONTACT WITH LD OXYGEN NAY EXPLODE O GHITIONOR MPACT. Dot hadieui sl precautons e st e ad understod. Keepan e avay fom clthing and ater combusale materi. Keep valws and ftigs foe fom aense and . Useand stor oy utdors or 3 et e Wear cod nsuaing goves, e shik, ard e proecon.In cas of e Slo ek s o doso. Us bk o prevetie et iing.Us nly vt eigmentof compatie maerls o consructon and ated for ylnder prssre. Use oy wih eupment caned o oyge senvie. DO HOT charge o fore ft comectons. A i 00 ol wlk o1 cr o8 e o 35 Cos vale afer ach us and when ey, A K cuntaes i gt posiion, ad and fulow th sty Dt St 508)before s, FIRSTAID: IFON SKIN: T ot gt wih kv vt Do ot b aflctedae, Gt Inmdit magal aosston S TIR2447 DO HOT REMOVE THIS PRODUCT LABEL 772 MARION ROAD COLUMBUS, OH 43207 Js 877-935-3377 (oins)
e45c75dc-d381-475b-b649-a871c8a36e60_791_1.jpg DESCRIPTION: Eoch NDC 0527-4579-37 Store at 25°C (77°F);. ex'endediva\ense %nnsn\e T i exarslons permitted antans 10 g o : . ( 10 15> 30°C (59° el Methylphenidate HCl 867 [See USP o e Ilncibide. Controlled Room ~ === UISUAL DOSAGE: Ses Extended-Release Capsules (D Temperature]. ¥ pudhage diralor. Do not Keep out of the e s l wpsis reach of chidren. or the beads inside the o N . apsile. A Medication Guide is required for every prescription s @ o dispensed. Plewse use accompanying Medicaion Cuide. & 23 . D‘wsmchmedhv:‘ R Only £ 8 2 annett Company, Inc. o = o Phlodopho, P 19754 100 GENS = gg
e45c75dc-d381-475b-b649-a871c8a36e60_791_2.jpg e —— " DESCRITION: ¢ 0527458037 Store 1 25177 edendedelose opsule o excurslons prmite s 20 o o @ torsslcn T Methylphenidate HCl ot o == sunvosace: s Extended-Releuse Capsules CD P, ackage dircular. Do not S e 20 mg | et 1 the beads fnside the apsul. A Hedication Guide is required for every prescription dispersed. Please use accompanying Medication Guide. i D‘wsmchmedhv:‘ R Only annett Company, Inc. > o™ itopin, 9154 100 CAPSULES ‘ 2£08&72250 PT# CIPT0120 Rev. 09/18 L6840A
e45c75dc-d381-475b-b649-a871c8a36e60_791_3.jpg e —— " DESCRITION: ¢ 0527458037 Store 1 25177 edendedelose opsule o excurslons prmite s 20 o o @ torsslcn T Methylphenidate HCl ot o == sunvosace: s Extended-Releuse Capsules CD P, ackage dircular. Do not S e 20 mg | et 1 the beads fnside the apsul. A Hedication Guide is required for every prescription dispersed. Please use accompanying Medication Guide. i D‘wsmchmedhv:‘ R Only annett Company, Inc. > o™ itopin, 9154 100 CAPSULES ‘ 2£08&72250 PT# CIPT0120 Rev. 09/18 L6840A
e45c75dc-d381-475b-b649-a871c8a36e60_791_4.jpg DESCRIPTION: Euch extended-elease capsule contains 40 mg of methylphenidate hydrochloride. USUAL DOSAGE: See package dircular. Do not chew or crush the tuﬁm\ex or the beads fnside the capsule. Distributed by: Lannett Company, nc. Phiadeltin, P4 19154 NDC 0527858237 ety Methylphenidate HCl C Extended-Release Capsules CD 40mg A Medication Guide is required for every prescription dispensed. Please use uccompanying Medication Guide. B Only 100 CAPSULES Store at 25°C {77°F); exarslons permitted 1015°-30°C(59°- 86°F) [See USP Controlled Room Temperature]. Keep aut of the reach of dhldren. PT# CPT0121 Rev. 09/18
e45c75dc-d381-475b-b649-a871c8a36e60_791_5.jpg | ——————————————— DES(dRLP'I"ION: Euth‘ NDC 0527-4583-37 Store at 25°C (77°F); extendechelease capsule excrsions permitted to w cnis 0 g of @ 755 30° (59°- 86°F) mefylphenidate % I See USP Controlled S fydrochlrice. Methylphenidate HCl %Wm Tomperature]. o USUAL DOSAGE: See Extended-Releuse Capsules CD Keep out of the = package cireular. Do not reach of children. i chew or crush the capsules ml & or the beads inside tﬁe 4 capsule. A Medication Guide is required for every prescription dispensed. Please use w accompanying Medication Guide. Distributed by: Re iy Lonnett Company, Inc. - Philadelhio, PA 19154 100 CAPSULES — PT# CP70122 Rev. 09/18 L6843A
e45c75dc-d381-475b-b649-a871c8a36e60_791_6.jpg DESCRIPTION: Each NDC 0527-4584-37 Store at 25°C (77°F); extended-elease capsule excursions permitted fo antis 60y f 155 30° (59°- 86°F) mefhylphenidafe " Il [See USP Controlled fydrochloide. Methylphenidate H(l Room Termperature]. USUAL DOSAGE: See Extended-Relense Capsules CD Keep out of the package circular. Do not reach of children. chew or crush the tuﬁm\ex m or the beads fnside the capsule. A Medication Guide is required for every prescription dispensed. Please use accompanying Medication Guide. & o Distbuted by: R 1) =z 5 Iy £ 8 ot Compory e, g - Phiadeltin, P 19154 100, CAR3LES 2 2
e4682a6e-9624-48b0-978f-95da00cfb78f_556_1.jpg I Ed ML = @3 M A ok SwE sE S o_'=D ag e EES,9 i » ooe o d= T SRo= o & ™ zoum$P S 285385 S = - =T e Eo>cn £2 = MM IToON £ Each capsule contains amlodipine besylate, USP equivalent to 2.5 mg amlodipine and 10 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N 0093-7370-01 3 R only Rev. F 1/2015 323K303170215
e4682a6e-9624-48b0-978f-95da00cfb78f_556_2.jpg T 2 = =z S oo =& S By iE 5 nnu“rum.mm ~ |rms S 0 22E 00 s Sp— — ] s BNOST 48 S O ® = v D eg S S s =5 g Eo>cF &2 S <mmT o ik Each capsule contains amlodipine besylate, USP equivalent to 5 mg amlodipine and 10 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N 0093-7371-01 3 4 B only Rev. F1/2015 323K303180215
e4682a6e-9624-48b0-978f-95da00cfb78f_556_3.jpg d ipine an ATTACHED PATIENT INFORMATION LEAFLET NDC 0093-7372-01 Hydrochloride Capsules USP 5 mg/20 mg PHARMACIST: PLEASE DISPENSE WITH B only Amlod Benazepril Each capsule contains amlodipine besylate, USP equivalent to 5 mg amlodipine and 20 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. F1/2015 323K303190215 N 0093-7372-01 oo
e4682a6e-9624-48b0-978f-95da00cfb78f_556_4.jpg X r 2 = 2= = S < D A = S ok S =D o S EELO, E s 5 oo do 2= ~ .|ecm = & BNOSST ;= S O® = » O og S cBog i g Eo>c = 22 =z <M ITOL 5 Each capsule contains amlodipine besylate, USP equivalent to 5 mg amlodipine and 40 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N 0093-7670-01 3 8 B only Rev. F1/2015 323K301970215
e4682a6e-9624-48b0-978f-95da00cfb78f_556_5.jpg 5 = ES = = == S oo __ ZE . o S m. &2 o — o o o =0 = B= vir) M~ = = O I:= = m LC @O 5 - N =0 o=—"x= 2E £ Hh B N =D b M S e c-wnes3r =8 S =ewa=3zx =B 2 Eo>co z2 = S <«mmTrov«~ iE &/ 2 Each capsule contains amlodipine besylate, USP equivalent to 10 mg amlodipine and 20 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. w Store at 20° to 25°C (68° to 77°F) [See USP & Controlled Room Temperature]. Protect from — light and moisture. - Dispense in a tight, light-resistant container as £ defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF 2 THE REACH OF CHILDREN. o Manufactured In Israel By: 2 TEVA PHARMACEUTICAL IND. LTD. M Jerusalem, 9777402, Israel 2 Manufactured For: > TEVA PHARMACEUTICALS USA, INC. o~ North Wales, PA 19454 N - - B 0093-7373-01 3
e4682a6e-9624-48b0-978f-95da00cfb78f_556_6.jpg 5 = ES 3 = sz S oo _ =2E S TSwn m..mm S ®©u'= ap S =" W= ~ == = N Fc w = ©o QLC @< I N = o= — ZE Hh B N =D bs S 8cl®g o3 S =mcovo o= 3z g Eo>co &2 =2 <M ILTO~ Tk Each capsule contains amlodipine besylate, USP equivalent to 10 mg amlodipine and 40 mg benazepril hydrochloride, USP. Usual Dosage: See package insert for full prescribing information. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 0093-7671-01 N 3 B only Rev. F 1/2015 323K301960215 100 CAPSULES
e480912f-5b04-4206-998e-a44118839253_828_1.jpg nan
e480912f-5b04-4206-998e-a44118839253_828_2.jpg nan
e4f4d30e-4bb8-411c-a0d3-0be160f6745e_899_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALERTNESS. R k. WARNING:KEERTHIS/OUT{OFTHE REACH/IDECHILDREN = 55289-224-15 55289-224-15 DOSAGEand'STORAGE:SEE'PACKAGEINSERT: 55289-224-15 MAROON NDC: 55289-224-15 IH{PD-Rx 0 PHARMACEUTICALS 0STkETHAZSSE IR RRROT SR PROCHLORPERAZINE PROCHLORPERAZINE PROCHLORPERAZINE 5 PROCHLORPER AZINE MALEATE USP MALEATE USP MALEATE USP g 10 MG 10 MG 10 MG = MAL'ATE USP 15 TABLETS 15 TABLETS 15 TABLETS 3 £ ReOrder # 103337 ReOrder # 103337 ReOrder # 103337 ‘;‘ E LOT J18E1S LOT J1BE1S LOT J1BE1S & o EXP 10/20 EXP 10/20 EXP 10/20 :2‘ 10 MG < CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. 2 YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 o 15 TABLETS . AH i TAKE TABLET(S) TIMES A DAY Lk (01)10355289224150 TOME TABLETA(S) VECES AL DIA. (21) 18E15000002 Each TABLET Contains: 10 MG OF PROCHLORPERAZINE - I AS PROCHLORPERAZINE (17)201031 ARALFATE I WALLAT L or RCUND Ml s (i01i16ES “INI WHYHd NYTAW TOOTTSSLEOD
e505c31b-4618-4e4f-8da6-92030464004f_166_1.jpg MAY CAUSE DROWSINESS. USE CAUTION WHILE DRIVING OR PERFORMING TASKS REQUIRING MENTAL ALERTNESS g 5 R n] WARNING:KEERTHISIOUTIOF THE REACH OF CHILDREN 0111y, DOSAGE and STORAGE:'SEE PACIKAGEINSERT 43063-494-10 43063-494-10 43063-494-10 CYCLOBENZAPRINE CYCLOBENZAPRINE CYCLOBENZAPRINE o HCLUSP HCL USP HCL USP 2 5 MG 5 MG 5 MG = 10 TABLETS 10 TABLETS 10 TABLEI(S § ReOrder # 104566 ReOrder # 104566 ReOrder # 104566 E o LOT G1BB68 LOT G18B68 Lot G18B68 E = EXP 12/19 EXP 12/19 EXP 12/19 9_ < CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. 2 (=] YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) TIMES A DAY. TOME TABLETA(S) VECES AL DIA. Each TABLET Contains: CYCLOBENZAPRINE HYDROCHLORIDE USP 5 MG ROUND NDC: 43063-494-10 =PD-Rx I)'(l f‘,,_., PHARMACEUTICALS ) I ~{INCORPORATED, =] Oklahoma City, 0K + 73127 CYCLOBENZAPRINE HCL USP SRV(C 10 TABLETS A (01)10343063494103 (21)618B68000001 (17)191231 (10)G18858 E0TPEPEQUEYE O INI‘HOIL-NAN D19000Z0L0T
e53960ab-42a1-40d1-9c7d-eb013fe7f18f_758_1.jpg Each vial contains 20 mg of mogamulizumab in 5 mL of solution, Each mL of solution contains 4 mg POTELIGEO and is formulated in: V For Intravenous Infusion only Usual Dosage: See Package Insert. Store vial refrigerated at 2°C-8°C (36°F-46°F) in Ayl Rxonly Rxonly = ;7;:' ::u(u zzgns:;y)dra(e 44m) | renrsior NDC 42747.761401 ;’rgﬂﬁ hc'arlon to protect polysorbate 80 (0.2 mg), and POTELIGED" POTELIGED" Do not freeze. Water for Injection, USP. (mogamulizumab-kpkc) (mogamulizumab-kpkc) Do fiot shalks, No preservative. Injection Injection Manuvamurec; by: No U.S. standard of potency. 20 ma/5 mL Kyowa Kirin, Inc. g 20 mg/5 mL Bedminster, www poteligeo.com (4 mg/mL) (4 mg/mL) N 0782} For Intravenous Infusion For Iiitraverious liifusion US License No. 2077 Single-dose vial. Single-dose vial. Fiscard unused porticr: Discard unused porion. 8§ 742741761 KYOWAKIR KYOWAKinin NDC 42747-761-01 CTN-POT-US-001 POTELIGED" 20566084 (mogamulizumab-kpke) 20 mg/5 mL
e5dd43d8-2333-4145-a8f5-f60a3378c73a_250_1.jpg Olanzapine 20 mg Tablet arv: 30 ID #: R20;0168 Expires: NDC #: 70518-1500-00 Shape: Oval LOT #: Ref #: 55111-0168-30 MFG: Dr. Reddy's, Shreveport, LA 71106 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
e5f5223f-569c-40c6-a3c7-381bc61cf8c6_979_1.jpg Packaged by Evgant Ranch Berbank. @A 91504 Valacyclovir Hel "™ sueswais 1gm Tablet 892971 Store at room temp of Compare To: 20-25 C (68-77F) Valtrex 1gm Tablet Keep in light resistant HetroLabs Lited container perUSP #30 Exp: MMYY NDC 7133506301 048371116268 om
e60552c9-06ce-4790-95e7-aadd4df12b2a_422_1.jpg LBL #302.02 | 1366-00 11/2017 NDC 69344-111-11 Arymo ER >(/morphine suffate) @ extended-release tablets Attention Dispenser: Accompanying Medication Guide must be provided to the patient upon dispensing. 100 Tablets Rx only Swallow Tablets whole. (Epalet 5y cut, break, chew, crush, or dissolve. Usual Dosage: Read ‘accompanying prescribing information. Dispense in atight container with child-resistant closure. Storeat 25°C (77°F); excursions permitted between 15™-30°C (59-86'F). Distributed by: Egalet USInc. Wayne, PA 19087 US. Patent Nos. 9,044,402 and 9,549,899 3 366111111 g GTIN 00369344111118
e60552c9-06ce-4790-95e7-aadd4df12b2a_422_2.jpg gz NDC 6934421111 Usual Dosag g8 S = information. 3 ® Dispenseina tight container with child-resistant closure. Storeat 25°C (77F); e excursions permitted (morphme Sulfm-e) | between 15 30°C (59-86'F) Distributed by: extended-release tablefs Egalet US nc. Wayne, PA 19087 USS. Patent Nos. 9,044,402 30 mg and 954999 Attention Dispenser: Accompanying Medication Guide must be provided to the patient upon dispensing. 8 190Teblets Rxonly I I| | | |||||||||||I| 5 (Egalet Swallow Tablets whole. 5069344121111 1's s (E9 Do not cut, break, chew, crush, or dissolve. 6TIN 00369344211115
e60552c9-06ce-4790-95e7-aadd4df12b2a_422_3.jpg LBL #304.02 1368-00 11/2017 NDC 69344-311-11 Arymo ER >(/morphine suffate) @ extended-release tablets Attention Dispenser: Accompanying Medication Guide must be provided to the patient upon dispensing. 100 Tablets Rx only Swallow Tablets whole. (Egalet Do ot cut, break, chew, crush, or dissolve, Usual Dosage: Read ‘accompanying prescribing information. Dispense in a tight container with child-resistant closure. Storeat 25°C (77°F); excursions permitted between 15-30°C (59-86°F). Distributed by: Egalet USInc. Wayne, PA 19087 US. Patent Nos. 9,044,402 and 9,549,899 3695445111100 GTIN 00369344311112
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_1.jpg Sameores bomanne e ng NOCEHBI812:60 60 tablets b spdogivet - Twice-A-Day (every 12 hours) Svellow Tablets ol Tob AnNamBeEWmm = Opana® £R e ™ o mioeplions Iydnchieids) gl FAVE4 Extended-Release Tablets Doperseinatght iht eisont anongrs dned nthe UL wth il esont dsee s e st Rt e s by Pl i Paten. Pesench Senuces . a et i unvamished area
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_10.jpg T A enpone it oo Etonded o Tabets
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_11.jpg [ NDC63481-817-60 60 tablets Ogmophachyiodinice.. ng Ul pioge it Twice-A-Day (every 12 hours) orcmpilereating fomsun et Opana® £R (hewed, (nushed, or Dissolved. o 5T Foassors (OXymorphone hydrochloride) emitedto (96, ;wmmauw,wn.mmm Extended-Release Tablets okt o, EL0 1) St mpaning G Pamasdesre e, A5 Pamcesci st S Tortam 594
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_12.jpg [ NDC63481-817-60 60 tablets Ogmophachyiodinice.. ng Ul pioge it Twice-A-Day (every 12 hours) orcmpilereating fomsun et Opana® £R (hewed, (nushed, or Dissolved. o 5T Foassors (OXymorphone hydrochloride) emitedto (96, ;wmmauw,wn.mmm Extended-Release Tablets okt o, EL0 1) St mpaning G Pamasdesre e, A5 Pamcesci st S Tortam 594
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_13.jpg Dt NDCEMBIBIBS0 Coratles gt ndlste. 40ng - ettt Tuice-A-Day (every 12 hours) foranpld preciingomotn pmete Opang® £R rewed, Cushed orDisobved. Swet T eanes (0Xymorphone hydrochloride) perlo B e Extended-Release Tablets Degerseina g, ht it oninres denadin e USEwith ot dse s el Manctuadir: fhmedrii Dispense Acampanying Moy a5 ebicon Gange 1o Eath by Paseastntar Paent et nony @eNdo, LI 2 5 5 Lot: E "
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_14.jpg AT [
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_2.jpg I Etened Reless Tabts mff..mmuﬂ) @ i I 3 A
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_3.jpg comearnis NDC63481.813.40 60 tatlets Domtndiase. 1509 ot paager Twice-A-Day (every 12 hours) namieepmasngaiamin sewensiie ODANQ" ER e et Dok oxymarphone hydrochloride) pemasin 15200 ET. Extended-Release Tablets [—— s gm0 ) Gl st e ). Mt b oot e AT By Pttty Bt s . o B unvamished area
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_4.jpg (A [ EEQ, HEEEC, o la TRl [
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_5.jpg e 1wy DCEO481814:60 GOtlts yraphan Hdnhsde..0mg Ui padagereet | Tice-A-Day (every 12 hours) gl peatiog oo pemetie Opana’ £R pm S BT v (lm/mnrphnns hydrochloride) Il i pemtdte U Extended-Release Tablets Depesen s, It st ansisddned e % wih s ot G b ). it . e ey BT, @ unvamished arsa ¥ ety B o e neony @ENO. i
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_6.jpg A I
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_7.jpg oo 815 a OOty NDCEHEIBISE GOt Wellegesepnpren | Twice-A-Day (every 12hours) e amepsbegn Bt Opana £R Sz oores (0Xymorphone hydrochloride) pmRau AT Extended-Release Tablels Diprsiatipt gt s artinens el S et v e Rt U amcenasi Digense hcsampann et 55 HEHo SaeeToton by aesciintcrerg Fai e i wony @eNdo, Uniarrished e
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_8.jpg \MHMWIH v o oy 1) Opana’ £R (comaghan ytociids) @ Hg Etenced Rnase Tabets ml A L s
e6e34c18-fbc6-4cab-9aed-0905d93c2ab6_291_9.jpg Bt e Gymonhnelyindiite. omg "D 6348181660 E0tablets Ui piageivan Twice-A-Day (every 12 hours) orcmgiae psaing omstun e e ODANQ® ER (hewed, (nshed, or Dissolved. Sws 2 eorsws (0Xymorphone hydrochloride) St 54 5 ) 5 iy Extendod-Release Tablets T s 20mg g st o ramacedtas b, e et 55 7 e icumg Hiicion Gade 0otk e nony @endo, i & 5
e7aae9bc-79cf-4738-8376-fd010e9371db_977_1.jpg NDC 46672-193-10 100 tablets ~ Each tablet contains: Oxycodone and Oxycodone Hydrochloride, USP. 2.5mg* Acetaminophen, USP. 300 mg Acetaminophen *2.5 mg oxycodone HCl is equivalent to Tablets, USP 2.2409 mg of oxycodone. Usual Dosage: See package insert for 2.5 mg/300 mg complete prescribing information. = . Dispense in a tight, light-resistant container Multiple Strengths: as defined in the USP, with a child-resistant Do not dispense unless the closure (as required) strength is stated. Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] Rx only DEA ORDER FORM REQUIRED. Dispense the accompanying Mfg by: MIKART, INC., Atlanta, GA 30318 Medication Guide to each patient. Code 991210 Rev. 09/16
e7aae9bc-79cf-4738-8376-fd010e9371db_977_2.jpg NDC 46672-194-10 100 tablets Each tablet contains: Oxycodone and Oxycodone Hydrochloride, USP..... 5 mg* Acetaminophen, USP..... .. 300 mg Acetaminophen *5 mg oxycodone HCI s equivalent to 4.4815 mg of oxycodone, Tablets, USP Usual Dosage: See package insert for ——= 5 mg/300 mg complete prescribing information —_— == = . Dispense in a tight, light-resistant container = Multiple Strengths: as defined in the USP, with a child-resistant . Do not dispense unless the closure (as required). strength is stated. Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] Rx only DEA ORDER FORM REQUIRED. Dispense the accompanying Mfg by: MIKART, INC., Atlanta, GA 30318 Medication Guide to each patient. Code 992210 Rev. 09/16
e7aae9bc-79cf-4738-8376-fd010e9371db_977_3.jpg NDC 46672-195-10 100 tablets Each tablet contains Oxycodone Hydrochloride, USP..... 7.5 mg* Oxycodone and Acetaminophen, USP................ 300 mg Acetaminophen *7.5 mg oxycodone HC! is equivalent to Tablets, USP 6.7228 mg of oxycodone. Usual Dosage: See package insert for 7.5 mg/300 mg complete prescribing information Dispense in a tight, light-resistant container Multiple Strengths: as Gafied vt uspg, with a child-resistant Do not dispense unless the closure (as required) strength is stated. Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Rx only DEA ORDER FORM REQUIRED. Dispense the accompanying Mfg by: MIKART, INC., Atlanta, GA 30318 Medication Guide to each patient. 4. 993710 Rev. 09/16
e7aae9bc-79cf-4738-8376-fd010e9371db_977_4.jpg NDC 46672-196-10 100 tablets Each tablet contains: Oxycodone and Oxycodone Hydrochloride, USP... 10 mg* Acetaminophen, USP................ 300 mg Acetaminophen *10 mg oxycodone HCl is equivalent to O% 8.9637 mg of oxycodone. — Tablets, USP Usual Dosage: See package insert for =0 10 mg/300 mg complete prescribing information —o =0 = = Dispense in a tight, light-resistant container = Multiple Strengths: as defined in the USP, with a child-resistant =t Do not dispense unless the closure (as required). strength is stated. Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] Rxonly DEA ORDER FORM REQUIRED. Dispense the accompanying Mfg by: MIKART, INC., Atlanta, GA 30318 Medication Guide to each patient. Code 994210 Rev. 09/16
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_1.jpg “Each _extended-release _tablel Distributed by: NG 65862-554-30 contains: inocyciine hydrochloride, Aurobindo Pharma USA, Inc. USP equialenfo mnocycine 45, 379 princon: Hightstown Road Usual Adut Dosage: See package Lot W1ndsor 08520 insert. Made in India KEEP THIS AND ALL MEDICATIONS Minocycline Hydrochloride OUT OF REACH OF CHILDREN, U°0®: TSDRUGS/222009 Extended-Release Tablets, USP oeaprozcesoms pis20043 ) emperature. | % Rx only | I I Dispense i tight, light-resistant | i ontaners s daiid n the USP | i rotect from ligh, mosture, an 30 Tablets excessive heat. | | *Over Printing Zone Coding Area (@5 %15 mm)
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_2.jpg *Each extended-release tablet contains: Distributed by: Minocycline hydrochloride, USP equivalent to Aurobindo Pharma USA, Inc. 4 i minocycline 65 mg. 279 Princeton-Hightstown Road L e 555 S East Windsor, NJ 08520 Usual Adult Dosage: See package insert. Made in India Rx-nnly = = KEEP THIS AND ALL MEDICATIONS OUT OF Code: TS/DRUGS/22/2009 Minocycline Hydrochloride REAcH OF CHILDREN. Extended-Release Store at 20° to 25°C (68° to 77°F). [See USP , ______________ BASI 765 e oy Tablets, USP Gontrolled Room Temperature.] m Dispense in tight, light-resistant containers as defined in the USP. Protect from light, /52 AUROBINDO 30 Tablets moisture, and excessive heat. *Qver Printing Zone E l Coding Area (45 x15 mm) Dotted lines not to be printed
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_3.jpg *Each extended-release tablet contains: Distributed by: o Minocycline hydrochloride, USP equivalent ~ Aurobindo Pharma USA, Inc. o NDC 65852'884'30 to minocycline 80 mg. 279 Princeton-Hightstown Road ol Usual Adult Dosage: See package insert. East Wingsor RV & . ; Rx only Contains FD&G Yellow No.6 as a color hasc it il Minocycline Hydrochlotide v . SrlpEa 8 ! V/ Y KEEP THIS AND ALL MEDICATIONS OUT OF an Extended-Release REACH OF CHILDREN. s Tableis, USP Store at 20° to 25°C (68° to 77°F). [See ;’7;”7777””77777777777"7”””7””‘; o I ) USP Controlled Room Temperature.] i i Dispense in tight, light-resistant containers | as defined in the USP. Protect from light, i i 52 AUROBINDO 30 Tablets moisture, and excessive heat. | | i i I *Qver Printing Zone . l Coding Area (45x15 mm) Dotted lines not to be printed
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_4.jpg Rx only “Each _exlended-release _tablet NDG 65862-556-30 contains: Minocycine hydrochloride, USP equivalent to minocycine 90 m. Usual Adult Dosay insert. : See package KEEP THIS AND ALL MEDICATIONS Minocycline Hydrochloride OUT OF REACH OF CHILDREN. Extended-Release Tablets, USP stwre at 20 0 257 e o 77, /52 AUROBINDO See ~ USP Controlled Room emperature ] Dispense in tight, light-resistant 'c)nn‘tau;e;s as ‘ns,:\‘r\en msg‘m US; roect from light, moisture, an 30 Tablets excassive heat. Distributed by: Aurobindo Pharma USA, inc. 279 Princaton-Hightstown Road East Windsor, NJ 08520 Made in India Code: TS/DRUGS/22/2009 L05955298C9EN P1420046 *Over Printing Zone Coding Area (45x 15 mm)
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_5.jpg *Each extended-release tablet contains: Distributed by: Minocycline hydrochloride, USP equivalent ~ Aurobindo Pharma USA, Inc. NDC 65352'885'30 to minocycline 105 mg. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert. Made in India Rx only = E - KEEP THIS AND ALL MEDICATIONS OUT OF Code: TS/DRUGS/22/2009 Minocycline Hydrochloride geach or chiLoren. Extended-Release Tablets. USP Store at 20° 10 25° (68° to 77°F). [See ;- -~ ----- -~~~ B1422029 .. . o ssoc s | Dispense in tight, light-resistant containers 3 20£588298G9¢€N USP Controlled Room Temperature.] - as defined in the USP. Protect from light, /5 AUROBINDO 30 Tablets moisture, and excessive heat. *Qver Printing Zone & l Coding Area (45 x 15 mm) Dotted lines not to be printed
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_6.jpg NDC 65862-557-30 Rx only Minocycline Hydrochloride Extended-Release Tabhlets, USP /52 AUROBINDO 30 Tablets *Each extended-release tablet contains: Distributed by: Minocycline hydrochloride, USP equivalent to Aurobindo Pharma USA, Inc. minocycline 115 mg. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert. Made in India KEEP THIS AND ALL MEDICATIONS OUT OF Code: TS/DRUGS/22/2009 REACH OF CHILDREN. 80£.6529859EN Store at 20° to 25°C (68° to 77°F). [See USP , -~ _________ B e Controlled Room Temperature.] Dispense in tight, light-resistant containers as defined in the USP. Protect from light, moisture, and excessive heat. *Qver Printing Zone Coding Area (45x15 mm) Dotted lines not to be printed
e7b88a48-12b3-461d-b356-0d7ae4e8fd44_388_7.jpg *Each extended:-release tablet contains: Distributed by: NDC 65862-558-30 Minocycline hydrochloride, USP Aurobindo Pharma USA, Inc. equivalent to minocycline 135 mg. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Usual Adult Dosage: See package insert. Rx only o Made in India i " : KEEP THIS AND ALL MEDICATIONS Minocycline Hydrochloride OUT OF REACH OF CHILDREN, Co0% TS/DRUGS/22/2009 Extended-Release Tablets, USP = 7 S (R B USP Gortrolled Room Temperature] 2= = == =S TS T oo o s mmmm oo ¥ 1 Dispense in tight, light-resistant | containers as defined in the USP. ! 1 1 1 S0£85529859EN s Protect from light, moisture, and /52 AUROBINDO 30 Tablets excessive heat. *Over Printing Zone Coding Area (45x 15 mm)
e81341c6-0e25-4860-adda-2d3cebe88d62_180_1.jpg PINIEH ALL MEDICATION UMILESS OTHERWISE ATVISED BY YOLIK DUCT IR g |PHARMACEUTICALS ) = INCORPORATED® g | Oklahoma City, OK « 73127 43063-265-30 43063-869-30 43063 869-30 LIPROFLOXACIN CIPROFLOXACIN CiPROFLOXATIN & C!pROFLOXA |M 1se usp usp g C i 500 MG 500 MG 400 MG =z USP 30 TABLETS 30 TABLETS 30 TABLEIS g ReOrder # 110622 ReOrder # 110622 ReOrder # 110622 = .i; LOT 118C78 1or 118C78 tor J18C78 &= — £xp i0/20 =wp 1a/2n0 Evp 100 g ! z 25 = o= = s : gck CALL YOUR DOGTOR FOR MEDICAL ADVICE ABCUT SIDE EFFECTS g Emg YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 = 30 TABLETS z g B TAKE TABLET(S) TIMES A DAY. gL *F TOME___ TABLETA(S) VECES AL DIA. S e 5 Each TABLET Contains' (|PEOFLOXACIN HYDROCHLORIDE g e | LiSP EQUIVALENT T0 500 MG 3 {17)201031 OF CIPROFLOXACIN @ (10))18C78
e83f43dd-f79e-4166-9bee-9427e235c876_453_1.jpg 600my 42.9mg * = mUm S22 —_—e .|y K825 £ S8 =3 5 =8 s o £ S o 7 AMPn.m og £ ~ e |52 £ w =B ST 85E 5 2 EE g3 N = |E: 28 8 EC= 2558 4, S BSEo|iiEiis g 8SSE|Eiin - S EmSS|E82E s s -_ 00 |[Z82<S § S oL ®lxz3e8: =2 671N 0300938675746 Usual Dasage: Administer every 12 hours, See package insert for full prescribing information, irections for 2, Add approximately 2/3 Shake vigorously, inand 1716 g clavulanic acid, ‘The potassium content per 5 mL is 0,23 mEq, Use only if inner seal s intact. Prior to reconsiitution store dry powder at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF GHILDREN. Manufactured In Ganada By: TEVA GANADA LIMITED Toronto, Canada Manufactured F TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 N 0093=-8675=74 6 = g = 7 E g = 2 = = E Rev. D 312015 6695962534 Rev 05 361-32- Non Varnish/Coding Area [0
e842fa14-b18e-4463-9bf1-a1c8700fe33c_880_1.jpg Each uncoated tablt contains: NDC 62332-051-30 150 mg of Irbesartan USP and 125mgof Hydochorotiazideuse [rB@S@rtan and = USUAL ADULT DOSE: EooF g Sccpadage e or dosig Hydrochlorothiazide = information. Store at 25°C (17°F); excursions. Tablets, USP s ted to 15°C to 30°C g Coding Area {69°F to 86°F) [see USP Controtled [N L A VAN [1] 8 NOTTOBE Room Temperature]. ] PRNTED ety _— Alembic Pharmaceuticals Limited Ry only 30 Tablets (Formuation Division) Pandav 339350, Gujarat, India Manufactured for Alembic; Alembic Pharmaceuticals, Inc. > 750 Route 202, Bridgewater, NJ 08807 USA Mig. Lic. No. G/959
e842fa14-b18e-4463-9bf1-a1c8700fe33c_880_2.jpg Each uncoated tablt contains: NDC 62332-052-30 300 mg of Irbesartan USP and 125mgoydochiontrizzdeuse [rhesartan and g USUAL ADULT DOSE: fooi s See package insert for dosing Hydrochlorothlazme g information. Store at25°C (77°F); excursions Tahlﬂsa USP o A permitted to 15°C to 30°C g n Coding Area T59°F to 86°F) see UsP Controtled [/ LLILLLT!TA P21 1] 8 o NOT TO BE Room Temperature]. 8 A '1"“‘:‘;53" —_— Manufactured by — Alembic Pharmaceuticals Limted Ry only 30 Tablets ., S— 1o (Formution Division), B« Panelav 389350, Gujarat, India © — Manufactured for: Alembic) 2 — Alembic Pharmaceuticals, Inc. > s 750 Route 202, Bridgewater, NJ 08807 2 USA £
e842fa14-b18e-4463-9bf1-a1c8700fe33c_880_3.jpg Each uncoated tablet contains: NDC 62332-053-30 300 mg of Irbesartan USP and 25 mg of Hydrochlorothiazide USP Irbesartan and g USUAL ADULT DOSE: a7 s oo ke e G Hydrochlorothiazide = =="- information. M Store at 25°C (T7°F); excursions Tahlﬂs’ usp 8 — permitted to 15°C to 30°C 2 n Coding Area (59°F to 86°F) [see USP Controlled kLD mg/25 mg g =" NOT TO BE Room Temperature]. = 'J’:":‘;E.?“ —— Manufactured by — Alembic Pharmaceuticals Limited Ry only 30 Tablets ., S—rq (Formultion Diviion), g — Panelav 389350, Gujarat, India o mm— o Manufactured for: Alembic) > — Alembic Pharmaceuticals, Inc. > s 12 oo 202, icoeitab HI000T | I USA £
e84c0dfc-a4e9-4c89-b6ea-45732eb412f5_484_1.jpg S %% g NDC 0093-8034-01 o oo = 3 _ GIyBURIDE g 25 2 . Tablets USP - I 1.5mg = b 361-32- 734526240 Rey 06 Rev E 11/2017 R only LoT 100 TABLETS EXP. -
e84c0dfc-a4e9-4c89-b6ea-45732eb412f5_484_2.jpg NDC 0093-8035-01 GIyBURIDE = E Tablets USP 3 GTIN 0300938035014 KEEP THIS AND ALL WEDIGATIONS OUT OF THE REAGH OF CHILDREN, N 3 0093 -8035-01 B ony Rey E 11/2017 734536240 Rev 06 361-32- LOT EXP.
e84c0dfc-a4e9-4c89-b6ea-45732eb412f5_484_3.jpg N 10-9£08-€600 £ L LoT EXP. 361-32- 734566240 Rey 06 Rev. E 11/2017 NDC 0093-8036-01 GlyBURIDE Tablets USP 6 mg 1108088600200 NILY B ony
e86fbda8-00e4-4d54-841a-59dea6c15e70_770_1.jpg (ww g} x ww zg) ‘dx3 %8 107 10} EIY paysiuseAun L n L2l0/ 10-810¢-¥0 "8y 20880 N ‘leremabipuig 71 S29UBIs0Ig [BauLIY Aq PaNQLSI VIONI U 8Pl 6€G1/82/9 ON 9N B “uopewojul Buiquosald Buifuedwoase 89S :38N ANY I9YS0A W61 wouy 1931044 “uonod pasnun pJeasiq ‘[eln asop ajbuig “Jaufeju0d ul pazyydok ‘B o dsn ‘guojosiupa.djfiyat 0} Juseainbe 4sn ‘a1eUj29Ns WNIPos auojosiupaldiAyisw SUIBIU0D (pax|W Uaym) Jw yae3, “Joyooyy |Azuag yim uopoafu] 1o} Jajey onelsouajoRg W | yum amsuosay MethylPREDNISolone Sodium Succinate for Injection, USP Intravenous Use Only. g, only 40 mg™* per vial 1 mL SINGLE DOSE VIAL NDC 70121-1000-1 For Intramuscular or
e86fbda8-00e4-4d54-841a-59dea6c15e70_770_2.jpg | i i i i i “(ww g9xpz1) i pajuud aq |[eys X1jew ejep gz YHM UoMed Yoes uo ‘ou [euas anbjun | i | i 1 i pue dx3 ‘107 ‘|19 O BIep ajqeLeA Joj Baly paysiuie)-uoN TVIA 3500 ITINIS TW | i dsn ‘uondsfuj 4oy 23eUINS WNIPOS 3UoloSINATHdIAUIDW NDC 70121-1000-5 Reconstitute with 1 mL Bacteriostatic Water for Injection with Benzyl Alcohol. NDC 70121-1000-5 %anufa?g;'ed by: sticals Pyt L. Mfg. Lic. No. G/28/1539 . , *Each mL (when mixed) contains methylprednisolone sodium succinate, USP equivalent to methylprednisolone, USP, . . Mied’: Barmacelhcais - MethylPREDNISolone Sodium Succinate 40 mg. Also contains lactose hydrous, 25 mg; monabasic sodium phosphate anhydrous, 1.6 mg and dibasic sodium MethylPREDNISolone Sodium Succinate ﬁrr:"edﬁg:ggggm 3 DA for Injection, USP phosphate dried, 17.46 mg. When necessary, pH was adjusted with sodium hydroxide. Lyophilized in container. for Injection, USP ' Use solution within 48 hours after mixing. Distributed by: 40 * |l 40 | : i LR Amneal Biosciences LLC 1 mL SINGLE DOSE VIAL DOSAGE AND USE: See accompanying prescribing information. 1 mL SINGLE DOSE VIAL Bridgewater, NJ 08807 Discard unused portion L . Discard unused portion Rev. 04-2018-01 For Intramuscular or Intravenous Use Only Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. For Intramuscular or Intravenous Use Only The Recommended Diluent (Bacteriostatic Water for Injection) Contains Benzyl Alcohol as a Preservative. The Recommended Diluent (Bacteriostatic Water for Injection) Contains Benzyl Alcohol as a Preservative. 251 Vials Rx only 251 Vials Rx only 8
e86fbda8-00e4-4d54-841a-59dea6c15e70_770_3.jpg (s f x i ) *dx3 % 107 “10} eIy paysiuseAUn | PN_\ON— 10-8102-170 '\od 20880 PN ‘Uaremabpug 0T1589ua19501g [eaULY q PANALSI VIONI Ul OpeN 6EG 1/82/9 ON "I "By ‘uoneuojul buiquosaid Buifuedwoode 89S :38N ANY 39YS0A W61 wouy 1931014 ‘uorpod pasnun pJeasiq ‘|eln asop ajbuig “Jauleju09 Ut paziiydof ‘b Gz | 4sn ‘guojosiupaidifiypaw o} Juseanbe 4sn ‘9JUI2INS LUNIPOS BUOjosIUpaIdALaL SUIBJUOI (PaXILU Usym) W Z 4oed, "|oyoaly [Azuag yum uonoaluj 1o} Jayep oneysoLajoeg TW g YUm anpisu0say per via MethylPREDNISolone Sodium Succinate for Injection, USP Intravenous Use Only. only 2 mL SINGLE DOSE VIAL NDC 70121-1001-1 For Intramuscular or =il T
e86fbda8-00e4-4d54-841a-59dea6c15e70_770_4.jpg pajuud aq |[eys XiAjew eep (Z Y}M UOLRO YOS UO "OU [eLias anbiun pue dx3 ‘307 'NILD JO eIep ajqeue Joj eaty paysiulen-uoN 238UIaNg WNIPOS 2UOJOSINAIYAIKNIZW (ww Goxgz1) VIA 300 ITONIS TWZ 12w sad B G2L dsn ‘uondaluj Joy NDC 70121-1001-5 251 Vials MethylPREDNISolone Sodium Succinate The Recommended Diluent (Bacteriostatic Water for Injection) Gontains Benzyl Alcohol as a Preservative. for Injection, USP e 2 mL SINGLE DOSE VIAL Discard unused portion For Intramuscular or Itravenous Use Only Rx only Reconstitute with 2 mL Bacteriostatic Water for Injection with Benzyl Alcohol. “Each 2 mL (when mixed) contains methylprecisolone sodium succinate, USP equivalent to methylpredrisolone, USP. 125 mg. Also contains monobsic sodium phosphate anhycrous, 1.6 mg and dibasic sodium phosphate drid, 17.4 mg. When necessary, pH was adjusted with sodium hycroxide. Lyophilized in container. Use soluton within 48 Hours afer miing. DOSAGE AND USE: See accompanying préscribing information Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. NDC 70121-1001-5 25 x1 Vials MethylPREDNISolone Sodium Succinate for Injection, USP L 2 mL SINGLE DOSE VIAL Discard unused portion For Intramuscular or Intravenous Use Only The Recommended Diluent (Bacteriostatic Water for Injection) Contains Benzyl Alcohol as a Preservative. Rx only Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit Ahmedabad 382213, INDIA Distributed by Amneal Biosciences LLC Bridgewater, NJ 08807 Rev. 04-2018-01 Mfg. Lic. No. G/28/1539
e8727958-697d-4b20-b55e-f9d317470dec_321_1.jpg R - CAUTION: Federal law PROHIBITS transfer of Armodafinil Phomaceitcal I ‘mE.thisdrugtoanﬁpev_s'onorhev(h@;etgepatlenlfm Anmodafin Tabits 200m (C1V) P S — whom it was prescribed. i Buk Tablets 200mg Brode (NBC) Gene(nc for: Nuvigil ) Each tablet contains: Armodafinil . 200mg n .g Anmodaliall Tabjts 200mg (C1Y) Pkg Size: Exp Date = [ = E = Lo Bu# Lotr Brichd Eoug 3,5 Prod# (NDC) I S o) Mfg: Sandoz Inc = _‘g 8% d00 3 " Prod# : 8<Q 2 B8oo Slr:nodunml Tablets 200mg (CIV) T o £ = £ & nsurance NDC A Bl et L AT Yoo £ | F g E Faif” B £ 0 £ a % o o E‘S £o 'O Armodatnl Tiblets 200me (C1V) X gx EDE Co "B M© > © O-U o Prod# (NDC| # (NDC) S =26 2 Chart Log Billing Patient
e8e1b3d7-0272-4278-b2a3-1d10dbeb0a5a_960_1.jpg PHENOBARBITAL 32.4 MG TAB #30 I 0L Rx Only CONTROLLED SUBSTANCE LOT: SAMPLE PILLID: 5012V EXP:02/02/13 QUALITEST Packaged By: Contract Pharmacy Services-PA 125 Titus Ave, Suite #200, Warrington, PA 18976 Usual Dosage: See package insert 3706035716632 "3 Store at 20-25°C (68-77°F) [See USP Controlled Room Temperature] Each tablet contains: Phenobarbital”, USP 32.4 mg (112 gr) "WARNING: May be habit forming. CPSNDC: 67046-350-30
e8e1b3d7-0272-4278-b2a3-1d10dbeb0a5a_960_2.jpg PHENOBARBITAL Usual Dosage: See 64.8 MG TAB #30 package insert 306035167320 Store at 20-25°C (68-77°F) [See USP Controlled Rx Only Room Temperature] CONTROLLED SUBSTANCE LOT. SAMPLE Each tablet contains: Phenobarbital*, USP 64.8 mg (1 gr) PILLID: 5013V “WARNING: May be habit forming EXP:02/02/13 QUALITEST Packaged By: Contract Pharmacy Services-PA A - 125 Titus Ave, Suite #200, Warrington, PA 18976 CPSNDC: 67046-953-30
e8f94df9-0692-4462-a7f0-fe019a0a3f07_45_1.jpg ic/olo00¢ 5 TN L2604 AN BpEmnsaAr) Ranme ey sog “Aq panqusig soteETOLY] £lison [Emesaduag uicoy pajaue) s ses] ol £ 958 045 9 o7 UsBE] aios tionBiliop Bugosai Px Only (amenssaIdanEE 2501 [SURnaeIop 61 01 8pncid i 1ge3 s 2 =2 2o} SEgE 5 3 eossE = 2 E2SBE_E 5 SEScWmEE E B SmSgEEEe SEES ooty SascRESLE
e8f94df9-0692-4462-a7f0-fe019a0a3f07_45_2.jpg 1401 0108 sotezafLLLY] 0N faneaduis ooy PSjonIC) S 335 ol 939 0 05 U oyoqe fausq Bul 7 2 2 7 uco 3N A Px Only £ (g sapnod 1 yee3 R DELESTROGEN® estradiol valerate , USP) For ntramuscular SmL_ Wultple Dose il HOC 42023-111-01 lise Only injection, I
e8f94df9-0692-4462-a7f0-fe019a0a3f07_45_3.jpg iri0100¢ Teonnmaeueyg seg Aqpanqusig sovezaILN cys0d fmyesaduag wigoy psjonuE) dsin 295 ouecte izuaq Fui 7 ‘aye0alaq zuaq Bus £y BuieUo0 Aokn oup sy [opeiyss B O sapncid i 1e3 s DELESTROGEN® (estradiol valerate injection, USP) For ntramuscular 5L orpleDese Vil HOE 42023-112-01 se Only
e93b356e-49da-4053-8714-a093e02fd038_682_1.jpg Pashaged by Eryane Reanch Bunbank. @4 91500 BENZONATATE § "®t0W cavsuis s 9 100 MG CAPSULE-LIB 165671 Store at room temp of Compare To: 20°25°C (68°-77°F) TESSALON 100MG CAPSULE-LS Reepall drgsatof Itergel Division of IVC Ind reach of children. #500 Exp: MMYY NDC 6362976321 076321119591 om
e93b356e-49da-4053-8714-a093e02fd038_682_2.jpg Paclaged by Ergant Raxch Bnban. 04 91506 BENZONATATE G etovcasuine 200 MG CAPSULE Store at room temp of Compare To: 20°25°C (68°77°F) TESSALON200MG CAPSULE-LIB Keep all drugs outof g reach of children. #21 Exp: MMYY NDC 6362976471 076471123857 om
e9cf3792-3574-4105-b21c-34fca47f4c29_595_1.jpg Pacbaged by Eryant Rench Bbank. ¢4 91506 5 VHITE ROUND PLIVA 324 Bethanechol g Chloride 10mg Tablet 5 & Store at room temp of Compare To: 20°25°C (68°77°F) Utecholne 10mg Tabket “Keop all drugs outof Teva Pharmaceuticals USA Inc. reach of children. #30 Exp: MMYY NDC 7133509041 070671121259 om
ea125240-342b-4cd0-953d-1991b1e54d71_337_1.jpg NDC: 50436-0438-3 ATENOLOL 50MG / 90 TAB Mg by: Each film-coated tablet contains: Unique Pharmaceutial Laboratories. Atenolol USP 50 mg, Mumbai 400 030, India Dispense in wellclosed, light-resistant conti WARNING: KEEP OUT OF REACH OF CHILDREN, STORE AT 20-25° (68-7%F) ‘CONTROLLED ROOM TEMPERATURE. SEE PACKAGE INSERT FOR DOSAGE INFORMATION. MFG NDC: 64980-438-10 MFG LOT: X0000000K LOT: 00000 EXP: Phg by: Unit Dose Services, LLC Dania, FL 33004 Rev.d ;Y0000 RXONLY NOC: 50436-0438-3 ORUG: ATENOLOL 501G /90 TAB. LOT: 000000 BXP: 00000 NDC: 50436.0438-3 ORUG, ATENOLOL ~ SOMG /90 TAB LOT: 000000 BXP: 300000€ NOC: 5043604383 ORUG ATENOLOL ~ SOMG / 90 TAB LOT: 000000¢ BXP: 100000K NOC: 043604383 DRUGATENOLOL ~ 50VG / 0TAS LOT: 000000 EXP: X00000X
ea2067bd-1622-4d98-8012-2c09405aa88d_309_1.jpg Rronly noc esa62-159-01 Zolpidem Tartrate Tablets, USP @D @ PRARMACIST: PLEASE DISPENSE WITH 'WEDICATION GUIDE PROVIDED SEPARATELY A AumoBNDO 100 Tablets Exch . catod il conans: Zupioam s UsP 5 g sua A Dsage: o ot tasts 3t DT 2 it 58 COMpE oG tomaion. St 271027 550 777 s Tt 0 15° 1 S0°C (59 0 86 5 USP Confoea oo Tempezr, Dipars 2t gt it en essan connar, Revset 042078 Dsimiany: AutoingoPrama US, . s niga Cade TSORUGSZ22009 270 Pincto-Higisown a0 Estnasor ) esen % “Over printing Zone P1420584. Coting Area Dot s s o be gl
ea2067bd-1622-4d98-8012-2c09405aa88d_309_2.jpg » @ dSN ‘sialqel ajeipe) wapidjoz (g0 01 x00) 2emes o0k NDC 65862-159-10 Rronly Zolpidem Tartrate Tablets, USP ac PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE PROVIDED SEPARATELY /5 AUROBINDO 100 Tables (10 x 10 Unit-dose) Zolpidem Tartrate Tablets, USP an e Eath m-outog tet conan: 0o s USP 5 g 100 Talets (1010 Uni-dose) 10U 1 SO RSSO eSS {ormdueL w0 pcaioodSnes] 595615 24001510 PR OS5, 0 901952 3,020 D8 e o pns o e pup'e 1 R0 oot || BaSe) DD B cEARRT DAL oo Sugyns e ascunses PaceIDse suPRG RS O B 10 310 1Y 1D H D SN SialeL aReiue] wapilpz esupion o xo) samon o oo oEzmN w HOD woun o dSN ‘S1ae] ajeike] wapidjoy ozm oo EE o GRG0 02 30 ‘v e 2 wUTORY e oLxo) saveionn sy
ea2067bd-1622-4d98-8012-2c09405aa88d_309_3.jpg Each fim-coted tablel contins: Distibuted by Wate i lnda NDC 65862-160-01 Zobidem e USP 10, Aurobindo Pharma USA, nc. Code. TSDAUGS 222000 270 Picuon-Histoun Aoad Uil Adlt Dsage: Ons ot at O o wintoor NJD3s20 /8 AUROBINDO 100 Tablets Roise: 04201 faesr et S i s Zolpidem Tartrate Sreat 201025 8o 77w 7 £1420386 e Tablets, USPEEDD) & S omcinonrommnet = 1% — PUAGST PLLSE DSPENSEWT iprsina ot et | I MEDCATONCUDE PAOVIDD SEPRATELY e cortsot { i3 : = “Over printing Zone Goding Area (sx Tomm) O cc.c0
ea2067bd-1622-4d98-8012-2c09405aa88d_309_4.jpg dSn ‘sia|qe] ajedel wapidjoz (asop-un 01 x 01) S1e198L 0L * Over Prning Zone. {Dotted s nt o e prin) UNVARNISH ZONE NDC 65862-160-10 Rxonly Zolpidem Tartrate Tablets, USP ad e PHARMACIST: PLEASE DISPENSE WITH MEDICATION GUIDE PROVIDED SEPARATELY /A AUROBINDO 100 Tablets (10 x 10 Unit-dose) Zolpidem Tartrate Tablets, USP ad e Each film-coated tablet contains: Zolpidem tartrate USP 10 mg. Pz 100 Tablets (10 x 10 Unit-dose) JRR00 ESIS-PIUD ‘BASERIUD) 0B U asiadsi [aampesadwiay wooy pajosue) dsn 2] (4.2 01.65) .06 01,5401 PApILISd SUOISINTS (4,1101.89) 0.5 0 J B 910§ a5 30DIMUS JAURUOD EISSE) PO S MWEEAND.0; pESSIp I VRIS PING 10U § aBEX0ed 20PN SUL 01091p298 69 oo Buignses p(dwoo S PAOEIDSE WIPE R IRIGR A0 SRQUNRY BN HQ@ID dsn ‘sia|qeL sjeiye] wapidioz (as0p-11un 01X 01) SI919eL 00} BIE/0 Pashe muu@m dgy) ‘sja|qe) ajeipel wapidjoz 02580 ™ Jospuy 123 Pe0t UNOISIUDIH-UDROULL 6.2 "1 VSN ewimyd opuigainy {o5-yun 01X 1) Io19EL L 4 panqusig
ea24a07b-34ca-4da4-ba69-73bbf44de20d_493_1.jpg NDC 5556667001 i 9 a/:’ £ [LONCPNTnS CLENPIQ™ SR Read the enclosed Instructions for Use and | | | | i i i - Lo i (sodium picosulfate, magnesium oxide, Medication Guide AT LEAST 2 DAYS BEFORE | | | | | i Cranberry Flavor and anhydrous citric acid) Oral Solution et it 10 mg/3.5 9/12 g per 160 mL bottle P L Lo [See USP controlled room temperature] [P R CLENPIQ™ is a ready-to-drink oral solution that doesn't need to be diluted. Read the inclosed Instructions for Use and Medication Guide ¥ AT LEAST 2 DAYS BEFORE your colonoscopy o and again right before taking CLENPIQ™. T Ferring Phamaceutcals ic Parsippany,N.J. 07084 o Contains two (2) 160 mL bottles CLENPIQ™ CLENPIQ™ . . (sodum icosulate, magnesum o, (sodium p\cosuﬁﬁtg/ magnesium OXId.!y i and anhycrouscitric aci) Orel Soluton and anhydrous citric acid) Oral Solution i 10mg/35 /129 per 160 mL botle 10 mg/3,5 g/12 g per 160 mL bottle CLENPIQ™ is a ready-to-drink oral solution that doesn't need to be diluted. LT Read the enclosed Instructions for Use and « Prescribing Information with Medication Guide AT LEAST 2 DAYS BEFORE your [ R e R T colonoscopy ar in right before taking CLENPIQ™. f you have questions about how to take CLENPIQ™, talk to your healthcare provider. For more information, o to www.clenpia.com or call * Two (2) 160 mL bottles, each containings: +888-337-7464. 10 mg sodium picosulfate, USP Keep this and il drugs out of the reach of children. P * Cup to be used for drinking clear liquids e TR DS
ea66eb30-e665-4693-99a1-a9d3b4bbe2d6_664_1.jpg 1 Single-Dose Vial AMGEN" Kyprolis (carfilzomib) for Injection 10 mg/vial Single-dose vial Discard unused portion. For Intravenous Admiristration Orly Store Refigerated at 2 1o 8°C (36°F to 46°F), Store in carton to protect from light. 'NDC 76075-103-01 R Only
ea66eb30-e665-4693-99a1-a9d3b4bbe2d6_664_2.jpg 1Single-Dose Vial NDC 76075-102-01 Kyprolis' carfilzomib) for Infection 30 mg/vial Single-dose via. Discard unused portion. For Intravenous Administration Only R Only
ea66eb30-e665-4693-99a1-a9d3b4bbe2d6_664_3.jpg 1 Single-Use Vial NDC 76075-101-01 AMGEN"® Kyprohs (carfilzomib) for Injection M 60 mg/vial W&y’ Single-use vial. Discard unused portion. For Intravenous Administration Only R Only
ea95d182-453b-4c43-8402-d65c488d55f2_446_1.jpg NDC 60687-377-01 Alprazolam Tablets, USP 100 Tablets (10 x 10) (0 LTI (01) 0 03 60687 377 01 8 Lo Loy e Tl h Alprazolam (7! Tablets, USP L > ﬁ 100 Tablets (10 x 10) PARMAGIST: Disganss w6 Zocompanying edoalior ‘Blids ( cach patient Each Tabist Gontaims: Alprazotam USE. 025mg Usual Dosage: Sea packaga insert fo ulproscrbing nformaton Store2120°1025°C 68 1o 71, oxeusions ponie between T51050°C (59 10 86°F) ls06 USP Contoled Room Temparaiure. Protect fromlight. Keep this and al drugs out of reach of children. FOR YOUR PROTECTION: Do ot use bister i tor or broken. RxOnly The orug prosuot contained n ths package s rom NG # 55852.675, Aurobingd harma USK, . Packaged and Distributed by American fealt Packaging 737701 s, Olo 45217 osTTO0STE
ea95d182-453b-4c43-8402-d65c488d55f2_446_2.jpg Alprazolam Tl Us 025 g g 0 o 005 soear 37 117 Alprazolam g @ 01) 00367 377 11 7 Aprazoam Ao §5ing € @0 003 50587377 11 7 Alprazolam b % 28y @ O cussoea7 377117 Aprazoiam AU §3ng € I oy oosenear a7 117 o000t 10 oooec 107 ooncee 107 o000t 101 WCRIAE AN P A o000t 307 o AU AU EXPIRY: xuixx ot o000 Lot o EXPIRY: EXPIRY: o Lot oo EXPIRY: xuicx Lot ooooox EXPIRY: xdx L Alprazolam TeherUs 675 e @ oo cosar 77 117 Aprazolam Ao s @ 101)003so07 377 11 7 Alprazolam ez 3Ehng @ £ I 91003 60587 377 11 7 Alprazolam Tabier UsP 0725 g € 8 i I 1) 00360687 377 11 7 Alprazolam e §35g @ o cosapear 377117
ea95d182-453b-4c43-8402-d65c488d55f2_446_3.jpg NDC 60687-388-01 Alprazolam Tablets, USP 0.5 mg 100 Tablets (10 x 10) (01) 0 03 60687 388 01 4 NDC 60687-388-01 Alprazolam @ Tablets, USP 0.5 mg R ERL) PRARMAGIST: Deparse wit Tha accampanying WMedeaton "BUids t each patient Each Tabiet Gontains Aprazoam USP. 05mg Usual Dosage: See packaga inser for il prescribing iformation Store at20° 10 25°G 65" to 7T excursions pormitiod betwoen T57Ta50°C (59" to 86'F) 04 USP Contronisd Hoom Temparaiurel Protect fromlight. Keep this and al drugs out of reach of children. FOR YOUR PROTECTION: Do not use bister s foror broken RxOnly The drug prociuct contained i this package s from NDC' 85362.677, Aurobinda Pharina USh,Inc. Packaged and Distributed by Amarican fealt ackaging 738801 Colombus, Onlo 43217 043880710518
ea95d182-453b-4c43-8402-d65c488d55f2_446_4.jpg Alprazolam @ g Alprazolam e c8 &y ppzem B - R @ %: ii‘ i | eeate £% & LGNNI Alprazglam g Apezam e £ g, hpe g @5 fpe @ e 83 2 i O, g ¢ s MOIET, Agoan oy Apeoan 9 B g, Sk 05 mg @5 %fosmg @ agen o . N fpmoen g oy Apol e es] BlEE e Aot el i Sz % ¥, S Es @ss fpin € o €88 BB WA £ o MR
eb13c96f-319a-46f4-9955-ef5fa0a5f110_610_1.jpg oLstLL [ € NDC 68220-115-10 Levbid syesese (hyoscyamine sulfate, 0.375 mg) Rxonly ALNVEN 100 tablets For medical inquiries call 1-888-317-0001 TN XXy SN XO000000K EXPADIYYYY LOT XXunn USUAL DOSAGE: vl ndpedavicpatents 12years o ageand older 102 {abltsavry 12 hours Seepackage e forurther formation. Store at controlled room tamparature 20 25° (65°-77°% bk Sxcursons pamitad 0 157 0 (55 867 Plasa efr 13 GumentUSF, Dispense i tightlht esstant contaners a defined in USPINF i Chi 1St o, g, for Alven Pramaceutic LLC SR oS Aty Haret Ghsoony o com 0063308 Revo/2017
eb3691d3-08ec-4472-9cf8-b2e23c47c743_751_1.jpg Rosuvastatin Calcium 5 mg Tablet arv: 90 ID #: H;R3 Expires: NDC #: 70518-1219-00 Shape: Round LOT #: Ref #: 31722-0882-90 MFG: Camber Pharma, Inc, Piscataway, NJ 08854 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
eb3691d3-08ec-4472-9cf8-b2e23c47c743_751_2.jpg Rosuvastatin Calcium 5 mg Tablet ary: 12 ID #: H;R3 Expires: NDC #: 70518-1219-01 Shape: Round LOT #: Ref #: 31722-0882-90 MFG: Camber Pharma, Inc, Piscataway, NJ 08854 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
ebb0c5d6-d816-44fa-8422-82aa63076d55_498_1.jpg Pachaged by Eopant Raeck Bnbank, €4 91504 Rosuvastatin g '™®!%w0 o= Calcium 20mg Tablet 5 & Store at room temp of Compare To: 20°25°C (68°-77°F) Crestor 20mg Tablet “Keep ail drugs outof | i o teachofchildren. #30 Exp: MMYY 3 NDC 7133509051 070571121256
ebe89ab6-24c0-4214-853f-67e2e0c7daa9_948_1.jpg mn R TAKE __TABLETS _ THES. ADAY AS ORECTED. R s ISR e wos o am REE o
ec04ecbb-2896-3feb-85fd-a64aba93b289_215_1.jpg eI Bsog-3MN T G (wybw o) Jwged B pg {dsn ‘uoisuadsns ajgriselul apIojage aUo|oUIoUIRL) 0l-.Bojeusy Ao xy Each mL provides 10 mg triamginolone acetonide with 0.66% sodium chloride for isotonicity, 0.99% (vi/v) benzyl alcohol as a preservative, 0.63% carboxymethylcellulose sodium, and 0.04% polysorbate 80 in an aqueous suspension; sodium hydroxide or hydrochloric acid may have been added to adjust pH between 5.0and 7.5. Shake well before using. For intra-articular or intralesional use only. NOT FOR IV, IM, INTRAOCULAR, EPIDURAL, OR INTRATHECAL USE. See insert for dosage information. Bristol-Myers Squibb Company Princeton, N.J 08543 USA Product of Spain 1132706A8 SY90L2EL) Store at controlled room temperature, 20° to 25°C 68° to 77°F); protect from temperatures below 20°C (68°F). Do not refrigerate. Store vial in carton to protect from light. Do not use if vial seal is broken or missing. See bottom panel for lot number and expiration date. NDC 0003-0494-20 Kenalog™10 (triamcinolone acetonide injectable suspension, USP) 50mg per5mL (10 mg/mL) For intra-articular or intralesional use only 5 mL Multiple-Dose Vial Rx only| Read all sides @B Bristol-Myers Squibb 3 0003049420 7 GTIN: SIN: Lot: ~ Hiw % ¢ @
ec8c699f-a8de-4e5a-a223-8de3f5dfe20d_274_1.jpg Pacbaged by Eryant Ranch. Bupropion HCL ER(12h) 150mg Tablet Compare To: Welloutrn SR(120) 150mg Tablet #60 NDC Epic Phama LLC Exp: MMYY 7133501351 10° 9v9YTT Binbank. 04 91500 PURPLE ROUND E 15 May Cause Drowsiness | Keepall drugs outof reach of children Store at room temp of 20-25 C (68-77F) 028731114646
ec8c699f-a8de-4e5a-a223-8de3f5dfe20d_274_2.jpg Pacbaged by Eryant Ranch. Bupropion HCL ER(12h) 100mg Tablet Compare To: Welloutrn SR(126) 100mg Tablet #60 NDC Epic Phama LLC Exp: MMYY 7133503141 10° S90YTT om Bnban. ¢4 91504 BLUERONDE 410 May Cause Drowsiness Store at room temp of 20-25 C (68-77F) Keep all drugs out of reach of children 031961114065
ec8f8062-a065-41d8-a2ad-97aa49bf1c27_10_1.jpg ki Gt Rean CEPHALEXN SONG CPSILES —— A o ez THKE1 CAPSULE __THESADAYFOR _DRYS ORAS RECTED. rsiss v worsass e ooner
ec8f8062-a065-41d8-a2ad-97aa49bf1c27_10_2.jpg e TR s rouc s TKE 1 RPSULE 4 THES ADAYFORTODAYS ORAS DRECTED. rsiss v worsass wa ooner
ec962052-7bea-4aeb-ac49-0072fdc77385_714_1.jpg i " TeRkzosh o GRFSULES —— g o o e st 3 R e oesieoy 3 ¢ o 1B ‘ORASDRECTED. § § R cmeomee T iy 1
ec962052-7bea-4aeb-ac49-0072fdc77385_714_2.jpg T T — o et O o i s Eie ROV ooy o ORASDRECTED.
ec962052-7bea-4aeb-ac49-0072fdc77385_714_3.jpg S T &8 o O R s E, R TKE1 RPSULE DALY i e ORASDRECTED.
ec962052-7bea-4aeb-ac49-0072fdc77385_714_4.jpg o e Raow TERAZOSH 10 CRFSUES —— o AR TR 3 TKE1 RPSULE DALY ORASDRECTED. o cinss IR o o s N Bus Omianerer
ec979d2b-b0dc-406d-9868-4a71a811642e_761_1.jpg Olanzapine 2.5 mg Tablet arv: 30 ID #: 0163;R2.5 Expires: NDC #: 70518-1535-00 Shape: Oval LOT #: Ref #: 55111-0163-05 MFG: Dr. Reddy's, Shreveport, LA 71106 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_1.jpg 4 750458-387-30 s unitpeg vap| 9580 PN ‘HIASTIL “2U) ‘SIRONNGOLLIR] LaSSUer 1o} B 84400 Yd '0dRING “JT1 04O udssuer :Aq BN g o r0d TYa . 8 Ih oy 7 i3 ‘i f o3 Sl R E i NEH S mwmm £ 2§ Wizl i 8 ~Eupmees SISO {(3,1/) 0,52 R 2085 101 aa NS BOEL8EBSYOSEO0 NLO
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_2.jpg N 3 50458-388-30 5 wnifog el W wonneoeumig uassue| hqpompepue s st . ~uf Seungoeey wssuer 0, D 100 4 00T ‘9] 40 ossumr o wnibyeg JO 190p0d| 2N s 8 SN E : EE s g S 5g%¢ REH i ZW mmmm Mol it g7 & = S 8288 =z i el m {amessduay ooy pepae dsn o] (4098-469) 00E G 1 01 papyuuied U0 (4,21) 9,62 e 201 101 el NS S0EB8EBSPOSE00 NUO
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_3.jpg I 3 50458-389-30 2 wnig i) A eOaewIRy uossuer fa poumoeynue syoyod fnsde) 09580 (N ‘SIS " JNNGIRULRLG UoSSURP 10} B4 194400 ‘o0eang “0T1 00 uessuer K0 i fy am i W 58t : = 20€68€8570SE00 NLLO A e
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_4.jpg woss *SOID0T10UNIAN TIENAAN-OHLIO O 'NDC 50458-49040 Razadyne’ AT HB s Rxonly Dosage: See accompenying roccteraure, Dispensing: Fornformaton concaming proper sage ofthe Contaner and dspansing pipete, S06 accompanying PatentInstructions. Keep out o reach of hiren. Store 2t 25°CTT'F excursions permitsd o 15-30°C58-85°F (s00 USP Contoled Room Tompeatur), DO NOT FREEZE. ©omPI2005 Disrtutad by, Orho-MeNel Neurdlogics, Dvision of (Orho-MeNai-Janssen Pharmaceutcal,inc. Tiusile, \J 08580 Manutactured by: Janson Pharmaceutca N\ Boorse, Bogum & ORTHO-McNEIL NEUROLOGICS. OniontOmokist s Frameesit e, H00mL e ORTHO-McNEIL NEUROLOGICS. [y Razadyne' NI s NDC 50458-490-40 100mL Razadyne’ GAATIEHBY Gt soon 4mg/mL Each 1mL contains the equivalent of 4mg galantamine In'an aqueous solution. - ORTHO-McNEIL NEUROLOGICS. vt Crnootl s ey Razadyne' A v
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_5.jpg GTIN 00350458396607 60TABLETS NDC 50458-396-60 Razadyne‘ \galantamine HB aviers Each tablet contains the equivalent of 4mg galantamine, Keep out of reach of children, s janssen J 7 Rxonly Dosage: See accompanying producterature, tore at 25°C (7°F); excursions permittedto 15°-30°C (60°-86°F). [see USP Gontalled Room Tomperature] ©2005 Janssen Pharmaceutical Companies Productof Belgium Mig by: Janssen Ortho LLC Gurabo, PR 00778 Migfor: Janssen Phamaceuticals, Inc. Titusville, NJ 08560 i (01)0035045839660:
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_6.jpg z I 3 50458-397-60 4 SeluRdUIOD [E0lINedEULIEU USSSUET 5002 O| Jeduse] woog| 1698-065) 0,0€-o51 | ) paijied SUOIINOKS {[.7/) .52 12 SM0IS| ~ainiesal| onpoid buiAueduicae 558 rabesoq Ao xy : Q 3 5 2 2 " - 3B g y s 2z 8 = =.5 S W i3 2 SS SE§ NS 558 e NE 55~ w = 3 am D353 § = € sEa 4 & S £ 2 c gs§ & 3 § o 3¢ 5 00580 PN ‘SiAsniL g s 8£/00 d 'oqeing)| B e bR jo onposd| 101 aa NS $09.6E8SPOSE00 NUD | Lt 2/
ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc_820_7.jpg 4 750458-398-60 1 solueduon [eopneseULRYY pegonuo) dsi e 0} pajuiad suofsinax . . g g & 8 2 Q 3 v i 8 ] 3 8 g 5 g s 2,z o = 89 o ﬂu./ 2Es ¢ GE H @ ZW, £85 M~ EC] £ FRES el f S sg 2 3 S, ¢ S @ i 1200k o) OT1 oyu Usssuer Aa Byl uinbpeg o 1onpoid| LO9BEEBSYOSEND NLIO
eccd8340-ead3-4363-8902-0c19d33aa2ac_548_1.jpg NDC 42023-105-01 L2601 AN 2BpiY 3nuassyy Jeonanaoeueyg seg :Aq paanquasig £0°0625TS0LY ] 80N Bus g sieUOGIE WNIPog SnospAuy (wnipos EIxe OB ) Bui 005 wnipog @TvLIAHE WINWEOS (aumeadua] Wooy pajeauo) ds #85) (ol £ Y 29] 0oGZ O Z USBMIE] 21015 SIN3NTI] 3354 OIIYISOI4310vE 35N AINO—SNOILIFHIA Suonesjsiunupe abesans [e1049s 10) [eusalew WAt UM —ININHVM ANESTHETIC BARBITURATE G Methohexital Sodium ,USP 1a Discard Unused Portion Brevital® Sodium For Injection 500 mg/vi Preservative Free — After 24 hours 500 mg Multiple Dose Vial
eccd8340-ead3-4363-8902-0c19d33aa2ac_548_2.jpg 3Ls8000¢ L0901 ,£2024 20062577901 ] Bui 051 S1U0GIEY WNnIpog snopALuy Bgz (aimesmdu (L2 93529) IL¥LSOIH3LIVE 35N KINO—SNOLLIIHIA 10} JeLsalew uaIINS SWEIIO)—ININHVM = Methohexital Sodium Brevital® Sodium NDC 42023-106-01 wonsour Buiguasasd [y 8g Hitbidi ¢ L2601 AN "2Bpid anuisayy (LINIPOS [B3IXBLOLA 3} wnipos @y1IAIHE WINWHOS i3] ooy p| pue uogeRsuLIpE Besop ‘sBeioss [euonppe SIN3NTIQ 3354 Suogensiurupe sberase (219405 UsP 2.5 g/vial ANESTHETIC BARBITURATE Preservative Free — Discard Unused Portion 2.5 g Multiple Dose Vial For Injection After 24 hours
ecd379b1-0cb2-413a-96d9-8b96e8e34eaf_693_1.jpg Pactoped by Eopast Reeck Bnbank. @A 9504 ONDANSETRON G "TE0LF:st HCL 4MG TAB 10 vELzy Store at room temp of Compare To: 20°25°C (68°77°F) ZOFRAN4MG TABLET- LB Keep all drugs outof Aurobindo Pharma Limited reach of children. #4 Exp: MMYY NDC 6362977811 077811121734 om
ed710c62-8ba6-4f19-b240-3ee73cd03d67_799_1.jpg No Varmished Area (Do Not Print) (18x50.5 mm) R Divalproex Sodium usvessorszrasne Delayed-Release e e Capsules, USP yreie 07 s (Sprinkle) i ety e for comelte prescrbing nformation. 125 m Store at20° 0 25°C (B8° 10 T7°F) [See. 9 USP Gontolo Room Tenportre Dispense in a ight, ightresistant conainer. n KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN Code No. GUIDRUGI1AB5 (Valproic Acid Activity) Manufactured by: DHARNACIST: Dispense the ledic Catla Healircare Lt provided separatly o cach patent. o ams RS e i
ed8079a1-670c-48fb-92ff-6e6ad51e6ad3_136_1.jpg NDC 68084-396-65 Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg 50 Tablets (5 x 10) Rx Only (LI 1 A (01) 0 03 68084 396 65 6 NDC 68084-396-65 Butalbital, Acetaminophen and Caffeine Tablets, USP 50 mg/325 mg/40 mg 50 Tablets (5 x 10) RxOnly Each Tablet Gontains: Ectalital, USF. 59mg Acstaminophes, USH! 538 mg Caftone, JSP omy Usual AdutDosage: o2 it sery oo 3 nescs Tolalcally oss shud ot sxcesd & ablets. Ses package meert for ol prescriong mformaton Slore 21201025 65 1o T axcrsons pormitd batwaen $5°1030°C (58 1o 66'F) fsse USP Controled Room Temparature. Koep this and al rugs outof reach of children. FOR YOUR PROTECTION: 00 notuss bister is foror broken. The drug product contained n this package i rom NBC # 56052544, Par Pharmaceutal Packaged and Diiruted by Amarican Heali Packaging ol Onio 43217 osasas 0239655/7070
ed8079a1-670c-48fb-92ff-6e6ad51e6ad3_136_2.jpg Buabial, utatial Ky 5§y Rt v Sty £ 1E BBl i £ o mung R emseceens, 0% 07 maemsmys R by e, vee e, voo iy BE égm T, % mg : £ o | 0B 5 il {61003 88084 396 FE W0 (o mgss0ed 38013 e B X g e St giing £33 S mie g 1 z d TR B2 e MR memusays, N8 97 prmemmny o ponmny Jor T - Hmasstigiimg 55 1 Somgszsmiiiomg TR fx o IR ol R € o on g R § 4 ;ﬁfagiazmyﬁmg i \} LT A - 30 mgi325 mgldo mg Wi @ymesmisars Lot ook Exp
ee1cd689-a622-4d84-b9a2-a9c841096e09_357_1.jpg nan
ee79a7fa-1c64-4b7b-822c-e0ddefc8ef86_695_1.jpg A st i LARIN"Fe IIETET (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP ‘and Ferrous Fumarate Tablets*) o arenlior | oo e [ T —— il LARIN Fe IR | | ARIN' Fe (TR LARIN FellEJET] | LARIN Fe BEER (Norethindrone Acetate and {Norethindrone Acetate and (Norethindrone Acetate and S M SR A Sy Esradl Teblet P Etiny| Estradiol Tablets,USP Ethinyl Estradiol Tablet USP Rl T and Ferous Fumarate Tablets*) and Ferrous Fumarate Tablets*) L T T o and Ferrous Fumarate Tablets*) | o ettt s T SRR e St = = - R R 1 2 i
eee37f88-ec6a-4c30-b8aa-e2c71f93088c_987_1.jpg 0078-0671-19 4 N 3 NDCO0780671-19 I, NOVARTIS Store 3t 25°C 77, excursions permited 101500 (5 0 7P, Eath tablt contans 356 mg apatin ltosyate equivalent to 250 mg apatinib. Dosage: See accomparyng presribing Information Important Use afety cosures when dlspensing this product uness otherwis diected by physclans orrequested by purchaser. . by: Gl Operations UKL Ware,Hontorenr, United Kingiom Dbt by Novars ramocatics Corp. ot Hanowe New ey 07938 Made n s 150 Tablets Ko 1000000146825 U A146825
eeee060c-a9ec-423e-a374-8484009f8524_421_1.jpg amg Hreaumn: = T et St it s BT R g e P o e i e s st oty g st e emle ol e s, o gy e crw: s emamat B g v i A —— ety sizwAoN By JNILWVIAH [ — 5| vty o g HYCAMTIN® ToPOTECAN FORINJECTION Novatis
ef29843d-d0ad-4de1-b1f5-c8d8a028829c_293_1.jpg oouoR ey B Rt HIOROGH FETERTE ph - TAKE 1 TABLET DALY ORASDRECTED.
efa111d5-ade4-4944-97e4-3c37b8b14ea8_220_1.jpg 75, VELLOWICLERR CAPSULE H 105 Indomethacin SR S 75mg Capsule % Takewith food & Store at room temp of Compare To: 20°25°C (68°-77°F) Indoch SR75mg Capsule "Keep all drugs outof | Hetero Labs Limed » __ reachof children. #30 Exp: MMYY ¢ INDC 7133507561 032011118033
efbdafa9-d18c-4e85-b4a2-1e620fc74e50_586_1.jpg Zydelig® Tablets Each tablet contains 100 mg ofidelaisb. Store between 20-30°C 68-86 ) with excursions permitted 15-30°C (5386 °F). Dispense only in original container. See package insertfor dosage and administration. Keep this and al medications out of the: reach of children. Manufactured for: Gilead Sciences, Inc. Foster ity, CA 84404 Madein Canada NDC61958-1701-1 60 tablets Zydelig® (idelalisib) Tablets DISPENSER: Each time Zydelig® | ispensed give the patient the attached Medication Guide. [ GILEAD 100817 = B 3 5 Reonly 2018 GlesdScieces nc
efbdafa9-d18c-4e85-b4a2-1e620fc74e50_586_2.jpg — e S s NDC61958-1702-1 60 tablets oo St v 2o30°C i (68-86 °F) with excursions ® - Lndier. Zydelig E Doy A e it = Seepackags nserlor (idelalisib) Tablets o b ot s ek g " Keep thisand 2 o R e P - e R . = i e = : T — PGy A hesnecnetedatonoe. KW ——————— Z
f01e56a9-847e-4a68-93d2-f8741d0ec71c_65_1.jpg ] §§’§E§§Q§E NOC 0093-7439-01 . %‘ifeﬁﬁ % Divalproex Sodium siag f Delayed-release é’firj 1 Tablets USP a3t g ;; 125 mg g o MR UetcsionGude o mcn e, 13 only 100TABLETS M = v
f01e56a9-847e-4a68-93d2-f8741d0ec71c_65_2.jpg PHARMACIST. Dispense the accomganying Medication Guide o each patint. e i3 §g NDC 0093-7440-01 =S §§§ Divalproex Sodium = it Delayed-release — if; TabletsUsP =: iz 250 mg — §g§ — — g §§ 1 only ' s I
f01e56a9-847e-4a68-93d2-f8741d0ec71c_65_3.jpg Divalproex Sodium Delayed-release Tablets USP PHARMACIT:Disers the sccompanying b e o e pta, NDC 0093-7441-01 500 mg Valproic Acid Actiey Each delayed-rlease tablet contains dhalproex ‘sodium equialent o 500 mg valproc 3. Do ot accept f seal over bottle opening Is S e i bk i Dt s . et osn core o e USP i ol ssan o (as required). KEEP THIS AND AL MEDICATIONS OUT OF -xm REACH OF CHILOREN. 323K30403091 North Wales. PA 19454 N 0093-7441-01
f01e56a9-847e-4a68-93d2-f8741d0ec71c_74_1.jpg g E 2 = o B2 - 52 28 = 3 22 @ DR . 28 2 x®w Ise ~ 852 _fes S 2 5 Beorgsieo 3 S=BE 25 S S22 g% g8 228« B33 Z QOQFr~ a2 GTIN 0030093743901 Eaoh delayed-relase tabet sontens dhlprosx sodum equialet to 125 mg vaproioacid Do nitaoeept sl aver botte opening isbisken o mising Dispense i ati contanea ened KEEP TH5 SDALL MEDICATIONS OUIT OF THE R Manutactured TEVA PHARMACEL 777402, rod For TEVA PHARMACELITICALS USA, ING. Horth Wiles, PA 10454 OF CHILDRER, N 3 0093-7439-01 B only Rev. G 8/2014 323K304000617 1 LOT o < )
f01e56a9-847e-4a68-93d2-f8741d0ec71c_74_2.jpg PHARMACIST. Dispense th accompanying Wedication Guide to each patie. Divalproex Sodium Delayed-release Tablets USP 250 mg Valproic Acid Activity E: onty NDC 0093-7440-01 GTIN 0030093740017 is broken Usual Dosage: See package insert for full prescribing information Store a 20° 10 25°C (88° 0 77°F) = & Dispense ina 2 a5 dofned P dlosure (as required) KEEP THIS AND ALL MEDIGITIONS OUT £~ OF THE REACH OF CHILDREN 5 TEVA PHARMAGEUTICALS USA, ING. m Morth Wales, PA 10454 o~ Y 0093-7440-01 - il LoT
f01e56a9-847e-4a68-93d2-f8741d0ec71c_74_3.jpg NDC 0093-7441-01 ivalproex Sodium elayed-release Tahlets USP 500 mg PHARMAGIST: Dispenss the accompanying Medication Guide to each patient. B only D D Valproic Acid Activity 3 2 g : 2 Each dekayed-releess tablet containg divalproex ‘sodlum equivalent to 500 mg valprok acid. Da not accept if seal aver bottle opening Is o0 packsge Insertforful 77°F) [See USP ure]. " with biack k. -resistant contaner a5 ‘achld-resistant TEVA PHARMACEUTICALS USA, ING. North Wales, PA 19454 W 0093-7441-01 & Rev. G 8/2014 323K304030117 100 TABLETS = 2 < = h= B 5 o R
f025900e-5d16-4614-93ad-7fe08a865458_953_1.jpg € N Each tablet contains: Dispense in a tight, light-resistant & Rz 57 025y ARG VN RT cortne s deedm e 9 2 6 ey, 8 ol o o el o b — Alprazolam me=wwe 2 b iy — Tablets, USP @ Storoat20° 25°C 68" 0 77°F). | = See USP Controled Room 2 sl Oi oK s Usual Adult Dosage: See accom- 2 SEc s | gk g PHARMACS Dispere the Necaon | This continer s not tended fo & g B Guide providd separately o each patient, | clapensing for housshold use. e—— Hedcation Guides may becbfaned £ [MMylan- *i=ie g g Myan Pharmaceuticals . T L Ll cegontoun, W 25505 US A
f025900e-5d16-4614-93ad-7fe08a865458_953_2.jpg Each tabletcontain: Dispense i a ight light-resistart s 05ms IR oo e 0 "2 =R CELIL T o Alprazolam [oomewme & outof th reach of chidren, Tablets, USP ([ s zeerumn. Temperature] Protect from light. Usual Adult Dosage: See accom- paming pescribing nformatin, [HARMACET Digere e Nedication | Thi contine i notntended for ide provded sepratly o sch patint. | cigpensingfo househald se Wedicaion Guides may be cbtained [IMylane s ecconsrccst Mylan Pharmaceuticals Inc. L I icgtonm, i 26505 U5 A
f025900e-5d16-4614-93ad-7fe08a865458_953_3.jpg Ench talt contin: Dispense i sght gt esitant = Rz 57+ g MKV cortane s dened e U5 % 2 wihg o chidressart e, 5 z AI razo I am Keep container fightly closed. pl Ko i et o mnton i Tablets, USP @ Shoret20" 0 25° 60 1077, [See USP Controlled Room Temperature.] Protect from light. i e Do S i e RTIGEE Do TGt | T ot o i e ne| | g ek el ey s [Mylane simss et Myan Pharmaceuticals . Rxonly 500 Tablets [EFSSNTIE=-IEY € 4 60=600%=-8/50 ¥
f025900e-5d16-4614-93ad-7fe08a865458_953_4.jpg / € = 10-200%=-8250 € Each tabetcontine: Alprazolam, USP 204 oty ooy Alprazolam Tablets, USP - ([ PHARMACST Dispees e accompanying Medicato Suid o schptien. [MMylan® R Dispense ina gt ightresistrt container a defnd i the USP usig a chidresstat osure. Keep conaine tight cose. Keep this and all medication outof the reach of chidren. Store at 20° o 25°C (68" o 77°F). [See USP Controlled Room Temperature] Protect from light. Usual Adult Dosage: See accom- panying prescring nformation. Mylan Pharmaceuticals In. Morgartoun, WA 26505 US A ([MMylan® RIMOOTAT Mylancom )
f05e00b3-25d1-4d96-a5d0-f6260b2507ac_812_1.jpg traMADOL ¢ Hydrochloride G Tablets, USP NDC 51079-991 -20 traMADOL Hydrochloride @ Tablets, USP (SUIE) Enin ot Vet somg el Do Ses et i AN SR 32 0 8 7P 6 V51 Contele o pértre] Mot ion Pammiat e gt 2655 U5 5 Masinfiersa [Mylan’ [ ssncon swoms
f05e00b3-25d1-4d96-a5d0-f6260b2507ac_812_2.jpg e bt
f07c0a35-fb5d-43a1-a33e-d6a51a5fcd77_965_1.jpg v S00mG. 7 TABLETS U
f0ee925d-fab9-49dd-8eb0-719ff2887531_38_1.jpg Batch 3000 Tablets Mg Exity To be repacked within six months from the dae of manufacturing DG 65862-207-39 BULK SHIPMENT PLEASE HANDLE CAREFULLY Rxonly Tablets 200 mg achim <osted et contain: i USP 200 CAUTION: FOR FEPRCKAGIG OLY Store at 20° 1o 25°C (68" 1o 77°F); excursions pernited to 1810 30°C (59710 86)[see USP Controled Room Temperature]. Manufetured by: Aurobindo Pharms Limited o |I|I|| | I Hyderabad-500 072, India 3 65862-207-39 5
f1076019-6f2c-4c90-9f3c-ab0c7cdd9315_797_1.jpg L. i | = 4 fmi = = L i B it A 3 | i 2 m .M_ nm_ 3= i | == ¥ { L P | o
f1076019-6f2c-4c90-9f3c-ab0c7cdd9315_797_2.jpg (™~ (levonorgestrelfethinyl estradiol tablets) 0.15 mg/0.03 mg | 2 i | | i | s h b e e ey TR Body e s-.-:::@ Jolssr (levonorgestrethinyl esradiol tabets) 0.15 mg/0.03 mg e 7 0 ) P ot Sepe TS MDA MECEATNS O T A& LA,
f108e431-f8d3-4442-8a60-bfc1d8a7bafc_468_1.jpg L og T ‘Ethacrynate iSodium 1 i for Injection, USP | | Ethacrynic Acid Equivalent | For Intravenous Use | | FOR THE PREPARATION OF | INTRAVENOUS SOLUTIONS [iMylan‘ Each vial contains: ettacrynate | sodium equivalent o 50 mg of ethacrynic acid.Inactive ingredient: 2.5 mg of mannitol To reconstute, add 50 mi of 5% Detross jecton or Sodium Chlorids njecion fc siow inravenous infction. Discard unused soluton after 24 ours Filld into contaer a5 a e solution, then cryodesiccated Usual Adult Dosage: 05mg to { mg ofethaciynic acd per kg of body weight, See acoompanying prescrbing information, Store at 20° 10 26°C (68° to T7°F). [See USP Controlled Room Temperature] Lo R T [Ethacrynate Sodium :for Injection, USP | | Ethacrynic Acid Equivalent For Intravenous Use |FOR THE PREPARATION OF | {INTRAVENOUS SOLUTIONS | Mot | Mylan isituonat LG | Fokdord, L6103 154, Moo 1 Caao: APIORUGSH0317
f16b14a2-297f-4adb-8d7a-5f43785faef7_44_1.jpg v = somG. = coTaBLETS
f1ac67b3-dfab-47af-8966-4727d1549054_939_1.jpg CLINICAL solutions WHOLESALE Glipizide 5mg Tablets NDC: 58118-0141-8 aty: 30 Mfg. NDC: 60505-0141-00 ‘GTIN: 0035818014181 Mig. Lot # SAMPLE123. Batch #: SAMPLE4S6 ig_By: Apoex Cor. Exp: 012010 Torot, K, anace, ML 170 SN: WMMDDO00OD0 Repcned anor Dt b it S Ui LLC
f1b24841-75a3-4eb8-8854-17ce832ff09d_741_1.jpg *EACH SOFTGEL (SOFT GELATIN NDC 51991-604-01 Protect from light. Protect CAPSULE) CONTAINS: from moisture. Vitamin D (Ergocalciferol) 1.25 mg 1 1 Dispensein a tight, equivdnt 1035000 USP Ui Vitamin D - paewpnon, gn:ngﬁggr?g‘?;y“l;enurv,\‘li?(?ﬁ ;s equivalent (Ergocalcﬁerol CAUTION: KEEP OUT OF DIRECTIONS AND DOSAGE: Capsules, USP) B"E ':)E‘ﬁ" u: Sl NN e padage st Pramcasme. WARNING: DO NOT EXCEED 100 Softgel goga Raton, FL 33487 RECOMMENDED DOSAGE. o i, Store at controlled room temperature psules Mig. by: Swiss Caps AG 20°25°C (68°-77°F). (50,000 USP Units) Rx Only ~Kirchberg, Switzerland [See USP Controlled Room Ternperature] Rev. 03/2017 o [JUIIIIIIINY - =Serecienridge Pharmaceutical, Inc
f1c077e5-6321-4519-b9bb-7718af9b62d6_950_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT. MAY CAUSE DROWSINESS. USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTNESS. CAUTION: FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG TC ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED. R WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN 8 DOSAGE and STORAGE: SEE PACKAGE INSERT 43063-554-18 ACETAMINOPHEN & CODEINE* 300MG/30MG 18 TABLETS ReOrder # 108825 LOT J18B50 EXP p3/20 43063-554-18 ACETAMINOPHEN & CODEINE* 300MG/30MG 18 TABLETS ReOrder # 108825 LOT 118850 EXP 03/20 43063-554-18 ACETAMINOPHEN & CODEINE* 300MG/30MG 18 TABLETS ReOrder # 108825 LOT ji8850 EXP 03/20 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 TAKE TABLET(S) EVERY. HOURS AS NEEDED FOR PAIN. TOME__TABLETA(S) CADA___HORA(S) COMO NECSARIO POR DOLOR Each TABLET Contains: ACETAMINOPHEN USP 300 MG CODEINE PHOSPHATE USP 30 MG *(WARNING. MAY BE HABIT FORMING) WHITE ORGANOLEPTIC MARKINGS: IP333 ROUND Q & CODEINE* 300MG/30MG 18 TABLETS PHARMACEUTICALS MINCORPORATED® L Oklahoma City, 0K » 73127 ACETAMINOPHEN (01)10343063554180 {21)J18B50000001 {17) 200331 (10)J18850 0B8TPSSEIOEVE OTEEDOZITSI JT1 AN 40 "WHVHd TVINWY
f1dc70f6-4329-46da-8990-7bd6eec9d37d_726_1.jpg NOC# 7161001360 Doxazosin, USP 2mg 90 Tablets
f1dc70f6-4329-46da-8990-7bd6eec9d37d_726_2.jpg Doxazosin NOC# 71610.0160-16 Doxazosin 8mg 6000 Tablets b S g M Aot Tocrt o Pz s rama __GdmmnER gy Doxazosin 8mg 6000 Tablets
f235ee45-9517-45de-8df7-9a06fdb43380_688_1.jpg Paroxetine Tablets, USP Tablets, USP s e Exch i ooat et s patetne T 0 NGSCEA B, Sttty 2 B 77 ManumcuRdr: Yt Pt e o 26608 S5 Wa i usia Em ao o T, e Bt 0 ngorpamme UtalD0sage: See s ganyg resiong 528 167 Dontated foom egarate] [MMylan’ | wencon Paroxetine m
f235ee45-9517-45de-8df7-9a06fdb43380_688_2.jpg e bt
f27f8c7c-ede6-4116-9b03-6be5357c35f1_944_1.jpg NDC 46672-092-10 Hydrocodone Bitartrate and Acetaminophen Tablets, USP Each debossed white tablet contains: Hydrocodone Bitartrate, USP.............. 2.5mg WARNING: May be habit-forming Acetaminophen, USP........ Dispense the accompanying Medication Guide to each patient Rx only Contents: 100 Tablets 325mg PHARMACIST: Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP. USUAL DOSAGE: See package insert for complete dosage recommendations. Keep this and all medication out of the reach of children. Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature]. Manufactured by. MIKART, INC. Aflanta, GA 30318 Code 1017210 Rev. 09/16
f34607bc-d4d3-4997-b4fb-1950efbc15ba_568_1.jpg s FL0Z @37ML)
f3b8e18e-d26e-4ae2-90f5-c01cc660ea4c_248_1.jpg CLINICAL solutions HEIE » o i Warfarin Sodium 4mg Tablets i 31 NDC: 58118-0033-8 ;gé i " e 0 o056 o omsarosss 155 Mig. Lot #: SAWPLE123 g SupLEee 58 Mig. By: Teva Pharmaceuticals USA Exp.: 0ct 2018 L North Wales, PA, USA, 19454 ay:30 Eg e Al e e { iy oy o D, S 515 v INSRTUSA. ot
f3b8e18e-d26e-4ae2-90f5-c01cc660ea4c_248_2.jpg CLINICAL solutions WHOLESALE Warfarin Sodium 5mg Tablets ay:30 Mg, NOC: 00083-1721-01 GTIN: 0035611004183 Mig_Lot : SAMPLE123 Batch #: SAMPLEASE Mig_By: Teva Phamaceuticals USA Inc Exp. 0ct2019 Noth Wales PA, USA. 19454 SH: YYMMDDOO0D00 Repacrad s et by it S sl LLC neandnmarenann
f3b8e18e-d26e-4ae2-90f5-c01cc660ea4c_248_3.jpg CLINICAL solutions 2 WHOLESAL? i Warfarin Sodium 6mg Tablets 35 NDC: 58118-0060-8 K 5§§ - i i 06 wss 7151 omcwosaroueon 155 ifg. Lot #: SAMPLE123 Bl £ SAMPLEASS 3 22 Mig. By: Teva Pharmaceuticals USA B 0ct2018 22 Nort Wales, PA USA, 19454 a0 3 e e Gty o s Wk LLC i iy it o B, G 515 P TSI A uons
f3b8e18e-d26e-4ae2-90f5-c01cc660ea4c_248_4.jpg CLINICAL solutions 8 WL i Warfarin Sodium 7.5mg Tablets £ NDC: 58118-0063-8 ;;i i g 105 oo 71901 e Mg, Lot #: SAMPLE123 Batch #: SAMPLE4S6. ;E; Mig. By: Teva Pharmaceuticals USA. Exp.: 0ct 2018 ot Wale, PA, USA, 19454 a2 £ : Ricpceas s teuge . il Sos ol LLC iy o o B, S5 P TSBET U s
f3b8e18e-d26e-4ae2-90f5-c01cc660ea4c_248_5.jpg CLINICAL solutions 5 WhLESALE i Warfarin Sodium 10mg Tablets 35 NDC: 58118-0064-8 ;g? e e I i 106 s 17201 ot 155 Mifg. Lot #: SAMPLE123 Bl £ SANPLESS 3 22 Mig. By: Teva Pharmaceuicals USA Bp: 002018 1% Nort Wales, PA USA, 19454 a0 3 : Rcpceas o it b Cirict Skos Ul LLC iy it o B, G 515 P TSI A uons
f41c04f9-33fb-47ae-a54d-a4292e559784_148_1.jpg PR 2 ORI —— e O o e APRLY TOAFFECTEDAREA STUESADAY ORAS DRECTED.
f455b415-12a2-4916-b826-246976a8af44_297_1.jpg NOC 71610014360 Gabapentin sf ci= 3001 90 l “‘;‘_ = img 90 Capsules 88 o1 3 S‘ Errere— = ""f.:z‘v’k';:" Gmevm"mmg KJCWM
f495b76d-96c6-48e5-8fa3-30a4336628eb_963_1.jpg *Each capsule contains C 0378-9040-05 cysteamine bitartrate equivalent 10,50 mg of cysteamine. CYSTAGON® (cysteamine bitartrate) : Capsules £ [PRERMACIST: Dispense te accompanyig Fatient |and Parent Information Leaflet to each patient. [MMylan® T e Dispense in a tight light-resistant container as defined in the USP using a chid-resistant closure. Keep container tighty closed. Keep this and all medication out of the reach of children. Store at 20° to 25°C (68° to 77°F). [See USP Gontrolled Room Temperature.] Protect from light and moisture. Usual Dosage: See accompanying prescribing information This container is notntended fordispensing for household use Mylan Pharmaceuticals Inc Morgantown, WY 26305 US A [MMylan® | wncon RM9040B5
f495b76d-96c6-48e5-8fa3-30a4336628eb_963_2.jpg € N 8 60-G%06-8.¢0 “Each capsule contains cysteamine bitartrate equivalent 10150 mg of cysteamine. Dispense in a tight, light-resistant container L e as defined in the USP using a child-resistant CYSTAGON® (cysteamine bitartrate) Capsules PAARIVACIST: Dispense the accompanying Patient Jand Parent Information Lealet to ach patient. [MMylan® 500 Capsules 12 E01\ closre. Keep container tightly closed. Keep this and all medication out of the reach of children. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light and moisture. Usual Dosage: See accompanying prescribing information. This container is not intended for dispensing for household use. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 US.A. [Mylan® | wyin.con RM9045B6
f4ae091d-9b74-4a0e-ac68-057effd91e17_669_1.jpg NDC 65862-783-30 Rxonly Esomeprazole Magnesium Delayed-Release Capsules USP am PHARMACIST: Dispease he Medication Guide provided separately . 2 AROBNDO P aten. s “Each delyed-release capsul conain: Esomeprazoie magnesium dinydate US? equivalnt o esomeprazole 20mg. UsualAdult Dosage:Sez package inert. Store8120° t0 25°C (8° 10 77°F)[se ISP Contrlled Foom Temperature]. Kesp container ity cosed Disbuted b Mage i india Aurobindo Pharma USA. . Goge TS/DRUGS 2272008 278 Princeton-Hightstown Aoad East Windsor, W 02520 * LOEC8) 29859 5N “Over printing Zone cotig Area PO B0
f4ae091d-9b74-4a0e-ac68-057effd91e17_669_2.jpg *Each delayed-release capsule contains: Esomeprazole magnesium dihydrate USP equivalent to esomeprazole 20 mg. Usual Adult Dosage: See package insert. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. 6586278378 '3 Keep container tightly closed. dispensed for outpatient use, a child resistant container should be used. This unit-dose package is not child resistant. If ||| N 3 (Dotted ines ot o be printed) UNVARNISH ZONE o AN L Esomeprazole Magnesium Delayed-Release Capsules USP 100 (10 x 10) Unit-dose Capsules 0866201 NDC 65862-783-78 Rx only Esomeprazole Magnesium Delayed-Release Capsules USP PHARMACIST: Dispense the Medication Guide provided separately to each patient. sa|nsdeg asop-iun (oL X 0L) 001 dSn sajnsde) aseajay-pakejaq wnisaufiey ajozeidawosy A‘?AUROBINL)O 100 (10 x 10) Unit-dose Capsules il Distributed by: Esomeprazme Magnesmm A:lsm’:li:;n P%arma USA, Inc. Delayed-Release Capsules USP 279 Princeton-Hightstoun Road m East Windsor, NJ 08520 Made in India 100 (10 x 10) Unit-dose Capsules Code: TS/DRUGS/22/2009
f4ae091d-9b74-4a0e-ac68-057effd91e17_669_3.jpg “Each delayed-release capsule contains: Distrbuted by: Made in India /2 AUROBINDO 30 Capsules Keep container tightly closed. 78430 Esomeprazole magnesium diydrate USP Aurobindo Pharma USA, Inc. Code: TS/DRUGS/22/2000 & NDC Ga8E2-784-30 e e o 279 Princeton-Highistown Road o — East Windsor, NJ 08520 o iy —— Esomeprazole Magnesium Usual Adult Dosage: See package insert —— & AR Delayed-Release Capsules USP lig 1o am Store a1 20° to 25°C (68" to 77°F) [see USP | | — PHARMACIST: Dispense the Medication CO"r0led Room Temperatur]. ! [pe— Guide provided separatly o each paient. | = *Over printing Zone Coding Area a5 15 mm) Dot s ot o e prtes
f4ae091d-9b74-4a0e-ac68-057effd91e17_669_4.jpg “Each delayed-release capsule contains: Distrbuted by: Made in India /2 AUROBINDO 30 Capsules Keep container tightly closed. 78430 Esomeprazole magnesium diydrate USP Aurobindo Pharma USA, Inc. Code: TS/DRUGS/22/2000 & NDC Ga8E2-784-30 e e o 279 Princeton-Highistown Road o — East Windsor, NJ 08520 o iy —— Esomeprazole Magnesium Usual Adult Dosage: See package insert —— & AR Delayed-Release Capsules USP lig 1o am Store a1 20° to 25°C (68" to 77°F) [see USP | | — PHARMACIST: Dispense the Medication CO"r0led Room Temperatur]. ! [pe— Guide provided separatly o each paient. | = *Over printing Zone Coding Area a5 15 mm) Dot s ot o e prtes
f4b2b88c-946c-4670-8538-84f858b7af33_429_1.jpg T D 69084-205.21 Extended-release Tablets 30 Tablets (3% 1 Fronly o ¢ o (07)00368084 29521 5. NDC 68084-295-21 GlipiZIDE Extended-release Tablets 30 Tablets (3 x 10) RxOnly Esch Extonded st . Usaa Dosage: S package nsr o1 presciong Inormaton Store a120° 10 257G (38" 1o 77°F): excirsions permited between 35710 30°C 680 56r)ee USb Catraad oo Tamperatrel Frotect i mosirs i oy Keep this and allcrugs out of reach of hildran. FOR YOUR PROTECTION: Do not uss bista or o broken. The arug productcantaned n s package s rom NG s BT0560; Atavs Pharma ne. Paskaged ana Disroutad by: e e Cackaging i, Oni 43517 u25my 205210 0229521018 .~
f4b2b88c-946c-4670-8538-84f858b7af33_429_2.jpg GlipiZIDE GlipiZIDE Efriedivoase Tabot 0 % Exerdsdrcioase Talt 25mg 88 3 § 25mg it | § T | WAL, 5% §s MMM, GlipiZIDE GlipiZIDE Bircedclease Tavlet =1 Celondad relesse Tablt 25mg 28 §f2smo 6B E; 55 g | 01) 3 saoea 95 1 0 £ 83 pyocscemsszs s GlipiZIDE GlipZIDE Exlrtedroloase Tablet £ ¥ Enrerelease Tablt S5 5§ £ 5hhe B ! gq 23 Hltgi | GlpiZIDE GlpzIDE I I 25mg 8§ §%35mo } e | g 2 g WA, 2% 53 GlipiZIDE GlpZIDE Exbrasd-roloase Tablel ExBrdsclolease Tablet 25mg 25mg 0105 sa0m4 253 11 5 o) 0353084 58 1 5 oaee s oovcee 101
f4b2b88c-946c-4670-8538-84f858b7af33_429_3.jpg NDG 68084-111-01 ‘GlipiZIDE Extended-release Tablets 100 Tablets (10 x 10) RxOnly [ 1 T0E T (01) 003 68084 111 01 3 NDC 68084-111-01 GlipiZIDE Extended-release Tablets 100 Tablets (10 x 10) RxOnly Each Extended-Release Tablet Contains: Gipizaa Ler. s5mg Usual Dosage: See package nsert for ul prescrbing nformation. Store at 20° 1025°C (6810 7°F) excursions permited between TE15 30°C (53¢ 1 8 fs2e USP Contolies Room Temparaure. Frotéet from moisira and rumty. Koop this and all drugs out of reach of childron. FOR YOUR PROTECTION: Donol use f bister & torn o brcken. The dhug product contained i s package i fom. NBC'S G108t Actavis Prarma. ne Packaged and Distrbuted by Amarican toaith Packaing Columbus, O &3517 110010 o2rm0iDE e ——————
f4b2b88c-946c-4670-8538-84f858b7af33_429_4.jpg GlipiZIDE gipzIE EErdeaireloase Tablt enedelease Teblet 5mg I o) 003804 17112 i I Il d s, oo 107 o R GlpzIoE SlpizioE e wease Tablet 0 i 5 EErdiaroloase Talet Smg 28 % § §mg i ERLE e N, gy gs AN Gipizioe SlpizioE SR ease Taiet Smg mg £ % mma foloaso Tablat £ o 0000 107 o) ) I o sos e 117 112 07) 003 6a0e4 11112 Gipizine SipiZIDE ElGealease Tabet £ 1 5 Enerdareieasa Talt 5mg 88 3 § 5mg it e 2 o f mig g szl DI F S R SlpiziE SlpizIDE Sindodrocase Tabel £ Sibhdsdoloaso Tt Smg 58 {fsmg g § : i . g 83 enesmssrine B8 33 oymses iz
f4b2b88c-946c-4670-8538-84f858b7af33_429_5.jpg NDC 68084-112-01 GlipiZIDE Extended-release Tablets 100 Tablets (10 x 10) Rx Only [HI0 1 E (01) 0 03 68084 112 01 0 NDC 68084-112-01 GlipiZIDE Extended-release Tablets 100 Tablets (10 x 10) RxOnly Each Extended-Release Tablat Contains: Glipzise USP 10mg Usual Dosage: Se packaga inser for (i preseribing information Storeat 20° 1925 68" 10 77*F); excursions permited betwen T5°10.30°C (53" 10 86°F) see USP Controles Room Temperaturel, Protect from moistre and numidty. Keep this and al drugs out of reach of hildren. FOR YOUR PROTEGTION: Do not s f biste s fornar broken. Thedrug proguct contained n this package s fram NEC s G5 0535: Aetavs pharmat ne. Packaged and Disrbuted by Amencan Halh Packagng Columbus, O 43217 112010 ozrzovi0e
f4b2b88c-946c-4670-8538-84f858b7af33_429_6.jpg GiiZIDE GipiZIDE DG rosso Tt =1 % 5 SkoaGoaroloaso Tkt oy R s §q 25 pnt ¥ £l (07) 003 68084 11211 9 ¥ @~ @onoosssoes 211 cipzpe cipape IO cessoTablet £ F 5 AR caase Tabiot 10 mg g § § 10mg ¢ R 1 ¥ & 1 5% gr sl lotsoatoaarizris EE 53 onomsmmeniznns cippe spzpe S reemse ot @ % brdairiens Tabet Soma 2§ §p%ome I B sl 0 o ga0ea 112115, & 83 ohovsanniizno aipzE sipizpe SR oo Tobet £ 3 ARGl Tablet o mo 2§ §§'ome — §§ 3 (o) aus s 1211 5 83 oyt gipzE aipzpe SN esse Tavet @ % SAbREreesse Tt i 5§ %3 Tt £ 5 MR
f51ca007-3955-4540-a88a-0ddae8d8e8ab_506_1.jpg Each tablet contains: Distributed by: NDC 65862-601-01 Woafini UsP 100 mo. Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Rx only Usual Dosage: See package insert Modafinil for full prescribing information. Made in India oaatini Tabl USP Code: TS/DRUGS/22/2009 ablets, Store at 20° to 25°C (68° to 77°F). m WV [See USP Controlled Room ~ ,—cccceem P1421859 . Temperature.] * PHARMACIST: DISPENSE THE MEDICATION GUIDE | PROVIDED SEPARATELY T0 EACH PATIENT. . e 5 ! Dispense in a tight container as | /52 AUROBINDO 100 Tahlets defined in the USP. *Over printing Zone Coding Area (45 x 15 mm) Dotted lines not to be printed
f51ca007-3955-4540-a88a-0ddae8d8e8ab_506_2.jpg Each tablet contains: NDC 65862-602-01 viagaiiil Usp 200 mg. Disbitaly; Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road Rx only East Windsor, NJ 08520 o Usual Dosage: See package insert for ful i Modafinil prescribing nformation. Sy e Code: TS/DRUGS/22/2009 Tablets, USP Store at 20° to 25°C (68° to 77°F). [See =----=------ EUEIS e ; m @ USP Controlled Room Temperature.] * PHARMACIST: DISPENSE THE MEDICATION GUIDE 'PROVIDED SEPARATELY TO EACH PATIENT. Dispense in a tight container as defined in /A2 AUROBINDO 100 Tahlets the USP. *Over printing Zone Coding Area @5x 20 mm) Doted lnes not to be printed
f562ab1a-adb9-4154-81cd-ceb480234331_643_1.jpg 304657-08 Aq porodel b €0-€0.-858¢1 € 91820 I ‘A3uanoy “d"1 S[EOINSJBULIEY SAPOUY 25880 N ‘Uopouny yinowuoy .uc_mémiezumam 10} paanjoeynuey 1906 | Vd ‘ufmujoog 971 *Blydieped-$e0uaiog Juatjonn q painjoejnuel| "NIUQTIHO 40 HOVIY JHL 40 1N0 NOILYOIGIW TIV ANY SIHL 43D “[anjesadusa | wooy pajjosu09 dsn 2as] (4022 03 4,89) 52 01 9,02 12 21018 S12|je} 8u} ysnio 10 maijo30u 0g S0y I o ens “UogewIojul Buiquasa Buifueduwoooe sag :abesoq [ensn “aunaxosed Bu G'Z| 0} juajeanba apuojyooiphy augexosed :surejuo jajqe} Paje0o ouajua ‘aseajos PapualXa Yoeg ine . 30 Tablets NDC 42858-703-03 Paroxet Extended-Release Tablets, USP Guide to each patient PHARMACIST: Dispense the accompanying Med
f562ab1a-adb9-4154-81cd-ceb480234331_643_2.jpg S €0-60£-8582Y € 91820 1y ‘Auanog “d"1 SeonnaoBLLELJ SapOUY :Aq payeeqy 25880 N ‘Uonounp Lgnowuo *0U| BULIBYJ 81N09105 110} painjoejnuep] 19061 vd ‘uimoog 304656-08 OT1"eydjapey "NIHQTIHD 40 HOV3Y JHL 40 1N0 NOLLYDIGIW TT¥ ONY SIHL d33) “[anjesaduia] wooy pajjonuog dsn 2es] (4022 03 4.89) .52 0} 9402 1€ 21015 “S|a[qE} ) ysnid 10 MY J0U 0Q "3JOYM SJ[GB} MOJ[EMG “uonjeuuojul buiquosald Burfuedwoooe asg :abesoq [ensn “aujaxosed Bul Gz 0} juajeninba apuojy0spAy aunaxosed :sureju0d Jajqe} Pajeod oLa)ua ‘aseajal PapuUaIXa yoe3 ine . 30 Tablets NDC 42858-705-03 T s 3 5 g = s 8 § 2 2 5 3 /U Paroxet , Extended-Release e 25 2% - 83 RE Qg %S, I Ma £c 58 25 ;
f562ab1a-adb9-4154-81cd-ceb480234331_643_3.jpg €0-,0/-8982 91820 I4 ‘Auaroy 4" SfeogfisoeiLLBld SBpOLY L :hq pajaxey 26880 N ‘uonounp LpNOWuUoW *0U| BULIRYJ BINDBIOS 304659-08 110} paINJOBJNUEBH 9061 Vd ‘ufmyjoog 1 ‘Blydjepeyud-seoualos Janonp :Aq painjoenuely "NIHOTIHD 40 HOV3Y JHL 40 1N0 NOLLYJIQ3W 1TV ONV SIHL d33) Joame.adwa) wooy pajjonpuog dsn 9as] (4£2 04 4589) 052 0} 907 12 21013 “513]qe} 3y} ysnio 10 MBL J0U 0 "BJOYM SIB|GE} MOJ[EMS “uonjewJojul buiquiosad Buikuedwoooe sag :abesoq [ensp “aunjexo.ed bw g ¢ 0} juajeainba apuojyooiphy aunaxosed :suiejuoa jajqe} Pa}e0d oLajua ‘aseajal PApUa}Xa yoeg . ine 30 Tablets isp NDC 42858-707-03 Paroxet _Tablets, USP Guide to each patient Extended-Release accompanying Meication des. PHARMACIST: Rh
f5c25553-1546-451d-8069-c0f484c47741_472_1.jpg Raloxifeno Hydrochioride Tablets, USP. 30 Tablots (3 x10) (0TI T AR (01) 0 03 60687 266 21 3 O] Raloxifene Hydrochloride Taviets, USP EOERES) PHARMACIST: peee T T sccompamig i aion Goids o s patnt S Costed Tabie Contais: Filoxans hyarocnionc somg Useal AduliDosag aonpackage T s g Store 512010 25° (8" to 7] sxcursons permi 2R O e R oo el Kaep this and aldrugs out of each o children. FOR YOUR PROTEGTION: 00 not se Bister s orn o boken. Rxonly Tne drugorodut conained n s packege s fom NDC A 69057455, Cpa USA I Packages an Dsviute by e Voo Bagiagng 722 o, B 4351 ouzseziions
f5c25553-1546-451d-8069-c0f484c47741_472_2.jpg Ralotans Hydrachioride Raloxfens Hydrochioride Taviah UsP Taoia, USP 60 mg §0mg B i Tt it {o1) 0036087 250 114 0900300687 208 114 o s Lot oo Expiy: ot oooeet 107 Raostens Hyachrida [ — e cp g e &my gf §§ g A il 2] & i I# it 5 | pssoraons B3 &3 ol ocmrnnis Roloons s Rasfene ydachiorde Sanited co g T g B fEdm gr Bzl 1 lomwarnts 35 3 oty Roloens s Rasfene ydachore s cn oz TATE g Bl g t foEr o e ] onmesras s A% 53 wpmmmeis RaosfonsHycochioids Rabxtons yctocniorce Tablet, USP i Tablat, USP il & &g opoc s Expiy Lot xoeoos s g I I
f618a091-ade1-4c39-ab76-f6218b606e05_67_1.jpg Pashaged by Eryane Reanch Biabank. 04 91500 5 VHITE OVAL 728 Hydroxychloroqui S ne Sulf. 200mg Tablet = & store at room temp of Compare To: 20°25°C (68°77°F) Plaqueni| 200mg Tabet “Keop all drugs outof Cadila HealthCare Inc. reach of children. #100 Exp: MMYY NDC 7133508971 033431121095 om
f63c325a-1de1-48a8-bd6b-8d521b51405c_404_1.jpg £ IININVINYT 3SIVI = o, = Tz, s F5 on JE5 S Lo = 3 . D m 23 2 == g% 8 = <t =533 g ZEs —_— o83 S cEg BRI TS W USONS, mm HT LIGHT RESISTANT s INER AS DEFINED IN THE USP AL i o S uLc £2 B b 8% 57237-0075-30 8 mn 144D rasers 85z ONDANSETRON & 4mg g exe: MM 8 h 00179024744 LIININVINYI J3SIV
f63c325a-1de1-48a8-bd6b-8d521b51405c_404_2.jpg L IININVINYId ¥3SIVI oy NDC 00176 - 02482 [FOR INDICATIONS, DOSAGE, PRECAUTIONS, ETC, SEE FULL DISCLOSURE BOOK. Distributed by Kaiser Foundation Hospitals, Oakland, CA 94621 ONDANSETRON 8mg Rx ONLY STURE AT 68 10 77°F, EXCURSIONS PERMITTED 10 83° TO 86°F DISPENSE 14 A TIGHT LIGHT RESISTANT CONTAINER AS DEFINED IX THE USP BROTECT FROM LG T DIST BY: CITRON PHARMA LLC EAST BRUNSWICK. N 08816 57237-0076-30 1440 rasLeTs ONDANSETRON 0 wor: M — 18011 o000 o 00179024844 LIININVINRIE ¥3SIVI
f68aa10b-d6bd-4fb4-a652-fad85efdaabd_253_1.jpg NDC 68180-730-09 “Eachi-coatedtabetcortans rosuastatacakiumequtabet o osustata . Usial Dosage: See acconganyng prscibing omain. £ Sarage:Sore a75°% 175 excsirsprtos a 015630 59136 e U5 CorackaRoom g s Tenpasure, rcetron e, 3 Keto s nd A madestons . f e s f * PHARMACIST: DISPENSE WITHPATENT e, FORMATION LEAFLEYPROVIDED ! SEARATEA To AEh RTIENT e o Ve Ll Phamacoutls, b, LupinLiniod | Rx only dinor, Nanfnd 2200 Nagar 441108 90 Tablets v Sas o LUPIN uL x00000¢
f68aa10b-d6bd-4fb4-a652-fad85efdaabd_253_2.jpg NDC 68180-731-09 10 mg”) PHARNACIST: DISPENSE WITH PATIENT INFORMATION LEAFLET PROVIDED SEPARATELY TO EACH PATENT. Rx only LUPIN 90 Tablets “Eanfimecosadtibbtoonians roswastacakumocunakintoroswastai 107, Usut Dossge: Ses acssmpnyng rescrting - womatn. 1 Storage: Store at25°C (7T encursions peritoq S 101530 (5970 85 se2 USP Contoles Room B Tomperaee]Proloctommostre, = Kesp tis and o medcatons o o te rezch of enleren, —_— Nanactro o Nantscuroq vy, E— Lupin Pharmaceutical, e, Lupin Linieq Emmmmmmmmt Baltmore, Varyland 21202 Nagour 441108 ) Unic States oK g wL oo 58
f68aa10b-d6bd-4fb4-a652-fad85efdaabd_253_3.jpg NDC 68180-732-02 *Ezch film-coated tabletcontains rosuvastatin calgium equivalenttorosuvastatin 20 mo. Usual Dosage: See accompanying prescribing information. » Storage: Store at 25°C (77°F); excursions permitted to (20mg 15 10 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Protect from moisture, PHARMACIST: DISPENSE WITH i IO cenpyKeop his andal mecications outofthereachaf chlren. PROVIDED SEPARATELY T anufachred (o Mantactured by EACH PATIENT. Lupin Pharmaceuticals, Inc. Lupin Limited Rxonly Balmare, Veryland 21202 Nagour 441 108 DI 500 Tablets e st LUPIN we B
f68aa10b-d6bd-4fb4-a652-fad85efdaabd_253_4.jpg NDC 68180-733-06 W PHARMACIST: DISPENSE WITH PATIENT INFORMATION LEAFLET PROVIDED SEPARATELY TO EACH PATIENT. Rx only LUPIN 30Tablets “Eaenineosestablscontans roswasttncabium oouhakr o oswasta €0 g. Usual Dosage: See sccompanying preseioing - ermaton, — Storage: Siors 125°C 776, excursionspernitted s 101510 30 5910 85)[see USP Contlled Room =™ Tompratrol, Protetrommoisrs, Keep tis and ol medicatons ot of the each o ehlen, Wanutactuad o Manttactred Lupi Prarmacestcas e, Lupin Linfed Batmore, Narand 21202 Nagour 441108 Unied Sies Holi . oo
f6d10c2f-f1fc-465a-ab9e-ca839a8b51bc_807_1.jpg AVOID ALCOHOL WHILE TAKING THIS PRODUCT. MAY CAUSE DROWSINESS. NDC 43063-631-90 USE CAUTION WHILE PERFORMING TASKS REQUIRING MENTAL ALERTRESS. CAUTIOR: FEDERAL LAW PRUHIBITS THE TRARSFEK OUF THIS DRUG TO ANY PERSON OTHER THAN TO WHOM IT WAS PRESCRIBED. R v WARNING: KEEP THIS OUT OF THE REACH OF CHILDREN ol DOSAGE and STORAGE: SEE PACKAGE INSERT ONI ‘HOAL-MAH (WL TR HIRIi 1 i M -00000001 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 TAKE __ TABLET{S|EVERY__HOURS AS NEEDED FOR PAIN. TOME _ TABLETA(S)CADA__HORA COMO NECESARIO POR DOLOR. ORGANOLEPTIC MARKINGS: WHITE ROUND/BISECT K 18 90 TABLETS Each Tablet Contains: OXYCODONE HYDROCHLORIDE USP 5 MG *WARNING: MAY BE HARIT FORMING) 43063-631-90 43063-631-90 43063-631-90 i oxyCODONE oxyCODONE oxryCODONE i HCL USP CL USP HCL USP E== 0 CODONE gos'rrggms ms'ﬁl.m 9os'rn:gw'rs 3 = xx REORDER #109047 REORDER #109047 REORDER 4109047 53 = Hoor LOT [18B09 LOT [18B09 LOT 118B09 = g EXP 09/20 EXP 09/20 EXP 09/20 £ SMG =5 i ; | IV PD-RX NET ITEM # 109047 LOT# 118809 LOT: 118809 10810020401
f6d3d076-fc15-4178-b159-4100fc39066e_396_1.jpg (10 mL Single-dose NDC 0409-5921-09 Rx only | Each mL contains aminophylline (calculated . - Amlnoph!“l“e as_the dihydrate) 25 mg (equivalent to lniectinn, us 19.7 mg/mL of anhydrous theophylline). 250 mg/10 mL (25 mg/mL) Protect from light. DO NOT USE IF CRYSTALS HAVE SEPARATED FROM SOLUTION. May contain an excess of ethylenediamine for pH adjustment. pH 8.8 (8.6 to 9.0). Sterile, nonpyrogenic. Discard unused portion. == For intravenous use. Usual dose: See insert. == Mfd. by Hospira, Inc., Lake Forest, IL 60045 USA NOVAPLUS® R
f6d3d076-fc15-4178-b159-4100fc39066e_396_2.jpg \ gedoss Rxony NDCOMS5521-10 | ‘ 10 mL soge Cntains 25 of NDC 0408 552109 Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) [ et 1L US A @SNIdVAON T (1uw/Buw Gz) Jw o1 /B 5z dsn ‘uonaaluj aujAydouty e om0 Ao s quigy | ] cA-7001
f77885b2-a006-4c29-beae-6e8be81ac2b1_926_1.jpg NDC'60760-:981-30 Spironolactone Spironolactone Spironolactone Spironolactone Spironolactone allels USP Tablls USP Tablts USP Tablels USP Tablets USP o 25mg 25mg 25mg 25mg 25m 3 al v QTY: 30 Qry: 30 QTY: 30 g & RX# 0000000 RX# 0000000 RX# 0000000 RX# 0000000 QTY: 30 @ NDC 60760-981-30 NDC 60760-981-30 NDC 60760-981-30 NDC 60760-981-30 LOT# XXXXXXX g LOTHXOXXXX LOTH XXXXXXX LOT# XXXXXXX LOT# XXXXXXX EXP XX-XX EXP XX-XX EXP XX-XX EXP XX-XX EXP XX-XX RX# 0000000 MANUFACTURED BY: Mutual Pharmaceutical Co_Inc. Philadelphia, PA 19124 USA TAKE AS DIRECTED PACKAGED BY: S e, St. Mary's Jiglary 3 10560 MAVINEE DR, === OROVALLEY, AZ85737 MANAGED PHARMACY PROGRAMS Rxonly STORE AT CONTROLLED ROOM TEMPERATURE 15°- 30° C (59°-86°F)
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_1.jpg Y G3HSINYVANN VMY dX3 3 10T L0222y Lcll0 9L02/L1 s0-5201 rers vo pr o g (X mm@ w@ MhP mmm _ Suwn £ mSR.U £2 5 3% SE%Y s $ £E3 D g5 B & Fg2 E 5: 2% o 6% g5 5 a XE& O E£ Sg 2 EWU N EEES
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_2.jpg MU NDC 0115-1278-01 QIHSINEVAND VY dX3 B 10T 2pt sl i 9L02/LL A3y S0-9201 spaj3d asvoapopuens s sunidiots L ge S0 ainsdss 3 e (% TONE) MMP mm E Sowv g2 “weEd £z T 25 £33% B2 8 EBS o i 3 aga E 2% =% o= Q ££% 5O Oxrmo EI°Sg =Wy m EEES
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_3.jpg D J3HSINYVANN V3HY dX3 B 101 8102/10 °sSI Lo-Lize 516 v prefe Soueueg xedul :4q 0 Buissiu o uaoxq st dea sapun [oas Aiajes pajupid 1 asn 1ou og amsiow pueyybi worj aoig aimeaduus) wooy pajjonuoy S 995] (4,22 01 1.89) .52 9 0. ansofo JeuEoo “pamay a1 LON pinoys sajnsdea oy ‘opeutiop Buguosaid aduoa 10 s Buyueduoos 908 39Y500 TYNSN “syed ose auydiow Bu gy ‘su) o 2 (X mm@ w@ £9p iz E _Sou £z MSRU £z 9T g5 © §ET P 2 2 5 g8 £ 528 CO...P B 50 a XK O £ °g 2 SWV + EEES \|
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_4.jpg QIHSINHVAND VMY dX3 3 10T SLlLo 9L02/LL “hay 50-6201 oy v Py St edul 10°180 Sulfate Extended-Release Capsules, USP C 50 mg I NDC 0115-1279-01 Morphine 100 Capsules £ £ Rx only
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_5.jpg S GIHSINMVANN VAUV dX3 B 1O , —__ _ q__ _____ ____ z 9L02/LL S0-2801 P oy s s o oy oo Bkoose 863 Y500 14 s apuaes sy Suydio Bu 0g suiios Ssdes 3 2 (% £3S 1 (D £3p 5 E -~ 300 g2 MSRU 2z TP EEY s w £E8F O 2 3 5653 E B -5 g Sk&e EIGg 2 Swu 9 EE &S
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_6.jpg 5 A QIHSINYVANN VIV dX3 B 101 ___f__u—_r __ _(_ _ m L 9102/LL “nay 50-5801 weoug 3 des sapun 633 s o o Buunduiosos 25 3000 NS spad s papuas 2 s Suydio B gg susy mm@ £ (3 MEP wmm _S3a i3 5 wed 22 T 0B 3% 8B i s w £2F O 2 3 EEERE 525 g S%&o EESS £ SwUw iE&S i ‘\l
f7e9a4b3-a2ee-4f0a-becd-6ef90867332b_675_7.jpg QIHSINYVANND VAU X3 B 107 SLLO 9102/1L “A3y 50-956 2 (R § mm@m@ § £9p 5 E 38 W B2 52 3g8 i g5 ev, i3 SESES0 nE: & w=5ERSE 2f 2 ﬁeman e gz 5¥do 2228 Sz 9%xrmo EE So 2EEEWU = EEES
f845fac9-5ca8-40e5-b316-a748508380e6_634_1.jpg Diclofenac ojEEEE Potassium 50mg Tablet B0EYTT " Keepall drugs outof Compare To: reach of children Cataflam 50mg Tablel Siore at room tempof | Won Plarmaceutiabine. | 20-25 C (68-T7F) #20 Exp: MMYY ¢ oo 7iassodes |0iosiitdavs. |
f8d16c85-50e2-4d99-afae-6fb902734e42_662_1.jpg Rl gy USUALDOSAGE: S pcoeet. Depemern st e Stome ot w25 @ w1 e U5 Gt o - ety rcee NDC 43547-414-10 R only ST Lisinopril QeI 100 Tablets
f8d16c85-50e2-4d99-afae-6fb902734e42_662_2.jpg S ™ ow NDC43sT-415-10 Reonly | i o it S i S gt oty e e ks [y . L Once-Daily Lisinopril Tablets, USP 100 Tablets
f8d16c85-50e2-4d99-afae-6fb902734e42_662_3.jpg ol T jomg [ e —— Dopenern st e Stome ot w25 @) e U Gt o e pimae P rom e, ety rce e NDC 43547-416-10 &unly (oL I Lisinopril Tablets, USP 100 Tablets
f8d16c85-50e2-4d99-afae-6fb902734e42_662_4.jpg USUALDOSAGE:Sepcteeet. Depemern st e STome ot w25 @) iU Comtet o -, ety e NDC 43547-417-10 [ Lisinopril Tablets, USP 100 Tablets R only
f8d16c85-50e2-4d99-afae-6fb902734e42_662_5.jpg EAGH TABLET CONTAWS: Lisiope, USP mg USUAL DOSAGE: See package isert WARNING: Keep this and al drugs, outof reach of chidren. Dispense na ight contaner. STORE 2t 20° 0 25°C (68" 0 T7°F) see USP Contrlled Room Temperatre] Protect from mosture, freezing and excessive heat. Manufactred by ‘Soko Heahcre US, LG by, 08512, USA Rev. FEE0D a2 NDC 43547418-10 R only Once-Daily Lisinopril Tablets, USP 100 Tablets
f8d16c85-50e2-4d99-afae-6fb902734e42_662_6.jpg EAGH TABLET CONTAMS: Lisinoprd, USP. T NDC43547419-10 Reonly | USUAL DOSAGE: S package nset. 5 WARNING: Keep this and al drugs Once-Daily outofreach o niren, S . Depere ma ot coname. Lisinopril STORE 2t 20° t025°C (68° 0 TT°F) Tablets, USP see USP Contrlled Room Temperatre] Protect from mosture, freezing and excessive heat. Manufactred by i S R FER0G olco” 0404702 gﬁ“’_ 100 Tablets
f94ae052-5d59-4750-aab7-1fdb989503aa_574_1.jpg € N i o i o [FISTRVITO DRI ocperce naton. gt resent Felodipine, USP 25mg s 5011-01 container a defined i the USP § S o using a chilg-resistant ciosure. Keep container tihtlyclosed. £ e o |p| ne Keep this and all medication = out of the reach of children. B Store at 20° o 25°C (68° to 77°F). Extended-release ise comvoed noom Tablets, USP Temperature ] Protect from light. Usual Adult Dosage: See accompa- nying prescribing Information. F Tablets should be swallowed whole, not crushed or chevied. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S A [Mylan® [MMylan Rxonly 100 Tablets Mylan.com 10=-1106=-8/2¢0 &g g8 g4 6 T S AECEVEVCRVCRNY NI
f94ae052-5d59-4750-aab7-1fdb989503aa_574_2.jpg 7 \ P ey _ o s AR e wz Felodipine, USP 5mg Rl 1 container as defined in the USP using a child-esistant closure Felodipine imimmsene., RM5012A: out ofthe reach of children. s Store 3t 20° 10 25°C (68° 0 77°F). Extended-release i3 tamaid oom Temperature.] Tablets, USP Protect from light, Usual Adult Dosage: See accompa- nyingprescribng Information. Fie “Tabiets should be swallowed whole, - notcrushed orchewed. Mylan Pharmaceuticals Inc. Morgantown, Wy 26505 U.5 A (I Mylan® [MMylan® Rxonly 100 Tablets Mylan.com '
f94ae052-5d59-4750-aab7-1fdb989503aa_574_3.jpg N Each fim-coated tablt contains: Dispense In a iht, ght-resstant 2 Felodipine, USP 10 mg Rl Rkl container as defined in e USP & = using a chig-resistant cosure, 3 Keep container tighty osed. = e o Iplne Keep this and all medication = out of the reach of children. 7 Store at 20° to 25°C (68° to T7°F). Extended-release [See USP Controlled Room Tablets, USP Temperature.] = T Protect from light. o== 884 g Usual Adult Dosage: See accompa- —_— nying prescribing information. W é E g g I3 Tablets should be swallowed whoke, —— 9 gg g not crushed or chewed. o= i _— Mylan Pharmaceuticals Inc. = i i = £ (lMylan® g Y [MMylan® w i Rxonly 100 Tablets Mylan.com
f99ebf66-f207-4a97-9666-4da1d72b061c_962_1.jpg . DT BB YION S[ERNIEULIEYY LIEAD epeues Jo Lol EpEUED /7] 96 G PEquIlS 2] ‘RUONEWIRIT| S[EINNIIEULIEY EDEA :Aq paunysenuely VSN £0880 [N ‘s23emadpug D71 E21RWY IO S[EANGSEULIPYJ WEAEA 140} panyoEnuELy 4N/ Ut PP St 12U umsisa-1yBy 3D © U1 asuads 4,98 © 93,51 @ paBILLE suosinoe 57 3 2,035 98eI00S “UBAPIIYP J6 U7 Jo an0 doay st afeped posopua 935 ‘uoneiol Buiquosa.d uesiodu U0 pUe SUOREPUBLILIOSAI 9BesOp [UOPPE 104°3I0PO J¢ PUE S[ESW 10J3q ‘AEP © SN 40 g sajnsde> owa 10 uQ aBes0Q INPY eNsn by @ ZWazz E |3 fegsk i5 .au.xmum s 82E¢ L W.munm s S fgrEe m > 2 B c - m =3 i 9% u B & o= ® © .m.m % o S o' ws E o Mmm RS D Lt 2 EER o 05 5 B 8 55 5 KRS z =1 © RS 81700-20001772
f9aa7dd7-e407-41d8-b0bf-c29c8787bd3d_819_1.jpg Pachaged by Eopant Reech Benbank. €4 91504 Thyroid 1 Grain G " mouow:is (60mg) Tablet 10 vEE9TT Keep in light resistant Compare To: container perUSP Armour Thyrok 0mg Tablet "Store at room temp of | wrrssie | " o006'C ga77R) #60 Exp: MMYY & NDC 7133506711 043681116334
f9aa7dd7-e407-41d8-b0bf-c29c8787bd3d_819_2.jpg Packbaged by Eryant Ranch Buabank. A 91504 Thyroid 1/2 grain g *o""®x = (30mg) Tablet 10 899971 Keep in light resistant Compare To: container perUSP Amour Thyroi 30mg Tablet "Store atroom tempof | Acella Pharmaceuticaks LLC . 20-25 C (68-77F) #30 Exp: MMYY 5 NDC 7133506721 045561116668
fa0b0881-97f3-4ca2-bc15-0954293081db_966_1.jpg Pacbaged by Eryant Rench Biabank. ¢4 91500 5 YELLOW OVAL 50 Naltrexone Hel g 50mg Tablet | B & Store at room temp of Compare To: 2025 C (68-77F) Revia 50mg Tablet Keep all drugs out of Intas Phamaceuticals Limited 5 reach of children #30 Exp: MMYY 3 NDC 7133500141 053041113256
fa5ebedb-069c-4a1e-9a25-b6fa957e6c2b_864_1.jpg carse99ia byt ALBUTEROL SULFATE INHALATION SOLUTION 063mg’ 063 mg*/3 ml. 25 Vials Sterle UnitDose Vals For Inhalation Only SR, EPLI G LR GG : e ¥ PR 3 . B = HE i : ‘ AIV4INS 10¥ILNETY L ] L r ] t ‘ E F -uggp %! r NOLLTIOS NOYIY VNI F 1| rocome9iss [ ALBUTEROL SULFATE INHALATION SOLUTION
fa5ebedb-069c-4a1e-9a25-b6fa957e6c2b_864_2.jpg [ ‘ Wyt ‘ ALBUTEROL SULFATE INHALATION SOLUTION 125mg | zsng/ink 25V | " Stetile UnicDose Viels For Inhalaton Orly PR G KT [ O NS TOHLEIY e cszesasio i -Augzl . I3 NOLLTIOS NOLIYIVHNI B ‘ AVANS TOYILNETY ‘ N wagonsa A \ ™ ATBUTEROL SULFATE INRAATION SOIUTION
fa69eeb8-ec82-4be1-8cb7-f64094ed957c_264_1.jpg Triamterene and exyesmspmomins Hydrochlorothiazide, USP 25mg o H yd rochlorothiazide - uzse o et cosee Store at 20° to 25°C (68° to 77°F) Ta b Iets ; U s P E;:e egts'z mrg;?ued Room Temperature]. Dispense in a fight, light.resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Keep this and all medication out of the reach of children. Manufactured by: Cadia Healthcare Ltd Maloda, Ahmedabad, India 100 Tablets bistributed by: Zydus Pharmaceuticals (USA) Inc. i Rxonly Pennington, NJ 08534 841207034
fa69eeb8-ec82-4be1-8cb7-f64094ed957c_264_2.jpg 68382-857-01 Triamterene and Hydrochlorothiazide Tablets, USP 75 mg/50 mg 100 Tablets Rx only Each uncoated tablet contains Triamterene, USP. 75mg Hydrochlorothiazide, USP 50mg Usual Dosage: See package insert for complete prescribing information Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] Protect from light Dispense in a fight, light resistant container as defined in the USP using a child-resistant closure. Keep container tightly closed. Keep this and all medication out of the reach of children. » Manufactured by: 4 Cadila Healthcare Ltd. 3 Matoda, Ahmedabad, India & Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534
fb67e8c7-b817-4253-a1a1-5ecdcee694cf_55_1.jpg Each capsule contains Ranitidine . = hydrochloride, USP equivalent to n 180/mg of Ranitidine: NDC 27241-109-06 60 Capsules Protect from light. Replace cap Bridgewater, NJ 08807. Bony Usual Dosage: See accompanying Ranitidine securely after opening. Made in India Code No. : MH/DRUGS/AD/018 product Information. Capsules Dispense in tight, light-resistant Storage: Store at 20°C to 25°C container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. (68°F to 77°F) [see USP Controlled Marketed by : Room Temperature] in a dry place. Ajanta Pharma USA Inc. 3005003 ajanta OPZ Area 29 x 26 mm 3lim27241110906!0l5 ) Lot Exp.
fb67e8c7-b817-4253-a1a1-5ecdcee694cf_55_2.jpg Each capsule contains Ranitidine hydrochloride, USP equivalent to 300 mg of Ranitidine. Usual Dosage: See accompanying product Information. Storage: Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature] in a dry place. Protect from light. Replace cap securely after opening. Dispense i tight, light-resistant container. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Marketed by : Ajanta Pharma USA Inc. Bridgewater, NJ 08807. Made in India Code No. : MH/DRUGS/AD/018 3005005 n NDC 27241-110-03 30 Capsules Ranitidine Capsules R ony a]anta 27241 1 1OD3|
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_1.jpg LR s Carvedilol Tablets, USP EEm @ Ny Carvedilol Tablets, USP & ] Ech i cones et cori: Eatic (57 a1 ng o e T Soeatineo % i 77 hee i o et Foom eyeiatie) Froect fom gt mostre Cote R4 Naupcumoti oy P11 acaatca e [ o i [MMylan’ [ieneen st
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_2.jpg e bt
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_3.jpg LL Rk Carvedilol Tablets, USP ; LRk Carvedilol Tablets, USP EEr ] Each i oxad et G e 525 ng st Gotage S g et i aton P e et S a1 20°T 26 5 0777, AR IS ontaned hoom eyeiatie] Frotct fomgitand ot Conetn LPTAEN AT ManBoUR: Yt PR 1 o 2580 1S5 a e [Mylan [uuncen s
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_4.jpg e bt
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_5.jpg Carvedilol Tablets, USP & Carvedilol Tablets, UsP (BT 1 AN Fucon ] Esh i ocad et o Caegi (5 12500 o e T Somat it G e 77 e 8 o ened Foom eyeiatue) Froect fomightand mastre Cate AP TFLEN 74 Neuctmo oy P11 acautca e BN 2686 LS. Ma it [MMylan’ [iencon st
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_6.jpg e bt
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_7.jpg e Carvedilol Tablets, USP ¢ [ Carvedilol g Tablets, USP C [ ] Each i oxas et o Caetio e 20y sl Gntage: S xngonyi o o e et SO ar20°T 26 6 077 a8 00 ontaned hoom ayeiate] Pt fomgitan moistre. ConeDLPIREN AT ManuBeuRar: oyt Pt 1 Mo 25508 LS5 ek e [MMylan’ [iencon st e
fbbab179-d1eb-48a6-8e2b-1c71606fe50d_407_8.jpg e bt
fc942fc9-7c8b-485f-b9e5-66f21caba7e7_27_1.jpg NDC: 63629-7619-01 PENICILLIN V POTASSIUM 500mg Rx Only 40 Tablets Lot 17102A1 Usual adult dosage. Seo package insert Store at controlied room temporature. 20.25 G (5877 F) Mig For CitronPhama LLC East Brunswick NJ 08816 MG NDC: 725704105 Mg Lot PESOI7I0A Dist by Bryant Ranch Burbank CA 91504 11/20 1N a18 w9 3 63629
fcb081e9-4d0b-4863-8178-05958c43d998_284_1.jpg NDC 42192-113-60 Sodium Sulfacetamide 10% - Sulfur 4% Cleansing Pads In a vehicle containing Green Tea and Aloe Rx Only 1 cleansing pad » Net weight 3.7 g Acella PHARMACEUTICALS, LLC Idicaions: For e toicalconol o acne vlgars, e o208 a0 seborneic. dermalts Ses package et forfull pescibig rfomalon Directions: Washafcte areas with Soclum Sufcetamics 10% - Sulur 4% Cleasing Pacs o o wie dlly, or 25 2 Wet Socium Sufacelamide 10% - Sufur &% Cleansing Pa wih walerand wor nfo ull e 3. Cleans facewih Sodum Sufacetamide 0% - Sullur % Clansing Pad for 10 -2 seconcs, avoldng ees. 4 Fise horoughlyandpat . 5.Discard ad. Do ol ish. ‘Warnings: For extermal use only. Kesp ou of reach ofcrilren. Avod conact it yes. ‘Contraindications: Sodium Sulsceamids 10% - Suur 4% Cleansing Pads are coiraingicaled for use I atetshaving Known hypersensiiviy 1 Sulfnamices, sl or any ofner component of s pregaraton.Sodium Sufacetamice 10% - Sulr 4% Cleansing Pas ar ol 1o be used by palfents win Kidhey iscase. ontens:Sud e (0% 300 sl 4% Other Ingredients: e et oo <oy e 0 oamico VA ulosae gee eaextact et alcono) eyl il gt sl e 10 et et b, gy praten, 0l o e, 312 e gl g i ot ot EDIA, magnesm ‘akiminim ilcae, arthan qur, Sodim eyl cocot i, Whiteperolatum. Storeat 15°- 25°C (59° - 7T°). Ssons o oo e s ot e et st st et St a Book product, No representation s mat as to generi stas or bioedquivalency. Plessesee package nser fo mafe fomton. Manufactur For: Aol Pramasaulcs, LLC 9005 Wesisice Parokay At 6A 30008 18005414802 374219211360 2 e 0510
fcb081e9-4d0b-4863-8178-05958c43d998_284_2.jpg 1 NDG 42192-113-60 Sodium Sulfacetamide 10%- Sulfur 4% Cleansing Pads TVovbivi In a vehicle containing Green Tea and Aloe Rx Only 60 cleansing pads e Net weight 3.7 g each Acella PrasAGEUTEALS, LG NDC 42162-113-60 Sodium Sulfacetamide 10%- Sulfur 4% Cleansing Pads NDG 4219211360 Sodium Sulfacetamide 10%- | Sulfur 4% Cleansing Pads irections: Wash affected areas with Sodium Sulfacetamide Sultr 4% Cleansing ads onceorbice dly or a5 kb jou physcan, with water. Sodium Sulfacetamide 10% - Sulfur 4% Cleansing Pad cter and work nto 2 ul vt i i i i |3 Cleans e wih S 0 Rx Only | Grnsing P 1 10-20 seconds, aoioing s ! oo i i i Indications: Forthe topical contl o s s, ane rosaeea and seborhle Storeat 16° - 25°C (58° - 77, ol See pakage et ot pessing momaon: % i " | Contraindications: Sodium Sulfacetamide 10% - Sufur 4% Cleansing Pads are S contraindicated for use in patients having known hypersensitivity to sulfonamides, sulfur 3 e eSO S hepaton S SUTaaTle % U 5% | R G (e o 1 Crage Book poduct. In a vehicle containing Green Tea and Aloe e im Sulceamide 10% - Sullr 4% | Cleansing Pads ar ot be used by palers WithKidey diseas. cy. Plese sce package nset or more s Doroury and e Gomtens: S sl 10% snd sl %, Othor ngrednts: e 5. Discard pad. Do not flush. sodium cocoyl isethionate disodium oleamido MEA sulfosuctinale, green tea extract, e | Manufactured For: 60 cleansing pads © Net weight 3.7 g each Acella PHARMACEUTICALS, LG lcohol, sl aieo. hosol S and PEG 100 st el patzn, Brop S o e o g S s Qg TR fools ramiceea, LLG | magnesfum aluminum silcao, xanthan gur, Sodum methyl cocoy taurate, white 50009 g RS Acella PHARMAGEUTICALS, LLG Warnings: For extemnal use only, Keep out of reach of children. Avoid contact with eyes. I
fd085485-998d-42a3-879a-b2d96cb8aed7_544_1.jpg NDC 0270-0083-20 CHOLETEC" NONRADIOACTIVE Kit for the Preparation of Technetium Tc 99m Mebrofenin R &%wmmmwmmummmn.wmmm)mm ucrde dyetale Sy 2170200 10 g ksl Bn, Madmum (as Slannus fuorde didrio, SiFa2H,0) and nof moee hian 5.2 mg melhy!paraben and 0.5 mg propyiparaben as presenvatives, pH wh sociue hydeodda or hydeochior ankd por to lyophilzatan. The pH of e reconetited producl fs 4210 57 Disager Sea nsert + Diagnostic - For Intravenous Use - Multidoss - Stare at 20.25°C (§8-7T°F) [Se0 USP] before and after reconstitution « Use within 18 baurs aer reconstitution List 0e20 Manactured lor uHMHI" e by Jubrlant HolsterSbar LLC " l Spokane, WA w207 USA B73081-HO4
fd085485-998d-42a3-879a-b2d96cb8aed7_544_2.jpg 10 vials INTRAVENOUS + DIAGNOSTIC « MULTIDOSE List DEJ?D\ CHOLETEC® NDC 0270-0083-20 Kit for the Preparation of Technetium Tc 99m Mebrofenin Rxonly Store a1 20-25 °C (68-77 °F) [See USP] before and afer reconstition 0" Technical information Use within 18 hours after reconstiution (GalR 00 257.5) Y pjoceoveaness [ NNINAMIN €01)30302700083200(30) 1 CHOLETEC® voummooncve Kit for the Preparation of Technetium Tc 99m Mebrofenin Fos praparationof vt To 99 mobrcfnin o hpaislary g S st Vil coteris ara sl unor e s mulios roscin vl iz 2 e, enpyageic hophiod poucer attmoof mandactes Tho i o proaie o 48 g mebobri, 056 (i) s e iy, oot pchet 4257, S, 240 103 gt 0, maxiu as stamous o o, Dosage:Sos st 1, 240), a v an 5.2 g ey ard .58 prapyraben a8 osoatv; pH e with o Py o oo e o hizaton. Meruotos o Ercco iagpostcs Mervoe Tup. NJ 9831 by Jbtan HolisterStr LLC. Sgolane, WASR20T USA - EremseHos
fd56674a-841d-4263-91c2-c7d1f2f17a9e_866_1.jpg Metoclopramide G "rruew:uz 10mg Tablet | I & May Cause Drowsiness Compare To: Reglan 10mg Tablet “keep all drugs outof Waton Pharma Private Limited 5 reach of children #30 Exp: MMYY 3 INDC 7183508221 016181114325
fd56674a-841d-4263-91c2-c7d1f2f17a9e_866_2.jpg 5, CREEN(Ightgreen) ROUND WP1 Metoclopramide 9. 5mg Tablet 10 Store at room temp of Compare To: 20-25 C (68-77F) Reglan 5mg Tablet Watson Pharma Prate Liied #30 Exp: MMYY INDC 7133508281 043901110499 WMay Cause Drowsiness om
fd79c41e-b0e9-47dc-a3ce-caacdc66bc96_800_1.jpg NDC 16714-400-01 Cefuroxime Axetil Tablets, USP 250 mg* *N ORTHSTAI;'(" 20 Tablets *Each film-coated tablet contains: Cefuroxime Axetil USP (amorphous) equivalent to 250 mg of cefuroxime. See package insert for Dosage and Administration. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Replace cap securely after each opening. Keep this and all drugs out of the reach of children. M.L.No.: 78/MD/AP/96/F/B/R Product of India Revised: 01/2018 Manufactured for: Northstar Rx LLC Memphis, TN 38141 © 2005 NorthStar Healthcare Holdings UC. Manufactured by: Aurobindo Pharma Limited Chitkul (V)-502 307, India. P1418972 Over Printing Zone (45x 15 mm) Dotted lines not to be printed
fd79c41e-b0e9-47dc-a3ce-caacdc66bc96_800_2.jpg NDC 16714-401-01 Cefuroxime Axetil Tablets, USP 500 mg* 20 Tablets *N ORTHSTAB'(“ *Each film-coated tablet contains: Cefuroxime Axetil USP (amorphous) equivalent to 500 mg of cefuroxime. See package insert for Dosage and Administration. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15°to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Replace cap securely after each opening. Keep this and all drugs out of the reach of children. M.L.No.: 78/MD/AP/96/F/B/R Product of India Revised: 01/2018 Manufactured for: Northstar Rx LLC Memphis, TN 38141 © 2005 NorthStar Healthcare Holdings UC. Manufactured by: Aurobindo Pharma Limited Chitkul (V)-502 307, India. P1418974 Over Printing Zone (45x 15 mm) Dotted lines not to be printed
fd9b0d5b-c54a-40a6-a79f-10ae952eecf2_279_1.jpg I gos3 NDC 55154-9580-5 ENOXAPARIN SODIUM INJECTION 100'mg /1 mL 5x 1 mL SYRINGES SINGLE DOSE SYRINGES WITH AUTOMATIC SAFETY DEVICE FOR SUBCUTANEOUS INJECTION Each Syringe contains 100 mg Enoxaparin Sodium Injection derived from porcine intestinal mucosa in Water for Injection, Dosage and Administration: For subcutaneous injection See product insert for dosage information, directions for use, prescriing information, precations and warnings Each 0,025 mL graduation equals 2.5 mg Enoxaparin Sodium Injection STORAGE: Store at 25° C (77° F); excursions permitted to 15-30° C (59 - 86° F) [see USP Controlled Room Temperature] RXONLY WARNING: This Unit Dose package s not child resistant and is Inended for Institutional Use Only Keep out of reach of children. FRESENIUS KABI Manufactured for Fresenius Kabi USA, LLC Lake Zurich, IL 60047 Origin Singapore Distriuted by Cardinal Health Dublin, OH 43017 L5170881-10318 LOT # XXXXXXXXXX ~ EXP.DATE: XX/XX/XX Distributed by Cardinal Heath Dublin, OH 43017 1517088120318 Directions for Use of Enoxaparin Sodium Injection Single Dose Syringe with Automatic Safety Device: 1. Remove the needie shield by pulling it straight offthe syringe. I adjusting the dose is required, the dose adjustment must e done prior to injecting the prescribed dose to the patient. 2. Inject using standard technique, pushing the plunger to the bottcm of the syringe. 3. Remove the syringe from the injection site keeping your finger on the plunger rod. 4. Orienting the needle away from you and ofhers, activate the safety system by firmly pushing the plunger rod. The protective siseve will automaically cover the needle and an audible "click” will be heard to zonfirm shield activation. 5. Immediately dispose of the syringe in the nearest sharps container. NoTE: The safety system can only be activated cnce the syrings has been emptied. Activation of the safety system must be dne only after removing the neede from the patients skin. Do not replace the neadle shield after injection The safety system should not be sterilizec. Activation o the safety system may cause minimal splatter of luid. For optimal safety activate the system while orienting it downwards away from yourself and others.
fda2d3a2-0914-4ab1-8517-8a2029a25403_344_1.jpg 43063-433-60 43063-433-60 43063-433-60 glyBURIDE glyBURIDE glyBURIDE & usp usp usp g 5 MG 5 MG 5 MG = 60 TABLETS 50 TABLETS 60 TABLETS . ReOrder # 104546 ReOrder # 104546 ReOrder # 104546 E é LoT J18F03 LoT J18F03 LOT J18F03 é @ EXP 02/20 EXP 02/20 EXP 02/20 2 < CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. 2 YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088 e TAKE__ TABLET(S) TIMES A DAY. g TOME TABLETA(S) VECES AL DIA. S Each TABLET Contains: 5 MG GLYBURIDE USP L"J 5 c & BLUE NDC: 43063-433-60 3 PD-Rx PHARMACEUTICALS INCORPORATED" Oklahoma City, OK = 73127 glyBURIDE USP ER\Y (€ 60 TABLETS e (01)10343063433607 (21)118F03000002 (17) 200228 {10}i16703 LO9EEPEIOEYE O O OO T0VSEGEG000 NI VSN YINNYHC VAL
fda2d3a2-0914-4ab1-8517-8a2029a25403_378_1.jpg 43063-433-60 43063-433-60 i glyBURIDE glyBURIDE 433;%{;'%96%0 USP Usp Usp 5 MG 5 MG 5 MG 60 TABLETS 60 TABLETS 60 TABLETS REORDER #104546 REORDER #104546 REORDER #104546 LOT I18F34 LOT 118F34 LOT I18F34 EXF 08/19 EXP 08/19 EXP 08/19 CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO FDA AT 1-800-FDA-1088 TAKE_TABLETIS)__TINES A DAT, TOME__TABLETA(S) VECES AL DIA. ORGANOLEPTIC MARKINGS: OBLONG/SCORED GLYBUR BLUE -00000001 L Il e NTTACH LABEL HERE < ITEM 4 104546 LOT# 118 IR LOT: 118F34 EXP: PD-RX NET NDC 43063-433-60 PD-Rx PHARMACEUTICALS INCORPORATED® Oklahoma City, 0K « 73127 olyBURIDE USP )t 60 TABLETS Each Tablet Contains: 5 MG GLYBURIDE USP VIONI 40 .10Nnaodd M 10¥9€6£6000
fdb134dd-90dc-44d4-8c41-8af97fb6b1e9_520_1.jpg Packbaged by Eryant Ranch Buabank. A 950G Oxybutynin 5 e v - Chloride ER 10mg Tab. 522971 Keep all drugs out of Compare To: reach of children PO el Store at room temp of LannetCompany, e 2025 C (68-77F) #30 Exp: MMYY NDC 7133506691 054841116225 om
fdccb7bd-6eb5-4bc2-b4f5-b49608df479f_183_1.jpg G " GlPdE i TBLETS i e 0% o Sttt Ry THKE TBLET DALY o ORASDRECTED. s " wonrs e ooner
fdccb7bd-6eb5-4bc2-b4f5-b49608df479f_183_2.jpg = ., R ‘olabE s TEEE —— e O L R T TAKE 1 TABLET DALY ORASDRECTED. g e wnars e ooner
fe790439-85d4-4cd8-a385-149ea3442a38_437_1.jpg NDC70771-1030-9 Diltiazem B, o o0 Hydrochloride UsifDusg: o g et Extended-Release e Store at 20° to 25°C (63° to 77°F) Caps u | es’ U SP [See USP Controlled Room Temperature] Avoid excessive humidiy, Disperse in ightresstan, fght cortainer @ED inchidresstontsurs KEEP THIS AND ALL DRUGS OUT Once-A-Day Dosage OF THE REACH OF CHILDREN. 90 CAPSULES Menufactured by: 77 zydus Foconly, B . 2180 ey
fe790439-85d4-4cd8-a385-149ea3442a38_437_2.jpg Dilti azem Each capsule contains Diltiaze m Hydrochloride, USP..... 180 mg Hydrochloride Usual Dosage: See package insert for EXten dEd- Release complete prescribing information CaPSUIes, USP Store at 20° 10 25°C (88° to 77°F) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 : [See USP Controlled Room Temperature] 1 Avoid excessive humidity. 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 0 mg Dispense in light resistant, tight container with child-resistant closure. Once:A-Day.Dosage KEEP THIS AND ALL DRUGS OUT - OF THE REACH OF CHILDREN. Manufactured by: zyd"s 90 CAPSULES Cadila Healthcare Ltd., pesetents Rxonly Ahmedabad, India 2H80 ey
fe790439-85d4-4cd8-a385-149ea3442a38_437_3.jpg £ ‘l““ 62¢0LiLel0d Diltiazem Hydrochloride Extended-Release Capsules, USP Once-A-Day Dosage 90 CAPSULES Rx only Each capsule contains Diltiaze m Hydrochloride, USP.... 240 mg Usual Dosage: See package insert for complete prescribing information Store at 20° 10 25°C (88° to 77°F) [See USP Controlled Room Temperature]. Avoid excessive humidity. Dispense in light resistant, tight container with child-resistant closure. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India 2480 ey
fe790439-85d4-4cd8-a385-149ea3442a38_437_4.jpg f?p zydus Diltiazem Hydrochloride Extended-Release Capsules, USP 300 mg Once-A-Day Dosage 90 CAPSULES Rx only Each capsule contains Diltiazem Hydrochloride, USP....300 mg Usual Dosage: See package insert for complete prescribing information Store at 20° 10 25°C (88° to 77°F) [See USP Controlled Room Temperature]. Avoid excessive humidity. Dispense in light resistant, tight container with child-resistant closure. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. 2180 ey Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India
fe790439-85d4-4cd8-a385-149ea3442a38_437_5.jpg Diltiazem Hydrochloride Extended-Release Capsules, USP Once-A-Day Dosage 90 CAPSULES Rx only .?p zydus Each capsule contains Diltiazem Hydrochloride, USP.... 380 mg Usual Dosage: See package insert for complete prescribing information Store at 20° 10 25°C (88° to 77°F) [See USP Controlled Room Temperature]. Avoid excessive humidity. Dispense in light resistant, tight container with child-resistant closure. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India 2180 ey
feb9f3f3-f910-4936-8cde-60e1b8cf76bc_947_1.jpg NG 4, o i et —— S TR nlsige o s o e i v o U oty y A g o, DG S s o o bt - e Ko L o Ramie prt b i 06 E HEATED. o s e sy XCAAT o e cns B i 0wl e, n w5 S BN, 500 U sl conpe Syt e oot ot o e 9 S o A e et g e AgE 1Y CONPRNY —A\_ gt sy soe STAR 1X 75668 » 006:656-3485 e A e
ff8f652b-2555-494b-b822-ecf6d668c593_385_1.jpg Benztropine Mesylate 2 mg Tablet arv: 30 ID #: EP;138 Expires: NDC #: 70518-1470-00 Shape: Round LOT #: Ref #: 76385-0105-10 MFG: Bayshore Pharma, Short Hills, NJ 07078 RX ONLY Directions For Use: See Package Insert Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [See USP] Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 1-724-465-8762
ffbf7573-c726-42f6-bbd5-5d2533d8288f_789_1.jpg wz St s o Al E;mi:&}}:a@‘?:;;:&’?@ - Diclofenac e E 3 Sodium e e oo Extended-Release sweoat2ntozc 077, = Tablets, USP e il oo o ek ] ' Temperatie] o 917 Protect from light and misture. b PR E 100 mg Usual Dosage: Sec acoompaning = ¢ HAICST Do T smparng | Pescri o —0 55 : edcsion G sy, ts i — . " ‘ (Mylan [Mylan- g T Myiancom
